data_2rqs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rqs _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.545 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.593 0 CA-C-O 121.764 0.793 . . . . 0.0 112.142 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.84 138.36 45.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.569 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.445 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.9 mtpt -108.87 97.82 7.4 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.494 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.734 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 1.9 t -135.34 179.88 6.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.555 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.444 ' OG ' ' CD2' ' A' ' 36' ' ' PHE . 2.4 p -134.75 162.44 32.34 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.441 ' C ' HD12 ' A' ' 15' ' ' ILE . 12.3 p-80 -136.55 148.57 47.65 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.566 HD12 ' CE2' ' A' ' 36' ' ' PHE . 1.6 mp -130.74 154.14 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.675 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.455 ' HG ' ' CD2' ' A' ' 91' ' ' HIS . 2.5 mt -137.32 135.4 37.04 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.552 ' CG2' ' HG3' ' A' ' 22' ' ' GLU . 23.3 m -149.2 134.27 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.589 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -35.92 74.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.979 0.419 . . . . 0.0 110.323 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.582 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 37.2 pttt -72.13 79.66 0.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.474 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 12.1 pt20 -45.62 -26.28 0.59 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.867 -1.061 . . . . 0.0 112.441 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.17 -31.75 75.25 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.975 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.582 ' HG2' ' HG3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -69.36 -42.84 74.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.013 0.435 . . . . 0.0 110.238 179.178 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.526 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -47.64 -38.3 14.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.279 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.41 -31.93 64.14 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.667 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.76 -52.93 8.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.068 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 30' ' ' LEU . 19.9 m -50.12 -46.69 24.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.68 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.53 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -54.07 -36.36 63.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.549 . . . . 0.0 109.955 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.53 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -72.84 -47.15 48.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.43 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.9 -23.18 44.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.146 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER -52.87 -47.63 67.69 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.768 0.318 . . . . 0.0 111.293 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -72.01 -9.42 58.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.386 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.27 -23.24 46.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 111.333 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.45 -12.47 3.24 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.399 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -75.08 153.8 38.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.797 0.332 . . . . 0.0 110.605 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -87.57 131.2 34.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.979 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.566 ' CE2' HD12 ' A' ' 15' ' ' ILE . 5.0 t80 -48.8 -49.52 38.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.013 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.65 -34.22 55.78 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.051 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -57.38 -53.59 56.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.943 0.402 . . . . 0.0 110.358 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -53.59 -29.93 39.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.393 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.48 -53.7 34.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.697 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.76 -23.74 27.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.81 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.506 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.17 -68.38 0.42 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.506 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.29 -12.21 9.44 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.559 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -63.84 128.81 37.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.91 0.386 . . . . 0.0 111.216 -179.502 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.475 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.15 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.88 0.372 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -68.12 -14.2 62.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.23 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -104.81 24.71 11.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.728 0.299 . . . . 0.0 110.405 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.5 OUTLIER 60.53 24.28 13.95 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.143 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 59.53 19.89 49.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.69 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 m -63.6 83.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.925 0.393 . . . . 0.0 110.677 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.734 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 16.5 mt -63.78 -24.06 67.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.882 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.04 -160.88 8.47 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.817 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.479 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -67.28 111.54 4.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.868 0.366 . . . . 0.0 111.783 -179.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.545 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 8.1 m-30 -119.05 156.64 29.32 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.27 -173.96 15.64 Favored Glycine 0 C--N 1.317 -0.501 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.431 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -75.53 80.0 2.55 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.99 0.424 . . . . 0.0 110.182 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.15 36.94 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.956 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.97 -43.11 1.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.623 0.249 . . . . 0.0 111.396 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.54 167.47 9.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 0.0 111.26 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.517 HG23 ' CB ' ' A' ' 68' ' ' PHE . 29.1 m -56.93 160.29 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.626 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.522 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -56.5 -48.19 97.55 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.57 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 20.7 Cg_endo -66.89 -36.26 23.85 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.062 1.842 . . . . 0.0 112.205 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 93' ' ' ILE . 15.5 t80 -74.88 -51.0 15.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.588 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.8 -32.39 60.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.839 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 1.6 m-20 -65.75 -53.15 44.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.886 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.11 -9.15 58.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.87 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.02 -36.81 78.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.613 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 3.0 p90 -107.06 16.79 23.8 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.81 -28.18 13.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.76 0.314 . . . . 0.0 110.879 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 80' ' ' VAL . 3.2 mt -103.47 63.57 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.213 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -70.83 -18.27 62.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.05 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.45 -26.92 40.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.559 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.05 57.59 1.21 Allowed Glycine 0 CA--C 1.502 -0.733 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.74 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.54 175.92 9.14 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.746 0.308 . . . . 0.0 111.114 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.43 ' O ' HD12 ' A' ' 75' ' ' LEU . 41.6 t -81.33 145.9 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.918 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.16 164.11 12.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.162 0.505 . . . . 0.0 111.54 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -50.73 153.73 2.72 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.967 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 18.1 Cg_endo -59.27 105.5 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.361 2.041 . . . . 0.0 111.799 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.57 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 97.5 t -101.33 119.21 49.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.783 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.437 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -103.35 112.69 25.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.006 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.51 -171.7 1.9 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.276 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -60.33 -18.04 47.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.025 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -89.69 -40.79 12.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.424 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.66 -158.81 29.05 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.801 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -82.11 98.14 8.53 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.455 ' CD2' ' HG ' ' A' ' 16' ' ' LEU . 34.6 m80 -84.22 170.1 14.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.044 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.5 t -146.22 153.04 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.692 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.542 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -143.11 122.36 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.578 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.506 ' CB ' ' CD1' ' A' ' 36' ' ' PHE . 13.8 tptp -128.88 116.88 20.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.127 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.408 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -57.33 133.99 55.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.533 0.682 . . . . 0.0 112.231 -177.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -154.55 116.54 4.21 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.744 -1.117 . . . . 0.0 109.573 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.451 -1.194 . . . . 0.0 112.636 179.892 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.684 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.586 0 CA-C-O 121.634 0.731 . . . . 0.0 112.112 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.427 HD12 HG21 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -120.23 139.51 47.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.499 178.417 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.438 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.2 mtpt -110.88 99.27 8.2 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.434 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.732 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 2.2 t -129.98 -179.76 5.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.7 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 2.8 t -118.79 163.58 16.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -138.39 141.02 39.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.136 0.493 . . . . 0.0 111.821 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.509 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 4.5 mp -151.47 119.67 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.491 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.525 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -109.14 137.42 47.07 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.763 0.315 . . . . 0.0 111.596 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 16' ' ' LEU . 17.1 m -147.95 134.39 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.481 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.27 -36.62 79.68 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.813 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.594 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.18 78.35 0.97 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.644 0.735 . . . . 0.0 109.04 178.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.449 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 5.0 pt20 -46.59 -25.81 0.77 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.288 -177.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.1 -31.29 77.33 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.178 -1.486 . . . . 0.0 111.069 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.646 ' HG3' ' N ' ' A' ' 23' ' ' ALA . 0.3 OUTLIER -70.45 -38.56 74.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.382 0.611 . . . . 0.0 109.828 178.371 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.646 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -51.5 -37.67 50.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.533 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -73.13 -30.45 63.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.794 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.77 -41.04 19.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.41 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 30' ' ' LEU . 2.8 m -51.11 -35.14 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.288 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.661 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -60.38 -48.41 81.87 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.661 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.57 -28.06 61.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.308 0.575 . . . . 0.0 110.642 178.436 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.44 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 3.1 tpp180 -78.85 -35.97 43.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.891 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.2 tm? -52.74 -59.01 5.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.278 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -9.39 54.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.488 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.61 50.14 0.42 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.6 -10.54 44.35 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.659 -0.781 . . . . 0.0 114.143 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.04 157.64 15.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.506 0.653 . . . . 0.0 111.061 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -110.28 144.49 38.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.205 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.45 ' CZ ' ' CD2' ' A' ' 96' ' ' LEU . 1.9 p90 -49.05 -28.49 4.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.726 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.409 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -59.9 -34.07 81.37 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.574 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -74.4 -49.96 20.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.593 0.235 . . . . 0.0 110.827 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -53.28 -36.14 60.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.286 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 44' ' ' SER . . . -52.1 -52.77 49.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.127 0.489 . . . . 0.0 110.744 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -85.64 -23.7 27.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.809 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -72.52 -67.51 0.55 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.227 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.6 -14.96 9.59 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -178.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.512 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 1.8 t -63.74 126.25 26.99 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.365 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.327 -0.402 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.518 -0.286 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -86.64 -18.82 30.4 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.789 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.503 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 15.4 mtt180 -104.23 25.0 10.61 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.964 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.526 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER 67.61 40.52 2.51 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.429 0.633 . . . . 0.0 111.629 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 53.63 30.33 42.61 Favored Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.79 -0.641 . . . . 0.0 113.018 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.9 p -92.37 86.35 5.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.739 0.304 . . . . 0.0 110.993 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.732 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 69.9 mt -54.03 -40.0 66.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.051 0.453 . . . . 0.0 110.21 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 78.07 -168.25 53.94 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.538 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.438 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -69.75 111.39 5.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.044 0.449 . . . . 0.0 111.717 -179.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.684 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 13.0 m-85 -125.83 152.82 44.97 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -100.71 -174.03 29.43 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.238 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.95 99.93 12.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.951 0.405 . . . . 0.0 110.316 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.97 -7.91 1.24 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.426 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -92.29 -40.82 10.73 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.924 0.362 . . . . 0.0 111.522 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.2 166.59 12.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.913 0.387 . . . . 0.0 111.447 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.507 HG23 ' CB ' ' A' ' 68' ' ' PHE . 35.2 m -58.0 163.85 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.815 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.493 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 16.8 tttp -58.93 -48.33 96.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.521 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 17.7 Cg_endo -67.11 -37.34 19.0 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 121.856 1.704 . . . . 0.0 112.192 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CB ' HG23 ' A' ' 65' ' ' VAL . 40.9 t80 -74.41 -50.78 17.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.623 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -56.75 -32.35 65.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.703 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.2 OUTLIER -67.42 -49.43 63.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.072 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.99 -9.56 58.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.753 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.82 -51.26 42.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.912 0.387 . . . . 0.0 111.447 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 3.5 p90 -94.24 16.71 14.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.452 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -97.39 -29.38 13.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 110.804 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 80' ' ' VAL . 3.4 mt -103.48 67.1 0.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.454 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -74.35 -17.78 60.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.049 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -66.66 -26.74 38.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.447 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.14 59.8 1.09 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.521 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.33 176.14 9.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.841 0.353 . . . . 0.0 111.123 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.487 ' O ' HD12 ' A' ' 75' ' ' LEU . 50.0 t -81.46 147.99 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.17 159.3 15.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.293 0.568 . . . . 0.0 111.56 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -50.68 155.23 1.99 Allowed Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.567 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.468 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 18.4 Cg_endo -58.53 106.67 0.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.335 2.023 . . . . 0.0 111.534 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.521 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 90.8 t -101.03 101.92 12.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.754 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.439 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 6.5 tptt -91.89 112.69 24.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.632 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.423 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 2.0 m -114.27 -173.19 2.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.55 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -58.29 -20.27 41.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.929 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -89.37 -23.97 22.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.309 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.404 ' O ' ' ND1' ' A' ' 91' ' ' HIS . . . 136.97 -167.88 24.49 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.883 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.468 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -74.98 98.35 3.58 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 86' ' ' SER . 53.3 m80 -80.86 167.63 19.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.343 0.592 . . . . 0.0 112.437 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.0 t -147.73 153.16 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.395 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.466 ' CG2' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -150.82 127.46 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -179.03 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.4 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 2.6 tmtm? -128.59 116.1 19.11 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.677 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -57.44 134.58 56.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.495 0.664 . . . . 0.0 112.046 -178.055 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -157.1 116.67 3.42 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.771 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 CA-C-O 118.321 -1.266 . . . . 0.0 112.57 179.845 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.538 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.47 0.653 . . . . 0.0 112.138 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.407 ' O ' ' O ' ' A' ' 57' ' ' GLY . 1.5 mt -110.98 136.15 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.869 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.457 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.4 mtpt -109.17 90.76 3.39 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.21 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.769 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 13.7 m -130.69 -179.59 5.39 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.055 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 94' ' ' LYS . 9.5 t -124.87 163.45 22.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.851 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.436 ' CD2' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -139.87 155.54 47.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.363 0.602 . . . . 0.0 112.583 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 16' ' ' LEU . 3.0 mp -143.77 139.43 25.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.48 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.435 ' O ' ' CG1' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -127.38 133.55 50.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.508 ' CG2' ' CG ' ' A' ' 22' ' ' GLU . 25.3 m -154.61 134.42 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.807 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -65.92 -16.58 63.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -72.29 78.24 0.99 Allowed 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.813 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.436 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 0.8 OUTLIER -47.27 -40.52 16.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.156 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.09 -31.54 72.27 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.848 -1.168 . . . . 0.0 112.774 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.57 ' HG3' ' N ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -66.9 -43.73 82.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.237 0.541 . . . . 0.0 110.407 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.57 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -46.95 -39.28 12.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.535 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.666 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -72.79 -29.16 63.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.112 179.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.91 -54.01 6.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.459 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.4 m -49.52 -34.27 8.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.666 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.9 pt20 -59.78 -47.72 84.56 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.907 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.52 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.23 -29.22 62.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.202 0.525 . . . . 0.0 110.499 178.731 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -36.2 45.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.792 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.419 ' CD1' ' C ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -52.77 -58.1 7.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.259 -179.363 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -71.36 -9.58 58.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.301 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.52 -23.7 63.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.887 0.375 . . . . 0.0 111.181 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.26 -19.47 0.93 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.275 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -80.93 157.65 25.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 110.773 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -101.43 148.28 25.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.168 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.443 ' CE1' HD21 ' A' ' 96' ' ' LEU . 1.1 p90 -50.44 -39.35 47.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.035 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.94 -34.21 71.26 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.746 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -65.85 -54.12 30.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.701 0.286 . . . . 0.0 110.913 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.404 ' CD2' ' CD2' ' A' ' 30' ' ' LEU . 2.8 mm? -56.32 -32.56 64.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.681 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.44 -52.78 43.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.175 0.512 . . . . 0.0 110.642 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.39 -23.77 26.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.133 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -69.62 -68.94 0.37 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.461 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.75 -12.63 9.21 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.529 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -63.68 131.69 48.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.885 0.374 . . . . 0.0 111.436 -179.123 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.505 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.3 pt . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.941 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.875 0.369 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.25 -12.25 60.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.827 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -104.43 24.88 10.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.678 0.275 . . . . 0.0 110.529 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.4 OUTLIER 65.79 20.83 11.49 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.129 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.84 17.92 65.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.615 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -68.53 86.07 0.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.362 . . . . 0.0 110.713 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.769 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 23.2 mt -54.56 -24.58 21.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.696 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 59.5 -166.18 9.41 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.233 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.457 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -67.27 111.51 4.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.9 0.381 . . . . 0.0 111.897 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.538 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 4.4 m-85 -117.43 156.3 28.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.59 -174.0 14.1 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.506 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.23 80.13 5.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.924 0.392 . . . . 0.0 110.225 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.26 36.68 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.03 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.01 -48.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 0.0 111.135 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.6 mtm -95.52 170.95 8.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.086 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.459 HG23 ' CB ' ' A' ' 68' ' ' PHE . 34.3 m -59.44 159.12 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.954 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.548 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -61.0 -47.97 93.88 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 12.2 Cg_endo -63.75 -41.14 25.62 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.955 1.77 . . . . 0.0 111.836 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.459 ' CB ' HG23 ' A' ' 65' ' ' VAL . 9.3 t80 -74.96 -52.35 11.39 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.843 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -55.36 -32.24 62.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.991 0.424 . . . . 0.0 110.647 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.443 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 29.9 t70 -65.38 -53.07 48.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.744 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.21 -9.31 58.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.559 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.32 -47.0 78.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.721 0.296 . . . . 0.0 111.376 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.443 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 11.4 p90 -93.24 16.19 13.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.345 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -98.3 -30.51 12.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 81' ' ' SER . 7.9 mt -97.73 56.81 1.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.177 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -63.75 -23.75 67.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.758 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.87 -26.79 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.855 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.534 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 91.16 63.08 1.2 Allowed Glycine 0 CA--C 1.499 -0.949 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.122 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.411 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -141.05 176.61 8.68 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.611 -0.294 . . . . 0.0 110.62 -178.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 61.1 t -80.16 147.91 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.485 ' HA ' HD12 ' A' ' 75' ' ' LEU . 12.8 t -104.53 162.97 12.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.611 0.72 . . . . 0.0 111.924 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.592 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -50.37 163.46 0.45 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.396 -179.268 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 35.8 Cg_endo -65.71 103.59 0.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.617 2.211 . . . . 0.0 112.321 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 89.8 t -101.66 99.56 8.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.456 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.437 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -95.21 115.31 27.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.072 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.9 m -105.51 -175.64 2.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.367 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -20.13 26.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.958 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -88.18 -39.88 14.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.433 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.58 -171.6 36.03 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.978 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.437 ' CD1' ' HB3' ' A' ' 85' ' ' LYS . 0.6 OUTLIER -74.95 108.59 7.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.957 0.408 . . . . 0.0 110.043 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -95.46 169.39 10.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.381 0.61 . . . . 0.0 112.368 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.4 t -147.81 152.68 12.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.594 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.4 OUTLIER -133.4 122.15 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 13' ' ' SER . 10.3 tptt -128.71 109.07 11.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.392 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.534 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 1.1 ttt-85 -57.1 138.78 54.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.776 0.798 . . . . 0.0 112.625 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -161.98 116.42 1.9 Allowed 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.484 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.626 179.8 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.448 ' CB ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.466 0 CA-C-O 121.3 0.572 . . . . 0.0 111.553 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.474 ' O ' ' O ' ' A' ' 57' ' ' GLY . 1.2 mt -111.33 135.68 49.77 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.043 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.47 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.7 mtpt -109.67 89.49 3.02 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.132 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.785 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 8.5 m -131.97 -179.55 5.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.081 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 94' ' ' LYS . 8.7 p -127.07 163.43 23.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.156 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.426 ' CD2' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -136.08 157.46 46.78 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.295 0.569 . . . . 0.0 112.412 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 mp -149.24 125.43 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.038 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.471 ' HB3' ' CG1' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -105.84 136.94 44.57 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.844 0.354 . . . . 0.0 111.893 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 16' ' ' LEU . 22.7 m -150.67 134.39 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.389 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -71.8 -35.84 70.09 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.626 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 5.9 tttt -73.15 79.19 1.26 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.449 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 3.2 pt20 -46.49 -25.89 0.76 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.153 -0.93 . . . . 0.0 113.108 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.15 -29.47 74.5 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 119.194 -1.479 . . . . 0.0 110.82 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.626 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -73.99 -38.02 64.27 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.26 0.553 . . . . 0.0 110.017 178.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.603 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.57 -33.76 23.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.651 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -73.48 -39.8 64.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.417 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.17 -47.03 38.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.961 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 30' ' ' LEU . 21.3 m -46.6 -37.49 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.361 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.708 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -58.4 -48.51 80.41 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.118 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.708 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.65 -30.21 62.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.072 0.463 . . . . 0.0 110.822 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.44 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 16.8 tpt180 -79.18 -27.07 42.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.866 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.4 tm? -70.47 -44.82 66.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.222 0.534 . . . . 0.0 110.278 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -9.46 58.72 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.769 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.02 -27.89 69.42 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.902 0.382 . . . . 0.0 111.352 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.68 -17.92 0.98 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.629 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -74.22 157.56 35.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.813 0.339 . . . . 0.0 110.879 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.08 139.94 33.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.093 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.448 ' CZ ' ' CD2' ' A' ' 96' ' ' LEU . 3.0 p90 -49.97 -33.81 18.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.99 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.98 -37.43 93.83 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.352 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -64.06 -52.92 57.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.778 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -53.55 -31.14 45.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.725 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.16 -55.17 19.26 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.115 0.483 . . . . 0.0 110.778 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -23.34 27.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.966 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.539 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 1.0 OUTLIER -70.17 -68.29 0.43 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.539 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.37 -13.3 9.28 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -64.13 135.65 56.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.163 0.506 . . . . 0.0 111.203 -179.295 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.471 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 43.2 pt . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.216 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.84 0.352 . . . . 0.0 110.89 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -79.78 -4.22 51.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.396 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mtp-105 -104.33 24.62 11.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.223 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.0 22.53 12.77 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.014 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 57.45 20.44 37.6 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.799 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m -61.85 85.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.775 0.321 . . . . 0.0 110.987 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.785 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 21.5 mt -60.76 -24.86 66.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.535 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 56.78 -165.14 5.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.416 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.47 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -64.93 121.07 13.79 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.225 0.536 . . . . 0.0 112.209 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.434 ' CZ ' ' O ' ' A' ' 56' ' ' LEU . 12.0 m-30 -136.8 148.49 47.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.017 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.84 -173.81 21.37 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.44 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.46 87.36 7.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.152 0.501 . . . . 0.0 110.189 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.32 36.78 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.901 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.62 -45.24 0.67 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.712 0.292 . . . . 0.0 111.144 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.32 171.4 8.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.135 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.47 HG23 ' CB ' ' A' ' 68' ' ' PHE . 34.3 m -55.13 157.56 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.106 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.527 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.52 -48.11 97.52 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.582 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 18.6 Cg_endo -65.69 -39.92 19.16 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.946 1.764 . . . . 0.0 112.187 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CB ' HG23 ' A' ' 65' ' ' VAL . 23.8 t80 -74.91 -49.17 21.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.459 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.94 -32.73 61.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.524 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -67.45 -51.56 50.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.901 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.89 -9.59 58.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.593 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.84 -43.29 84.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.848 0.356 . . . . 0.0 111.448 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.416 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 1.1 p90 -102.26 16.77 25.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.401 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.07 -27.31 15.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.748 0.308 . . . . 0.0 110.831 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 80' ' ' VAL . 3.3 mt -103.53 63.55 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.305 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -70.56 -18.53 62.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.965 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -64.6 -26.91 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.35 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.19 58.15 1.17 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.802 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -140.5 176.36 8.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.672 0.272 . . . . 0.0 110.977 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 56.8 t -84.65 147.05 5.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.098 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.21 161.96 13.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.186 0.517 . . . . 0.0 111.434 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -50.85 153.9 2.72 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.033 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.431 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 22.5 Cg_endo -60.84 106.35 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.1 1.867 . . . . 0.0 111.523 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.582 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 86.1 t -101.01 108.33 23.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.7 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 90' ' ' TYR . 14.7 tmtt? -91.7 113.17 25.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.408 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.48 -172.38 2.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.199 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -16.42 48.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.213 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -94.08 -35.28 12.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.713 0.292 . . . . 0.0 111.594 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.66 -167.03 34.57 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.666 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 1.2 m-85 -82.44 98.26 8.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.266 0.555 . . . . 0.0 109.994 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.446 ' CD2' ' CD2' ' A' ' 16' ' ' LEU . 11.3 m80 -83.09 169.64 15.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.007 -177.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 38.3 t -149.03 150.72 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.014 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -130.62 122.41 52.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' SER . 3.8 tmtt? -128.58 110.44 12.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.113 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.508 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -57.47 139.44 53.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.853 0.835 . . . . 0.0 112.73 -178.463 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -162.82 116.42 1.67 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.491 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.402 ' CA ' ' HE2' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.323 -1.265 . . . . 0.0 112.621 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.571 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.719 0 CA-C-O 121.376 0.607 . . . . 0.0 112.034 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.412 ' O ' ' O ' ' A' ' 57' ' ' GLY . 1.2 mt -111.01 136.0 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.15 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.6 mtpt -108.32 89.78 3.1 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.115 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.797 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.4 m -132.69 -179.61 5.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.747 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 m -131.25 163.75 27.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.371 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.466 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -132.16 156.31 46.63 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.555 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 1.5 mp -141.43 120.01 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.045 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.419 ' O ' ' CG1' ' A' ' 45' ' ' ILE . 2.0 mt -104.44 128.28 52.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.466 ' CG2' ' CG ' ' A' ' 22' ' ' GLU . 17.9 m -140.57 133.91 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.017 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -36.7 70.55 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.84 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.605 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.23 78.53 0.98 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.385 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.456 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -46.51 -26.05 0.8 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.058 -177.47 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.42 -31.12 76.05 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.855 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.652 ' HG3' ' N ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -70.06 -39.56 75.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.081 0.467 . . . . 0.0 110.3 178.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.652 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.34 -38.1 40.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.986 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.586 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -73.61 -29.4 62.36 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.244 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.38 -43.7 14.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.543 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 30' ' ' LEU . 2.5 m -54.89 -40.66 53.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.275 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.2 pt20 -53.2 -52.61 58.31 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.691 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -73.28 -31.51 64.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.08 0.467 . . . . 0.0 110.998 179.141 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.41 -25.61 54.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.706 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -58.38 -48.31 81.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.4 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.93 -9.32 58.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.428 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.26 -22.15 28.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.802 0.334 . . . . 0.0 111.403 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.13 -10.76 3.59 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.536 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -79.02 153.24 30.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.929 0.395 . . . . 0.0 110.988 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.4 135.51 33.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.792 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.555 ' CE2' ' CD1' ' A' ' 15' ' ' ILE . 9.6 t80 -53.29 -47.78 68.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.218 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.59 -34.12 63.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.239 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -58.82 -50.26 74.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.704 0.288 . . . . 0.0 110.87 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -53.07 -33.28 51.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.808 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.52 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.25 -54.24 27.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.127 0.489 . . . . 0.0 110.496 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.4 pttp -85.77 -23.5 27.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.023 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.535 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -70.54 -67.91 0.47 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.535 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.94 -15.69 9.3 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.52 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -63.99 138.31 58.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 0.0 111.275 -179.475 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.419 ' CG1' ' O ' ' A' ' 16' ' ' LEU . 2.0 pt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.18 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 121.388 0.613 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -16.17 63.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.065 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.22 24.64 11.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.29 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.3 OUTLIER 64.5 17.54 10.89 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.434 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.83 27.37 49.93 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.37 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -60.06 84.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.959 0.409 . . . . 0.0 110.815 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.797 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 22.8 mt -60.5 -19.66 57.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.725 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 50.33 -169.07 0.27 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.735 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.497 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -61.69 111.44 1.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.929 0.395 . . . . 0.0 111.723 -179.385 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.571 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 2.4 m-85 -124.78 163.8 21.34 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.35 -174.04 13.67 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.656 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -86.9 95.72 9.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.052 0.453 . . . . 0.0 110.283 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.23 36.47 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.756 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -152.05 -42.62 0.11 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.74 0.305 . . . . 0.0 111.187 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 8.9 mtm -91.07 167.12 12.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.93 0.395 . . . . 0.0 111.27 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.457 HG23 ' CB ' ' A' ' 68' ' ' PHE . 33.7 m -58.97 156.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.854 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.533 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.5 ttpt -58.14 -47.98 97.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.547 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 12.7 Cg_endo -64.4 -40.1 26.18 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 121.995 1.797 . . . . 0.0 112.239 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CB ' HG23 ' A' ' 65' ' ' VAL . 11.3 t80 -75.11 -50.17 17.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.696 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.63 -32.33 58.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.689 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.409 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 1.5 t70 -66.87 -52.47 43.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.851 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.87 -9.5 58.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.478 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.18 -43.19 98.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.415 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.409 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 2.8 p90 -98.29 16.54 21.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.386 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -98.18 -28.14 13.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.172 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 79' ' ' GLU . 8.5 mt -96.0 51.6 1.25 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 111.301 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -58.91 -33.14 70.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 109.868 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -63.55 -26.68 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.33 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.465 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 90.37 72.01 1.24 Allowed Glycine 0 CA--C 1.5 -0.905 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.819 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.525 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -142.28 177.6 8.14 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.132 -0.534 . . . . 0.0 110.014 -178.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.67 149.73 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.421 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -104.49 153.08 21.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.354 0.597 . . . . 0.0 111.401 -178.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.425 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -50.76 156.1 1.73 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.834 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 82' ' ' GLU . 11.2 Cg_endo -53.67 102.83 0.08 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.514 2.143 . . . . 0.0 111.96 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.547 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 57.6 t -103.07 103.05 14.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.599 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.465 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.79 112.5 24.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.9 0.381 . . . . 0.0 110.966 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.63 -176.9 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.398 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -59.33 -19.07 43.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.958 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -89.93 -40.53 12.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.386 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.83 -164.09 35.65 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.826 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -83.43 98.17 9.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.406 ' CD2' ' HG ' ' A' ' 16' ' ' LEU . 15.5 m80 -83.68 167.1 17.55 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 18.0 t -145.11 153.42 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.772 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.433 HD11 ' CE1' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -138.02 121.58 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.489 ' CB ' ' CE1' ' A' ' 36' ' ' PHE . 5.1 tptm -129.62 113.27 14.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.168 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.465 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.8 OUTLIER -57.97 139.19 54.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.787 0.803 . . . . 0.0 112.631 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -159.62 116.18 2.56 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.351 179.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.555 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.547 ' HD2' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.668 0.27 . . . . 0.0 111.081 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -114.14 136.97 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 121.4 0.619 . . . . 0.0 110.752 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.657 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -107.29 95.39 5.67 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.738 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 1.9 t -120.4 179.35 4.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.794 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.7 p -120.56 163.35 18.12 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.445 ' CE1' ' HA2' ' A' ' 54' ' ' GLY . 24.6 p-80 -134.68 151.59 51.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.517 0.675 . . . . 0.0 112.633 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 mp -155.61 127.09 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.764 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.659 ' HB3' HG13 ' A' ' 45' ' ' ILE . 10.9 tp -114.15 129.06 56.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.935 0.398 . . . . 0.0 112.029 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.603 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 28.1 m -143.26 134.35 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.635 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.418 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -77.9 -33.97 51.64 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.478 -179.013 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.605 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 13.2 tttp -72.3 79.14 1.0 Allowed 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.453 ' HG3' ' CD1' ' A' ' 90' ' ' TYR . 0.9 OUTLIER -46.18 -25.39 0.59 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.939 -177.026 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.55 -31.33 78.35 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 118.865 -1.636 . . . . 0.0 110.429 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.605 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -73.2 -37.65 66.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.06 0.457 . . . . 0.0 109.777 178.062 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.597 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -53.31 -36.2 60.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.738 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.615 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.59 -29.28 62.3 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.762 178.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.9 -43.53 14.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.633 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.446 ' HA ' ' HB3' ' A' ' 29' ' ' ARG . 3.3 m -55.28 -36.72 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.428 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.5 pt20 -56.27 -53.27 59.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.696 0.284 . . . . 0.0 110.541 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.51 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -73.62 -26.95 61.03 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.965 0.412 . . . . 0.0 110.866 179.055 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.446 ' HB3' ' HA ' ' A' ' 26' ' ' VAL . 2.0 tpp180 -78.41 -34.02 48.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.784 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.408 ' CD2' HD23 ' A' ' 39' ' ' LEU . 1.3 tm? -53.52 -57.47 10.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.03 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -9.41 58.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.253 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.46 -23.77 58.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.938 0.399 . . . . 0.0 111.32 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.51 -17.38 1.13 Allowed Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.374 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -78.46 157.64 28.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.876 0.369 . . . . 0.0 110.861 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -100.75 140.41 35.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.107 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.425 ' CE1' HD22 ' A' ' 96' ' ' LEU . 5.4 p90 -49.53 -31.66 10.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.949 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.47 -33.98 88.71 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.376 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 4.9 mmmt -67.94 -53.89 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.697 0.284 . . . . 0.0 110.999 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.408 HD23 ' CD2' ' A' ' 30' ' ' LEU . 2.8 mm? -53.86 -33.86 57.62 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.68 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.526 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.79 -52.5 48.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.109 0.48 . . . . 0.0 110.543 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -86.51 -23.34 25.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.341 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.472 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -71.7 -69.05 0.41 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.116 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.472 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.68 -12.44 9.26 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.526 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -63.85 137.68 58.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.895 0.379 . . . . 0.0 111.151 -179.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.659 HG13 ' HB3' ' A' ' 16' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.965 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.089 0 CA-C-O 120.906 0.384 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -75.23 -4.73 40.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.235 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.12 24.69 11.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.399 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 p30 56.17 33.59 22.34 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.159 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.445 ' HA2' ' CE1' ' A' ' 14' ' ' HIS . . . 50.84 24.41 8.13 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.938 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.53 87.51 7.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.018 0.437 . . . . 0.0 110.428 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.693 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 13.9 mt -62.42 -17.12 58.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.794 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 53.6 -171.76 0.71 Allowed Glycine 0 CA--C 1.507 -0.408 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.204 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.657 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 8.5 p90 -59.95 117.02 4.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.122 0.486 . . . . 0.0 111.619 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.487 ' C ' ' HB2' ' A' ' 9' ' ' LYS . 8.6 p90 -139.37 141.22 37.6 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.429 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.446 ' CA ' ' HB2' ' A' ' 9' ' ' LYS . . . -90.89 -173.78 44.02 Favored Glycine 0 C--N 1.311 -0.816 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.404 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.67 100.18 13.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.749 0.309 . . . . 0.0 110.362 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.32 36.49 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.312 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -151.18 18.44 0.76 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.861 0.331 . . . . 0.0 111.595 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.48 ' CE ' ' CE1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -151.61 174.12 13.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.697 0.284 . . . . 0.0 111.075 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.465 HG21 ' CB ' ' A' ' 68' ' ' PHE . 33.1 m -60.74 158.46 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.803 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -61.32 -47.84 92.91 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.607 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 19.8 Cg_endo -64.28 -40.1 26.99 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.024 1.816 . . . . 0.0 112.048 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.465 ' CB ' HG21 ' A' ' 65' ' ' VAL . 26.1 t80 -74.95 -51.19 14.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.799 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -57.42 -32.47 66.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.749 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.465 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 23.7 t70 -66.08 -49.39 67.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.969 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.87 -9.49 58.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.816 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.31 -47.39 73.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.753 0.311 . . . . 0.0 111.556 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.465 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 8.6 p90 -92.93 16.69 12.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.499 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -100.4 -27.3 13.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.787 0.327 . . . . 0.0 110.933 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.408 HD11 ' O ' ' A' ' 80' ' ' VAL . 1.5 mt -103.53 58.5 0.74 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.454 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -69.22 -18.31 63.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.975 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -66.29 -26.82 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.688 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.42 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 96.23 58.2 1.1 Allowed Glycine 0 CA--C 1.502 -0.744 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.568 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.56 176.5 8.67 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.726 0.298 . . . . 0.0 111.055 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.408 ' O ' HD11 ' A' ' 75' ' ' LEU . 24.8 t -87.18 148.56 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.198 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -105.37 157.34 17.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.245 0.545 . . . . 0.0 111.335 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -50.96 155.81 1.93 Allowed Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.066 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.26 106.26 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.208 1.939 . . . . 0.0 111.6 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.607 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 70.9 t -100.9 108.06 22.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.597 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.449 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 28.2 tptt -91.65 113.0 25.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.96 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.04 -171.38 1.83 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.321 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.79 -18.4 21.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.277 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . 0.443 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 12.1 m-85 -93.69 -38.9 11.08 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.722 0.296 . . . . 0.0 111.677 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.58 -166.19 32.22 Favored Glycine 0 CA--C 1.508 -0.384 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.848 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.603 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 59.3 m-85 -74.73 98.21 3.41 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.306 0.574 . . . . 0.0 110.161 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.45 ' CD2' ' CD1' ' A' ' 16' ' ' LEU . 79.6 m80 -86.53 169.88 12.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.575 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.6 t -145.88 147.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.848 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.46 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -134.67 123.22 41.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.081 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.407 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 3.3 tmtm? -128.14 110.1 12.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.843 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -57.39 131.74 50.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.416 0.627 . . . . 0.0 111.872 -178.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -158.7 116.92 2.94 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.989 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.407 -1.219 . . . . 0.0 112.52 179.836 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.635 ' HD3' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.542 0.21 . . . . 0.0 110.748 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -109.95 137.14 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-O 121.635 0.731 . . . . 0.0 111.161 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.528 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -110.4 89.22 2.97 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.286 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.739 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 35.8 m -120.87 179.91 4.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.193 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -119.52 163.39 17.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.949 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.429 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -134.45 147.73 50.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.229 0.538 . . . . 0.0 112.249 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.6 mp -145.41 115.3 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.942 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.417 ' O ' HG12 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.41 129.14 45.58 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.076 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.732 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 20.2 m -143.25 133.73 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.597 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -71.18 -36.0 71.79 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.849 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.586 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -71.44 78.19 0.77 Allowed 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 1.1 tm0? -46.72 -25.78 0.8 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.935 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.85 -31.37 78.04 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 119.069 -1.538 . . . . 0.0 110.72 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.682 ' HG3' ' N ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -71.46 -39.64 70.84 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.195 0.522 . . . . 0.0 109.726 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.682 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -52.9 -36.5 59.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.796 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.624 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.6 OUTLIER -73.64 -29.3 62.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.981 178.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.03 -42.06 13.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.888 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.401 ' HA ' ' HB3' ' A' ' 29' ' ' ARG . 3.4 m -54.92 -33.83 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.315 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.624 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.3 pt20 -51.31 -55.33 18.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.675 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.441 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.8 OUTLIER -73.16 -31.29 64.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.14 0.495 . . . . 0.0 110.479 178.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.401 ' HB3' ' HA ' ' A' ' 26' ' ' VAL . 10.0 tpt180 -68.38 -37.99 80.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.725 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.95 -58.97 5.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.345 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -72.12 -9.52 58.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.396 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.42 -21.92 52.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 0.0 111.341 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.35 -18.49 1.17 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.293 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -80.48 157.56 26.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.914 0.388 . . . . 0.0 110.824 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -97.35 138.59 34.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.029 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.442 ' CE1' HD23 ' A' ' 96' ' ' LEU . 1.9 p90 -49.23 -35.39 17.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.964 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.6 -34.09 88.98 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.542 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.6 OUTLIER -63.38 -53.85 46.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.626 0.25 . . . . 0.0 111.192 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -53.17 -34.34 56.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.044 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.513 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.45 -53.61 35.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.017 0.436 . . . . 0.0 110.524 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -85.97 -23.63 26.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.179 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.497 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.37 -68.65 0.41 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -177.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.497 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.5 -14.0 9.17 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -64.18 137.87 58.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.168 0.509 . . . . 0.0 111.549 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.028 179.595 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.192 0 CA-C-O 121.256 0.55 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.64 -12.06 61.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.659 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -103.46 24.03 11.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.582 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 72.68 10.25 5.58 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.554 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.29 22.01 66.9 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.205 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.4 89.07 2.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.106 0.479 . . . . 0.0 110.622 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.739 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 12.1 mt -63.41 -15.03 56.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.775 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 48.22 -171.17 0.06 OUTLIER Glycine 0 CA--C 1.507 -0.468 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.339 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.635 ' HB2' ' HD3' ' A' ' 9' ' ' LYS . 16.8 p90 -56.51 122.62 12.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.211 0.529 . . . . 0.0 111.872 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.468 ' C ' ' HB2' ' A' ' 9' ' ' LYS . 7.3 p90 -146.09 140.88 27.05 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.48 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.2 -173.9 23.41 Favored Glycine 0 C--N 1.315 -0.632 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.982 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 88.54 1.1 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.033 0.444 . . . . 0.0 110.129 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.53 36.88 0.05 OUTLIER Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.934 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.63 -41.67 0.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.596 0.236 . . . . 0.0 111.462 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.461 ' HE2' ' CD1' ' A' ' 59' ' ' PHE . 1.9 mpp? -105.73 174.0 6.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.032 0.444 . . . . 0.0 111.468 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.455 HG21 ' CB ' ' A' ' 68' ' ' PHE . 34.4 m -56.81 161.39 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.069 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.534 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -60.36 -48.03 94.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.594 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 15.5 Cg_endo -64.85 -42.01 16.25 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 121.911 1.741 . . . . 0.0 111.731 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.455 ' CB ' HG21 ' A' ' 65' ' ' VAL . 15.2 t80 -72.65 -51.51 19.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.472 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.7 tt0 -56.34 -32.29 64.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.614 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 35.2 t70 -65.97 -51.6 56.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.707 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.12 -12.12 60.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.429 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.83 -49.21 77.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.886 0.374 . . . . 0.0 111.265 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 2.8 p90 -93.96 16.58 14.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.239 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -98.27 -26.39 14.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.375 . . . . 0.0 110.705 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mt -103.46 53.08 0.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.145 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -59.72 -22.02 61.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.165 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 p -61.92 -26.77 40.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.533 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.17 55.62 1.46 Allowed Glycine 0 CA--C 1.503 -0.717 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.741 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.44 176.53 8.62 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.692 0.282 . . . . 0.0 111.01 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 59.5 t -86.43 147.43 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.533 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.47 160.48 15.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.202 0.525 . . . . 0.0 111.409 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -50.89 155.49 2.0 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.159 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -56.93 105.96 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.228 1.952 . . . . 0.0 111.772 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.594 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 85.0 t -100.93 106.8 20.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.115 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.467 ' CG ' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.52 112.89 25.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.494 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.422 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 0.5 OUTLIER -105.19 -171.65 1.95 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.051 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -14.94 36.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.202 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -96.47 -36.36 10.82 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.612 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.19 -166.53 34.16 Favored Glycine 0 CA--C 1.508 -0.403 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.86 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.732 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 91.7 m-85 -80.73 98.07 7.58 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.237 0.542 . . . . 0.0 109.941 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.422 ' CE1' ' HB2' ' A' ' 86' ' ' SER . 50.9 m80 -82.95 169.73 15.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.812 -178.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 19.4 t -149.52 145.6 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.445 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.5 OUTLIER -123.3 122.28 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.005 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 13' ' ' SER . 2.4 tptm -128.72 108.98 10.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.406 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 2.0 ttp85 -57.26 132.8 54.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.562 0.696 . . . . 0.0 112.346 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -163.17 116.71 1.6 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.782 179.747 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.417 -1.213 . . . . 0.0 112.67 179.754 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.482 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.41 0 CA-C-O 121.214 0.53 . . . . 0.0 111.357 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.45 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 1.4 mt -110.74 136.04 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.904 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.105 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.0 mtpt -107.73 88.4 2.72 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.668 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.804 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 8.6 m -131.41 -179.82 5.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.735 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 94' ' ' LYS . 45.2 t -121.1 163.44 18.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.226 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -130.68 150.78 51.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.172 0.511 . . . . 0.0 111.857 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.532 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 4.1 mp -154.27 130.15 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.527 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.521 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -123.2 138.04 54.74 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.868 0.366 . . . . 0.0 111.858 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.638 HG23 ' OE2' ' A' ' 22' ' ' GLU . 24.2 m -151.02 135.84 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.516 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -64.91 -19.5 65.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.504 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.39 76.4 1.03 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.796 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 2.6 pt20 -47.79 -33.14 6.81 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.32 -31.17 61.55 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 119.915 -1.136 . . . . 0.0 112.599 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.674 ' HG3' ' N ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -68.16 -42.68 79.7 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.451 0.643 . . . . 0.0 109.92 179.359 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.674 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -49.64 -36.81 25.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.526 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.405 HD22 ' HG3' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -72.71 -33.83 66.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.812 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.11 -44.15 22.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.514 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.442 ' CG1' ' OE2' ' A' ' 22' ' ' GLU . 2.8 m -47.96 -36.34 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.394 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.7 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -58.01 -49.26 77.45 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.522 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.7 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 4.0 pt-20 -73.89 -30.37 62.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.838 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 -78.83 -33.12 46.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.83 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.53 -51.93 57.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.688 0.28 . . . . 0.0 111.424 -178.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -9.29 58.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.186 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.72 47.2 0.17 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.32 -10.66 41.73 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.737 -0.744 . . . . 0.0 114.153 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -91.97 153.98 19.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.437 0.618 . . . . 0.0 110.78 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -104.22 139.22 39.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.419 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.482 ' CE1' ' CD2' ' A' ' 96' ' ' LEU . 2.2 p90 -47.18 -31.75 3.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.841 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.11 -34.17 88.15 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.372 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.8 ttpm? -68.1 -51.99 40.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.654 0.264 . . . . 0.0 111.112 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.406 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . 2.9 mm? -53.13 -36.01 60.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.412 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.522 ' O ' ' HB3' ' A' ' 44' ' ' SER . . . -51.93 -53.2 43.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.167 0.508 . . . . 0.0 110.634 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -85.64 -23.6 27.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.791 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -72.06 -67.52 0.53 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.133 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.523 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.36 -14.62 9.75 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.532 ' OG ' ' HA ' ' A' ' 15' ' ' ILE . 1.4 t -63.42 126.8 28.66 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.227 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.479 HG12 ' HA ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.553 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.188 0 CA-C-O 121.307 0.575 . . . . 0.0 109.624 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -88.9 -5.44 58.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.184 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.466 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 1.7 mmt85 -122.36 24.55 9.3 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.9 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER 74.51 26.96 1.43 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.344 0.592 . . . . 0.0 111.085 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 55.56 20.31 23.31 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.789 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.45 84.66 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.027 0.442 . . . . 0.0 110.752 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.804 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 12.8 mt -58.92 -21.73 58.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.788 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 55.93 -163.85 5.05 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.413 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.494 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -64.23 119.48 10.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.028 0.442 . . . . 0.0 111.835 -179.38 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.482 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 19.1 p90 -141.27 139.34 33.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.571 177.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.402 ' CA ' ' HE2' ' A' ' 9' ' ' LYS . . . -98.35 -173.95 32.67 Favored Glycine 0 C--N 1.318 -0.463 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.504 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -82.8 98.27 9.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.199 0.524 . . . . 0.0 109.955 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.45 36.48 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.636 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -140.25 -46.87 0.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.837 0.351 . . . . 0.0 110.952 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.431 ' CE ' ' CE1' ' A' ' 59' ' ' PHE . 1.4 mpp? -91.92 170.04 10.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.963 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.486 HG21 ' CB ' ' A' ' 68' ' ' PHE . 34.8 m -59.58 162.34 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.018 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.481 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.63 -48.18 97.37 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.068 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.554 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 10.0 Cg_endo -66.02 -38.37 22.6 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 121.858 1.706 . . . . 0.0 112.171 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.486 ' CB ' HG21 ' A' ' 65' ' ' VAL . 8.8 t80 -74.97 -50.01 18.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.746 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -57.04 -32.49 66.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.651 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -64.61 -50.65 66.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.849 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.85 -9.57 58.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.524 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.15 -50.45 54.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.782 0.325 . . . . 0.0 111.301 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 6.4 p90 -93.28 16.56 12.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.343 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.48 -25.19 14.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 0.0 110.863 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 80' ' ' VAL . 1.6 mt -103.53 55.15 0.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.219 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -63.49 -19.55 64.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.098 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -63.66 -26.72 41.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.403 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.479 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.13 55.58 1.37 Allowed Glycine 0 CA--C 1.503 -0.674 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.629 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.63 176.17 8.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.858 0.361 . . . . 0.0 111.221 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.472 ' O ' HD11 ' A' ' 75' ' ' LEU . 60.2 t -83.16 149.09 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.903 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.0 t -104.4 154.8 19.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.448 0.642 . . . . 0.0 111.764 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -50.8 163.5 0.48 Allowed Pre-proline 0 C--O 1.235 0.307 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.573 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.456 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 17.8 Cg_endo -59.15 104.56 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.604 2.203 . . . . 0.0 112.226 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.554 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 93.7 t -101.43 101.54 12.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.373 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.69 113.01 25.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.851 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.3 m -108.71 -171.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.6 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -57.7 -20.28 33.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.33 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -91.34 -40.49 11.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.424 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.33 -164.51 32.97 Favored Glycine 0 CA--C 1.508 -0.354 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.073 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 0.7 OUTLIER -74.59 98.39 3.37 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.052 0.453 . . . . 0.0 110.39 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.422 ' CE1' HD12 ' A' ' 16' ' ' LEU . 31.0 m80 -81.71 169.95 16.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.236 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 t -149.29 150.6 13.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.01 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -138.1 124.14 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.319 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 13' ' ' SER . 15.8 tptp -128.45 109.29 11.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.594 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.479 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.5 OUTLIER -57.7 136.61 56.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.601 0.715 . . . . 0.0 112.206 -179.289 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -161.27 116.52 2.1 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.718 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.28 -1.289 . . . . 0.0 112.659 179.76 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.72 ' HD3' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 120.498 0.19 . . . . 0.0 110.727 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 58' ' ' TYR . 1.5 mm -109.3 149.64 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 CA-C-O 121.765 0.793 . . . . 0.0 111.276 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.621 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -125.34 76.3 1.54 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.102 -179.546 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.873 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 10.3 m -117.63 -179.68 3.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.258 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -115.66 163.49 15.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.651 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -132.44 153.03 51.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.54 0.686 . . . . 0.0 112.483 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.408 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 2.8 mp -155.85 123.18 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.899 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.571 ' HB3' ' CG1' ' A' ' 45' ' ' ILE . 12.8 tp -111.61 131.17 55.45 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 16' ' ' LEU . 17.3 m -143.65 134.71 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.67 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -35.77 68.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.513 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.635 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 3.3 tttp -74.31 79.33 1.84 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.467 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -46.28 -25.85 0.7 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.153 -0.931 . . . . 0.0 113.254 -176.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.15 -31.24 77.05 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.9 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.635 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -70.88 -38.23 73.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.009 0.433 . . . . 0.0 110.354 178.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.598 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.83 -37.68 44.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.088 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.588 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -73.44 -29.53 62.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.773 179.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.24 -42.8 15.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.47 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 30' ' ' LEU . 2.9 m -55.89 -39.24 55.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.203 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.2 pt20 -56.12 -51.49 67.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.886 0.374 . . . . 0.0 110.26 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.531 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 2.8 pt-20 -73.19 -29.62 62.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.09 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.401 ' HB3' ' HA ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -78.83 -29.75 44.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.656 -178.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.0 OUTLIER -55.27 -55.33 32.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.944 0.402 . . . . 0.0 110.827 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -9.55 58.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.202 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.2 -24.02 62.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.913 0.387 . . . . 0.0 111.232 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.1 -18.53 0.94 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.307 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -80.72 157.52 25.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.905 0.383 . . . . 0.0 110.807 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.4 138.47 39.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.048 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.438 ' CZ ' HD21 ' A' ' 96' ' ' LEU . 2.4 p90 -47.09 -29.86 2.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.996 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.45 -35.8 92.39 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.429 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.4 OUTLIER -66.19 -53.3 39.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.737 0.303 . . . . 0.0 110.869 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 44' ' ' SER . 2.9 mm? -53.62 -32.55 51.72 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.484 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.7 -53.27 41.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.617 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -86.33 -23.32 26.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.245 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.471 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 2.6 mm-40 -70.68 -69.22 0.38 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.471 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.61 -13.44 9.17 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.518 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -63.96 136.91 57.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.95 0.405 . . . . 0.0 111.2 -179.231 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.571 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 27.9 pt . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.803 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.154 0 CA-C-O 121.179 0.514 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -73.8 -10.58 59.82 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.645 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.95 24.81 10.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.522 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.6 OUTLIER 60.06 27.81 17.29 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.227 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 57.36 20.08 35.53 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.759 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 99.2 p -76.24 87.73 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.944 0.402 . . . . 0.0 110.234 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.873 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 14.4 mt -63.67 -16.48 61.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.548 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 46.55 -169.34 0.04 OUTLIER Glycine 0 CA--C 1.506 -0.522 0 C-N-CA 121.028 -0.605 . . . . 0.0 112.682 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.72 ' HB2' ' HD3' ' A' ' 9' ' ' LYS . 27.5 p90 -66.82 111.48 3.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.527 ' C ' ' HB2' ' A' ' 9' ' ' LYS . 13.0 m-30 -141.96 148.05 37.98 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.0 -174.01 19.0 Favored Glycine 0 C--N 1.311 -0.811 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.406 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -75.3 154.74 37.23 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.2 -37.03 1.17 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.445 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.14 24.77 1.78 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.738 0.304 . . . . 0.0 111.059 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 13.8 mtp -112.95 162.44 15.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.675 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.433 ' CG2' ' CB ' ' A' ' 68' ' ' PHE . 17.7 m -79.28 147.08 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.986 0.422 . . . . 0.0 110.951 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.56 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.23 -44.21 99.01 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 16.8 Cg_endo -65.3 -42.7 12.6 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 121.808 1.672 . . . . 0.0 112.207 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.433 ' CB ' ' CG2' ' A' ' 65' ' ' VAL . 16.6 t80 -74.88 -49.39 20.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.842 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.61 -32.33 70.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.825 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.446 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 4.1 m-20 -64.6 -46.85 80.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.257 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.82 -18.4 60.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.749 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.15 -53.06 58.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.727 0.299 . . . . 0.0 111.57 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.446 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -87.74 16.84 5.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.833 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -100.53 -31.58 11.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.822 0.344 . . . . 0.0 110.72 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 80' ' ' VAL . 2.8 mt -103.78 69.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.766 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -78.03 -16.41 58.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.088 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 p -69.07 -26.79 33.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.94 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.544 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 96.84 60.08 0.99 Allowed Glycine 0 CA--C 1.504 -0.634 0 C-N-CA 120.43 -0.89 . . . . 0.0 111.199 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.89 176.49 8.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.894 0.378 . . . . 0.0 111.025 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.452 ' O ' HD11 ' A' ' 75' ' ' LEU . 48.1 t -85.31 148.49 4.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.879 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t -104.5 163.96 12.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.212 0.529 . . . . 0.0 111.342 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -50.59 158.16 1.13 Allowed Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.187 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.432 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 16.5 Cg_endo -57.15 104.08 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.538 2.159 . . . . 0.0 111.793 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.55 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 57.9 t -101.82 105.91 18.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.782 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.462 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 3.0 tmtt? -98.76 112.86 24.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 21.8 m -110.47 -172.47 2.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.475 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -57.76 -20.37 34.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.964 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -88.74 -30.89 18.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.381 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.62 -169.7 25.91 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.885 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.467 ' CD1' ' HB3' ' A' ' 20' ' ' GLN . 0.4 OUTLIER -74.68 98.33 3.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.982 0.42 . . . . 0.0 110.017 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.421 ' CG ' HD11 ' A' ' 16' ' ' LEU . 6.1 m80 -89.02 169.7 11.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.421 0.629 . . . . 0.0 112.294 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.0 t -139.86 134.64 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.614 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -118.29 121.86 68.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.93 108.06 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.312 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.544 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.4 OUTLIER -59.07 131.87 52.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.398 0.618 . . . . 0.0 111.816 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -160.35 116.02 2.33 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.001 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.312 -1.271 . . . . 0.0 112.591 179.731 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.548 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 121.214 0.53 . . . . 0.0 111.096 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.27 138.62 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.008 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.47 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -106.66 98.23 7.92 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.523 -178.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.806 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 2.8 t -127.25 179.98 5.17 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.929 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.5 t -121.23 163.27 18.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.904 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.402 ' HB3' ' CD1' ' A' ' 56' ' ' LEU . 0.0 OUTLIER -131.04 149.55 52.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.045 0.45 . . . . 0.0 111.967 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.49 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 3.7 mp -155.94 131.58 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.452 ' O ' HG12 ' A' ' 17' ' ' VAL . 4.0 mm? -123.0 138.1 54.78 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.94 0.4 . . . . 0.0 111.64 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.456 ' CG2' ' CG ' ' A' ' 22' ' ' GLU . 18.3 m -148.98 134.11 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.93 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -69.84 -36.7 75.77 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.188 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.586 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.31 78.37 1.0 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.464 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -46.69 -25.79 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.768 -1.105 . . . . 0.0 113.238 -177.448 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.1 -31.48 77.83 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 119.045 -1.55 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.655 ' HG3' ' N ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -70.13 -39.22 75.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.247 0.546 . . . . 0.0 109.969 178.302 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.655 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -49.24 -39.5 30.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.376 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.537 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.33 -29.66 62.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.16 179.244 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.01 -36.49 23.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.755 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 30' ' ' LEU . 2.4 m -57.27 -33.29 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.213 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.639 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -59.76 -50.26 74.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.639 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -73.12 -27.26 61.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.243 0.544 . . . . 0.0 110.348 178.507 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -77.86 -33.93 51.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.702 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -53.32 -59.4 4.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.245 -179.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -9.39 58.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.287 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.78 -22.31 35.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.866 0.365 . . . . 0.0 111.416 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.01 -16.91 1.05 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.368 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -86.47 157.37 19.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.791 0.329 . . . . 0.0 110.682 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -99.51 142.38 31.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.091 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.44 ' CE1' HD22 ' A' ' 96' ' ' LEU . 2.9 p90 -47.65 -29.53 3.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.797 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.437 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -66.53 -38.93 93.79 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.563 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 5.1 ttpp -59.82 -50.98 71.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.72 0.295 . . . . 0.0 110.822 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -53.4 -34.85 59.32 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.741 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 44' ' ' SER . . . -52.09 -52.96 47.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.29 0.566 . . . . 0.0 110.665 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.46 -22.74 26.31 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.285 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.555 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -75.59 -68.4 0.57 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -176.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.523 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.63 -10.72 9.99 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.551 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -63.75 125.89 25.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.908 0.385 . . . . 0.0 109.993 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 16' ' ' LEU . 4.9 pt . . . . . 0 C--N 1.33 -0.259 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.517 -0.319 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -88.78 -19.69 25.68 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.913 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.462 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 3.2 mtt180 -104.43 24.68 11.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.168 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.495 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.6 OUTLIER 62.19 40.96 11.13 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.259 0.552 . . . . 0.0 111.583 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 53.36 30.51 40.83 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.213 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.4 p -88.74 85.09 6.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.729 0.3 . . . . 0.0 110.827 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.806 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 16.4 mt -58.3 -31.67 67.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.637 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 70.76 -170.12 47.03 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.453 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.522 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -60.64 118.47 6.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.151 0.501 . . . . 0.0 111.661 -179.384 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.548 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 2.4 m-85 -127.18 164.08 22.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.76 -174.02 13.25 Favored Glycine 0 C--N 1.319 -0.411 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.672 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -74.3 84.23 1.91 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.168 0.508 . . . . 0.0 110.121 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.33 36.78 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.056 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.0 -48.6 0.61 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.674 0.273 . . . . 0.0 111.39 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.9 ptp -108.42 169.51 8.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.025 0.441 . . . . 0.0 111.406 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.461 HG23 ' CB ' ' A' ' 68' ' ' PHE . 35.6 m -54.72 161.71 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.666 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -61.65 -48.14 90.74 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 11.8 Cg_endo -63.33 -42.0 24.25 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 121.999 1.799 . . . . 0.0 111.744 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.461 ' CB ' HG23 ' A' ' 65' ' ' VAL . 17.9 t80 -73.11 -51.78 16.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.662 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -59.24 -32.98 70.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.774 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 6.7 m-20 -61.48 -48.57 80.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.127 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.83 -9.57 58.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.737 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.42 -47.72 78.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.771 0.32 . . . . 0.0 111.515 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.435 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 10.2 p90 -92.7 16.6 11.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.476 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -99.99 -25.82 14.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 111.205 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.487 HD11 ' O ' ' A' ' 79' ' ' GLU . 11.0 mt -101.25 56.9 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.389 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -61.42 -31.7 71.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.979 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -63.15 -26.88 41.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.124 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.457 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 89.94 70.21 1.23 Allowed Glycine 0 CA--C 1.499 -0.915 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.951 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.487 ' O ' HD11 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -142.29 177.35 8.31 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.122 -0.539 . . . . 0.0 109.998 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.0 t -79.72 150.61 4.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.457 ' CB ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -105.04 164.31 11.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.608 0.718 . . . . 0.0 111.907 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.605 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -50.5 164.31 0.41 Allowed Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.896 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 55.5 Cg_endo -68.73 103.44 0.99 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.398 2.065 . . . . 0.0 112.123 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.505 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 81.4 t -101.89 104.31 16.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.087 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.455 ' CG ' ' CD1' ' A' ' 90' ' ' TYR . 12.2 tmtt? -99.78 112.67 24.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.584 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.437 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 74.4 m -112.82 -176.44 2.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.858 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -51.83 -25.95 8.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.178 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -80.81 -39.95 25.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.087 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.56 -163.45 31.2 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.701 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.455 ' CD1' ' CG ' ' A' ' 85' ' ' LYS . 0.2 OUTLIER -80.39 100.28 8.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.632 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.439 ' CG ' HD13 ' A' ' 16' ' ' LEU . 60.5 m80 -85.05 162.24 19.4 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.7 t -146.82 125.19 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.011 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.436 HG12 ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -113.68 124.49 70.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.25 112.77 14.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.189 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.526 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.27 135.92 56.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.552 0.691 . . . . 0.0 112.356 -177.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -156.74 116.76 3.54 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.578 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.424 -1.209 . . . . 0.0 112.564 179.823 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.519 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.601 0 CA-C-O 121.089 0.471 . . . . 0.0 111.089 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.14 129.52 66.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.528 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.1 mtpt -95.79 97.74 9.91 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.948 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.7 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -126.65 -179.73 4.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.839 -177.083 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 p -124.43 159.81 29.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.348 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.411 ' O ' ' CD2' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -131.92 146.54 52.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.17 0.51 . . . . 0.0 112.302 -179.419 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.526 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 4.1 mp -149.73 132.78 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.673 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.516 ' O ' HG12 ' A' ' 17' ' ' VAL . 4.1 mm? -119.54 137.55 53.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.784 0.326 . . . . 0.0 111.598 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 16' ' ' LEU . 15.7 m -148.54 134.23 11.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.17 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -36.46 72.13 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.412 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.622 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -74.42 79.15 1.89 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.878 0.846 . . . . 0.0 108.73 178.499 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.468 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -45.82 -25.28 0.49 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.363 -1.289 . . . . 0.0 113.162 -177.447 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.61 -30.37 76.28 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.124 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.72 ' HG3' ' N ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -72.02 -39.72 68.97 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.049 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.72 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -49.84 -35.02 21.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.205 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -40.1 64.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.613 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.56 -48.78 30.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.589 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 23' ' ' ALA . 2.7 m -46.55 -40.53 4.45 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.249 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.45 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -59.01 -45.13 91.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.45 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.4 mm-40 -73.69 -33.06 64.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.82 178.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.69 -30.41 46.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.842 -178.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.99 -58.95 5.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.895 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -9.38 58.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.383 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.29 -24.32 59.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.927 0.394 . . . . 0.0 111.327 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.93 -18.61 0.96 Allowed Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.191 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -82.15 157.59 23.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.862 0.363 . . . . 0.0 110.503 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.38 141.75 33.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.091 0.472 . . . . 0.0 111.216 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 96' ' ' LEU . 3.2 p90 -45.8 -31.4 2.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.762 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.491 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.58 -41.65 99.78 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.178 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.572 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 2.9 tttt -58.16 -51.97 67.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.516 0.198 . . . . 0.0 110.785 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.402 HD12 ' CD1' ' A' ' 43' ' ' LEU . 3.1 mm? -53.36 -35.14 59.95 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.654 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.86 -53.52 39.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.215 0.531 . . . . 0.0 110.65 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -86.42 -23.1 26.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.126 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.572 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -75.77 -68.26 0.59 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.074 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.517 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.88 -8.3 10.3 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -179.011 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.529 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -63.66 125.79 25.44 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.66 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 16' ' ' LEU . 1.9 pt . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.78 0.324 . . . . 0.0 111.42 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.51 ' HD2' ' N ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -87.96 -21.38 24.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.355 0.598 . . . . 0.0 111.716 -179.436 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.51 ' N ' ' HD2' ' A' ' 51' ' ' LYS . 1.4 ptp180 -103.59 24.92 10.37 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.193 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.491 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER 77.34 6.91 2.98 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.703 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.07 24.42 75.82 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.877 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . 0.418 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 82.0 p -66.73 88.61 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.872 0.367 . . . . 0.0 111.261 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.7 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 16.2 mt -60.36 -27.42 67.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.402 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.79 -172.99 27.74 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.252 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.508 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -59.07 119.19 6.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.05 0.453 . . . . 0.0 111.491 -179.504 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.519 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 3.1 m-85 -128.46 163.0 25.86 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -139.19 -173.88 13.26 Favored Glycine 0 C--N 1.315 -0.592 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.803 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.27 87.47 1.98 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.116 0.484 . . . . 0.0 109.904 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.59 36.69 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.918 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -147.31 -47.04 0.17 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.701 0.286 . . . . 0.0 111.083 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.4 mtm -98.3 168.43 10.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.098 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.474 HG22 ' CB ' ' A' ' 68' ' ' PHE . 36.0 m -61.22 161.44 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.786 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 4.0 mtpt -61.22 -47.98 92.93 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 12.9 Cg_endo -64.23 -41.37 21.82 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.834 1.689 . . . . 0.0 111.809 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.474 ' CB ' HG22 ' A' ' 65' ' ' VAL . 30.5 t80 -73.82 -52.35 13.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.628 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -57.73 -32.46 67.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.755 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 7.2 m-20 -62.47 -51.15 68.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.854 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.02 -9.5 58.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.664 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.99 -49.19 66.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.875 0.369 . . . . 0.0 111.589 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 9.0 p90 -93.32 16.68 12.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.381 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.14 -27.98 12.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.817 0.341 . . . . 0.0 110.798 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 80' ' ' VAL . 2.5 mt -103.55 54.7 0.75 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.471 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -62.16 -20.13 63.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.915 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -61.01 -26.92 40.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.225 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.447 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 95.25 55.13 1.39 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.845 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -139.51 176.16 8.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.746 0.308 . . . . 0.0 111.105 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 45.0 t -83.91 148.92 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.27 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.4 m -104.93 163.91 12.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.26 0.552 . . . . 0.0 111.588 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -50.86 155.0 2.16 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.384 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.37 104.68 0.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.659 2.239 . . . . 0.0 112.047 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.548 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 67.4 t -101.47 105.2 17.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.454 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 5.1 tptm -94.32 112.99 24.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.757 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.43 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 0.5 OUTLIER -107.9 -175.41 2.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.544 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -59.06 -20.24 51.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.948 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -88.5 -40.8 13.17 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.303 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.22 -164.29 35.41 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.868 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.468 ' CE1' ' HB3' ' A' ' 20' ' ' GLN . 0.3 OUTLIER -81.35 98.29 8.1 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.439 ' CG ' HD11 ' A' ' 16' ' ' LEU . 35.9 m80 -81.22 169.53 17.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.833 -177.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.5 t -154.61 123.76 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.719 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -105.38 122.69 59.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -128.32 116.13 19.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.495 178.294 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.447 ' CB ' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -58.54 136.04 57.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.507 0.67 . . . . 0.0 112.315 -178.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -160.38 116.76 2.39 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.925 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.479 -1.178 . . . . 0.0 112.718 179.866 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.558 ' CD ' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.124 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 58' ' ' TYR . 1.5 mm -109.4 148.94 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 CA-C-O 121.714 0.769 . . . . 0.0 111.247 -178.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.618 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -124.75 77.22 1.58 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.943 -179.61 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.802 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 13.8 m -117.54 -179.91 3.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.171 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 94' ' ' LYS . 3.5 t -109.38 163.67 13.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.297 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.4 ' CE1' ' CD2' ' A' ' 91' ' ' HIS . 12.9 t60 -126.4 142.12 51.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.339 0.59 . . . . 0.0 112.061 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.405 ' CG2' ' OG ' ' A' ' 44' ' ' SER . 3.5 mp -151.27 120.32 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.93 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.463 ' CD1' ' CE1' ' A' ' 91' ' ' HIS . 0.4 OUTLIER -113.98 135.89 53.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.206 -178.621 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.657 HG23 ' HG3' ' A' ' 22' ' ' GLU . 15.4 m -151.83 134.11 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.682 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -35.0 66.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.955 0.407 . . . . 0.0 110.469 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.505 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 13.2 pttm -71.99 80.34 0.92 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.468 ' HG3' ' CZ ' ' A' ' 90' ' ' TYR . 5.7 tt0 -45.03 -25.75 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.376 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.56 -32.13 78.04 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.209 -1.472 . . . . 0.0 111.444 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.657 ' HG3' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -69.05 -42.57 76.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.354 0.597 . . . . 0.0 109.662 178.326 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.522 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -46.97 -41.42 16.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.219 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.648 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.76 -28.9 61.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.078 179.101 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.41 -50.71 10.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.781 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 30' ' ' LEU . 11.3 m -54.25 -38.4 39.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.915 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.648 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.7 pt20 -53.7 -53.04 57.66 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.655 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.463 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.8 tt0 -73.28 -30.25 63.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.963 0.411 . . . . 0.0 110.937 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.411 ' HB3' ' HA ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -77.47 -28.93 52.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.857 -178.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -57.45 -58.02 10.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.785 -179.584 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -9.22 58.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.562 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' A' ' 29' ' ' ARG . . . -59.2 -25.99 64.44 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.856 0.36 . . . . 0.0 111.375 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.28 -17.21 0.52 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.694 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -88.11 157.59 18.81 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.054 0.454 . . . . 0.0 110.887 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.74 144.04 28.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.64 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.463 ' CE1' HD22 ' A' ' 96' ' ' LEU . 1.5 p90 -48.15 -34.8 10.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.951 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.7 -34.23 81.17 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.399 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.553 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -66.45 -53.75 31.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.706 0.288 . . . . 0.0 110.734 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 44' ' ' SER . 3.2 mm? -53.48 -34.76 59.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.522 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.34 -54.48 25.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.102 0.477 . . . . 0.0 110.893 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.15 -22.6 26.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.376 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.553 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 3.4 mm-40 -72.14 -69.28 0.41 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.495 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.52 -14.09 9.15 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.522 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -63.95 126.72 28.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.86 0.362 . . . . 0.0 111.088 -179.31 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.411 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.3 pt . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.987 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.819 0.343 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -72.7 -10.75 60.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.148 0.499 . . . . 0.0 110.179 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.412 ' O ' ' CG ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -104.13 24.73 10.98 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.255 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.412 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 1.1 p30 59.45 28.76 18.21 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.049 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.89 20.25 25.47 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.758 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.0 92.69 4.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.963 0.411 . . . . 0.0 110.328 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.802 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 11.9 mt -66.61 -13.9 61.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.778 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 45.0 -164.56 0.06 OUTLIER Glycine 0 CA--C 1.505 -0.535 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.261 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.618 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 25.8 p90 -70.87 111.37 6.23 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.221 0.534 . . . . 0.0 111.881 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.447 ' CE2' ' O ' ' A' ' 56' ' ' LEU . 13.9 m-30 -132.95 148.4 52.28 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.1 -173.9 21.92 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.667 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.4 mtm105 -84.7 122.84 29.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.46 -20.34 1.51 Allowed Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.083 -1.056 . . . . 0.0 113.119 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.9 tptm -120.58 -22.55 6.35 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 9.8 mtp -91.12 162.25 14.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 0.0 111.055 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.456 HG21 ' HB3' ' A' ' 68' ' ' PHE . 21.6 m -67.13 154.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.93 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.551 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 14.3 tttt -60.2 -47.07 97.65 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.625 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 17.8 Cg_endo -65.27 -42.28 13.82 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.864 1.71 . . . . 0.0 112.131 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.464 ' CE2' HG12 ' A' ' 93' ' ' ILE . 22.8 t80 -74.91 -49.72 19.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.646 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.01 -31.51 67.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.855 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.437 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 27.5 t70 -67.16 -48.62 67.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.194 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HA ' ' CG ' ' A' ' 74' ' ' ARG . . . -75.14 -9.63 58.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.931 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.27 -44.71 94.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.726 0.298 . . . . 0.0 111.542 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.437 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 18.4 p90 -90.6 16.88 8.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.928 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.411 ' CG ' ' HA ' ' A' ' 71' ' ' ALA . 3.2 mmm180 -99.76 -30.67 11.94 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.78 0.324 . . . . 0.0 110.881 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 80' ' ' VAL . 2.7 mt -103.6 68.34 0.93 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.598 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -77.45 -16.84 58.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.98 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.38 -26.87 34.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.807 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.431 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 97.03 60.76 0.96 Allowed Glycine 0 CA--C 1.504 -0.65 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.577 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.02 176.44 8.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.794 0.331 . . . . 0.0 110.999 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.44 ' O ' HD12 ' A' ' 75' ' ' LEU . 58.2 t -84.9 147.07 5.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.942 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.97 161.3 14.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.266 0.555 . . . . 0.0 111.479 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -50.81 155.87 1.84 Allowed Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.263 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.49 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 20.3 Cg_endo -59.99 105.74 0.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.347 2.031 . . . . 0.0 111.699 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.625 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 77.2 t -100.97 108.25 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.516 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 90' ' ' TYR . 3.7 tmtt? -91.74 113.07 25.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.082 0.467 . . . . 0.0 111.423 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -104.22 -171.4 1.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.119 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -12.88 43.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.366 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -99.7 -31.94 11.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.603 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.04 -170.9 33.83 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.542 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 1.2 m-85 -79.62 98.19 6.81 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.299 0.571 . . . . 0.0 110.303 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.463 ' CE1' ' CD1' ' A' ' 16' ' ' LEU . 3.2 m80 -80.46 169.94 17.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.318 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.5 t -145.85 140.69 21.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.818 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.464 HG12 ' CE2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -120.99 122.6 68.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 13' ' ' SER . 0.2 OUTLIER -128.54 108.69 10.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.907 178.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -57.68 129.68 42.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.556 0.693 . . . . 0.0 112.166 -178.658 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -161.4 116.43 2.06 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.77 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.456 -1.191 . . . . 0.0 112.64 179.746 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.516 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.573 0 CA-C-O 121.168 0.509 . . . . 0.0 110.973 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -111.18 136.68 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.08 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.455 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.7 mtpt -105.87 97.44 7.26 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.561 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.696 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 3.0 t -126.34 179.34 5.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.814 -178.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 t -124.06 163.31 21.71 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.16 152.41 51.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.207 0.527 . . . . 0.0 112.023 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.449 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 3.0 mp -151.07 115.4 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.137 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.736 ' HB3' HG13 ' A' ' 45' ' ' ILE . 7.4 tp -102.15 128.73 48.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.874 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 16' ' ' LEU . 14.5 m -142.1 134.28 27.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.596 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -74.6 -35.93 62.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.463 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.645 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 10.7 tttp -72.48 79.32 1.04 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.429 ' HG2' ' CD1' ' A' ' 90' ' ' TYR . 29.5 mt-30 -46.27 -25.94 0.71 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.969 -176.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.41 -31.24 76.38 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 119.216 -1.469 . . . . 0.0 110.953 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.645 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -70.68 -38.54 73.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.047 0.451 . . . . 0.0 110.296 178.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.605 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.34 -37.77 38.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.107 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.639 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.19 -29.53 62.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.809 179.129 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.05 -49.44 8.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.18 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.407 ' CG1' ' OE1' ' A' ' 22' ' ' GLU . 3.6 m -49.32 -37.24 10.41 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.13 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.639 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.9 pt20 -59.28 -48.95 79.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.552 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 3.7 pt-20 -73.17 -29.03 62.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.759 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -78.64 -35.13 45.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.965 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -53.04 -55.6 22.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.271 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -9.62 58.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.273 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.09 -22.95 61.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.871 0.367 . . . . 0.0 111.159 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.08 -17.27 1.37 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.309 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -80.67 157.59 25.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.902 0.382 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -100.06 144.84 28.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.918 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.415 ' CE1' HD22 ' A' ' 96' ' ' LEU . 6.2 p90 -53.65 -33.42 55.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.932 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.77 -33.96 87.04 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.462 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 4.0 tttt -68.35 -52.9 28.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 111.165 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -53.42 -33.16 52.87 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.834 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.526 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.57 -52.98 42.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.122 0.487 . . . . 0.0 110.659 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -86.3 -23.41 26.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.192 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.508 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -71.2 -68.67 0.42 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.508 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.0 -13.35 9.43 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.526 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -64.06 142.22 58.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.958 0.409 . . . . 0.0 110.833 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.736 HG13 ' HB3' ' A' ' 16' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.115 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.098 0 CA-C-O 120.979 0.419 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -6.38 51.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.463 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.32 24.78 11.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.234 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 p30 58.64 28.86 17.74 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.155 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.69 22.18 31.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.825 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.88 86.94 0.52 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.874 0.369 . . . . 0.0 110.841 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.696 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 16.4 mt -56.66 -28.97 61.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.463 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 67.39 -165.12 43.97 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.739 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.484 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -67.98 120.95 15.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.203 0.525 . . . . 0.0 111.895 -179.402 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.516 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 11.7 m-30 -133.08 153.72 51.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.121 177.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -121.4 -174.0 14.72 Favored Glycine 0 C--N 1.318 -0.465 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.469 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.93 85.66 6.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.373 . . . . 0.0 110.186 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.33 36.75 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.048 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.91 -48.55 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.806 0.303 . . . . 0.0 111.243 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.66 170.18 10.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 111.134 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.463 HG22 ' CB ' ' A' ' 68' ' ' PHE . 35.5 m -57.48 167.37 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.776 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.506 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -64.93 -47.9 73.06 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.516 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 13.0 Cg_endo -66.3 -39.55 17.23 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.873 1.715 . . . . 0.0 112.064 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.463 ' CB ' HG22 ' A' ' 65' ' ' VAL . 11.4 t80 -74.99 -50.79 15.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.819 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -58.92 -32.8 69.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.801 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 59.4 t0 -67.8 -46.39 72.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.002 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.0 -14.41 60.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.647 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.33 -46.38 79.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.741 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.444 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 12.1 p90 -92.05 16.64 10.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.528 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.49 -27.5 15.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.342 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.518 HD13 ' O ' ' A' ' 79' ' ' GLU . 4.8 mt -102.35 60.43 0.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.813 0.34 . . . . 0.0 111.449 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -68.08 -25.04 65.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.009 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -70.82 -26.84 28.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.556 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.46 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 92.65 69.33 1.13 Allowed Glycine 0 CA--C 1.501 -0.806 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.599 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.518 ' O ' HD13 ' A' ' 75' ' ' LEU . 1.4 tm-20 -142.25 177.86 7.96 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.111 -0.544 . . . . 0.0 110.08 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 27' ' ' GLN . 97.8 t -79.58 151.25 4.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.42 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -104.69 157.06 17.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.334 0.588 . . . . 0.0 111.528 -178.374 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.406 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 1.5 mt-10 -52.36 154.67 4.13 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.237 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 82' ' ' GLU . 14.0 Cg_endo -55.2 103.5 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.763 2.309 . . . . 0.0 111.762 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.516 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 92.9 t -101.8 99.68 8.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.564 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.447 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -92.06 112.72 24.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.063 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.42 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 74.1 m -114.48 -175.6 2.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.463 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -56.07 -21.9 24.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.751 0.31 . . . . 0.0 110.874 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -86.78 -23.67 25.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.311 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.97 -170.73 23.05 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.821 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 0.2 OUTLIER -74.66 98.66 3.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.038 0.446 . . . . 0.0 109.905 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.423 ' CD2' HD12 ' A' ' 16' ' ' LEU . 79.4 m80 -86.38 169.34 13.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.455 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.6 t -145.21 153.26 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.664 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.455 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -137.27 122.4 25.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.062 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.404 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 4.1 tptt -128.63 112.87 14.72 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.528 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -57.23 136.5 56.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.701 0.762 . . . . 0.0 112.436 -177.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -159.01 116.82 2.83 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.814 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.565 179.871 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.616 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.425 0 CA-C-O 121.583 0.706 . . . . 0.0 112.332 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -111.2 139.89 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.978 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.5 mtpt -108.88 96.91 6.65 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.446 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.649 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 3.0 t -125.86 179.13 5.34 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.876 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.49 161.4 24.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.431 ' CG ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -136.59 153.4 50.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.534 0.683 . . . . 0.0 112.664 -179.376 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -152.14 115.14 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.85 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.468 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -100.4 128.41 46.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.852 -179.129 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 16' ' ' LEU . 10.9 m -145.14 134.38 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.054 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -76.1 -35.81 59.18 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.617 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -72.25 79.7 0.99 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.458 ' HG3' ' CE1' ' A' ' 90' ' ' TYR . 34.6 tt0 -46.05 -25.47 0.58 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.9 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.86 -31.58 78.61 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 118.836 -1.65 . . . . 0.0 110.44 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.617 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -73.21 -37.96 66.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.079 0.466 . . . . 0.0 109.957 178.194 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.606 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -54.08 -35.9 62.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.908 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.622 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -73.76 -29.39 62.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.802 178.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.87 -48.33 10.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.187 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 30' ' ' LEU . 3.1 m -49.74 -38.93 14.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.066 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.622 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.6 pt20 -58.83 -48.87 79.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.571 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 4.4 pt-20 -73.19 -29.36 62.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.598 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.58 -31.2 47.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.743 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.3 tm? -56.82 -58.95 5.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.238 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -9.51 58.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.626 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.3 -23.35 62.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 111.397 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.23 -15.91 0.88 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.719 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -89.37 157.49 18.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.751 0.31 . . . . 0.0 110.862 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 pttt -100.68 153.95 19.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.133 0.492 . . . . 0.0 111.148 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CZ ' HD23 ' A' ' 96' ' ' LEU . 2.5 p90 -52.63 -40.34 62.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.117 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.4 -34.17 59.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.704 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -67.21 -54.04 24.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.779 0.323 . . . . 0.0 110.854 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -55.92 -32.28 63.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.827 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.27 -53.78 32.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.948 0.404 . . . . 0.0 110.811 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -86.16 -23.37 26.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.164 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 3.0 mm-40 -70.02 -68.94 0.38 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.487 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.77 -13.55 9.09 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.703 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.537 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -64.1 133.59 53.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.912 0.387 . . . . 0.0 111.195 -179.178 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.444 HG13 ' HB3' ' A' ' 16' ' ' LEU . 1.4 pt . . . . . 0 N--CA 1.462 0.167 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.064 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.941 0.401 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -76.79 -4.34 42.98 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.361 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.23 24.59 11.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.422 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 p30 55.74 31.82 18.24 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.337 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 52.97 33.45 44.02 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.914 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 m -84.82 89.43 7.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 110.847 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.649 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 69.6 mt -56.35 -30.05 62.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.503 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 64.54 -165.67 32.01 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.887 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.475 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -68.82 111.01 4.63 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.515 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.616 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 4.9 m-85 -117.03 153.94 31.82 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.04 -174.14 17.51 Favored Glycine 0 C--N 1.312 -0.784 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.446 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -79.57 79.86 6.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.138 0.494 . . . . 0.0 110.033 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.94 36.62 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.66 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -126.6 -41.57 1.85 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.594 0.235 . . . . 0.0 111.181 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -114.51 171.3 7.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.049 0.452 . . . . 0.0 111.297 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 68' ' ' PHE . 32.7 m -52.35 161.92 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.406 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.579 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -65.59 -47.4 67.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.591 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 15.7 Cg_endo -63.27 -40.31 33.09 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.028 1.819 . . . . 0.0 111.893 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.468 ' HB3' HG23 ' A' ' 65' ' ' VAL . 35.6 t80 -74.93 -52.64 10.71 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.036 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.55 -32.48 67.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.8 OUTLIER -63.13 -50.68 69.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.047 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.0 -9.98 59.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.65 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.04 99.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.808 0.337 . . . . 0.0 111.293 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 20.2 p90 -96.46 16.83 17.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.419 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.87 -30.76 12.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.931 0.396 . . . . 0.0 110.827 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 80' ' ' VAL . 4.2 mt -103.57 68.21 0.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.262 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -73.26 -18.26 61.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.155 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -66.55 -26.75 38.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.755 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.419 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 95.18 57.14 1.23 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.598 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.64 176.45 8.68 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.839 0.352 . . . . 0.0 110.801 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.414 ' O ' HD12 ' A' ' 75' ' ' LEU . 42.6 t -84.43 146.08 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.502 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 t -105.37 164.07 12.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.171 0.51 . . . . 0.0 111.477 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -50.89 154.72 2.33 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.107 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.48 105.32 0.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.25 1.967 . . . . 0.0 111.797 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.591 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 59.4 t -101.19 102.14 13.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.549 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -92.11 113.14 25.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.315 -179.628 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.96 -171.46 1.89 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.205 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.88 -19.13 15.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.532 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -92.24 -40.82 10.76 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.89 -172.19 36.38 Favored Glycine 0 CA--C 1.506 -0.473 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.731 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.458 ' CE1' ' HG3' ' A' ' 20' ' ' GLN . 6.2 m-85 -74.91 98.19 3.51 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.364 0.602 . . . . 0.0 110.162 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -82.4 169.14 16.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.465 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 17.9 t -145.49 146.51 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.295 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.451 HG23 ' CE1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -131.22 122.7 51.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.426 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 8.2 tptm -128.29 109.96 11.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.468 178.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.17 134.5 55.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.631 0.729 . . . . 0.0 112.298 -177.62 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -157.51 116.67 3.28 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.67 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.42 -1.211 . . . . 0.0 112.604 179.831 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.603 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.604 0 CA-C-O 121.51 0.671 . . . . 0.0 111.728 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.39 139.48 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.821 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.452 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.9 mtpt -109.63 96.57 6.36 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.653 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.688 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 2.6 t -131.6 179.62 5.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.63 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 6.5 t -127.47 162.74 25.66 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.406 ' CD2' HD23 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -134.17 148.92 50.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.349 0.595 . . . . 0.0 112.556 -179.404 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.6 mp -145.49 131.39 13.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.709 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mt -123.31 133.41 54.15 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.493 ' CG2' ' CG ' ' A' ' 22' ' ' GLU . 21.5 m -150.91 135.85 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.695 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -17.64 64.59 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -72.22 78.34 0.97 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.683 179.062 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -47.07 -41.71 17.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.017 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.6 -31.46 73.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.959 -1.115 . . . . 0.0 112.898 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.561 ' HG3' ' N ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -65.58 -44.44 86.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.223 0.535 . . . . 0.0 110.666 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.561 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -47.67 -40.6 20.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.286 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.71 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -72.9 -28.87 62.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.045 179.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.44 -44.23 17.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.254 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 30' ' ' LEU . 14.7 m -58.2 -29.0 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.71 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.8 pt20 -54.91 -53.47 55.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.989 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.485 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.0 OUTLIER -73.83 -28.91 61.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.127 0.489 . . . . 0.0 110.634 178.551 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.98 -34.29 59.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.273 -178.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.1 tm? -52.81 -49.68 65.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.173 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 -9.19 58.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.301 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.36 49.11 0.36 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.52 -10.51 36.79 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.758 -0.734 . . . . 0.0 114.171 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -92.62 153.83 18.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.378 0.589 . . . . 0.0 110.852 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 143.38 30.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.274 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.442 ' CE1' HD21 ' A' ' 96' ' ' LEU . 5.2 p90 -52.89 -35.79 58.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.748 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.46 -36.37 93.05 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.27 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 10.5 tttt -60.83 -53.77 53.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.843 0.354 . . . . 0.0 110.807 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.406 ' O ' HD22 ' A' ' 43' ' ' LEU . 2.8 mm? -53.64 -34.12 57.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.007 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.63 -53.41 38.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.956 0.408 . . . . 0.0 110.81 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -23.55 26.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.934 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -68.96 -68.69 0.38 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.076 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.66 -16.07 8.86 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.423 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -64.23 141.5 58.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.192 0.52 . . . . 0.0 111.522 -179.193 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.9 pt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.894 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.162 0 CA-C-O 121.245 0.545 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.6 -13.17 61.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.942 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.87 24.43 11.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.381 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 73.5 9.24 5.06 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.27 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.3 24.63 70.76 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.225 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.4 p -75.94 82.77 2.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.97 0.414 . . . . 0.0 110.615 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.688 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 14.6 mt -53.94 -24.5 16.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.992 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.04 -163.67 20.03 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.828 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.452 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -72.68 111.51 7.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.995 0.426 . . . . 0.0 111.744 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.603 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 3.8 m-85 -123.71 163.62 20.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.77 -173.99 14.96 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.628 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.55 93.89 7.94 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.897 0.38 . . . . 0.0 110.189 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.42 36.79 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.854 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.43 -44.54 0.22 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.622 0.249 . . . . 0.0 111.241 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.05 165.74 13.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 111.298 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.48 HG23 ' CB ' ' A' ' 68' ' ' PHE . 35.9 m -61.7 165.06 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.894 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.501 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -60.63 -48.06 94.34 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 13.8 Cg_endo -66.2 -37.68 23.95 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 121.897 1.731 . . . . 0.0 111.962 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.48 ' CB ' HG23 ' A' ' 65' ' ' VAL . 40.0 t80 -74.96 -52.31 11.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.905 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.79 -32.27 63.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.799 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 2.6 m-20 -65.19 -52.08 57.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.995 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.42 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . . . -75.09 -9.28 58.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.908 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.27 -38.31 71.85 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 2.8 p90 -106.04 16.76 24.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.42 ' HG2' ' HA ' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -98.76 -27.69 13.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.329 . . . . 0.0 110.98 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 80' ' ' VAL . 3.1 mt -103.47 66.43 0.88 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.076 0.465 . . . . 0.0 111.447 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -73.29 -18.23 61.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.005 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.96 -27.0 39.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.663 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.425 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 95.6 58.74 1.11 Allowed Glycine 0 CA--C 1.503 -0.67 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.536 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.33 176.28 8.9 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.776 0.322 . . . . 0.0 111.084 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.452 ' O ' HD12 ' A' ' 75' ' ' LEU . 55.6 t -82.84 146.58 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.158 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 t -104.84 164.14 12.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.346 0.593 . . . . 0.0 111.917 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -50.75 156.42 1.62 Allowed Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.634 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.411 ' HG3' ' CD2' ' A' ' 24' ' ' LEU . 26.9 Cg_endo -61.09 105.17 0.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.583 2.188 . . . . 0.0 112.141 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.498 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 87.7 t -101.27 99.47 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.582 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.446 ' CG ' ' CD1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -97.97 112.79 24.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.798 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.9 m -110.62 -175.75 2.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.635 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.34 -21.64 25.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.093 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -85.45 -26.73 26.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.38 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 144.18 -165.32 27.42 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.771 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.446 ' CD1' ' CG ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -83.26 106.68 15.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -92.64 157.92 16.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.476 0.655 . . . . 0.0 112.597 -178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.1 t -140.72 153.17 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.264 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.459 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -141.26 124.16 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -128.11 113.87 16.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.282 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.5 135.4 56.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.54 0.686 . . . . 0.0 112.231 -177.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -157.38 116.65 3.32 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.733 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.605 -179.999 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.696 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.651 0 CA-C-O 121.429 0.633 . . . . 0.0 111.595 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -111.31 139.11 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.828 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.478 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.5 mtpt -107.93 98.3 7.9 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.366 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.778 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 2.1 t -130.32 -179.84 5.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.824 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.4 t -120.73 162.89 18.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.975 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.449 ' O ' ' CD2' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -130.33 139.32 50.7 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.997 0.427 . . . . 0.0 111.781 -179.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.453 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 4.7 mp -153.3 118.97 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.45 HD12 ' CD2' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -109.63 140.91 42.89 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.922 0.391 . . . . 0.0 111.034 179.649 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 43' ' ' LEU . 4.4 m -149.1 134.35 10.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.732 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -35.86 69.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.808 -178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.634 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 4.7 tttp -72.83 78.8 1.14 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.49 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -46.64 -25.99 0.82 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.027 -0.988 . . . . 0.0 113.225 -176.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.54 -31.53 76.72 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 119.026 -1.559 . . . . 0.0 110.921 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.634 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -71.07 -38.81 72.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.059 0.457 . . . . 0.0 110.491 178.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.613 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -52.03 -37.15 52.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.363 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.521 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.25 -29.86 63.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.646 179.046 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.99 -41.45 18.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.496 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.1 m -52.33 -37.83 24.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.014 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.64 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -59.24 -48.84 80.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.64 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.3 pt-20 -73.27 -29.0 62.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.66 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.438 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 8.1 tpt180 -78.86 -32.28 45.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.01 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.401 ' HG ' ' HG3' ' A' ' 94' ' ' LYS . 0.7 OUTLIER -53.12 -59.4 4.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.171 -179.048 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 -9.44 58.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.371 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.04 -24.96 63.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.858 0.361 . . . . 0.0 111.327 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.4 -17.01 0.77 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.579 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -86.84 154.99 20.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.901 0.382 . . . . 0.0 110.79 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.92 146.2 27.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.129 0.49 . . . . 0.0 111.079 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.441 ' CE2' ' HB2' ' A' ' 96' ' ' LEU . 3.7 p90 -47.1 -30.76 2.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.743 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.47 -34.24 88.81 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.178 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -66.64 -53.47 33.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.766 0.317 . . . . 0.0 110.765 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -53.37 -36.07 60.99 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.273 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 44' ' ' SER . . . -52.1 -52.94 48.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.178 0.513 . . . . 0.0 110.701 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.57 -23.57 27.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.727 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 1.1 mt-10 -73.58 -67.86 0.55 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.52 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.99 -12.56 9.51 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 3.3 t -63.12 125.98 25.86 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.891 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 pt . . . . . 0 C--N 1.326 -0.423 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.096 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 121.345 0.593 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -88.78 -5.29 58.17 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.2 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.431 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 2.5 mtt180 -119.06 24.98 10.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.84 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 76.39 16.06 2.15 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.332 -179.722 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.18 17.01 65.39 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.577 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.0 m -70.91 86.32 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.672 0.272 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.778 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 23.4 mt -54.77 -31.15 58.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.037 0.446 . . . . 0.0 110.577 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 69.94 -170.29 44.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.43 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.478 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -67.87 111.58 4.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 111.625 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.696 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 6.4 m-85 -123.89 159.21 30.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.666 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.72 -174.06 18.67 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.293 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -88.01 96.82 10.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.988 0.423 . . . . 0.0 110.335 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.16 36.73 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.373 -0.917 . . . . 0.0 113.067 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 tptm -143.45 -47.51 0.3 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.75 0.31 . . . . 0.0 111.259 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.17 166.93 12.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.878 0.371 . . . . 0.0 111.278 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.468 HG23 ' CB ' ' A' ' 68' ' ' PHE . 35.0 m -54.63 165.75 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.174 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 20.7 tttm -64.29 -47.93 77.15 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 14.0 Cg_endo -65.46 -38.16 27.02 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 121.861 1.708 . . . . 0.0 111.939 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.486 ' CZ ' HG21 ' A' ' 93' ' ' ILE . 24.4 t80 -74.94 -52.69 10.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.647 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.17 -34.03 68.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.779 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.456 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 23.6 t0 -69.03 -47.95 64.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.059 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.33 -9.69 58.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.785 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.37 -49.03 68.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.785 0.326 . . . . 0.0 111.709 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 3.0 p90 -92.7 16.92 11.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.601 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.7 -29.37 14.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 80' ' ' VAL . 4.3 mt -103.57 66.01 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.474 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -69.9 -19.97 63.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.061 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 p -64.54 -26.88 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.57 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.414 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 94.22 58.05 1.25 Allowed Glycine 0 CA--C 1.504 -0.645 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.719 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.13 176.37 8.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.779 0.323 . . . . 0.0 111.077 -178.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.468 ' O ' HD13 ' A' ' 75' ' ' LEU . 86.2 t -81.28 146.7 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.0 t -104.68 164.1 12.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.222 0.534 . . . . 0.0 111.777 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -50.54 155.08 1.96 Allowed Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.328 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.503 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 18.5 Cg_endo -60.18 106.33 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.358 2.038 . . . . 0.0 111.741 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.513 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 97.5 t -100.95 100.22 9.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.608 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.451 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.7 OUTLIER -94.53 112.96 24.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.942 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.63 -172.11 1.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.505 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -57.54 -20.95 35.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.858 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -85.86 -37.23 19.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.245 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.81 -168.46 30.56 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.656 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.503 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -75.34 98.57 3.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.005 0.431 . . . . 0.0 109.926 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.45 ' CD2' HD12 ' A' ' 16' ' ' LEU . 70.1 m80 -80.41 165.08 22.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.397 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.7 t -149.19 138.38 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.762 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.486 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -127.99 122.7 59.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.403 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 1.4 tmtm? -126.18 112.27 15.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.186 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.5 132.33 52.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.559 0.695 . . . . 0.0 111.89 -177.697 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -155.06 116.75 4.09 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.685 179.643 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.339 -1.256 . . . . 0.0 112.619 179.914 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.481 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 3.5 mptt . . . . . 0 CA--C 1.517 -0.304 0 CA-C-O 121.123 0.487 . . . . 0.0 111.707 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 mt -111.03 128.08 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.349 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.428 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.8 mtpt -97.9 92.73 5.96 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.109 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.598 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -124.06 -179.89 4.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.309 -177.552 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 94' ' ' LYS . 2.0 t -123.14 160.17 27.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.954 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.404 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -136.29 147.23 47.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.335 0.588 . . . . 0.0 111.977 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.404 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 3.2 mp -151.91 115.39 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.314 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.576 ' HB3' ' CG1' ' A' ' 45' ' ' ILE . 7.7 tp -100.77 132.37 46.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 16' ' ' LEU . 12.3 m -146.07 134.11 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.815 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -75.01 -36.29 61.94 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.415 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.616 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -71.84 79.35 0.87 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.597 0.713 . . . . 0.0 109.078 178.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.495 ' HG3' ' CZ ' ' A' ' 90' ' ' TYR . 1.3 tm0? -45.71 -25.73 0.53 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.218 -177.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.73 -31.55 78.72 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 118.774 -1.679 . . . . 0.0 110.688 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.665 ' HG3' ' N ' ' A' ' 23' ' ' ALA . 0.3 OUTLIER -71.77 -39.41 69.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.152 0.501 . . . . 0.0 109.803 178.146 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.665 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -51.5 -36.91 46.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.996 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.605 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.55 -29.44 62.44 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.949 179.011 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.08 -40.46 16.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.51 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.3 m -56.92 -37.55 54.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.058 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.605 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.0 pt20 -56.84 -51.33 69.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.542 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.6 pt-20 -73.45 -29.18 62.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.618 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -75.6 -33.57 60.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.633 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.436 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -52.94 -58.91 5.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 -179.44 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -8.78 56.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.521 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.99 -20.09 21.95 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.39 -10.47 1.73 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.131 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.436 ' OE1' ' HA ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -103.77 158.2 16.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.904 0.383 . . . . 0.0 110.677 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -97.29 154.26 17.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.37 0.605 . . . . 0.0 112.17 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -53.0 -35.22 59.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.388 179.316 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.413 ' HA2' ' CA ' ' A' ' 53' ' ' ASP . . . -53.54 -34.16 49.01 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.001 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 9.7 mtpp -69.98 -53.63 16.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.656 0.265 . . . . 0.0 110.442 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.417 HD23 ' CD2' ' A' ' 30' ' ' LEU . 2.9 mm? -54.0 -33.36 56.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.716 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.52 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.59 -53.36 39.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.071 0.462 . . . . 0.0 110.657 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.21 -23.33 26.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.214 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.474 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 1.3 mt-10 -71.15 -69.18 0.39 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.474 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.78 -11.64 9.34 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.582 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.52 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -63.9 138.53 58.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.03 0.443 . . . . 0.0 111.33 -179.035 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.576 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 43.1 pt . . . . . 0 C--N 1.333 -0.139 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.959 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.924 0.392 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -8.08 32.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.17 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -104.21 23.69 12.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.89 0.376 . . . . 0.0 110.702 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.413 ' CA ' ' HA2' ' A' ' 37' ' ' GLY . 0.0 OUTLIER 71.96 13.0 6.04 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.241 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.3 16.69 80.52 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.418 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 m -74.06 89.77 1.97 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.783 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.598 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 13.2 mt -56.5 -28.35 59.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.665 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.59 -166.62 42.35 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.428 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -68.31 118.71 11.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.112 0.482 . . . . 0.0 111.923 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.481 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 10.5 m-85 -131.57 150.44 52.15 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.39 -173.88 18.27 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.577 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 -76.27 81.97 3.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 110.084 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.46 36.67 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.939 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -134.8 -48.52 0.75 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.815 0.34 . . . . 0.0 111.232 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.58 170.61 8.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.137 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.46 HG23 ' CB ' ' A' ' 68' ' ' PHE . 33.0 m -57.06 159.56 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.544 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -62.1 -47.9 89.44 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.592 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 17.5 Cg_endo -64.63 -39.2 28.27 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.932 1.754 . . . . 0.0 112.115 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.46 ' CB ' HG23 ' A' ' 65' ' ' VAL . 17.6 t80 -74.92 -52.02 12.3 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.728 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -56.01 -32.29 63.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.676 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -64.26 -52.62 57.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.871 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.0 -11.96 60.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.638 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.32 -48.5 81.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.799 0.333 . . . . 0.0 111.407 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 6.7 p90 -93.23 16.83 12.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.372 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.31 -28.58 13.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.895 0.379 . . . . 0.0 110.834 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 80' ' ' VAL . 3.0 mt -103.63 62.81 0.77 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.291 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -69.61 -18.39 63.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.087 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -64.61 -26.86 41.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.53 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.27 56.88 1.24 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.669 -0.776 . . . . 0.0 111.731 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -139.36 176.29 8.84 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.89 0.376 . . . . 0.0 110.982 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 61.1 t -84.29 147.55 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.069 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.97 164.12 12.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.225 0.536 . . . . 0.0 111.431 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -50.48 154.43 2.22 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.986 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.0 104.97 0.25 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.177 1.918 . . . . 0.0 111.819 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.592 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 59.3 t -101.33 102.0 12.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.528 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 90' ' ' TYR . 3.9 tmtt? -92.38 112.87 24.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.351 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.4 -171.58 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.141 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -16.26 40.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.217 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -94.01 -40.82 9.9 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.65 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.17 -174.24 40.25 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.812 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 1.7 m-85 -76.92 98.38 4.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.233 0.54 . . . . 0.0 110.374 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.443 ' CD2' HD13 ' A' ' 16' ' ' LEU . 58.2 m80 -78.24 169.78 17.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.669 -178.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 29.6 t -151.33 128.57 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.363 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.455 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -111.5 123.2 67.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.25 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 13' ' ' SER . 28.1 tptp -128.28 115.17 17.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.454 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.426 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -58.33 134.87 56.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.45 0.643 . . . . 0.0 112.134 -178.544 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -160.72 116.6 2.27 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.217 179.605 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.414 -1.214 . . . . 0.0 112.532 179.642 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.512 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 121.029 0.442 . . . . 0.0 111.128 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.448 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -111.03 135.88 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.5 mtpt -106.83 95.11 5.5 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.653 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.704 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 2.4 t -124.06 179.58 4.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.894 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 1.8 p -123.37 162.25 23.12 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.438 ' CE1' ' HA2' ' A' ' 54' ' ' GLY . 20.4 p-80 -133.97 153.75 51.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.399 0.619 . . . . 0.0 112.327 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.408 HG23 ' OG ' ' A' ' 44' ' ' SER . 2.9 mp -156.75 122.73 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.777 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.567 ' HB3' ' CG1' ' A' ' 45' ' ' ILE . 10.3 tp -110.32 132.15 54.43 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 16' ' ' LEU . 15.5 m -142.88 134.45 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.391 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.53 -35.78 63.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.5 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.618 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -73.12 79.3 1.24 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 2.0 pt20 -46.28 -25.58 0.65 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.328 -0.851 . . . . 0.0 113.154 -176.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.02 -31.4 77.84 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.119 -1.515 . . . . 0.0 110.67 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.618 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -71.26 -37.85 71.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.084 0.469 . . . . 0.0 109.928 178.39 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.581 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.87 -38.01 46.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.15 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.593 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -73.07 -29.58 63.05 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.823 179.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.95 -53.33 5.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.795 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.409 ' CG1' ' OE1' ' A' ' 22' ' ' GLU . 3.8 m -47.03 -37.34 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.322 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.593 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.5 pt20 -59.92 -48.21 82.64 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.554 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 3.4 pt-20 -73.06 -29.01 62.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.648 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -78.62 -35.37 45.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.771 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -52.74 -58.81 5.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.29 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.97 -9.6 58.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.254 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.25 -24.57 63.31 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.864 0.364 . . . . 0.0 111.114 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.36 -17.21 1.15 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.436 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -78.92 157.7 28.18 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.985 0.422 . . . . 0.0 110.949 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -98.08 140.1 32.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.027 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -51.39 -32.13 25.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.848 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.4 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -62.79 -34.25 89.23 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.213 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.2 mmtt -65.96 -53.57 37.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.661 0.267 . . . . 0.0 110.783 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -53.85 -32.33 52.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.517 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.535 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.36 -53.78 32.88 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.549 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.18 -23.47 26.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.224 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.494 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.78 -68.8 0.41 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -177.43 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.494 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.63 -12.25 9.31 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.535 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -64.05 140.32 58.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.931 0.396 . . . . 0.0 111.289 -179.241 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.567 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 31.7 pt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.686 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 121.28 0.562 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.36 -8.79 57.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.373 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.418 ' O ' ' CG ' ' A' ' 53' ' ' ASP . 0.5 OUTLIER -103.67 24.67 10.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.423 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.418 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 2.1 p30 54.08 34.8 20.73 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.97 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.438 ' HA2' ' CE1' ' A' ' 14' ' ' HIS . . . 56.76 21.47 36.59 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.417 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.7 p -70.38 86.81 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.85 0.357 . . . . 0.0 111.257 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.704 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 46.6 mt -59.69 -33.4 71.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.102 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.94 -167.13 48.98 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.947 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -69.19 119.15 13.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.045 0.45 . . . . 0.0 111.851 -179.387 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.512 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 9.3 p90 -135.46 135.48 40.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.48 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.42 -174.01 49.89 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.601 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 ptt-85 -89.73 89.4 7.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.948 0.404 . . . . 0.0 110.505 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.1 36.45 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.057 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -146.52 7.01 0.97 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.449 ' CE ' ' CD1' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -141.33 174.24 10.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.75 0.31 . . . . 0.0 110.844 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.449 HG23 ' HB3' ' A' ' 68' ' ' PHE . 23.9 m -68.35 154.48 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.804 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -59.65 -46.94 98.59 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 17.5 Cg_endo -64.45 -41.22 21.07 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.937 1.758 . . . . 0.0 112.155 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.465 ' CZ ' HG22 ' A' ' 93' ' ' ILE . 26.2 t80 -74.98 -51.4 13.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.77 -32.31 65.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.797 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 11.6 t70 -63.82 -51.21 65.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.109 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.9 -10.02 59.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.756 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.46 -50.01 66.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.727 0.299 . . . . 0.0 111.497 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 6.2 p90 -93.33 16.51 13.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.464 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.4 ttm-85 -96.57 -31.9 12.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.658 0.266 . . . . 0.0 111.226 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' A' ' 79' ' ' GLU . 0.7 OUTLIER -103.37 55.88 0.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.385 -179.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -58.83 -22.21 58.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.089 0.471 . . . . 0.0 110.029 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.07 -28.43 39.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.435 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.466 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 97.05 59.09 1.0 Allowed Glycine 0 CA--C 1.508 -0.397 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.303 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.522 ' O ' ' CD1' ' A' ' 75' ' ' LEU . 5.6 pt-20 -130.22 177.38 7.36 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.7 t -88.65 148.41 4.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' SER . . . . . 0.46 ' CA ' HD13 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -104.42 164.03 12.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.136 0.493 . . . . 0.0 111.282 -178.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -50.43 154.76 2.04 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.866 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.403 ' HG3' ' CD2' ' A' ' 24' ' ' LEU . 14.1 Cg_endo -55.58 104.53 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.367 2.045 . . . . 0.0 111.721 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 94.3 t -101.64 101.54 12.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.684 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.455 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 19.2 tptp -95.54 112.49 24.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.573 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.9 m -112.5 -176.97 3.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.468 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.81 -22.33 14.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.939 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.94 -27.57 24.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.331 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.5 -170.71 24.06 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.823 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.46 ' CD1' ' HB3' ' A' ' 20' ' ' GLN . 0.5 OUTLIER -74.56 100.78 4.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.045 0.45 . . . . 0.0 109.927 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.424 ' CD2' ' CD1' ' A' ' 16' ' ' LEU . 10.3 m80 -87.35 169.31 12.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.586 0.707 . . . . 0.0 112.742 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.1 t -146.76 136.29 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.119 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.465 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -126.58 122.5 61.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.352 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -128.54 110.33 12.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.456 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.56 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.62 134.36 56.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.596 0.713 . . . . 0.0 112.195 -177.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -153.8 116.4 4.42 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.593 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.415 ' HA3' ' HD3' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.424 -1.209 . . . . 0.0 112.541 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.668 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.65 0 CA-C-O 121.442 0.639 . . . . 0.0 111.933 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mt -111.0 136.93 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.944 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.488 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.4 mtpt -108.11 86.71 2.34 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.577 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.81 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 7.1 m -130.58 179.98 5.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.636 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.463 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 2.9 p -135.33 161.76 34.49 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.428 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 0.7 OUTLIER -141.24 155.49 46.01 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.196 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.56 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 1.7 mp -134.95 141.81 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.863 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.444 ' O ' HG11 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -121.48 128.84 52.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.77 0.319 . . . . 0.0 111.723 -179.499 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.475 ' CG2' ' CG ' ' A' ' 22' ' ' GLU . 24.7 m -144.12 134.21 20.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.465 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.12 -36.27 74.7 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.732 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.612 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.09 78.55 0.94 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.486 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.453 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -46.67 -25.98 0.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.714 -1.13 . . . . 0.0 113.191 -177.584 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.39 -31.31 76.61 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.086 -1.531 . . . . 0.0 111.091 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.678 ' HG3' ' N ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -70.25 -39.91 74.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.142 0.496 . . . . 0.0 110.03 178.568 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.678 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -51.15 -37.16 44.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.227 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.607 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.41 -29.46 62.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.922 179.17 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.66 -42.53 14.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.484 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 30' ' ' LEU . 2.7 m -53.4 -39.17 34.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.881 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.607 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.5 pt20 -56.33 -50.19 72.17 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.578 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 4.6 pt-20 -73.36 -30.98 63.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.803 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -77.18 -27.52 53.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.011 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -60.78 -52.76 63.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.419 -179.101 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -9.4 49.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.525 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.28 -22.05 27.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.761 0.315 . . . . 0.0 111.387 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.37 -10.73 3.8 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.387 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -77.81 157.46 29.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.823 0.344 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.12 136.01 33.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.789 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.56 ' CE2' ' CD1' ' A' ' 15' ' ' ILE . 4.8 t80 -53.94 -48.15 70.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.236 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.26 -33.9 53.03 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.293 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.0 mmmt -60.33 -52.26 66.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.707 0.289 . . . . 0.0 110.873 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.4 ' HA ' ' HB2' ' A' ' 42' ' ' GLU . 2.9 mm? -53.34 -33.54 53.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.49 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.45 -53.81 33.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.074 0.464 . . . . 0.0 110.582 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -85.94 -23.66 26.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.059 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.493 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -69.12 -68.35 0.41 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.493 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.21 -15.43 9.18 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.72 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.49 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -64.28 134.5 54.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.115 0.483 . . . . 0.0 111.14 -179.588 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.172 179.854 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.171 0 CA-C-O 120.915 0.388 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -6.1 51.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.522 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.419 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -104.15 24.09 12.01 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.406 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 72.04 12.87 5.96 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.354 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 59.59 21.6 54.99 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.535 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m -74.7 84.7 2.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.972 0.415 . . . . 0.0 110.548 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.81 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 20.4 mt -59.43 -20.24 53.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.883 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 49.06 -170.94 0.08 OUTLIER Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.57 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.488 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -56.17 111.4 0.95 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.038 0.447 . . . . 0.0 111.678 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.668 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 2.3 m-85 -128.48 164.37 22.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.265 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.08 -174.09 13.65 Favored Glycine 0 C--N 1.317 -0.528 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.159 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -86.48 116.38 24.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.922 0.392 . . . . 0.0 110.023 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.28 -12.05 1.38 Allowed Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.082 -1.056 . . . . 0.0 113.357 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.43 30.78 4.42 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.031 0.415 . . . . 0.0 111.754 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.401 ' CG ' ' HG3' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -151.36 149.37 29.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.804 0.335 . . . . 0.0 111.191 179.433 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.475 HG22 ' HB3' ' A' ' 68' ' ' PHE . 33.4 m -52.6 156.26 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.197 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.547 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.15 -47.8 98.2 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.022 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 18.8 Cg_endo -65.43 -38.8 24.43 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.061 1.841 . . . . 0.0 112.367 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.475 ' HB3' HG22 ' A' ' 65' ' ' VAL . 18.1 t80 -74.92 -49.8 19.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.475 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.401 ' HG3' ' CG ' ' A' ' 64' ' ' MET . 0.2 OUTLIER -54.5 -35.8 63.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.21 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.418 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 6.8 t70 -68.67 -49.94 55.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.798 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.94 -10.68 59.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.659 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.1 -45.48 85.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.722 0.296 . . . . 0.0 111.618 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.418 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 1.4 p90 -99.33 16.94 21.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.712 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -95.07 -28.66 14.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.75 0.31 . . . . 0.0 110.918 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.453 HD11 ' O ' ' A' ' 80' ' ' VAL . 2.7 mt -103.7 65.37 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.026 0.441 . . . . 0.0 111.678 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -74.32 -17.65 60.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.938 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -67.66 -26.82 36.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.842 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.555 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 96.06 59.14 1.06 Allowed Glycine 0 CA--C 1.503 -0.672 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.393 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.5 176.24 8.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.931 0.395 . . . . 0.0 111.007 -178.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.453 ' O ' HD11 ' A' ' 75' ' ' LEU . 38.4 t -83.75 147.76 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.962 178.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.66 159.09 16.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.224 0.535 . . . . 0.0 111.197 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -50.61 159.49 0.89 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.077 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.43 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 18.9 Cg_endo -59.02 104.08 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.474 2.116 . . . . 0.0 111.913 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.531 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 95.7 t -101.54 102.52 13.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.682 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.469 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 5.5 tptp -91.86 112.95 25.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.859 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.25 -173.12 2.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.418 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.18 -16.2 51.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.064 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -93.56 -38.76 11.21 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.534 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.97 -168.74 35.75 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.898 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -77.0 99.53 5.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.418 ' CE1' HD13 ' A' ' 16' ' ' LEU . 17.1 m80 -88.42 165.27 15.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.45 0.643 . . . . 0.0 112.734 -178.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 40.5 t -143.79 152.39 16.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.117 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.454 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -139.59 122.05 17.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -179.045 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.496 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -129.37 108.69 10.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.955 178.051 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.555 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 6.9 ttt85 -58.11 135.68 57.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.642 0.734 . . . . 0.0 112.275 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.4 OUTLIER -154.3 116.48 4.28 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.24 179.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.378 -1.234 . . . . 0.0 112.586 179.912 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LYS . . . . . 0.505 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.617 0 CA-C-O 121.204 0.526 . . . . 0.0 111.128 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.41 138.35 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.654 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.029 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.439 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.6 mtpt -108.72 96.16 6.15 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.067 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' CYS . . . . . 0.632 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 2.4 t -127.7 179.39 5.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.273 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 t -126.37 159.79 32.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' HIS . . . . . 0.42 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -136.66 150.88 48.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.405 0.621 . . . . 0.0 112.553 -179.405 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.446 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 3.5 mp -153.27 115.34 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.009 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.412 HD23 ' CD2' ' A' ' 91' ' ' HIS . 0.9 OUTLIER -100.1 139.09 36.27 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.513 ' CG2' ' CG ' ' A' ' 22' ' ' GLU . 30.0 m -155.22 134.19 3.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.793 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -19.31 65.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -72.38 78.36 1.02 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.149 179.093 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 5.8 pt20 -47.34 -40.0 16.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.32 -31.14 66.27 Favored Glycine 0 CA--C 1.511 -0.19 0 C-N-CA 119.925 -1.131 . . . . 0.0 112.697 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -65.6 -39.79 91.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.339 0.59 . . . . 0.0 110.253 179.525 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.729 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . -43.8 -42.16 5.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.387 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.581 ' HA ' ' HG3' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -72.66 -45.47 58.77 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.266 178.215 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.0 -57.31 9.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.694 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 23' ' ' ALA . 4.8 m -55.07 -30.42 23.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.684 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLN . . . . . 0.729 ' HG3' ' O ' ' A' ' 23' ' ' ALA . 52.9 mt-30 -53.04 -60.06 3.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.28 0.562 . . . . 0.0 109.939 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -26.03 61.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.82 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.417 ' HB3' ' HA ' ' A' ' 26' ' ' VAL . 14.2 tpp85 -78.51 -30.31 47.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.094 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.5 OUTLIER -56.7 -59.04 5.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 0.0 110.932 -179.234 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -9.3 58.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.322 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.05 -25.81 64.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.996 0.427 . . . . 0.0 111.35 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.99 -17.15 0.92 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.491 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 29' ' ' ARG . 21.9 pt-20 -79.76 157.81 27.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.993 0.425 . . . . 0.0 110.816 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -96.23 137.07 35.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.079 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.43 ' CZ ' HD21 ' A' ' 96' ' ' LEU . 2.4 p90 -47.61 -33.53 6.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.628 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -65.28 -34.93 90.83 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.137 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -60.16 -53.81 53.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.598 0.237 . . . . 0.0 110.592 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.41 HD23 ' CD2' ' A' ' 30' ' ' LEU . 2.6 mm? -55.68 -34.36 64.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.803 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.3 -53.77 32.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.029 0.442 . . . . 0.0 110.503 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -85.97 -23.63 26.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.18 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 1.0 OUTLIER -70.14 -68.7 0.4 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -177.721 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.484 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.54 -11.36 9.47 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.531 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.537 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -63.58 134.46 55.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.273 0.559 . . . . 0.0 111.333 -179.165 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 16' ' ' LEU . 25.1 pt . . . . . 0 N--CA 1.452 -0.345 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.358 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.132 0 CA-C-O 120.797 0.332 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -68.36 -2.95 9.51 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.972 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.466 ' O ' ' CG ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -103.65 24.78 10.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.697 0.284 . . . . 0.0 110.539 179.767 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.467 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 1.5 p30 59.58 29.62 19.19 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.189 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 53.78 23.35 21.67 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.841 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.92 89.96 4.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.809 0.338 . . . . 0.0 110.825 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.632 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 87.0 mt -58.37 -28.83 65.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.58 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.42 -166.26 15.74 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.991 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . 0.5 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -65.14 117.59 7.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.117 0.484 . . . . 0.0 111.749 -179.474 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.505 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 5.3 m-85 -128.44 158.63 37.79 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.52 -173.95 13.59 Favored Glycine 0 C--N 1.317 -0.49 0 C-N-CA 120.199 -1.0 . . . . 0.0 112.497 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.09 84.57 2.32 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.044 0.45 . . . . 0.0 110.126 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.42 36.85 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.063 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.05 -48.67 0.61 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.637 0.256 . . . . 0.0 111.292 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.55 169.84 9.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.937 0.399 . . . . 0.0 111.306 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . 0.471 HG23 ' CB ' ' A' ' 68' ' ' PHE . 35.9 m -59.43 165.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.965 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LYS . . . . . 0.534 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 7.5 ttpt -62.73 -48.01 86.58 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 15.2 Cg_endo -65.36 -39.34 22.75 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.863 1.709 . . . . 0.0 111.897 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.471 ' CB ' HG23 ' A' ' 65' ' ' VAL . 24.5 t80 -75.0 -52.49 10.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.98 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -57.52 -32.66 67.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 1.9 m-20 -63.7 -50.56 68.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.049 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.3 -9.49 58.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.798 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.42 -47.52 75.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 111.602 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 11.4 p90 -93.89 16.78 13.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.535 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -97.98 -30.39 12.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.93 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 80' ' ' VAL . 3.9 mt -103.49 68.08 0.93 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.471 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -72.8 -19.28 61.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.096 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -65.86 -26.67 39.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.725 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLY . . . . . 0.433 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 94.66 59.44 1.14 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.57 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -141.03 176.34 8.9 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.826 0.346 . . . . 0.0 111.104 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.513 HG21 ' HA ' ' A' ' 27' ' ' GLN . 26.9 t -81.01 146.6 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.84 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.2 t -104.66 164.11 12.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.258 0.551 . . . . 0.0 111.583 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -50.51 152.1 3.52 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.463 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.447 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 19.5 Cg_endo -58.46 106.09 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.466 2.111 . . . . 0.0 111.65 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.531 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 93.0 t -100.96 101.14 11.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.593 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . 0.448 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 4.8 tptm -91.63 112.8 24.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.757 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.1 m -114.73 -171.95 2.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.578 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.35 -18.62 51.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.184 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -90.91 -24.48 20.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.467 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 141.48 -161.66 26.96 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.784 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.448 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 0.2 OUTLIER -83.02 98.14 9.11 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' HIS . . . . . 0.412 ' CD2' HD23 ' A' ' 16' ' ' LEU . 9.8 m80 -81.49 154.35 26.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.481 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 37.2 t -139.71 135.84 39.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.296 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . 0.467 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -123.84 122.52 64.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.423 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.412 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -128.2 112.69 14.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.197 178.36 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -57.34 136.45 56.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.705 0.764 . . . . 0.0 112.517 -177.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -157.69 116.73 3.23 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.616 179.595 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.352 -1.249 . . . . 0.0 112.554 179.93 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.86 162.59 41.56 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.585 2.19 . . . . 0.0 112.268 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.38 134.03 52.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.82 46.07 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.513 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.63 164.84 22.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.328 . . . . 0.0 110.979 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.58 112.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.959 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.11 39.87 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.976 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -51.06 -36.91 42.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.812 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.545 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.64 171.63 12.25 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.764 0.793 . . . . 0.0 112.142 -179.61 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -114.84 138.36 45.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.569 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.445 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.9 mtpt -108.87 97.82 7.4 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.494 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.734 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 1.9 t -135.34 179.88 6.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.555 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.444 ' OG ' ' CD2' ' A' ' 36' ' ' PHE . 2.4 p -134.75 162.44 32.34 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.441 ' C ' HD12 ' A' ' 15' ' ' ILE . 12.3 p-80 -136.55 148.57 47.65 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.566 HD12 ' CE2' ' A' ' 36' ' ' PHE . 1.6 mp -130.74 154.14 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.675 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.455 ' HG ' ' CD2' ' A' ' 91' ' ' HIS . 2.5 mt -137.32 135.4 37.04 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.552 ' CG2' ' HG3' ' A' ' 22' ' ' GLU . 23.3 m -149.2 134.27 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.589 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -35.92 74.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.979 0.419 . . . . 0.0 110.323 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.582 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 37.2 pttt -72.13 79.66 0.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.474 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 12.1 pt20 -45.62 -26.28 0.59 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.867 -1.061 . . . . 0.0 112.441 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.17 -31.75 75.25 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.975 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.582 ' HG2' ' HG3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -69.36 -42.84 74.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.013 0.435 . . . . 0.0 110.238 179.178 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.526 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -47.64 -38.3 14.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.279 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.41 -31.93 64.14 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.667 179.055 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.76 -52.93 8.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.068 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.487 ' O ' ' N ' ' A' ' 30' ' ' LEU . 19.9 m -50.12 -46.69 24.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.68 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.53 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -54.07 -36.36 63.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.549 . . . . 0.0 109.955 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.53 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -72.84 -47.15 48.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.43 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.9 -23.18 44.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.146 -178.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.487 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.9 OUTLIER -52.87 -47.63 67.69 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.768 0.318 . . . . 0.0 111.293 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.406 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -72.01 -9.42 58.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.386 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.27 -23.24 46.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 111.333 -179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.45 -12.47 3.24 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.399 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -75.08 153.8 38.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.797 0.332 . . . . 0.0 110.605 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -87.57 131.2 34.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.979 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.566 ' CE2' HD12 ' A' ' 15' ' ' ILE . 5.0 t80 -48.8 -49.52 38.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.013 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.65 -34.22 55.78 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.051 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -57.38 -53.59 56.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.943 0.402 . . . . 0.0 110.358 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -53.59 -29.93 39.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.393 179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.48 -53.7 34.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.697 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.76 -23.74 27.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.81 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.506 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.17 -68.38 0.42 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.818 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.506 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.29 -12.21 9.44 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.559 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -63.84 128.81 37.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.91 0.386 . . . . 0.0 111.216 -179.502 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.475 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -92.87 -5.83 10.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.15 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.408 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 34.3 t0 -46.34 135.48 8.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.083 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.662 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.11 -178.76 3.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.357 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 51' ' ' LYS . . . -11.73 -44.49 0.0 OUTLIER Glycine 0 N--CA 1.467 0.73 0 N-CA-C 115.464 0.946 . . . . 0.0 115.464 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.662 ' N ' ' O ' ' A' ' 47' ' ' GLY . 1.4 p -51.38 -26.32 7.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.603 0.702 . . . . 0.0 111.476 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.408 ' HB3' ' O ' ' A' ' 46' ' ' ASP . . . -71.62 -22.39 61.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.88 0.372 . . . . 0.0 111.308 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 8.3 mtpt -68.12 -14.2 62.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.23 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 49' ' ' SER . 6.2 ptp180 -104.81 24.71 11.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.728 0.299 . . . . 0.0 110.405 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.405 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.5 OUTLIER 60.53 24.28 13.95 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.143 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 59.53 19.89 49.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.69 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 m -63.6 83.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.925 0.393 . . . . 0.0 110.677 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.734 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 16.5 mt -63.78 -24.06 67.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.882 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.04 -160.88 8.47 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.817 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.479 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -67.28 111.54 4.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.868 0.366 . . . . 0.0 111.783 -179.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.545 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 8.1 m-30 -119.05 156.64 29.32 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.27 -173.96 15.64 Favored Glycine 0 C--N 1.317 -0.501 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.431 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -75.53 80.0 2.55 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.99 0.424 . . . . 0.0 110.182 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.15 36.94 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.956 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.97 -43.11 1.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.623 0.249 . . . . 0.0 111.396 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.54 167.47 9.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 0.0 111.26 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.517 HG23 ' CB ' ' A' ' 68' ' ' PHE . 29.1 m -56.93 160.29 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.626 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.522 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -56.5 -48.19 97.55 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.733 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.57 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 20.7 Cg_endo -66.89 -36.26 23.85 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.062 1.842 . . . . 0.0 112.205 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.542 ' CZ ' HG22 ' A' ' 93' ' ' ILE . 15.5 t80 -74.88 -51.0 15.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.588 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.8 -32.39 60.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.839 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 1.6 m-20 -65.75 -53.15 44.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.886 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.11 -9.15 58.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.87 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.02 -36.81 78.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.613 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 3.0 p90 -107.06 16.79 23.8 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.81 -28.18 13.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.76 0.314 . . . . 0.0 110.879 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.43 HD12 ' O ' ' A' ' 80' ' ' VAL . 3.2 mt -103.47 63.57 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.213 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -70.83 -18.27 62.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.05 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.45 -26.92 40.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.559 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.408 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.05 57.59 1.21 Allowed Glycine 0 CA--C 1.502 -0.733 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.74 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -138.54 175.92 9.14 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.746 0.308 . . . . 0.0 111.114 -178.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.43 ' O ' HD12 ' A' ' 75' ' ' LEU . 41.6 t -81.33 145.9 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.918 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.16 164.11 12.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.162 0.505 . . . . 0.0 111.54 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -50.73 153.73 2.72 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.967 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 18.1 Cg_endo -59.27 105.5 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.361 2.041 . . . . 0.0 111.799 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.57 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 97.5 t -101.33 119.21 49.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.783 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.437 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -103.35 112.69 25.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.006 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.51 -171.7 1.9 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.276 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -60.33 -18.04 47.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.025 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -89.69 -40.79 12.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.424 -179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.66 -158.81 29.05 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.801 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -82.11 98.14 8.53 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.455 ' CD2' ' HG ' ' A' ' 16' ' ' LEU . 34.6 m80 -84.22 170.1 14.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.044 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 9.5 t -146.22 153.04 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.692 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.542 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -143.11 122.36 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.578 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.506 ' CB ' ' CD1' ' A' ' 36' ' ' PHE . 13.8 tptp -128.88 116.88 20.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.127 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.408 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -57.33 133.99 55.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.533 0.682 . . . . 0.0 112.231 -177.686 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.512 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -154.55 116.54 4.21 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.744 -1.117 . . . . 0.0 109.573 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.451 -1.194 . . . . 0.0 112.636 179.892 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.13 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.11 171.71 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.555 2.17 . . . . 0.0 112.34 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.2 134.25 54.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.888 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.8 56.51 1.51 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.511 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.1 m -88.38 150.0 23.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 0.0 110.858 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.3 ttt -113.24 121.98 46.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.879 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.73 35.15 3.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.129 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.03 -29.47 43.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.725 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.684 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.95 176.22 8.59 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.634 0.731 . . . . 0.0 112.112 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.427 HD12 HG21 ' A' ' 10' ' ' ILE . 0.1 OUTLIER -120.23 139.51 47.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.499 178.417 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.438 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.2 mtpt -110.88 99.27 8.2 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.434 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.732 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 2.2 t -129.98 -179.76 5.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.7 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.44 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 2.8 t -118.79 163.58 16.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -138.39 141.02 39.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.136 0.493 . . . . 0.0 111.821 -179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.509 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 4.5 mp -151.47 119.67 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.491 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.525 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -109.14 137.42 47.07 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.763 0.315 . . . . 0.0 111.596 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 16' ' ' LEU . 17.1 m -147.95 134.39 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.481 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -68.27 -36.62 79.68 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.813 -179.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.594 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.18 78.35 0.97 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.644 0.735 . . . . 0.0 109.04 178.59 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.449 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 5.0 pt20 -46.59 -25.81 0.77 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.288 -177.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.1 -31.29 77.33 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.178 -1.486 . . . . 0.0 111.069 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.646 ' HG3' ' N ' ' A' ' 23' ' ' ALA . 0.3 OUTLIER -70.45 -38.56 74.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.382 0.611 . . . . 0.0 109.828 178.371 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.646 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -51.5 -37.67 50.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.533 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.463 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -73.13 -30.45 63.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.794 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.77 -41.04 19.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.41 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 30' ' ' LEU . 2.8 m -51.11 -35.14 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.288 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.661 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -60.38 -48.41 81.87 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.661 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.57 -28.06 61.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.308 0.575 . . . . 0.0 110.642 178.436 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.44 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 3.1 tpp180 -78.85 -35.97 43.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.891 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.2 tm? -52.74 -59.01 5.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.278 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -9.39 54.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.488 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.61 50.14 0.42 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.6 -10.54 44.35 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.659 -0.781 . . . . 0.0 114.143 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.04 157.64 15.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.506 0.653 . . . . 0.0 111.061 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -110.28 144.49 38.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.205 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.45 ' CZ ' ' CD2' ' A' ' 96' ' ' LEU . 1.9 p90 -49.05 -28.49 4.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.726 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.409 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -59.9 -34.07 81.37 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.574 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -74.4 -49.96 20.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.593 0.235 . . . . 0.0 110.827 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -53.28 -36.14 60.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.286 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.512 ' O ' ' HB3' ' A' ' 44' ' ' SER . . . -52.1 -52.77 49.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.127 0.489 . . . . 0.0 110.744 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -85.64 -23.7 27.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.809 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.54 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 0.7 OUTLIER -72.52 -67.51 0.55 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.227 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.6 -14.96 9.59 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -178.946 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.512 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 1.8 t -63.74 126.25 26.99 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.365 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.449 HG12 ' HA ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -107.74 -28.06 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.472 ' HB3' ' CD1' ' A' ' 16' ' ' LEU . 15.0 t70 -128.69 106.66 9.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.77 143.85 4.98 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.903 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.28 -33.55 28.46 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 54' ' ' GLY . 1.8 p -79.57 3.75 17.94 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.333 -0.433 . . . . 0.0 110.952 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -68.0 -23.97 65.07 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -86.64 -18.82 30.4 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.789 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.503 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 15.4 mtt180 -104.23 25.0 10.61 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.964 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.526 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER 67.61 40.52 2.51 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.429 0.633 . . . . 0.0 111.629 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 53.63 30.33 42.61 Favored Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.79 -0.641 . . . . 0.0 113.018 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 85.9 p -92.37 86.35 5.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.739 0.304 . . . . 0.0 110.993 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.732 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 69.9 mt -54.03 -40.0 66.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.051 0.453 . . . . 0.0 110.21 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 78.07 -168.25 53.94 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.538 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.438 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -69.75 111.39 5.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.044 0.449 . . . . 0.0 111.717 -179.429 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.684 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 13.0 m-85 -125.83 152.82 44.97 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -100.71 -174.03 29.43 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.238 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.95 99.93 12.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.951 0.405 . . . . 0.0 110.316 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.97 -7.91 1.24 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.426 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -92.29 -40.82 10.73 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.924 0.362 . . . . 0.0 111.522 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.2 166.59 12.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.913 0.387 . . . . 0.0 111.447 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.507 HG23 ' CB ' ' A' ' 68' ' ' PHE . 35.2 m -58.0 163.85 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.815 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.493 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 16.8 tttp -58.93 -48.33 96.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.521 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 17.7 Cg_endo -67.11 -37.34 19.0 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 121.856 1.704 . . . . 0.0 112.192 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.507 ' CB ' HG23 ' A' ' 65' ' ' VAL . 40.9 t80 -74.41 -50.78 17.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.623 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -56.75 -32.35 65.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.703 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.2 OUTLIER -67.42 -49.43 63.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.072 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.99 -9.56 58.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.753 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.82 -51.26 42.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.912 0.387 . . . . 0.0 111.447 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 3.5 p90 -94.24 16.71 14.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.452 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -97.39 -29.38 13.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 110.804 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.487 HD12 ' O ' ' A' ' 80' ' ' VAL . 3.4 mt -103.48 67.1 0.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.454 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -74.35 -17.78 60.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.049 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -66.66 -26.74 38.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.447 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.436 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.14 59.8 1.09 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.521 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -141.33 176.14 9.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.841 0.353 . . . . 0.0 111.123 -178.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.487 ' O ' HD12 ' A' ' 75' ' ' LEU . 50.0 t -81.46 147.99 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.17 159.3 15.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.293 0.568 . . . . 0.0 111.56 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -50.68 155.23 1.99 Allowed Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.567 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.468 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 18.4 Cg_endo -58.53 106.67 0.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.335 2.023 . . . . 0.0 111.534 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.521 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 90.8 t -101.03 101.92 12.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.754 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.439 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 6.5 tptt -91.89 112.69 24.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.632 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.423 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 2.0 m -114.27 -173.19 2.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.55 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -58.29 -20.27 41.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.929 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -89.37 -23.97 22.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.309 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.404 ' O ' ' ND1' ' A' ' 91' ' ' HIS . . . 136.97 -167.88 24.49 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.883 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.468 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -74.98 98.35 3.58 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 86' ' ' SER . 53.3 m80 -80.86 167.63 19.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.343 0.592 . . . . 0.0 112.437 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.0 t -147.73 153.16 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.395 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.466 ' CG2' ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -150.82 127.46 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -179.03 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.4 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 2.6 tmtm? -128.59 116.1 19.11 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.677 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -57.44 134.58 56.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.495 0.664 . . . . 0.0 112.046 -178.055 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -157.1 116.67 3.42 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.771 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 CA-C-O 118.321 -1.266 . . . . 0.0 112.57 179.845 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.78 124.79 11.42 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.456 2.104 . . . . 0.0 112.253 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.56 134.79 34.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.009 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.35 58.17 0.28 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.508 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -62.45 164.92 6.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.773 0.32 . . . . 0.0 110.646 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.21 -43.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.274 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.31 17.5 11.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.642 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.23 -25.47 47.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.975 0.417 . . . . 0.0 110.599 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.538 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 1.0 OUTLIER -84.77 173.7 10.46 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.47 0.653 . . . . 0.0 112.138 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.407 ' O ' ' O ' ' A' ' 57' ' ' GLY . 1.5 mt -110.98 136.15 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.869 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.457 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.4 mtpt -109.17 90.76 3.39 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.21 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.769 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 13.7 m -130.69 -179.59 5.39 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.055 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.458 ' N ' ' O ' ' A' ' 94' ' ' LYS . 9.5 t -124.87 163.45 22.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.851 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.436 ' CD2' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -139.87 155.54 47.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.363 0.602 . . . . 0.0 112.583 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.401 HG22 ' N ' ' A' ' 16' ' ' LEU . 3.0 mp -143.77 139.43 25.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.48 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.435 ' O ' ' CG1' ' A' ' 45' ' ' ILE . 0.4 OUTLIER -127.38 133.55 50.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.508 ' CG2' ' CG ' ' A' ' 22' ' ' GLU . 25.3 m -154.61 134.42 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.807 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.6 mttt -65.92 -16.58 63.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -72.29 78.24 0.99 Allowed 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.813 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.436 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 0.8 OUTLIER -47.27 -40.52 16.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.156 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.09 -31.54 72.27 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.848 -1.168 . . . . 0.0 112.774 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.57 ' HG3' ' N ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -66.9 -43.73 82.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.237 0.541 . . . . 0.0 110.407 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.57 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -46.95 -39.28 12.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.535 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.666 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -72.79 -29.16 63.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.112 179.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.91 -54.01 6.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.459 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.4 m -49.52 -34.27 8.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.666 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.9 pt20 -59.78 -47.72 84.56 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.907 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.52 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.23 -29.22 62.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.202 0.525 . . . . 0.0 110.499 178.731 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.53 -36.2 45.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.792 -179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.419 ' CD1' ' C ' ' A' ' 30' ' ' LEU . 0.8 OUTLIER -52.77 -58.1 7.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.259 -179.363 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.404 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -71.36 -9.58 58.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.301 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.52 -23.7 63.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.887 0.375 . . . . 0.0 111.181 -179.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.26 -19.47 0.93 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.275 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 20.5 pt-20 -80.93 157.65 25.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 110.773 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -101.43 148.28 25.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.168 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.443 ' CE1' HD21 ' A' ' 96' ' ' LEU . 1.1 p90 -50.44 -39.35 47.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.035 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -57.94 -34.21 71.26 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.746 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -65.85 -54.12 30.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.701 0.286 . . . . 0.0 110.913 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.404 ' CD2' ' CD2' ' A' ' 30' ' ' LEU . 2.8 mm? -56.32 -32.56 64.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.681 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.44 -52.78 43.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.175 0.512 . . . . 0.0 110.642 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.39 -23.77 26.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.133 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -69.62 -68.94 0.37 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.537 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.461 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.75 -12.63 9.21 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.601 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.529 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -63.68 131.69 48.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.885 0.374 . . . . 0.0 111.436 -179.123 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.505 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.3 pt -100.04 -8.64 9.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.941 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.9 p-10 -45.87 135.21 7.29 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.962 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.693 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.27 -178.27 3.44 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.775 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 51' ' ' LYS . . . -11.75 -41.74 0.0 OUTLIER Glycine 0 N--CA 1.467 0.736 0 N-CA-C 115.63 1.012 . . . . 0.0 115.63 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.693 ' N ' ' O ' ' A' ' 47' ' ' GLY . 48.3 t -51.21 -22.3 2.57 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.564 0.682 . . . . 0.0 111.462 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.64 -21.17 61.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.875 0.369 . . . . 0.0 111.217 179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -68.25 -12.25 60.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.827 -179.056 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 49' ' ' SER . 9.2 ptp180 -104.43 24.88 10.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.678 0.275 . . . . 0.0 110.529 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.4 OUTLIER 65.79 20.83 11.49 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.129 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.84 17.92 65.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.615 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -68.53 86.07 0.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.362 . . . . 0.0 110.713 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.769 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 23.2 mt -54.56 -24.58 21.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.696 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 59.5 -166.18 9.41 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.233 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.457 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -67.27 111.51 4.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.9 0.381 . . . . 0.0 111.897 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.538 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 4.4 m-85 -117.43 156.3 28.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.59 -174.0 14.1 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.506 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.23 80.13 5.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.924 0.392 . . . . 0.0 110.225 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.26 36.68 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.03 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.01 -48.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 0.0 111.135 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.6 mtm -95.52 170.95 8.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.086 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.459 HG23 ' CB ' ' A' ' 68' ' ' PHE . 34.3 m -59.44 159.12 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.954 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.548 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -61.0 -47.97 93.88 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 12.2 Cg_endo -63.75 -41.14 25.62 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.955 1.77 . . . . 0.0 111.836 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.459 ' CB ' HG23 ' A' ' 65' ' ' VAL . 9.3 t80 -74.96 -52.35 11.39 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.843 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -55.36 -32.24 62.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.991 0.424 . . . . 0.0 110.647 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.443 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 29.9 t70 -65.38 -53.07 48.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.744 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.21 -9.31 58.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.559 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.32 -47.0 78.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.721 0.296 . . . . 0.0 111.376 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.443 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 11.4 p90 -93.24 16.19 13.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.345 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -98.3 -30.51 12.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.485 HD12 ' HA ' ' A' ' 81' ' ' SER . 7.9 mt -97.73 56.81 1.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.177 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -63.75 -23.75 67.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.758 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.87 -26.79 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.855 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.534 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 91.16 63.08 1.2 Allowed Glycine 0 CA--C 1.499 -0.949 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.122 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.411 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -141.05 176.61 8.68 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.611 -0.294 . . . . 0.0 110.62 -178.92 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 61.1 t -80.16 147.91 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.485 ' HA ' HD12 ' A' ' 75' ' ' LEU . 12.8 t -104.53 162.97 12.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.611 0.72 . . . . 0.0 111.924 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.592 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -50.37 163.46 0.45 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.396 -179.268 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.592 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 35.8 Cg_endo -65.71 103.59 0.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.617 2.211 . . . . 0.0 112.321 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 89.8 t -101.66 99.56 8.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.456 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.437 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -95.21 115.31 27.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.072 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.9 m -105.51 -175.64 2.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.367 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -20.13 26.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.958 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -88.18 -39.88 14.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.433 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.58 -171.6 36.03 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.978 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.437 ' CD1' ' HB3' ' A' ' 85' ' ' LYS . 0.6 OUTLIER -74.95 108.59 7.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.957 0.408 . . . . 0.0 110.043 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 56.6 m80 -95.46 169.39 10.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.381 0.61 . . . . 0.0 112.368 -178.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 20.4 t -147.81 152.68 12.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.594 179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.488 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.4 OUTLIER -133.4 122.15 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 13' ' ' SER . 10.3 tptt -128.71 109.07 11.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.392 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.534 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 1.1 ttt-85 -57.1 138.78 54.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.776 0.798 . . . . 0.0 112.625 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -161.98 116.42 1.9 Allowed 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.484 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.626 179.8 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.71 122.15 8.85 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.589 2.193 . . . . 0.0 112.262 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.88 146.84 52.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.15 58.6 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.532 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.0 p -82.78 126.54 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.33 . . . . 0.0 110.965 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -114.97 169.14 9.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.737 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.87 29.48 6.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.265 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.39 -25.15 22.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.654 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.448 ' CB ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -85.13 163.93 18.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.3 0.572 . . . . 0.0 111.553 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.474 ' O ' ' O ' ' A' ' 57' ' ' GLY . 1.2 mt -111.33 135.68 49.77 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.043 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.47 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.7 mtpt -109.67 89.49 3.02 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.132 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.785 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 8.5 m -131.97 -179.55 5.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.081 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 94' ' ' LYS . 8.7 p -127.07 163.43 23.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.156 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.426 ' CD2' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -136.08 157.46 46.78 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.295 0.569 . . . . 0.0 112.412 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 mp -149.24 125.43 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.038 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.471 ' HB3' ' CG1' ' A' ' 45' ' ' ILE . 1.0 OUTLIER -105.84 136.94 44.57 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.844 0.354 . . . . 0.0 111.893 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.41 HG12 ' O ' ' A' ' 16' ' ' LEU . 22.7 m -150.67 134.39 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.389 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 17.3 mtmt -71.8 -35.84 70.09 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.626 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 5.9 tttt -73.15 79.19 1.26 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.449 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 3.2 pt20 -46.49 -25.89 0.76 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.153 -0.93 . . . . 0.0 113.108 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.15 -29.47 74.5 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 119.194 -1.479 . . . . 0.0 110.82 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.626 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -73.99 -38.02 64.27 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.26 0.553 . . . . 0.0 110.017 178.466 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.603 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.57 -33.76 23.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.651 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -73.48 -39.8 64.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.417 178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -74.17 -47.03 38.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.961 -179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.459 ' O ' ' N ' ' A' ' 30' ' ' LEU . 21.3 m -46.6 -37.49 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.361 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.708 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -58.4 -48.51 80.41 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.118 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.708 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.65 -30.21 62.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.072 0.463 . . . . 0.0 110.822 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.44 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 16.8 tpt180 -79.18 -27.07 42.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.866 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.4 tm? -70.47 -44.82 66.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.222 0.534 . . . . 0.0 110.278 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -9.46 58.72 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.769 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.02 -27.89 69.42 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.902 0.382 . . . . 0.0 111.352 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.68 -17.92 0.98 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.629 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -74.22 157.56 35.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.813 0.339 . . . . 0.0 110.879 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.08 139.94 33.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.093 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.448 ' CZ ' ' CD2' ' A' ' 96' ' ' LEU . 3.0 p90 -49.97 -33.81 18.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.99 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -60.98 -37.43 93.83 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.352 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -64.06 -52.92 57.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.778 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -53.55 -31.14 45.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.725 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.533 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.16 -55.17 19.26 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.115 0.483 . . . . 0.0 110.778 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -23.34 27.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.966 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.539 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 1.0 OUTLIER -70.17 -68.29 0.43 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.84 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.539 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.37 -13.3 9.28 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.533 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -64.13 135.65 56.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.163 0.506 . . . . 0.0 111.203 -179.295 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.471 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 43.2 pt -97.56 -14.25 7.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.216 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -46.04 134.84 7.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.217 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.647 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.15 -178.63 3.48 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.63 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.42 -45.72 0.0 OUTLIER Glycine 0 N--CA 1.467 0.702 0 N-CA-C 115.458 0.943 . . . . 0.0 115.458 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.647 ' N ' ' O ' ' A' ' 47' ' ' GLY . 33.2 m -51.69 -24.96 6.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.361 0.58 . . . . 0.0 111.108 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.0 -20.94 62.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.89 179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -79.78 -4.22 51.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.396 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mtp-105 -104.33 24.62 11.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.223 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.0 22.53 12.77 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.014 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 57.45 20.44 37.6 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.799 179.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m -61.85 85.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.775 0.321 . . . . 0.0 110.987 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.785 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 21.5 mt -60.76 -24.86 66.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.535 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 56.78 -165.14 5.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.416 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.47 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -64.93 121.07 13.79 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.225 0.536 . . . . 0.0 112.209 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.434 ' CZ ' ' O ' ' A' ' 56' ' ' LEU . 12.0 m-30 -136.8 148.49 47.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.017 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.84 -173.81 21.37 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.44 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.46 87.36 7.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.152 0.501 . . . . 0.0 110.189 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.32 36.78 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.901 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.62 -45.24 0.67 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.712 0.292 . . . . 0.0 111.144 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.32 171.4 8.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.135 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.47 HG23 ' CB ' ' A' ' 68' ' ' PHE . 34.3 m -55.13 157.56 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.106 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.527 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.52 -48.11 97.52 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.582 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 18.6 Cg_endo -65.69 -39.92 19.16 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.946 1.764 . . . . 0.0 112.187 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.47 ' CB ' HG23 ' A' ' 65' ' ' VAL . 23.8 t80 -74.91 -49.17 21.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.459 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.94 -32.73 61.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.524 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.416 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -67.45 -51.56 50.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.901 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.89 -9.59 58.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.593 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.84 -43.29 84.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.848 0.356 . . . . 0.0 111.448 -179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.416 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 1.1 p90 -102.26 16.77 25.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.401 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.07 -27.31 15.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.748 0.308 . . . . 0.0 110.831 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 80' ' ' VAL . 3.3 mt -103.53 63.55 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.305 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -70.56 -18.53 62.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.965 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -64.6 -26.91 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.35 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.19 58.15 1.17 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.802 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -140.5 176.36 8.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.672 0.272 . . . . 0.0 110.977 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 56.8 t -84.65 147.05 5.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.098 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.21 161.96 13.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.186 0.517 . . . . 0.0 111.434 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -50.85 153.9 2.72 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.033 -179.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.431 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 22.5 Cg_endo -60.84 106.35 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.1 1.867 . . . . 0.0 111.523 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.582 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 86.1 t -101.01 108.33 23.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.7 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.513 ' HA ' ' HA ' ' A' ' 90' ' ' TYR . 14.7 tmtt? -91.7 113.17 25.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.408 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.48 -172.38 2.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.199 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -16.42 48.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.213 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -94.08 -35.28 12.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.713 0.292 . . . . 0.0 111.594 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.66 -167.03 34.57 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.666 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.513 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 1.2 m-85 -82.44 98.26 8.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.266 0.555 . . . . 0.0 109.994 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.446 ' CD2' ' CD2' ' A' ' 16' ' ' LEU . 11.3 m80 -83.09 169.64 15.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.007 -177.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.425 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 38.3 t -149.03 150.72 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.014 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -130.62 122.41 52.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' SER . 3.8 tmtt? -128.58 110.44 12.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.113 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.508 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -57.47 139.44 53.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.853 0.835 . . . . 0.0 112.73 -178.463 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -162.82 116.42 1.67 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.491 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.402 ' CA ' ' HE2' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.323 -1.265 . . . . 0.0 112.621 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.2 133.53 47.66 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.534 2.156 . . . . 0.0 112.321 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.7 ttt -130.72 127.79 39.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.4 -45.01 2.07 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.542 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.52 124.24 26.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.88 0.372 . . . . 0.0 110.825 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.2 ttt -134.19 152.7 51.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.956 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.65 29.27 4.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.27 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.448 ' CB ' ' HE3' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -57.47 -21.5 37.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.756 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.571 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.03 168.47 15.9 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.376 0.607 . . . . 0.0 112.034 -179.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.412 ' O ' ' O ' ' A' ' 57' ' ' GLY . 1.2 mt -111.01 136.0 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.15 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.497 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.6 mtpt -108.32 89.78 3.1 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.115 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.797 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.4 m -132.69 -179.61 5.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.747 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 3.0 m -131.25 163.75 27.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.371 -179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.466 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -132.16 156.31 46.63 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.555 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 1.5 mp -141.43 120.01 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.045 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.419 ' O ' ' CG1' ' A' ' 45' ' ' ILE . 2.0 mt -104.44 128.28 52.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.466 ' CG2' ' CG ' ' A' ' 22' ' ' GLU . 17.9 m -140.57 133.91 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.017 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -36.7 70.55 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.84 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.605 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.23 78.53 0.98 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.385 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.456 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -46.51 -26.05 0.8 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.058 -177.47 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.42 -31.12 76.05 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.855 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.652 ' HG3' ' N ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -70.06 -39.56 75.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.081 0.467 . . . . 0.0 110.3 178.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.652 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.34 -38.1 40.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.986 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.586 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -73.61 -29.4 62.36 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.244 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.38 -43.7 14.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.543 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.456 ' O ' ' N ' ' A' ' 30' ' ' LEU . 2.5 m -54.89 -40.66 53.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.275 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.586 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.2 pt20 -53.2 -52.61 58.31 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.691 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.529 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -73.28 -31.51 64.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.08 0.467 . . . . 0.0 110.998 179.141 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -76.41 -25.61 54.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.706 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.456 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -58.38 -48.31 81.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.4 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.93 -9.32 58.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.428 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.26 -22.15 28.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.802 0.334 . . . . 0.0 111.403 -179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.13 -10.76 3.59 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.536 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 15.2 pt-20 -79.02 153.24 30.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.929 0.395 . . . . 0.0 110.988 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.4 135.51 33.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.792 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.555 ' CE2' ' CD1' ' A' ' 15' ' ' ILE . 9.6 t80 -53.29 -47.78 68.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.218 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -56.59 -34.12 63.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.239 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.445 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -58.82 -50.26 74.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.704 0.288 . . . . 0.0 110.87 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -53.07 -33.28 51.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.808 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.52 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.25 -54.24 27.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.127 0.489 . . . . 0.0 110.496 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.4 pttp -85.77 -23.5 27.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.023 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.535 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -70.54 -67.91 0.47 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.914 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.535 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.94 -15.69 9.3 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.52 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -63.99 138.31 58.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 0.0 111.275 -179.475 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.419 ' CG1' ' O ' ' A' ' 16' ' ' LEU . 2.0 pt -99.49 -10.02 8.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.18 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.405 ' OD2' ' CE1' ' A' ' 14' ' ' HIS . 14.2 t0 -46.21 135.31 7.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.959 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.646 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -61.93 -178.56 3.24 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.173 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.35 -45.73 0.0 OUTLIER Glycine 0 N--CA 1.467 0.73 0 N-CA-C 115.416 0.926 . . . . 0.0 115.416 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.646 ' N ' ' O ' ' A' ' 47' ' ' GLY . 14.4 m -51.55 -24.64 5.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.365 0.582 . . . . 0.0 111.379 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.08 -31.61 66.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.388 0.613 . . . . 0.0 110.248 179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -68.09 -16.17 63.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.065 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.22 24.64 11.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.29 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.3 OUTLIER 64.5 17.54 10.89 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.434 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.83 27.37 49.93 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.37 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -60.06 84.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.959 0.409 . . . . 0.0 110.815 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.797 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 22.8 mt -60.5 -19.66 57.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.725 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 50.33 -169.07 0.27 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.735 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.497 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -61.69 111.44 1.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.929 0.395 . . . . 0.0 111.723 -179.385 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.571 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 2.4 m-85 -124.78 163.8 21.34 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.35 -174.04 13.67 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.656 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -86.9 95.72 9.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.052 0.453 . . . . 0.0 110.283 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.23 36.47 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.756 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -152.05 -42.62 0.11 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.74 0.305 . . . . 0.0 111.187 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 8.9 mtm -91.07 167.12 12.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.93 0.395 . . . . 0.0 111.27 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.457 HG23 ' CB ' ' A' ' 68' ' ' PHE . 33.7 m -58.97 156.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.854 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.533 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.5 ttpt -58.14 -47.98 97.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.547 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 12.7 Cg_endo -64.4 -40.1 26.18 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 121.995 1.797 . . . . 0.0 112.239 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.457 ' CB ' HG23 ' A' ' 65' ' ' VAL . 11.3 t80 -75.11 -50.17 17.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.696 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.63 -32.33 58.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.689 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.409 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 1.5 t70 -66.87 -52.47 43.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.851 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.87 -9.5 58.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.478 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.18 -43.19 98.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.415 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.409 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 2.8 p90 -98.29 16.54 21.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.386 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -98.18 -28.14 13.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.172 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 79' ' ' GLU . 8.5 mt -96.0 51.6 1.25 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 111.301 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -58.91 -33.14 70.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 109.868 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -63.55 -26.68 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.33 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.465 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 90.37 72.01 1.24 Allowed Glycine 0 CA--C 1.5 -0.905 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.819 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.525 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -142.28 177.6 8.14 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.132 -0.534 . . . . 0.0 110.014 -178.744 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 93.5 t -79.67 149.73 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.421 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -104.49 153.08 21.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.354 0.597 . . . . 0.0 111.401 -178.419 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.425 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -50.76 156.1 1.73 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.834 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 82' ' ' GLU . 11.2 Cg_endo -53.67 102.83 0.08 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.514 2.143 . . . . 0.0 111.96 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.547 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 57.6 t -103.07 103.05 14.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.599 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.465 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.79 112.5 24.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.9 0.381 . . . . 0.0 110.966 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.63 -176.9 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.398 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -59.33 -19.07 43.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.958 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -89.93 -40.53 12.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.386 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.83 -164.09 35.65 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.826 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.465 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -83.43 98.17 9.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.406 ' CD2' ' HG ' ' A' ' 16' ' ' LEU . 15.5 m80 -83.68 167.1 17.55 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 18.0 t -145.11 153.42 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.772 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.433 HD11 ' CE1' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -138.02 121.58 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.661 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.489 ' CB ' ' CE1' ' A' ' 36' ' ' PHE . 5.1 tptm -129.62 113.27 14.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.168 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.465 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.8 OUTLIER -57.97 139.19 54.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.787 0.803 . . . . 0.0 112.631 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -159.62 116.18 2.56 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.351 179.098 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.555 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.62 88.5 0.76 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.602 2.201 . . . . 0.0 112.28 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.56 147.1 46.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.33 -1.71 7.66 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.786 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.6 t -62.33 130.62 46.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.875 0.369 . . . . 0.0 110.819 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.49 -163.82 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.11 47.96 1.46 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.129 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.8 -39.34 87.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.769 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.547 ' HD2' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -85.84 174.96 8.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.081 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -114.14 136.97 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 121.4 0.619 . . . . 0.0 110.752 -178.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.657 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -107.29 95.39 5.67 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.738 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.693 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 1.9 t -120.4 179.35 4.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.794 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 14.7 p -120.56 163.35 18.12 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.445 ' CE1' ' HA2' ' A' ' 54' ' ' GLY . 24.6 p-80 -134.68 151.59 51.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.517 0.675 . . . . 0.0 112.633 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.9 mp -155.61 127.09 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.764 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.659 ' HB3' HG13 ' A' ' 45' ' ' ILE . 10.9 tp -114.15 129.06 56.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.935 0.398 . . . . 0.0 112.029 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.603 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 28.1 m -143.26 134.35 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.635 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.418 ' O ' ' CE2' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -77.9 -33.97 51.64 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.478 -179.013 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.605 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 13.2 tttp -72.3 79.14 1.0 Allowed 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.453 ' HG3' ' CD1' ' A' ' 90' ' ' TYR . 0.9 OUTLIER -46.18 -25.39 0.59 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.939 -177.026 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.55 -31.33 78.35 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 118.865 -1.636 . . . . 0.0 110.429 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.605 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -73.2 -37.65 66.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.06 0.457 . . . . 0.0 109.777 178.062 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.597 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -53.31 -36.2 60.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.738 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.615 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.59 -29.28 62.3 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.762 178.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.9 -43.53 14.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.633 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.446 ' HA ' ' HB3' ' A' ' 29' ' ' ARG . 3.3 m -55.28 -36.72 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.428 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.615 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.5 pt20 -56.27 -53.27 59.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.696 0.284 . . . . 0.0 110.541 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.51 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -73.62 -26.95 61.03 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.965 0.412 . . . . 0.0 110.866 179.055 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.446 ' HB3' ' HA ' ' A' ' 26' ' ' VAL . 2.0 tpp180 -78.41 -34.02 48.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.784 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.408 ' CD2' HD23 ' A' ' 39' ' ' LEU . 1.3 tm? -53.52 -57.47 10.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.03 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -9.41 58.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.253 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.46 -23.77 58.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.938 0.399 . . . . 0.0 111.32 -179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.51 -17.38 1.13 Allowed Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.374 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -78.46 157.64 28.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.876 0.369 . . . . 0.0 110.861 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -100.75 140.41 35.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.107 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.425 ' CE1' HD22 ' A' ' 96' ' ' LEU . 5.4 p90 -49.53 -31.66 10.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.949 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.47 -33.98 88.71 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.376 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.467 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 4.9 mmmt -67.94 -53.89 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.697 0.284 . . . . 0.0 110.999 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.408 HD23 ' CD2' ' A' ' 30' ' ' LEU . 2.8 mm? -53.86 -33.86 57.62 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.68 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.526 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.79 -52.5 48.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.109 0.48 . . . . 0.0 110.543 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -86.51 -23.34 25.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.341 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.472 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -71.7 -69.05 0.41 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.116 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.472 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.68 -12.44 9.26 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.526 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -63.85 137.68 58.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.895 0.379 . . . . 0.0 111.151 -179.282 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.659 HG13 ' HB3' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -106.55 -3.25 9.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.965 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.459 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 24.8 p-10 -46.41 135.66 8.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.021 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.691 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.08 -178.46 3.34 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.046 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.75 -42.9 0.0 OUTLIER Glycine 0 N--CA 1.468 0.802 0 N-CA-C 115.395 0.918 . . . . 0.0 115.395 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.691 ' N ' ' O ' ' A' ' 47' ' ' GLY . 20.8 t -51.4 -19.42 1.35 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.427 0.613 . . . . 0.0 111.736 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.459 ' HB1' ' O ' ' A' ' 46' ' ' ASP . . . -70.75 -20.43 62.63 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.906 0.384 . . . . 0.0 110.925 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -75.23 -4.73 40.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.235 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.12 24.69 11.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.399 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 p30 56.17 33.59 22.34 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.159 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.445 ' HA2' ' CE1' ' A' ' 14' ' ' HIS . . . 50.84 24.41 8.13 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.938 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.53 87.51 7.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.018 0.437 . . . . 0.0 110.428 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.693 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 13.9 mt -62.42 -17.12 58.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.794 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 53.6 -171.76 0.71 Allowed Glycine 0 CA--C 1.507 -0.408 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.204 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.657 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 8.5 p90 -59.95 117.02 4.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.122 0.486 . . . . 0.0 111.619 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.487 ' C ' ' HB2' ' A' ' 9' ' ' LYS . 8.6 p90 -139.37 141.22 37.6 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.429 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.446 ' CA ' ' HB2' ' A' ' 9' ' ' LYS . . . -90.89 -173.78 44.02 Favored Glycine 0 C--N 1.311 -0.816 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.404 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.67 100.18 13.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.749 0.309 . . . . 0.0 110.362 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.32 36.49 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.312 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -151.18 18.44 0.76 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.861 0.331 . . . . 0.0 111.595 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.48 ' CE ' ' CE1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -151.61 174.12 13.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.697 0.284 . . . . 0.0 111.075 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.465 HG21 ' CB ' ' A' ' 68' ' ' PHE . 33.1 m -60.74 158.46 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.803 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -61.32 -47.84 92.91 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.194 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.607 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 19.8 Cg_endo -64.28 -40.1 26.99 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.024 1.816 . . . . 0.0 112.048 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.465 ' CB ' HG21 ' A' ' 65' ' ' VAL . 26.1 t80 -74.95 -51.19 14.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.799 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -57.42 -32.47 66.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.749 179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.465 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 23.7 t70 -66.08 -49.39 67.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.969 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.87 -9.49 58.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.816 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.31 -47.39 73.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.753 0.311 . . . . 0.0 111.556 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.465 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 8.6 p90 -92.93 16.69 12.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.499 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -100.4 -27.3 13.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.787 0.327 . . . . 0.0 110.933 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.408 HD11 ' O ' ' A' ' 80' ' ' VAL . 1.5 mt -103.53 58.5 0.74 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.454 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -69.22 -18.31 63.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.975 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -66.29 -26.82 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.688 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.42 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 96.23 58.2 1.1 Allowed Glycine 0 CA--C 1.502 -0.744 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.568 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -139.56 176.5 8.67 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.726 0.298 . . . . 0.0 111.055 -178.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.408 ' O ' HD11 ' A' ' 75' ' ' LEU . 24.8 t -87.18 148.56 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.198 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -105.37 157.34 17.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.245 0.545 . . . . 0.0 111.335 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -50.96 155.81 1.93 Allowed Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.066 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -56.26 106.26 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.208 1.939 . . . . 0.0 111.6 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.607 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 70.9 t -100.9 108.06 22.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.597 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.449 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 28.2 tptt -91.65 113.0 25.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.96 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -110.04 -171.38 1.83 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.321 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.79 -18.4 21.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.277 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . 0.443 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 12.1 m-85 -93.69 -38.9 11.08 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.722 0.296 . . . . 0.0 111.677 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.58 -166.19 32.22 Favored Glycine 0 CA--C 1.508 -0.384 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.848 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.603 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 59.3 m-85 -74.73 98.21 3.41 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.306 0.574 . . . . 0.0 110.161 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.45 ' CD2' ' CD1' ' A' ' 16' ' ' LEU . 79.6 m80 -86.53 169.88 12.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.575 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.6 t -145.88 147.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.848 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.46 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -134.67 123.22 41.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.081 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.407 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 3.3 tmtm? -128.14 110.1 12.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.843 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.544 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -57.39 131.74 50.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.416 0.627 . . . . 0.0 111.872 -178.031 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -158.7 116.92 2.94 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.989 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.407 -1.219 . . . . 0.0 112.52 179.836 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.133 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.13 149.76 20.84 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.499 2.133 . . . . 0.0 112.383 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.5 ptp -145.48 143.78 30.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.922 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.71 -27.39 2.59 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.465 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.8 p -88.38 141.44 28.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.911 0.386 . . . . 0.0 110.897 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.3 ttt -152.85 179.82 8.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.741 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.5 22.04 10.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.388 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -56.07 -46.92 78.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.274 0.559 . . . . 0.0 110.462 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.635 ' HD3' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -85.53 178.0 7.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.748 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -109.95 137.14 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-O 121.635 0.731 . . . . 0.0 111.161 -178.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.528 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -110.4 89.22 2.97 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.286 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.739 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 35.8 m -120.87 179.91 4.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.193 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -119.52 163.39 17.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.949 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.429 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -134.45 147.73 50.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.229 0.538 . . . . 0.0 112.249 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.6 mp -145.41 115.3 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.942 179.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.417 ' O ' HG12 ' A' ' 17' ' ' VAL . 0.8 OUTLIER -99.41 129.14 45.58 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.076 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.732 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 20.2 m -143.25 133.73 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.597 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.7 mttm -71.18 -36.0 71.79 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.849 -179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.586 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -71.44 78.19 0.77 Allowed 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.675 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.453 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 1.1 tm0? -46.72 -25.78 0.8 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.935 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.85 -31.37 78.04 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 119.069 -1.538 . . . . 0.0 110.72 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.682 ' HG3' ' N ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -71.46 -39.64 70.84 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.195 0.522 . . . . 0.0 109.726 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.682 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -52.9 -36.5 59.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.796 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.624 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.6 OUTLIER -73.64 -29.3 62.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.981 178.934 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.03 -42.06 13.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.888 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.401 ' HA ' ' HB3' ' A' ' 29' ' ' ARG . 3.4 m -54.92 -33.83 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.315 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.624 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.3 pt20 -51.31 -55.33 18.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.675 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.441 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.8 OUTLIER -73.16 -31.29 64.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.14 0.495 . . . . 0.0 110.479 178.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.401 ' HB3' ' HA ' ' A' ' 26' ' ' VAL . 10.0 tpt180 -68.38 -37.99 80.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.725 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -52.95 -58.97 5.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.345 -179.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -72.12 -9.52 58.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.396 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.42 -21.92 52.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 0.0 111.341 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.35 -18.49 1.17 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.293 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -80.48 157.56 26.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.914 0.388 . . . . 0.0 110.824 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -97.35 138.59 34.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.029 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.442 ' CE1' HD23 ' A' ' 96' ' ' LEU . 1.9 p90 -49.23 -35.39 17.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.964 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.6 -34.09 88.98 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.542 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.478 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.6 OUTLIER -63.38 -53.85 46.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.626 0.25 . . . . 0.0 111.192 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -53.17 -34.34 56.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.044 -179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.513 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.45 -53.61 35.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.017 0.436 . . . . 0.0 110.524 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -85.97 -23.63 26.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.179 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.497 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.37 -68.65 0.41 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -177.776 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.497 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.5 -14.0 9.17 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.647 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.513 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -64.18 137.87 58.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.168 0.509 . . . . 0.0 111.549 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 pt -102.76 -8.29 9.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.028 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -46.17 135.3 7.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.992 179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.66 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -61.83 -178.54 3.13 Favored Glycine 0 C--O 1.225 -0.41 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.303 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 51' ' ' LYS . . . -11.32 -44.91 0.0 OUTLIER Glycine 0 N--CA 1.467 0.712 0 N-CA-C 115.399 0.92 . . . . 0.0 115.399 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.66 ' N ' ' O ' ' A' ' 47' ' ' GLY . 32.5 m -51.63 -28.47 14.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.673 0.736 . . . . 0.0 111.248 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.28 -24.46 61.35 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.256 0.55 . . . . 0.0 110.624 179.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.569 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.3 OUTLIER -70.64 -12.06 61.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.659 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -103.46 24.03 11.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.582 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 72.68 10.25 5.58 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.554 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.29 22.01 66.9 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.205 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.4 89.07 2.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.106 0.479 . . . . 0.0 110.622 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.739 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 12.1 mt -63.41 -15.03 56.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.775 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 48.22 -171.17 0.06 OUTLIER Glycine 0 CA--C 1.507 -0.468 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.339 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.635 ' HB2' ' HD3' ' A' ' 9' ' ' LYS . 16.8 p90 -56.51 122.62 12.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.211 0.529 . . . . 0.0 111.872 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.468 ' C ' ' HB2' ' A' ' 9' ' ' LYS . 7.3 p90 -146.09 140.88 27.05 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.48 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.2 -173.9 23.41 Favored Glycine 0 C--N 1.315 -0.632 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.982 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 88.54 1.1 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.033 0.444 . . . . 0.0 110.129 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.53 36.88 0.05 OUTLIER Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.934 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.63 -41.67 0.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.596 0.236 . . . . 0.0 111.462 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.461 ' HE2' ' CD1' ' A' ' 59' ' ' PHE . 1.9 mpp? -105.73 174.0 6.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.032 0.444 . . . . 0.0 111.468 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.455 HG21 ' CB ' ' A' ' 68' ' ' PHE . 34.4 m -56.81 161.39 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.069 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.534 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -60.36 -48.03 94.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.594 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 15.5 Cg_endo -64.85 -42.01 16.25 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 121.911 1.741 . . . . 0.0 111.731 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.455 ' CB ' HG21 ' A' ' 65' ' ' VAL . 15.2 t80 -72.65 -51.51 19.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.472 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.401 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.7 tt0 -56.34 -32.29 64.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.614 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 35.2 t70 -65.97 -51.6 56.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.707 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.12 -12.12 60.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.429 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.83 -49.21 77.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.886 0.374 . . . . 0.0 111.265 -179.853 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 2.8 p90 -93.96 16.58 14.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.239 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -98.27 -26.39 14.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.375 . . . . 0.0 110.705 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.0 mt -103.46 53.08 0.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.145 -179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -59.72 -22.02 61.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.165 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 p -61.92 -26.77 40.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.533 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . . . . . . . . . . . 94.17 55.62 1.46 Allowed Glycine 0 CA--C 1.503 -0.717 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.741 -179.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.44 176.53 8.62 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.692 0.282 . . . . 0.0 111.01 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.498 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 59.5 t -86.43 147.43 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.533 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.47 160.48 15.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.202 0.525 . . . . 0.0 111.409 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 21.0 mp0 -50.89 155.49 2.0 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.159 -179.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -56.93 105.96 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.228 1.952 . . . . 0.0 111.772 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.594 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 85.0 t -100.93 106.8 20.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.115 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.467 ' CG ' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.52 112.89 25.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.494 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.422 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 0.5 OUTLIER -105.19 -171.65 1.95 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.051 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -14.94 36.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.202 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -96.47 -36.36 10.82 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.612 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.19 -166.53 34.16 Favored Glycine 0 CA--C 1.508 -0.403 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.86 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.732 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 91.7 m-85 -80.73 98.07 7.58 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.237 0.542 . . . . 0.0 109.941 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.422 ' CE1' ' HB2' ' A' ' 86' ' ' SER . 50.9 m80 -82.95 169.73 15.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.812 -178.009 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 19.4 t -149.52 145.6 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.445 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.498 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.5 OUTLIER -123.3 122.28 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.005 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 13' ' ' SER . 2.4 tptm -128.72 108.98 10.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.406 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.462 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 2.0 ttp85 -57.26 132.8 54.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.562 0.696 . . . . 0.0 112.346 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -163.17 116.71 1.6 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.782 179.747 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.417 -1.213 . . . . 0.0 112.67 179.754 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.05 156.6 64.71 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.521 2.147 . . . . 0.0 112.347 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.1 mtt -144.67 118.47 9.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.954 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.25 58.61 0.96 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.53 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.7 m -88.35 135.86 33.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.717 0.294 . . . . 0.0 111.01 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 58.3 mtt -116.1 -177.64 3.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.827 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.82 28.12 2.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.454 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.455 ' C ' ' HE3' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -57.07 -23.38 46.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.98 0.419 . . . . 0.0 110.671 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.482 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.07 166.2 17.89 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.357 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.45 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 1.4 mt -110.74 136.04 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.904 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.105 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.494 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.0 mtpt -107.73 88.4 2.72 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.668 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.804 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 8.6 m -131.41 -179.82 5.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.735 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 94' ' ' LYS . 45.2 t -121.1 163.44 18.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.226 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -130.68 150.78 51.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.172 0.511 . . . . 0.0 111.857 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.532 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 4.1 mp -154.27 130.15 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.527 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.521 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.5 OUTLIER -123.2 138.04 54.74 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.868 0.366 . . . . 0.0 111.858 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.638 HG23 ' OE2' ' A' ' 22' ' ' GLU . 24.2 m -151.02 135.84 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.516 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -64.91 -19.5 65.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.504 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.39 76.4 1.03 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.796 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.431 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 2.6 pt20 -47.79 -33.14 6.81 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.32 -31.17 61.55 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 119.915 -1.136 . . . . 0.0 112.599 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.674 ' HG3' ' N ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -68.16 -42.68 79.7 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.451 0.643 . . . . 0.0 109.92 179.359 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.674 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -49.64 -36.81 25.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.526 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.405 HD22 ' HG3' ' A' ' 83' ' ' PRO . 0.9 OUTLIER -72.71 -33.83 66.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.812 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.11 -44.15 22.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.514 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.442 ' CG1' ' OE2' ' A' ' 22' ' ' GLU . 2.8 m -47.96 -36.34 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.394 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.7 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -58.01 -49.26 77.45 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.522 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.7 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 4.0 pt-20 -73.89 -30.37 62.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.838 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.4 tpp85 -78.83 -33.12 46.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.83 -178.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.53 -51.93 57.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.688 0.28 . . . . 0.0 111.424 -178.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.99 -9.29 58.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.186 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -72.72 47.2 0.17 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.32 -10.66 41.73 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.737 -0.744 . . . . 0.0 114.153 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -91.97 153.98 19.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.437 0.618 . . . . 0.0 110.78 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -104.22 139.22 39.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.419 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.482 ' CE1' ' CD2' ' A' ' 96' ' ' LEU . 2.2 p90 -47.18 -31.75 3.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.841 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.44 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.11 -34.17 88.15 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.372 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.534 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.8 ttpm? -68.1 -51.99 40.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.654 0.264 . . . . 0.0 111.112 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.406 ' HB3' ' CD2' ' A' ' 43' ' ' LEU . 2.9 mm? -53.13 -36.01 60.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.412 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.522 ' O ' ' HB3' ' A' ' 44' ' ' SER . . . -51.93 -53.2 43.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.167 0.508 . . . . 0.0 110.634 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -85.64 -23.6 27.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.791 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -72.06 -67.52 0.53 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.133 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.523 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.36 -14.62 9.75 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.875 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.532 ' OG ' ' HA ' ' A' ' 15' ' ' ILE . 1.4 t -63.42 126.8 28.66 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.227 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.479 HG12 ' HA ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -107.3 -26.7 3.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -178.744 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.44 ' HB3' ' CD1' ' A' ' 16' ' ' LEU . 12.6 t70 -127.44 103.0 7.12 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.125 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.82 143.45 4.82 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.58 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.96 -33.83 28.7 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.037 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 54' ' ' GLY . 3.9 m -76.81 -1.83 30.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.324 -0.438 . . . . 0.0 111.249 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.13 -22.79 66.12 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.307 0.575 . . . . 0.0 109.624 179.069 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -88.9 -5.44 58.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.184 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.466 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 1.7 mmt85 -122.36 24.55 9.3 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.9 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER 74.51 26.96 1.43 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.344 0.592 . . . . 0.0 111.085 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 55.56 20.31 23.31 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.789 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.45 84.66 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.027 0.442 . . . . 0.0 110.752 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.804 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 12.8 mt -58.92 -21.73 58.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.788 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 55.93 -163.85 5.05 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.413 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.494 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -64.23 119.48 10.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.028 0.442 . . . . 0.0 111.835 -179.38 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.482 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 19.1 p90 -141.27 139.34 33.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.571 177.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.402 ' CA ' ' HE2' ' A' ' 9' ' ' LYS . . . -98.35 -173.95 32.67 Favored Glycine 0 C--N 1.318 -0.463 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.504 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -82.8 98.27 9.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.199 0.524 . . . . 0.0 109.955 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.45 36.48 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.636 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -140.25 -46.87 0.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.837 0.351 . . . . 0.0 110.952 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.431 ' CE ' ' CE1' ' A' ' 59' ' ' PHE . 1.4 mpp? -91.92 170.04 10.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.963 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.486 HG21 ' CB ' ' A' ' 68' ' ' PHE . 34.8 m -59.58 162.34 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.018 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.481 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.63 -48.18 97.37 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.068 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.554 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 10.0 Cg_endo -66.02 -38.37 22.6 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 121.858 1.706 . . . . 0.0 112.171 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.486 ' CB ' HG21 ' A' ' 65' ' ' VAL . 8.8 t80 -74.97 -50.01 18.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.746 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -57.04 -32.49 66.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.651 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -64.61 -50.65 66.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.849 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.85 -9.57 58.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.524 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -68.15 -50.45 54.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.782 0.325 . . . . 0.0 111.301 -179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 6.4 p90 -93.28 16.56 12.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.343 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.48 -25.19 14.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 0.0 110.863 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.472 HD11 ' O ' ' A' ' 80' ' ' VAL . 1.6 mt -103.53 55.15 0.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.219 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -63.49 -19.55 64.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.098 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -63.66 -26.72 41.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.403 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.479 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.13 55.58 1.37 Allowed Glycine 0 CA--C 1.503 -0.674 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.629 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.63 176.17 8.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.858 0.361 . . . . 0.0 111.221 -178.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.472 ' O ' HD11 ' A' ' 75' ' ' LEU . 60.2 t -83.16 149.09 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.903 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.0 t -104.4 154.8 19.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.448 0.642 . . . . 0.0 111.764 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -50.8 163.5 0.48 Allowed Pre-proline 0 C--O 1.235 0.307 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.573 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.456 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 17.8 Cg_endo -59.15 104.56 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.604 2.203 . . . . 0.0 112.226 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.554 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 93.7 t -101.43 101.54 12.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.373 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.69 113.01 25.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.851 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.3 m -108.71 -171.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.6 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -57.7 -20.28 33.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.33 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -91.34 -40.49 11.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.424 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 157.33 -164.51 32.97 Favored Glycine 0 CA--C 1.508 -0.354 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.073 -179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 0.7 OUTLIER -74.59 98.39 3.37 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.052 0.453 . . . . 0.0 110.39 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.422 ' CE1' HD12 ' A' ' 16' ' ' LEU . 31.0 m80 -81.71 169.95 16.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.236 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 t -149.29 150.6 13.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.01 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.47 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -138.1 124.14 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.319 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 13' ' ' SER . 15.8 tptp -128.45 109.29 11.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.594 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.479 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.5 OUTLIER -57.7 136.61 56.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.601 0.715 . . . . 0.0 112.206 -179.289 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -161.27 116.52 2.1 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.718 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.28 -1.289 . . . . 0.0 112.659 179.76 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.18 90.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.544 2.163 . . . . 0.0 112.292 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.8 mmt -98.48 136.57 38.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.823 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.57 -56.04 1.2 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.464 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.3 t -88.33 123.37 32.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 110.839 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.94 111.39 11.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.872 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.12 25.62 6.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.345 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -54.45 -35.61 63.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.113 0.482 . . . . 0.0 110.371 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.72 ' HD3' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -105.71 178.56 4.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.727 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 58' ' ' TYR . 1.5 mm -109.3 149.64 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 CA-C-O 121.765 0.793 . . . . 0.0 111.276 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.621 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -125.34 76.3 1.54 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.102 -179.546 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.873 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 10.3 m -117.63 -179.68 3.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.258 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 22.6 t -115.66 163.49 15.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.651 179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -132.44 153.03 51.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.54 0.686 . . . . 0.0 112.483 -179.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.408 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 2.8 mp -155.85 123.18 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.899 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.571 ' HB3' ' CG1' ' A' ' 45' ' ' ILE . 12.8 tp -111.61 131.17 55.45 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.456 HG13 ' O ' ' A' ' 16' ' ' LEU . 17.3 m -143.65 134.71 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.67 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -35.77 68.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.513 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.635 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 3.3 tttp -74.31 79.33 1.84 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.467 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -46.28 -25.85 0.7 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.153 -0.931 . . . . 0.0 113.254 -176.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.15 -31.24 77.05 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.9 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.635 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -70.88 -38.23 73.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.009 0.433 . . . . 0.0 110.354 178.798 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.598 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.83 -37.68 44.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.088 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.588 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -73.44 -29.53 62.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.773 179.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.24 -42.8 15.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.47 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.467 ' O ' ' N ' ' A' ' 30' ' ' LEU . 2.9 m -55.89 -39.24 55.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.203 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.588 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.2 pt20 -56.12 -51.49 67.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.886 0.374 . . . . 0.0 110.26 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.531 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 2.8 pt-20 -73.19 -29.62 62.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.09 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.401 ' HB3' ' HA ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -78.83 -29.75 44.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.656 -178.771 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.467 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.0 OUTLIER -55.27 -55.33 32.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.944 0.402 . . . . 0.0 110.827 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -9.55 58.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.202 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.2 -24.02 62.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.913 0.387 . . . . 0.0 111.232 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.1 -18.53 0.94 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.307 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -80.72 157.52 25.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.905 0.383 . . . . 0.0 110.807 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.4 138.47 39.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.048 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.438 ' CZ ' HD21 ' A' ' 96' ' ' LEU . 2.4 p90 -47.09 -29.86 2.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.996 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -64.45 -35.8 92.39 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.429 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.449 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.4 OUTLIER -66.19 -53.3 39.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.737 0.303 . . . . 0.0 110.869 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.41 ' O ' ' HB2' ' A' ' 44' ' ' SER . 2.9 mm? -53.62 -32.55 51.72 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.484 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.518 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.7 -53.27 41.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.617 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -86.33 -23.32 26.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.245 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.471 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 2.6 mm-40 -70.68 -69.22 0.38 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.471 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.61 -13.44 9.17 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.518 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -63.96 136.91 57.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.95 0.405 . . . . 0.0 111.2 -179.231 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.571 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 27.9 pt -101.55 -6.71 9.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.803 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 31.0 p-10 -46.04 135.21 7.66 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.24 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.67 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.39 -178.48 3.64 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.617 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.77 -43.05 0.0 OUTLIER Glycine 0 C--N 1.34 0.8 0 N-CA-C 115.493 0.957 . . . . 0.0 115.493 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.67 ' N ' ' O ' ' A' ' 47' ' ' GLY . 30.5 t -51.44 -17.6 0.82 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.463 0.631 . . . . 0.0 111.824 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.43 -21.14 62.02 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.179 0.514 . . . . 0.0 110.481 179.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 8.2 mmtt -73.8 -10.58 59.82 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.645 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.95 24.81 10.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.522 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.417 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.6 OUTLIER 60.06 27.81 17.29 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.227 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 57.36 20.08 35.53 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.759 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 99.2 p -76.24 87.73 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.944 0.402 . . . . 0.0 110.234 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.873 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 14.4 mt -63.67 -16.48 61.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.548 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 46.55 -169.34 0.04 OUTLIER Glycine 0 CA--C 1.506 -0.522 0 C-N-CA 121.028 -0.605 . . . . 0.0 112.682 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.72 ' HB2' ' HD3' ' A' ' 9' ' ' LYS . 27.5 p90 -66.82 111.48 3.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.527 ' C ' ' HB2' ' A' ' 9' ' ' LYS . 13.0 m-30 -141.96 148.05 37.98 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.412 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.0 -174.01 19.0 Favored Glycine 0 C--N 1.311 -0.811 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.406 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -75.3 154.74 37.23 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.2 -37.03 1.17 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.445 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.14 24.77 1.78 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.738 0.304 . . . . 0.0 111.059 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 13.8 mtp -112.95 162.44 15.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.675 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.433 ' CG2' ' CB ' ' A' ' 68' ' ' PHE . 17.7 m -79.28 147.08 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.986 0.422 . . . . 0.0 110.951 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.56 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.23 -44.21 99.01 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.221 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 16.8 Cg_endo -65.3 -42.7 12.6 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 121.808 1.672 . . . . 0.0 112.207 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.433 ' CB ' ' CG2' ' A' ' 65' ' ' VAL . 16.6 t80 -74.88 -49.39 20.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.842 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.61 -32.33 70.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.825 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.446 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 4.1 m-20 -64.6 -46.85 80.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.257 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.82 -18.4 60.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.749 -179.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -54.15 -53.06 58.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.727 0.299 . . . . 0.0 111.57 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.446 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -87.74 16.84 5.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.833 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -100.53 -31.58 11.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.822 0.344 . . . . 0.0 110.72 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.452 HD11 ' O ' ' A' ' 80' ' ' VAL . 2.8 mt -103.78 69.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.766 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -78.03 -16.41 58.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.088 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 p -69.07 -26.79 33.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.94 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.544 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 96.84 60.08 0.99 Allowed Glycine 0 CA--C 1.504 -0.634 0 C-N-CA 120.43 -0.89 . . . . 0.0 111.199 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -141.89 176.49 8.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.894 0.378 . . . . 0.0 111.025 -178.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.452 ' O ' HD11 ' A' ' 75' ' ' LEU . 48.1 t -85.31 148.49 4.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.879 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t -104.5 163.96 12.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.212 0.529 . . . . 0.0 111.342 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -50.59 158.16 1.13 Allowed Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.187 -178.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.432 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 16.5 Cg_endo -57.15 104.08 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.538 2.159 . . . . 0.0 111.793 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.55 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 57.9 t -101.82 105.91 18.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.782 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.462 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 3.0 tmtt? -98.76 112.86 24.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 21.8 m -110.47 -172.47 2.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.475 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -57.76 -20.37 34.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.964 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -88.74 -30.89 18.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.381 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 143.62 -169.7 25.91 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.885 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.467 ' CD1' ' HB3' ' A' ' 20' ' ' GLN . 0.4 OUTLIER -74.68 98.33 3.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.982 0.42 . . . . 0.0 110.017 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.421 ' CG ' HD11 ' A' ' 16' ' ' LEU . 6.1 m80 -89.02 169.7 11.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.421 0.629 . . . . 0.0 112.294 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 25.0 t -139.86 134.64 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.614 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.3 OUTLIER -118.29 121.86 68.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.655 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.93 108.06 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.312 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.544 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.4 OUTLIER -59.07 131.87 52.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.398 0.618 . . . . 0.0 111.816 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -160.35 116.02 2.33 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.001 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.312 -1.271 . . . . 0.0 112.591 179.731 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.05 163.85 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.559 2.172 . . . . 0.0 112.319 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.61 112.72 7.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.848 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.63 39.52 2.03 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.502 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -68.01 131.09 44.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 110.859 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.67 -22.66 11.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.114 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.21 28.26 3.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.218 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.439 ' C ' ' HE3' ' A' ' 9' ' ' LYS . 26.2 t70 -55.94 -23.13 30.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.765 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.548 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.08 166.14 17.93 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.214 0.53 . . . . 0.0 111.096 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.27 138.62 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.008 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.47 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -106.66 98.23 7.92 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.523 -178.614 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.806 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 2.8 t -127.25 179.98 5.17 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.929 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.5 t -121.23 163.27 18.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.904 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.421 ' CE1' ' HB2' ' A' ' 49' ' ' SER . 0.0 OUTLIER -131.04 149.55 52.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.045 0.45 . . . . 0.0 111.967 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.49 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 3.7 mp -155.94 131.58 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.452 ' O ' HG12 ' A' ' 17' ' ' VAL . 4.0 mm? -123.0 138.1 54.78 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.94 0.4 . . . . 0.0 111.64 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.456 ' CG2' ' CG ' ' A' ' 22' ' ' GLU . 18.3 m -148.98 134.11 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.93 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -69.84 -36.7 75.77 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.188 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.586 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.31 78.37 1.0 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.464 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.45 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -46.69 -25.79 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.768 -1.105 . . . . 0.0 113.238 -177.448 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.1 -31.48 77.83 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 119.045 -1.55 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.655 ' HG3' ' N ' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -70.13 -39.22 75.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.247 0.546 . . . . 0.0 109.969 178.302 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.655 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -49.24 -39.5 30.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.376 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.537 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.33 -29.66 62.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.16 179.244 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.01 -36.49 23.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.755 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.406 ' O ' ' N ' ' A' ' 30' ' ' LEU . 2.4 m -57.27 -33.29 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.213 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.639 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -59.76 -50.26 74.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.639 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -73.12 -27.26 61.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.243 0.544 . . . . 0.0 110.348 178.507 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.9 tpt180 -77.86 -33.93 51.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.702 -179.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.406 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.7 OUTLIER -53.32 -59.4 4.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.245 -179.255 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.41 -9.39 58.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.287 179.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.78 -22.31 35.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.866 0.365 . . . . 0.0 111.416 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.01 -16.91 1.05 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.368 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -86.47 157.37 19.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.791 0.329 . . . . 0.0 110.682 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -99.51 142.38 31.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.091 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.44 ' CE1' HD22 ' A' ' 96' ' ' LEU . 2.9 p90 -47.65 -29.53 3.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.797 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.437 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -66.53 -38.93 93.79 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.563 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.555 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 5.1 ttpp -59.82 -50.98 71.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.72 0.295 . . . . 0.0 110.822 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -53.4 -34.85 59.32 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.741 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.551 ' O ' ' HB2' ' A' ' 44' ' ' SER . . . -52.09 -52.96 47.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.29 0.566 . . . . 0.0 110.665 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.46 -22.74 26.31 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.285 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.555 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -75.59 -68.4 0.57 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -176.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.523 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.63 -10.72 9.99 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.232 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.551 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -63.75 125.89 25.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.908 0.385 . . . . 0.0 109.993 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.462 HG13 ' N ' ' A' ' 46' ' ' ASP . 4.9 pt -107.54 -26.6 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.462 ' N ' HG13 ' A' ' 45' ' ' ILE . 18.9 t70 -127.89 103.05 7.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.77 143.31 4.75 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.022 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.97 -31.13 32.95 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 54' ' ' GLY . 0.7 OUTLIER -76.73 8.13 3.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.188 -0.506 . . . . 0.0 111.093 179.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -64.54 -24.2 67.52 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -88.78 -19.69 25.68 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.913 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.462 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 3.2 mtt180 -104.43 24.68 11.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.168 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.495 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.6 OUTLIER 62.19 40.96 11.13 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.259 0.552 . . . . 0.0 111.583 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 53.36 30.51 40.83 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.213 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 65.4 p -88.74 85.09 6.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.729 0.3 . . . . 0.0 110.827 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.806 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 16.4 mt -58.3 -31.67 67.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.637 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 70.76 -170.12 47.03 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.453 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.522 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -60.64 118.47 6.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.151 0.501 . . . . 0.0 111.661 -179.384 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.548 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 2.4 m-85 -127.18 164.08 22.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.443 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.76 -174.02 13.25 Favored Glycine 0 C--N 1.319 -0.411 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.672 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -74.3 84.23 1.91 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.168 0.508 . . . . 0.0 110.121 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.33 36.78 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.056 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.0 -48.6 0.61 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.674 0.273 . . . . 0.0 111.39 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.9 ptp -108.42 169.51 8.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.025 0.441 . . . . 0.0 111.406 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.461 HG23 ' CB ' ' A' ' 68' ' ' PHE . 35.6 m -54.72 161.71 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.666 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -61.65 -48.14 90.74 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 11.8 Cg_endo -63.33 -42.0 24.25 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 121.999 1.799 . . . . 0.0 111.744 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.461 ' CB ' HG23 ' A' ' 65' ' ' VAL . 17.9 t80 -73.11 -51.78 16.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.662 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -59.24 -32.98 70.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.774 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.435 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 6.7 m-20 -61.48 -48.57 80.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.127 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.83 -9.57 58.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.737 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.42 -47.72 78.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.771 0.32 . . . . 0.0 111.515 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.435 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 10.2 p90 -92.7 16.6 11.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.476 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -99.99 -25.82 14.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 111.205 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.487 HD11 ' O ' ' A' ' 79' ' ' GLU . 11.0 mt -101.25 56.9 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.389 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -61.42 -31.7 71.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.979 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -63.15 -26.88 41.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.124 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.457 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 89.94 70.21 1.23 Allowed Glycine 0 CA--C 1.499 -0.915 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.951 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.487 ' O ' HD11 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -142.29 177.35 8.31 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.122 -0.539 . . . . 0.0 109.998 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 87.0 t -79.72 150.61 4.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.457 ' CB ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -105.04 164.31 11.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.608 0.718 . . . . 0.0 111.907 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.605 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -50.5 164.31 0.41 Allowed Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.896 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.605 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 55.5 Cg_endo -68.73 103.44 0.99 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.398 2.065 . . . . 0.0 112.123 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.505 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 81.4 t -101.89 104.31 16.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.087 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.455 ' CG ' ' CD1' ' A' ' 90' ' ' TYR . 12.2 tmtt? -99.78 112.67 24.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.584 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.437 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 74.4 m -112.82 -176.44 2.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.858 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -51.83 -25.95 8.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.178 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -80.81 -39.95 25.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.087 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.56 -163.45 31.2 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.701 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.455 ' CD1' ' CG ' ' A' ' 85' ' ' LYS . 0.2 OUTLIER -80.39 100.28 8.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.632 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.439 ' CG ' HD13 ' A' ' 16' ' ' LEU . 60.5 m80 -85.05 162.24 19.4 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.7 t -146.82 125.19 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.011 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.436 HG12 ' CE1' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -113.68 124.49 70.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.25 112.77 14.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.189 178.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.526 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.27 135.92 56.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.552 0.691 . . . . 0.0 112.356 -177.746 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -156.74 116.76 3.54 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.578 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.424 -1.209 . . . . 0.0 112.564 179.823 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.449 -0.26 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.17 110.52 0.46 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.649 2.233 . . . . 0.0 112.292 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.4 mmt -86.74 129.4 34.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 117.64 -36.57 3.63 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.512 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.6 m -77.44 123.85 27.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.758 0.314 . . . . 0.0 110.89 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.1 ttt 79.35 -5.02 1.99 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.682 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.22 28.57 0.66 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.708 0.289 . . . . 0.0 110.96 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.458 ' C ' ' HE3' ' A' ' 9' ' ' LYS . 21.7 t0 -53.47 -26.15 19.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.519 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.17 161.67 20.49 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.089 0.471 . . . . 0.0 111.089 -179.618 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.14 129.52 66.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.528 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.49 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.1 mtpt -95.79 97.74 9.91 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.948 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.7 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -126.65 -179.73 4.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.839 -177.083 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.8 p -124.43 159.81 29.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.348 179.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.411 ' O ' ' CD2' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -131.92 146.54 52.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.17 0.51 . . . . 0.0 112.302 -179.419 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.526 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 4.1 mp -149.73 132.78 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.673 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.516 ' O ' HG12 ' A' ' 17' ' ' VAL . 4.1 mm? -119.54 137.55 53.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.784 0.326 . . . . 0.0 111.598 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.516 HG12 ' O ' ' A' ' 16' ' ' LEU . 15.7 m -148.54 134.23 11.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.17 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.12 -36.46 72.13 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.412 -178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.622 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -74.42 79.15 1.89 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.878 0.846 . . . . 0.0 108.73 178.499 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.468 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -45.82 -25.28 0.49 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.363 -1.289 . . . . 0.0 113.162 -177.447 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.61 -30.37 76.28 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.124 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.72 ' HG3' ' N ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -72.02 -39.72 68.97 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.049 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.72 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -49.84 -35.02 21.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.205 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -73.3 -40.1 64.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.613 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.56 -48.78 30.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.589 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 23' ' ' ALA . 2.7 m -46.55 -40.53 4.45 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.249 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.45 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -59.01 -45.13 91.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.45 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.4 mm-40 -73.69 -33.06 64.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.82 178.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -78.69 -30.41 46.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.842 -178.539 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -52.99 -58.95 5.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.895 -179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -9.38 58.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.383 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -58.29 -24.32 59.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.927 0.394 . . . . 0.0 111.327 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.93 -18.61 0.96 Allowed Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.191 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -82.15 157.59 23.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.862 0.363 . . . . 0.0 110.503 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.38 141.75 33.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.091 0.472 . . . . 0.0 111.216 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.443 ' CZ ' ' HB2' ' A' ' 96' ' ' LEU . 3.2 p90 -45.8 -31.4 2.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.762 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.491 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.58 -41.65 99.78 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.178 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.572 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 2.9 tttt -58.16 -51.97 67.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.516 0.198 . . . . 0.0 110.785 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.402 HD12 ' CD1' ' A' ' 43' ' ' LEU . 3.1 mm? -53.36 -35.14 59.95 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.654 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.529 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.86 -53.52 39.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.215 0.531 . . . . 0.0 110.65 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -86.42 -23.1 26.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.126 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.572 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 0.4 OUTLIER -75.77 -68.26 0.59 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.074 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.517 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.88 -8.3 10.3 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -179.011 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.529 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -63.66 125.79 25.44 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.66 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.459 HG13 ' N ' ' A' ' 46' ' ' ASP . 1.9 pt -107.61 -26.64 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.459 ' N ' HG13 ' A' ' 45' ' ' ILE . 34.1 t70 -127.7 97.32 4.8 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -177.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.94 142.25 4.33 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.813 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.548 ' O ' ' HE2' ' A' ' 51' ' ' LYS . . . -79.61 -43.73 9.99 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.237 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.454 ' CA ' ' HG2' ' A' ' 52' ' ' ARG . 50.7 m -63.66 -0.6 1.02 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.634 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -49.79 -27.37 4.89 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.78 0.324 . . . . 0.0 111.42 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.548 ' HE2' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -87.96 -21.38 24.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.355 0.598 . . . . 0.0 111.716 -179.436 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.51 ' N ' ' HD2' ' A' ' 51' ' ' LYS . 1.4 ptp180 -103.59 24.92 10.37 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.193 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.491 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER 77.34 6.91 2.98 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.703 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.449 ' HA2' ' CB ' ' A' ' 49' ' ' SER . . . 73.07 24.42 75.82 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.877 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . 0.418 ' HA ' ' CD2' ' A' ' 96' ' ' LEU . 82.0 p -66.73 88.61 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.872 0.367 . . . . 0.0 111.261 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.7 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 16.2 mt -60.36 -27.42 67.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.402 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.79 -172.99 27.74 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.252 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.508 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -59.07 119.19 6.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.05 0.453 . . . . 0.0 111.491 -179.504 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.519 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 3.1 m-85 -128.46 163.0 25.86 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -139.19 -173.88 13.26 Favored Glycine 0 C--N 1.315 -0.592 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.803 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.27 87.47 1.98 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.116 0.484 . . . . 0.0 109.904 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.59 36.69 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.918 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -147.31 -47.04 0.17 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.701 0.286 . . . . 0.0 111.083 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.4 mtm -98.3 168.43 10.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.098 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.474 HG22 ' CB ' ' A' ' 68' ' ' PHE . 36.0 m -61.22 161.44 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.786 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 4.0 mtpt -61.22 -47.98 92.93 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.55 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 12.9 Cg_endo -64.23 -41.37 21.82 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.834 1.689 . . . . 0.0 111.809 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.474 ' CB ' HG22 ' A' ' 65' ' ' VAL . 30.5 t80 -73.82 -52.35 13.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.628 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -57.73 -32.46 67.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.755 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 7.2 m-20 -62.47 -51.15 68.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.854 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.02 -9.5 58.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.664 -179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.99 -49.19 66.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.875 0.369 . . . . 0.0 111.589 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 9.0 p90 -93.32 16.68 12.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.381 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.14 -27.98 12.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.817 0.341 . . . . 0.0 110.798 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.46 HD13 ' O ' ' A' ' 80' ' ' VAL . 2.5 mt -103.55 54.7 0.75 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.471 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -62.16 -20.13 63.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.915 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -61.01 -26.92 40.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.225 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.447 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 95.25 55.13 1.39 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.845 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -139.51 176.16 8.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.746 0.308 . . . . 0.0 111.105 -178.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.511 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 45.0 t -83.91 148.92 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.27 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.4 m -104.93 163.91 12.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.26 0.552 . . . . 0.0 111.588 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -50.86 155.0 2.16 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.384 -178.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -54.37 104.68 0.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.659 2.239 . . . . 0.0 112.047 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.548 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 67.4 t -101.47 105.2 17.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.454 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 5.1 tptm -94.32 112.99 24.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.757 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.43 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 0.5 OUTLIER -107.9 -175.41 2.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.544 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -59.06 -20.24 51.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.948 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -88.5 -40.8 13.17 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.303 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.22 -164.29 35.41 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.868 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.468 ' CE1' ' HB3' ' A' ' 20' ' ' GLN . 0.3 OUTLIER -81.35 98.29 8.1 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.439 ' CG ' HD11 ' A' ' 16' ' ' LEU . 35.9 m80 -81.22 169.53 17.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.833 -177.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.5 t -154.61 123.76 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.719 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -105.38 122.69 59.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.4 ' HD3' ' N ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -128.32 116.13 19.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.495 178.294 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.447 ' CB ' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -58.54 136.04 57.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.507 0.67 . . . . 0.0 112.315 -178.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -160.38 116.76 2.39 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.925 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.479 -1.178 . . . . 0.0 112.718 179.866 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 112.56 -0.216 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.86 -178.86 2.58 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.58 2.186 . . . . 0.0 112.237 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.3 mtt -69.23 125.87 28.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.08 42.94 1.7 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.509 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.0 t -69.76 155.83 39.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.903 0.382 . . . . 0.0 110.876 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.7 ttm -142.48 76.5 1.54 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -123.19 25.64 8.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.337 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -54.83 -49.18 71.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.176 0.512 . . . . 0.0 110.393 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.558 ' CD ' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -88.26 178.19 6.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.419 179.376 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 58' ' ' TYR . 1.5 mm -109.4 148.94 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 CA-C-O 121.714 0.769 . . . . 0.0 111.247 -178.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.618 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -124.75 77.22 1.58 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.943 -179.61 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.802 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 13.8 m -117.54 -179.91 3.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.171 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.435 ' N ' ' O ' ' A' ' 94' ' ' LYS . 3.5 t -109.38 163.67 13.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.297 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.4 ' CE1' ' CD2' ' A' ' 91' ' ' HIS . 12.9 t60 -126.4 142.12 51.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.339 0.59 . . . . 0.0 112.061 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.405 ' CG2' ' OG ' ' A' ' 44' ' ' SER . 3.5 mp -151.27 120.32 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.93 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.463 ' CD1' ' CE1' ' A' ' 91' ' ' HIS . 0.4 OUTLIER -113.98 135.89 53.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.206 -178.621 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.657 HG23 ' HG3' ' A' ' 22' ' ' GLU . 15.4 m -151.83 134.11 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.682 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.09 -35.0 66.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.955 0.407 . . . . 0.0 110.469 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.505 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 13.2 pttm -71.99 80.34 0.92 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.468 ' HG3' ' CZ ' ' A' ' 90' ' ' TYR . 5.7 tt0 -45.03 -25.75 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.376 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.56 -32.13 78.04 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.209 -1.472 . . . . 0.0 111.444 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.657 ' HG3' HG23 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -69.05 -42.57 76.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.354 0.597 . . . . 0.0 109.662 178.326 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.522 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -46.97 -41.42 16.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.219 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.648 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.76 -28.9 61.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.078 179.101 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.41 -50.71 10.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.781 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 30' ' ' LEU . 11.3 m -54.25 -38.4 39.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.915 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.648 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.7 pt20 -53.7 -53.04 57.66 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.655 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.463 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.8 tt0 -73.28 -30.25 63.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.963 0.411 . . . . 0.0 110.937 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.411 ' HB3' ' HA ' ' A' ' 26' ' ' VAL . 0.0 OUTLIER -77.47 -28.93 52.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.857 -178.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.476 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -57.45 -58.02 10.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.785 -179.584 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -9.22 58.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.562 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.403 ' HB3' ' HA ' ' A' ' 29' ' ' ARG . . . -59.2 -25.99 64.44 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.856 0.36 . . . . 0.0 111.375 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.28 -17.21 0.52 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.694 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.6 pt-20 -88.11 157.59 18.81 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.054 0.454 . . . . 0.0 110.887 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.74 144.04 28.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.64 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.463 ' CE1' HD22 ' A' ' 96' ' ' LEU . 1.5 p90 -48.15 -34.8 10.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.951 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.7 -34.23 81.17 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.399 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.553 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -66.45 -53.75 31.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.706 0.288 . . . . 0.0 110.734 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' A' ' 44' ' ' SER . 3.2 mm? -53.48 -34.76 59.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.522 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.34 -54.48 25.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.102 0.477 . . . . 0.0 110.893 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.15 -22.6 26.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.376 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.553 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 3.4 mm-40 -72.14 -69.28 0.41 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.039 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.495 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.52 -14.09 9.15 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.744 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.522 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -63.95 126.72 28.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.86 0.362 . . . . 0.0 111.088 -179.31 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.411 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.3 pt -95.89 -0.93 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.987 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.438 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 20.7 p-10 -46.35 135.9 7.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.017 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.691 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -61.6 -178.08 2.75 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.309 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.53 -42.34 0.0 OUTLIER Glycine 0 N--CA 1.468 0.794 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.691 ' N ' ' O ' ' A' ' 47' ' ' GLY . 0.4 OUTLIER -51.27 -20.01 1.48 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.504 0.652 . . . . 0.0 111.641 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 46' ' ' ASP . . . -70.96 -20.67 62.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.819 0.343 . . . . 0.0 110.933 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -72.7 -10.75 60.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.148 0.499 . . . . 0.0 110.179 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.412 ' O ' ' CG ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -104.13 24.73 10.98 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.255 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.412 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 1.1 p30 59.45 28.76 18.21 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.049 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.89 20.25 25.47 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.758 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.0 92.69 4.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.963 0.411 . . . . 0.0 110.328 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.802 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 11.9 mt -66.61 -13.9 61.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.778 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.53 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 45.0 -164.56 0.06 OUTLIER Glycine 0 CA--C 1.505 -0.535 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.261 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.618 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 25.8 p90 -70.87 111.37 6.23 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.221 0.534 . . . . 0.0 111.881 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.447 ' CE2' ' O ' ' A' ' 56' ' ' LEU . 13.9 m-30 -132.95 148.4 52.28 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.1 -173.9 21.92 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.667 -178.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 8.4 mtm105 -84.7 122.84 29.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.858 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.46 -20.34 1.51 Allowed Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.083 -1.056 . . . . 0.0 113.119 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.9 tptm -120.58 -22.55 6.35 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 9.8 mtp -91.12 162.25 14.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 0.0 111.055 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.456 HG21 ' HB3' ' A' ' 68' ' ' PHE . 21.6 m -67.13 154.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.93 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.551 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 14.3 tttt -60.2 -47.07 97.65 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.625 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 17.8 Cg_endo -65.27 -42.28 13.82 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.864 1.71 . . . . 0.0 112.131 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.464 ' CE2' HG12 ' A' ' 93' ' ' ILE . 22.8 t80 -74.91 -49.72 19.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.646 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.01 -31.51 67.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.855 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.437 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 27.5 t70 -67.16 -48.62 67.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.194 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HA ' ' CG ' ' A' ' 74' ' ' ARG . . . -75.14 -9.63 58.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.931 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -63.27 -44.71 94.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.726 0.298 . . . . 0.0 111.542 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.437 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 18.4 p90 -90.6 16.88 8.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.928 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' CG ' ' HA ' ' A' ' 71' ' ' ALA . 3.2 mmm180 -99.76 -30.67 11.94 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.78 0.324 . . . . 0.0 110.881 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 80' ' ' VAL . 2.7 mt -103.6 68.34 0.93 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.598 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -77.45 -16.84 58.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.98 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.38 -26.87 34.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.807 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.431 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 97.03 60.76 0.96 Allowed Glycine 0 CA--C 1.504 -0.65 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.577 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -142.02 176.44 8.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.794 0.331 . . . . 0.0 110.999 -178.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.44 ' O ' HD12 ' A' ' 75' ' ' LEU . 58.2 t -84.9 147.07 5.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.942 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.97 161.3 14.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.266 0.555 . . . . 0.0 111.479 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -50.81 155.87 1.84 Allowed Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.263 -179.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.49 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 20.3 Cg_endo -59.99 105.74 0.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.347 2.031 . . . . 0.0 111.699 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.625 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 77.2 t -100.97 108.25 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.516 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.529 ' HA ' ' HA ' ' A' ' 90' ' ' TYR . 3.7 tmtt? -91.74 113.07 25.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.082 0.467 . . . . 0.0 111.423 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -104.22 -171.4 1.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.119 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -12.88 43.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.366 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -99.7 -31.94 11.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.603 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.04 -170.9 33.83 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.542 -179.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.529 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 1.2 m-85 -79.62 98.19 6.81 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.299 0.571 . . . . 0.0 110.303 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.463 ' CE1' ' CD1' ' A' ' 16' ' ' LEU . 3.2 m80 -80.46 169.94 17.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.318 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 12.5 t -145.85 140.69 21.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.818 179.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.464 HG12 ' CE2' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -120.99 122.6 68.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.958 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 13' ' ' SER . 0.2 OUTLIER -128.54 108.69 10.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.907 178.606 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.446 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -57.68 129.68 42.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.556 0.693 . . . . 0.0 112.166 -178.658 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -161.4 116.43 2.06 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.77 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.456 -1.191 . . . . 0.0 112.64 179.746 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.49 99.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.601 2.2 . . . . 0.0 112.317 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.4 ptp -99.6 129.08 45.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.92 45.47 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.555 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.1 p -74.31 164.11 27.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 110.889 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.1 mmt -106.82 -74.02 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.01 31.13 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.268 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.431 ' C ' ' HE3' ' A' ' 9' ' ' LYS . 1.6 m-20 -54.54 -27.23 37.0 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.607 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.516 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.22 163.68 19.56 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.973 -179.578 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -111.18 136.68 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.08 178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.455 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.7 mtpt -105.87 97.44 7.26 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.561 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.696 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 3.0 t -126.34 179.34 5.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.814 -178.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.4 t -124.06 163.31 21.71 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.16 152.41 51.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.207 0.527 . . . . 0.0 112.023 -179.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.449 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 3.0 mp -151.07 115.4 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.137 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.736 ' HB3' HG13 ' A' ' 45' ' ' ILE . 7.4 tp -102.15 128.73 48.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.874 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.431 HG13 ' O ' ' A' ' 16' ' ' LEU . 14.5 m -142.1 134.28 27.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.596 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -74.6 -35.93 62.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.463 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.645 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 10.7 tttp -72.48 79.32 1.04 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.429 ' HG2' ' CD1' ' A' ' 90' ' ' TYR . 29.5 mt-30 -46.27 -25.94 0.71 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.969 -176.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.41 -31.24 76.38 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 119.216 -1.469 . . . . 0.0 110.953 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.645 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -70.68 -38.54 73.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.047 0.451 . . . . 0.0 110.296 178.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.605 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.34 -37.77 38.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.107 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.639 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.19 -29.53 62.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.809 179.129 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.05 -49.44 8.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.18 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.407 ' CG1' ' OE1' ' A' ' 22' ' ' GLU . 3.6 m -49.32 -37.24 10.41 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.13 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.639 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.9 pt20 -59.28 -48.95 79.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.552 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 3.7 pt-20 -73.17 -29.03 62.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.759 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.9 tpt180 -78.64 -35.13 45.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.965 -178.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -53.04 -55.6 22.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.271 -179.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -9.62 58.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.273 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.09 -22.95 61.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.871 0.367 . . . . 0.0 111.159 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.08 -17.27 1.37 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.309 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -80.67 157.59 25.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.902 0.382 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -100.06 144.84 28.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.918 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.415 ' CE1' HD22 ' A' ' 96' ' ' LEU . 6.2 p90 -53.65 -33.42 55.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.932 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.77 -33.96 87.04 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.462 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.447 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 4.0 tttt -68.35 -52.9 28.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 111.165 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -53.42 -33.16 52.87 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.834 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.526 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.57 -52.98 42.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.122 0.487 . . . . 0.0 110.659 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -86.3 -23.41 26.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.192 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.508 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 0.3 OUTLIER -71.2 -68.67 0.42 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.412 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.508 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.0 -13.35 9.43 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.495 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.526 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.5 OUTLIER -64.06 142.22 58.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.958 0.409 . . . . 0.0 110.833 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.736 HG13 ' HB3' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -105.5 -6.19 9.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.115 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.441 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 29.4 p-10 -46.37 135.51 8.09 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.674 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.33 -178.63 3.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.626 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.84 -43.63 0.0 OUTLIER Glycine 0 C--N 1.34 0.762 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.674 ' N ' ' O ' ' A' ' 47' ' ' GLY . 1.1 m -51.53 -18.27 1.06 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.301 0.551 . . . . 0.0 111.764 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 46' ' ' ASP . . . -70.79 -20.81 62.55 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.979 0.419 . . . . 0.0 110.842 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -6.38 51.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.463 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.32 24.78 11.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.234 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 p30 58.64 28.86 17.74 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.155 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.69 22.18 31.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.825 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.88 86.94 0.52 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.874 0.369 . . . . 0.0 110.841 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.696 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 16.4 mt -56.66 -28.97 61.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.463 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.419 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 67.39 -165.12 43.97 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.739 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.484 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -67.98 120.95 15.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.203 0.525 . . . . 0.0 111.895 -179.402 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.516 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 11.7 m-30 -133.08 153.72 51.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.121 177.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -121.4 -174.0 14.72 Favored Glycine 0 C--N 1.318 -0.465 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.469 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.93 85.66 6.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.373 . . . . 0.0 110.186 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.33 36.75 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.048 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.91 -48.55 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.806 0.303 . . . . 0.0 111.243 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.66 170.18 10.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 111.134 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.463 HG22 ' CB ' ' A' ' 68' ' ' PHE . 35.5 m -57.48 167.37 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.776 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.506 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -64.93 -47.9 73.06 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.989 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.516 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 13.0 Cg_endo -66.3 -39.55 17.23 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.873 1.715 . . . . 0.0 112.064 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.463 ' CB ' HG22 ' A' ' 65' ' ' VAL . 11.4 t80 -74.99 -50.79 15.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.819 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -58.92 -32.8 69.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.801 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 59.4 t0 -67.8 -46.39 72.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.002 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.0 -14.41 60.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.647 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -56.33 -46.38 79.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.741 -179.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.444 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 12.1 p90 -92.05 16.64 10.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.528 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.49 -27.5 15.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.342 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.518 HD13 ' O ' ' A' ' 79' ' ' GLU . 4.8 mt -102.35 60.43 0.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.813 0.34 . . . . 0.0 111.449 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -68.08 -25.04 65.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.009 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -70.82 -26.84 28.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.556 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.46 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 92.65 69.33 1.13 Allowed Glycine 0 CA--C 1.501 -0.806 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.599 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.518 ' O ' HD13 ' A' ' 75' ' ' LEU . 1.4 tm-20 -142.25 177.86 7.96 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.111 -0.544 . . . . 0.0 110.08 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.441 HG12 ' HA ' ' A' ' 27' ' ' GLN . 97.8 t -79.58 151.25 4.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.42 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -104.69 157.06 17.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.334 0.588 . . . . 0.0 111.528 -178.374 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.406 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 1.5 mt-10 -52.36 154.67 4.13 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.237 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 82' ' ' GLU . 14.0 Cg_endo -55.2 103.5 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.763 2.309 . . . . 0.0 111.762 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.516 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 92.9 t -101.8 99.68 8.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.564 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.447 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -92.06 112.72 24.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.063 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.42 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 74.1 m -114.48 -175.6 2.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.463 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -56.07 -21.9 24.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.751 0.31 . . . . 0.0 110.874 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -86.78 -23.67 25.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.311 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.97 -170.73 23.05 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.821 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 0.2 OUTLIER -74.66 98.66 3.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.038 0.446 . . . . 0.0 109.905 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.423 ' CD2' HD12 ' A' ' 16' ' ' LEU . 79.4 m80 -86.38 169.34 13.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.455 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.6 t -145.21 153.26 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.664 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.455 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -137.27 122.4 25.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.062 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.404 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 4.1 tptt -128.63 112.87 14.72 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.528 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -57.23 136.5 56.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.701 0.762 . . . . 0.0 112.436 -177.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.516 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -159.01 116.82 2.83 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.814 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.565 179.871 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.609 -0.196 . . . . 0.0 112.609 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.5 92.99 0.58 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.623 2.215 . . . . 0.0 112.408 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.56 112.81 6.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.15 44.18 2.08 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.575 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.2 t -72.79 123.44 23.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 110.742 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 19.3 mtt -146.2 -43.58 0.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.286 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.66 30.73 1.48 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.408 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -63.03 -17.96 62.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.883 0.373 . . . . 0.0 110.73 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.616 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.71 172.52 11.45 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.583 0.706 . . . . 0.0 112.332 -179.172 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -111.2 139.89 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.978 178.809 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.5 mtpt -108.88 96.91 6.65 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.446 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.649 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 3.0 t -125.86 179.13 5.34 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.876 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.49 161.4 24.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.431 ' CG ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -136.59 153.4 50.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.534 0.683 . . . . 0.0 112.664 -179.376 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 2.6 mp -152.14 115.14 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.85 179.653 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.468 ' O ' HG13 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -100.4 128.41 46.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.852 -179.129 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.468 HG13 ' O ' ' A' ' 16' ' ' LEU . 10.9 m -145.14 134.38 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.054 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -76.1 -35.81 59.18 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.617 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -72.25 79.7 0.99 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.458 ' HG3' ' CE1' ' A' ' 90' ' ' TYR . 34.6 tt0 -46.05 -25.47 0.58 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.9 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.86 -31.58 78.61 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 118.836 -1.65 . . . . 0.0 110.44 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.617 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -73.21 -37.96 66.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.079 0.466 . . . . 0.0 109.957 178.194 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.606 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -54.08 -35.9 62.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.908 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.622 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -73.76 -29.39 62.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.802 178.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.87 -48.33 10.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.187 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 30' ' ' LEU . 3.1 m -49.74 -38.93 14.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.066 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.622 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.6 pt20 -58.83 -48.87 79.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.571 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 4.4 pt-20 -73.19 -29.36 62.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.598 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.58 -31.2 47.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.743 -178.846 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.451 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.3 tm? -56.82 -58.95 5.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.238 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -9.51 58.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.626 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.3 -23.35 62.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 111.397 -179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.23 -15.91 0.88 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.719 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -89.37 157.49 18.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.751 0.31 . . . . 0.0 110.862 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 pttt -100.68 153.95 19.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.133 0.492 . . . . 0.0 111.148 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.433 ' CZ ' HD23 ' A' ' 96' ' ' LEU . 2.5 p90 -52.63 -40.34 62.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.117 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -55.4 -34.17 59.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.704 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -67.21 -54.04 24.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.779 0.323 . . . . 0.0 110.854 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -55.92 -32.28 63.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.827 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.27 -53.78 32.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.948 0.404 . . . . 0.0 110.811 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -86.16 -23.37 26.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.164 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 3.0 mm-40 -70.02 -68.94 0.38 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.389 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.487 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.77 -13.55 9.09 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.703 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.537 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -64.1 133.59 53.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.912 0.387 . . . . 0.0 111.195 -179.178 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.444 HG13 ' HB3' ' A' ' 16' ' ' LEU . 1.4 pt -99.94 -8.51 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.064 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 50' ' ' ALA . 18.9 p-10 -46.05 135.62 7.34 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.674 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.02 -178.45 3.28 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.0 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.66 -43.1 0.0 OUTLIER Glycine 0 C--N 1.34 0.797 0 N-CA-C 115.629 1.012 . . . . 0.0 115.629 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.674 ' N ' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -51.43 -18.69 1.11 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 117.394 0.597 . . . . 0.0 111.614 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.421 ' HB3' ' O ' ' A' ' 46' ' ' ASP . . . -70.58 -20.37 62.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.941 0.401 . . . . 0.0 110.926 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -76.79 -4.34 42.98 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.361 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.23 24.59 11.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.422 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 p30 55.74 31.82 18.24 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.337 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 52.97 33.45 44.02 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.914 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 m -84.82 89.43 7.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 110.847 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.649 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 69.6 mt -56.35 -30.05 62.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.503 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 64.54 -165.67 32.01 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.887 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.475 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -68.82 111.01 4.63 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.515 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.616 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 4.9 m-85 -117.03 153.94 31.82 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.04 -174.14 17.51 Favored Glycine 0 C--N 1.312 -0.784 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.446 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -79.57 79.86 6.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.138 0.494 . . . . 0.0 110.033 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.94 36.62 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.66 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -126.6 -41.57 1.85 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.594 0.235 . . . . 0.0 111.181 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -114.51 171.3 7.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.049 0.452 . . . . 0.0 111.297 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 68' ' ' PHE . 32.7 m -52.35 161.92 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.406 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.579 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -65.59 -47.4 67.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.591 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 15.7 Cg_endo -63.27 -40.31 33.09 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.028 1.819 . . . . 0.0 111.893 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.468 ' HB3' HG23 ' A' ' 65' ' ' VAL . 35.6 t80 -74.93 -52.64 10.71 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.036 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -57.55 -32.48 67.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.8 OUTLIER -63.13 -50.68 69.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.047 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.0 -9.98 59.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.65 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.04 99.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.808 0.337 . . . . 0.0 111.293 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.447 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 20.2 p90 -96.46 16.83 17.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.419 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.87 -30.76 12.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.931 0.396 . . . . 0.0 110.827 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.414 HD12 ' O ' ' A' ' 80' ' ' VAL . 4.2 mt -103.57 68.21 0.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.262 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -73.26 -18.26 61.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.155 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -66.55 -26.75 38.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.755 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.419 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 95.18 57.14 1.23 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.598 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -138.64 176.45 8.68 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.839 0.352 . . . . 0.0 110.801 -178.434 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.414 ' O ' HD12 ' A' ' 75' ' ' LEU . 42.6 t -84.43 146.08 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.502 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 t -105.37 164.07 12.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.171 0.51 . . . . 0.0 111.477 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -50.89 154.72 2.33 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.107 -179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.48 105.32 0.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.25 1.967 . . . . 0.0 111.797 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.591 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 59.4 t -101.19 102.14 13.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.549 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -92.11 113.14 25.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.315 -179.628 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.96 -171.46 1.89 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.205 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -56.88 -19.13 15.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.532 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -92.24 -40.82 10.76 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.89 -172.19 36.38 Favored Glycine 0 CA--C 1.506 -0.473 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.731 -179.463 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.458 ' CE1' ' HG3' ' A' ' 20' ' ' GLN . 6.2 m-85 -74.91 98.19 3.51 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.364 0.602 . . . . 0.0 110.162 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 79.9 m80 -82.4 169.14 16.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.465 -178.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 17.9 t -145.49 146.51 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.295 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.451 HG23 ' CE1' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -131.22 122.7 51.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.675 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.426 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 8.2 tptm -128.29 109.96 11.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.468 178.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.17 134.5 55.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.631 0.729 . . . . 0.0 112.298 -177.62 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -157.51 116.67 3.28 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.67 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.42 -1.211 . . . . 0.0 112.604 179.831 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.11 163.16 39.55 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.574 2.183 . . . . 0.0 112.323 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.99 149.4 47.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.84 31.49 1.45 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.616 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.11 123.74 32.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.787 0.327 . . . . 0.0 110.855 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.5 tpp 61.16 103.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.589 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.51 35.06 1.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.29 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.471 ' CB ' ' HE3' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -55.97 -25.57 44.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.606 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.603 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.26 168.33 15.8 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.51 0.671 . . . . 0.0 111.728 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.39 139.48 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.821 178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.452 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.9 mtpt -109.63 96.57 6.36 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.653 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.688 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 2.6 t -131.6 179.62 5.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.63 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.404 ' O ' ' HA ' ' A' ' 93' ' ' ILE . 6.5 t -127.47 162.74 25.66 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.423 ' CE1' ' HB3' ' A' ' 49' ' ' SER . 0.0 OUTLIER -134.17 148.92 50.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.349 0.595 . . . . 0.0 112.556 -179.404 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 3.6 mp -145.49 131.39 13.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.709 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.0 mt -123.31 133.41 54.15 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.493 ' CG2' ' CG ' ' A' ' 22' ' ' GLU . 21.5 m -150.91 135.85 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.695 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -17.64 64.59 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -72.22 78.34 0.97 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.683 179.062 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.438 ' HB3' ' CZ ' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -47.07 -41.71 17.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.017 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.6 -31.46 73.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.959 -1.115 . . . . 0.0 112.898 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.561 ' HG3' ' N ' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -65.58 -44.44 86.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.223 0.535 . . . . 0.0 110.666 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.561 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -47.67 -40.6 20.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.286 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.71 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -72.9 -28.87 62.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.045 179.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.44 -44.23 17.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.254 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.463 ' O ' ' N ' ' A' ' 30' ' ' LEU . 14.7 m -58.2 -29.0 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.71 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.8 pt20 -54.91 -53.47 55.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.989 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.485 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.0 OUTLIER -73.83 -28.91 61.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.127 0.489 . . . . 0.0 110.634 178.551 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -75.98 -34.29 59.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.273 -178.51 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.463 ' N ' ' O ' ' A' ' 26' ' ' VAL . 1.1 tm? -52.81 -49.68 65.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.173 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 -9.19 58.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.301 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.36 49.11 0.36 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.52 -10.51 36.79 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.758 -0.734 . . . . 0.0 114.171 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -92.62 153.83 18.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.378 0.589 . . . . 0.0 110.852 -179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 143.38 30.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.274 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.442 ' CE1' HD21 ' A' ' 96' ' ' LEU . 5.2 p90 -52.89 -35.79 58.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.748 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.406 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.46 -36.37 93.05 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.27 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 10.5 tttt -60.83 -53.77 53.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.843 0.354 . . . . 0.0 110.807 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.406 ' O ' HD22 ' A' ' 43' ' ' LEU . 2.8 mm? -53.64 -34.12 57.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.007 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.423 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.63 -53.41 38.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.956 0.408 . . . . 0.0 110.81 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -23.55 26.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.934 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -68.96 -68.69 0.38 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.076 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.457 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.66 -16.07 8.86 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.423 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.3 OUTLIER -64.23 141.5 58.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.192 0.52 . . . . 0.0 111.522 -179.193 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.9 pt -105.74 -9.08 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.894 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -46.08 135.6 7.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.005 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.675 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -61.47 -178.08 2.63 Favored Glycine 0 C--O 1.226 -0.35 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.508 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 51' ' ' LYS . . . -11.14 -44.22 0.0 OUTLIER Glycine 0 N--CA 1.468 0.827 0 N-CA-C 115.512 0.965 . . . . 0.0 115.512 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.675 ' N ' ' O ' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -51.58 -31.14 23.55 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.759 0.78 . . . . 0.0 111.042 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -72.49 -26.37 61.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.245 0.545 . . . . 0.0 110.548 178.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.6 OUTLIER -72.6 -13.17 61.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.942 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.87 24.43 11.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.381 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 73.5 9.24 5.06 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.27 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.3 24.63 70.76 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.225 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.4 p -75.94 82.77 2.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.97 0.414 . . . . 0.0 110.615 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.688 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 14.6 mt -53.94 -24.5 16.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.992 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.04 -163.67 20.03 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.828 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.452 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -72.68 111.51 7.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.995 0.426 . . . . 0.0 111.744 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.603 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 3.8 m-85 -123.71 163.62 20.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.455 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.77 -173.99 14.96 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.628 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.55 93.89 7.94 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.897 0.38 . . . . 0.0 110.189 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.42 36.79 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.854 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.43 -44.54 0.22 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.622 0.249 . . . . 0.0 111.241 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.05 165.74 13.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 111.298 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.48 HG23 ' CB ' ' A' ' 68' ' ' PHE . 35.9 m -61.7 165.06 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.894 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.501 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -60.63 -48.06 94.34 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.501 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 13.8 Cg_endo -66.2 -37.68 23.95 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 121.897 1.731 . . . . 0.0 111.962 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.48 ' CB ' HG23 ' A' ' 65' ' ' VAL . 40.0 t80 -74.96 -52.31 11.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.905 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.79 -32.27 63.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.799 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.469 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 2.6 m-20 -65.19 -52.08 57.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.995 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.42 ' HA ' ' HG2' ' A' ' 74' ' ' ARG . . . -75.09 -9.28 58.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.908 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.27 -38.31 71.85 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.469 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 2.8 p90 -106.04 16.76 24.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.42 ' HG2' ' HA ' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -98.76 -27.69 13.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.329 . . . . 0.0 110.98 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.452 HD12 ' O ' ' A' ' 80' ' ' VAL . 3.1 mt -103.47 66.43 0.88 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.076 0.465 . . . . 0.0 111.447 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -73.29 -18.23 61.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.005 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.96 -27.0 39.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.663 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.425 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 95.6 58.74 1.11 Allowed Glycine 0 CA--C 1.503 -0.67 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.536 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -140.33 176.28 8.9 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.776 0.322 . . . . 0.0 111.084 -178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.452 ' O ' HD12 ' A' ' 75' ' ' LEU . 55.6 t -82.84 146.58 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.158 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 t -104.84 164.14 12.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.346 0.593 . . . . 0.0 111.917 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -50.75 156.42 1.62 Allowed Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.634 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.411 ' HG3' ' CD2' ' A' ' 24' ' ' LEU . 26.9 Cg_endo -61.09 105.17 0.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.583 2.188 . . . . 0.0 112.141 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.498 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 87.7 t -101.27 99.47 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.582 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.446 ' CG ' ' CD1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -97.97 112.79 24.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.798 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.9 m -110.62 -175.75 2.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.635 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.34 -21.64 25.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.093 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -85.45 -26.73 26.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.38 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 144.18 -165.32 27.42 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.771 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.446 ' CD1' ' CG ' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -83.26 106.68 15.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -92.64 157.92 16.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.476 0.655 . . . . 0.0 112.597 -178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.1 t -140.72 153.17 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.264 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.459 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -141.26 124.16 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.878 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -128.11 113.87 16.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.282 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.485 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.5 135.4 56.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.54 0.686 . . . . 0.0 112.231 -177.617 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -157.38 116.65 3.32 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.733 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.605 -179.999 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.454 -0.258 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.21 125.44 17.46 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.643 2.229 . . . . 0.0 112.308 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.2 mtp -110.21 126.1 53.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.854 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.82 52.42 1.8 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.573 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.43 140.89 29.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.754 0.312 . . . . 0.0 110.878 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.4 tpt -96.32 158.37 15.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.15 29.86 3.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.132 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.448 ' CB ' ' HE3' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -56.84 -22.36 36.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.844 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.696 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.27 168.55 15.58 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.429 0.633 . . . . 0.0 111.595 -179.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -111.31 139.11 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.828 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.478 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.5 mtpt -107.93 98.3 7.9 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.366 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.778 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 2.1 t -130.32 -179.84 5.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.824 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.4 t -120.73 162.89 18.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.975 179.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.449 ' O ' ' CD2' ' A' ' 14' ' ' HIS . 0.6 OUTLIER -130.33 139.32 50.7 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.997 0.427 . . . . 0.0 111.781 -179.694 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.453 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 4.7 mp -153.3 118.97 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.482 HD11 ' O ' ' A' ' 46' ' ' ASP . 0.3 OUTLIER -109.63 140.91 42.89 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.922 0.391 . . . . 0.0 111.034 179.649 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.443 HG13 ' O ' ' A' ' 43' ' ' LEU . 4.4 m -149.1 134.35 10.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.732 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -35.86 69.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.808 -178.796 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.634 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 4.7 tttp -72.83 78.8 1.14 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.49 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -46.64 -25.99 0.82 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.027 -0.988 . . . . 0.0 113.225 -176.73 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.54 -31.53 76.72 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 119.026 -1.559 . . . . 0.0 110.921 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.634 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 0.3 OUTLIER -71.07 -38.81 72.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.059 0.457 . . . . 0.0 110.491 178.725 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.613 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -52.03 -37.15 52.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.363 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.521 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.25 -29.86 63.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.646 179.046 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.99 -41.45 18.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.496 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.1 m -52.33 -37.83 24.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.014 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.64 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -59.24 -48.84 80.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.64 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.3 pt-20 -73.27 -29.0 62.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.66 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.438 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 8.1 tpt180 -78.86 -32.28 45.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.01 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.401 ' HG ' ' HG3' ' A' ' 94' ' ' LYS . 0.7 OUTLIER -53.12 -59.4 4.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.171 -179.048 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.46 -9.44 58.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.371 179.498 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.04 -24.96 63.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.858 0.361 . . . . 0.0 111.327 -179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.4 -17.01 0.77 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.579 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -86.84 154.99 20.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.901 0.382 . . . . 0.0 110.79 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.92 146.2 27.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.129 0.49 . . . . 0.0 111.079 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.441 ' CE2' ' HB2' ' A' ' 96' ' ' LEU . 3.7 p90 -47.1 -30.76 2.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.743 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.443 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.47 -34.24 88.81 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.178 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.536 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -66.64 -53.47 33.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.766 0.317 . . . . 0.0 110.765 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -53.37 -36.07 60.99 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.273 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.499 ' O ' ' HB3' ' A' ' 44' ' ' SER . . . -52.1 -52.94 48.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.178 0.513 . . . . 0.0 110.701 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.57 -23.57 27.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.727 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 1.1 mt-10 -73.58 -67.86 0.55 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.52 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.99 -12.56 9.51 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.499 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 3.3 t -63.12 125.98 25.86 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.891 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 3.8 pt -107.86 -26.97 3.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.482 ' O ' HD11 ' A' ' 16' ' ' LEU . 23.7 t0 -127.57 102.38 6.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.81 143.64 4.9 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.86 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.25 -35.39 23.74 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.442 ' O ' ' N ' ' A' ' 54' ' ' GLY . 0.1 OUTLIER -76.68 0.16 21.36 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.244 -0.478 . . . . 0.0 111.008 179.218 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -62.16 -23.67 66.73 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.345 0.593 . . . . 0.0 109.586 178.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -88.78 -5.29 58.17 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.2 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.431 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 2.5 mtt180 -119.06 24.98 10.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.84 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 76.39 16.06 2.15 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.332 -179.722 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.442 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 66.18 17.01 65.39 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.577 179.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.0 m -70.91 86.32 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.672 0.272 . . . . 0.0 110.901 179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.778 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 23.4 mt -54.77 -31.15 58.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.037 0.446 . . . . 0.0 110.577 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 69.94 -170.29 44.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.43 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.478 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -67.87 111.58 4.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 111.625 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.696 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 6.4 m-85 -123.89 159.21 30.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.666 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.72 -174.06 18.67 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.293 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -88.01 96.82 10.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.988 0.423 . . . . 0.0 110.335 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.16 36.73 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.373 -0.917 . . . . 0.0 113.067 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 tptm -143.45 -47.51 0.3 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.75 0.31 . . . . 0.0 111.259 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.17 166.93 12.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.878 0.371 . . . . 0.0 111.278 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.468 HG23 ' CB ' ' A' ' 68' ' ' PHE . 35.0 m -54.63 165.75 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.174 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.517 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 20.7 tttm -64.29 -47.93 77.15 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.517 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 14.0 Cg_endo -65.46 -38.16 27.02 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 121.861 1.708 . . . . 0.0 111.939 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.486 ' CZ ' HG21 ' A' ' 93' ' ' ILE . 24.4 t80 -74.94 -52.69 10.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.647 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -57.17 -34.03 68.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.779 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.456 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 23.6 t0 -69.03 -47.95 64.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.059 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.33 -9.69 58.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.785 -179.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.37 -49.03 68.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.785 0.326 . . . . 0.0 111.709 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.456 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 3.0 p90 -92.7 16.92 11.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.601 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.7 -29.37 14.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.468 HD13 ' O ' ' A' ' 80' ' ' VAL . 4.3 mt -103.57 66.01 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.474 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -69.9 -19.97 63.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.061 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 p -64.54 -26.88 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.57 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.414 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 94.22 58.05 1.25 Allowed Glycine 0 CA--C 1.504 -0.645 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.719 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -140.13 176.37 8.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.779 0.323 . . . . 0.0 111.077 -178.475 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.468 ' O ' HD13 ' A' ' 75' ' ' LEU . 86.2 t -81.28 146.7 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.0 t -104.68 164.1 12.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.222 0.534 . . . . 0.0 111.777 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -50.54 155.08 1.96 Allowed Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.328 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.503 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 18.5 Cg_endo -60.18 106.33 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.358 2.038 . . . . 0.0 111.741 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.513 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 97.5 t -100.95 100.22 9.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.608 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.451 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.7 OUTLIER -94.53 112.96 24.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.942 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.63 -172.11 1.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.505 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -57.54 -20.95 35.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.858 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -85.86 -37.23 19.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.245 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.81 -168.46 30.56 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.656 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.503 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -75.34 98.57 3.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.005 0.431 . . . . 0.0 109.926 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.45 ' CD2' HD12 ' A' ' 16' ' ' LEU . 70.1 m80 -80.41 165.08 22.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.397 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.7 t -149.19 138.38 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.762 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.486 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -127.99 122.7 59.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.741 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.403 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 1.4 tmtm? -126.18 112.27 15.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.186 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.5 132.33 52.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.559 0.695 . . . . 0.0 111.89 -177.697 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.52 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -155.06 116.75 4.09 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.685 179.643 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.339 -1.256 . . . . 0.0 112.619 179.914 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.96 126.98 13.8 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.652 2.235 . . . . 0.0 112.294 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.1 ttm -96.35 145.76 25.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.937 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.61 43.31 0.12 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.547 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 m -76.09 141.07 42.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.711 0.291 . . . . 0.0 110.954 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 82.5 mtp -123.0 -41.01 2.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.143 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.54 31.3 3.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.457 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.17 -24.77 28.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.906 0.384 . . . . 0.0 110.661 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.481 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 3.5 mptt -85.01 161.22 19.83 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.707 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 mt -111.03 128.08 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.349 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.428 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.8 mtpt -97.9 92.73 5.96 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.109 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.598 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -124.06 -179.89 4.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.309 -177.552 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.424 ' N ' ' O ' ' A' ' 94' ' ' LYS . 2.0 t -123.14 160.17 27.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.954 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.404 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -136.29 147.23 47.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.335 0.588 . . . . 0.0 111.977 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.404 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 3.2 mp -151.91 115.39 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.314 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.576 ' HB3' ' CG1' ' A' ' 45' ' ' ILE . 7.7 tp -100.77 132.37 46.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.49 HG12 ' O ' ' A' ' 16' ' ' LEU . 12.3 m -146.07 134.11 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.815 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -75.01 -36.29 61.94 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.415 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.616 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -71.84 79.35 0.87 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.597 0.713 . . . . 0.0 109.078 178.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.495 ' HG3' ' CZ ' ' A' ' 90' ' ' TYR . 1.3 tm0? -45.71 -25.73 0.53 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.218 -177.254 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.73 -31.55 78.72 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 118.774 -1.679 . . . . 0.0 110.688 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.665 ' HG3' ' N ' ' A' ' 23' ' ' ALA . 0.3 OUTLIER -71.77 -39.41 69.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.152 0.501 . . . . 0.0 109.803 178.146 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.665 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -51.5 -36.91 46.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.996 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.605 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.55 -29.44 62.44 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.949 179.011 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.08 -40.46 16.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.51 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 2.3 m -56.92 -37.55 54.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.058 -179.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.605 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.0 pt20 -56.84 -51.33 69.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.542 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.6 pt-20 -73.45 -29.18 62.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.618 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -75.6 -33.57 60.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.633 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.436 ' HA ' ' OE1' ' A' ' 34' ' ' GLU . 0.9 OUTLIER -52.94 -58.91 5.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 -179.44 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -8.78 56.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.521 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.99 -20.09 21.95 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.39 -10.47 1.73 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.131 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.436 ' OE1' ' HA ' ' A' ' 30' ' ' LEU . 0.0 OUTLIER -103.77 158.2 16.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.904 0.383 . . . . 0.0 110.677 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -97.29 154.26 17.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.37 0.605 . . . . 0.0 112.17 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.416 ' CZ ' ' HB2' ' A' ' 96' ' ' LEU . 0.2 OUTLIER -53.0 -35.22 59.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.388 179.316 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.413 ' HA2' ' CA ' ' A' ' 53' ' ' ASP . . . -53.54 -34.16 49.01 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.001 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.469 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 9.7 mtpp -69.98 -53.63 16.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.656 0.265 . . . . 0.0 110.442 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.417 HD23 ' CD2' ' A' ' 30' ' ' LEU . 2.9 mm? -54.0 -33.36 56.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.716 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.52 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.59 -53.36 39.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.071 0.462 . . . . 0.0 110.657 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.21 -23.33 26.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.214 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.474 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 1.3 mt-10 -71.15 -69.18 0.39 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.474 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.78 -11.64 9.34 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.582 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.52 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -63.9 138.53 58.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.03 0.443 . . . . 0.0 111.33 -179.035 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.576 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 43.1 pt -104.66 -12.67 9.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.959 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.411 ' O ' ' HB1' ' A' ' 50' ' ' ALA . 21.7 p-10 -45.67 135.14 6.91 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.325 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.66 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.68 -178.63 3.99 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.109 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.457 ' O ' ' HB2' ' A' ' 51' ' ' LYS . . . -11.86 -43.13 0.0 OUTLIER Glycine 0 N--CA 1.468 0.802 0 N-CA-C 115.571 0.988 . . . . 0.0 115.571 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.66 ' N ' ' O ' ' A' ' 47' ' ' GLY . 3.8 m -51.17 -21.5 2.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.573 0.686 . . . . 0.0 111.379 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.411 ' HB1' ' O ' ' A' ' 46' ' ' ASP . . . -71.2 -20.77 62.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.924 0.392 . . . . 0.0 111.255 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -67.8 -8.08 32.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.17 -179.004 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.404 ' HG2' ' O ' ' A' ' 49' ' ' SER . 11.5 ptp180 -104.21 23.69 12.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.89 0.376 . . . . 0.0 110.702 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.413 ' CA ' ' HA2' ' A' ' 37' ' ' GLY . 0.0 OUTLIER 71.96 13.0 6.04 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.241 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.3 16.69 80.52 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.418 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 m -74.06 89.77 1.97 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.783 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.598 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 13.2 mt -56.5 -28.35 59.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.665 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.59 -166.62 42.35 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.428 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -68.31 118.71 11.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.112 0.482 . . . . 0.0 111.923 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.481 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 10.5 m-85 -131.57 150.44 52.15 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.39 -173.88 18.27 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.577 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 -76.27 81.97 3.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 110.084 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.46 36.67 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.939 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -134.8 -48.52 0.75 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.815 0.34 . . . . 0.0 111.232 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.58 170.61 8.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.137 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.46 HG23 ' CB ' ' A' ' 68' ' ' PHE . 33.0 m -57.06 159.56 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.544 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -62.1 -47.9 89.44 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.592 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 17.5 Cg_endo -64.63 -39.2 28.27 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.932 1.754 . . . . 0.0 112.115 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.46 ' CB ' HG23 ' A' ' 65' ' ' VAL . 17.6 t80 -74.92 -52.02 12.3 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.728 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -56.01 -32.29 63.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.676 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -64.26 -52.62 57.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.871 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.0 -11.96 60.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.638 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.32 -48.5 81.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.799 0.333 . . . . 0.0 111.407 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 6.7 p90 -93.23 16.83 12.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.372 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.31 -28.58 13.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.895 0.379 . . . . 0.0 110.834 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.434 HD13 ' O ' ' A' ' 80' ' ' VAL . 3.0 mt -103.63 62.81 0.77 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.291 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -69.61 -18.39 63.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.087 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -64.61 -26.86 41.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.53 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.426 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.27 56.88 1.24 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.669 -0.776 . . . . 0.0 111.731 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -139.36 176.29 8.84 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.89 0.376 . . . . 0.0 110.982 -178.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 61.1 t -84.29 147.55 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.069 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.97 164.12 12.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.225 0.536 . . . . 0.0 111.431 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -50.48 154.43 2.22 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.986 -178.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -60.0 104.97 0.25 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.177 1.918 . . . . 0.0 111.819 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.592 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 59.3 t -101.33 102.0 12.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.528 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.524 ' HA ' ' HA ' ' A' ' 90' ' ' TYR . 3.9 tmtt? -92.38 112.87 24.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.351 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.4 -171.58 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.141 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -16.26 40.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.217 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -94.01 -40.82 9.9 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.65 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.17 -174.24 40.25 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.812 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.524 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 1.7 m-85 -76.92 98.38 4.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.233 0.54 . . . . 0.0 110.374 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.443 ' CD2' HD13 ' A' ' 16' ' ' LEU . 58.2 m80 -78.24 169.78 17.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.669 -178.237 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 29.6 t -151.33 128.57 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.363 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.455 HG21 ' CZ ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -111.5 123.2 67.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.25 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.424 ' O ' ' N ' ' A' ' 13' ' ' SER . 28.1 tptp -128.28 115.17 17.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.454 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.426 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -58.33 134.87 56.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.45 0.643 . . . . 0.0 112.134 -178.544 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.524 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -160.72 116.6 2.27 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.217 179.605 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.414 -1.214 . . . . 0.0 112.532 179.642 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.409 -0.277 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.02 127.44 23.36 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.667 2.244 . . . . 0.0 112.259 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.2 mtp -80.94 145.92 31.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.922 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.6 53.8 15.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.43 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -77.54 123.3 26.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.857 0.36 . . . . 0.0 110.844 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.29 -22.34 10.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.207 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.4 29.89 2.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.303 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -51.39 -27.63 10.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.948 0.404 . . . . 0.0 110.551 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.512 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.8 OUTLIER -85.22 160.84 19.79 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.128 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.448 ' HB ' ' CE1' ' A' ' 59' ' ' PHE . 0.4 OUTLIER -111.03 135.88 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.848 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.5 mtpt -106.83 95.11 5.5 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.653 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.704 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 2.4 t -124.06 179.58 4.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.894 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' A' ' 54' ' ' GLY . 1.8 p -123.37 162.25 23.12 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.438 ' CE1' ' HA2' ' A' ' 54' ' ' GLY . 20.4 p-80 -133.97 153.75 51.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.399 0.619 . . . . 0.0 112.327 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.408 HG23 ' OG ' ' A' ' 44' ' ' SER . 2.9 mp -156.75 122.73 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.777 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.567 ' HB3' ' CG1' ' A' ' 45' ' ' ILE . 10.3 tp -110.32 132.15 54.43 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 16' ' ' LEU . 15.5 m -142.88 134.45 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.391 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.53 -35.78 63.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.5 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.618 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -73.12 79.3 1.24 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.46 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 2.0 pt20 -46.28 -25.58 0.65 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.328 -0.851 . . . . 0.0 113.154 -176.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.02 -31.4 77.84 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.119 -1.515 . . . . 0.0 110.67 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.618 ' HB3' ' HG2' ' A' ' 19' ' ' LYS . 0.4 OUTLIER -71.26 -37.85 71.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.084 0.469 . . . . 0.0 109.928 178.39 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.581 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.87 -38.01 46.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.15 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.593 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -73.07 -29.58 63.05 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.823 179.278 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.95 -53.33 5.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.795 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.409 ' CG1' ' OE1' ' A' ' 22' ' ' GLU . 3.8 m -47.03 -37.34 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.322 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.593 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.5 pt20 -59.92 -48.21 82.64 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.554 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 3.4 pt-20 -73.06 -29.01 62.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.648 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -78.62 -35.37 45.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.771 -178.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -52.74 -58.81 5.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.29 -179.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.97 -9.6 58.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.254 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.25 -24.57 63.31 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.864 0.364 . . . . 0.0 111.114 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.36 -17.21 1.15 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.436 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -78.92 157.7 28.18 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.985 0.422 . . . . 0.0 110.949 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -98.08 140.1 32.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.027 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.4 p90 -51.39 -32.13 25.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.848 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.4 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -62.79 -34.25 89.23 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.213 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.2 mmtt -65.96 -53.57 37.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.661 0.267 . . . . 0.0 110.783 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -53.85 -32.33 52.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.517 179.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.535 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.36 -53.78 32.88 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.549 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.18 -23.47 26.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.224 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.494 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.78 -68.8 0.41 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -177.43 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.494 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.63 -12.25 9.31 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.535 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.6 OUTLIER -64.05 140.32 58.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.931 0.396 . . . . 0.0 111.289 -179.241 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.567 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 31.7 pt -103.43 -10.81 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.686 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 24.4 p-10 -45.84 134.98 7.4 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.404 -179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.681 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.44 -178.31 3.62 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.683 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.76 -42.9 0.0 OUTLIER Glycine 0 N--CA 1.468 0.782 0 N-CA-C 115.485 0.954 . . . . 0.0 115.485 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.681 ' N ' ' O ' ' A' ' 47' ' ' GLY . 1.5 t -51.46 -16.91 0.66 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.5 0.65 . . . . 0.0 111.701 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -71.04 -20.82 62.34 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 121.28 0.562 . . . . 0.0 110.303 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.3 OUTLIER -74.36 -8.79 57.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.373 179.444 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.418 ' O ' ' CG ' ' A' ' 53' ' ' ASP . 0.5 OUTLIER -103.67 24.67 10.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.423 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.418 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 2.1 p30 54.08 34.8 20.73 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.97 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.438 ' HA2' ' CE1' ' A' ' 14' ' ' HIS . . . 56.76 21.47 36.59 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.417 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.7 p -70.38 86.81 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.85 0.357 . . . . 0.0 111.257 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.704 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 46.6 mt -59.69 -33.4 71.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.102 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.94 -167.13 48.98 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.947 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -69.19 119.15 13.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.045 0.45 . . . . 0.0 111.851 -179.387 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.512 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 9.3 p90 -135.46 135.48 40.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.48 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.42 -174.01 49.89 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.601 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 ptt-85 -89.73 89.4 7.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.948 0.404 . . . . 0.0 110.505 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.1 36.45 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.057 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -146.52 7.01 0.97 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.449 ' CE ' ' CD1' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -141.33 174.24 10.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.75 0.31 . . . . 0.0 110.844 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.449 HG23 ' HB3' ' A' ' 68' ' ' PHE . 23.9 m -68.35 154.48 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.804 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -59.65 -46.94 98.59 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 17.5 Cg_endo -64.45 -41.22 21.07 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.937 1.758 . . . . 0.0 112.155 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.465 ' CZ ' HG22 ' A' ' 93' ' ' ILE . 26.2 t80 -74.98 -51.4 13.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.77 -32.31 65.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.797 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 11.6 t70 -63.82 -51.21 65.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.109 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.9 -10.02 59.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.756 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.46 -50.01 66.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.727 0.299 . . . . 0.0 111.497 -179.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 6.2 p90 -93.33 16.51 13.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.464 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 4.4 ttm-85 -96.57 -31.9 12.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.658 0.266 . . . . 0.0 111.226 -179.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.522 ' CD1' ' O ' ' A' ' 79' ' ' GLU . 0.7 OUTLIER -103.37 55.88 0.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.385 -179.792 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -58.83 -22.21 58.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.089 0.471 . . . . 0.0 110.029 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.07 -28.43 39.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.435 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.466 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 97.05 59.09 1.0 Allowed Glycine 0 CA--C 1.508 -0.397 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.303 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.522 ' O ' ' CD1' ' A' ' 75' ' ' LEU . 5.6 pt-20 -130.22 177.38 7.36 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 21.7 t -88.65 148.41 4.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.695 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.46 ' CA ' HD13 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -104.42 164.03 12.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.136 0.493 . . . . 0.0 111.282 -178.883 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -50.43 154.76 2.04 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.866 -178.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.403 ' HG3' ' CD2' ' A' ' 24' ' ' LEU . 14.1 Cg_endo -55.58 104.53 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.367 2.045 . . . . 0.0 111.721 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.535 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 94.3 t -101.64 101.54 12.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.684 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.455 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 19.2 tptp -95.54 112.49 24.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.573 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.9 m -112.5 -176.97 3.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.468 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.81 -22.33 14.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.939 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.94 -27.57 24.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.331 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.5 -170.71 24.06 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.823 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.46 ' CD1' ' HB3' ' A' ' 20' ' ' GLN . 0.5 OUTLIER -74.56 100.78 4.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.045 0.45 . . . . 0.0 109.927 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.424 ' CD2' ' CD1' ' A' ' 16' ' ' LEU . 10.3 m80 -87.35 169.31 12.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.586 0.707 . . . . 0.0 112.742 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.1 t -146.76 136.29 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.119 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.465 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -126.58 122.5 61.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.352 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 22.0 tptp -128.54 110.33 12.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.456 178.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.56 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.62 134.36 56.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.596 0.713 . . . . 0.0 112.195 -177.89 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.51 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -153.8 116.4 4.42 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.593 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.415 ' HA3' ' HD3' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.424 -1.209 . . . . 0.0 112.541 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.14 151.85 76.78 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.579 2.186 . . . . 0.0 112.257 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.0 mtp -85.25 149.49 25.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.967 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.1 20.62 73.09 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.665 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 97.3 p -88.43 123.38 32.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.384 . . . . 0.0 111.007 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.2 mtt -108.29 129.23 55.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.547 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.07 26.87 1.82 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.606 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.473 ' CB ' ' HE3' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -59.49 -22.13 61.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 110.595 179.642 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.668 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -83.96 172.95 11.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.442 0.639 . . . . 0.0 111.933 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.5 mt -111.0 136.93 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.944 178.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.488 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.4 mtpt -108.11 86.71 2.34 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.577 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.81 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 7.1 m -130.58 179.98 5.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.636 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.463 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 2.9 p -135.33 161.76 34.49 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.428 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 0.7 OUTLIER -141.24 155.49 46.01 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.196 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.56 ' CD1' ' CE2' ' A' ' 36' ' ' PHE . 1.7 mp -134.95 141.81 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.863 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.444 ' O ' HG11 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -121.48 128.84 52.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.77 0.319 . . . . 0.0 111.723 -179.499 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.475 ' CG2' ' CG ' ' A' ' 22' ' ' GLU . 24.7 m -144.12 134.21 20.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.465 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.12 -36.27 74.7 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.732 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.612 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.09 78.55 0.94 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.486 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.453 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -46.67 -25.98 0.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.714 -1.13 . . . . 0.0 113.191 -177.584 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.39 -31.31 76.61 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.086 -1.531 . . . . 0.0 111.091 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.678 ' HG3' ' N ' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -70.25 -39.91 74.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.142 0.496 . . . . 0.0 110.03 178.568 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.678 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -51.15 -37.16 44.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.227 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.607 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.41 -29.46 62.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.922 179.17 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.66 -42.53 14.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.484 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.457 ' O ' ' N ' ' A' ' 30' ' ' LEU . 2.7 m -53.4 -39.17 34.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.881 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.607 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.5 pt20 -56.33 -50.19 72.17 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.578 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 4.6 pt-20 -73.36 -30.98 63.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.803 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.9 tpm_? -77.18 -27.52 53.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.011 -178.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.457 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.8 OUTLIER -60.78 -52.76 63.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.419 -179.101 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.57 -9.4 49.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.525 -179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.28 -22.05 27.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.761 0.315 . . . . 0.0 111.387 -179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.37 -10.73 3.8 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.387 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -77.81 157.46 29.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.823 0.344 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.12 136.01 33.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.789 179.969 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.56 ' CE2' ' CD1' ' A' ' 15' ' ' ILE . 4.8 t80 -53.94 -48.15 70.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.236 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.26 -33.9 53.03 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.293 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.0 mmmt -60.33 -52.26 66.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.707 0.289 . . . . 0.0 110.873 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.4 ' HA ' ' HB2' ' A' ' 42' ' ' GLU . 2.9 mm? -53.34 -33.54 53.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.49 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.45 -53.81 33.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.074 0.464 . . . . 0.0 110.582 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -85.94 -23.66 26.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.059 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.493 ' HB3' ' CD1' ' A' ' 43' ' ' LEU . 0.2 OUTLIER -69.12 -68.35 0.41 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.941 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.493 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.21 -15.43 9.18 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.72 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.49 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -64.28 134.5 54.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.115 0.483 . . . . 0.0 111.14 -179.588 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 1.3 pt -97.26 -8.77 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.172 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.425 ' O ' ' HB2' ' A' ' 50' ' ' ALA . 6.0 t0 -46.42 135.25 8.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.977 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.629 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.44 -178.86 3.85 Favored Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.441 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.83 -46.02 0.0 OUTLIER Glycine 0 N--CA 1.467 0.763 0 N-CA-C 115.563 0.985 . . . . 0.0 115.563 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.629 ' N ' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -51.42 -34.56 35.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.454 0.627 . . . . 0.0 111.342 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.425 ' HB2' ' O ' ' A' ' 46' ' ' ASP . . . -71.21 -21.16 62.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.076 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.406 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -77.0 -6.1 51.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.522 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.419 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -104.15 24.09 12.01 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.406 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 72.04 12.87 5.96 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.354 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 59.59 21.6 54.99 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.535 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m -74.7 84.7 2.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.972 0.415 . . . . 0.0 110.548 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.81 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 20.4 mt -59.43 -20.24 53.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.883 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 49.06 -170.94 0.08 OUTLIER Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.57 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.488 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -56.17 111.4 0.95 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.038 0.447 . . . . 0.0 111.678 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.668 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 2.3 m-85 -128.48 164.37 22.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.265 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.08 -174.09 13.65 Favored Glycine 0 C--N 1.317 -0.528 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.159 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -86.48 116.38 24.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.922 0.392 . . . . 0.0 110.023 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.28 -12.05 1.38 Allowed Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.082 -1.056 . . . . 0.0 113.357 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.43 30.78 4.42 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.031 0.415 . . . . 0.0 111.754 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.401 ' CG ' ' HG3' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -151.36 149.37 29.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.804 0.335 . . . . 0.0 111.191 179.433 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.475 HG22 ' HB3' ' A' ' 68' ' ' PHE . 33.4 m -52.6 156.26 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.197 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.547 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.15 -47.8 98.2 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.022 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.547 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 18.8 Cg_endo -65.43 -38.8 24.43 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.061 1.841 . . . . 0.0 112.367 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.475 ' HB3' HG22 ' A' ' 65' ' ' VAL . 18.1 t80 -74.92 -49.8 19.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.475 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.401 ' HG3' ' CG ' ' A' ' 64' ' ' MET . 0.2 OUTLIER -54.5 -35.8 63.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.21 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.418 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 6.8 t70 -68.67 -49.94 55.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.798 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.94 -10.68 59.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.659 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.1 -45.48 85.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.722 0.296 . . . . 0.0 111.618 -179.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.418 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 1.4 p90 -99.33 16.94 21.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.712 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -95.07 -28.66 14.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.75 0.31 . . . . 0.0 110.918 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.453 HD11 ' O ' ' A' ' 80' ' ' VAL . 2.7 mt -103.7 65.37 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.026 0.441 . . . . 0.0 111.678 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -74.32 -17.65 60.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.938 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -67.66 -26.82 36.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.842 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.555 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 96.06 59.14 1.06 Allowed Glycine 0 CA--C 1.503 -0.672 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.393 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -140.5 176.24 8.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.931 0.395 . . . . 0.0 111.007 -178.253 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.453 ' O ' HD11 ' A' ' 75' ' ' LEU . 38.4 t -83.75 147.76 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.962 178.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.66 159.09 16.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.224 0.535 . . . . 0.0 111.197 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -50.61 159.49 0.89 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.077 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.43 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 18.9 Cg_endo -59.02 104.08 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.474 2.116 . . . . 0.0 111.913 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.531 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 95.7 t -101.54 102.52 13.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.682 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.469 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 5.5 tptp -91.86 112.95 25.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.859 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.25 -173.12 2.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.418 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.18 -16.2 51.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.064 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -93.56 -38.76 11.21 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.534 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.97 -168.74 35.75 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.898 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.469 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -77.0 99.53 5.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.418 ' CE1' HD13 ' A' ' 16' ' ' LEU . 17.1 m80 -88.42 165.27 15.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.45 0.643 . . . . 0.0 112.734 -178.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 40.5 t -143.79 152.39 16.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.117 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.454 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -139.59 122.05 17.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -179.045 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.496 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -129.37 108.69 10.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.955 178.051 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.555 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 6.9 ttt85 -58.11 135.68 57.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.642 0.734 . . . . 0.0 112.275 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.4 OUTLIER -154.3 116.48 4.28 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.24 179.415 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.378 -1.234 . . . . 0.0 112.586 179.912 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.96 140.5 79.52 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.459 2.106 . . . . 0.0 112.254 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.4 137.32 58.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.968 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.61 -18.25 1.65 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.925 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.1 p -62.31 132.83 53.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.837 0.351 . . . . 0.0 111.065 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -179.25 -174.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.829 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.79 32.35 1.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.268 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASP . . . . . 0.426 ' C ' ' HE3' ' A' ' 9' ' ' LYS . 29.8 t70 -56.39 -25.93 51.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.675 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LYS . . . . . 0.505 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.2 164.98 18.78 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.128 -179.623 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.41 138.35 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.654 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.029 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.439 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.6 mtpt -108.72 96.16 6.15 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.067 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' CYS . . . . . 0.632 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 2.4 t -127.7 179.39 5.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.273 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 2.7 t -126.37 159.79 32.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' HIS . . . . . 0.42 ' HA ' ' O ' ' A' ' 92' ' ' VAL . 0.0 OUTLIER -136.66 150.88 48.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.405 0.621 . . . . 0.0 112.553 -179.405 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.446 ' HA ' ' OG ' ' A' ' 44' ' ' SER . 3.5 mp -153.27 115.34 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.009 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.412 HD23 ' CD2' ' A' ' 91' ' ' HIS . 0.9 OUTLIER -100.1 139.09 36.27 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.513 ' CG2' ' CG ' ' A' ' 22' ' ' GLU . 30.0 m -155.22 134.19 3.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.793 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -19.31 65.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.561 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -72.38 78.36 1.02 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.149 179.093 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 5.8 pt20 -47.34 -40.0 16.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.32 -31.14 66.27 Favored Glycine 0 CA--C 1.511 -0.19 0 C-N-CA 119.925 -1.131 . . . . 0.0 112.697 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.561 ' HB3' ' HB3' ' A' ' 19' ' ' LYS . 0.0 OUTLIER -65.6 -39.79 91.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.339 0.59 . . . . 0.0 110.253 179.525 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.729 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . -43.8 -42.16 5.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.387 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.581 ' HA ' ' HG3' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -72.66 -45.47 58.77 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.266 178.215 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.0 -57.31 9.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.694 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' VAL . . . . . 0.426 HG22 ' O ' ' A' ' 23' ' ' ALA . 4.8 m -55.07 -30.42 23.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.684 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLN . . . . . 0.729 ' HG3' ' O ' ' A' ' 23' ' ' ALA . 52.9 mt-30 -53.04 -60.06 3.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.28 0.562 . . . . 0.0 109.939 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -26.03 61.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.82 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.417 ' HB3' ' HA ' ' A' ' 26' ' ' VAL . 14.2 tpp85 -78.51 -30.31 47.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.094 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.42 ' N ' ' O ' ' A' ' 26' ' ' VAL . 0.5 OUTLIER -56.7 -59.04 5.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 0.0 110.932 -179.234 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -9.3 58.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.322 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -59.05 -25.81 64.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.996 0.427 . . . . 0.0 111.35 -179.53 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.99 -17.15 0.92 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.491 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.4 ' HG2' ' O ' ' A' ' 29' ' ' ARG . 21.9 pt-20 -79.76 157.81 27.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.993 0.425 . . . . 0.0 110.816 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -96.23 137.07 35.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.079 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.43 ' CZ ' HD21 ' A' ' 96' ' ' LEU . 2.4 p90 -47.61 -33.53 6.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.628 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -65.28 -34.93 90.83 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.137 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.543 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -60.16 -53.81 53.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.598 0.237 . . . . 0.0 110.592 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.41 HD23 ' CD2' ' A' ' 30' ' ' LEU . 2.6 mm? -55.68 -34.36 64.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.803 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.537 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.3 -53.77 32.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.029 0.442 . . . . 0.0 110.503 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -85.97 -23.63 26.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.18 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 38' ' ' LYS . 1.0 OUTLIER -70.14 -68.7 0.4 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -177.721 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.484 ' CD1' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.54 -11.36 9.47 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.531 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.537 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -63.58 134.46 55.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.273 0.559 . . . . 0.0 111.333 -179.165 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . 0.406 HG12 ' O ' ' A' ' 16' ' ' LEU . 25.1 pt -94.7 -17.45 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.358 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -45.78 134.25 7.75 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.106 0.479 . . . . 0.0 111.079 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.668 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.89 -178.62 4.19 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.939 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.44 ' O ' ' HB2' ' A' ' 51' ' ' LYS . . . -12.91 -42.2 0.0 OUTLIER Glycine 0 C--N 1.339 0.737 0 N-CA-C 115.349 0.9 . . . . 0.0 115.349 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . 0.668 ' N ' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -51.21 -21.07 1.83 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.333 0.567 . . . . 0.0 111.484 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.71 -21.04 62.6 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.797 0.332 . . . . 0.0 110.924 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.44 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 2.8 mttt -68.36 -2.95 9.51 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.972 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.466 ' O ' ' CG ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -103.65 24.78 10.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.697 0.284 . . . . 0.0 110.539 179.767 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.467 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 1.5 p30 59.58 29.62 19.19 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.189 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 53.78 23.35 21.67 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.841 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.92 89.96 4.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.809 0.338 . . . . 0.0 110.825 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.632 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 87.0 mt -58.37 -28.83 65.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.58 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.42 -166.26 15.74 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.991 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . 0.5 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -65.14 117.59 7.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.117 0.484 . . . . 0.0 111.749 -179.474 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.505 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 5.3 m-85 -128.44 158.63 37.79 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.52 -173.95 13.59 Favored Glycine 0 C--N 1.317 -0.49 0 C-N-CA 120.199 -1.0 . . . . 0.0 112.497 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.09 84.57 2.32 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.044 0.45 . . . . 0.0 110.126 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.42 36.85 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.063 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.05 -48.67 0.61 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.637 0.256 . . . . 0.0 111.292 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.55 169.84 9.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.937 0.399 . . . . 0.0 111.306 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.471 HG23 ' CB ' ' A' ' 68' ' ' PHE . 35.9 m -59.43 165.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.965 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.534 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 7.5 ttpt -62.73 -48.01 86.58 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 15.2 Cg_endo -65.36 -39.34 22.75 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.863 1.709 . . . . 0.0 111.897 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.471 ' CB ' HG23 ' A' ' 65' ' ' VAL . 24.5 t80 -75.0 -52.49 10.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.98 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -57.52 -32.66 67.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 1.9 m-20 -63.7 -50.56 68.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.049 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.3 -9.49 58.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.798 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.42 -47.52 75.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 111.602 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 11.4 p90 -93.89 16.78 13.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.535 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -97.98 -30.39 12.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.93 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.47 HD13 ' O ' ' A' ' 80' ' ' VAL . 3.9 mt -103.49 68.08 0.93 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.471 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -72.8 -19.28 61.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.096 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -65.86 -26.67 39.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.725 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLY . . . . . 0.433 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 94.66 59.44 1.14 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.57 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -141.03 176.34 8.9 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.826 0.346 . . . . 0.0 111.104 -178.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.513 HG21 ' HA ' ' A' ' 27' ' ' GLN . 26.9 t -81.01 146.6 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.84 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.2 t -104.66 164.11 12.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.258 0.551 . . . . 0.0 111.583 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -50.51 152.1 3.52 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.463 -178.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.447 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 19.5 Cg_endo -58.46 106.09 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.466 2.111 . . . . 0.0 111.65 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.531 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 93.0 t -100.96 101.14 11.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.593 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . 0.448 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 4.8 tptm -91.63 112.8 24.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.757 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.1 m -114.73 -171.95 2.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.578 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.35 -18.62 51.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.184 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -90.91 -24.48 20.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.467 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 141.48 -161.66 26.96 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.784 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.448 ' CD1' ' HB2' ' A' ' 85' ' ' LYS . 0.2 OUTLIER -83.02 98.14 9.11 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' HIS . . . . . 0.412 ' CD2' HD23 ' A' ' 16' ' ' LEU . 9.8 m80 -81.49 154.35 26.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.481 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 37.2 t -139.71 135.84 39.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.296 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . 0.467 HG22 ' CZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -123.84 122.52 64.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.423 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.412 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -128.2 112.69 14.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.197 178.36 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -57.34 136.45 56.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.705 0.764 . . . . 0.0 112.517 -177.436 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.511 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.3 OUTLIER -157.69 116.73 3.23 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.616 179.595 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.352 -1.249 . . . . 0.0 112.554 179.93 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.554 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.593 0 CA-C-O 121.764 0.793 . . . . 0.0 112.142 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.666 HD13 ' HB3' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -114.84 138.36 45.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.569 178.178 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.466 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.9 mtpt -108.87 97.82 7.4 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.494 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.949 ' SG ' HG22 ' A' ' 93' ' ' ILE . 1.9 t -135.34 179.88 6.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.555 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.491 ' HB3' HD23 ' A' ' 96' ' ' LEU . 2.4 p -134.75 162.44 32.34 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.588 ' C ' HD12 ' A' ' 15' ' ' ILE . 12.3 p-80 -136.55 148.57 47.65 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.81 HD13 ' CE2' ' A' ' 36' ' ' PHE . 1.6 mp -130.74 154.14 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.675 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 88' ' ' PHE . 2.5 mt -137.32 135.4 37.04 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.942 HG21 ' HG3' ' A' ' 22' ' ' GLU . 23.3 m -149.2 134.27 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.589 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -35.92 74.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.979 0.419 . . . . 0.0 110.323 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.624 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 37.2 pttt -72.13 79.66 0.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.495 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 12.1 pt20 -45.62 -26.28 0.59 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.867 -1.061 . . . . 0.0 112.441 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.17 -31.75 75.25 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.975 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.942 ' HG3' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -69.36 -42.84 74.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.013 0.435 . . . . 0.0 110.238 179.178 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.513 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -47.64 -38.3 14.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.279 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.649 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -73.41 -31.93 64.14 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.667 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.76 -52.93 8.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.068 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.499 HG23 ' N ' ' A' ' 27' ' ' GLN . 19.9 m -50.12 -46.69 24.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.68 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.632 ' CB ' HG11 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -54.07 -36.36 63.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.549 . . . . 0.0 109.955 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.539 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -72.84 -47.15 48.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.43 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.488 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.9 -23.18 44.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.146 -178.639 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.743 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -52.87 -47.63 67.69 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.768 0.318 . . . . 0.0 111.293 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -72.01 -9.42 58.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.386 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -57.27 -23.24 46.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 111.333 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.45 -12.47 3.24 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.399 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -75.08 153.8 38.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.797 0.332 . . . . 0.0 110.605 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -87.57 131.2 34.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.979 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.81 ' CE2' HD13 ' A' ' 15' ' ' ILE . 5.0 t80 -48.8 -49.52 38.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.013 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.61 ' O ' ' HB3' ' A' ' 40' ' ' ALA . . . -54.65 -34.22 55.78 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.051 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -57.38 -53.59 56.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.943 0.402 . . . . 0.0 110.358 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.009 HD12 HD11 ' A' ' 43' ' ' LEU . 3.0 mm? -53.59 -29.93 39.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.393 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 37' ' ' GLY . . . -51.48 -53.7 34.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.697 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.76 -23.74 27.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.81 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.9 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.17 -68.38 0.42 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.818 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.009 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.29 -12.21 9.44 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.605 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -63.84 128.81 37.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.91 0.386 . . . . 0.0 111.216 -179.502 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.505 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.15 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.88 0.372 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -68.12 -14.2 62.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.23 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -104.81 24.71 11.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.728 0.299 . . . . 0.0 110.405 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.414 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 0.5 OUTLIER 60.53 24.28 13.95 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.143 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 59.53 19.89 49.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.69 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 m -63.6 83.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.925 0.393 . . . . 0.0 110.677 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.743 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 16.5 mt -63.78 -24.06 67.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.882 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.04 -160.88 8.47 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.817 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.519 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -67.28 111.54 4.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.868 0.366 . . . . 0.0 111.783 -179.244 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.676 ' HE2' HD22 ' A' ' 56' ' ' LEU . 8.1 m-30 -119.05 156.64 29.32 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.27 -173.96 15.64 Favored Glycine 0 C--N 1.317 -0.501 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.431 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -75.53 80.0 2.55 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.99 0.424 . . . . 0.0 110.182 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.15 36.94 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.956 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.97 -43.11 1.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.623 0.249 . . . . 0.0 111.396 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.54 167.47 9.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 0.0 111.26 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.705 HG23 ' H ' ' A' ' 68' ' ' PHE . 29.1 m -56.93 160.29 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.626 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.547 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -56.5 -48.19 97.55 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.733 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.589 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 20.7 Cg_endo -66.89 -36.26 23.85 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.062 1.842 . . . . 0.0 112.205 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.705 ' H ' HG23 ' A' ' 65' ' ' VAL . 15.5 t80 -74.88 -51.0 15.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.588 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.8 -32.39 60.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.839 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 1.6 m-20 -65.75 -53.15 44.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.886 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.474 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.11 -9.15 58.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.87 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.02 -36.81 78.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.613 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.666 ' HB3' HD13 ' A' ' 10' ' ' ILE . 3.0 p90 -107.06 16.79 23.8 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.81 -28.18 13.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.76 0.314 . . . . 0.0 110.879 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 79' ' ' GLU . 3.2 mt -103.47 63.57 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.213 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -70.83 -18.27 62.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.05 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.45 -26.92 40.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.559 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.05 57.59 1.21 Allowed Glycine 0 CA--C 1.502 -0.733 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.74 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.491 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -138.54 175.92 9.14 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.746 0.308 . . . . 0.0 111.114 -178.63 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.632 HG11 ' CB ' ' A' ' 27' ' ' GLN . 41.6 t -81.33 145.9 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.918 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.16 164.11 12.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.162 0.505 . . . . 0.0 111.54 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.419 ' O ' HG23 ' A' ' 84' ' ' VAL . 3.5 mp0 -50.73 153.73 2.72 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.967 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.649 ' HG3' HD23 ' A' ' 24' ' ' LEU . 18.1 Cg_endo -59.27 105.5 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.361 2.041 . . . . 0.0 111.799 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.589 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 97.5 t -101.33 119.21 49.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.783 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.443 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -103.35 112.69 25.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.006 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.51 -171.7 1.9 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.276 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -60.33 -18.04 47.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.025 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.499 ' HB3' HD11 ' A' ' 16' ' ' LEU . 6.3 m-85 -89.69 -40.79 12.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.424 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.66 -158.81 29.05 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.801 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -82.11 98.14 8.53 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.457 ' CD2' ' HG ' ' A' ' 16' ' ' LEU . 34.6 m80 -84.22 170.1 14.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.044 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.439 ' CG1' HG13 ' A' ' 80' ' ' VAL . 9.5 t -146.22 153.04 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.692 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.949 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -143.11 122.36 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.578 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.665 ' HE3' HD12 ' A' ' 30' ' ' LEU . 13.8 tptp -128.88 116.88 20.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.127 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.444 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -57.33 133.99 55.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.533 0.682 . . . . 0.0 112.231 -177.686 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.555 ' C ' HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -154.55 116.54 4.21 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.744 -1.117 . . . . 0.0 109.573 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.451 -1.194 . . . . 0.0 112.636 179.892 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.702 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.586 0 CA-C-O 121.634 0.731 . . . . 0.0 112.112 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.522 HD12 ' HB1' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -120.23 139.51 47.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.499 178.417 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.453 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.2 mtpt -110.88 99.27 8.2 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.434 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.736 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 2.2 t -129.98 -179.76 5.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.7 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.545 ' HB2' HD23 ' A' ' 96' ' ' LEU . 2.8 t -118.79 163.58 16.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.746 ' HB3' HD21 ' A' ' 56' ' ' LEU . 12.0 t-80 -138.39 141.02 39.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.136 0.493 . . . . 0.0 111.821 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.74 HD12 ' C ' ' A' ' 14' ' ' HIS . 4.5 mp -151.47 119.67 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.491 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 88' ' ' PHE . 0.5 OUTLIER -109.14 137.42 47.07 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.763 0.315 . . . . 0.0 111.596 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.749 HG21 ' CG ' ' A' ' 22' ' ' GLU . 17.1 m -147.95 134.39 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.481 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.407 ' HD2' HD13 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -68.27 -36.62 79.68 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.813 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.592 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.18 78.35 0.97 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.644 0.735 . . . . 0.0 109.04 178.59 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 14.2 pt20 -46.59 -25.81 0.77 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.288 -177.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.1 -31.29 77.33 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.178 -1.486 . . . . 0.0 111.069 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.9 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -70.45 -38.56 74.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.382 0.611 . . . . 0.0 109.828 178.371 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.647 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -51.5 -37.67 50.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.533 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.611 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.3 OUTLIER -73.13 -30.45 63.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.794 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.77 -41.04 19.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.41 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.9 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.8 m -51.11 -35.14 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.288 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.678 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -60.38 -48.41 81.87 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.538 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.678 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.57 -28.06 61.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.308 0.575 . . . . 0.0 110.642 178.436 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 3.1 tpp180 -78.85 -35.97 43.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.891 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.481 HD13 ' C ' ' A' ' 30' ' ' LEU . 1.2 tm? -52.74 -59.01 5.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.278 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -9.39 54.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.488 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -74.61 50.14 0.42 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.6 -10.54 44.35 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.659 -0.781 . . . . 0.0 114.143 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.04 157.64 15.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.506 0.653 . . . . 0.0 111.061 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -110.28 144.49 38.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.205 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.95 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 1.9 p90 -49.05 -28.49 4.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.726 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.408 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -59.9 -34.07 81.37 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.574 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -74.4 -49.96 20.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.593 0.235 . . . . 0.0 110.827 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.79 HD12 HD11 ' A' ' 43' ' ' LEU . 3.0 mm? -53.28 -36.14 60.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.286 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.686 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -52.1 -52.77 49.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.127 0.489 . . . . 0.0 110.744 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -85.64 -23.7 27.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.809 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.965 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -72.52 -67.51 0.55 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.227 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.965 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.6 -14.96 9.59 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -178.946 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.542 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 1.8 t -63.74 126.25 26.99 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.365 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.327 -0.402 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.686 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . . . . . . . . 0 CA--C 1.518 -0.286 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -86.64 -18.82 30.4 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.789 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.503 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 15.4 mtt180 -104.23 25.0 10.61 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.964 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.526 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER 67.61 40.52 2.51 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.429 0.633 . . . . 0.0 111.629 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 53.63 30.33 42.61 Favored Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.79 -0.641 . . . . 0.0 113.018 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.572 ' HA ' HD21 ' A' ' 96' ' ' LEU . 85.9 p -92.37 86.35 5.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.739 0.304 . . . . 0.0 110.993 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.746 HD21 ' HB3' ' A' ' 14' ' ' HIS . 69.9 mt -54.03 -40.0 66.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.051 0.453 . . . . 0.0 110.21 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 78.07 -168.25 53.94 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.538 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.462 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -69.75 111.39 5.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.044 0.449 . . . . 0.0 111.717 -179.429 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.702 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 13.0 m-85 -125.83 152.82 44.97 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -100.71 -174.03 29.43 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.238 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.95 99.93 12.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.951 0.405 . . . . 0.0 110.316 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.97 -7.91 1.24 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.426 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -92.29 -40.82 10.73 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.924 0.362 . . . . 0.0 111.522 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.2 166.59 12.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.913 0.387 . . . . 0.0 111.447 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.761 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.2 m -58.0 163.85 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.815 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.51 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 16.8 tttp -58.93 -48.33 96.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.543 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 17.7 Cg_endo -67.11 -37.34 19.0 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 121.856 1.704 . . . . 0.0 112.192 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.761 ' H ' HG23 ' A' ' 65' ' ' VAL . 40.9 t80 -74.41 -50.78 17.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.623 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -56.75 -32.35 65.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.703 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.2 OUTLIER -67.42 -49.43 63.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.072 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.404 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -74.99 -9.56 58.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.753 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.522 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -68.82 -51.26 42.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.912 0.387 . . . . 0.0 111.447 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.458 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 3.5 p90 -94.24 16.71 14.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.452 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -97.39 -29.38 13.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 110.804 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.544 HD11 ' O ' ' A' ' 80' ' ' VAL . 3.4 mt -103.48 67.1 0.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.454 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -74.35 -17.78 60.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.049 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -66.66 -26.74 38.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.447 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.14 59.8 1.09 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.521 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.513 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -141.33 176.14 9.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.841 0.353 . . . . 0.0 111.123 -178.381 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.544 ' O ' HD11 ' A' ' 75' ' ' LEU . 50.0 t -81.46 147.99 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.17 159.3 15.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.293 0.568 . . . . 0.0 111.56 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -50.68 155.23 1.99 Allowed Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.567 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.611 ' HG3' HD23 ' A' ' 24' ' ' LEU . 18.4 Cg_endo -58.53 106.67 0.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.335 2.023 . . . . 0.0 111.534 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.543 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 90.8 t -101.03 101.92 12.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.754 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.438 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 6.5 tptt -91.89 112.69 24.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.632 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.412 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 2.0 m -114.27 -173.19 2.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.55 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -58.29 -20.27 41.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.929 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.488 ' HB3' HD11 ' A' ' 16' ' ' LEU . 2.6 m-85 -89.37 -23.97 22.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.309 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.481 ' C ' HD21 ' A' ' 16' ' ' LEU . . . 136.97 -167.88 24.49 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.883 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.496 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -74.98 98.35 3.58 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.412 ' CE1' ' HB2' ' A' ' 86' ' ' SER . 53.3 m80 -80.86 167.63 19.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.343 0.592 . . . . 0.0 112.437 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.0 t -147.73 153.16 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.395 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.667 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -150.82 127.46 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -179.03 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.485 ' HG2' HG22 ' A' ' 80' ' ' VAL . 2.6 tmtm? -128.59 116.1 19.11 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.677 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.56 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -57.44 134.58 56.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.495 0.664 . . . . 0.0 112.046 -178.055 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.95 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -157.1 116.67 3.42 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.771 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 CA-C-O 118.321 -1.266 . . . . 0.0 112.57 179.845 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.547 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.47 0.653 . . . . 0.0 112.138 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.575 HG22 ' SG ' ' A' ' 12' ' ' CYS . 1.5 mt -110.98 136.15 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.869 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.475 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.4 mtpt -109.17 90.76 3.39 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.21 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.775 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 13.7 m -130.69 -179.59 5.39 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.055 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.658 ' HB2' HD23 ' A' ' 96' ' ' LEU . 9.5 t -124.87 163.45 22.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.851 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.793 ' CG ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -139.87 155.54 47.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.363 0.602 . . . . 0.0 112.583 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.754 HG23 ' OG ' ' A' ' 44' ' ' SER . 3.0 mp -143.77 139.43 25.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.48 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.757 HD11 ' NE2' ' A' ' 91' ' ' HIS . 0.4 OUTLIER -127.38 133.55 50.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.968 HG21 ' CG ' ' A' ' 22' ' ' GLU . 25.3 m -154.61 134.42 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.807 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.533 ' HE3' HD13 ' A' ' 45' ' ' ILE . 9.6 mttt -65.92 -16.58 63.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.515 ' HB3' ' CG ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -72.29 78.24 0.99 Allowed 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.813 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.453 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 0.8 OUTLIER -47.27 -40.52 16.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.156 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.09 -31.54 72.27 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.848 -1.168 . . . . 0.0 112.774 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.968 ' CG ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -66.9 -43.73 82.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.237 0.541 . . . . 0.0 110.407 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.557 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -46.95 -39.28 12.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.535 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.691 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -72.79 -29.16 63.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.112 179.392 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.91 -54.01 6.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.459 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.4 m -49.52 -34.27 8.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.691 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.9 pt20 -59.78 -47.72 84.56 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.907 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.23 -29.22 62.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.202 0.525 . . . . 0.0 110.499 178.731 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.596 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.53 -36.2 45.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.792 -179.001 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.594 ' CD2' HD23 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -52.77 -58.1 7.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.259 -179.363 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -71.36 -9.58 58.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.301 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.52 -23.7 63.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.887 0.375 . . . . 0.0 111.181 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.26 -19.47 0.93 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.275 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.415 ' HG3' HD21 ' A' ' 39' ' ' LEU . 20.5 pt-20 -80.93 157.65 25.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 110.773 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -101.43 148.28 25.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.168 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.845 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 1.1 p90 -50.44 -39.35 47.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.035 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.4 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -57.94 -34.21 71.26 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.746 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -65.85 -54.12 30.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.701 0.286 . . . . 0.0 110.913 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.014 HD12 HD11 ' A' ' 43' ' ' LEU . 2.8 mm? -56.32 -32.56 64.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.681 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.566 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.44 -52.78 43.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.175 0.512 . . . . 0.0 110.642 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.39 -23.77 26.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.133 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.848 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -69.62 -68.94 0.37 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.537 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.014 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.75 -12.63 9.21 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.601 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.754 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -63.68 131.69 48.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.885 0.374 . . . . 0.0 111.436 -179.123 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.554 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.3 pt . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.941 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.875 0.369 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.25 -12.25 60.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.827 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -104.43 24.88 10.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.678 0.275 . . . . 0.0 110.529 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.4 OUTLIER 65.79 20.83 11.49 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.129 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.84 17.92 65.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.615 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -68.53 86.07 0.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.362 . . . . 0.0 110.713 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.793 HD21 ' CG ' ' A' ' 14' ' ' HIS . 23.2 mt -54.56 -24.58 21.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.696 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 59.5 -166.18 9.41 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.233 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.499 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -67.27 111.51 4.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.9 0.381 . . . . 0.0 111.897 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.547 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 4.4 m-85 -117.43 156.3 28.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.59 -174.0 14.1 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.506 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.23 80.13 5.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.924 0.392 . . . . 0.0 110.225 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.26 36.68 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.03 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.01 -48.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 0.0 111.135 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.6 mtm -95.52 170.95 8.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.086 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.793 HG23 ' H ' ' A' ' 68' ' ' PHE . 34.3 m -59.44 159.12 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.954 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -61.0 -47.97 93.88 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 12.2 Cg_endo -63.75 -41.14 25.62 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.955 1.77 . . . . 0.0 111.836 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.804 ' CE1' HG23 ' A' ' 93' ' ' ILE . 9.3 t80 -74.96 -52.35 11.39 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.843 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -55.36 -32.24 62.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.991 0.424 . . . . 0.0 110.647 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.457 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 29.9 t70 -65.38 -53.07 48.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.744 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.21 -9.31 58.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.559 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.32 -47.0 78.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.721 0.296 . . . . 0.0 111.376 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.457 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 11.4 p90 -93.24 16.19 13.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.345 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -98.3 -30.51 12.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.585 HD11 ' HA ' ' A' ' 81' ' ' SER . 7.9 mt -97.73 56.81 1.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.177 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -63.75 -23.75 67.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.758 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.87 -26.79 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.855 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.573 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 91.16 63.08 1.2 Allowed Glycine 0 CA--C 1.499 -0.949 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.122 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.401 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -141.05 176.61 8.68 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.611 -0.294 . . . . 0.0 110.62 -178.92 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 27' ' ' GLN . 61.1 t -80.16 147.91 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.585 ' HA ' HD11 ' A' ' 75' ' ' LEU . 12.8 t -104.53 162.97 12.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.611 0.72 . . . . 0.0 111.924 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.607 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -50.37 163.46 0.45 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.396 -179.268 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 35.8 Cg_endo -65.71 103.59 0.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.617 2.211 . . . . 0.0 112.321 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.555 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 89.8 t -101.66 99.56 8.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.456 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -95.21 115.31 27.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.072 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.9 m -105.51 -175.64 2.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.367 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -20.13 26.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.958 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -88.18 -39.88 14.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.433 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.58 -171.6 36.03 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.978 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.46 ' CD1' ' HB3' ' A' ' 85' ' ' LYS . 0.6 OUTLIER -74.95 108.59 7.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.957 0.408 . . . . 0.0 110.043 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.757 ' NE2' HD11 ' A' ' 16' ' ' LEU . 56.6 m80 -95.46 169.39 10.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.381 0.61 . . . . 0.0 112.368 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.426 ' CG1' HG13 ' A' ' 80' ' ' VAL . 20.4 t -147.81 152.68 12.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.594 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.804 HG23 ' CE1' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -133.4 122.15 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.13 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 13' ' ' SER . 10.3 tptt -128.71 109.07 11.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.392 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.573 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 1.1 ttt-85 -57.1 138.78 54.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.776 0.798 . . . . 0.0 112.625 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.845 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -161.98 116.42 1.9 Allowed 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.484 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.626 179.8 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.463 ' CB ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.466 0 CA-C-O 121.3 0.572 . . . . 0.0 111.553 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.618 HG22 ' SG ' ' A' ' 12' ' ' CYS . 1.2 mt -111.33 135.68 49.77 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.043 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.492 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.7 mtpt -109.67 89.49 3.02 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.132 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.793 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 8.5 m -131.97 -179.55 5.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.081 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.705 ' HB3' HD23 ' A' ' 96' ' ' LEU . 8.7 p -127.07 163.43 23.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.156 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.747 ' CD2' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -136.08 157.46 46.78 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.295 0.569 . . . . 0.0 112.412 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.722 HD12 ' C ' ' A' ' 14' ' ' HIS . 2.9 mp -149.24 125.43 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.038 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.945 HD21 ' CD2' ' A' ' 91' ' ' HIS . 1.0 OUTLIER -105.84 136.94 44.57 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.844 0.354 . . . . 0.0 111.893 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.64 HG21 ' CD ' ' A' ' 22' ' ' GLU . 22.7 m -150.67 134.39 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.389 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.404 ' HG3' HD13 ' A' ' 45' ' ' ILE . 17.3 mtmt -71.8 -35.84 70.09 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.617 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 5.9 tttt -73.15 79.19 1.26 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.469 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 3.2 pt20 -46.49 -25.89 0.76 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.153 -0.93 . . . . 0.0 113.108 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.15 -29.47 74.5 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 119.194 -1.479 . . . . 0.0 110.82 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.64 ' CD ' HG21 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -73.99 -38.02 64.27 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.26 0.553 . . . . 0.0 110.017 178.466 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.61 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.57 -33.76 23.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.651 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.544 ' O ' HD13 ' A' ' 24' ' ' LEU . 1.3 tm? -73.48 -39.8 64.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.417 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 28' ' ' GLU . . . -74.17 -47.03 38.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.961 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 22' ' ' GLU . 21.3 m -46.6 -37.49 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.361 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.726 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -58.4 -48.51 80.41 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.118 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.726 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.65 -30.21 62.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.072 0.463 . . . . 0.0 110.822 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.458 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 16.8 tpt180 -79.18 -27.07 42.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.866 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.668 HD13 ' O ' ' A' ' 30' ' ' LEU . 1.4 tm? -70.47 -44.82 66.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.222 0.534 . . . . 0.0 110.278 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -9.46 58.72 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.769 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.02 -27.89 69.42 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.902 0.382 . . . . 0.0 111.352 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.68 -17.92 0.98 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.629 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.48 ' HG3' HD22 ' A' ' 30' ' ' LEU . 25.3 pt-20 -74.22 157.56 35.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.813 0.339 . . . . 0.0 110.879 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.08 139.94 33.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.093 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.921 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 3.0 p90 -49.97 -33.81 18.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.99 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 40' ' ' ALA . . . -60.98 -37.43 93.83 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.352 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -64.06 -52.92 57.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.778 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.773 HD12 HD11 ' A' ' 43' ' ' LEU . 3.2 mm? -53.55 -31.14 45.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.725 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.588 ' HB1' ' O ' ' A' ' 50' ' ' ALA . . . -51.16 -55.17 19.26 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.115 0.483 . . . . 0.0 110.778 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -23.34 27.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.966 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.937 ' HB3' HD13 ' A' ' 43' ' ' LEU . 1.0 OUTLIER -70.17 -68.29 0.43 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.937 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.37 -13.3 9.28 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.582 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -64.13 135.65 56.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.163 0.506 . . . . 0.0 111.203 -179.295 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.49 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 43.2 pt . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.216 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.588 ' O ' ' HB1' ' A' ' 40' ' ' ALA . . . . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.84 0.352 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -79.78 -4.22 51.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.396 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mtp-105 -104.33 24.62 11.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.223 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.0 22.53 12.77 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.014 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 57.45 20.44 37.6 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.799 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m -61.85 85.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.775 0.321 . . . . 0.0 110.987 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.793 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 21.5 mt -60.76 -24.86 66.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.535 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 56.78 -165.14 5.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.416 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.492 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -64.93 121.07 13.79 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.225 0.536 . . . . 0.0 112.209 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.434 ' CZ ' ' O ' ' A' ' 56' ' ' LEU . 12.0 m-30 -136.8 148.49 47.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.017 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.84 -173.81 21.37 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.44 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.46 87.36 7.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.152 0.501 . . . . 0.0 110.189 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.32 36.78 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.901 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.62 -45.24 0.67 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.712 0.292 . . . . 0.0 111.144 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.32 171.4 8.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.135 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.794 HG23 ' H ' ' A' ' 68' ' ' PHE . 34.3 m -55.13 157.56 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.106 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.52 -48.11 97.52 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.605 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 18.6 Cg_endo -65.69 -39.92 19.16 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.946 1.764 . . . . 0.0 112.187 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.794 ' H ' HG23 ' A' ' 65' ' ' VAL . 23.8 t80 -74.91 -49.17 21.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.459 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.5 OUTLIER -54.94 -32.73 61.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.524 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -67.45 -51.56 50.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.901 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.438 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -74.89 -9.59 58.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.593 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.472 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -66.84 -43.29 84.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.848 0.356 . . . . 0.0 111.448 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 1.1 p90 -102.26 16.77 25.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.401 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.07 -27.31 15.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.748 0.308 . . . . 0.0 110.831 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 79' ' ' GLU . 3.3 mt -103.53 63.55 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.305 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -70.56 -18.53 62.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.965 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -64.6 -26.91 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.35 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.544 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.19 58.15 1.17 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.802 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.521 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.8 tm-20 -140.5 176.36 8.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.672 0.272 . . . . 0.0 110.977 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.553 HG11 ' HA ' ' A' ' 27' ' ' GLN . 56.8 t -84.65 147.05 5.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.098 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.21 161.96 13.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.186 0.517 . . . . 0.0 111.434 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.7 mp0 -50.85 153.9 2.72 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.033 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.446 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 22.5 Cg_endo -60.84 106.35 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.1 1.867 . . . . 0.0 111.523 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.605 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 86.1 t -101.01 108.33 23.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.7 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 90' ' ' TYR . 14.7 tmtt? -91.7 113.17 25.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.408 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.48 -172.38 2.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.199 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -16.42 48.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.213 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -94.08 -35.28 12.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.713 0.292 . . . . 0.0 111.594 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.66 -167.03 34.57 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.666 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.579 ' O ' HD13 ' A' ' 16' ' ' LEU . 1.2 m-85 -82.44 98.26 8.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.266 0.555 . . . . 0.0 109.994 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.945 ' CD2' HD21 ' A' ' 16' ' ' LEU . 11.3 m80 -83.09 169.64 15.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.007 -177.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 38.3 t -149.03 150.72 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.014 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.54 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -130.62 122.41 52.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.788 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' SER . 3.8 tmtt? -128.58 110.44 12.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.113 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.544 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -57.47 139.44 53.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.853 0.835 . . . . 0.0 112.73 -178.463 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.921 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -162.82 116.42 1.67 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.491 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.417 ' CA ' ' HE2' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.323 -1.265 . . . . 0.0 112.621 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.579 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.719 0 CA-C-O 121.376 0.607 . . . . 0.0 112.034 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.674 HD12 ' HB1' ' A' ' 72' ' ' ALA . 1.2 mt -111.01 136.0 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.15 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.517 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.6 mtpt -108.32 89.78 3.1 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.115 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.808 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.4 m -132.69 -179.61 5.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.747 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.588 ' OG ' HD23 ' A' ' 96' ' ' LEU . 3.0 m -131.25 163.75 27.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.371 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.808 ' O ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -132.16 156.31 46.63 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.808 HD12 ' O ' ' A' ' 14' ' ' HIS . 1.5 mp -141.43 120.01 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.045 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.55 HD11 ' CE1' ' A' ' 91' ' ' HIS . 2.0 mt -104.44 128.28 52.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.788 HG21 ' CG ' ' A' ' 22' ' ' GLU . 17.9 m -140.57 133.91 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.017 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -36.7 70.55 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.84 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.613 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.23 78.53 0.98 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.385 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.477 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -46.51 -26.05 0.8 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.058 -177.47 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.42 -31.12 76.05 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.855 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.859 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -70.06 -39.56 75.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.081 0.467 . . . . 0.0 110.3 178.729 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.659 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.34 -38.1 40.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.986 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.815 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.4 OUTLIER -73.61 -29.4 62.36 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.244 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.38 -43.7 14.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.543 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.5 m -54.89 -40.66 53.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.275 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.678 ' HA ' HG11 ' A' ' 80' ' ' VAL . 12.4 pt20 -53.2 -52.61 58.31 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.691 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.546 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -73.28 -31.51 64.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.08 0.467 . . . . 0.0 110.998 179.141 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.448 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -76.41 -25.61 54.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.706 -178.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -58.38 -48.31 81.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.4 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.93 -9.32 58.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.428 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -56.26 -22.15 28.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.802 0.334 . . . . 0.0 111.403 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.13 -10.76 3.59 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.536 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.452 ' OE1' HD11 ' A' ' 39' ' ' LEU . 15.2 pt-20 -79.02 153.24 30.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.929 0.395 . . . . 0.0 110.988 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.4 135.51 33.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.792 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.781 ' CZ ' HD13 ' A' ' 15' ' ' ILE . 9.6 t80 -53.29 -47.78 68.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.218 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 40' ' ' ALA . . . -56.59 -34.12 63.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.239 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -58.82 -50.26 74.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.704 0.288 . . . . 0.0 110.87 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.787 ' CD1' HD11 ' A' ' 43' ' ' LEU . 3.2 mm? -53.07 -33.28 51.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.808 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.25 -54.24 27.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.127 0.489 . . . . 0.0 110.496 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.4 pttp -85.77 -23.5 27.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.023 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.924 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -70.54 -67.91 0.47 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.914 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.924 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.94 -15.69 9.3 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -63.99 138.31 58.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 0.0 111.275 -179.475 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.419 ' CG1' ' O ' ' A' ' 16' ' ' LEU . 2.0 pt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.18 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.447 ' O ' ' HB1' ' A' ' 40' ' ' ALA . . . . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 121.388 0.613 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -16.17 63.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.065 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.22 24.64 11.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.29 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.3 OUTLIER 64.5 17.54 10.89 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.434 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.83 27.37 49.93 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.37 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -60.06 84.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.959 0.409 . . . . 0.0 110.815 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.808 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 22.8 mt -60.5 -19.66 57.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.725 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 50.33 -169.07 0.27 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.735 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.517 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -61.69 111.44 1.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.929 0.395 . . . . 0.0 111.723 -179.385 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.579 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 2.4 m-85 -124.78 163.8 21.34 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.35 -174.04 13.67 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.656 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -86.9 95.72 9.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.052 0.453 . . . . 0.0 110.283 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.23 36.47 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.756 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -152.05 -42.62 0.11 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.74 0.305 . . . . 0.0 111.187 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 8.9 mtm -91.07 167.12 12.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.93 0.395 . . . . 0.0 111.27 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.799 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.7 m -58.97 156.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.854 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.557 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.5 ttpt -58.14 -47.98 97.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.562 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 12.7 Cg_endo -64.4 -40.1 26.18 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 121.995 1.797 . . . . 0.0 112.239 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.799 ' H ' HG23 ' A' ' 65' ' ' VAL . 11.3 t80 -75.11 -50.17 17.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.696 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.63 -32.33 58.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.689 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 1.5 t70 -66.87 -52.47 43.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.851 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.87 -9.5 58.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.478 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.674 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -63.18 -43.19 98.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.415 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 2.8 p90 -98.29 16.54 21.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.386 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -98.18 -28.14 13.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.172 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.782 HD11 ' CB ' ' A' ' 81' ' ' SER . 8.5 mt -96.0 51.6 1.25 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 111.301 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -58.91 -33.14 70.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 109.868 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -63.55 -26.68 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.33 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.514 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 90.37 72.01 1.24 Allowed Glycine 0 CA--C 1.5 -0.905 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.819 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.749 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -142.28 177.6 8.14 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.132 -0.534 . . . . 0.0 110.014 -178.744 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.678 HG11 ' HA ' ' A' ' 27' ' ' GLN . 93.5 t -79.67 149.73 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.782 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -104.49 153.08 21.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.354 0.597 . . . . 0.0 111.401 -178.419 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.587 ' O ' HG23 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -50.76 156.1 1.73 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.834 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.815 ' HG3' HD23 ' A' ' 24' ' ' LEU . 11.2 Cg_endo -53.67 102.83 0.08 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.514 2.143 . . . . 0.0 111.96 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 82' ' ' GLU . 57.6 t -103.07 103.05 14.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.599 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.79 112.5 24.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.9 0.381 . . . . 0.0 110.966 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.63 -176.9 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.398 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -59.33 -19.07 43.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.958 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -89.93 -40.53 12.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.386 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.83 -164.09 35.65 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.826 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.477 ' CD1' ' HB3' ' A' ' 20' ' ' GLN . 0.3 OUTLIER -83.43 98.17 9.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.55 ' CE1' HD11 ' A' ' 16' ' ' LEU . 15.5 m80 -83.68 167.1 17.55 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.557 ' CG1' HG13 ' A' ' 80' ' ' VAL . 18.0 t -145.11 153.42 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.772 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.493 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -138.02 121.58 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.661 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.489 ' CB ' ' CE1' ' A' ' 36' ' ' PHE . 5.1 tptm -129.62 113.27 14.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.168 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.514 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.8 OUTLIER -57.97 139.19 54.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.787 0.803 . . . . 0.0 112.631 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.588 HD23 ' OG ' ' A' ' 13' ' ' SER . 0.2 OUTLIER -159.62 116.18 2.56 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.351 179.098 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.555 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.568 ' HD2' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.668 0.27 . . . . 0.0 111.081 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.402 HD11 ' HB3' ' A' ' 73' ' ' PHE . 0.4 OUTLIER -114.14 136.97 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 121.4 0.619 . . . . 0.0 110.752 -178.703 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.717 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -107.29 95.39 5.67 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.738 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.842 ' SG ' HG22 ' A' ' 93' ' ' ILE . 1.9 t -120.4 179.35 4.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.794 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.917 ' HB3' HD23 ' A' ' 96' ' ' LEU . 14.7 p -120.56 163.35 18.12 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.69 ' C ' HD12 ' A' ' 15' ' ' ILE . 24.6 p-80 -134.68 151.59 51.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.517 0.675 . . . . 0.0 112.633 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.769 HG23 ' OG ' ' A' ' 44' ' ' SER . 2.9 mp -155.61 127.09 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.764 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.884 HD13 ' CD2' ' A' ' 91' ' ' HIS . 10.9 tp -114.15 129.06 56.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.935 0.398 . . . . 0.0 112.029 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.768 HG11 ' OE1' ' A' ' 22' ' ' GLU . 28.1 m -143.26 134.35 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.635 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.504 ' HD2' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -77.9 -33.97 51.64 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.478 -179.013 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.6 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 13.2 tttp -72.3 79.14 1.0 Allowed 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 0.9 OUTLIER -46.18 -25.39 0.59 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.939 -177.026 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.55 -31.33 78.35 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 118.865 -1.636 . . . . 0.0 110.429 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.868 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -73.2 -37.65 66.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.06 0.457 . . . . 0.0 109.777 178.062 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.602 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -53.31 -36.2 60.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.738 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.632 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.59 -29.28 62.3 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.762 178.815 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.9 -43.53 14.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.633 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.868 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.3 m -55.28 -36.72 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.428 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.822 ' HA ' HG11 ' A' ' 80' ' ' VAL . 14.6 pt20 -56.27 -53.27 59.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.696 0.284 . . . . 0.0 110.541 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.526 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -73.62 -26.95 61.03 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.965 0.412 . . . . 0.0 110.866 179.055 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.578 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.0 tpp180 -78.41 -34.02 48.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.784 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.506 ' CD2' HD23 ' A' ' 39' ' ' LEU . 1.3 tm? -53.52 -57.47 10.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.03 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -9.41 58.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.253 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -58.46 -23.77 58.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.938 0.399 . . . . 0.0 111.32 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.51 -17.38 1.13 Allowed Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.374 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -78.46 157.64 28.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.876 0.369 . . . . 0.0 110.861 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -100.75 140.41 35.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.107 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.882 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 5.4 p90 -49.53 -31.66 10.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.949 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.47 -33.98 88.71 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.376 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 4.9 mmmt -67.94 -53.89 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.697 0.284 . . . . 0.0 110.999 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.038 HD12 HD11 ' A' ' 43' ' ' LEU . 2.8 mm? -53.86 -33.86 57.62 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.68 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.79 -52.5 48.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.109 0.48 . . . . 0.0 110.543 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -86.51 -23.34 25.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.341 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.849 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -71.7 -69.05 0.41 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.116 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.038 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.68 -12.44 9.26 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.769 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -63.85 137.68 58.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.895 0.379 . . . . 0.0 111.151 -179.282 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.673 HG13 ' HB3' ' A' ' 16' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.965 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.089 0 CA-C-O 120.906 0.384 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -75.23 -4.73 40.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.235 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.12 24.69 11.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.399 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 p30 56.17 33.59 22.34 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.159 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.455 ' HA2' ' CE1' ' A' ' 14' ' ' HIS . . . 50.84 24.41 8.13 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.938 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.53 87.51 7.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.018 0.437 . . . . 0.0 110.428 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.702 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 13.9 mt -62.42 -17.12 58.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.794 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 53.6 -171.76 0.71 Allowed Glycine 0 CA--C 1.507 -0.408 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.204 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.717 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 8.5 p90 -59.95 117.02 4.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.122 0.486 . . . . 0.0 111.619 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.498 ' C ' ' HB2' ' A' ' 9' ' ' LYS . 8.6 p90 -139.37 141.22 37.6 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.429 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.469 ' CA ' ' HB2' ' A' ' 9' ' ' LYS . . . -90.89 -173.78 44.02 Favored Glycine 0 C--N 1.311 -0.816 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.404 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.67 100.18 13.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.749 0.309 . . . . 0.0 110.362 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.32 36.49 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.312 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -151.18 18.44 0.76 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.861 0.331 . . . . 0.0 111.595 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.486 ' HE3' ' CE1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -151.61 174.12 13.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.697 0.284 . . . . 0.0 111.075 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.796 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.1 m -60.74 158.46 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.803 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.571 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -61.32 -47.84 92.91 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.194 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.627 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 19.8 Cg_endo -64.28 -40.1 26.99 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.024 1.816 . . . . 0.0 112.048 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.796 ' H ' HG23 ' A' ' 65' ' ' VAL . 26.1 t80 -74.95 -51.19 14.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.799 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 3.2 tm-20 -57.42 -32.47 66.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.749 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 23.7 t70 -66.08 -49.39 67.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.969 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.458 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -74.87 -9.49 58.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.816 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.408 ' HB1' ' HE1' ' A' ' 59' ' ' PHE . . . -66.31 -47.39 73.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.753 0.311 . . . . 0.0 111.556 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 8.6 p90 -92.93 16.69 12.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.499 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -100.4 -27.3 13.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.787 0.327 . . . . 0.0 110.933 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 79' ' ' GLU . 1.5 mt -103.53 58.5 0.74 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.454 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -69.22 -18.31 63.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.975 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -66.29 -26.82 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.688 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.429 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 96.23 58.2 1.1 Allowed Glycine 0 CA--C 1.502 -0.744 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.568 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.603 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -139.56 176.5 8.67 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.726 0.298 . . . . 0.0 111.055 -178.445 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.822 HG11 ' HA ' ' A' ' 27' ' ' GLN . 24.8 t -87.18 148.56 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.198 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -105.37 157.34 17.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.245 0.545 . . . . 0.0 111.335 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.47 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.9 mp0 -50.96 155.81 1.93 Allowed Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.066 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HG3' HD23 ' A' ' 24' ' ' LEU . 12.8 Cg_endo -56.26 106.26 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.208 1.939 . . . . 0.0 111.6 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.627 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 70.9 t -100.9 108.06 22.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.597 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.452 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 28.2 tptt -91.65 113.0 25.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.96 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.448 ' HG ' ' CE1' ' A' ' 91' ' ' HIS . 0.9 OUTLIER -110.04 -171.38 1.83 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.321 179.354 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.79 -18.4 21.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.277 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . 0.468 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 12.1 m-85 -93.69 -38.9 11.08 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.722 0.296 . . . . 0.0 111.677 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.401 ' HA2' ' NZ ' ' A' ' 85' ' ' LYS . . . 154.58 -166.19 32.22 Favored Glycine 0 CA--C 1.508 -0.384 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.848 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.615 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 59.3 m-85 -74.73 98.21 3.41 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.306 0.574 . . . . 0.0 110.161 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.884 ' CD2' HD13 ' A' ' 16' ' ' LEU . 79.6 m80 -86.53 169.88 12.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.575 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.6 t -145.88 147.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.848 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.842 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -134.67 123.22 41.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.081 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.407 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 3.3 tmtm? -128.14 110.1 12.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.843 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -57.39 131.74 50.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.416 0.627 . . . . 0.0 111.872 -178.031 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.917 HD23 ' HB3' ' A' ' 13' ' ' SER . 0.3 OUTLIER -158.7 116.92 2.94 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.989 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.407 -1.219 . . . . 0.0 112.52 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.676 ' HD3' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.542 0.21 . . . . 0.0 110.748 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.692 HD11 ' HB3' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -109.95 137.14 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-O 121.635 0.731 . . . . 0.0 111.161 -178.537 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.577 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -110.4 89.22 2.97 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.286 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.753 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 35.8 m -120.87 179.91 4.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.193 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.54 ' CB ' HD23 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -119.52 163.39 17.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.949 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.462 ' C ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -134.45 147.73 50.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.229 0.538 . . . . 0.0 112.249 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.546 HG23 ' OG ' ' A' ' 44' ' ' SER . 3.6 mp -145.41 115.3 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.942 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.643 HD11 ' NE2' ' A' ' 91' ' ' HIS . 0.8 OUTLIER -99.41 129.14 45.58 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.076 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.796 HG21 ' CG ' ' A' ' 22' ' ' GLU . 20.2 m -143.25 133.73 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.597 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HE2' HD13 ' A' ' 45' ' ' ILE . 4.7 mttm -71.18 -36.0 71.79 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.849 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.584 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -71.44 78.19 0.77 Allowed 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.675 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 1.1 tm0? -46.72 -25.78 0.8 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.935 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.85 -31.37 78.04 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 119.069 -1.538 . . . . 0.0 110.72 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.896 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -71.46 -39.64 70.84 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.195 0.522 . . . . 0.0 109.726 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.69 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -52.9 -36.5 59.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.796 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.758 ' O ' HD13 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -73.64 -29.3 62.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.981 178.934 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.03 -42.06 13.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.888 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.4 m -54.92 -33.83 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.315 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.704 ' HA ' HG11 ' A' ' 80' ' ' VAL . 15.9 pt20 -51.31 -55.33 18.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.675 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.457 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.8 OUTLIER -73.16 -31.29 64.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.14 0.495 . . . . 0.0 110.479 178.877 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.553 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 10.0 tpt180 -68.38 -37.99 80.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.725 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.848 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -52.95 -58.97 5.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.345 -179.293 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -72.12 -9.52 58.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.396 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -58.42 -21.92 52.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 0.0 111.341 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.35 -18.49 1.17 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.293 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HG3' HD21 ' A' ' 39' ' ' LEU . 23.2 pt-20 -80.48 157.56 26.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.914 0.388 . . . . 0.0 110.824 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -97.35 138.59 34.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.029 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.848 ' HA ' HD21 ' A' ' 30' ' ' LEU . 1.9 p90 -49.23 -35.39 17.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.964 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -64.6 -34.09 88.98 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.542 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.6 OUTLIER -63.38 -53.85 46.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.626 0.25 . . . . 0.0 111.192 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.961 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.17 -34.34 56.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.044 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.45 -53.61 35.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.017 0.436 . . . . 0.0 110.524 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -85.97 -23.63 26.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.179 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.85 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.37 -68.65 0.41 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -177.776 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.961 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.5 -14.0 9.17 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.647 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.553 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -64.18 137.87 58.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.168 0.509 . . . . 0.0 111.549 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.575 HD13 ' HE2' ' A' ' 18' ' ' LYS . 1.4 pt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.028 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.192 0 CA-C-O 121.256 0.55 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.64 -12.06 61.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.659 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -103.46 24.03 11.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.582 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 72.68 10.25 5.58 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.554 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.29 22.01 66.9 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.205 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.4 89.07 2.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.106 0.479 . . . . 0.0 110.622 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.753 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 12.1 mt -63.41 -15.03 56.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.775 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 48.22 -171.17 0.06 OUTLIER Glycine 0 CA--C 1.507 -0.468 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.339 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.676 ' HB2' ' HD3' ' A' ' 9' ' ' LYS . 16.8 p90 -56.51 122.62 12.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.211 0.529 . . . . 0.0 111.872 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.66 ' HE1' ' HB1' ' A' ' 72' ' ' ALA . 7.3 p90 -146.09 140.88 27.05 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.48 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.2 -173.9 23.41 Favored Glycine 0 C--N 1.315 -0.632 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.982 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 88.54 1.1 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.033 0.444 . . . . 0.0 110.129 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.53 36.88 0.05 OUTLIER Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.934 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.63 -41.67 0.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.596 0.236 . . . . 0.0 111.462 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.435 ' HE2' ' HB2' ' A' ' 64' ' ' MET . 1.9 mpp? -105.73 174.0 6.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.032 0.444 . . . . 0.0 111.468 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.777 HG23 ' H ' ' A' ' 68' ' ' PHE . 34.4 m -56.81 161.39 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.069 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.553 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -60.36 -48.03 94.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.611 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 15.5 Cg_endo -64.85 -42.01 16.25 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 121.911 1.741 . . . . 0.0 111.731 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.777 ' H ' HG23 ' A' ' 65' ' ' VAL . 15.2 t80 -72.65 -51.51 19.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.472 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.7 tt0 -56.34 -32.29 64.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.614 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 35.2 t70 -65.97 -51.6 56.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.707 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.405 ' HB3' HD11 ' A' ' 93' ' ' ILE . . . -75.12 -12.12 60.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.429 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.66 ' HB1' ' HE1' ' A' ' 59' ' ' PHE . . . -61.83 -49.21 77.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.886 0.374 . . . . 0.0 111.265 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.692 ' HB3' HD11 ' A' ' 10' ' ' ILE . 2.8 p90 -93.96 16.58 14.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.239 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -98.27 -26.39 14.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.375 . . . . 0.0 110.705 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.572 HD12 ' O ' ' A' ' 79' ' ' GLU . 2.0 mt -103.46 53.08 0.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.145 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -59.72 -22.02 61.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.165 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 p -61.92 -26.77 40.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.533 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 94.17 55.62 1.46 Allowed Glycine 0 CA--C 1.503 -0.717 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.741 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.572 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -137.44 176.53 8.62 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.692 0.282 . . . . 0.0 111.01 -178.758 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.704 HG11 ' HA ' ' A' ' 27' ' ' GLN . 59.5 t -86.43 147.43 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.533 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.47 160.48 15.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.202 0.525 . . . . 0.0 111.409 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.47 ' O ' HG23 ' A' ' 84' ' ' VAL . 21.0 mp0 -50.89 155.49 2.0 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.159 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.408 ' HG3' HD23 ' A' ' 24' ' ' LEU . 14.6 Cg_endo -56.93 105.96 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.228 1.952 . . . . 0.0 111.772 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.611 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 85.0 t -100.93 106.8 20.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.115 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.467 ' CG ' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.52 112.89 25.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.494 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.445 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 0.5 OUTLIER -105.19 -171.65 1.95 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.051 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -14.94 36.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.202 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -96.47 -36.36 10.82 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.612 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.19 -166.53 34.16 Favored Glycine 0 CA--C 1.508 -0.403 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.86 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.742 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 91.7 m-85 -80.73 98.07 7.58 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.237 0.542 . . . . 0.0 109.941 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.643 ' NE2' HD11 ' A' ' 16' ' ' LEU . 50.9 m80 -82.95 169.73 15.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.812 -178.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.447 ' CG1' HG13 ' A' ' 80' ' ' VAL . 19.4 t -149.52 145.6 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.445 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.622 HG23 ' CE1' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -123.3 122.28 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.005 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 13' ' ' SER . 2.4 tptm -128.72 108.98 10.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.406 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 2.0 ttp85 -57.26 132.8 54.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.562 0.696 . . . . 0.0 112.346 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.844 HD22 ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -163.17 116.71 1.6 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.782 179.747 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.417 -1.213 . . . . 0.0 112.67 179.754 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.41 0 CA-C-O 121.214 0.53 . . . . 0.0 111.357 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.582 HG22 ' SG ' ' A' ' 12' ' ' CYS . 1.4 mt -110.74 136.04 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.904 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.105 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.515 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.0 mtpt -107.73 88.4 2.72 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.668 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.818 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 8.6 m -131.41 -179.82 5.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.735 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.683 ' HB2' HD23 ' A' ' 96' ' ' LEU . 45.2 t -121.1 163.44 18.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.226 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.67 ' C ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -130.68 150.78 51.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.172 0.511 . . . . 0.0 111.857 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.67 HD12 ' C ' ' A' ' 14' ' ' HIS . 4.1 mp -154.27 130.15 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.527 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.5 HD21 ' C ' ' A' ' 89' ' ' GLY . 0.5 OUTLIER -123.2 138.04 54.74 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.868 0.366 . . . . 0.0 111.858 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 1.014 HG21 ' CG ' ' A' ' 22' ' ' GLU . 24.2 m -151.02 135.84 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.516 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -64.91 -19.5 65.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.39 76.4 1.03 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.796 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 2.6 pt20 -47.79 -33.14 6.81 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.32 -31.17 61.55 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 119.915 -1.136 . . . . 0.0 112.599 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 1.014 ' CG ' HG21 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -68.16 -42.68 79.7 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.451 0.643 . . . . 0.0 109.92 179.359 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.669 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -49.64 -36.81 25.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.526 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.706 ' O ' HD13 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -72.71 -33.83 66.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.812 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.11 -44.15 22.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.514 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.807 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.8 m -47.96 -36.34 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.394 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.718 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -58.01 -49.26 77.45 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.522 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.718 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 4.0 pt-20 -73.89 -30.37 62.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.838 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.538 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 10.4 tpp85 -78.83 -33.12 46.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.83 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.571 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.8 OUTLIER -52.53 -51.93 57.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.688 0.28 . . . . 0.0 111.424 -178.718 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.401 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -71.99 -9.29 58.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.186 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -72.72 47.2 0.17 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.32 -10.66 41.73 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.737 -0.744 . . . . 0.0 114.153 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 29' ' ' ARG . 6.6 pt-20 -91.97 153.98 19.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.437 0.618 . . . . 0.0 110.78 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -104.22 139.22 39.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.419 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 1.023 ' CE1' HD22 ' A' ' 96' ' ' LEU . 2.2 p90 -47.18 -31.75 3.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.841 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.11 -34.17 88.15 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.372 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.8 ttpm? -68.1 -51.99 40.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.654 0.264 . . . . 0.0 111.112 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.846 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.13 -36.01 60.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.412 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.783 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -51.93 -53.2 43.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.167 0.508 . . . . 0.0 110.634 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -85.64 -23.6 27.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.791 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.973 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -72.06 -67.52 0.53 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.133 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.973 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.36 -14.62 9.75 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.875 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.559 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 1.4 t -63.42 126.8 28.66 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.227 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.522 HG12 ' HA ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.553 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.783 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . . . . . . . . 0 CA--C 1.52 -0.188 0 CA-C-O 121.307 0.575 . . . . 0.0 109.624 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -88.9 -5.44 58.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.184 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.466 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 1.7 mmt85 -122.36 24.55 9.3 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.9 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER 74.51 26.96 1.43 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.344 0.592 . . . . 0.0 111.085 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 55.56 20.31 23.31 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.789 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.45 84.66 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.027 0.442 . . . . 0.0 110.752 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.818 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 12.8 mt -58.92 -21.73 58.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.788 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 55.93 -163.85 5.05 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.413 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.515 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -64.23 119.48 10.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.028 0.442 . . . . 0.0 111.835 -179.38 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.546 ' HE1' ' HB1' ' A' ' 72' ' ' ALA . 19.1 p90 -141.27 139.34 33.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.571 177.377 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.419 ' CA ' ' HE2' ' A' ' 9' ' ' LYS . . . -98.35 -173.95 32.67 Favored Glycine 0 C--N 1.318 -0.463 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.504 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -82.8 98.27 9.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.199 0.524 . . . . 0.0 109.955 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.45 36.48 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.636 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -140.25 -46.87 0.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.837 0.351 . . . . 0.0 110.952 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.431 ' CE ' ' CE1' ' A' ' 59' ' ' PHE . 1.4 mpp? -91.92 170.04 10.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.963 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.77 HG23 ' H ' ' A' ' 68' ' ' PHE . 34.8 m -59.58 162.34 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.018 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.498 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.63 -48.18 97.37 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.068 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.573 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 10.0 Cg_endo -66.02 -38.37 22.6 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 121.858 1.706 . . . . 0.0 112.171 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.77 ' H ' HG23 ' A' ' 65' ' ' VAL . 8.8 t80 -74.97 -50.01 18.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.746 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -57.04 -32.49 66.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.651 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -64.61 -50.65 66.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.849 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.85 -9.57 58.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.524 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.546 ' HB1' ' HE1' ' A' ' 59' ' ' PHE . . . -68.15 -50.45 54.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.782 0.325 . . . . 0.0 111.301 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 6.4 p90 -93.28 16.56 12.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.343 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.48 -25.19 14.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 0.0 110.863 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 79' ' ' GLU . 1.6 mt -103.53 55.15 0.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.219 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -63.49 -19.55 64.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.098 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -63.66 -26.72 41.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.403 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.503 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.13 55.58 1.37 Allowed Glycine 0 CA--C 1.503 -0.674 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.629 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.558 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -137.63 176.17 8.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.858 0.361 . . . . 0.0 111.221 -178.388 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.63 HG11 ' HA ' ' A' ' 27' ' ' GLN . 60.2 t -83.16 149.09 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.903 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.0 t -104.4 154.8 19.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.448 0.642 . . . . 0.0 111.764 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -50.8 163.5 0.48 Allowed Pre-proline 0 C--O 1.235 0.307 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.573 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.563 ' HG3' HD23 ' A' ' 24' ' ' LEU . 17.8 Cg_endo -59.15 104.56 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.604 2.203 . . . . 0.0 112.226 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.573 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 93.7 t -101.43 101.54 12.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.373 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.69 113.01 25.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.851 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.3 m -108.71 -171.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.6 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -57.7 -20.28 33.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.33 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -91.34 -40.49 11.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.424 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.5 ' C ' HD21 ' A' ' 16' ' ' LEU . . . 157.33 -164.51 32.97 Favored Glycine 0 CA--C 1.508 -0.354 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.073 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.484 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 0.7 OUTLIER -74.59 98.39 3.37 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.052 0.453 . . . . 0.0 110.39 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.473 ' NE2' HD12 ' A' ' 16' ' ' LEU . 31.0 m80 -81.71 169.95 16.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.236 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 t -149.29 150.6 13.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.01 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.492 HG23 ' CE1' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -138.1 124.14 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.319 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 13' ' ' SER . 15.8 tptp -128.45 109.29 11.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.594 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.503 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.5 OUTLIER -57.7 136.61 56.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.601 0.715 . . . . 0.0 112.206 -179.289 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 1.023 HD22 ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -161.27 116.52 2.1 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.718 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.28 -1.289 . . . . 0.0 112.659 179.76 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.76 ' HD3' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 120.498 0.19 . . . . 0.0 110.727 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 58' ' ' TYR . 1.5 mm -109.3 149.64 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 CA-C-O 121.765 0.793 . . . . 0.0 111.276 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.666 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -125.34 76.3 1.54 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.102 -179.546 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.886 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 10.3 m -117.63 -179.68 3.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.258 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.828 ' HB2' HD23 ' A' ' 96' ' ' LEU . 22.6 t -115.66 163.49 15.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.651 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.692 ' C ' HD12 ' A' ' 15' ' ' ILE . 0.7 OUTLIER -132.44 153.03 51.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.54 0.686 . . . . 0.0 112.483 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.75 HG23 ' OG ' ' A' ' 44' ' ' SER . 2.8 mp -155.85 123.18 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.899 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.759 ' HG ' HD11 ' A' ' 45' ' ' ILE . 12.8 tp -111.61 131.17 55.45 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.825 HG11 ' OE1' ' A' ' 22' ' ' GLU . 17.3 m -143.65 134.71 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.67 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HD3' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -72.41 -35.77 68.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.513 -179.227 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.623 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 3.3 tttp -74.31 79.33 1.84 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.489 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -46.28 -25.85 0.7 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.153 -0.931 . . . . 0.0 113.254 -176.98 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.15 -31.24 77.05 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.9 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.849 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -70.88 -38.23 73.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.009 0.433 . . . . 0.0 110.354 178.798 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.602 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.83 -37.68 44.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.088 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.707 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.3 OUTLIER -73.44 -29.53 62.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.773 179.105 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.24 -42.8 15.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.47 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.9 m -55.89 -39.24 55.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.203 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.2 pt20 -56.12 -51.49 67.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.886 0.374 . . . . 0.0 110.26 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.547 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 2.8 pt-20 -73.19 -29.62 62.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.09 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.572 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.83 -29.75 44.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.656 -178.771 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.639 HD21 ' HA ' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -55.27 -55.33 32.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.944 0.402 . . . . 0.0 110.827 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -9.55 58.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.202 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.2 -24.02 62.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.913 0.387 . . . . 0.0 111.232 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.1 -18.53 0.94 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.307 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -80.72 157.52 25.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.905 0.383 . . . . 0.0 110.807 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.4 138.47 39.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.048 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.865 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 2.4 p90 -47.09 -29.86 2.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.996 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -64.45 -35.8 92.39 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.429 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.4 OUTLIER -66.19 -53.3 39.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.737 0.303 . . . . 0.0 110.869 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.003 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.62 -32.55 51.72 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.484 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.556 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.7 -53.27 41.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.617 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -86.33 -23.32 26.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.245 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.849 ' HB3' HD13 ' A' ' 43' ' ' LEU . 2.6 mm-40 -70.68 -69.22 0.38 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.003 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.61 -13.44 9.17 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.75 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -63.96 136.91 57.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.95 0.405 . . . . 0.0 111.2 -179.231 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.759 HD11 ' HG ' ' A' ' 16' ' ' LEU . 27.9 pt . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.803 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.154 0 CA-C-O 121.179 0.514 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -73.8 -10.58 59.82 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.645 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.95 24.81 10.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.522 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.424 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 0.6 OUTLIER 60.06 27.81 17.29 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.227 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 57.36 20.08 35.53 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.759 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 99.2 p -76.24 87.73 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.944 0.402 . . . . 0.0 110.234 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.886 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 14.4 mt -63.67 -16.48 61.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.548 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 46.55 -169.34 0.04 OUTLIER Glycine 0 CA--C 1.506 -0.522 0 C-N-CA 121.028 -0.605 . . . . 0.0 112.682 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.76 ' HB2' ' HD3' ' A' ' 9' ' ' LYS . 27.5 p90 -66.82 111.48 3.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.539 ' C ' ' HB2' ' A' ' 9' ' ' LYS . 13.0 m-30 -141.96 148.05 37.98 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.0 -174.01 19.0 Favored Glycine 0 C--N 1.311 -0.811 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.406 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -75.3 154.74 37.23 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.2 -37.03 1.17 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.445 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.14 24.77 1.78 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.738 0.304 . . . . 0.0 111.059 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 13.8 mtp -112.95 162.44 15.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.675 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.799 HG23 ' H ' ' A' ' 68' ' ' PHE . 17.7 m -79.28 147.08 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.986 0.422 . . . . 0.0 110.951 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.584 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.23 -44.21 99.01 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.221 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 16.8 Cg_endo -65.3 -42.7 12.6 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 121.808 1.672 . . . . 0.0 112.207 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.799 ' H ' HG23 ' A' ' 65' ' ' VAL . 16.6 t80 -74.88 -49.39 20.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.842 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.61 -32.33 70.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.825 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 4.1 m-20 -64.6 -46.85 80.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.257 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.875 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -74.82 -18.4 60.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.749 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 10' ' ' ILE . . . -54.15 -53.06 58.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.727 0.299 . . . . 0.0 111.57 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -87.74 16.84 5.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.833 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -100.53 -31.58 11.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.822 0.344 . . . . 0.0 110.72 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 79' ' ' GLU . 2.8 mt -103.78 69.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.766 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -78.03 -16.41 58.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.088 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 p -69.07 -26.79 33.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.94 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.545 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 96.84 60.08 0.99 Allowed Glycine 0 CA--C 1.504 -0.634 0 C-N-CA 120.43 -0.89 . . . . 0.0 111.199 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.571 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -141.89 176.49 8.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.894 0.378 . . . . 0.0 111.025 -178.094 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.559 HG11 ' HA ' ' A' ' 27' ' ' GLN . 48.1 t -85.31 148.49 4.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.879 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t -104.5 163.96 12.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.212 0.529 . . . . 0.0 111.342 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.502 ' O ' HG23 ' A' ' 84' ' ' VAL . 14.8 mt-10 -50.59 158.16 1.13 Allowed Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.187 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.707 ' HG3' HD23 ' A' ' 24' ' ' LEU . 16.5 Cg_endo -57.15 104.08 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.538 2.159 . . . . 0.0 111.793 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.571 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 57.9 t -101.82 105.91 18.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.782 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 3.0 tmtt? -98.76 112.86 24.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 21.8 m -110.47 -172.47 2.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.475 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -57.76 -20.37 34.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.964 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -88.74 -30.89 18.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.381 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.428 ' C ' HD11 ' A' ' 16' ' ' LEU . . . 143.62 -169.7 25.91 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.885 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.489 ' CD1' ' HB3' ' A' ' 20' ' ' GLN . 0.4 OUTLIER -74.68 98.33 3.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.982 0.42 . . . . 0.0 110.017 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.671 ' CG ' HD13 ' A' ' 16' ' ' LEU . 18.5 m-70 -89.02 169.7 11.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.421 0.629 . . . . 0.0 112.294 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.444 ' CG1' HG13 ' A' ' 80' ' ' VAL . 25.0 t -139.86 134.64 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.614 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.875 HD12 ' HB3' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -118.29 121.86 68.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.655 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.93 108.06 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.312 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.545 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.4 OUTLIER -59.07 131.87 52.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.398 0.618 . . . . 0.0 111.816 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.865 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -160.35 116.02 2.33 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.001 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.312 -1.271 . . . . 0.0 112.591 179.731 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 121.214 0.53 . . . . 0.0 111.096 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.27 138.62 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.008 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.496 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -106.66 98.23 7.92 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.523 -178.614 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.816 ' SG ' HG22 ' A' ' 93' ' ' ILE . 2.8 t -127.25 179.98 5.17 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.929 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.742 ' HB2' HD23 ' A' ' 96' ' ' LEU . 7.5 t -121.23 163.27 18.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.904 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.805 ' HB3' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -131.04 149.55 52.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.045 0.45 . . . . 0.0 111.967 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.711 HD12 ' C ' ' A' ' 14' ' ' HIS . 3.7 mp -155.94 131.58 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.944 HD21 ' CD2' ' A' ' 91' ' ' HIS . 4.0 mm? -123.0 138.1 54.78 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.94 0.4 . . . . 0.0 111.64 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.812 HG21 ' CG ' ' A' ' 22' ' ' GLU . 18.3 m -148.98 134.11 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.93 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -69.84 -36.7 75.77 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.188 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.594 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.31 78.37 1.0 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.464 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -46.69 -25.79 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.768 -1.105 . . . . 0.0 113.238 -177.448 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.1 -31.48 77.83 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 119.045 -1.55 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.901 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -70.13 -39.22 75.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.247 0.546 . . . . 0.0 109.969 178.302 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.664 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -49.24 -39.5 30.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.376 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.556 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.33 -29.66 62.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.16 179.244 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.01 -36.49 23.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.755 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.901 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.4 m -57.27 -33.29 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.213 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.657 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -59.76 -50.26 74.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.657 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -73.12 -27.26 61.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.243 0.544 . . . . 0.0 110.348 178.507 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.567 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.9 tpt180 -77.86 -33.93 51.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.702 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.681 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -53.32 -59.4 4.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.245 -179.255 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -72.41 -9.39 58.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.287 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -56.78 -22.31 35.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.866 0.365 . . . . 0.0 111.416 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.01 -16.91 1.05 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.368 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -86.47 157.37 19.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.791 0.329 . . . . 0.0 110.682 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -99.51 142.38 31.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.091 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.812 ' CE1' HD22 ' A' ' 96' ' ' LEU . 2.9 p90 -47.65 -29.53 3.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.797 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -66.53 -38.93 93.79 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.563 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.557 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 5.1 ttpp -59.82 -50.98 71.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.72 0.295 . . . . 0.0 110.822 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.819 HD12 HD11 ' A' ' 43' ' ' LEU . 3.1 mm? -53.4 -34.85 59.32 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.741 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.678 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -52.09 -52.96 47.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.29 0.566 . . . . 0.0 110.665 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.46 -22.74 26.31 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.285 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.92 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -75.59 -68.4 0.57 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -176.763 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.92 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.63 -10.72 9.99 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.232 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.592 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -63.75 125.89 25.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.908 0.385 . . . . 0.0 109.993 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 16' ' ' LEU . 4.9 pt . . . . . 0 C--N 1.33 -0.259 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.678 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . . . . . . . . 0 CA--C 1.517 -0.319 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -88.78 -19.69 25.68 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.913 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.462 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 3.2 mtt180 -104.43 24.68 11.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.168 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.495 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.6 OUTLIER 62.19 40.96 11.13 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.259 0.552 . . . . 0.0 111.583 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 53.36 30.51 40.83 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.213 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.849 ' HA ' HD21 ' A' ' 96' ' ' LEU . 65.4 p -88.74 85.09 6.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.729 0.3 . . . . 0.0 110.827 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.806 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 16.4 mt -58.3 -31.67 67.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.637 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 70.76 -170.12 47.03 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.453 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.561 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -60.64 118.47 6.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.151 0.501 . . . . 0.0 111.661 -179.384 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.557 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 2.4 m-85 -127.18 164.08 22.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.443 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.76 -174.02 13.25 Favored Glycine 0 C--N 1.319 -0.411 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.672 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -74.3 84.23 1.91 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.168 0.508 . . . . 0.0 110.121 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.33 36.78 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.056 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.0 -48.6 0.61 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.674 0.273 . . . . 0.0 111.39 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.4 ' HG3' ' HB2' ' A' ' 69' ' ' GLU . 1.9 ptp -108.42 169.51 8.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.025 0.441 . . . . 0.0 111.406 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.76 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.6 m -54.72 161.71 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.666 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.57 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -61.65 -48.14 90.74 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 11.8 Cg_endo -63.33 -42.0 24.25 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 121.999 1.799 . . . . 0.0 111.744 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.76 ' H ' HG23 ' A' ' 65' ' ' VAL . 17.9 t80 -73.11 -51.78 16.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.662 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 3.4 tm-20 -59.24 -32.98 70.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.774 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 6.7 m-20 -61.48 -48.57 80.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.127 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.587 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -74.83 -9.57 58.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.737 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.42 -47.72 78.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.771 0.32 . . . . 0.0 111.515 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 10.2 p90 -92.7 16.6 11.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.476 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -99.99 -25.82 14.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 111.205 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.803 HD11 ' CB ' ' A' ' 81' ' ' SER . 11.0 mt -101.25 56.9 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.389 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -61.42 -31.7 71.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.979 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -63.15 -26.88 41.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.124 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.5 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 89.94 70.21 1.23 Allowed Glycine 0 CA--C 1.499 -0.915 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.951 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.797 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -142.29 177.35 8.31 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.122 -0.539 . . . . 0.0 109.998 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.546 HG11 ' HA ' ' A' ' 27' ' ' GLN . 87.0 t -79.72 150.61 4.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.803 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -105.04 164.31 11.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.608 0.718 . . . . 0.0 111.907 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.624 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -50.5 164.31 0.41 Allowed Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.896 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.624 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 55.5 Cg_endo -68.73 103.44 0.99 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.398 2.065 . . . . 0.0 112.123 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 81.4 t -101.89 104.31 16.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.087 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.455 ' CG ' ' CD1' ' A' ' 90' ' ' TYR . 12.2 tmtt? -99.78 112.67 24.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.584 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.441 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 74.4 m -112.82 -176.44 2.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.858 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -51.83 -25.95 8.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.178 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -80.81 -39.95 25.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.087 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.56 -163.45 31.2 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.701 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.635 ' O ' HD13 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -80.39 100.28 8.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.632 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.944 ' CD2' HD21 ' A' ' 16' ' ' LEU . 60.5 m80 -85.05 162.24 19.4 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.7 t -146.82 125.19 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.011 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.816 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -113.68 124.49 70.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.405 ' HG2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -128.25 112.77 14.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.189 178.521 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.27 135.92 56.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.552 0.691 . . . . 0.0 112.356 -177.746 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.849 HD21 ' HA ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -156.74 116.76 3.54 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.578 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.424 -1.209 . . . . 0.0 112.564 179.823 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.601 0 CA-C-O 121.089 0.471 . . . . 0.0 111.089 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.14 129.52 66.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.528 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.514 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.1 mtpt -95.79 97.74 9.91 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.948 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.79 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -126.65 -179.73 4.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.839 -177.083 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.864 ' HB3' HD23 ' A' ' 96' ' ' LEU . 5.8 p -124.43 159.81 29.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.348 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.842 ' HB3' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -131.92 146.54 52.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.17 0.51 . . . . 0.0 112.302 -179.419 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.73 HD12 ' C ' ' A' ' 14' ' ' HIS . 4.1 mp -149.73 132.78 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.673 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.75 HD21 ' CD2' ' A' ' 91' ' ' HIS . 4.1 mm? -119.54 137.55 53.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.784 0.326 . . . . 0.0 111.598 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.866 HG21 ' CG ' ' A' ' 22' ' ' GLU . 15.7 m -148.54 134.23 11.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.17 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.404 ' HD2' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -71.12 -36.46 72.13 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.412 -178.89 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.665 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -74.42 79.15 1.89 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.878 0.846 . . . . 0.0 108.73 178.499 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.489 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -45.82 -25.28 0.49 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.363 -1.289 . . . . 0.0 113.162 -177.447 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.61 -30.37 76.28 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.124 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.871 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -72.02 -39.72 68.97 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.049 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.724 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -49.84 -35.02 21.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.205 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.555 ' O ' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -73.3 -40.1 64.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.613 179.088 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.56 -48.78 30.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.589 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.7 m -46.55 -40.53 4.45 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.249 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.448 ' HA ' HG11 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -59.01 -45.13 91.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.444 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.4 mm-40 -73.69 -33.06 64.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.82 178.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.569 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -78.69 -30.41 46.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.842 -178.539 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.628 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -52.99 -58.95 5.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.895 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -9.38 58.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.383 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -58.29 -24.32 59.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.927 0.394 . . . . 0.0 111.327 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.93 -18.61 0.96 Allowed Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.191 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.515 ' CD ' HD21 ' A' ' 39' ' ' LEU . 6.9 pt-20 -82.15 157.59 23.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.862 0.363 . . . . 0.0 110.503 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.38 141.75 33.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.091 0.472 . . . . 0.0 111.216 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.628 ' HA ' HD21 ' A' ' 30' ' ' LEU . 3.2 p90 -45.8 -31.4 2.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.762 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.53 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.58 -41.65 99.78 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.178 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 2.9 tttt -58.16 -51.97 67.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.516 0.198 . . . . 0.0 110.785 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.803 ' CD1' HD11 ' A' ' 43' ' ' LEU . 3.1 mm? -53.36 -35.14 59.95 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.654 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.676 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -51.86 -53.52 39.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.215 0.531 . . . . 0.0 110.65 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -86.42 -23.1 26.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.126 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.911 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -75.77 -68.26 0.59 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.074 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.911 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.88 -8.3 10.3 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -179.011 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.661 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -63.66 125.79 25.44 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.66 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 16' ' ' LEU . 1.9 pt . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.676 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . . . . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.78 0.324 . . . . 0.0 111.42 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -87.96 -21.38 24.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.355 0.598 . . . . 0.0 111.716 -179.436 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.504 ' N ' ' HD2' ' A' ' 51' ' ' LYS . 1.4 ptp180 -103.59 24.92 10.37 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.193 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.53 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER 77.34 6.91 2.98 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.703 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.07 24.42 75.82 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.877 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.9 ' HA ' HD21 ' A' ' 96' ' ' LEU . 82.0 p -66.73 88.61 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.872 0.367 . . . . 0.0 111.261 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.842 HD11 ' HB3' ' A' ' 14' ' ' HIS . 16.2 mt -60.36 -27.42 67.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.402 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.79 -172.99 27.74 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.252 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.547 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -59.07 119.19 6.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.05 0.453 . . . . 0.0 111.491 -179.504 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.526 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 3.1 m-85 -128.46 163.0 25.86 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -139.19 -173.88 13.26 Favored Glycine 0 C--N 1.315 -0.592 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.803 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.27 87.47 1.98 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.116 0.484 . . . . 0.0 109.904 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.59 36.69 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.918 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -147.31 -47.04 0.17 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.701 0.286 . . . . 0.0 111.083 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.4 mtm -98.3 168.43 10.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.098 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.784 HG23 ' H ' ' A' ' 68' ' ' PHE . 36.0 m -61.22 161.44 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.786 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.57 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 4.0 mtpt -61.22 -47.98 92.93 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 12.9 Cg_endo -64.23 -41.37 21.82 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.834 1.689 . . . . 0.0 111.809 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.784 ' H ' HG23 ' A' ' 65' ' ' VAL . 30.5 t80 -73.82 -52.35 13.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.628 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -57.73 -32.46 67.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.755 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.481 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 7.2 m-20 -62.47 -51.15 68.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.854 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.02 -9.5 58.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.664 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.99 -49.19 66.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.875 0.369 . . . . 0.0 111.589 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 9.0 p90 -93.32 16.68 12.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.381 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.14 -27.98 12.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.817 0.341 . . . . 0.0 110.798 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.511 HD11 ' O ' ' A' ' 80' ' ' VAL . 2.5 mt -103.55 54.7 0.75 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.471 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -62.16 -20.13 63.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.915 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -61.01 -26.92 40.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.225 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.46 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 95.25 55.13 1.39 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.845 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.501 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.6 tm-20 -139.51 176.16 8.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.746 0.308 . . . . 0.0 111.105 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 45.0 t -83.91 148.92 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.27 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.4 m -104.93 163.91 12.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.26 0.552 . . . . 0.0 111.588 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.499 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.5 mt-10 -50.86 155.0 2.16 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.384 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.467 ' HG3' HD23 ' A' ' 24' ' ' LEU . 11.2 Cg_endo -54.37 104.68 0.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.659 2.239 . . . . 0.0 112.047 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.567 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 67.4 t -101.47 105.2 17.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 5.1 tptm -94.32 112.99 24.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.757 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.451 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 0.5 OUTLIER -107.9 -175.41 2.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.544 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -59.06 -20.24 51.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.948 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -88.5 -40.8 13.17 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.303 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.22 -164.29 35.41 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.868 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.615 ' O ' HD13 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -81.35 98.29 8.1 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.75 ' CD2' HD21 ' A' ' 16' ' ' LEU . 35.9 m80 -81.22 169.53 17.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.833 -177.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.5 t -154.61 123.76 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.719 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -105.38 122.69 59.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.501 ' HG2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -128.32 116.13 19.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.495 178.294 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.46 ' CB ' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -58.54 136.04 57.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.507 0.67 . . . . 0.0 112.315 -178.612 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.9 HD21 ' HA ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -160.38 116.76 2.39 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.925 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.479 -1.178 . . . . 0.0 112.718 179.866 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.587 ' CD ' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.124 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 58' ' ' TYR . 1.5 mm -109.4 148.94 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 CA-C-O 121.714 0.769 . . . . 0.0 111.247 -178.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.658 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -124.75 77.22 1.58 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.943 -179.61 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.814 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 13.8 m -117.54 -179.91 3.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.171 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.825 ' HB2' HD23 ' A' ' 96' ' ' LEU . 3.5 t -109.38 163.67 13.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.297 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.698 ' C ' HD12 ' A' ' 15' ' ' ILE . 12.9 t60 -126.4 142.12 51.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.339 0.59 . . . . 0.0 112.061 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.792 HG23 ' OG ' ' A' ' 44' ' ' SER . 3.5 mp -151.27 120.32 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.93 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.866 HD11 ' CE1' ' A' ' 91' ' ' HIS . 0.4 OUTLIER -113.98 135.89 53.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.206 -178.621 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.828 HG21 ' CG ' ' A' ' 22' ' ' GLU . 15.4 m -151.83 134.11 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.682 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HE3' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -73.09 -35.0 66.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.955 0.407 . . . . 0.0 110.469 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.544 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 13.2 pttm -71.99 80.34 0.92 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.46 ' HG3' ' CZ ' ' A' ' 90' ' ' TYR . 30.9 tt0 -45.03 -25.75 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.376 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.56 -32.13 78.04 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.209 -1.472 . . . . 0.0 111.444 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.828 ' CG ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -69.05 -42.57 76.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.354 0.597 . . . . 0.0 109.662 178.326 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.511 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -46.97 -41.42 16.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.219 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.728 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -73.76 -28.9 61.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.078 179.101 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.41 -50.71 10.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.781 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 30' ' ' LEU . 11.3 m -54.25 -38.4 39.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.915 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.668 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 15.9 pt20 -53.7 -53.04 57.66 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.655 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.478 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.8 tt0 -73.28 -30.25 63.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.963 0.411 . . . . 0.0 110.937 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -77.47 -28.93 52.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.857 -178.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.71 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.8 OUTLIER -57.45 -58.02 10.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.785 -179.584 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -9.22 58.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.562 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.2 -25.99 64.44 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.856 0.36 . . . . 0.0 111.375 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.28 -17.21 0.52 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.694 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.448 ' CD ' HD21 ' A' ' 39' ' ' LEU . 24.6 pt-20 -88.11 157.59 18.81 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.054 0.454 . . . . 0.0 110.887 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.74 144.04 28.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.64 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.916 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 1.5 p90 -48.15 -34.8 10.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.951 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.7 -34.23 81.17 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.399 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.551 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -66.45 -53.75 31.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.706 0.288 . . . . 0.0 110.734 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.838 ' CD1' HD11 ' A' ' 43' ' ' LEU . 3.2 mm? -53.48 -34.76 59.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.34 -54.48 25.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.102 0.477 . . . . 0.0 110.893 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.15 -22.6 26.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.376 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.847 ' HB3' HD13 ' A' ' 43' ' ' LEU . 3.4 mm-40 -72.14 -69.28 0.41 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.039 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.847 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.52 -14.09 9.15 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.744 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.792 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -63.95 126.72 28.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.86 0.362 . . . . 0.0 111.088 -179.31 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.437 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.3 pt . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.987 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.819 0.343 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -72.7 -10.75 60.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.148 0.499 . . . . 0.0 110.179 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.412 ' O ' ' CG ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -104.13 24.73 10.98 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.255 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.412 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 1.1 p30 59.45 28.76 18.21 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.049 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.89 20.25 25.47 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.758 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.0 92.69 4.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.963 0.411 . . . . 0.0 110.328 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.814 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 11.9 mt -66.61 -13.9 61.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.778 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 45.0 -164.56 0.06 OUTLIER Glycine 0 CA--C 1.505 -0.535 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.261 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.658 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 25.8 p90 -70.87 111.37 6.23 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.221 0.534 . . . . 0.0 111.881 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.447 ' CE2' ' O ' ' A' ' 56' ' ' LEU . 13.9 m-30 -132.95 148.4 52.28 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' CA ' ' HB2' ' A' ' 9' ' ' LYS . . . -108.1 -173.9 21.92 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.667 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ARG . . . . . 0.4 ' NH1' ' HB2' ' A' ' 61' ' ' ARG . 8.4 mtm105 -84.7 122.84 29.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.46 -20.34 1.51 Allowed Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.083 -1.056 . . . . 0.0 113.119 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.9 tptm -120.58 -22.55 6.35 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 9.8 mtp -91.12 162.25 14.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 0.0 111.055 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.778 HG23 ' H ' ' A' ' 68' ' ' PHE . 21.6 m -67.13 154.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.93 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.574 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 14.3 tttt -60.2 -47.07 97.65 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.645 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 17.8 Cg_endo -65.27 -42.28 13.82 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.864 1.71 . . . . 0.0 112.131 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.778 ' H ' HG23 ' A' ' 65' ' ' VAL . 22.8 t80 -74.91 -49.72 19.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.646 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.01 -31.51 67.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.855 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 27.5 t70 -67.16 -48.62 67.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.194 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.543 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.14 -9.63 58.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.931 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.458 ' O ' HG21 ' A' ' 10' ' ' ILE . . . -63.27 -44.71 94.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.726 0.298 . . . . 0.0 111.542 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 18.4 p90 -90.6 16.88 8.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.928 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.434 ' CG ' ' HA ' ' A' ' 71' ' ' ALA . 3.2 mmm180 -99.76 -30.67 11.94 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.78 0.324 . . . . 0.0 110.881 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 79' ' ' GLU . 2.7 mt -103.6 68.34 0.93 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.598 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -77.45 -16.84 58.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.98 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.38 -26.87 34.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.807 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.442 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 97.03 60.76 0.96 Allowed Glycine 0 CA--C 1.504 -0.65 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.577 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.558 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -142.02 176.44 8.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.794 0.331 . . . . 0.0 110.999 -178.359 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.641 HG11 ' HA ' ' A' ' 27' ' ' GLN . 58.2 t -84.9 147.07 5.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.942 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.97 161.3 14.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.266 0.555 . . . . 0.0 111.479 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.402 ' O ' HG23 ' A' ' 84' ' ' VAL . 7.2 mt-10 -50.81 155.87 1.84 Allowed Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.263 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.728 ' HG3' HD23 ' A' ' 24' ' ' LEU . 20.3 Cg_endo -59.99 105.74 0.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.347 2.031 . . . . 0.0 111.699 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.645 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 77.2 t -100.97 108.25 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.516 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 90' ' ' TYR . 3.7 tmtt? -91.74 113.07 25.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.082 0.467 . . . . 0.0 111.423 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -104.22 -171.4 1.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.119 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -12.88 43.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.366 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -99.7 -31.94 11.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.603 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.417 ' CA ' HD21 ' A' ' 16' ' ' LEU . . . 156.04 -170.9 33.83 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.542 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 1.2 m-85 -79.62 98.19 6.81 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.299 0.571 . . . . 0.0 110.303 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.866 ' CE1' HD11 ' A' ' 16' ' ' LEU . 3.2 m80 -80.46 169.94 17.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.318 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.421 ' HB ' ' HB ' ' A' ' 15' ' ' ILE . 12.5 t -145.85 140.69 21.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.818 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.577 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -120.99 122.6 68.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.958 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.495 ' HG2' HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -128.54 108.69 10.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.907 178.606 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -57.68 129.68 42.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.556 0.693 . . . . 0.0 112.166 -178.658 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.916 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -161.4 116.43 2.06 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.77 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.456 -1.191 . . . . 0.0 112.64 179.746 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.573 0 CA-C-O 121.168 0.509 . . . . 0.0 110.973 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.687 HD12 ' HB1' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -111.18 136.68 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.08 178.834 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.477 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.7 mtpt -105.87 97.44 7.26 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.561 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.917 ' SG ' HG22 ' A' ' 93' ' ' ILE . 3.0 t -126.34 179.34 5.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.814 -178.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.829 ' HB2' HD23 ' A' ' 96' ' ' LEU . 6.4 t -124.06 163.31 21.71 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.641 ' HB3' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -133.16 152.41 51.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.207 0.527 . . . . 0.0 112.023 -179.605 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.802 HG23 ' OG ' ' A' ' 44' ' ' SER . 3.0 mp -151.07 115.4 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.137 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.8 HD13 ' CD2' ' A' ' 91' ' ' HIS . 7.4 tp -102.15 128.73 48.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.874 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.823 HG11 ' OE1' ' A' ' 22' ' ' GLU . 14.5 m -142.1 134.28 27.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.596 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -74.6 -35.93 62.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.463 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.638 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 10.7 tttp -72.48 79.32 1.04 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.414 ' HG2' ' CD1' ' A' ' 90' ' ' TYR . 29.5 mt-30 -46.27 -25.94 0.71 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.969 -176.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.41 -31.24 76.38 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 119.216 -1.469 . . . . 0.0 110.953 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.823 ' OE1' HG11 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -70.68 -38.54 73.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.047 0.451 . . . . 0.0 110.296 178.827 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.607 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.34 -37.77 38.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.107 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.661 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.19 -29.53 62.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.809 179.129 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.05 -49.44 8.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.18 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.735 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.6 m -49.32 -37.24 10.41 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.13 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.729 ' HA ' HG11 ' A' ' 80' ' ' VAL . 9.4 pt20 -59.28 -48.95 79.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.566 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 3.7 pt-20 -73.17 -29.03 62.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.759 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.594 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 5.9 tpt180 -78.64 -35.13 45.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.965 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 36' ' ' PHE . 1.1 tm? -53.04 -55.6 22.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.271 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -9.62 58.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.273 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.09 -22.95 61.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.871 0.367 . . . . 0.0 111.159 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.08 -17.27 1.37 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.309 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -80.67 157.59 25.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.902 0.382 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -100.06 144.84 28.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.918 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.878 ' CE1' HD22 ' A' ' 96' ' ' LEU . 6.2 p90 -53.65 -33.42 55.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.932 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.77 -33.96 87.04 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.462 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 4.0 tttt -68.35 -52.9 28.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 111.165 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.995 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.42 -33.16 52.87 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.834 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.558 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.57 -52.98 42.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.122 0.487 . . . . 0.0 110.659 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -86.3 -23.41 26.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.192 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.886 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -71.2 -68.67 0.42 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.412 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.995 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.0 -13.35 9.43 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.495 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.802 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -64.06 142.22 58.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.958 0.409 . . . . 0.0 110.833 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.742 HG13 ' HB3' ' A' ' 16' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.115 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.098 0 CA-C-O 120.979 0.419 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -6.38 51.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.463 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.32 24.78 11.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.234 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 p30 58.64 28.86 17.74 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.155 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.69 22.18 31.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.825 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.529 ' HA ' HD21 ' A' ' 96' ' ' LEU . 0.7 OUTLIER -69.88 86.94 0.52 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.874 0.369 . . . . 0.0 110.841 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.698 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 16.4 mt -56.66 -28.97 61.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.463 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 67.39 -165.12 43.97 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.739 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.527 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -67.98 120.95 15.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.203 0.525 . . . . 0.0 111.895 -179.402 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.524 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 11.7 m-30 -133.08 153.72 51.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.121 177.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -121.4 -174.0 14.72 Favored Glycine 0 C--N 1.318 -0.465 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.469 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.93 85.66 6.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.373 . . . . 0.0 110.186 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.33 36.75 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.048 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.91 -48.55 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.806 0.303 . . . . 0.0 111.243 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.66 170.18 10.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 111.134 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.772 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.5 m -57.48 167.37 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.776 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.525 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -64.93 -47.9 73.06 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.989 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.539 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 13.0 Cg_endo -66.3 -39.55 17.23 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.873 1.715 . . . . 0.0 112.064 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.772 ' H ' HG23 ' A' ' 65' ' ' VAL . 11.4 t80 -74.99 -50.79 15.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.819 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -58.92 -32.8 69.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.801 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 59.4 t0 -67.8 -46.39 72.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.002 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.0 -14.41 60.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.647 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.687 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -56.33 -46.38 79.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.741 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.458 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 12.1 p90 -92.05 16.64 10.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.528 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.49 -27.5 15.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.342 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.783 HD13 ' O ' ' A' ' 79' ' ' GLU . 4.8 mt -102.35 60.43 0.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.813 0.34 . . . . 0.0 111.449 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -68.08 -25.04 65.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.009 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -70.82 -26.84 28.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.556 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.479 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 92.65 69.33 1.13 Allowed Glycine 0 CA--C 1.501 -0.806 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.599 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.783 ' O ' HD13 ' A' ' 75' ' ' LEU . 1.4 tm-20 -142.25 177.86 7.96 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.111 -0.544 . . . . 0.0 110.08 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.729 HG11 ' HA ' ' A' ' 27' ' ' GLN . 97.8 t -79.58 151.25 4.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.778 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -104.69 157.06 17.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.334 0.588 . . . . 0.0 111.528 -178.374 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.488 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.5 mt-10 -52.36 154.67 4.13 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.237 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.424 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 14.0 Cg_endo -55.2 103.5 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.763 2.309 . . . . 0.0 111.762 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 92.9 t -101.8 99.68 8.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.564 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.449 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -92.06 112.72 24.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.063 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.428 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 74.1 m -114.48 -175.6 2.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.463 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -56.07 -21.9 24.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.751 0.31 . . . . 0.0 110.874 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -86.78 -23.67 25.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.311 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.97 -170.73 23.05 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.821 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 0.2 OUTLIER -74.66 98.66 3.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.038 0.446 . . . . 0.0 109.905 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.8 ' CD2' HD13 ' A' ' 16' ' ' LEU . 79.4 m80 -86.38 169.34 13.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.455 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.6 t -145.21 153.26 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.664 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.917 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -137.27 122.4 25.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.062 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.404 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 4.1 tptt -128.63 112.87 14.72 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.528 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -57.23 136.5 56.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.701 0.762 . . . . 0.0 112.436 -177.815 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.878 HD22 ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -159.01 116.82 2.83 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.814 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.565 179.871 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.63 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.425 0 CA-C-O 121.583 0.706 . . . . 0.0 112.332 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.408 HD13 ' HB3' ' A' ' 73' ' ' PHE . 0.6 OUTLIER -111.2 139.89 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.978 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.5 mtpt -108.88 96.91 6.65 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.446 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.929 ' SG ' HG22 ' A' ' 93' ' ' ILE . 3.0 t -125.86 179.13 5.34 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.876 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.834 ' OG ' HD23 ' A' ' 96' ' ' LEU . 0.9 OUTLIER -123.49 161.4 24.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.403 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.866 ' CG ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -136.59 153.4 50.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.534 0.683 . . . . 0.0 112.664 -179.376 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.749 HG23 ' OG ' ' A' ' 44' ' ' SER . 2.6 mp -152.14 115.14 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.85 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.603 HD11 ' NE2' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -100.4 128.41 46.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.852 -179.129 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.73 HG11 ' OE1' ' A' ' 22' ' ' GLU . 10.9 m -145.14 134.38 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.054 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -76.1 -35.81 59.18 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.603 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -72.25 79.7 0.99 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.45 ' HG3' ' CE1' ' A' ' 90' ' ' TYR . 34.6 tt0 -46.05 -25.47 0.58 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.9 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.86 -31.58 78.61 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 118.836 -1.65 . . . . 0.0 110.44 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.883 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -73.21 -37.96 66.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.079 0.466 . . . . 0.0 109.957 178.194 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.609 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -54.08 -35.9 62.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.908 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.647 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -73.76 -29.39 62.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.802 178.863 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.87 -48.33 10.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.187 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.1 m -49.74 -38.93 14.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.066 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.647 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.6 pt20 -58.83 -48.87 79.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.585 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 4.4 pt-20 -73.19 -29.36 62.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.598 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.58 -31.2 47.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.743 -178.846 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.634 HD12 ' NZ ' ' A' ' 94' ' ' LYS . 1.3 tm? -56.82 -58.95 5.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.238 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -9.51 58.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.626 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.3 -23.35 62.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 111.397 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.23 -15.91 0.88 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.719 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -89.37 157.49 18.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.751 0.31 . . . . 0.0 110.862 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 pttt -100.68 153.95 19.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.133 0.492 . . . . 0.0 111.148 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.7 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 2.5 p90 -52.63 -40.34 62.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.117 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.404 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -55.4 -34.17 59.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.704 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -67.21 -54.04 24.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.779 0.323 . . . . 0.0 110.854 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.002 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -55.92 -32.28 63.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.827 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.27 -53.78 32.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.948 0.404 . . . . 0.0 110.811 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -86.16 -23.37 26.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.164 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.872 ' HB3' HD13 ' A' ' 43' ' ' LEU . 3.0 mm-40 -70.02 -68.94 0.38 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.389 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.002 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.77 -13.55 9.09 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.703 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.749 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -64.1 133.59 53.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.912 0.387 . . . . 0.0 111.195 -179.178 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.464 HG13 ' HB3' ' A' ' 16' ' ' LEU . 1.4 pt . . . . . 0 N--CA 1.462 0.167 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.064 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.941 0.401 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -76.79 -4.34 42.98 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.361 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.23 24.59 11.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.422 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.404 ' HB2' ' CA ' ' A' ' 37' ' ' GLY . 1.6 p30 55.74 31.82 18.24 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.337 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 52.97 33.45 44.02 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.914 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 m -84.82 89.43 7.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 110.847 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.866 HD21 ' CG ' ' A' ' 14' ' ' HIS . 69.6 mt -56.35 -30.05 62.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.503 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 64.54 -165.67 32.01 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.887 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.518 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -68.82 111.01 4.63 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.515 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.63 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 4.9 m-85 -117.03 153.94 31.82 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.04 -174.14 17.51 Favored Glycine 0 C--N 1.312 -0.784 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.446 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -79.57 79.86 6.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.138 0.494 . . . . 0.0 110.033 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.94 36.62 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.66 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -126.6 -41.57 1.85 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.594 0.235 . . . . 0.0 111.181 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -114.51 171.3 7.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.049 0.452 . . . . 0.0 111.297 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.783 HG23 ' H ' ' A' ' 68' ' ' PHE . 32.7 m -52.35 161.92 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.406 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.598 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -65.59 -47.4 67.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.612 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 15.7 Cg_endo -63.27 -40.31 33.09 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.028 1.819 . . . . 0.0 111.893 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.783 ' H ' HG23 ' A' ' 65' ' ' VAL . 35.6 t80 -74.93 -52.64 10.71 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.036 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -57.55 -32.48 67.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.8 OUTLIER -63.13 -50.68 69.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.047 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.535 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.0 -9.98 59.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.65 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.04 99.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.808 0.337 . . . . 0.0 111.293 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 20.2 p90 -96.46 16.83 17.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.419 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.87 -30.76 12.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.931 0.396 . . . . 0.0 110.827 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 79' ' ' GLU . 4.2 mt -103.57 68.21 0.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.262 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -73.26 -18.26 61.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.155 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -66.55 -26.75 38.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.755 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.431 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 95.18 57.14 1.23 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.598 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.513 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -138.64 176.45 8.68 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.839 0.352 . . . . 0.0 110.801 -178.434 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 27' ' ' GLN . 42.6 t -84.43 146.08 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.502 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 t -105.37 164.07 12.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.171 0.51 . . . . 0.0 111.477 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 84' ' ' VAL . 6.6 mp0 -50.89 154.72 2.33 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.107 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.48 105.32 0.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.25 1.967 . . . . 0.0 111.797 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.612 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 59.4 t -101.19 102.14 13.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.549 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.472 ' HG2' ' CD2' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -92.11 113.14 25.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.315 -179.628 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.96 -171.46 1.89 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.205 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLU . . . . . 0.43 ' OE2' HG11 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -56.88 -19.13 15.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.532 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -92.24 -40.82 10.76 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.43 ' CA ' HD21 ' A' ' 16' ' ' LEU . . . 159.89 -172.19 36.38 Favored Glycine 0 CA--C 1.506 -0.473 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.731 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.472 ' CD2' ' HG2' ' A' ' 85' ' ' LYS . 6.2 m-85 -74.91 98.19 3.51 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.364 0.602 . . . . 0.0 110.162 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.603 ' NE2' HD11 ' A' ' 16' ' ' LEU . 79.9 m80 -82.4 169.14 16.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.465 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 17.9 t -145.49 146.51 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.295 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.929 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -131.22 122.7 51.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.675 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.634 ' NZ ' HD12 ' A' ' 30' ' ' LEU . 8.2 tptm -128.29 109.96 11.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.468 178.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.17 134.5 55.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.631 0.729 . . . . 0.0 112.298 -177.62 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.834 HD23 ' OG ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -157.51 116.67 3.28 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.67 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.42 -1.211 . . . . 0.0 112.604 179.831 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.615 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.604 0 CA-C-O 121.51 0.671 . . . . 0.0 111.728 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.428 HD13 ' HB3' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -111.39 139.48 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.821 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.9 mtpt -109.63 96.57 6.36 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.653 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.845 ' SG ' HG22 ' A' ' 93' ' ' ILE . 2.6 t -131.6 179.62 5.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.63 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.764 ' HB2' HD23 ' A' ' 96' ' ' LEU . 6.5 t -127.47 162.74 25.66 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.741 ' CD2' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -134.17 148.92 50.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.349 0.595 . . . . 0.0 112.556 -179.404 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.678 HD12 ' C ' ' A' ' 14' ' ' HIS . 3.6 mp -145.49 131.39 13.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.709 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.735 HD23 ' O ' ' A' ' 90' ' ' TYR . 2.0 mt -123.31 133.41 54.15 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.922 HG21 ' CG ' ' A' ' 22' ' ' GLU . 21.5 m -150.91 135.85 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.695 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -17.64 64.59 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HB3' ' CG ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -72.22 78.34 0.97 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.683 179.062 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.443 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -47.07 -41.71 17.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.017 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.6 -31.46 73.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.959 -1.115 . . . . 0.0 112.898 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.922 ' CG ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -65.58 -44.44 86.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.223 0.535 . . . . 0.0 110.666 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.547 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -47.67 -40.6 20.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.286 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.789 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.3 OUTLIER -72.9 -28.87 62.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.045 179.159 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.44 -44.23 17.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.254 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.7 m -58.2 -29.0 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.727 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 14.5 pt20 -54.91 -53.47 55.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.989 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.499 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.0 OUTLIER -73.83 -28.91 61.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.127 0.489 . . . . 0.0 110.634 178.551 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.9 OUTLIER -75.98 -34.29 59.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.273 -178.51 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.863 HD21 ' HA ' ' A' ' 36' ' ' PHE . 1.1 tm? -52.81 -49.68 65.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.173 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 -9.19 58.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.301 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -74.36 49.11 0.36 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.52 -10.51 36.79 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.758 -0.734 . . . . 0.0 114.171 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.426 ' OE2' HD21 ' A' ' 39' ' ' LEU . 7.0 pt-20 -92.62 153.83 18.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.378 0.589 . . . . 0.0 110.852 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 143.38 30.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.274 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.909 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 5.2 p90 -52.89 -35.79 58.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.748 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.46 -36.37 93.05 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.27 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 10.5 tttt -60.83 -53.77 53.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.843 0.354 . . . . 0.0 110.807 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.968 HD12 HD11 ' A' ' 43' ' ' LEU . 2.8 mm? -53.64 -34.12 57.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.007 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.459 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.63 -53.41 38.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.956 0.408 . . . . 0.0 110.81 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -23.55 26.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.934 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.824 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -68.96 -68.69 0.38 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.076 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.968 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.66 -16.07 8.86 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.562 ' N ' HD22 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -64.23 141.5 58.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.192 0.52 . . . . 0.0 111.522 -179.193 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.444 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.9 pt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.894 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.162 0 CA-C-O 121.245 0.545 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.6 -13.17 61.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.942 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.87 24.43 11.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.381 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 73.5 9.24 5.06 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.27 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.3 24.63 70.76 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.225 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.4 p -75.94 82.77 2.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.97 0.414 . . . . 0.0 110.615 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.741 HD21 ' CD2' ' A' ' 14' ' ' HIS . 14.6 mt -53.94 -24.5 16.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.992 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 61.04 -163.67 20.03 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.828 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.468 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -72.68 111.51 7.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.995 0.426 . . . . 0.0 111.744 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.615 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 3.8 m-85 -123.71 163.62 20.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.77 -173.99 14.96 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.628 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.55 93.89 7.94 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.897 0.38 . . . . 0.0 110.189 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.42 36.79 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.854 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.43 -44.54 0.22 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.622 0.249 . . . . 0.0 111.241 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.05 165.74 13.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 111.298 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.734 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.9 m -61.7 165.06 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.894 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.526 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -60.63 -48.06 94.34 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 13.8 Cg_endo -66.2 -37.68 23.95 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 121.897 1.731 . . . . 0.0 111.962 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.734 ' H ' HG23 ' A' ' 65' ' ' VAL . 40.0 t80 -74.96 -52.31 11.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.905 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.79 -32.27 63.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.799 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 2.6 m-20 -65.19 -52.08 57.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.995 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.437 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.09 -9.28 58.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.908 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.27 -38.31 71.85 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 2.8 p90 -106.04 16.76 24.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -98.76 -27.69 13.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.329 . . . . 0.0 110.98 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 79' ' ' GLU . 3.1 mt -103.47 66.43 0.88 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.076 0.465 . . . . 0.0 111.447 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -73.29 -18.23 61.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.005 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.96 -27.0 39.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.663 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.438 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 95.6 58.74 1.11 Allowed Glycine 0 CA--C 1.503 -0.67 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.536 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.524 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.33 176.28 8.9 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.776 0.322 . . . . 0.0 111.084 -178.477 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.657 HG11 ' HA ' ' A' ' 27' ' ' GLN . 55.6 t -82.84 146.58 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.158 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 t -104.84 164.14 12.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.346 0.593 . . . . 0.0 111.917 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -50.75 156.42 1.62 Allowed Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.634 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.789 ' HG3' HD23 ' A' ' 24' ' ' LEU . 26.9 Cg_endo -61.09 105.17 0.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.583 2.188 . . . . 0.0 112.141 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 87.7 t -101.27 99.47 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.582 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.453 ' HG3' ' CD1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -97.97 112.79 24.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.798 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.9 m -110.62 -175.75 2.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.635 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.34 -21.64 25.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.093 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -85.45 -26.73 26.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.38 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 144.18 -165.32 27.42 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.771 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.735 ' O ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -83.26 106.68 15.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.472 ' NE2' HD11 ' A' ' 16' ' ' LEU . 41.6 m80 -92.64 157.92 16.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.476 0.655 . . . . 0.0 112.597 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.1 t -140.72 153.17 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.264 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.845 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -141.26 124.16 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.878 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -128.11 113.87 16.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.282 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.5 135.4 56.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.54 0.686 . . . . 0.0 112.231 -177.617 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.909 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -157.38 116.65 3.32 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.733 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.605 -179.999 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.716 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.651 0 CA-C-O 121.429 0.633 . . . . 0.0 111.595 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -111.31 139.11 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.828 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.499 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.5 mtpt -107.93 98.3 7.9 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.366 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.786 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 2.1 t -130.32 -179.84 5.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.824 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.773 ' HB2' HD23 ' A' ' 96' ' ' LEU . 34.4 t -120.73 162.89 18.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.975 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.753 ' CG ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -130.33 139.32 50.7 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.997 0.427 . . . . 0.0 111.781 -179.694 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.707 HD12 ' C ' ' A' ' 14' ' ' HIS . 4.7 mp -153.3 118.97 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.658 HD11 ' CD2' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -109.63 140.91 42.89 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.922 0.391 . . . . 0.0 111.034 179.649 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.731 HG21 ' HG3' ' A' ' 22' ' ' GLU . 4.4 m -149.1 134.35 10.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.732 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.545 ' CD ' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -72.0 -35.86 69.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.808 -178.796 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.623 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 4.7 tttp -72.83 78.8 1.14 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.497 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 4.6 mp0 -46.64 -25.99 0.82 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.027 -0.988 . . . . 0.0 113.225 -176.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.54 -31.53 76.72 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 119.026 -1.559 . . . . 0.0 110.921 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.887 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -71.07 -38.81 72.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.059 0.457 . . . . 0.0 110.491 178.725 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.616 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -52.03 -37.15 52.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.363 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.545 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.25 -29.86 63.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.646 179.046 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.99 -41.45 18.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.496 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.887 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.1 m -52.33 -37.83 24.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.014 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.656 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -59.24 -48.84 80.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.656 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.3 pt-20 -73.27 -29.0 62.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.66 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.54 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 8.1 tpt180 -78.86 -32.28 45.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.01 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.444 ' CD2' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -53.12 -59.4 4.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.171 -179.048 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -72.46 -9.44 58.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.371 179.498 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.04 -24.96 63.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.858 0.361 . . . . 0.0 111.327 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.4 -17.01 0.77 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.579 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.52 ' CD ' HD21 ' A' ' 39' ' ' LEU . 8.1 pt-20 -86.84 154.99 20.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.901 0.382 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.92 146.2 27.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.129 0.49 . . . . 0.0 111.079 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.913 ' CE1' HD22 ' A' ' 96' ' ' LEU . 3.7 p90 -47.1 -30.76 2.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.743 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.47 -34.24 88.81 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.178 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -66.64 -53.47 33.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.766 0.317 . . . . 0.0 110.765 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.763 HD12 HD11 ' A' ' 43' ' ' LEU . 3.1 mm? -53.37 -36.07 60.99 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.273 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 44' ' ' SER . . . -52.1 -52.94 48.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.178 0.513 . . . . 0.0 110.701 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.57 -23.57 27.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.727 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.952 ' HB3' HD13 ' A' ' 43' ' ' LEU . 1.1 mt-10 -73.58 -67.86 0.55 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.952 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.99 -12.56 9.51 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.893 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.53 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 3.3 t -63.12 125.98 25.86 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.891 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.545 HD13 ' CD ' ' A' ' 18' ' ' LYS . 3.8 pt . . . . . 0 C--N 1.326 -0.423 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.504 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . . . . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 121.345 0.593 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -88.78 -5.29 58.17 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.2 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.431 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 2.5 mtt180 -119.06 24.98 10.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.84 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 76.39 16.06 2.15 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.332 -179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.18 17.01 65.39 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.577 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.714 ' HA ' HD21 ' A' ' 96' ' ' LEU . 7.0 m -70.91 86.32 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.672 0.272 . . . . 0.0 110.901 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.786 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 23.4 mt -54.77 -31.15 58.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.037 0.446 . . . . 0.0 110.577 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 69.94 -170.29 44.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.43 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.499 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -67.87 111.58 4.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 111.625 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.716 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 6.4 m-85 -123.89 159.21 30.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.666 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.72 -174.06 18.67 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.293 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -88.01 96.82 10.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.988 0.423 . . . . 0.0 110.335 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.16 36.73 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.373 -0.917 . . . . 0.0 113.067 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 tptm -143.45 -47.51 0.3 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.75 0.31 . . . . 0.0 111.259 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.416 ' HG2' ' HG3' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -91.17 166.93 12.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.878 0.371 . . . . 0.0 111.278 -179.706 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.758 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.0 m -54.63 165.75 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.174 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.533 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 20.7 tttm -64.29 -47.93 77.15 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 14.0 Cg_endo -65.46 -38.16 27.02 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 121.861 1.708 . . . . 0.0 111.939 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.758 ' H ' HG23 ' A' ' 65' ' ' VAL . 24.4 t80 -74.94 -52.69 10.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.647 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.416 ' HG3' ' HG2' ' A' ' 64' ' ' MET . 0.8 OUTLIER -57.17 -34.03 68.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.779 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 23.6 t0 -69.03 -47.95 64.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.059 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.426 ' HB3' HD11 ' A' ' 93' ' ' ILE . . . -75.33 -9.69 58.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.785 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.37 -49.03 68.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.785 0.326 . . . . 0.0 111.709 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 3.0 p90 -92.7 16.92 11.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.601 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.7 -29.37 14.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 79' ' ' GLU . 4.3 mt -103.57 66.01 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.474 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -69.9 -19.97 63.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.061 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 p -64.54 -26.88 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.57 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.425 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 94.22 58.05 1.25 Allowed Glycine 0 CA--C 1.504 -0.645 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.719 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.522 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -140.13 176.37 8.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.779 0.323 . . . . 0.0 111.077 -178.475 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.508 ' O ' HD11 ' A' ' 75' ' ' LEU . 86.2 t -81.28 146.7 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.0 t -104.68 164.1 12.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.222 0.534 . . . . 0.0 111.777 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -50.54 155.08 1.96 Allowed Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.328 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.533 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 18.5 Cg_endo -60.18 106.33 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.358 2.038 . . . . 0.0 111.741 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 97.5 t -100.95 100.22 9.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.608 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.7 OUTLIER -94.53 112.96 24.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.942 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.63 -172.11 1.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.505 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -57.54 -20.95 35.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.858 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -85.86 -37.23 19.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.245 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.81 -168.46 30.56 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.656 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.533 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -75.34 98.57 3.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.005 0.431 . . . . 0.0 109.926 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.658 ' CD2' HD11 ' A' ' 16' ' ' LEU . 70.1 m80 -80.41 165.08 22.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.397 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.7 t -149.19 138.38 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.762 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.745 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -127.99 122.7 59.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.741 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.482 ' HG2' HG22 ' A' ' 80' ' ' VAL . 1.4 tmtm? -126.18 112.27 15.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.186 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.5 132.33 52.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.559 0.695 . . . . 0.0 111.89 -177.697 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.913 HD22 ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -155.06 116.75 4.09 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.685 179.643 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.339 -1.256 . . . . 0.0 112.619 179.914 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.484 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 3.5 mptt . . . . . 0 CA--C 1.517 -0.304 0 CA-C-O 121.123 0.487 . . . . 0.0 111.707 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 mt -111.03 128.08 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.349 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.8 mtpt -97.9 92.73 5.96 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.109 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.888 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -124.06 -179.89 4.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.309 -177.552 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.791 ' HB2' HD23 ' A' ' 96' ' ' LEU . 2.0 t -123.14 160.17 27.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.954 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.734 ' CD2' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -136.29 147.23 47.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.335 0.588 . . . . 0.0 111.977 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.75 HG23 ' OG ' ' A' ' 44' ' ' SER . 3.2 mp -151.91 115.39 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.314 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.584 ' HB3' ' CG1' ' A' ' 45' ' ' ILE . 7.7 tp -100.77 132.37 46.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.785 HG11 ' OE1' ' A' ' 22' ' ' GLU . 12.3 m -146.07 134.11 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.815 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -75.01 -36.29 61.94 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.415 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.614 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -71.84 79.35 0.87 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.597 0.713 . . . . 0.0 109.078 178.885 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.513 ' HG3' ' CZ ' ' A' ' 90' ' ' TYR . 1.3 tm0? -45.71 -25.73 0.53 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.218 -177.254 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.73 -31.55 78.72 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 118.774 -1.679 . . . . 0.0 110.688 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.901 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -71.77 -39.41 69.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.152 0.501 . . . . 0.0 109.803 178.146 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.689 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -51.5 -36.91 46.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.996 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.627 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.55 -29.44 62.44 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.949 179.011 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.08 -40.46 16.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.51 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.901 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.3 m -56.92 -37.55 54.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.058 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.0 pt20 -56.84 -51.33 69.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.558 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.6 pt-20 -73.45 -29.18 62.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.618 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.534 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.5 tpt180 -75.6 -33.57 60.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.633 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.462 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -52.94 -58.91 5.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 -179.44 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -8.78 56.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.521 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -56.99 -20.09 21.95 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.39 -10.47 1.73 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.131 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.493 ' OE1' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -103.77 158.2 16.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.904 0.383 . . . . 0.0 110.677 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -97.29 154.26 17.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.37 0.605 . . . . 0.0 112.17 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.71 ' CE1' HD22 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -53.0 -35.22 59.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.388 179.316 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA2' ' CA ' ' A' ' 53' ' ' ASP . . . -53.54 -34.16 49.01 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.001 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 9.7 mtpp -69.98 -53.63 16.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.656 0.265 . . . . 0.0 110.442 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.989 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -54.0 -33.36 56.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.716 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.59 -53.36 39.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.071 0.462 . . . . 0.0 110.657 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.21 -23.33 26.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.214 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.851 ' HB3' HD13 ' A' ' 43' ' ' LEU . 1.3 mt-10 -71.15 -69.18 0.39 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.989 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.78 -11.64 9.34 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.582 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.75 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -63.9 138.53 58.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.03 0.443 . . . . 0.0 111.33 -179.035 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.584 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 43.1 pt . . . . . 0 C--N 1.333 -0.139 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.959 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.924 0.392 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -8.08 32.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.17 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -104.21 23.69 12.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.89 0.376 . . . . 0.0 110.702 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.433 ' CA ' ' HA2' ' A' ' 37' ' ' GLY . 0.0 OUTLIER 71.96 13.0 6.04 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.241 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.3 16.69 80.52 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.418 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . 0.631 ' HA ' HD21 ' A' ' 96' ' ' LEU . 1.1 m -74.06 89.77 1.97 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.783 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.888 HD12 ' SG ' ' A' ' 12' ' ' CYS . 13.2 mt -56.5 -28.35 59.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.665 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.59 -166.62 42.35 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -68.31 118.71 11.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.112 0.482 . . . . 0.0 111.923 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.484 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 10.5 m-85 -131.57 150.44 52.15 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.39 -173.88 18.27 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.577 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 -76.27 81.97 3.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 110.084 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.46 36.67 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.939 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -134.8 -48.52 0.75 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.815 0.34 . . . . 0.0 111.232 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.58 170.61 8.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.137 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.789 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.0 m -57.06 159.56 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -62.1 -47.9 89.44 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.612 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 17.5 Cg_endo -64.63 -39.2 28.27 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.932 1.754 . . . . 0.0 112.115 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.859 ' CZ ' HG23 ' A' ' 93' ' ' ILE . 17.6 t80 -74.92 -52.02 12.3 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.728 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 4.0 tm-20 -56.01 -32.29 63.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.676 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.459 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -64.26 -52.62 57.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.871 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.531 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.0 -11.96 60.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.638 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.32 -48.5 81.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.799 0.333 . . . . 0.0 111.407 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.459 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 6.7 p90 -93.23 16.83 12.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.372 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.31 -28.58 13.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.895 0.379 . . . . 0.0 110.834 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 79' ' ' GLU . 3.0 mt -103.63 62.81 0.77 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.291 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -69.61 -18.39 63.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.087 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -64.61 -26.86 41.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.53 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.27 56.88 1.24 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.669 -0.776 . . . . 0.0 111.731 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.513 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.7 tm-20 -139.36 176.29 8.84 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.89 0.376 . . . . 0.0 110.982 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 27' ' ' GLN . 61.1 t -84.29 147.55 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.069 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.97 164.12 12.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.225 0.536 . . . . 0.0 111.431 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.0 mp0 -50.48 154.43 2.22 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.986 -178.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.517 ' HG3' HD23 ' A' ' 24' ' ' LEU . 19.1 Cg_endo -60.0 104.97 0.25 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.177 1.918 . . . . 0.0 111.819 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.612 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 59.3 t -101.33 102.0 12.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.528 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 90' ' ' TYR . 3.9 tmtt? -92.38 112.87 24.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.351 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.4 -171.58 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.141 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -16.26 40.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.217 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -94.01 -40.82 9.9 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.65 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.17 -174.24 40.25 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.812 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 1.7 m-85 -76.92 98.38 4.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.233 0.54 . . . . 0.0 110.374 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.47 ' CD2' HD13 ' A' ' 16' ' ' LEU . 58.2 m80 -78.24 169.78 17.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.669 -178.237 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 29.6 t -151.33 128.57 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.363 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.859 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -111.5 123.2 67.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.25 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.459 ' HE3' HD12 ' A' ' 30' ' ' LEU . 28.1 tptp -128.28 115.17 17.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.454 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.463 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -58.33 134.87 56.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.45 0.643 . . . . 0.0 112.134 -178.544 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.791 HD23 ' HB2' ' A' ' 13' ' ' SER . 0.3 OUTLIER -160.72 116.6 2.27 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.217 179.605 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.414 -1.214 . . . . 0.0 112.532 179.642 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.518 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 121.029 0.442 . . . . 0.0 111.128 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.656 HD13 ' HB3' ' A' ' 73' ' ' PHE . 0.4 OUTLIER -111.03 135.88 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.848 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.5 mtpt -106.83 95.11 5.5 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.653 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.929 ' SG ' HG22 ' A' ' 93' ' ' ILE . 2.4 t -124.06 179.58 4.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.894 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.507 ' HB3' HD23 ' A' ' 96' ' ' LEU . 1.8 p -123.37 162.25 23.12 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.665 ' HB3' HD11 ' A' ' 56' ' ' LEU . 20.4 p-80 -133.97 153.75 51.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.399 0.619 . . . . 0.0 112.327 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.767 HG23 ' OG ' ' A' ' 44' ' ' SER . 2.9 mp -156.75 122.73 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.777 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.704 HD13 ' ND1' ' A' ' 91' ' ' HIS . 10.3 tp -110.32 132.15 54.43 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.832 HG11 ' OE1' ' A' ' 22' ' ' GLU . 15.5 m -142.88 134.45 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.391 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.53 -35.78 63.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.5 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.615 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -73.12 79.3 1.24 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.83 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.484 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 2.0 pt20 -46.28 -25.58 0.65 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.328 -0.851 . . . . 0.0 113.154 -176.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.02 -31.4 77.84 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.119 -1.515 . . . . 0.0 110.67 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.832 ' OE1' HG11 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -71.26 -37.85 71.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.084 0.469 . . . . 0.0 109.928 178.39 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.608 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.87 -38.01 46.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.15 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.619 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -73.07 -29.58 63.05 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.823 179.278 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.95 -53.33 5.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.795 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.8 m -47.03 -37.34 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.322 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.628 ' HA ' HG11 ' A' ' 80' ' ' VAL . 2.5 pt20 -59.92 -48.21 82.64 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.571 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 3.4 pt-20 -73.06 -29.01 62.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.648 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.615 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 10.0 tpt180 -78.62 -35.37 45.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.771 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.583 HD21 ' HA ' ' A' ' 36' ' ' PHE . 1.1 tm? -52.74 -58.81 5.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.29 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.97 -9.6 58.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.254 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.25 -24.57 63.31 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.864 0.364 . . . . 0.0 111.114 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.36 -17.21 1.15 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.436 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -78.92 157.7 28.18 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.985 0.422 . . . . 0.0 110.949 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -98.08 140.1 32.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.027 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.76 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 3.4 p90 -51.39 -32.13 25.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.848 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.412 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -62.79 -34.25 89.23 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.213 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.2 mmtt -65.96 -53.57 37.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.661 0.267 . . . . 0.0 110.783 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.998 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.85 -32.33 52.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.517 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.36 -53.78 32.88 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.549 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.18 -23.47 26.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.224 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.89 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.78 -68.8 0.41 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -177.43 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.998 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.63 -12.25 9.31 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.767 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -64.05 140.32 58.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.931 0.396 . . . . 0.0 111.289 -179.241 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.571 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 31.7 pt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.686 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 121.28 0.562 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.36 -8.79 57.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.373 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.418 ' O ' ' CG ' ' A' ' 53' ' ' ASP . 0.5 OUTLIER -103.67 24.67 10.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.423 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.418 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 2.1 p30 54.08 34.8 20.73 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.97 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.45 ' HA2' ' CE1' ' A' ' 14' ' ' HIS . . . 56.76 21.47 36.59 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.417 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.7 p -70.38 86.81 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.85 0.357 . . . . 0.0 111.257 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.709 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 46.6 mt -59.69 -33.4 71.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.102 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.94 -167.13 48.98 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.947 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.468 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -69.19 119.15 13.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.045 0.45 . . . . 0.0 111.851 -179.387 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.518 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 9.3 p90 -135.46 135.48 40.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.48 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.42 -174.01 49.89 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.601 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 ptt-85 -89.73 89.4 7.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.948 0.404 . . . . 0.0 110.505 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.1 36.45 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.057 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -146.52 7.01 0.97 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.449 ' CE ' ' CD1' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -141.33 174.24 10.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.75 0.31 . . . . 0.0 110.844 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.77 HG23 ' H ' ' A' ' 68' ' ' PHE . 23.9 m -68.35 154.48 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.804 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.584 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -59.65 -46.94 98.59 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 17.5 Cg_endo -64.45 -41.22 21.07 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.937 1.758 . . . . 0.0 112.155 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.77 ' H ' HG23 ' A' ' 65' ' ' VAL . 26.2 t80 -74.98 -51.4 13.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.77 -32.31 65.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.797 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.438 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 11.6 t70 -63.82 -51.21 65.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.109 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.804 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -74.9 -10.02 59.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.756 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.517 ' HB1' ' HE1' ' A' ' 59' ' ' PHE . . . -65.46 -50.01 66.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.727 0.299 . . . . 0.0 111.497 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.656 ' HB3' HD13 ' A' ' 10' ' ' ILE . 6.2 p90 -93.33 16.51 13.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.464 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.526 ' C ' HD23 ' A' ' 75' ' ' LEU . 4.4 ttm-85 -96.57 -31.9 12.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.658 0.266 . . . . 0.0 111.226 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.704 HD12 ' O ' ' A' ' 79' ' ' GLU . 0.7 OUTLIER -103.37 55.88 0.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.385 -179.792 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -58.83 -22.21 58.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.089 0.471 . . . . 0.0 110.029 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.07 -28.43 39.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.435 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.489 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 97.05 59.09 1.0 Allowed Glycine 0 CA--C 1.508 -0.397 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.303 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.704 ' O ' HD12 ' A' ' 75' ' ' LEU . 5.6 pt-20 -130.22 177.38 7.36 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.628 HG11 ' HA ' ' A' ' 27' ' ' GLN . 21.7 t -88.65 148.41 4.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.695 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.646 ' OG ' HD21 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -104.42 164.03 12.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.136 0.493 . . . . 0.0 111.282 -178.883 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 84' ' ' VAL . 3.1 mp0 -50.43 154.76 2.04 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.866 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.568 ' HG3' HD23 ' A' ' 24' ' ' LEU . 14.1 Cg_endo -55.58 104.53 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.367 2.045 . . . . 0.0 111.721 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.555 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 94.3 t -101.64 101.54 12.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.684 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.456 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 19.2 tptp -95.54 112.49 24.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.573 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.9 m -112.5 -176.97 3.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.468 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.81 -22.33 14.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.939 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.94 -27.57 24.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.331 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.5 -170.71 24.06 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.823 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.484 ' CD1' ' HB3' ' A' ' 20' ' ' GLN . 0.5 OUTLIER -74.56 100.78 4.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.045 0.45 . . . . 0.0 109.927 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.704 ' ND1' HD13 ' A' ' 16' ' ' LEU . 30.7 m-70 -87.35 169.31 12.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.586 0.707 . . . . 0.0 112.742 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.1 t -146.76 136.29 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.119 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.929 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -126.58 122.5 61.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.352 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.571 ' HE3' HD12 ' A' ' 30' ' ' LEU . 22.0 tptp -128.54 110.33 12.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.456 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.588 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.62 134.36 56.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.596 0.713 . . . . 0.0 112.195 -177.89 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.76 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -153.8 116.4 4.42 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.593 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.428 ' HA3' ' HD3' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.424 -1.209 . . . . 0.0 112.541 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.681 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.65 0 CA-C-O 121.442 0.639 . . . . 0.0 111.933 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.605 HG22 ' SG ' ' A' ' 12' ' ' CYS . 1.5 mt -111.0 136.93 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.944 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.4 mtpt -108.11 86.71 2.34 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.577 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.818 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 7.1 m -130.58 179.98 5.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.636 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.449 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 2.9 p -135.33 161.76 34.49 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.789 ' O ' HD12 ' A' ' 15' ' ' ILE . 0.7 OUTLIER -141.24 155.49 46.01 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.196 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.789 HD12 ' O ' ' A' ' 14' ' ' HIS . 1.7 mp -134.95 141.81 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.863 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.74 HD11 ' CE1' ' A' ' 91' ' ' HIS . 1.0 OUTLIER -121.48 128.84 52.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.77 0.319 . . . . 0.0 111.723 -179.499 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.839 HG21 ' CG ' ' A' ' 22' ' ' GLU . 24.7 m -144.12 134.21 20.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.465 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' CD ' HD13 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -70.12 -36.27 74.7 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.732 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.612 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.09 78.55 0.94 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.486 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.474 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -46.67 -25.98 0.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.714 -1.13 . . . . 0.0 113.191 -177.584 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.39 -31.31 76.61 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.086 -1.531 . . . . 0.0 111.091 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.89 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -70.25 -39.91 74.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.142 0.496 . . . . 0.0 110.03 178.568 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.679 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -51.15 -37.16 44.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.227 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.627 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.41 -29.46 62.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.922 179.17 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.66 -42.53 14.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.484 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.89 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.7 m -53.4 -39.17 34.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.881 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.5 pt20 -56.33 -50.19 72.17 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.596 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 4.6 pt-20 -73.36 -30.98 63.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.803 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 3.9 tpm_? -77.18 -27.52 53.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.011 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.676 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.8 OUTLIER -60.78 -52.76 63.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.419 -179.101 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.405 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -68.57 -9.4 49.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.525 -179.897 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -56.28 -22.05 27.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.761 0.315 . . . . 0.0 111.387 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.37 -10.73 3.8 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.387 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -77.81 157.46 29.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.823 0.344 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.411 ' HB3' ' HG2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -89.12 136.01 33.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.789 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.676 ' HA ' HD21 ' A' ' 30' ' ' LEU . 4.8 t80 -53.94 -48.15 70.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.236 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.26 -33.9 53.03 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.293 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.0 mmmt -60.33 -52.26 66.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.707 0.289 . . . . 0.0 110.873 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.965 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.34 -33.54 53.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.561 ' HB1' ' O ' ' A' ' 50' ' ' ALA . . . -51.45 -53.81 33.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.074 0.464 . . . . 0.0 110.582 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -85.94 -23.66 26.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.059 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.848 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -69.12 -68.35 0.41 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.941 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.965 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.21 -15.43 9.18 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.72 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.532 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -64.28 134.5 54.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.115 0.483 . . . . 0.0 111.14 -179.588 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.538 HD13 ' CD ' ' A' ' 18' ' ' LYS . 1.3 pt . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.172 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.561 ' O ' ' HB1' ' A' ' 40' ' ' ALA . . . . . . . . 0 CA--C 1.521 -0.171 0 CA-C-O 120.915 0.388 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -6.1 51.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.522 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.419 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -104.15 24.09 12.01 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.406 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 72.04 12.87 5.96 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.354 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 59.59 21.6 54.99 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.535 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m -74.7 84.7 2.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.972 0.415 . . . . 0.0 110.548 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.818 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 20.4 mt -59.43 -20.24 53.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.883 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 49.06 -170.94 0.08 OUTLIER Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.57 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.506 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -56.17 111.4 0.95 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.038 0.447 . . . . 0.0 111.678 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.681 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 2.3 m-85 -128.48 164.37 22.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.265 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.08 -174.09 13.65 Favored Glycine 0 C--N 1.317 -0.528 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.159 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -86.48 116.38 24.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.922 0.392 . . . . 0.0 110.023 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.28 -12.05 1.38 Allowed Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.082 -1.056 . . . . 0.0 113.357 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.43 30.78 4.42 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.031 0.415 . . . . 0.0 111.754 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.425 ' HG3' ' CG ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -151.36 149.37 29.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.804 0.335 . . . . 0.0 111.191 179.433 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.753 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.4 m -52.6 156.26 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.197 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.565 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.15 -47.8 98.2 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.022 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 18.8 Cg_endo -65.43 -38.8 24.43 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.061 1.841 . . . . 0.0 112.367 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.753 ' H ' HG23 ' A' ' 65' ' ' VAL . 18.1 t80 -74.92 -49.8 19.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.475 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.425 ' CG ' ' HG3' ' A' ' 64' ' ' MET . 0.2 OUTLIER -54.5 -35.8 63.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.21 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 6.8 t70 -68.67 -49.94 55.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.798 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.94 -10.68 59.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.659 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.453 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -65.1 -45.48 85.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.722 0.296 . . . . 0.0 111.618 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 1.4 p90 -99.33 16.94 21.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.712 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -95.07 -28.66 14.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.75 0.31 . . . . 0.0 110.918 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 79' ' ' GLU . 2.7 mt -103.7 65.37 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.026 0.441 . . . . 0.0 111.678 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -74.32 -17.65 60.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.938 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -67.66 -26.82 36.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.842 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 96.06 59.14 1.06 Allowed Glycine 0 CA--C 1.503 -0.672 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.393 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.551 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -140.5 176.24 8.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.931 0.395 . . . . 0.0 111.007 -178.253 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.601 HG11 ' HA ' ' A' ' 27' ' ' GLN . 38.4 t -83.75 147.76 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.962 178.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.66 159.09 16.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.224 0.535 . . . . 0.0 111.197 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -50.61 159.49 0.89 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.077 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.561 ' HG3' HD23 ' A' ' 24' ' ' LEU . 18.9 Cg_endo -59.02 104.08 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.474 2.116 . . . . 0.0 111.913 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.55 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 95.7 t -101.54 102.52 13.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.682 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.478 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 5.5 tptp -91.86 112.95 25.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.859 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.25 -173.12 2.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.418 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.18 -16.2 51.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.064 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -93.56 -38.76 11.21 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.534 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.97 -168.74 35.75 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.898 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -77.0 99.53 5.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.74 ' CE1' HD11 ' A' ' 16' ' ' LEU . 17.1 m80 -88.42 165.27 15.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.45 0.643 . . . . 0.0 112.734 -178.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.484 ' CG1' HG13 ' A' ' 80' ' ' VAL . 40.5 t -143.79 152.39 16.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.117 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.605 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -139.59 122.05 17.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -179.045 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.521 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -129.37 108.69 10.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.955 178.051 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.578 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 6.9 ttt85 -58.11 135.68 57.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.642 0.734 . . . . 0.0 112.275 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.4 OUTLIER -154.3 116.48 4.28 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.24 179.415 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.378 -1.234 . . . . 0.0 112.586 179.912 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.617 0 CA-C-O 121.204 0.526 . . . . 0.0 111.128 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.41 138.35 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.654 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.029 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.461 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.6 mtpt -108.72 96.16 6.15 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.067 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' CYS . . . . . 0.914 ' SG ' HG22 ' A' ' 93' ' ' ILE . 2.4 t -127.7 179.39 5.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.273 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.789 ' HB2' HD23 ' A' ' 96' ' ' LEU . 2.7 t -126.37 159.79 32.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' HIS . . . . . 0.787 ' CG ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -136.66 150.88 48.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.405 0.621 . . . . 0.0 112.553 -179.405 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.597 HD12 ' C ' ' A' ' 14' ' ' HIS . 3.5 mp -153.27 115.34 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.009 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.907 HD21 ' CD2' ' A' ' 91' ' ' HIS . 0.9 OUTLIER -100.1 139.09 36.27 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.711 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.983 HG21 ' CG ' ' A' ' 22' ' ' GLU . 30.0 m -155.22 134.19 3.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.793 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -19.31 65.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.571 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -72.38 78.36 1.02 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.149 179.093 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 5.8 pt20 -47.34 -40.0 16.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.32 -31.14 66.27 Favored Glycine 0 CA--C 1.511 -0.19 0 C-N-CA 119.925 -1.131 . . . . 0.0 112.697 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.983 ' CG ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -65.6 -39.79 91.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.339 0.59 . . . . 0.0 110.253 179.525 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.761 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . -43.8 -42.16 5.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.387 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.57 ' HA ' ' HG3' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -72.66 -45.47 58.77 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.266 178.215 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.0 -57.31 9.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.694 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 23' ' ' ALA . 4.8 m -55.07 -30.42 23.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.684 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLN . . . . . 0.776 ' HG2' HG11 ' A' ' 80' ' ' VAL . 52.9 mt-30 -53.04 -60.06 3.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.28 0.562 . . . . 0.0 109.939 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -26.03 61.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.82 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.514 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 14.2 tpp85 -78.51 -30.31 47.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.094 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.705 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -56.7 -59.04 5.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 0.0 110.932 -179.234 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -9.3 58.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.322 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.05 -25.81 64.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.996 0.427 . . . . 0.0 111.35 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.99 -17.15 0.92 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.491 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.481 ' HG3' HD21 ' A' ' 39' ' ' LEU . 21.9 pt-20 -79.76 157.81 27.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.993 0.425 . . . . 0.0 110.816 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -96.23 137.07 35.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.079 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.705 ' HA ' HD21 ' A' ' 30' ' ' LEU . 2.4 p90 -47.61 -33.53 6.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.628 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . 0.513 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -65.28 -34.93 90.83 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.137 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -60.16 -53.81 53.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.598 0.237 . . . . 0.0 110.592 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 1.004 HD12 HD11 ' A' ' 43' ' ' LEU . 2.6 mm? -55.68 -34.36 64.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.803 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.3 -53.77 32.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.029 0.442 . . . . 0.0 110.503 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -85.97 -23.63 26.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.18 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.846 ' HB3' HD13 ' A' ' 43' ' ' LEU . 1.0 OUTLIER -70.14 -68.7 0.4 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -177.721 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 1.004 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.54 -11.36 9.47 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.531 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.575 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -63.58 134.46 55.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.273 0.559 . . . . 0.0 111.333 -179.165 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 16' ' ' LEU . 25.1 pt . . . . . 0 N--CA 1.452 -0.345 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.358 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.132 0 CA-C-O 120.797 0.332 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -68.36 -2.95 9.51 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.972 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.466 ' O ' ' CG ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -103.65 24.78 10.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.697 0.284 . . . . 0.0 110.539 179.767 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.513 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 1.5 p30 59.58 29.62 19.19 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.189 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 53.78 23.35 21.67 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.841 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.92 89.96 4.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.809 0.338 . . . . 0.0 110.825 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.787 HD21 ' CG ' ' A' ' 14' ' ' HIS . 87.0 mt -58.37 -28.83 65.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.58 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.42 -166.26 15.74 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.991 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . 0.538 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -65.14 117.59 7.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.117 0.484 . . . . 0.0 111.749 -179.474 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.514 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 5.3 m-85 -128.44 158.63 37.79 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.52 -173.95 13.59 Favored Glycine 0 C--N 1.317 -0.49 0 C-N-CA 120.199 -1.0 . . . . 0.0 112.497 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.09 84.57 2.32 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.044 0.45 . . . . 0.0 110.126 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.42 36.85 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.063 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.05 -48.67 0.61 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.637 0.256 . . . . 0.0 111.292 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.55 169.84 9.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.937 0.399 . . . . 0.0 111.306 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' VAL . . . . . 0.772 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.9 m -59.43 165.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.965 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LYS . . . . . 0.555 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 7.5 ttpt -62.73 -48.01 86.58 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 15.2 Cg_endo -65.36 -39.34 22.75 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.863 1.709 . . . . 0.0 111.897 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.772 ' H ' HG23 ' A' ' 65' ' ' VAL . 24.5 t80 -75.0 -52.49 10.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.98 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -57.52 -32.66 67.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 1.9 m-20 -63.7 -50.56 68.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.049 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.51 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.3 -9.49 58.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.798 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.42 -47.52 75.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 111.602 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PHE . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 11.4 p90 -93.89 16.78 13.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.535 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -97.98 -30.39 12.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.93 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.53 HD11 ' O ' ' A' ' 80' ' ' VAL . 3.9 mt -103.49 68.08 0.93 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.471 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -72.8 -19.28 61.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.096 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -65.86 -26.67 39.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.725 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLY . . . . . 0.445 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 94.66 59.44 1.14 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.57 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.511 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.7 tm-20 -141.03 176.34 8.9 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.826 0.346 . . . . 0.0 111.104 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.776 HG11 ' HG2' ' A' ' 27' ' ' GLN . 26.9 t -81.01 146.6 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.84 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.2 t -104.66 164.11 12.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.258 0.551 . . . . 0.0 111.583 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.4 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.0 mp0 -50.51 152.1 3.52 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.463 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 19.5 Cg_endo -58.46 106.09 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.466 2.111 . . . . 0.0 111.65 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.549 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 93.0 t -100.96 101.14 11.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.593 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 4.8 tptm -91.63 112.8 24.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.757 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.1 m -114.73 -171.95 2.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.578 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.35 -18.62 51.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.184 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -90.91 -24.48 20.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.467 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 141.48 -161.66 26.96 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.784 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.541 ' O ' HD13 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -83.02 98.14 9.11 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' HIS . . . . . 0.907 ' CD2' HD21 ' A' ' 16' ' ' LEU . 9.8 m80 -81.49 154.35 26.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.481 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 37.2 t -139.71 135.84 39.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.296 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ILE . . . . . 0.914 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -123.84 122.52 64.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.423 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.523 ' HG2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -128.2 112.69 14.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.197 178.36 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.552 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -57.34 136.45 56.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.705 0.764 . . . . 0.0 112.517 -177.436 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.789 HD23 ' HB2' ' A' ' 13' ' ' SER . 0.3 OUTLIER -157.69 116.73 3.23 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.616 179.595 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.352 -1.249 . . . . 0.0 112.554 179.93 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.86 162.59 41.56 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.585 2.19 . . . . 0.0 112.268 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.38 134.03 52.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.82 46.07 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.513 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.63 164.84 22.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.328 . . . . 0.0 110.979 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.58 112.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.959 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.11 39.87 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.976 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -51.06 -36.91 42.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.812 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.554 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.64 171.63 12.25 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.764 0.793 . . . . 0.0 112.142 -179.61 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.666 HD13 ' HB3' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -114.84 138.36 45.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.569 178.178 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.466 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.9 mtpt -108.87 97.82 7.4 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.494 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.949 ' SG ' HG22 ' A' ' 93' ' ' ILE . 1.9 t -135.34 179.88 6.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.555 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.491 ' HB3' HD23 ' A' ' 96' ' ' LEU . 2.4 p -134.75 162.44 32.34 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.588 ' C ' HD12 ' A' ' 15' ' ' ILE . 12.3 p-80 -136.55 148.57 47.65 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.81 HD13 ' CE2' ' A' ' 36' ' ' PHE . 1.6 mp -130.74 154.14 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.675 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 88' ' ' PHE . 2.5 mt -137.32 135.4 37.04 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.942 HG21 ' HG3' ' A' ' 22' ' ' GLU . 23.3 m -149.2 134.27 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.589 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -35.92 74.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.979 0.419 . . . . 0.0 110.323 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.624 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 37.2 pttt -72.13 79.66 0.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.495 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 12.1 pt20 -45.62 -26.28 0.59 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.867 -1.061 . . . . 0.0 112.441 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.17 -31.75 75.25 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.975 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.942 ' HG3' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -69.36 -42.84 74.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.013 0.435 . . . . 0.0 110.238 179.178 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.513 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -47.64 -38.3 14.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.279 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.649 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -73.41 -31.93 64.14 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.667 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.76 -52.93 8.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.068 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.499 HG23 ' N ' ' A' ' 27' ' ' GLN . 19.9 m -50.12 -46.69 24.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.68 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.632 ' CB ' HG11 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -54.07 -36.36 63.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.549 . . . . 0.0 109.955 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.539 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -72.84 -47.15 48.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.43 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.9 -23.18 44.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.146 -178.639 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.743 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -52.87 -47.63 67.69 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.768 0.318 . . . . 0.0 111.293 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -72.01 -9.42 58.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.386 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -57.27 -23.24 46.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 111.333 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.45 -12.47 3.24 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.399 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -75.08 153.8 38.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.797 0.332 . . . . 0.0 110.605 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -87.57 131.2 34.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.979 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.81 ' CE2' HD13 ' A' ' 15' ' ' ILE . 5.0 t80 -48.8 -49.52 38.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.013 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.61 ' O ' ' HB3' ' A' ' 40' ' ' ALA . . . -54.65 -34.22 55.78 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.051 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -57.38 -53.59 56.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.943 0.402 . . . . 0.0 110.358 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.009 HD12 HD11 ' A' ' 43' ' ' LEU . 3.0 mm? -53.59 -29.93 39.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.393 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 37' ' ' GLY . . . -51.48 -53.7 34.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.697 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.76 -23.74 27.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.81 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.9 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.17 -68.38 0.42 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.818 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.009 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.29 -12.21 9.44 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.605 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -63.84 128.81 37.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.91 0.386 . . . . 0.0 111.216 -179.502 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.505 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -92.87 -5.83 10.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.15 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.577 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 34.3 t0 -46.34 135.48 8.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.083 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.662 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.11 -178.76 3.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.357 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 51' ' ' LYS . . . -11.73 -44.49 0.0 OUTLIER Glycine 0 N--CA 1.467 0.73 0 N-CA-C 115.464 0.946 . . . . 0.0 115.464 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.662 ' N ' ' O ' ' A' ' 47' ' ' GLY . 1.4 p -51.38 -26.32 7.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.603 0.702 . . . . 0.0 111.476 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.577 ' HB2' ' HB3' ' A' ' 46' ' ' ASP . . . -71.62 -22.39 61.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.88 0.372 . . . . 0.0 111.308 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 8.3 mtpt -68.12 -14.2 62.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.23 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 49' ' ' SER . 6.2 ptp180 -104.81 24.71 11.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.728 0.299 . . . . 0.0 110.405 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.414 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 0.5 OUTLIER 60.53 24.28 13.95 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.143 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 59.53 19.89 49.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.69 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 m -63.6 83.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.925 0.393 . . . . 0.0 110.677 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.743 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 16.5 mt -63.78 -24.06 67.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.882 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.04 -160.88 8.47 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.817 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.519 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -67.28 111.54 4.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.868 0.366 . . . . 0.0 111.783 -179.244 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.676 ' HE2' HD22 ' A' ' 56' ' ' LEU . 8.1 m-30 -119.05 156.64 29.32 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.27 -173.96 15.64 Favored Glycine 0 C--N 1.317 -0.501 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.431 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -75.53 80.0 2.55 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.99 0.424 . . . . 0.0 110.182 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.15 36.94 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.956 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.97 -43.11 1.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.623 0.249 . . . . 0.0 111.396 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.54 167.47 9.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 0.0 111.26 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.705 HG23 ' H ' ' A' ' 68' ' ' PHE . 29.1 m -56.93 160.29 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.626 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.547 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -56.5 -48.19 97.55 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.733 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.589 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 20.7 Cg_endo -66.89 -36.26 23.85 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.062 1.842 . . . . 0.0 112.205 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.705 ' H ' HG23 ' A' ' 65' ' ' VAL . 15.5 t80 -74.88 -51.0 15.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.588 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.8 -32.39 60.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.839 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 1.6 m-20 -65.75 -53.15 44.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.886 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.474 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.11 -9.15 58.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.87 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.02 -36.81 78.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.613 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.666 ' HB3' HD13 ' A' ' 10' ' ' ILE . 3.0 p90 -107.06 16.79 23.8 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.81 -28.18 13.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.76 0.314 . . . . 0.0 110.879 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 79' ' ' GLU . 3.2 mt -103.47 63.57 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.213 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -70.83 -18.27 62.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.05 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.45 -26.92 40.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.559 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.05 57.59 1.21 Allowed Glycine 0 CA--C 1.502 -0.733 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.74 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.491 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -138.54 175.92 9.14 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.746 0.308 . . . . 0.0 111.114 -178.63 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.632 HG11 ' CB ' ' A' ' 27' ' ' GLN . 41.6 t -81.33 145.9 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.918 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.16 164.11 12.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.162 0.505 . . . . 0.0 111.54 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.419 ' O ' HG23 ' A' ' 84' ' ' VAL . 3.5 mp0 -50.73 153.73 2.72 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.967 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.649 ' HG3' HD23 ' A' ' 24' ' ' LEU . 18.1 Cg_endo -59.27 105.5 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.361 2.041 . . . . 0.0 111.799 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.589 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 97.5 t -101.33 119.21 49.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.783 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.443 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -103.35 112.69 25.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.006 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.51 -171.7 1.9 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.276 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -60.33 -18.04 47.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.025 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.499 ' HB3' HD11 ' A' ' 16' ' ' LEU . 6.3 m-85 -89.69 -40.79 12.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.424 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.66 -158.81 29.05 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.801 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -82.11 98.14 8.53 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.457 ' CD2' ' HG ' ' A' ' 16' ' ' LEU . 34.6 m80 -84.22 170.1 14.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.044 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.439 ' CG1' HG13 ' A' ' 80' ' ' VAL . 9.5 t -146.22 153.04 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.692 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.949 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -143.11 122.36 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.578 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.665 ' HE3' HD12 ' A' ' 30' ' ' LEU . 13.8 tptp -128.88 116.88 20.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.127 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.444 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -57.33 133.99 55.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.533 0.682 . . . . 0.0 112.231 -177.686 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.555 ' C ' HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -154.55 116.54 4.21 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.744 -1.117 . . . . 0.0 109.573 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.451 -1.194 . . . . 0.0 112.636 179.892 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.13 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.11 171.71 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.555 2.17 . . . . 0.0 112.34 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.2 134.25 54.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.888 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.8 56.51 1.51 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.511 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.1 m -88.38 150.0 23.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 0.0 110.858 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.3 ttt -113.24 121.98 46.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.879 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.73 35.15 3.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.129 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.03 -29.47 43.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.725 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.702 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.95 176.22 8.59 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.634 0.731 . . . . 0.0 112.112 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.522 HD12 ' HB1' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -120.23 139.51 47.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.499 178.417 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.453 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.2 mtpt -110.88 99.27 8.2 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.434 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.736 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 2.2 t -129.98 -179.76 5.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.7 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.545 ' HB2' HD23 ' A' ' 96' ' ' LEU . 2.8 t -118.79 163.58 16.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.746 ' HB3' HD21 ' A' ' 56' ' ' LEU . 12.0 t-80 -138.39 141.02 39.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.136 0.493 . . . . 0.0 111.821 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.74 HD12 ' C ' ' A' ' 14' ' ' HIS . 4.5 mp -151.47 119.67 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.491 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.579 HD13 ' HB3' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -109.14 137.42 47.07 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.763 0.315 . . . . 0.0 111.596 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.749 HG21 ' CG ' ' A' ' 22' ' ' GLU . 17.1 m -147.95 134.39 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.481 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.407 ' HD2' HD13 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -68.27 -36.62 79.68 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.813 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.592 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.18 78.35 0.97 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.644 0.735 . . . . 0.0 109.04 178.59 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 14.2 pt20 -46.59 -25.81 0.77 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.288 -177.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.1 -31.29 77.33 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.178 -1.486 . . . . 0.0 111.069 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.9 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -70.45 -38.56 74.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.382 0.611 . . . . 0.0 109.828 178.371 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.647 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -51.5 -37.67 50.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.533 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.611 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.3 OUTLIER -73.13 -30.45 63.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.794 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.77 -41.04 19.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.41 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.9 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.8 m -51.11 -35.14 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.288 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.678 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -60.38 -48.41 81.87 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.538 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.678 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.57 -28.06 61.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.308 0.575 . . . . 0.0 110.642 178.436 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 3.1 tpp180 -78.85 -35.97 43.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.891 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.481 HD13 ' C ' ' A' ' 30' ' ' LEU . 1.2 tm? -52.74 -59.01 5.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.278 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -9.39 54.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.488 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -74.61 50.14 0.42 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.6 -10.54 44.35 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.659 -0.781 . . . . 0.0 114.143 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.04 157.64 15.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.506 0.653 . . . . 0.0 111.061 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -110.28 144.49 38.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.205 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.95 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 1.9 p90 -49.05 -28.49 4.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.726 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -59.9 -34.07 81.37 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.574 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -74.4 -49.96 20.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.593 0.235 . . . . 0.0 110.827 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.79 HD12 HD11 ' A' ' 43' ' ' LEU . 3.0 mm? -53.28 -36.14 60.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.286 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.686 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -52.1 -52.77 49.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.127 0.489 . . . . 0.0 110.744 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -85.64 -23.7 27.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.809 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.965 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -72.52 -67.51 0.55 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.227 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.965 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.6 -14.96 9.59 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -178.946 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.542 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 1.8 t -63.74 126.25 26.99 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.365 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -107.74 -28.06 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.579 ' HB3' HD13 ' A' ' 16' ' ' LEU . 15.0 t70 -128.69 106.66 9.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.77 143.85 4.98 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.903 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.28 -33.55 28.46 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 54' ' ' GLY . 1.8 p -79.57 3.75 17.94 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.333 -0.433 . . . . 0.0 110.952 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.686 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . . . -68.0 -23.97 65.07 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -86.64 -18.82 30.4 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.789 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.503 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 15.4 mtt180 -104.23 25.0 10.61 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.964 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.526 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER 67.61 40.52 2.51 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.429 0.633 . . . . 0.0 111.629 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 53.63 30.33 42.61 Favored Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.79 -0.641 . . . . 0.0 113.018 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.572 ' HA ' HD21 ' A' ' 96' ' ' LEU . 85.9 p -92.37 86.35 5.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.739 0.304 . . . . 0.0 110.993 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.746 HD21 ' HB3' ' A' ' 14' ' ' HIS . 69.9 mt -54.03 -40.0 66.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.051 0.453 . . . . 0.0 110.21 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 78.07 -168.25 53.94 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.538 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.462 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -69.75 111.39 5.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.044 0.449 . . . . 0.0 111.717 -179.429 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.702 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 13.0 m-85 -125.83 152.82 44.97 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -100.71 -174.03 29.43 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.238 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.95 99.93 12.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.951 0.405 . . . . 0.0 110.316 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.97 -7.91 1.24 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.426 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -92.29 -40.82 10.73 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.924 0.362 . . . . 0.0 111.522 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.2 166.59 12.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.913 0.387 . . . . 0.0 111.447 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.761 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.2 m -58.0 163.85 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.815 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.51 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 16.8 tttp -58.93 -48.33 96.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.543 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 17.7 Cg_endo -67.11 -37.34 19.0 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 121.856 1.704 . . . . 0.0 112.192 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.761 ' H ' HG23 ' A' ' 65' ' ' VAL . 40.9 t80 -74.41 -50.78 17.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.623 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -56.75 -32.35 65.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.703 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.2 OUTLIER -67.42 -49.43 63.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.072 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.404 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -74.99 -9.56 58.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.753 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.522 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -68.82 -51.26 42.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.912 0.387 . . . . 0.0 111.447 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.458 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 3.5 p90 -94.24 16.71 14.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.452 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -97.39 -29.38 13.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 110.804 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.544 HD11 ' O ' ' A' ' 80' ' ' VAL . 3.4 mt -103.48 67.1 0.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.454 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -74.35 -17.78 60.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.049 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -66.66 -26.74 38.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.447 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.14 59.8 1.09 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.521 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.513 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -141.33 176.14 9.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.841 0.353 . . . . 0.0 111.123 -178.381 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.544 ' O ' HD11 ' A' ' 75' ' ' LEU . 50.0 t -81.46 147.99 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.17 159.3 15.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.293 0.568 . . . . 0.0 111.56 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -50.68 155.23 1.99 Allowed Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.567 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.611 ' HG3' HD23 ' A' ' 24' ' ' LEU . 18.4 Cg_endo -58.53 106.67 0.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.335 2.023 . . . . 0.0 111.534 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.543 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 90.8 t -101.03 101.92 12.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.754 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.438 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 6.5 tptt -91.89 112.69 24.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.632 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.412 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 2.0 m -114.27 -173.19 2.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.55 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -58.29 -20.27 41.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.929 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.488 ' HB3' HD11 ' A' ' 16' ' ' LEU . 2.6 m-85 -89.37 -23.97 22.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.309 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.481 ' C ' HD21 ' A' ' 16' ' ' LEU . . . 136.97 -167.88 24.49 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.883 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.496 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -74.98 98.35 3.58 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.412 ' CE1' ' HB2' ' A' ' 86' ' ' SER . 53.3 m80 -80.86 167.63 19.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.343 0.592 . . . . 0.0 112.437 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.0 t -147.73 153.16 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.395 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.667 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -150.82 127.46 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -179.03 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.485 ' HG2' HG22 ' A' ' 80' ' ' VAL . 2.6 tmtm? -128.59 116.1 19.11 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.677 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.56 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -57.44 134.58 56.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.495 0.664 . . . . 0.0 112.046 -178.055 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.95 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -157.1 116.67 3.42 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.771 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 CA-C-O 118.321 -1.266 . . . . 0.0 112.57 179.845 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.78 124.79 11.42 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.456 2.104 . . . . 0.0 112.253 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.56 134.79 34.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.009 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.35 58.17 0.28 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.508 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -62.45 164.92 6.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.773 0.32 . . . . 0.0 110.646 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.21 -43.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.274 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.31 17.5 11.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.642 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.23 -25.47 47.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.975 0.417 . . . . 0.0 110.599 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.547 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 1.0 OUTLIER -84.77 173.7 10.46 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.47 0.653 . . . . 0.0 112.138 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.575 HG22 ' SG ' ' A' ' 12' ' ' CYS . 1.5 mt -110.98 136.15 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.869 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.475 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.4 mtpt -109.17 90.76 3.39 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.21 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.775 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 13.7 m -130.69 -179.59 5.39 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.055 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.658 ' HB2' HD23 ' A' ' 96' ' ' LEU . 9.5 t -124.87 163.45 22.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.851 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.793 ' CG ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -139.87 155.54 47.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.363 0.602 . . . . 0.0 112.583 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.754 HG23 ' OG ' ' A' ' 44' ' ' SER . 3.0 mp -143.77 139.43 25.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.48 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.757 HD11 ' NE2' ' A' ' 91' ' ' HIS . 0.4 OUTLIER -127.38 133.55 50.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.968 HG21 ' CG ' ' A' ' 22' ' ' GLU . 25.3 m -154.61 134.42 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.807 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.533 ' HE3' HD13 ' A' ' 45' ' ' ILE . 9.6 mttt -65.92 -16.58 63.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.515 ' HB3' ' CG ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -72.29 78.24 0.99 Allowed 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.813 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.453 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 0.8 OUTLIER -47.27 -40.52 16.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.156 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.09 -31.54 72.27 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.848 -1.168 . . . . 0.0 112.774 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.968 ' CG ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -66.9 -43.73 82.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.237 0.541 . . . . 0.0 110.407 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.557 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -46.95 -39.28 12.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.535 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.691 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -72.79 -29.16 63.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.112 179.392 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.91 -54.01 6.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.459 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.4 m -49.52 -34.27 8.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.691 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.9 pt20 -59.78 -47.72 84.56 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.907 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.23 -29.22 62.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.202 0.525 . . . . 0.0 110.499 178.731 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.596 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.53 -36.2 45.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.792 -179.001 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.594 ' CD2' HD23 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -52.77 -58.1 7.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.259 -179.363 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -71.36 -9.58 58.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.301 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.52 -23.7 63.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.887 0.375 . . . . 0.0 111.181 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.26 -19.47 0.93 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.275 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.415 ' HG3' HD21 ' A' ' 39' ' ' LEU . 20.5 pt-20 -80.93 157.65 25.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 110.773 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -101.43 148.28 25.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.168 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.845 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 1.1 p90 -50.44 -39.35 47.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.035 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.4 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -57.94 -34.21 71.26 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.746 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -65.85 -54.12 30.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.701 0.286 . . . . 0.0 110.913 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.014 HD12 HD11 ' A' ' 43' ' ' LEU . 2.8 mm? -56.32 -32.56 64.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.681 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.566 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.44 -52.78 43.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.175 0.512 . . . . 0.0 110.642 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.39 -23.77 26.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.133 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.848 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -69.62 -68.94 0.37 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.537 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.014 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.75 -12.63 9.21 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.601 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.754 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -63.68 131.69 48.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.885 0.374 . . . . 0.0 111.436 -179.123 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.554 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.3 pt -100.04 -8.64 9.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.941 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.835 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 24.9 p-10 -45.87 135.21 7.29 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.962 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.693 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.27 -178.27 3.44 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.775 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 51' ' ' LYS . . . -11.75 -41.74 0.0 OUTLIER Glycine 0 N--CA 1.467 0.736 0 N-CA-C 115.63 1.012 . . . . 0.0 115.63 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.693 ' N ' ' O ' ' A' ' 47' ' ' GLY . 48.3 t -51.21 -22.3 2.57 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.564 0.682 . . . . 0.0 111.462 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.835 ' HB2' ' OD1' ' A' ' 46' ' ' ASP . . . -71.64 -21.17 61.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.875 0.369 . . . . 0.0 111.217 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -68.25 -12.25 60.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.827 -179.056 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 49' ' ' SER . 9.2 ptp180 -104.43 24.88 10.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.678 0.275 . . . . 0.0 110.529 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.451 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.4 OUTLIER 65.79 20.83 11.49 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.129 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.84 17.92 65.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.615 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -68.53 86.07 0.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.362 . . . . 0.0 110.713 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.793 HD21 ' CG ' ' A' ' 14' ' ' HIS . 23.2 mt -54.56 -24.58 21.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.696 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 59.5 -166.18 9.41 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.233 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.499 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -67.27 111.51 4.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.9 0.381 . . . . 0.0 111.897 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.547 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 4.4 m-85 -117.43 156.3 28.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.59 -174.0 14.1 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.506 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.23 80.13 5.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.924 0.392 . . . . 0.0 110.225 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.26 36.68 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.03 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.01 -48.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 0.0 111.135 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.6 mtm -95.52 170.95 8.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.086 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.793 HG23 ' H ' ' A' ' 68' ' ' PHE . 34.3 m -59.44 159.12 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.954 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -61.0 -47.97 93.88 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 12.2 Cg_endo -63.75 -41.14 25.62 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.955 1.77 . . . . 0.0 111.836 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.804 ' CE1' HG23 ' A' ' 93' ' ' ILE . 9.3 t80 -74.96 -52.35 11.39 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.843 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -55.36 -32.24 62.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.991 0.424 . . . . 0.0 110.647 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.457 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 29.9 t70 -65.38 -53.07 48.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.744 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.21 -9.31 58.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.559 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.32 -47.0 78.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.721 0.296 . . . . 0.0 111.376 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.457 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 11.4 p90 -93.24 16.19 13.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.345 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -98.3 -30.51 12.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.585 HD11 ' HA ' ' A' ' 81' ' ' SER . 7.9 mt -97.73 56.81 1.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.177 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -63.75 -23.75 67.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.758 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.87 -26.79 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.855 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.573 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 91.16 63.08 1.2 Allowed Glycine 0 CA--C 1.499 -0.949 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.122 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.401 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -141.05 176.61 8.68 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.611 -0.294 . . . . 0.0 110.62 -178.92 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 27' ' ' GLN . 61.1 t -80.16 147.91 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.585 ' HA ' HD11 ' A' ' 75' ' ' LEU . 12.8 t -104.53 162.97 12.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.611 0.72 . . . . 0.0 111.924 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.607 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -50.37 163.46 0.45 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.396 -179.268 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 35.8 Cg_endo -65.71 103.59 0.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.617 2.211 . . . . 0.0 112.321 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.555 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 89.8 t -101.66 99.56 8.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.456 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -95.21 115.31 27.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.072 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.9 m -105.51 -175.64 2.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.367 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -20.13 26.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.958 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -88.18 -39.88 14.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.433 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.58 -171.6 36.03 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.978 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.46 ' CD1' ' HB3' ' A' ' 85' ' ' LYS . 0.6 OUTLIER -74.95 108.59 7.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.957 0.408 . . . . 0.0 110.043 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.757 ' NE2' HD11 ' A' ' 16' ' ' LEU . 56.6 m80 -95.46 169.39 10.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.381 0.61 . . . . 0.0 112.368 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.426 ' CG1' HG13 ' A' ' 80' ' ' VAL . 20.4 t -147.81 152.68 12.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.594 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.804 HG23 ' CE1' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -133.4 122.15 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.13 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 13' ' ' SER . 10.3 tptt -128.71 109.07 11.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.392 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.573 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 1.1 ttt-85 -57.1 138.78 54.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.776 0.798 . . . . 0.0 112.625 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.845 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -161.98 116.42 1.9 Allowed 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.484 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.626 179.8 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.71 122.15 8.85 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.589 2.193 . . . . 0.0 112.262 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.88 146.84 52.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.15 58.6 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.532 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.0 p -82.78 126.54 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.33 . . . . 0.0 110.965 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -114.97 169.14 9.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.737 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.87 29.48 6.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.265 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.39 -25.15 22.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.654 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.463 ' CB ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -85.13 163.93 18.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.3 0.572 . . . . 0.0 111.553 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.618 HG22 ' SG ' ' A' ' 12' ' ' CYS . 1.2 mt -111.33 135.68 49.77 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.043 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.492 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.7 mtpt -109.67 89.49 3.02 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.132 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.793 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 8.5 m -131.97 -179.55 5.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.081 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.705 ' HB3' HD23 ' A' ' 96' ' ' LEU . 8.7 p -127.07 163.43 23.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.156 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.747 ' CD2' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -136.08 157.46 46.78 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.295 0.569 . . . . 0.0 112.412 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.722 HD12 ' C ' ' A' ' 14' ' ' HIS . 2.9 mp -149.24 125.43 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.038 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.945 HD21 ' CD2' ' A' ' 91' ' ' HIS . 1.0 OUTLIER -105.84 136.94 44.57 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.844 0.354 . . . . 0.0 111.893 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.64 HG21 ' CD ' ' A' ' 22' ' ' GLU . 22.7 m -150.67 134.39 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.389 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.404 ' HG3' HD13 ' A' ' 45' ' ' ILE . 17.3 mtmt -71.8 -35.84 70.09 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.617 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 5.9 tttt -73.15 79.19 1.26 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.469 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 3.2 pt20 -46.49 -25.89 0.76 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.153 -0.93 . . . . 0.0 113.108 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.15 -29.47 74.5 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 119.194 -1.479 . . . . 0.0 110.82 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.64 ' CD ' HG21 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -73.99 -38.02 64.27 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.26 0.553 . . . . 0.0 110.017 178.466 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.61 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.57 -33.76 23.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.651 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.544 ' O ' HD13 ' A' ' 24' ' ' LEU . 1.3 tm? -73.48 -39.8 64.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.417 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 28' ' ' GLU . . . -74.17 -47.03 38.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.961 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 22' ' ' GLU . 21.3 m -46.6 -37.49 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.361 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.726 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -58.4 -48.51 80.41 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.118 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.726 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.65 -30.21 62.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.072 0.463 . . . . 0.0 110.822 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.458 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 16.8 tpt180 -79.18 -27.07 42.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.866 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.668 HD13 ' O ' ' A' ' 30' ' ' LEU . 1.4 tm? -70.47 -44.82 66.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.222 0.534 . . . . 0.0 110.278 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -9.46 58.72 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.769 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.02 -27.89 69.42 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.902 0.382 . . . . 0.0 111.352 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.68 -17.92 0.98 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.629 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.48 ' HG3' HD22 ' A' ' 30' ' ' LEU . 25.3 pt-20 -74.22 157.56 35.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.813 0.339 . . . . 0.0 110.879 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.08 139.94 33.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.093 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.921 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 3.0 p90 -49.97 -33.81 18.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.99 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 40' ' ' ALA . . . -60.98 -37.43 93.83 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.352 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -64.06 -52.92 57.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.778 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.773 HD12 HD11 ' A' ' 43' ' ' LEU . 3.2 mm? -53.55 -31.14 45.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.725 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.588 ' HB1' ' O ' ' A' ' 50' ' ' ALA . . . -51.16 -55.17 19.26 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.115 0.483 . . . . 0.0 110.778 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -23.34 27.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.966 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.937 ' HB3' HD13 ' A' ' 43' ' ' LEU . 1.0 OUTLIER -70.17 -68.29 0.43 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.937 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.37 -13.3 9.28 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.582 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -64.13 135.65 56.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.163 0.506 . . . . 0.0 111.203 -179.295 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.49 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 43.2 pt -97.56 -14.25 7.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.216 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -46.04 134.84 7.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.217 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.647 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.15 -178.63 3.48 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.63 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.42 -45.72 0.0 OUTLIER Glycine 0 N--CA 1.467 0.702 0 N-CA-C 115.458 0.943 . . . . 0.0 115.458 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.647 ' N ' ' O ' ' A' ' 47' ' ' GLY . 33.2 m -51.69 -24.96 6.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.361 0.58 . . . . 0.0 111.108 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.588 ' O ' ' HB1' ' A' ' 40' ' ' ALA . . . -71.0 -20.94 62.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.89 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -79.78 -4.22 51.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.396 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mtp-105 -104.33 24.62 11.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.223 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.0 22.53 12.77 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.014 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 57.45 20.44 37.6 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.799 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m -61.85 85.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.775 0.321 . . . . 0.0 110.987 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.793 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 21.5 mt -60.76 -24.86 66.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.535 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 56.78 -165.14 5.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.416 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.492 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -64.93 121.07 13.79 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.225 0.536 . . . . 0.0 112.209 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.434 ' CZ ' ' O ' ' A' ' 56' ' ' LEU . 12.0 m-30 -136.8 148.49 47.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.017 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.84 -173.81 21.37 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.44 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.46 87.36 7.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.152 0.501 . . . . 0.0 110.189 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.32 36.78 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.901 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.62 -45.24 0.67 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.712 0.292 . . . . 0.0 111.144 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.32 171.4 8.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.135 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.794 HG23 ' H ' ' A' ' 68' ' ' PHE . 34.3 m -55.13 157.56 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.106 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.52 -48.11 97.52 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.605 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 18.6 Cg_endo -65.69 -39.92 19.16 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.946 1.764 . . . . 0.0 112.187 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.794 ' H ' HG23 ' A' ' 65' ' ' VAL . 23.8 t80 -74.91 -49.17 21.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.459 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.5 OUTLIER -54.94 -32.73 61.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.524 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -67.45 -51.56 50.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.901 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.438 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -74.89 -9.59 58.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.593 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.472 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -66.84 -43.29 84.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.848 0.356 . . . . 0.0 111.448 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 1.1 p90 -102.26 16.77 25.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.401 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.07 -27.31 15.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.748 0.308 . . . . 0.0 110.831 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 79' ' ' GLU . 3.3 mt -103.53 63.55 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.305 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -70.56 -18.53 62.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.965 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -64.6 -26.91 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.35 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.544 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.19 58.15 1.17 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.802 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.521 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.8 tm-20 -140.5 176.36 8.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.672 0.272 . . . . 0.0 110.977 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.553 HG11 ' HA ' ' A' ' 27' ' ' GLN . 56.8 t -84.65 147.05 5.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.098 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.21 161.96 13.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.186 0.517 . . . . 0.0 111.434 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.7 mp0 -50.85 153.9 2.72 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.033 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.446 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 22.5 Cg_endo -60.84 106.35 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.1 1.867 . . . . 0.0 111.523 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.605 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 86.1 t -101.01 108.33 23.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.7 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 90' ' ' TYR . 14.7 tmtt? -91.7 113.17 25.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.408 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.48 -172.38 2.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.199 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -16.42 48.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.213 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -94.08 -35.28 12.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.713 0.292 . . . . 0.0 111.594 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.66 -167.03 34.57 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.666 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.579 ' O ' HD13 ' A' ' 16' ' ' LEU . 1.2 m-85 -82.44 98.26 8.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.266 0.555 . . . . 0.0 109.994 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.945 ' CD2' HD21 ' A' ' 16' ' ' LEU . 11.3 m80 -83.09 169.64 15.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.007 -177.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 38.3 t -149.03 150.72 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.014 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.54 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -130.62 122.41 52.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' SER . 3.8 tmtt? -128.58 110.44 12.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.113 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.544 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -57.47 139.44 53.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.853 0.835 . . . . 0.0 112.73 -178.463 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.921 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -162.82 116.42 1.67 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.491 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.417 ' CA ' ' HE2' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.323 -1.265 . . . . 0.0 112.621 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.2 133.53 47.66 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.534 2.156 . . . . 0.0 112.321 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.7 ttt -130.72 127.79 39.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.4 -45.01 2.07 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.542 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.52 124.24 26.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.88 0.372 . . . . 0.0 110.825 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.2 ttt -134.19 152.7 51.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.956 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.65 29.27 4.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.27 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.474 ' CB ' ' HE3' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -57.47 -21.5 37.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.756 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.579 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.03 168.47 15.9 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.376 0.607 . . . . 0.0 112.034 -179.39 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.674 HD12 ' HB1' ' A' ' 72' ' ' ALA . 1.2 mt -111.01 136.0 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.15 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.517 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.6 mtpt -108.32 89.78 3.1 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.115 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.808 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.4 m -132.69 -179.61 5.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.747 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.588 ' OG ' HD23 ' A' ' 96' ' ' LEU . 3.0 m -131.25 163.75 27.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.371 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.808 ' O ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -132.16 156.31 46.63 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.808 HD12 ' O ' ' A' ' 14' ' ' HIS . 1.5 mp -141.43 120.01 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.045 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.55 HD11 ' CE1' ' A' ' 91' ' ' HIS . 2.0 mt -104.44 128.28 52.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.788 HG21 ' CG ' ' A' ' 22' ' ' GLU . 17.9 m -140.57 133.91 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.017 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -36.7 70.55 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.84 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.613 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.23 78.53 0.98 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.385 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.477 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -46.51 -26.05 0.8 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.058 -177.47 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.42 -31.12 76.05 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.855 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.859 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -70.06 -39.56 75.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.081 0.467 . . . . 0.0 110.3 178.729 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.659 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.34 -38.1 40.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.986 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.815 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.4 OUTLIER -73.61 -29.4 62.36 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.244 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.38 -43.7 14.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.543 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.5 m -54.89 -40.66 53.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.275 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.678 ' HA ' HG11 ' A' ' 80' ' ' VAL . 12.4 pt20 -53.2 -52.61 58.31 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.691 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.546 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -73.28 -31.51 64.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.08 0.467 . . . . 0.0 110.998 179.141 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.448 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -76.41 -25.61 54.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.706 -178.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -58.38 -48.31 81.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.4 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.93 -9.32 58.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.428 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -56.26 -22.15 28.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.802 0.334 . . . . 0.0 111.403 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.13 -10.76 3.59 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.536 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.452 ' OE1' HD11 ' A' ' 39' ' ' LEU . 15.2 pt-20 -79.02 153.24 30.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.929 0.395 . . . . 0.0 110.988 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.4 135.51 33.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.792 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.781 ' CZ ' HD13 ' A' ' 15' ' ' ILE . 9.6 t80 -53.29 -47.78 68.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.218 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 40' ' ' ALA . . . -56.59 -34.12 63.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.239 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -58.82 -50.26 74.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.704 0.288 . . . . 0.0 110.87 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.787 ' CD1' HD11 ' A' ' 43' ' ' LEU . 3.2 mm? -53.07 -33.28 51.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.808 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.25 -54.24 27.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.127 0.489 . . . . 0.0 110.496 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.4 pttp -85.77 -23.5 27.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.023 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.924 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -70.54 -67.91 0.47 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.914 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.924 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.94 -15.69 9.3 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -63.99 138.31 58.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 0.0 111.275 -179.475 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.419 ' CG1' ' O ' ' A' ' 16' ' ' LEU . 2.0 pt -99.49 -10.02 8.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.18 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.405 ' OD2' ' CE1' ' A' ' 14' ' ' HIS . 14.2 t0 -46.21 135.31 7.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.959 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.646 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -61.93 -178.56 3.24 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.173 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.35 -45.73 0.0 OUTLIER Glycine 0 N--CA 1.467 0.73 0 N-CA-C 115.416 0.926 . . . . 0.0 115.416 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.646 ' N ' ' O ' ' A' ' 47' ' ' GLY . 14.4 m -51.55 -24.64 5.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.365 0.582 . . . . 0.0 111.379 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.447 ' O ' ' HB1' ' A' ' 40' ' ' ALA . . . -72.08 -31.61 66.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.388 0.613 . . . . 0.0 110.248 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -68.09 -16.17 63.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.065 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -104.22 24.64 11.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.29 179.497 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.429 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.3 OUTLIER 64.5 17.54 10.89 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.434 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.83 27.37 49.93 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.37 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -60.06 84.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.959 0.409 . . . . 0.0 110.815 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.808 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 22.8 mt -60.5 -19.66 57.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.725 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 50.33 -169.07 0.27 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.735 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.517 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -61.69 111.44 1.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.929 0.395 . . . . 0.0 111.723 -179.385 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.579 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 2.4 m-85 -124.78 163.8 21.34 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.35 -174.04 13.67 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.656 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -86.9 95.72 9.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.052 0.453 . . . . 0.0 110.283 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.23 36.47 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.756 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -152.05 -42.62 0.11 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.74 0.305 . . . . 0.0 111.187 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 8.9 mtm -91.07 167.12 12.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.93 0.395 . . . . 0.0 111.27 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.799 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.7 m -58.97 156.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.854 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.557 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.5 ttpt -58.14 -47.98 97.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.562 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 12.7 Cg_endo -64.4 -40.1 26.18 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 121.995 1.797 . . . . 0.0 112.239 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.799 ' H ' HG23 ' A' ' 65' ' ' VAL . 11.3 t80 -75.11 -50.17 17.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.696 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.63 -32.33 58.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.689 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 1.5 t70 -66.87 -52.47 43.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.851 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.87 -9.5 58.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.478 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.674 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -63.18 -43.19 98.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.415 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 2.8 p90 -98.29 16.54 21.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.386 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -98.18 -28.14 13.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.172 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.782 HD11 ' CB ' ' A' ' 81' ' ' SER . 8.5 mt -96.0 51.6 1.25 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 111.301 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -58.91 -33.14 70.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 109.868 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -63.55 -26.68 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.33 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.514 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 90.37 72.01 1.24 Allowed Glycine 0 CA--C 1.5 -0.905 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.819 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.749 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -142.28 177.6 8.14 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.132 -0.534 . . . . 0.0 110.014 -178.744 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.678 HG11 ' HA ' ' A' ' 27' ' ' GLN . 93.5 t -79.67 149.73 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.782 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -104.49 153.08 21.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.354 0.597 . . . . 0.0 111.401 -178.419 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.587 ' O ' HG23 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -50.76 156.1 1.73 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.834 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.815 ' HG3' HD23 ' A' ' 24' ' ' LEU . 11.2 Cg_endo -53.67 102.83 0.08 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.514 2.143 . . . . 0.0 111.96 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 82' ' ' GLU . 57.6 t -103.07 103.05 14.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.599 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.79 112.5 24.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.9 0.381 . . . . 0.0 110.966 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.63 -176.9 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.398 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -59.33 -19.07 43.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.958 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -89.93 -40.53 12.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.386 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.83 -164.09 35.65 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.826 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.477 ' CD1' ' HB3' ' A' ' 20' ' ' GLN . 0.3 OUTLIER -83.43 98.17 9.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.55 ' CE1' HD11 ' A' ' 16' ' ' LEU . 15.5 m80 -83.68 167.1 17.55 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.557 ' CG1' HG13 ' A' ' 80' ' ' VAL . 18.0 t -145.11 153.42 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.772 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.493 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -138.02 121.58 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.661 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.489 ' CB ' ' CE1' ' A' ' 36' ' ' PHE . 5.1 tptm -129.62 113.27 14.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.168 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.514 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.8 OUTLIER -57.97 139.19 54.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.787 0.803 . . . . 0.0 112.631 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.588 HD23 ' OG ' ' A' ' 13' ' ' SER . 0.2 OUTLIER -159.62 116.18 2.56 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.351 179.098 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.555 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.62 88.5 0.76 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.602 2.201 . . . . 0.0 112.28 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.56 147.1 46.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.33 -1.71 7.66 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.786 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.6 t -62.33 130.62 46.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.875 0.369 . . . . 0.0 110.819 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.49 -163.82 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.11 47.96 1.46 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.129 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.8 -39.34 87.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.769 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.568 ' HD2' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -85.84 174.96 8.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.081 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.402 HD11 ' HB3' ' A' ' 73' ' ' PHE . 0.4 OUTLIER -114.14 136.97 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 121.4 0.619 . . . . 0.0 110.752 -178.703 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.717 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -107.29 95.39 5.67 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.738 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.842 ' SG ' HG22 ' A' ' 93' ' ' ILE . 1.9 t -120.4 179.35 4.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.794 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.917 ' HB3' HD23 ' A' ' 96' ' ' LEU . 14.7 p -120.56 163.35 18.12 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.69 ' C ' HD12 ' A' ' 15' ' ' ILE . 24.6 p-80 -134.68 151.59 51.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.517 0.675 . . . . 0.0 112.633 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.769 HG23 ' OG ' ' A' ' 44' ' ' SER . 2.9 mp -155.61 127.09 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.764 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.884 HD13 ' CD2' ' A' ' 91' ' ' HIS . 10.9 tp -114.15 129.06 56.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.935 0.398 . . . . 0.0 112.029 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.768 HG11 ' OE1' ' A' ' 22' ' ' GLU . 28.1 m -143.26 134.35 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.635 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.504 ' HD2' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -77.9 -33.97 51.64 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.478 -179.013 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.6 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 13.2 tttp -72.3 79.14 1.0 Allowed 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 0.9 OUTLIER -46.18 -25.39 0.59 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.939 -177.026 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.55 -31.33 78.35 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 118.865 -1.636 . . . . 0.0 110.429 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.868 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -73.2 -37.65 66.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.06 0.457 . . . . 0.0 109.777 178.062 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.602 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -53.31 -36.2 60.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.738 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.632 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.59 -29.28 62.3 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.762 178.815 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.9 -43.53 14.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.633 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.868 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.3 m -55.28 -36.72 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.428 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.822 ' HA ' HG11 ' A' ' 80' ' ' VAL . 14.6 pt20 -56.27 -53.27 59.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.696 0.284 . . . . 0.0 110.541 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.526 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -73.62 -26.95 61.03 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.965 0.412 . . . . 0.0 110.866 179.055 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.578 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.0 tpp180 -78.41 -34.02 48.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.784 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.506 ' CD2' HD23 ' A' ' 39' ' ' LEU . 1.3 tm? -53.52 -57.47 10.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.03 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -9.41 58.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.253 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -58.46 -23.77 58.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.938 0.399 . . . . 0.0 111.32 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.51 -17.38 1.13 Allowed Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.374 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -78.46 157.64 28.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.876 0.369 . . . . 0.0 110.861 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -100.75 140.41 35.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.107 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.882 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 5.4 p90 -49.53 -31.66 10.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.949 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.47 -33.98 88.71 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.376 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 4.9 mmmt -67.94 -53.89 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.697 0.284 . . . . 0.0 110.999 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.038 HD12 HD11 ' A' ' 43' ' ' LEU . 2.8 mm? -53.86 -33.86 57.62 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.68 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.79 -52.5 48.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.109 0.48 . . . . 0.0 110.543 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -86.51 -23.34 25.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.341 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.849 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -71.7 -69.05 0.41 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.116 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.038 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.68 -12.44 9.26 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.769 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -63.85 137.68 58.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.895 0.379 . . . . 0.0 111.151 -179.282 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.673 HG13 ' HB3' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -106.55 -3.25 9.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.965 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.796 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 24.8 p-10 -46.41 135.66 8.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.021 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.691 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.08 -178.46 3.34 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.046 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.75 -42.9 0.0 OUTLIER Glycine 0 N--CA 1.468 0.802 0 N-CA-C 115.395 0.918 . . . . 0.0 115.395 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.691 ' N ' ' O ' ' A' ' 47' ' ' GLY . 20.8 t -51.4 -19.42 1.35 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.427 0.613 . . . . 0.0 111.736 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.796 ' HB2' ' OD1' ' A' ' 46' ' ' ASP . . . -70.75 -20.43 62.63 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.906 0.384 . . . . 0.0 110.925 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -75.23 -4.73 40.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.235 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.12 24.69 11.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.399 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 p30 56.17 33.59 22.34 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.159 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.455 ' HA2' ' CE1' ' A' ' 14' ' ' HIS . . . 50.84 24.41 8.13 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.938 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.53 87.51 7.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.018 0.437 . . . . 0.0 110.428 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.702 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 13.9 mt -62.42 -17.12 58.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.794 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 53.6 -171.76 0.71 Allowed Glycine 0 CA--C 1.507 -0.408 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.204 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.717 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 8.5 p90 -59.95 117.02 4.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.122 0.486 . . . . 0.0 111.619 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.498 ' C ' ' HB2' ' A' ' 9' ' ' LYS . 8.6 p90 -139.37 141.22 37.6 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.429 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.469 ' CA ' ' HB2' ' A' ' 9' ' ' LYS . . . -90.89 -173.78 44.02 Favored Glycine 0 C--N 1.311 -0.816 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.404 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.67 100.18 13.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.749 0.309 . . . . 0.0 110.362 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.32 36.49 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.312 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -151.18 18.44 0.76 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.861 0.331 . . . . 0.0 111.595 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.486 ' HE3' ' CE1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -151.61 174.12 13.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.697 0.284 . . . . 0.0 111.075 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.796 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.1 m -60.74 158.46 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.803 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.571 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -61.32 -47.84 92.91 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.194 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.627 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 19.8 Cg_endo -64.28 -40.1 26.99 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.024 1.816 . . . . 0.0 112.048 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.796 ' H ' HG23 ' A' ' 65' ' ' VAL . 26.1 t80 -74.95 -51.19 14.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.799 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 3.2 tm-20 -57.42 -32.47 66.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.749 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 23.7 t70 -66.08 -49.39 67.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.969 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.458 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -74.87 -9.49 58.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.816 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.408 ' HB1' ' HE1' ' A' ' 59' ' ' PHE . . . -66.31 -47.39 73.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.753 0.311 . . . . 0.0 111.556 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 8.6 p90 -92.93 16.69 12.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.499 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -100.4 -27.3 13.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.787 0.327 . . . . 0.0 110.933 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 79' ' ' GLU . 1.5 mt -103.53 58.5 0.74 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.454 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -69.22 -18.31 63.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.975 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -66.29 -26.82 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.688 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.429 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 96.23 58.2 1.1 Allowed Glycine 0 CA--C 1.502 -0.744 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.568 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.603 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -139.56 176.5 8.67 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.726 0.298 . . . . 0.0 111.055 -178.445 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.822 HG11 ' HA ' ' A' ' 27' ' ' GLN . 24.8 t -87.18 148.56 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.198 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -105.37 157.34 17.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.245 0.545 . . . . 0.0 111.335 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.47 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.9 mp0 -50.96 155.81 1.93 Allowed Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.066 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HG3' HD23 ' A' ' 24' ' ' LEU . 12.8 Cg_endo -56.26 106.26 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.208 1.939 . . . . 0.0 111.6 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.627 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 70.9 t -100.9 108.06 22.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.597 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.452 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 28.2 tptt -91.65 113.0 25.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.96 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.448 ' HG ' ' CE1' ' A' ' 91' ' ' HIS . 0.9 OUTLIER -110.04 -171.38 1.83 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.321 179.354 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.79 -18.4 21.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.277 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . 0.468 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 12.1 m-85 -93.69 -38.9 11.08 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.722 0.296 . . . . 0.0 111.677 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.401 ' HA2' ' NZ ' ' A' ' 85' ' ' LYS . . . 154.58 -166.19 32.22 Favored Glycine 0 CA--C 1.508 -0.384 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.848 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.615 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 59.3 m-85 -74.73 98.21 3.41 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.306 0.574 . . . . 0.0 110.161 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.884 ' CD2' HD13 ' A' ' 16' ' ' LEU . 79.6 m80 -86.53 169.88 12.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.575 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.6 t -145.88 147.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.848 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.842 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -134.67 123.22 41.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.081 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.407 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 3.3 tmtm? -128.14 110.1 12.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.843 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -57.39 131.74 50.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.416 0.627 . . . . 0.0 111.872 -178.031 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.917 HD23 ' HB3' ' A' ' 13' ' ' SER . 0.3 OUTLIER -158.7 116.92 2.94 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.989 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.407 -1.219 . . . . 0.0 112.52 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.133 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.13 149.76 20.84 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.499 2.133 . . . . 0.0 112.383 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.5 ptp -145.48 143.78 30.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.922 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.71 -27.39 2.59 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.465 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.8 p -88.38 141.44 28.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.911 0.386 . . . . 0.0 110.897 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.3 ttt -152.85 179.82 8.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.741 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.5 22.04 10.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.388 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -56.07 -46.92 78.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.274 0.559 . . . . 0.0 110.462 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.676 ' HD3' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -85.53 178.0 7.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.748 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.692 HD11 ' HB3' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -109.95 137.14 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-O 121.635 0.731 . . . . 0.0 111.161 -178.537 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.577 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -110.4 89.22 2.97 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.286 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.753 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 35.8 m -120.87 179.91 4.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.193 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.54 ' CB ' HD23 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -119.52 163.39 17.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.949 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.462 ' C ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -134.45 147.73 50.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.229 0.538 . . . . 0.0 112.249 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.546 HG23 ' OG ' ' A' ' 44' ' ' SER . 3.6 mp -145.41 115.3 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.942 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.643 HD11 ' NE2' ' A' ' 91' ' ' HIS . 0.8 OUTLIER -99.41 129.14 45.58 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.076 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.796 HG21 ' CG ' ' A' ' 22' ' ' GLU . 20.2 m -143.25 133.73 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.597 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HE2' HD13 ' A' ' 45' ' ' ILE . 4.7 mttm -71.18 -36.0 71.79 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.849 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.584 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -71.44 78.19 0.77 Allowed 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.675 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 1.1 tm0? -46.72 -25.78 0.8 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.935 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.85 -31.37 78.04 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 119.069 -1.538 . . . . 0.0 110.72 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.896 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -71.46 -39.64 70.84 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.195 0.522 . . . . 0.0 109.726 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.69 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -52.9 -36.5 59.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.796 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.758 ' O ' HD13 ' A' ' 24' ' ' LEU . 0.6 OUTLIER -73.64 -29.3 62.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.981 178.934 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.03 -42.06 13.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.888 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.4 m -54.92 -33.83 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.315 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.704 ' HA ' HG11 ' A' ' 80' ' ' VAL . 15.9 pt20 -51.31 -55.33 18.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.675 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.457 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.8 OUTLIER -73.16 -31.29 64.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.14 0.495 . . . . 0.0 110.479 178.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.553 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 10.0 tpt180 -68.38 -37.99 80.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.725 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.848 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -52.95 -58.97 5.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.345 -179.293 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -72.12 -9.52 58.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.396 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -58.42 -21.92 52.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 0.0 111.341 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.35 -18.49 1.17 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.293 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HG3' HD21 ' A' ' 39' ' ' LEU . 23.2 pt-20 -80.48 157.56 26.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.914 0.388 . . . . 0.0 110.824 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -97.35 138.59 34.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.029 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.848 ' HA ' HD21 ' A' ' 30' ' ' LEU . 1.9 p90 -49.23 -35.39 17.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.964 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -64.6 -34.09 88.98 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.542 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.6 OUTLIER -63.38 -53.85 46.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.626 0.25 . . . . 0.0 111.192 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.961 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.17 -34.34 56.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.044 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.45 -53.61 35.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.017 0.436 . . . . 0.0 110.524 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -85.97 -23.63 26.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.179 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.85 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.37 -68.65 0.41 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -177.776 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.961 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.5 -14.0 9.17 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.647 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.553 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -64.18 137.87 58.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.168 0.509 . . . . 0.0 111.549 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.575 HD13 ' HE2' ' A' ' 18' ' ' LYS . 1.4 pt -102.76 -8.29 9.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.028 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 12.9 t70 -46.17 135.3 7.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.992 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.66 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -61.83 -178.54 3.13 Favored Glycine 0 C--O 1.225 -0.41 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.303 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' A' ' 51' ' ' LYS . . . -11.32 -44.91 0.0 OUTLIER Glycine 0 N--CA 1.467 0.712 0 N-CA-C 115.399 0.92 . . . . 0.0 115.399 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.66 ' N ' ' O ' ' A' ' 47' ' ' GLY . 32.5 m -51.63 -28.47 14.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.673 0.736 . . . . 0.0 111.248 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 46' ' ' ASP . . . -72.28 -24.46 61.35 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.256 0.55 . . . . 0.0 110.624 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.577 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.3 OUTLIER -70.64 -12.06 61.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.659 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -103.46 24.03 11.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.582 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.44 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 72.68 10.25 5.58 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.554 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.29 22.01 66.9 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.205 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.4 89.07 2.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.106 0.479 . . . . 0.0 110.622 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.753 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 12.1 mt -63.41 -15.03 56.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.775 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 48.22 -171.17 0.06 OUTLIER Glycine 0 CA--C 1.507 -0.468 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.339 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.676 ' HB2' ' HD3' ' A' ' 9' ' ' LYS . 16.8 p90 -56.51 122.62 12.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.211 0.529 . . . . 0.0 111.872 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.66 ' HE1' ' HB1' ' A' ' 72' ' ' ALA . 7.3 p90 -146.09 140.88 27.05 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.48 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.2 -173.9 23.41 Favored Glycine 0 C--N 1.315 -0.632 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.982 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 88.54 1.1 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.033 0.444 . . . . 0.0 110.129 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.53 36.88 0.05 OUTLIER Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.934 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.63 -41.67 0.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.596 0.236 . . . . 0.0 111.462 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.435 ' HE2' ' HB2' ' A' ' 64' ' ' MET . 1.9 mpp? -105.73 174.0 6.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.032 0.444 . . . . 0.0 111.468 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.777 HG23 ' H ' ' A' ' 68' ' ' PHE . 34.4 m -56.81 161.39 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.069 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.553 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -60.36 -48.03 94.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.611 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 15.5 Cg_endo -64.85 -42.01 16.25 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 121.911 1.741 . . . . 0.0 111.731 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.777 ' H ' HG23 ' A' ' 65' ' ' VAL . 15.2 t80 -72.65 -51.51 19.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.472 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.7 tt0 -56.34 -32.29 64.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.614 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 35.2 t70 -65.97 -51.6 56.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.707 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.405 ' HB3' HD11 ' A' ' 93' ' ' ILE . . . -75.12 -12.12 60.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.429 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.66 ' HB1' ' HE1' ' A' ' 59' ' ' PHE . . . -61.83 -49.21 77.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.886 0.374 . . . . 0.0 111.265 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.692 ' HB3' HD11 ' A' ' 10' ' ' ILE . 2.8 p90 -93.96 16.58 14.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.239 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -98.27 -26.39 14.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.375 . . . . 0.0 110.705 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.572 HD12 ' O ' ' A' ' 79' ' ' GLU . 2.0 mt -103.46 53.08 0.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.145 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -59.72 -22.02 61.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.165 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 p -61.92 -26.77 40.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.533 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 94.17 55.62 1.46 Allowed Glycine 0 CA--C 1.503 -0.717 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.741 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.572 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -137.44 176.53 8.62 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.692 0.282 . . . . 0.0 111.01 -178.758 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.704 HG11 ' HA ' ' A' ' 27' ' ' GLN . 59.5 t -86.43 147.43 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.533 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.47 160.48 15.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.202 0.525 . . . . 0.0 111.409 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.47 ' O ' HG23 ' A' ' 84' ' ' VAL . 21.0 mp0 -50.89 155.49 2.0 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.159 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.408 ' HG3' HD23 ' A' ' 24' ' ' LEU . 14.6 Cg_endo -56.93 105.96 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.228 1.952 . . . . 0.0 111.772 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.611 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 85.0 t -100.93 106.8 20.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.115 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.467 ' CG ' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.52 112.89 25.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.494 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.445 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 0.5 OUTLIER -105.19 -171.65 1.95 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.051 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -14.94 36.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.202 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -96.47 -36.36 10.82 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.612 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.19 -166.53 34.16 Favored Glycine 0 CA--C 1.508 -0.403 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.86 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.742 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 91.7 m-85 -80.73 98.07 7.58 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.237 0.542 . . . . 0.0 109.941 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.643 ' NE2' HD11 ' A' ' 16' ' ' LEU . 50.9 m80 -82.95 169.73 15.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.812 -178.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.447 ' CG1' HG13 ' A' ' 80' ' ' VAL . 19.4 t -149.52 145.6 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.445 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.622 HG23 ' CE1' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -123.3 122.28 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.005 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 13' ' ' SER . 2.4 tptm -128.72 108.98 10.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.406 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 2.0 ttp85 -57.26 132.8 54.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.562 0.696 . . . . 0.0 112.346 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.844 HD22 ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -163.17 116.71 1.6 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.782 179.747 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.417 -1.213 . . . . 0.0 112.67 179.754 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.05 156.6 64.71 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.521 2.147 . . . . 0.0 112.347 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.1 mtt -144.67 118.47 9.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.954 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.25 58.61 0.96 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.53 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.7 m -88.35 135.86 33.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.717 0.294 . . . . 0.0 111.01 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 58.3 mtt -116.1 -177.64 3.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.827 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.82 28.12 2.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.454 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.465 ' C ' ' HE3' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -57.07 -23.38 46.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.98 0.419 . . . . 0.0 110.671 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.07 166.2 17.89 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.357 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.582 HG22 ' SG ' ' A' ' 12' ' ' CYS . 1.4 mt -110.74 136.04 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.904 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.105 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.515 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.0 mtpt -107.73 88.4 2.72 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.668 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.818 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 8.6 m -131.41 -179.82 5.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.735 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.683 ' HB2' HD23 ' A' ' 96' ' ' LEU . 45.2 t -121.1 163.44 18.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.226 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.67 ' C ' HD12 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -130.68 150.78 51.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.172 0.511 . . . . 0.0 111.857 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.67 HD12 ' C ' ' A' ' 14' ' ' HIS . 4.1 mp -154.27 130.15 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.527 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.6 HD13 ' HB3' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -123.2 138.04 54.74 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.868 0.366 . . . . 0.0 111.858 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 1.014 HG21 ' CG ' ' A' ' 22' ' ' GLU . 24.2 m -151.02 135.84 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.516 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -64.91 -19.5 65.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.39 76.4 1.03 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.796 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 2.6 pt20 -47.79 -33.14 6.81 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.32 -31.17 61.55 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 119.915 -1.136 . . . . 0.0 112.599 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 1.014 ' CG ' HG21 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -68.16 -42.68 79.7 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.451 0.643 . . . . 0.0 109.92 179.359 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.669 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -49.64 -36.81 25.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.526 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.706 ' O ' HD13 ' A' ' 24' ' ' LEU . 0.9 OUTLIER -72.71 -33.83 66.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.812 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.11 -44.15 22.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.514 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.807 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.8 m -47.96 -36.34 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.394 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.718 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -58.01 -49.26 77.45 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.522 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.718 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 4.0 pt-20 -73.89 -30.37 62.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.838 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.538 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 10.4 tpp85 -78.83 -33.12 46.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.83 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.571 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.8 OUTLIER -52.53 -51.93 57.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.688 0.28 . . . . 0.0 111.424 -178.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.401 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -71.99 -9.29 58.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.186 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -72.72 47.2 0.17 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.32 -10.66 41.73 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.737 -0.744 . . . . 0.0 114.153 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 29' ' ' ARG . 6.6 pt-20 -91.97 153.98 19.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.437 0.618 . . . . 0.0 110.78 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -104.22 139.22 39.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.419 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 1.023 ' CE1' HD22 ' A' ' 96' ' ' LEU . 2.2 p90 -47.18 -31.75 3.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.841 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.11 -34.17 88.15 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.372 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.8 ttpm? -68.1 -51.99 40.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.654 0.264 . . . . 0.0 111.112 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.846 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.13 -36.01 60.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.412 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.783 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -51.93 -53.2 43.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.167 0.508 . . . . 0.0 110.634 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -85.64 -23.6 27.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.791 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.973 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -72.06 -67.52 0.53 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.133 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.973 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.36 -14.62 9.75 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.875 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.559 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 1.4 t -63.42 126.8 28.66 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.227 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.522 HG12 ' HA ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -107.3 -26.7 3.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -178.744 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.6 ' HB3' HD13 ' A' ' 16' ' ' LEU . 12.6 t70 -127.44 103.0 7.12 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.125 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.82 143.45 4.82 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.58 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.96 -33.83 28.7 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.037 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 54' ' ' GLY . 3.9 m -76.81 -1.83 30.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.324 -0.438 . . . . 0.0 111.249 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.783 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . . . -62.13 -22.79 66.12 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.307 0.575 . . . . 0.0 109.624 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -88.9 -5.44 58.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.184 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.466 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 1.7 mmt85 -122.36 24.55 9.3 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.9 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER 74.51 26.96 1.43 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.344 0.592 . . . . 0.0 111.085 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 55.56 20.31 23.31 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.789 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.45 84.66 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.027 0.442 . . . . 0.0 110.752 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.818 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 12.8 mt -58.92 -21.73 58.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.788 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 55.93 -163.85 5.05 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.413 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.515 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -64.23 119.48 10.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.028 0.442 . . . . 0.0 111.835 -179.38 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.546 ' HE1' ' HB1' ' A' ' 72' ' ' ALA . 19.1 p90 -141.27 139.34 33.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.571 177.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.419 ' CA ' ' HE2' ' A' ' 9' ' ' LYS . . . -98.35 -173.95 32.67 Favored Glycine 0 C--N 1.318 -0.463 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.504 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -82.8 98.27 9.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.199 0.524 . . . . 0.0 109.955 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.45 36.48 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.636 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -140.25 -46.87 0.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.837 0.351 . . . . 0.0 110.952 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.431 ' CE ' ' CE1' ' A' ' 59' ' ' PHE . 1.4 mpp? -91.92 170.04 10.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.963 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.77 HG23 ' H ' ' A' ' 68' ' ' PHE . 34.8 m -59.58 162.34 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.018 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.498 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.63 -48.18 97.37 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.068 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.573 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 10.0 Cg_endo -66.02 -38.37 22.6 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 121.858 1.706 . . . . 0.0 112.171 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.77 ' H ' HG23 ' A' ' 65' ' ' VAL . 8.8 t80 -74.97 -50.01 18.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.746 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -57.04 -32.49 66.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.651 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -64.61 -50.65 66.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.849 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.85 -9.57 58.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.524 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.546 ' HB1' ' HE1' ' A' ' 59' ' ' PHE . . . -68.15 -50.45 54.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.782 0.325 . . . . 0.0 111.301 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 6.4 p90 -93.28 16.56 12.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.343 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.48 -25.19 14.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 0.0 110.863 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 79' ' ' GLU . 1.6 mt -103.53 55.15 0.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.219 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -63.49 -19.55 64.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.098 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -63.66 -26.72 41.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.403 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.503 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.13 55.58 1.37 Allowed Glycine 0 CA--C 1.503 -0.674 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.629 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.558 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -137.63 176.17 8.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.858 0.361 . . . . 0.0 111.221 -178.388 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.63 HG11 ' HA ' ' A' ' 27' ' ' GLN . 60.2 t -83.16 149.09 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.903 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.0 t -104.4 154.8 19.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.448 0.642 . . . . 0.0 111.764 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -50.8 163.5 0.48 Allowed Pre-proline 0 C--O 1.235 0.307 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.573 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.563 ' HG3' HD23 ' A' ' 24' ' ' LEU . 17.8 Cg_endo -59.15 104.56 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.604 2.203 . . . . 0.0 112.226 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.573 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 93.7 t -101.43 101.54 12.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.373 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.69 113.01 25.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.851 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.3 m -108.71 -171.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.6 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -57.7 -20.28 33.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.33 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -91.34 -40.49 11.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.424 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.5 ' C ' HD21 ' A' ' 16' ' ' LEU . . . 157.33 -164.51 32.97 Favored Glycine 0 CA--C 1.508 -0.354 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.073 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.484 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 0.7 OUTLIER -74.59 98.39 3.37 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.052 0.453 . . . . 0.0 110.39 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.473 ' NE2' HD12 ' A' ' 16' ' ' LEU . 31.0 m80 -81.71 169.95 16.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.236 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 t -149.29 150.6 13.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.01 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.492 HG23 ' CE1' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -138.1 124.14 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.319 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 13' ' ' SER . 15.8 tptp -128.45 109.29 11.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.594 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.503 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.5 OUTLIER -57.7 136.61 56.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.601 0.715 . . . . 0.0 112.206 -179.289 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 1.023 HD22 ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -161.27 116.52 2.1 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.718 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.28 -1.289 . . . . 0.0 112.659 179.76 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.18 90.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.544 2.163 . . . . 0.0 112.292 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.8 mmt -98.48 136.57 38.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.823 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.57 -56.04 1.2 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.464 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.3 t -88.33 123.37 32.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 110.839 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.94 111.39 11.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.872 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.12 25.62 6.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.345 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -54.45 -35.61 63.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.113 0.482 . . . . 0.0 110.371 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.76 ' HD3' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -105.71 178.56 4.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.727 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 58' ' ' TYR . 1.5 mm -109.3 149.64 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 CA-C-O 121.765 0.793 . . . . 0.0 111.276 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.666 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -125.34 76.3 1.54 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.102 -179.546 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.886 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 10.3 m -117.63 -179.68 3.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.258 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.828 ' HB2' HD23 ' A' ' 96' ' ' LEU . 22.6 t -115.66 163.49 15.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.651 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.692 ' C ' HD12 ' A' ' 15' ' ' ILE . 0.7 OUTLIER -132.44 153.03 51.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.54 0.686 . . . . 0.0 112.483 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.75 HG23 ' OG ' ' A' ' 44' ' ' SER . 2.8 mp -155.85 123.18 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.899 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.759 ' HG ' HD11 ' A' ' 45' ' ' ILE . 12.8 tp -111.61 131.17 55.45 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.825 HG11 ' OE1' ' A' ' 22' ' ' GLU . 17.3 m -143.65 134.71 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.67 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HD3' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -72.41 -35.77 68.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.513 -179.227 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.623 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 3.3 tttp -74.31 79.33 1.84 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.489 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -46.28 -25.85 0.7 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.153 -0.931 . . . . 0.0 113.254 -176.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.15 -31.24 77.05 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.9 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.849 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -70.88 -38.23 73.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.009 0.433 . . . . 0.0 110.354 178.798 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.602 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.83 -37.68 44.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.088 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.707 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.3 OUTLIER -73.44 -29.53 62.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.773 179.105 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.24 -42.8 15.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.47 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.9 m -55.89 -39.24 55.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.203 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.2 pt20 -56.12 -51.49 67.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.886 0.374 . . . . 0.0 110.26 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.547 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 2.8 pt-20 -73.19 -29.62 62.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.09 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.572 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.83 -29.75 44.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.656 -178.771 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.639 HD21 ' HA ' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -55.27 -55.33 32.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.944 0.402 . . . . 0.0 110.827 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -9.55 58.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.202 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.2 -24.02 62.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.913 0.387 . . . . 0.0 111.232 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.1 -18.53 0.94 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.307 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -80.72 157.52 25.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.905 0.383 . . . . 0.0 110.807 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.4 138.47 39.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.048 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.865 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 2.4 p90 -47.09 -29.86 2.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.996 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -64.45 -35.8 92.39 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.429 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.4 OUTLIER -66.19 -53.3 39.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.737 0.303 . . . . 0.0 110.869 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.003 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.62 -32.55 51.72 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.484 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.556 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.7 -53.27 41.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.617 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -86.33 -23.32 26.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.245 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.849 ' HB3' HD13 ' A' ' 43' ' ' LEU . 2.6 mm-40 -70.68 -69.22 0.38 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.003 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.61 -13.44 9.17 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.75 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -63.96 136.91 57.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.95 0.405 . . . . 0.0 111.2 -179.231 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.759 HD11 ' HG ' ' A' ' 16' ' ' LEU . 27.9 pt -101.55 -6.71 9.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.803 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.807 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 31.0 p-10 -46.04 135.21 7.66 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.24 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.67 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.39 -178.48 3.64 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.617 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.77 -43.05 0.0 OUTLIER Glycine 0 C--N 1.34 0.8 0 N-CA-C 115.493 0.957 . . . . 0.0 115.493 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.67 ' N ' ' O ' ' A' ' 47' ' ' GLY . 30.5 t -51.44 -17.6 0.82 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.463 0.631 . . . . 0.0 111.824 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.807 ' HB2' ' OD1' ' A' ' 46' ' ' ASP . . . -71.43 -21.14 62.02 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.179 0.514 . . . . 0.0 110.481 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 8.2 mmtt -73.8 -10.58 59.82 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.645 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.95 24.81 10.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.522 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.424 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 0.6 OUTLIER 60.06 27.81 17.29 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.227 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 57.36 20.08 35.53 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.759 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 99.2 p -76.24 87.73 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.944 0.402 . . . . 0.0 110.234 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.886 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 14.4 mt -63.67 -16.48 61.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.548 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 46.55 -169.34 0.04 OUTLIER Glycine 0 CA--C 1.506 -0.522 0 C-N-CA 121.028 -0.605 . . . . 0.0 112.682 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.76 ' HB2' ' HD3' ' A' ' 9' ' ' LYS . 27.5 p90 -66.82 111.48 3.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.539 ' C ' ' HB2' ' A' ' 9' ' ' LYS . 13.0 m-30 -141.96 148.05 37.98 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.0 -174.01 19.0 Favored Glycine 0 C--N 1.311 -0.811 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.406 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -75.3 154.74 37.23 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.2 -37.03 1.17 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.445 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.14 24.77 1.78 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.738 0.304 . . . . 0.0 111.059 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 13.8 mtp -112.95 162.44 15.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.675 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.799 HG23 ' H ' ' A' ' 68' ' ' PHE . 17.7 m -79.28 147.08 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.986 0.422 . . . . 0.0 110.951 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.584 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.23 -44.21 99.01 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.221 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 16.8 Cg_endo -65.3 -42.7 12.6 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 121.808 1.672 . . . . 0.0 112.207 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.799 ' H ' HG23 ' A' ' 65' ' ' VAL . 16.6 t80 -74.88 -49.39 20.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.842 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.61 -32.33 70.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.825 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 4.1 m-20 -64.6 -46.85 80.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.257 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.875 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -74.82 -18.4 60.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.749 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 10' ' ' ILE . . . -54.15 -53.06 58.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.727 0.299 . . . . 0.0 111.57 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -87.74 16.84 5.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.833 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -100.53 -31.58 11.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.822 0.344 . . . . 0.0 110.72 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 79' ' ' GLU . 2.8 mt -103.78 69.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.766 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -78.03 -16.41 58.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.088 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 p -69.07 -26.79 33.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.94 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.545 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 96.84 60.08 0.99 Allowed Glycine 0 CA--C 1.504 -0.634 0 C-N-CA 120.43 -0.89 . . . . 0.0 111.199 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.571 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -141.89 176.49 8.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.894 0.378 . . . . 0.0 111.025 -178.094 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.559 HG11 ' HA ' ' A' ' 27' ' ' GLN . 48.1 t -85.31 148.49 4.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.879 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t -104.5 163.96 12.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.212 0.529 . . . . 0.0 111.342 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.502 ' O ' HG23 ' A' ' 84' ' ' VAL . 14.8 mt-10 -50.59 158.16 1.13 Allowed Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.187 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.707 ' HG3' HD23 ' A' ' 24' ' ' LEU . 16.5 Cg_endo -57.15 104.08 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.538 2.159 . . . . 0.0 111.793 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.571 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 57.9 t -101.82 105.91 18.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.782 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 3.0 tmtt? -98.76 112.86 24.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 21.8 m -110.47 -172.47 2.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.475 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -57.76 -20.37 34.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.964 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -88.74 -30.89 18.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.381 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.428 ' C ' HD11 ' A' ' 16' ' ' LEU . . . 143.62 -169.7 25.91 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.885 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.489 ' CD1' ' HB3' ' A' ' 20' ' ' GLN . 0.4 OUTLIER -74.68 98.33 3.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.982 0.42 . . . . 0.0 110.017 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.671 ' CG ' HD13 ' A' ' 16' ' ' LEU . 18.5 m-70 -89.02 169.7 11.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.421 0.629 . . . . 0.0 112.294 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.444 ' CG1' HG13 ' A' ' 80' ' ' VAL . 25.0 t -139.86 134.64 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.614 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.875 HD12 ' HB3' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -118.29 121.86 68.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.655 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.93 108.06 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.312 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.545 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.4 OUTLIER -59.07 131.87 52.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.398 0.618 . . . . 0.0 111.816 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.865 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -160.35 116.02 2.33 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.001 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.312 -1.271 . . . . 0.0 112.591 179.731 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.05 163.85 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.559 2.172 . . . . 0.0 112.319 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.61 112.72 7.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.848 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.63 39.52 2.03 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.502 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -68.01 131.09 44.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 110.859 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.67 -22.66 11.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.114 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.21 28.26 3.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.218 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.459 ' C ' ' HE3' ' A' ' 9' ' ' LYS . 26.2 t70 -55.94 -23.13 30.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.765 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -84.08 166.14 17.93 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.214 0.53 . . . . 0.0 111.096 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.27 138.62 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.008 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.496 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -106.66 98.23 7.92 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.523 -178.614 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.816 ' SG ' HG22 ' A' ' 93' ' ' ILE . 2.8 t -127.25 179.98 5.17 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.929 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.742 ' HB2' HD23 ' A' ' 96' ' ' LEU . 7.5 t -121.23 163.27 18.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.904 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.805 ' HB3' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -131.04 149.55 52.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.045 0.45 . . . . 0.0 111.967 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.711 HD12 ' C ' ' A' ' 14' ' ' HIS . 3.7 mp -155.94 131.58 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.944 HD21 ' CD2' ' A' ' 91' ' ' HIS . 4.0 mm? -123.0 138.1 54.78 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.94 0.4 . . . . 0.0 111.64 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.812 HG21 ' CG ' ' A' ' 22' ' ' GLU . 18.3 m -148.98 134.11 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.93 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -69.84 -36.7 75.77 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.188 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.594 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.31 78.37 1.0 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.464 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -46.69 -25.79 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.768 -1.105 . . . . 0.0 113.238 -177.448 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.1 -31.48 77.83 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 119.045 -1.55 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.901 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -70.13 -39.22 75.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.247 0.546 . . . . 0.0 109.969 178.302 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.664 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -49.24 -39.5 30.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.376 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.556 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.33 -29.66 62.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.16 179.244 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.01 -36.49 23.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.755 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.901 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.4 m -57.27 -33.29 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.213 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.657 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -59.76 -50.26 74.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.657 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -73.12 -27.26 61.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.243 0.544 . . . . 0.0 110.348 178.507 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.567 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.9 tpt180 -77.86 -33.93 51.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.702 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.681 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -53.32 -59.4 4.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.245 -179.255 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -72.41 -9.39 58.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.287 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -56.78 -22.31 35.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.866 0.365 . . . . 0.0 111.416 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.01 -16.91 1.05 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.368 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -86.47 157.37 19.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.791 0.329 . . . . 0.0 110.682 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -99.51 142.38 31.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.091 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.812 ' CE1' HD22 ' A' ' 96' ' ' LEU . 2.9 p90 -47.65 -29.53 3.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.797 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -66.53 -38.93 93.79 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.563 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.557 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 5.1 ttpp -59.82 -50.98 71.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.72 0.295 . . . . 0.0 110.822 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.819 HD12 HD11 ' A' ' 43' ' ' LEU . 3.1 mm? -53.4 -34.85 59.32 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.741 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.678 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -52.09 -52.96 47.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.29 0.566 . . . . 0.0 110.665 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.46 -22.74 26.31 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.285 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.92 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -75.59 -68.4 0.57 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -176.763 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.92 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.63 -10.72 9.99 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.232 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.592 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -63.75 125.89 25.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.908 0.385 . . . . 0.0 109.993 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.476 HG13 ' N ' ' A' ' 46' ' ' ASP . 4.9 pt -107.54 -26.6 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.476 ' N ' HG13 ' A' ' 45' ' ' ILE . 18.9 t70 -127.89 103.05 7.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.77 143.31 4.75 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.022 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.97 -31.13 32.95 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 54' ' ' GLY . 0.7 OUTLIER -76.73 8.13 3.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.188 -0.506 . . . . 0.0 111.093 179.088 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.678 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . . . -64.54 -24.2 67.52 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -88.78 -19.69 25.68 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.913 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.462 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 3.2 mtt180 -104.43 24.68 11.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.168 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.495 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.6 OUTLIER 62.19 40.96 11.13 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.259 0.552 . . . . 0.0 111.583 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 53.36 30.51 40.83 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.213 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.849 ' HA ' HD21 ' A' ' 96' ' ' LEU . 65.4 p -88.74 85.09 6.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.729 0.3 . . . . 0.0 110.827 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.806 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 16.4 mt -58.3 -31.67 67.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.637 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 70.76 -170.12 47.03 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.453 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.561 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -60.64 118.47 6.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.151 0.501 . . . . 0.0 111.661 -179.384 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.557 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 2.4 m-85 -127.18 164.08 22.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.443 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.76 -174.02 13.25 Favored Glycine 0 C--N 1.319 -0.411 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.672 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -74.3 84.23 1.91 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.168 0.508 . . . . 0.0 110.121 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.33 36.78 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.056 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.0 -48.6 0.61 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.674 0.273 . . . . 0.0 111.39 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.4 ' HG3' ' HB2' ' A' ' 69' ' ' GLU . 1.9 ptp -108.42 169.51 8.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.025 0.441 . . . . 0.0 111.406 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.76 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.6 m -54.72 161.71 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.666 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.57 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -61.65 -48.14 90.74 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 11.8 Cg_endo -63.33 -42.0 24.25 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 121.999 1.799 . . . . 0.0 111.744 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.76 ' H ' HG23 ' A' ' 65' ' ' VAL . 17.9 t80 -73.11 -51.78 16.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.662 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 3.4 tm-20 -59.24 -32.98 70.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.774 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 6.7 m-20 -61.48 -48.57 80.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.127 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.587 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -74.83 -9.57 58.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.737 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.42 -47.72 78.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.771 0.32 . . . . 0.0 111.515 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 10.2 p90 -92.7 16.6 11.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.476 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -99.99 -25.82 14.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 111.205 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.803 HD11 ' CB ' ' A' ' 81' ' ' SER . 11.0 mt -101.25 56.9 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.389 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -61.42 -31.7 71.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.979 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -63.15 -26.88 41.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.124 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.5 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 89.94 70.21 1.23 Allowed Glycine 0 CA--C 1.499 -0.915 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.951 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.797 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -142.29 177.35 8.31 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.122 -0.539 . . . . 0.0 109.998 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.546 HG11 ' HA ' ' A' ' 27' ' ' GLN . 87.0 t -79.72 150.61 4.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.803 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -105.04 164.31 11.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.608 0.718 . . . . 0.0 111.907 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.624 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -50.5 164.31 0.41 Allowed Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.896 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.624 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 55.5 Cg_endo -68.73 103.44 0.99 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.398 2.065 . . . . 0.0 112.123 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 81.4 t -101.89 104.31 16.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.087 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.455 ' CG ' ' CD1' ' A' ' 90' ' ' TYR . 12.2 tmtt? -99.78 112.67 24.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.584 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.441 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 74.4 m -112.82 -176.44 2.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.858 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -51.83 -25.95 8.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.178 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -80.81 -39.95 25.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.087 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.56 -163.45 31.2 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.701 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.635 ' O ' HD13 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -80.39 100.28 8.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.632 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.944 ' CD2' HD21 ' A' ' 16' ' ' LEU . 60.5 m80 -85.05 162.24 19.4 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.7 t -146.82 125.19 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.011 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.816 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -113.68 124.49 70.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.405 ' HG2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -128.25 112.77 14.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.189 178.521 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.27 135.92 56.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.552 0.691 . . . . 0.0 112.356 -177.746 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.849 HD21 ' HA ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -156.74 116.76 3.54 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.578 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.424 -1.209 . . . . 0.0 112.564 179.823 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.449 -0.26 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.17 110.52 0.46 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.649 2.233 . . . . 0.0 112.292 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.4 mmt -86.74 129.4 34.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 117.64 -36.57 3.63 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.512 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.6 m -77.44 123.85 27.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.758 0.314 . . . . 0.0 110.89 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.1 ttt 79.35 -5.02 1.99 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.682 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.22 28.57 0.66 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.708 0.289 . . . . 0.0 110.96 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.474 ' C ' ' HE3' ' A' ' 9' ' ' LYS . 21.7 t0 -53.47 -26.15 19.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -84.17 161.67 20.49 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.089 0.471 . . . . 0.0 111.089 -179.618 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.14 129.52 66.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.528 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.514 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.1 mtpt -95.79 97.74 9.91 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.948 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.79 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -126.65 -179.73 4.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.839 -177.083 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.864 ' HB3' HD23 ' A' ' 96' ' ' LEU . 5.8 p -124.43 159.81 29.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.348 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.842 ' HB3' HD11 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -131.92 146.54 52.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.17 0.51 . . . . 0.0 112.302 -179.419 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.73 HD12 ' C ' ' A' ' 14' ' ' HIS . 4.1 mp -149.73 132.78 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.673 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.75 HD21 ' CD2' ' A' ' 91' ' ' HIS . 4.1 mm? -119.54 137.55 53.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.784 0.326 . . . . 0.0 111.598 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.866 HG21 ' CG ' ' A' ' 22' ' ' GLU . 15.7 m -148.54 134.23 11.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.17 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.404 ' HD2' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -71.12 -36.46 72.13 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.412 -178.89 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.665 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -74.42 79.15 1.89 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.878 0.846 . . . . 0.0 108.73 178.499 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.489 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -45.82 -25.28 0.49 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.363 -1.289 . . . . 0.0 113.162 -177.447 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.61 -30.37 76.28 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.124 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.871 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -72.02 -39.72 68.97 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.049 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.724 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -49.84 -35.02 21.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.205 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.555 ' O ' HD13 ' A' ' 24' ' ' LEU . 0.2 OUTLIER -73.3 -40.1 64.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.613 179.088 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.56 -48.78 30.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.589 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.7 m -46.55 -40.53 4.45 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.249 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.448 ' HA ' HG11 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -59.01 -45.13 91.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.444 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.4 mm-40 -73.69 -33.06 64.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.82 178.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.569 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -78.69 -30.41 46.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.842 -178.539 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.628 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -52.99 -58.95 5.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.895 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -9.38 58.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.383 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -58.29 -24.32 59.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.927 0.394 . . . . 0.0 111.327 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.93 -18.61 0.96 Allowed Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.191 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.515 ' CD ' HD21 ' A' ' 39' ' ' LEU . 6.9 pt-20 -82.15 157.59 23.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.862 0.363 . . . . 0.0 110.503 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.38 141.75 33.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.091 0.472 . . . . 0.0 111.216 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.628 ' HA ' HD21 ' A' ' 30' ' ' LEU . 3.2 p90 -45.8 -31.4 2.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.762 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.53 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.58 -41.65 99.78 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.178 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 2.9 tttt -58.16 -51.97 67.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.516 0.198 . . . . 0.0 110.785 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.803 ' CD1' HD11 ' A' ' 43' ' ' LEU . 3.1 mm? -53.36 -35.14 59.95 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.654 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.676 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -51.86 -53.52 39.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.215 0.531 . . . . 0.0 110.65 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -86.42 -23.1 26.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.126 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.911 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -75.77 -68.26 0.59 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.074 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.911 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.88 -8.3 10.3 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -179.011 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.661 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -63.66 125.79 25.44 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.66 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 46' ' ' ASP . 1.9 pt -107.61 -26.64 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 45' ' ' ILE . 34.1 t70 -127.7 97.32 4.8 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -177.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.94 142.25 4.33 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.813 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.566 ' O ' ' HE2' ' A' ' 51' ' ' LYS . . . -79.61 -43.73 9.99 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.237 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.47 ' CA ' ' HG2' ' A' ' 52' ' ' ARG . 50.7 m -63.66 -0.6 1.02 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.634 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.676 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . . . -49.79 -27.37 4.89 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.78 0.324 . . . . 0.0 111.42 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.566 ' HE2' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -87.96 -21.38 24.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.355 0.598 . . . . 0.0 111.716 -179.436 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.504 ' N ' ' HD2' ' A' ' 51' ' ' LYS . 1.4 ptp180 -103.59 24.92 10.37 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.193 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.53 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER 77.34 6.91 2.98 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.703 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.445 ' HA2' ' CB ' ' A' ' 49' ' ' SER . . . 73.07 24.42 75.82 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.877 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.9 ' HA ' HD21 ' A' ' 96' ' ' LEU . 82.0 p -66.73 88.61 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.872 0.367 . . . . 0.0 111.261 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.842 HD11 ' HB3' ' A' ' 14' ' ' HIS . 16.2 mt -60.36 -27.42 67.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.402 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.79 -172.99 27.74 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.252 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.547 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -59.07 119.19 6.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.05 0.453 . . . . 0.0 111.491 -179.504 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.526 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 3.1 m-85 -128.46 163.0 25.86 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -139.19 -173.88 13.26 Favored Glycine 0 C--N 1.315 -0.592 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.803 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.27 87.47 1.98 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.116 0.484 . . . . 0.0 109.904 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.59 36.69 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.918 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -147.31 -47.04 0.17 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.701 0.286 . . . . 0.0 111.083 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.4 mtm -98.3 168.43 10.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.098 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.784 HG23 ' H ' ' A' ' 68' ' ' PHE . 36.0 m -61.22 161.44 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.786 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.57 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 4.0 mtpt -61.22 -47.98 92.93 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 12.9 Cg_endo -64.23 -41.37 21.82 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.834 1.689 . . . . 0.0 111.809 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.784 ' H ' HG23 ' A' ' 65' ' ' VAL . 30.5 t80 -73.82 -52.35 13.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.628 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -57.73 -32.46 67.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.755 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.481 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 7.2 m-20 -62.47 -51.15 68.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.854 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.02 -9.5 58.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.664 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.99 -49.19 66.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.875 0.369 . . . . 0.0 111.589 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 9.0 p90 -93.32 16.68 12.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.381 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.14 -27.98 12.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.817 0.341 . . . . 0.0 110.798 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.511 HD11 ' O ' ' A' ' 80' ' ' VAL . 2.5 mt -103.55 54.7 0.75 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.471 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -62.16 -20.13 63.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.915 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -61.01 -26.92 40.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.225 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.46 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 95.25 55.13 1.39 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.845 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.501 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.6 tm-20 -139.51 176.16 8.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.746 0.308 . . . . 0.0 111.105 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 45.0 t -83.91 148.92 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.27 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.4 m -104.93 163.91 12.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.26 0.552 . . . . 0.0 111.588 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.499 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.5 mt-10 -50.86 155.0 2.16 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.384 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.467 ' HG3' HD23 ' A' ' 24' ' ' LEU . 11.2 Cg_endo -54.37 104.68 0.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.659 2.239 . . . . 0.0 112.047 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.567 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 67.4 t -101.47 105.2 17.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 5.1 tptm -94.32 112.99 24.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.757 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.451 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 0.5 OUTLIER -107.9 -175.41 2.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.544 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -59.06 -20.24 51.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.948 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -88.5 -40.8 13.17 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.303 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.22 -164.29 35.41 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.868 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.615 ' O ' HD13 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -81.35 98.29 8.1 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.75 ' CD2' HD21 ' A' ' 16' ' ' LEU . 35.9 m80 -81.22 169.53 17.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.833 -177.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.5 t -154.61 123.76 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.719 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -105.38 122.69 59.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.501 ' HG2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -128.32 116.13 19.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.495 178.294 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.46 ' CB ' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -58.54 136.04 57.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.507 0.67 . . . . 0.0 112.315 -178.612 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.9 HD21 ' HA ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -160.38 116.76 2.39 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.925 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.479 -1.178 . . . . 0.0 112.718 179.866 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 112.56 -0.216 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.86 -178.86 2.58 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.58 2.186 . . . . 0.0 112.237 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.3 mtt -69.23 125.87 28.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.08 42.94 1.7 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.509 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.0 t -69.76 155.83 39.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.903 0.382 . . . . 0.0 110.876 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.7 ttm -142.48 76.5 1.54 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -123.19 25.64 8.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.337 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -54.83 -49.18 71.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.176 0.512 . . . . 0.0 110.393 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.587 ' CD ' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -88.26 178.19 6.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.419 179.376 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 58' ' ' TYR . 1.5 mm -109.4 148.94 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 CA-C-O 121.714 0.769 . . . . 0.0 111.247 -178.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.658 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -124.75 77.22 1.58 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.943 -179.61 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.814 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 13.8 m -117.54 -179.91 3.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.171 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.825 ' HB2' HD23 ' A' ' 96' ' ' LEU . 3.5 t -109.38 163.67 13.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.297 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.698 ' C ' HD12 ' A' ' 15' ' ' ILE . 12.9 t60 -126.4 142.12 51.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.339 0.59 . . . . 0.0 112.061 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.792 HG23 ' OG ' ' A' ' 44' ' ' SER . 3.5 mp -151.27 120.32 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.93 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.866 HD11 ' CE1' ' A' ' 91' ' ' HIS . 0.4 OUTLIER -113.98 135.89 53.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.206 -178.621 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.828 HG21 ' CG ' ' A' ' 22' ' ' GLU . 15.4 m -151.83 134.11 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.682 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HE3' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -73.09 -35.0 66.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.955 0.407 . . . . 0.0 110.469 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.544 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 13.2 pttm -71.99 80.34 0.92 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.46 ' HG3' ' CZ ' ' A' ' 90' ' ' TYR . 30.9 tt0 -45.03 -25.75 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.376 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.56 -32.13 78.04 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.209 -1.472 . . . . 0.0 111.444 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.828 ' CG ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -69.05 -42.57 76.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.354 0.597 . . . . 0.0 109.662 178.326 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.511 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -46.97 -41.42 16.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.219 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.728 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -73.76 -28.9 61.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.078 179.101 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.41 -50.71 10.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.781 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 30' ' ' LEU . 11.3 m -54.25 -38.4 39.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.915 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.668 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 15.9 pt20 -53.7 -53.04 57.66 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.655 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.478 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.8 tt0 -73.28 -30.25 63.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.963 0.411 . . . . 0.0 110.937 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -77.47 -28.93 52.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.857 -178.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.71 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.8 OUTLIER -57.45 -58.02 10.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.785 -179.584 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -9.22 58.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.562 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.2 -25.99 64.44 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.856 0.36 . . . . 0.0 111.375 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.28 -17.21 0.52 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.694 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.448 ' CD ' HD21 ' A' ' 39' ' ' LEU . 24.6 pt-20 -88.11 157.59 18.81 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.054 0.454 . . . . 0.0 110.887 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.74 144.04 28.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.64 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.916 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 1.5 p90 -48.15 -34.8 10.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.951 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.7 -34.23 81.17 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.399 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.551 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -66.45 -53.75 31.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.706 0.288 . . . . 0.0 110.734 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.838 ' CD1' HD11 ' A' ' 43' ' ' LEU . 3.2 mm? -53.48 -34.76 59.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.34 -54.48 25.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.102 0.477 . . . . 0.0 110.893 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.15 -22.6 26.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.376 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.847 ' HB3' HD13 ' A' ' 43' ' ' LEU . 3.4 mm-40 -72.14 -69.28 0.41 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.039 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.847 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.52 -14.09 9.15 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.744 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.792 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -63.95 126.72 28.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.86 0.362 . . . . 0.0 111.088 -179.31 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.437 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.3 pt -95.89 -0.93 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.987 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.829 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 20.7 p-10 -46.35 135.9 7.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.017 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.691 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -61.6 -178.08 2.75 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.309 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.53 -42.34 0.0 OUTLIER Glycine 0 N--CA 1.468 0.794 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.691 ' N ' ' O ' ' A' ' 47' ' ' GLY . 0.4 OUTLIER -51.27 -20.01 1.48 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.504 0.652 . . . . 0.0 111.641 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.829 ' HB2' ' OD1' ' A' ' 46' ' ' ASP . . . -70.96 -20.67 62.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.819 0.343 . . . . 0.0 110.933 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -72.7 -10.75 60.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.148 0.499 . . . . 0.0 110.179 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.412 ' O ' ' CG ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -104.13 24.73 10.98 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.255 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.412 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 1.1 p30 59.45 28.76 18.21 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.049 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.89 20.25 25.47 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.758 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.0 92.69 4.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.963 0.411 . . . . 0.0 110.328 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.814 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 11.9 mt -66.61 -13.9 61.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.778 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 45.0 -164.56 0.06 OUTLIER Glycine 0 CA--C 1.505 -0.535 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.261 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.658 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 25.8 p90 -70.87 111.37 6.23 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.221 0.534 . . . . 0.0 111.881 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.447 ' CE2' ' O ' ' A' ' 56' ' ' LEU . 13.9 m-30 -132.95 148.4 52.28 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' CA ' ' HB2' ' A' ' 9' ' ' LYS . . . -108.1 -173.9 21.92 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.667 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ARG . . . . . 0.4 ' NH1' ' HB2' ' A' ' 61' ' ' ARG . 8.4 mtm105 -84.7 122.84 29.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.46 -20.34 1.51 Allowed Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.083 -1.056 . . . . 0.0 113.119 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.9 tptm -120.58 -22.55 6.35 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 9.8 mtp -91.12 162.25 14.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 0.0 111.055 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.778 HG23 ' H ' ' A' ' 68' ' ' PHE . 21.6 m -67.13 154.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.93 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.574 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 14.3 tttt -60.2 -47.07 97.65 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.645 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 17.8 Cg_endo -65.27 -42.28 13.82 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.864 1.71 . . . . 0.0 112.131 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.778 ' H ' HG23 ' A' ' 65' ' ' VAL . 22.8 t80 -74.91 -49.72 19.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.646 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.01 -31.51 67.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.855 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 27.5 t70 -67.16 -48.62 67.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.194 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.543 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.14 -9.63 58.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.931 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.458 ' O ' HG21 ' A' ' 10' ' ' ILE . . . -63.27 -44.71 94.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.726 0.298 . . . . 0.0 111.542 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 18.4 p90 -90.6 16.88 8.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.928 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.434 ' CG ' ' HA ' ' A' ' 71' ' ' ALA . 3.2 mmm180 -99.76 -30.67 11.94 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.78 0.324 . . . . 0.0 110.881 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 79' ' ' GLU . 2.7 mt -103.6 68.34 0.93 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.598 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -77.45 -16.84 58.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.98 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.38 -26.87 34.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.807 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.442 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 97.03 60.76 0.96 Allowed Glycine 0 CA--C 1.504 -0.65 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.577 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.558 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -142.02 176.44 8.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.794 0.331 . . . . 0.0 110.999 -178.359 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.641 HG11 ' HA ' ' A' ' 27' ' ' GLN . 58.2 t -84.9 147.07 5.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.942 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.97 161.3 14.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.266 0.555 . . . . 0.0 111.479 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.402 ' O ' HG23 ' A' ' 84' ' ' VAL . 7.2 mt-10 -50.81 155.87 1.84 Allowed Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.263 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.728 ' HG3' HD23 ' A' ' 24' ' ' LEU . 20.3 Cg_endo -59.99 105.74 0.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.347 2.031 . . . . 0.0 111.699 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.645 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 77.2 t -100.97 108.25 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.516 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 90' ' ' TYR . 3.7 tmtt? -91.74 113.07 25.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.082 0.467 . . . . 0.0 111.423 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -104.22 -171.4 1.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.119 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -12.88 43.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.366 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -99.7 -31.94 11.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.603 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.417 ' CA ' HD21 ' A' ' 16' ' ' LEU . . . 156.04 -170.9 33.83 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.542 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 1.2 m-85 -79.62 98.19 6.81 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.299 0.571 . . . . 0.0 110.303 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.866 ' CE1' HD11 ' A' ' 16' ' ' LEU . 3.2 m80 -80.46 169.94 17.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.318 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.421 ' HB ' ' HB ' ' A' ' 15' ' ' ILE . 12.5 t -145.85 140.69 21.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.818 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.577 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -120.99 122.6 68.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.958 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.495 ' HG2' HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -128.54 108.69 10.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.907 178.606 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -57.68 129.68 42.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.556 0.693 . . . . 0.0 112.166 -178.658 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.916 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -161.4 116.43 2.06 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.77 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.456 -1.191 . . . . 0.0 112.64 179.746 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.49 99.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.601 2.2 . . . . 0.0 112.317 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.4 ptp -99.6 129.08 45.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.92 45.47 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.555 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.1 p -74.31 164.11 27.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 110.889 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.1 mmt -106.82 -74.02 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.01 31.13 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.268 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.45 ' C ' ' HE3' ' A' ' 9' ' ' LYS . 1.6 m-20 -54.54 -27.23 37.0 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.607 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -84.22 163.68 19.56 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.973 -179.578 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.687 HD12 ' HB1' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -111.18 136.68 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.08 178.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.477 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.7 mtpt -105.87 97.44 7.26 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.561 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.917 ' SG ' HG22 ' A' ' 93' ' ' ILE . 3.0 t -126.34 179.34 5.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.814 -178.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.829 ' HB2' HD23 ' A' ' 96' ' ' LEU . 6.4 t -124.06 163.31 21.71 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.641 ' HB3' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -133.16 152.41 51.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.207 0.527 . . . . 0.0 112.023 -179.605 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.802 HG23 ' OG ' ' A' ' 44' ' ' SER . 3.0 mp -151.07 115.4 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.137 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.8 HD13 ' CD2' ' A' ' 91' ' ' HIS . 7.4 tp -102.15 128.73 48.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.874 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.823 HG11 ' OE1' ' A' ' 22' ' ' GLU . 14.5 m -142.1 134.28 27.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.596 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -74.6 -35.93 62.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.463 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.638 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 10.7 tttp -72.48 79.32 1.04 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.414 ' HG2' ' CD1' ' A' ' 90' ' ' TYR . 29.5 mt-30 -46.27 -25.94 0.71 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.969 -176.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.41 -31.24 76.38 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 119.216 -1.469 . . . . 0.0 110.953 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.823 ' OE1' HG11 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -70.68 -38.54 73.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.047 0.451 . . . . 0.0 110.296 178.827 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.607 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.34 -37.77 38.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.107 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.661 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.19 -29.53 62.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.809 179.129 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.05 -49.44 8.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.18 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.735 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.6 m -49.32 -37.24 10.41 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.13 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.729 ' HA ' HG11 ' A' ' 80' ' ' VAL . 9.4 pt20 -59.28 -48.95 79.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.566 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 3.7 pt-20 -73.17 -29.03 62.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.759 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.594 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 5.9 tpt180 -78.64 -35.13 45.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.965 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 36' ' ' PHE . 1.1 tm? -53.04 -55.6 22.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.271 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -9.62 58.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.273 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.09 -22.95 61.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.871 0.367 . . . . 0.0 111.159 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.08 -17.27 1.37 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.309 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -80.67 157.59 25.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.902 0.382 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -100.06 144.84 28.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.918 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.878 ' CE1' HD22 ' A' ' 96' ' ' LEU . 6.2 p90 -53.65 -33.42 55.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.932 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.77 -33.96 87.04 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.462 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 4.0 tttt -68.35 -52.9 28.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 111.165 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.995 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.42 -33.16 52.87 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.834 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.558 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.57 -52.98 42.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.122 0.487 . . . . 0.0 110.659 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -86.3 -23.41 26.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.192 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.886 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -71.2 -68.67 0.42 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.412 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.995 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.0 -13.35 9.43 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.495 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.802 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -64.06 142.22 58.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.958 0.409 . . . . 0.0 110.833 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.742 HG13 ' HB3' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -105.5 -6.19 9.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.115 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.771 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 29.4 p-10 -46.37 135.51 8.09 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.674 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.33 -178.63 3.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.626 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.84 -43.63 0.0 OUTLIER Glycine 0 C--N 1.34 0.762 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.674 ' N ' ' O ' ' A' ' 47' ' ' GLY . 1.1 m -51.53 -18.27 1.06 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.301 0.551 . . . . 0.0 111.764 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.771 ' HB2' ' OD1' ' A' ' 46' ' ' ASP . . . -70.79 -20.81 62.55 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.979 0.419 . . . . 0.0 110.842 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -6.38 51.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.463 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.32 24.78 11.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.234 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 p30 58.64 28.86 17.74 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.155 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.69 22.18 31.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.825 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.529 ' HA ' HD21 ' A' ' 96' ' ' LEU . 0.7 OUTLIER -69.88 86.94 0.52 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.874 0.369 . . . . 0.0 110.841 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.698 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 16.4 mt -56.66 -28.97 61.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.463 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 67.39 -165.12 43.97 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.739 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.527 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -67.98 120.95 15.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.203 0.525 . . . . 0.0 111.895 -179.402 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.524 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 11.7 m-30 -133.08 153.72 51.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.121 177.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -121.4 -174.0 14.72 Favored Glycine 0 C--N 1.318 -0.465 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.469 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.93 85.66 6.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.373 . . . . 0.0 110.186 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.33 36.75 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.048 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.91 -48.55 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.806 0.303 . . . . 0.0 111.243 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.66 170.18 10.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 111.134 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.772 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.5 m -57.48 167.37 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.776 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.525 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -64.93 -47.9 73.06 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.989 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.539 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 13.0 Cg_endo -66.3 -39.55 17.23 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.873 1.715 . . . . 0.0 112.064 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.772 ' H ' HG23 ' A' ' 65' ' ' VAL . 11.4 t80 -74.99 -50.79 15.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.819 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -58.92 -32.8 69.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.801 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 59.4 t0 -67.8 -46.39 72.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.002 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.0 -14.41 60.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.647 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.687 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -56.33 -46.38 79.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.741 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.458 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 12.1 p90 -92.05 16.64 10.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.528 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.49 -27.5 15.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.342 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.783 HD13 ' O ' ' A' ' 79' ' ' GLU . 4.8 mt -102.35 60.43 0.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.813 0.34 . . . . 0.0 111.449 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -68.08 -25.04 65.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.009 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -70.82 -26.84 28.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.556 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.479 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 92.65 69.33 1.13 Allowed Glycine 0 CA--C 1.501 -0.806 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.599 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.783 ' O ' HD13 ' A' ' 75' ' ' LEU . 1.4 tm-20 -142.25 177.86 7.96 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.111 -0.544 . . . . 0.0 110.08 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.729 HG11 ' HA ' ' A' ' 27' ' ' GLN . 97.8 t -79.58 151.25 4.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.778 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -104.69 157.06 17.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.334 0.588 . . . . 0.0 111.528 -178.374 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.488 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.5 mt-10 -52.36 154.67 4.13 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.237 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.424 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 14.0 Cg_endo -55.2 103.5 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.763 2.309 . . . . 0.0 111.762 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 92.9 t -101.8 99.68 8.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.564 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.449 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -92.06 112.72 24.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.063 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.428 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 74.1 m -114.48 -175.6 2.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.463 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -56.07 -21.9 24.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.751 0.31 . . . . 0.0 110.874 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -86.78 -23.67 25.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.311 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.97 -170.73 23.05 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.821 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 0.2 OUTLIER -74.66 98.66 3.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.038 0.446 . . . . 0.0 109.905 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.8 ' CD2' HD13 ' A' ' 16' ' ' LEU . 79.4 m80 -86.38 169.34 13.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.455 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.6 t -145.21 153.26 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.664 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.917 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -137.27 122.4 25.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.062 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.404 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 4.1 tptt -128.63 112.87 14.72 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.528 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -57.23 136.5 56.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.701 0.762 . . . . 0.0 112.436 -177.815 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.878 HD22 ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -159.01 116.82 2.83 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.814 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.565 179.871 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.609 -0.196 . . . . 0.0 112.609 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.5 92.99 0.58 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.623 2.215 . . . . 0.0 112.408 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.56 112.81 6.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.15 44.18 2.08 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.575 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.2 t -72.79 123.44 23.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 110.742 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 19.3 mtt -146.2 -43.58 0.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.286 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.66 30.73 1.48 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.408 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -63.03 -17.96 62.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.883 0.373 . . . . 0.0 110.73 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.63 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.71 172.52 11.45 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.583 0.706 . . . . 0.0 112.332 -179.172 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.408 HD13 ' HB3' ' A' ' 73' ' ' PHE . 0.6 OUTLIER -111.2 139.89 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.978 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.5 mtpt -108.88 96.91 6.65 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.446 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.929 ' SG ' HG22 ' A' ' 93' ' ' ILE . 3.0 t -125.86 179.13 5.34 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.876 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.834 ' OG ' HD23 ' A' ' 96' ' ' LEU . 0.9 OUTLIER -123.49 161.4 24.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.403 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.866 ' CG ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -136.59 153.4 50.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.534 0.683 . . . . 0.0 112.664 -179.376 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.749 HG23 ' OG ' ' A' ' 44' ' ' SER . 2.6 mp -152.14 115.14 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.85 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.603 HD11 ' NE2' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -100.4 128.41 46.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.852 -179.129 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.73 HG11 ' OE1' ' A' ' 22' ' ' GLU . 10.9 m -145.14 134.38 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.054 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -76.1 -35.81 59.18 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.603 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -72.25 79.7 0.99 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.45 ' HG3' ' CE1' ' A' ' 90' ' ' TYR . 34.6 tt0 -46.05 -25.47 0.58 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.9 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.86 -31.58 78.61 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 118.836 -1.65 . . . . 0.0 110.44 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.883 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -73.21 -37.96 66.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.079 0.466 . . . . 0.0 109.957 178.194 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.609 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -54.08 -35.9 62.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.908 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.647 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -73.76 -29.39 62.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.802 178.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.87 -48.33 10.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.187 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.1 m -49.74 -38.93 14.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.066 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.647 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.6 pt20 -58.83 -48.87 79.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.585 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 4.4 pt-20 -73.19 -29.36 62.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.598 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.58 -31.2 47.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.743 -178.846 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.634 HD12 ' NZ ' ' A' ' 94' ' ' LYS . 1.3 tm? -56.82 -58.95 5.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.238 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -9.51 58.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.626 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.3 -23.35 62.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 111.397 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.23 -15.91 0.88 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.719 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -89.37 157.49 18.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.751 0.31 . . . . 0.0 110.862 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 pttt -100.68 153.95 19.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.133 0.492 . . . . 0.0 111.148 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.7 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 2.5 p90 -52.63 -40.34 62.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.117 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.404 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -55.4 -34.17 59.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.704 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -67.21 -54.04 24.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.779 0.323 . . . . 0.0 110.854 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.002 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -55.92 -32.28 63.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.827 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.27 -53.78 32.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.948 0.404 . . . . 0.0 110.811 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -86.16 -23.37 26.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.164 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.872 ' HB3' HD13 ' A' ' 43' ' ' LEU . 3.0 mm-40 -70.02 -68.94 0.38 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.389 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.002 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.77 -13.55 9.09 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.703 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.749 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -64.1 133.59 53.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.912 0.387 . . . . 0.0 111.195 -179.178 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.464 HG13 ' HB3' ' A' ' 16' ' ' LEU . 1.4 pt -99.94 -8.51 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.064 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.8 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 18.9 p-10 -46.05 135.62 7.34 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.674 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.02 -178.45 3.28 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.0 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.66 -43.1 0.0 OUTLIER Glycine 0 C--N 1.34 0.797 0 N-CA-C 115.629 1.012 . . . . 0.0 115.629 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.674 ' N ' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -51.43 -18.69 1.11 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 117.394 0.597 . . . . 0.0 111.614 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.8 ' HB2' ' OD1' ' A' ' 46' ' ' ASP . . . -70.58 -20.37 62.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.941 0.401 . . . . 0.0 110.926 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -76.79 -4.34 42.98 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.361 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.23 24.59 11.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.422 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.404 ' HB2' ' CA ' ' A' ' 37' ' ' GLY . 1.6 p30 55.74 31.82 18.24 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.337 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 52.97 33.45 44.02 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.914 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 m -84.82 89.43 7.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 110.847 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.866 HD21 ' CG ' ' A' ' 14' ' ' HIS . 69.6 mt -56.35 -30.05 62.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.503 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 64.54 -165.67 32.01 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.887 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.518 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -68.82 111.01 4.63 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.515 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.63 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 4.9 m-85 -117.03 153.94 31.82 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.04 -174.14 17.51 Favored Glycine 0 C--N 1.312 -0.784 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.446 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -79.57 79.86 6.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.138 0.494 . . . . 0.0 110.033 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.94 36.62 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.66 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -126.6 -41.57 1.85 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.594 0.235 . . . . 0.0 111.181 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -114.51 171.3 7.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.049 0.452 . . . . 0.0 111.297 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.783 HG23 ' H ' ' A' ' 68' ' ' PHE . 32.7 m -52.35 161.92 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.406 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.598 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -65.59 -47.4 67.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.612 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 15.7 Cg_endo -63.27 -40.31 33.09 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.028 1.819 . . . . 0.0 111.893 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.783 ' H ' HG23 ' A' ' 65' ' ' VAL . 35.6 t80 -74.93 -52.64 10.71 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.036 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -57.55 -32.48 67.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.8 OUTLIER -63.13 -50.68 69.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.047 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.535 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.0 -9.98 59.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.65 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.04 99.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.808 0.337 . . . . 0.0 111.293 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 20.2 p90 -96.46 16.83 17.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.419 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.87 -30.76 12.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.931 0.396 . . . . 0.0 110.827 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 79' ' ' GLU . 4.2 mt -103.57 68.21 0.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.262 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -73.26 -18.26 61.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.155 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -66.55 -26.75 38.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.755 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.431 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 95.18 57.14 1.23 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.598 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.513 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -138.64 176.45 8.68 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.839 0.352 . . . . 0.0 110.801 -178.434 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 27' ' ' GLN . 42.6 t -84.43 146.08 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.502 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 t -105.37 164.07 12.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.171 0.51 . . . . 0.0 111.477 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 84' ' ' VAL . 6.6 mp0 -50.89 154.72 2.33 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.107 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.48 105.32 0.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.25 1.967 . . . . 0.0 111.797 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.612 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 59.4 t -101.19 102.14 13.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.549 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.472 ' HG2' ' CD2' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -92.11 113.14 25.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.315 -179.628 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.96 -171.46 1.89 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.205 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' OE2' HG11 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -56.88 -19.13 15.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.532 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -92.24 -40.82 10.76 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.43 ' CA ' HD21 ' A' ' 16' ' ' LEU . . . 159.89 -172.19 36.38 Favored Glycine 0 CA--C 1.506 -0.473 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.731 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.472 ' CD2' ' HG2' ' A' ' 85' ' ' LYS . 6.2 m-85 -74.91 98.19 3.51 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.364 0.602 . . . . 0.0 110.162 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.603 ' NE2' HD11 ' A' ' 16' ' ' LEU . 79.9 m80 -82.4 169.14 16.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.465 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 17.9 t -145.49 146.51 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.295 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.929 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -131.22 122.7 51.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.675 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.634 ' NZ ' HD12 ' A' ' 30' ' ' LEU . 8.2 tptm -128.29 109.96 11.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.468 178.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.17 134.5 55.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.631 0.729 . . . . 0.0 112.298 -177.62 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.834 HD23 ' OG ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -157.51 116.67 3.28 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.67 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.42 -1.211 . . . . 0.0 112.604 179.831 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.11 163.16 39.55 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.574 2.183 . . . . 0.0 112.323 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.99 149.4 47.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.84 31.49 1.45 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.616 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.11 123.74 32.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.787 0.327 . . . . 0.0 110.855 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.5 tpp 61.16 103.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.589 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.51 35.06 1.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.29 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.501 ' CB ' ' HE3' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -55.97 -25.57 44.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.606 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.615 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.26 168.33 15.8 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.51 0.671 . . . . 0.0 111.728 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.428 HD13 ' HB3' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -111.39 139.48 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.821 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.9 mtpt -109.63 96.57 6.36 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.653 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.845 ' SG ' HG22 ' A' ' 93' ' ' ILE . 2.6 t -131.6 179.62 5.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.63 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.764 ' HB2' HD23 ' A' ' 96' ' ' LEU . 6.5 t -127.47 162.74 25.66 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.741 ' CD2' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -134.17 148.92 50.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.349 0.595 . . . . 0.0 112.556 -179.404 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.678 HD12 ' C ' ' A' ' 14' ' ' HIS . 3.6 mp -145.49 131.39 13.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.709 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.735 HD23 ' O ' ' A' ' 90' ' ' TYR . 2.0 mt -123.31 133.41 54.15 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.922 HG21 ' CG ' ' A' ' 22' ' ' GLU . 21.5 m -150.91 135.85 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.695 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -17.64 64.59 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HB3' ' CG ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -72.22 78.34 0.97 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.683 179.062 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.443 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -47.07 -41.71 17.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.017 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.6 -31.46 73.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.959 -1.115 . . . . 0.0 112.898 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.922 ' CG ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -65.58 -44.44 86.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.223 0.535 . . . . 0.0 110.666 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.547 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -47.67 -40.6 20.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.286 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.789 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.3 OUTLIER -72.9 -28.87 62.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.045 179.159 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.44 -44.23 17.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.254 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.7 m -58.2 -29.0 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.727 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 14.5 pt20 -54.91 -53.47 55.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.989 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.499 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.0 OUTLIER -73.83 -28.91 61.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.127 0.489 . . . . 0.0 110.634 178.551 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.9 OUTLIER -75.98 -34.29 59.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.273 -178.51 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.863 HD21 ' HA ' ' A' ' 36' ' ' PHE . 1.1 tm? -52.81 -49.68 65.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.173 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 -9.19 58.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.301 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -74.36 49.11 0.36 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.52 -10.51 36.79 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.758 -0.734 . . . . 0.0 114.171 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.426 ' OE2' HD21 ' A' ' 39' ' ' LEU . 7.0 pt-20 -92.62 153.83 18.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.378 0.589 . . . . 0.0 110.852 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 143.38 30.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.274 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.909 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 5.2 p90 -52.89 -35.79 58.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.748 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.46 -36.37 93.05 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.27 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 10.5 tttt -60.83 -53.77 53.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.843 0.354 . . . . 0.0 110.807 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.968 HD12 HD11 ' A' ' 43' ' ' LEU . 2.8 mm? -53.64 -34.12 57.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.007 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.459 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.63 -53.41 38.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.956 0.408 . . . . 0.0 110.81 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -23.55 26.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.934 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.824 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -68.96 -68.69 0.38 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.076 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.968 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.66 -16.07 8.86 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.562 ' N ' HD22 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -64.23 141.5 58.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.192 0.52 . . . . 0.0 111.522 -179.193 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.444 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.9 pt -105.74 -9.08 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.894 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 3.2 t70 -46.08 135.6 7.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.005 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.675 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -61.47 -178.08 2.63 Favored Glycine 0 C--O 1.226 -0.35 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.508 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 51' ' ' LYS . . . -11.14 -44.22 0.0 OUTLIER Glycine 0 N--CA 1.468 0.827 0 N-CA-C 115.512 0.965 . . . . 0.0 115.512 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.675 ' N ' ' O ' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -51.58 -31.14 23.55 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.759 0.78 . . . . 0.0 111.042 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 46' ' ' ASP . . . -72.49 -26.37 61.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.245 0.545 . . . . 0.0 110.548 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.6 OUTLIER -72.6 -13.17 61.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.942 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.87 24.43 11.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.381 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.436 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 73.5 9.24 5.06 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.27 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.3 24.63 70.76 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.225 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.4 p -75.94 82.77 2.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.97 0.414 . . . . 0.0 110.615 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.741 HD21 ' CD2' ' A' ' 14' ' ' HIS . 14.6 mt -53.94 -24.5 16.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.992 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 61.04 -163.67 20.03 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.828 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.468 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -72.68 111.51 7.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.995 0.426 . . . . 0.0 111.744 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.615 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 3.8 m-85 -123.71 163.62 20.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.77 -173.99 14.96 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.628 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.55 93.89 7.94 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.897 0.38 . . . . 0.0 110.189 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.42 36.79 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.854 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.43 -44.54 0.22 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.622 0.249 . . . . 0.0 111.241 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.05 165.74 13.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 111.298 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.734 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.9 m -61.7 165.06 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.894 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.526 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -60.63 -48.06 94.34 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 13.8 Cg_endo -66.2 -37.68 23.95 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 121.897 1.731 . . . . 0.0 111.962 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.734 ' H ' HG23 ' A' ' 65' ' ' VAL . 40.0 t80 -74.96 -52.31 11.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.905 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.79 -32.27 63.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.799 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 2.6 m-20 -65.19 -52.08 57.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.995 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.437 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.09 -9.28 58.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.908 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.27 -38.31 71.85 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 2.8 p90 -106.04 16.76 24.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -98.76 -27.69 13.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.329 . . . . 0.0 110.98 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 79' ' ' GLU . 3.1 mt -103.47 66.43 0.88 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.076 0.465 . . . . 0.0 111.447 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -73.29 -18.23 61.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.005 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.96 -27.0 39.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.663 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.438 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 95.6 58.74 1.11 Allowed Glycine 0 CA--C 1.503 -0.67 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.536 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.524 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.33 176.28 8.9 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.776 0.322 . . . . 0.0 111.084 -178.477 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.657 HG11 ' HA ' ' A' ' 27' ' ' GLN . 55.6 t -82.84 146.58 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.158 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 t -104.84 164.14 12.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.346 0.593 . . . . 0.0 111.917 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -50.75 156.42 1.62 Allowed Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.634 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.789 ' HG3' HD23 ' A' ' 24' ' ' LEU . 26.9 Cg_endo -61.09 105.17 0.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.583 2.188 . . . . 0.0 112.141 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 87.7 t -101.27 99.47 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.582 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.453 ' HG3' ' CD1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -97.97 112.79 24.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.798 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.9 m -110.62 -175.75 2.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.635 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.34 -21.64 25.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.093 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -85.45 -26.73 26.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.38 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 144.18 -165.32 27.42 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.771 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.735 ' O ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -83.26 106.68 15.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.472 ' NE2' HD11 ' A' ' 16' ' ' LEU . 41.6 m80 -92.64 157.92 16.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.476 0.655 . . . . 0.0 112.597 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.1 t -140.72 153.17 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.264 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.845 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -141.26 124.16 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.878 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -128.11 113.87 16.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.282 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.5 135.4 56.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.54 0.686 . . . . 0.0 112.231 -177.617 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.909 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -157.38 116.65 3.32 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.733 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.605 -179.999 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.454 -0.258 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.21 125.44 17.46 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.643 2.229 . . . . 0.0 112.308 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.2 mtp -110.21 126.1 53.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.854 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.82 52.42 1.8 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.573 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.43 140.89 29.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.754 0.312 . . . . 0.0 110.878 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.4 tpt -96.32 158.37 15.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.15 29.86 3.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.132 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.477 ' CB ' ' HE3' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -56.84 -22.36 36.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.844 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.716 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.27 168.55 15.58 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.429 0.633 . . . . 0.0 111.595 -179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -111.31 139.11 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.828 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.499 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.5 mtpt -107.93 98.3 7.9 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.366 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.786 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 2.1 t -130.32 -179.84 5.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.824 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.773 ' HB2' HD23 ' A' ' 96' ' ' LEU . 34.4 t -120.73 162.89 18.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.975 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.753 ' CG ' HD21 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -130.33 139.32 50.7 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.997 0.427 . . . . 0.0 111.781 -179.694 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.707 HD12 ' C ' ' A' ' 14' ' ' HIS . 4.7 mp -153.3 118.97 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.838 HD13 ' HB3' ' A' ' 46' ' ' ASP . 0.3 OUTLIER -109.63 140.91 42.89 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.922 0.391 . . . . 0.0 111.034 179.649 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.731 HG21 ' HG3' ' A' ' 22' ' ' GLU . 4.4 m -149.1 134.35 10.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.732 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.545 ' CD ' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -72.0 -35.86 69.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.808 -178.796 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.623 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 4.7 tttp -72.83 78.8 1.14 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.497 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 4.6 mp0 -46.64 -25.99 0.82 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.027 -0.988 . . . . 0.0 113.225 -176.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.54 -31.53 76.72 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 119.026 -1.559 . . . . 0.0 110.921 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.887 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -71.07 -38.81 72.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.059 0.457 . . . . 0.0 110.491 178.725 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.616 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -52.03 -37.15 52.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.363 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.545 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.25 -29.86 63.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.646 179.046 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.99 -41.45 18.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.496 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.887 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.1 m -52.33 -37.83 24.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.014 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.656 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -59.24 -48.84 80.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.656 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.3 pt-20 -73.27 -29.0 62.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.66 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.54 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 8.1 tpt180 -78.86 -32.28 45.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.01 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.444 ' CD2' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -53.12 -59.4 4.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.171 -179.048 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -72.46 -9.44 58.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.371 179.498 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.04 -24.96 63.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.858 0.361 . . . . 0.0 111.327 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.4 -17.01 0.77 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.579 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.52 ' CD ' HD21 ' A' ' 39' ' ' LEU . 8.1 pt-20 -86.84 154.99 20.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.901 0.382 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.92 146.2 27.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.129 0.49 . . . . 0.0 111.079 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.913 ' CE1' HD22 ' A' ' 96' ' ' LEU . 3.7 p90 -47.1 -30.76 2.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.743 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.47 -34.24 88.81 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.178 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -66.64 -53.47 33.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.766 0.317 . . . . 0.0 110.765 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.763 HD12 HD11 ' A' ' 43' ' ' LEU . 3.1 mm? -53.37 -36.07 60.99 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.273 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 44' ' ' SER . . . -52.1 -52.94 48.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.178 0.513 . . . . 0.0 110.701 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.57 -23.57 27.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.727 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.952 ' HB3' HD13 ' A' ' 43' ' ' LEU . 1.1 mt-10 -73.58 -67.86 0.55 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.952 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.99 -12.56 9.51 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.53 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 3.3 t -63.12 125.98 25.86 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.891 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.545 HD13 ' CD ' ' A' ' 18' ' ' LYS . 3.8 pt -107.86 -26.97 3.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.838 ' HB3' HD13 ' A' ' 16' ' ' LEU . 23.7 t0 -127.57 102.38 6.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.81 143.64 4.9 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.86 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.25 -35.39 23.74 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.68 0.16 21.36 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.244 -0.478 . . . . 0.0 111.008 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.504 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . . . -62.16 -23.67 66.73 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.345 0.593 . . . . 0.0 109.586 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -88.78 -5.29 58.17 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.2 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.431 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 2.5 mtt180 -119.06 24.98 10.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.84 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.516 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 76.39 16.06 2.15 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.332 -179.722 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.18 17.01 65.39 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.577 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.714 ' HA ' HD21 ' A' ' 96' ' ' LEU . 7.0 m -70.91 86.32 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.672 0.272 . . . . 0.0 110.901 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.786 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 23.4 mt -54.77 -31.15 58.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.037 0.446 . . . . 0.0 110.577 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 69.94 -170.29 44.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.43 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.499 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -67.87 111.58 4.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 111.625 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.716 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 6.4 m-85 -123.89 159.21 30.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.666 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.72 -174.06 18.67 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.293 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -88.01 96.82 10.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.988 0.423 . . . . 0.0 110.335 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.16 36.73 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.373 -0.917 . . . . 0.0 113.067 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 tptm -143.45 -47.51 0.3 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.75 0.31 . . . . 0.0 111.259 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.416 ' HG2' ' HG3' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -91.17 166.93 12.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.878 0.371 . . . . 0.0 111.278 -179.706 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.758 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.0 m -54.63 165.75 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.174 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.533 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 20.7 tttm -64.29 -47.93 77.15 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 14.0 Cg_endo -65.46 -38.16 27.02 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 121.861 1.708 . . . . 0.0 111.939 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.758 ' H ' HG23 ' A' ' 65' ' ' VAL . 24.4 t80 -74.94 -52.69 10.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.647 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.416 ' HG3' ' HG2' ' A' ' 64' ' ' MET . 0.8 OUTLIER -57.17 -34.03 68.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.779 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 23.6 t0 -69.03 -47.95 64.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.059 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.426 ' HB3' HD11 ' A' ' 93' ' ' ILE . . . -75.33 -9.69 58.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.785 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.37 -49.03 68.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.785 0.326 . . . . 0.0 111.709 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 3.0 p90 -92.7 16.92 11.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.601 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.7 -29.37 14.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 79' ' ' GLU . 4.3 mt -103.57 66.01 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.474 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -69.9 -19.97 63.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.061 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 p -64.54 -26.88 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.57 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.425 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 94.22 58.05 1.25 Allowed Glycine 0 CA--C 1.504 -0.645 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.719 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.522 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -140.13 176.37 8.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.779 0.323 . . . . 0.0 111.077 -178.475 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.508 ' O ' HD11 ' A' ' 75' ' ' LEU . 86.2 t -81.28 146.7 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.0 t -104.68 164.1 12.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.222 0.534 . . . . 0.0 111.777 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -50.54 155.08 1.96 Allowed Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.328 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.533 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 18.5 Cg_endo -60.18 106.33 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.358 2.038 . . . . 0.0 111.741 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 97.5 t -100.95 100.22 9.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.608 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.7 OUTLIER -94.53 112.96 24.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.942 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.63 -172.11 1.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.505 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -57.54 -20.95 35.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.858 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -85.86 -37.23 19.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.245 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.81 -168.46 30.56 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.656 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.533 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -75.34 98.57 3.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.005 0.431 . . . . 0.0 109.926 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.658 ' CD2' HD11 ' A' ' 16' ' ' LEU . 70.1 m80 -80.41 165.08 22.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.397 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.7 t -149.19 138.38 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.762 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.745 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -127.99 122.7 59.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.741 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.482 ' HG2' HG22 ' A' ' 80' ' ' VAL . 1.4 tmtm? -126.18 112.27 15.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.186 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.5 132.33 52.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.559 0.695 . . . . 0.0 111.89 -177.697 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.913 HD22 ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -155.06 116.75 4.09 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.685 179.643 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.339 -1.256 . . . . 0.0 112.619 179.914 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.96 126.98 13.8 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.652 2.235 . . . . 0.0 112.294 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.1 ttm -96.35 145.76 25.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.937 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.61 43.31 0.12 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.547 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 m -76.09 141.07 42.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.711 0.291 . . . . 0.0 110.954 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 82.5 mtp -123.0 -41.01 2.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.143 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.54 31.3 3.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.457 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.17 -24.77 28.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.906 0.384 . . . . 0.0 110.661 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.484 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 3.5 mptt -85.01 161.22 19.83 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.707 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 mt -111.03 128.08 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.349 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.8 mtpt -97.9 92.73 5.96 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.109 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.888 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -124.06 -179.89 4.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.309 -177.552 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.791 ' HB2' HD23 ' A' ' 96' ' ' LEU . 2.0 t -123.14 160.17 27.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.954 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.734 ' CD2' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -136.29 147.23 47.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.335 0.588 . . . . 0.0 111.977 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.75 HG23 ' OG ' ' A' ' 44' ' ' SER . 3.2 mp -151.91 115.39 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.314 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.584 ' HB3' ' CG1' ' A' ' 45' ' ' ILE . 7.7 tp -100.77 132.37 46.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.785 HG11 ' OE1' ' A' ' 22' ' ' GLU . 12.3 m -146.07 134.11 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.815 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -75.01 -36.29 61.94 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.415 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.614 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -71.84 79.35 0.87 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.597 0.713 . . . . 0.0 109.078 178.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.513 ' HG3' ' CZ ' ' A' ' 90' ' ' TYR . 1.3 tm0? -45.71 -25.73 0.53 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.218 -177.254 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.73 -31.55 78.72 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 118.774 -1.679 . . . . 0.0 110.688 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.901 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -71.77 -39.41 69.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.152 0.501 . . . . 0.0 109.803 178.146 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.689 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -51.5 -36.91 46.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.996 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.627 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.55 -29.44 62.44 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.949 179.011 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.08 -40.46 16.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.51 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.901 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.3 m -56.92 -37.55 54.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.058 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.0 pt20 -56.84 -51.33 69.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.558 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.6 pt-20 -73.45 -29.18 62.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.618 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.534 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.5 tpt180 -75.6 -33.57 60.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.633 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.462 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -52.94 -58.91 5.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 -179.44 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -8.78 56.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.521 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -56.99 -20.09 21.95 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.39 -10.47 1.73 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.131 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.493 ' OE1' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -103.77 158.2 16.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.904 0.383 . . . . 0.0 110.677 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -97.29 154.26 17.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.37 0.605 . . . . 0.0 112.17 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.71 ' CE1' HD22 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -53.0 -35.22 59.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.388 179.316 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA2' ' CA ' ' A' ' 53' ' ' ASP . . . -53.54 -34.16 49.01 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.001 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 9.7 mtpp -69.98 -53.63 16.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.656 0.265 . . . . 0.0 110.442 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.989 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -54.0 -33.36 56.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.716 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.59 -53.36 39.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.071 0.462 . . . . 0.0 110.657 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.21 -23.33 26.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.214 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.851 ' HB3' HD13 ' A' ' 43' ' ' LEU . 1.3 mt-10 -71.15 -69.18 0.39 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.989 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.78 -11.64 9.34 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.582 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.75 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -63.9 138.53 58.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.03 0.443 . . . . 0.0 111.33 -179.035 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.584 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 43.1 pt -104.66 -12.67 9.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.959 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.78 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 21.7 p-10 -45.67 135.14 6.91 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.325 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.66 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.68 -178.63 3.99 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.109 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 51' ' ' LYS . . . -11.86 -43.13 0.0 OUTLIER Glycine 0 N--CA 1.468 0.802 0 N-CA-C 115.571 0.988 . . . . 0.0 115.571 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.66 ' N ' ' O ' ' A' ' 47' ' ' GLY . 3.8 m -51.17 -21.5 2.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.573 0.686 . . . . 0.0 111.379 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.78 ' HB2' ' OD1' ' A' ' 46' ' ' ASP . . . -71.2 -20.77 62.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.924 0.392 . . . . 0.0 111.255 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -67.8 -8.08 32.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.17 -179.004 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 49' ' ' SER . 11.5 ptp180 -104.21 23.69 12.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.89 0.376 . . . . 0.0 110.702 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.433 ' CA ' ' HA2' ' A' ' 37' ' ' GLY . 0.0 OUTLIER 71.96 13.0 6.04 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.241 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.3 16.69 80.52 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.418 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . 0.631 ' HA ' HD21 ' A' ' 96' ' ' LEU . 1.1 m -74.06 89.77 1.97 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.783 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.888 HD12 ' SG ' ' A' ' 12' ' ' CYS . 13.2 mt -56.5 -28.35 59.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.665 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.59 -166.62 42.35 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -68.31 118.71 11.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.112 0.482 . . . . 0.0 111.923 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.484 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 10.5 m-85 -131.57 150.44 52.15 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.39 -173.88 18.27 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.577 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 -76.27 81.97 3.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 110.084 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.46 36.67 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.939 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -134.8 -48.52 0.75 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.815 0.34 . . . . 0.0 111.232 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.58 170.61 8.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.137 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.789 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.0 m -57.06 159.56 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -62.1 -47.9 89.44 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.612 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 17.5 Cg_endo -64.63 -39.2 28.27 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.932 1.754 . . . . 0.0 112.115 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.859 ' CZ ' HG23 ' A' ' 93' ' ' ILE . 17.6 t80 -74.92 -52.02 12.3 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.728 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 4.0 tm-20 -56.01 -32.29 63.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.676 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.459 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -64.26 -52.62 57.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.871 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.531 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.0 -11.96 60.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.638 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.32 -48.5 81.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.799 0.333 . . . . 0.0 111.407 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.459 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 6.7 p90 -93.23 16.83 12.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.372 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.31 -28.58 13.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.895 0.379 . . . . 0.0 110.834 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 79' ' ' GLU . 3.0 mt -103.63 62.81 0.77 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.291 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -69.61 -18.39 63.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.087 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -64.61 -26.86 41.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.53 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.27 56.88 1.24 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.669 -0.776 . . . . 0.0 111.731 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.513 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.7 tm-20 -139.36 176.29 8.84 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.89 0.376 . . . . 0.0 110.982 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 27' ' ' GLN . 61.1 t -84.29 147.55 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.069 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.97 164.12 12.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.225 0.536 . . . . 0.0 111.431 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.0 mp0 -50.48 154.43 2.22 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.986 -178.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.517 ' HG3' HD23 ' A' ' 24' ' ' LEU . 19.1 Cg_endo -60.0 104.97 0.25 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.177 1.918 . . . . 0.0 111.819 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.612 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 59.3 t -101.33 102.0 12.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.528 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 90' ' ' TYR . 3.9 tmtt? -92.38 112.87 24.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.351 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.4 -171.58 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.141 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -16.26 40.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.217 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -94.01 -40.82 9.9 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.65 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.17 -174.24 40.25 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.812 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 1.7 m-85 -76.92 98.38 4.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.233 0.54 . . . . 0.0 110.374 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.47 ' CD2' HD13 ' A' ' 16' ' ' LEU . 58.2 m80 -78.24 169.78 17.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.669 -178.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 29.6 t -151.33 128.57 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.363 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.859 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -111.5 123.2 67.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.25 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.459 ' HE3' HD12 ' A' ' 30' ' ' LEU . 28.1 tptp -128.28 115.17 17.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.454 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.463 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -58.33 134.87 56.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.45 0.643 . . . . 0.0 112.134 -178.544 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.791 HD23 ' HB2' ' A' ' 13' ' ' SER . 0.3 OUTLIER -160.72 116.6 2.27 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.217 179.605 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.414 -1.214 . . . . 0.0 112.532 179.642 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.409 -0.277 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.02 127.44 23.36 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.667 2.244 . . . . 0.0 112.259 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.2 mtp -80.94 145.92 31.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.922 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.6 53.8 15.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.43 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -77.54 123.3 26.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.857 0.36 . . . . 0.0 110.844 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.29 -22.34 10.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.207 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.4 29.89 2.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.303 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -51.39 -27.63 10.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.948 0.404 . . . . 0.0 110.551 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.518 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.8 OUTLIER -85.22 160.84 19.79 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.128 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.656 HD13 ' HB3' ' A' ' 73' ' ' PHE . 0.4 OUTLIER -111.03 135.88 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.848 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.5 mtpt -106.83 95.11 5.5 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.653 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.929 ' SG ' HG22 ' A' ' 93' ' ' ILE . 2.4 t -124.06 179.58 4.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.894 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.507 ' HB3' HD23 ' A' ' 96' ' ' LEU . 1.8 p -123.37 162.25 23.12 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.665 ' HB3' HD11 ' A' ' 56' ' ' LEU . 20.4 p-80 -133.97 153.75 51.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.399 0.619 . . . . 0.0 112.327 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.767 HG23 ' OG ' ' A' ' 44' ' ' SER . 2.9 mp -156.75 122.73 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.777 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.704 HD13 ' ND1' ' A' ' 91' ' ' HIS . 10.3 tp -110.32 132.15 54.43 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.832 HG11 ' OE1' ' A' ' 22' ' ' GLU . 15.5 m -142.88 134.45 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.391 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.53 -35.78 63.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.5 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.615 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -73.12 79.3 1.24 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.83 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.484 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 2.0 pt20 -46.28 -25.58 0.65 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.328 -0.851 . . . . 0.0 113.154 -176.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.02 -31.4 77.84 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.119 -1.515 . . . . 0.0 110.67 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.832 ' OE1' HG11 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -71.26 -37.85 71.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.084 0.469 . . . . 0.0 109.928 178.39 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.608 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.87 -38.01 46.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.15 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.619 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -73.07 -29.58 63.05 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.823 179.278 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.95 -53.33 5.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.795 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.8 m -47.03 -37.34 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.322 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.628 ' HA ' HG11 ' A' ' 80' ' ' VAL . 2.5 pt20 -59.92 -48.21 82.64 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.571 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 3.4 pt-20 -73.06 -29.01 62.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.648 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.615 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 10.0 tpt180 -78.62 -35.37 45.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.771 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.583 HD21 ' HA ' ' A' ' 36' ' ' PHE . 1.1 tm? -52.74 -58.81 5.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.29 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.97 -9.6 58.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.254 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.25 -24.57 63.31 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.864 0.364 . . . . 0.0 111.114 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.36 -17.21 1.15 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.436 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -78.92 157.7 28.18 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.985 0.422 . . . . 0.0 110.949 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -98.08 140.1 32.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.027 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.76 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 3.4 p90 -51.39 -32.13 25.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.848 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.412 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -62.79 -34.25 89.23 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.213 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.2 mmtt -65.96 -53.57 37.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.661 0.267 . . . . 0.0 110.783 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.998 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.85 -32.33 52.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.517 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.36 -53.78 32.88 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.549 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.18 -23.47 26.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.224 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.89 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.78 -68.8 0.41 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -177.43 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.998 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.63 -12.25 9.31 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.767 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -64.05 140.32 58.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.931 0.396 . . . . 0.0 111.289 -179.241 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.571 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 31.7 pt -103.43 -10.81 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.686 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.811 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 24.4 p-10 -45.84 134.98 7.4 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.404 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.681 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.44 -178.31 3.62 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.683 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.76 -42.9 0.0 OUTLIER Glycine 0 N--CA 1.468 0.782 0 N-CA-C 115.485 0.954 . . . . 0.0 115.485 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.681 ' N ' ' O ' ' A' ' 47' ' ' GLY . 1.5 t -51.46 -16.91 0.66 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.5 0.65 . . . . 0.0 111.701 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.811 ' HB2' ' OD1' ' A' ' 46' ' ' ASP . . . -71.04 -20.82 62.34 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 121.28 0.562 . . . . 0.0 110.303 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.3 OUTLIER -74.36 -8.79 57.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.373 179.444 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.418 ' O ' ' CG ' ' A' ' 53' ' ' ASP . 0.5 OUTLIER -103.67 24.67 10.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.423 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.418 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 2.1 p30 54.08 34.8 20.73 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.97 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.45 ' HA2' ' CE1' ' A' ' 14' ' ' HIS . . . 56.76 21.47 36.59 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.417 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.7 p -70.38 86.81 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.85 0.357 . . . . 0.0 111.257 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.709 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 46.6 mt -59.69 -33.4 71.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.102 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.94 -167.13 48.98 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.947 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.468 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -69.19 119.15 13.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.045 0.45 . . . . 0.0 111.851 -179.387 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.518 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 9.3 p90 -135.46 135.48 40.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.48 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.42 -174.01 49.89 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.601 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 ptt-85 -89.73 89.4 7.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.948 0.404 . . . . 0.0 110.505 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.1 36.45 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.057 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -146.52 7.01 0.97 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.449 ' CE ' ' CD1' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -141.33 174.24 10.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.75 0.31 . . . . 0.0 110.844 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.77 HG23 ' H ' ' A' ' 68' ' ' PHE . 23.9 m -68.35 154.48 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.804 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.584 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -59.65 -46.94 98.59 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 17.5 Cg_endo -64.45 -41.22 21.07 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.937 1.758 . . . . 0.0 112.155 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.77 ' H ' HG23 ' A' ' 65' ' ' VAL . 26.2 t80 -74.98 -51.4 13.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.77 -32.31 65.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.797 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.438 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 11.6 t70 -63.82 -51.21 65.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.109 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.804 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -74.9 -10.02 59.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.756 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.517 ' HB1' ' HE1' ' A' ' 59' ' ' PHE . . . -65.46 -50.01 66.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.727 0.299 . . . . 0.0 111.497 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.656 ' HB3' HD13 ' A' ' 10' ' ' ILE . 6.2 p90 -93.33 16.51 13.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.464 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.526 ' C ' HD23 ' A' ' 75' ' ' LEU . 4.4 ttm-85 -96.57 -31.9 12.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.658 0.266 . . . . 0.0 111.226 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.704 HD12 ' O ' ' A' ' 79' ' ' GLU . 0.7 OUTLIER -103.37 55.88 0.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.385 -179.792 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -58.83 -22.21 58.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.089 0.471 . . . . 0.0 110.029 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.07 -28.43 39.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.435 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.489 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 97.05 59.09 1.0 Allowed Glycine 0 CA--C 1.508 -0.397 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.303 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.704 ' O ' HD12 ' A' ' 75' ' ' LEU . 5.6 pt-20 -130.22 177.38 7.36 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.628 HG11 ' HA ' ' A' ' 27' ' ' GLN . 21.7 t -88.65 148.41 4.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.695 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.646 ' OG ' HD21 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -104.42 164.03 12.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.136 0.493 . . . . 0.0 111.282 -178.883 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 84' ' ' VAL . 3.1 mp0 -50.43 154.76 2.04 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.866 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.568 ' HG3' HD23 ' A' ' 24' ' ' LEU . 14.1 Cg_endo -55.58 104.53 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.367 2.045 . . . . 0.0 111.721 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.555 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 94.3 t -101.64 101.54 12.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.684 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.456 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 19.2 tptp -95.54 112.49 24.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.573 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.9 m -112.5 -176.97 3.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.468 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.81 -22.33 14.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.939 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.94 -27.57 24.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.331 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.5 -170.71 24.06 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.823 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.484 ' CD1' ' HB3' ' A' ' 20' ' ' GLN . 0.5 OUTLIER -74.56 100.78 4.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.045 0.45 . . . . 0.0 109.927 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.704 ' ND1' HD13 ' A' ' 16' ' ' LEU . 30.7 m-70 -87.35 169.31 12.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.586 0.707 . . . . 0.0 112.742 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.1 t -146.76 136.29 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.119 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.929 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -126.58 122.5 61.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.352 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.571 ' HE3' HD12 ' A' ' 30' ' ' LEU . 22.0 tptp -128.54 110.33 12.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.456 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.588 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.62 134.36 56.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.596 0.713 . . . . 0.0 112.195 -177.89 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.76 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -153.8 116.4 4.42 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.593 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.428 ' HA3' ' HD3' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.424 -1.209 . . . . 0.0 112.541 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.14 151.85 76.78 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.579 2.186 . . . . 0.0 112.257 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.0 mtp -85.25 149.49 25.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.967 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.1 20.62 73.09 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.665 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 97.3 p -88.43 123.38 32.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.384 . . . . 0.0 111.007 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.2 mtt -108.29 129.23 55.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.547 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.07 26.87 1.82 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.606 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.501 ' CB ' ' HE3' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -59.49 -22.13 61.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 110.595 179.642 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.681 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -83.96 172.95 11.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.442 0.639 . . . . 0.0 111.933 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.605 HG22 ' SG ' ' A' ' 12' ' ' CYS . 1.5 mt -111.0 136.93 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.944 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.4 mtpt -108.11 86.71 2.34 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.577 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.818 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 7.1 m -130.58 179.98 5.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.636 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.449 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 2.9 p -135.33 161.76 34.49 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.789 ' O ' HD12 ' A' ' 15' ' ' ILE . 0.7 OUTLIER -141.24 155.49 46.01 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.196 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.789 HD12 ' O ' ' A' ' 14' ' ' HIS . 1.7 mp -134.95 141.81 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.863 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.74 HD11 ' CE1' ' A' ' 91' ' ' HIS . 1.0 OUTLIER -121.48 128.84 52.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.77 0.319 . . . . 0.0 111.723 -179.499 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.839 HG21 ' CG ' ' A' ' 22' ' ' GLU . 24.7 m -144.12 134.21 20.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.465 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' CD ' HD13 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -70.12 -36.27 74.7 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.732 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.612 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.09 78.55 0.94 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.486 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.474 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -46.67 -25.98 0.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.714 -1.13 . . . . 0.0 113.191 -177.584 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.39 -31.31 76.61 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.086 -1.531 . . . . 0.0 111.091 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.89 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -70.25 -39.91 74.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.142 0.496 . . . . 0.0 110.03 178.568 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.679 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -51.15 -37.16 44.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.227 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.627 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.41 -29.46 62.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.922 179.17 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.66 -42.53 14.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.484 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.89 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.7 m -53.4 -39.17 34.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.881 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.5 pt20 -56.33 -50.19 72.17 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.596 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 4.6 pt-20 -73.36 -30.98 63.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.803 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 3.9 tpm_? -77.18 -27.52 53.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.011 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.676 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.8 OUTLIER -60.78 -52.76 63.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.419 -179.101 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.405 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -68.57 -9.4 49.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.525 -179.897 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -56.28 -22.05 27.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.761 0.315 . . . . 0.0 111.387 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.37 -10.73 3.8 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.387 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -77.81 157.46 29.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.823 0.344 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.411 ' HB3' ' HG2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -89.12 136.01 33.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.789 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.676 ' HA ' HD21 ' A' ' 30' ' ' LEU . 4.8 t80 -53.94 -48.15 70.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.236 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.26 -33.9 53.03 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.293 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.0 mmmt -60.33 -52.26 66.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.707 0.289 . . . . 0.0 110.873 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.965 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.34 -33.54 53.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.561 ' HB1' ' O ' ' A' ' 50' ' ' ALA . . . -51.45 -53.81 33.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.074 0.464 . . . . 0.0 110.582 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -85.94 -23.66 26.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.059 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.848 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -69.12 -68.35 0.41 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.941 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.965 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.21 -15.43 9.18 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.72 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.532 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -64.28 134.5 54.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.115 0.483 . . . . 0.0 111.14 -179.588 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.538 HD13 ' CD ' ' A' ' 18' ' ' LYS . 1.3 pt -97.26 -8.77 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.172 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.795 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 6.0 t0 -46.42 135.25 8.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.977 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.629 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.44 -178.86 3.85 Favored Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.441 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.83 -46.02 0.0 OUTLIER Glycine 0 N--CA 1.467 0.763 0 N-CA-C 115.563 0.985 . . . . 0.0 115.563 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.629 ' N ' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -51.42 -34.56 35.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.454 0.627 . . . . 0.0 111.342 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.795 ' HB2' ' HB3' ' A' ' 46' ' ' ASP . . . -71.21 -21.16 62.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.076 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -77.0 -6.1 51.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.522 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.419 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -104.15 24.09 12.01 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.406 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.434 ' OD1' ' O ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 72.04 12.87 5.96 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.354 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 59.59 21.6 54.99 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.535 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m -74.7 84.7 2.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.972 0.415 . . . . 0.0 110.548 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.818 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 20.4 mt -59.43 -20.24 53.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.883 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 49.06 -170.94 0.08 OUTLIER Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.57 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.506 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -56.17 111.4 0.95 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.038 0.447 . . . . 0.0 111.678 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.681 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 2.3 m-85 -128.48 164.37 22.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.265 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.08 -174.09 13.65 Favored Glycine 0 C--N 1.317 -0.528 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.159 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -86.48 116.38 24.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.922 0.392 . . . . 0.0 110.023 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.28 -12.05 1.38 Allowed Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.082 -1.056 . . . . 0.0 113.357 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.43 30.78 4.42 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.031 0.415 . . . . 0.0 111.754 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.425 ' HG3' ' CG ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -151.36 149.37 29.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.804 0.335 . . . . 0.0 111.191 179.433 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.753 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.4 m -52.6 156.26 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.197 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.565 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.15 -47.8 98.2 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.022 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 18.8 Cg_endo -65.43 -38.8 24.43 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.061 1.841 . . . . 0.0 112.367 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.753 ' H ' HG23 ' A' ' 65' ' ' VAL . 18.1 t80 -74.92 -49.8 19.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.475 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.425 ' CG ' ' HG3' ' A' ' 64' ' ' MET . 0.2 OUTLIER -54.5 -35.8 63.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.21 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 6.8 t70 -68.67 -49.94 55.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.798 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.94 -10.68 59.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.659 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.453 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -65.1 -45.48 85.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.722 0.296 . . . . 0.0 111.618 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 1.4 p90 -99.33 16.94 21.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.712 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -95.07 -28.66 14.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.75 0.31 . . . . 0.0 110.918 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 79' ' ' GLU . 2.7 mt -103.7 65.37 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.026 0.441 . . . . 0.0 111.678 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -74.32 -17.65 60.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.938 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -67.66 -26.82 36.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.842 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 96.06 59.14 1.06 Allowed Glycine 0 CA--C 1.503 -0.672 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.393 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.551 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -140.5 176.24 8.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.931 0.395 . . . . 0.0 111.007 -178.253 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.601 HG11 ' HA ' ' A' ' 27' ' ' GLN . 38.4 t -83.75 147.76 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.962 178.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.66 159.09 16.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.224 0.535 . . . . 0.0 111.197 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -50.61 159.49 0.89 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.077 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.561 ' HG3' HD23 ' A' ' 24' ' ' LEU . 18.9 Cg_endo -59.02 104.08 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.474 2.116 . . . . 0.0 111.913 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.55 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 95.7 t -101.54 102.52 13.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.682 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.478 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 5.5 tptp -91.86 112.95 25.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.859 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.25 -173.12 2.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.418 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.18 -16.2 51.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.064 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -93.56 -38.76 11.21 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.534 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.97 -168.74 35.75 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.898 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -77.0 99.53 5.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.74 ' CE1' HD11 ' A' ' 16' ' ' LEU . 17.1 m80 -88.42 165.27 15.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.45 0.643 . . . . 0.0 112.734 -178.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.484 ' CG1' HG13 ' A' ' 80' ' ' VAL . 40.5 t -143.79 152.39 16.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.117 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.605 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -139.59 122.05 17.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -179.045 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.521 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -129.37 108.69 10.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.955 178.051 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.578 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 6.9 ttt85 -58.11 135.68 57.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.642 0.734 . . . . 0.0 112.275 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 96' ' ' LEU . 0.4 OUTLIER -154.3 116.48 4.28 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.24 179.415 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.378 -1.234 . . . . 0.0 112.586 179.912 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.96 140.5 79.52 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.459 2.106 . . . . 0.0 112.254 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.4 137.32 58.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.968 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.61 -18.25 1.65 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.925 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.1 p -62.31 132.83 53.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.837 0.351 . . . . 0.0 111.065 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -179.25 -174.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.829 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.79 32.35 1.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.268 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASP . . . . . 0.439 ' C ' ' HE3' ' A' ' 9' ' ' LYS . 29.8 t70 -56.39 -25.93 51.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.675 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -84.2 164.98 18.78 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.128 -179.623 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.41 138.35 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.654 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.029 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.461 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.6 mtpt -108.72 96.16 6.15 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.067 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' CYS . . . . . 0.914 ' SG ' HG22 ' A' ' 93' ' ' ILE . 2.4 t -127.7 179.39 5.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.273 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.789 ' HB2' HD23 ' A' ' 96' ' ' LEU . 2.7 t -126.37 159.79 32.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' HIS . . . . . 0.787 ' CG ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -136.66 150.88 48.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.405 0.621 . . . . 0.0 112.553 -179.405 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.597 HD12 ' C ' ' A' ' 14' ' ' HIS . 3.5 mp -153.27 115.34 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.009 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.907 HD21 ' CD2' ' A' ' 91' ' ' HIS . 0.9 OUTLIER -100.1 139.09 36.27 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.711 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.983 HG21 ' CG ' ' A' ' 22' ' ' GLU . 30.0 m -155.22 134.19 3.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.793 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -19.31 65.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.571 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -72.38 78.36 1.02 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.149 179.093 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 5.8 pt20 -47.34 -40.0 16.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.32 -31.14 66.27 Favored Glycine 0 CA--C 1.511 -0.19 0 C-N-CA 119.925 -1.131 . . . . 0.0 112.697 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.983 ' CG ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -65.6 -39.79 91.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.339 0.59 . . . . 0.0 110.253 179.525 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.761 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . -43.8 -42.16 5.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.387 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.57 ' HA ' ' HG3' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -72.66 -45.47 58.77 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.266 178.215 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.0 -57.31 9.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.694 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 23' ' ' ALA . 4.8 m -55.07 -30.42 23.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.684 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLN . . . . . 0.776 ' HG2' HG11 ' A' ' 80' ' ' VAL . 52.9 mt-30 -53.04 -60.06 3.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.28 0.562 . . . . 0.0 109.939 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -26.03 61.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.82 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.514 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 14.2 tpp85 -78.51 -30.31 47.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.094 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.705 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -56.7 -59.04 5.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 0.0 110.932 -179.234 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -9.3 58.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.322 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.05 -25.81 64.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.996 0.427 . . . . 0.0 111.35 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.99 -17.15 0.92 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.491 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.481 ' HG3' HD21 ' A' ' 39' ' ' LEU . 21.9 pt-20 -79.76 157.81 27.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.993 0.425 . . . . 0.0 110.816 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -96.23 137.07 35.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.079 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.705 ' HA ' HD21 ' A' ' 30' ' ' LEU . 2.4 p90 -47.61 -33.53 6.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.628 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . 0.513 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -65.28 -34.93 90.83 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.137 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -60.16 -53.81 53.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.598 0.237 . . . . 0.0 110.592 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 1.004 HD12 HD11 ' A' ' 43' ' ' LEU . 2.6 mm? -55.68 -34.36 64.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.803 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.3 -53.77 32.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.029 0.442 . . . . 0.0 110.503 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -85.97 -23.63 26.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.18 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.846 ' HB3' HD13 ' A' ' 43' ' ' LEU . 1.0 OUTLIER -70.14 -68.7 0.4 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -177.721 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 1.004 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.54 -11.36 9.47 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.531 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.575 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -63.58 134.46 55.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.273 0.559 . . . . 0.0 111.333 -179.165 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 16' ' ' LEU . 25.1 pt -94.7 -17.45 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.358 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -45.78 134.25 7.75 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.106 0.479 . . . . 0.0 111.079 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.668 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.89 -178.62 4.19 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.939 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 51' ' ' LYS . . . -12.91 -42.2 0.0 OUTLIER Glycine 0 C--N 1.339 0.737 0 N-CA-C 115.349 0.9 . . . . 0.0 115.349 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . 0.668 ' N ' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -51.21 -21.07 1.83 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.333 0.567 . . . . 0.0 111.484 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.71 -21.04 62.6 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.797 0.332 . . . . 0.0 110.924 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 2.8 mttt -68.36 -2.95 9.51 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.972 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.466 ' O ' ' CG ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -103.65 24.78 10.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.697 0.284 . . . . 0.0 110.539 179.767 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.513 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 1.5 p30 59.58 29.62 19.19 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.189 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 53.78 23.35 21.67 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.841 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.92 89.96 4.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.809 0.338 . . . . 0.0 110.825 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.787 HD21 ' CG ' ' A' ' 14' ' ' HIS . 87.0 mt -58.37 -28.83 65.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.58 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.42 -166.26 15.74 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.991 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . 0.538 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -65.14 117.59 7.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.117 0.484 . . . . 0.0 111.749 -179.474 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.514 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 5.3 m-85 -128.44 158.63 37.79 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.52 -173.95 13.59 Favored Glycine 0 C--N 1.317 -0.49 0 C-N-CA 120.199 -1.0 . . . . 0.0 112.497 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.09 84.57 2.32 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.044 0.45 . . . . 0.0 110.126 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.42 36.85 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.063 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.05 -48.67 0.61 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.637 0.256 . . . . 0.0 111.292 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.55 169.84 9.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.937 0.399 . . . . 0.0 111.306 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.772 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.9 m -59.43 165.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.965 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.555 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 7.5 ttpt -62.73 -48.01 86.58 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 15.2 Cg_endo -65.36 -39.34 22.75 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.863 1.709 . . . . 0.0 111.897 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.772 ' H ' HG23 ' A' ' 65' ' ' VAL . 24.5 t80 -75.0 -52.49 10.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.98 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -57.52 -32.66 67.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 1.9 m-20 -63.7 -50.56 68.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.049 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.51 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.3 -9.49 58.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.798 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.42 -47.52 75.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 111.602 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PHE . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 11.4 p90 -93.89 16.78 13.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.535 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -97.98 -30.39 12.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.93 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.53 HD11 ' O ' ' A' ' 80' ' ' VAL . 3.9 mt -103.49 68.08 0.93 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.471 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -72.8 -19.28 61.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.096 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -65.86 -26.67 39.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.725 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLY . . . . . 0.445 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 94.66 59.44 1.14 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.57 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.511 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.7 tm-20 -141.03 176.34 8.9 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.826 0.346 . . . . 0.0 111.104 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.776 HG11 ' HG2' ' A' ' 27' ' ' GLN . 26.9 t -81.01 146.6 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.84 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.2 t -104.66 164.11 12.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.258 0.551 . . . . 0.0 111.583 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.4 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.0 mp0 -50.51 152.1 3.52 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.463 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 19.5 Cg_endo -58.46 106.09 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.466 2.111 . . . . 0.0 111.65 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.549 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 93.0 t -100.96 101.14 11.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.593 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 4.8 tptm -91.63 112.8 24.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.757 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.1 m -114.73 -171.95 2.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.578 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.35 -18.62 51.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.184 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -90.91 -24.48 20.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.467 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 141.48 -161.66 26.96 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.784 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.541 ' O ' HD13 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -83.02 98.14 9.11 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' HIS . . . . . 0.907 ' CD2' HD21 ' A' ' 16' ' ' LEU . 9.8 m80 -81.49 154.35 26.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.481 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 37.2 t -139.71 135.84 39.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.296 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ILE . . . . . 0.914 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -123.84 122.52 64.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.423 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.523 ' HG2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -128.2 112.69 14.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.197 178.36 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.552 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -57.34 136.45 56.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.705 0.764 . . . . 0.0 112.517 -177.436 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.789 HD23 ' HB2' ' A' ' 13' ' ' SER . 0.3 OUTLIER -157.69 116.73 3.23 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.616 179.595 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.352 -1.249 . . . . 0.0 112.554 179.93 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.554 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.593 0 CA-C-O 121.764 0.793 . . . . 0.0 112.142 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.666 HD13 ' HB3' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -114.84 138.36 45.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.569 178.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.466 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.9 mtpt -108.87 97.82 7.4 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.494 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.949 ' SG ' HG22 ' A' ' 93' ' ' ILE . 1.9 t -135.34 179.88 6.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.555 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.491 ' HB3' HD23 ' A' ' 96' ' ' LEU . 2.4 p -134.75 162.44 32.34 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.588 ' C ' HD12 ' A' ' 15' ' ' ILE . 12.3 p-80 -136.55 148.57 47.65 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.81 HD13 ' CE2' ' A' ' 36' ' ' PHE . 1.6 mp -130.74 154.14 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.675 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 88' ' ' PHE . 2.5 mt -137.32 135.4 37.04 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.942 HG21 ' HG3' ' A' ' 22' ' ' GLU . 23.3 m -149.2 134.27 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.589 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -35.92 74.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.979 0.419 . . . . 0.0 110.323 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.624 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 37.2 pttt -72.13 79.66 0.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.495 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 12.1 pt20 -45.62 -26.28 0.59 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.867 -1.061 . . . . 0.0 112.441 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.17 -31.75 75.25 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.975 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.942 ' HG3' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -69.36 -42.84 74.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.013 0.435 . . . . 0.0 110.238 179.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.513 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -47.64 -38.3 14.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.279 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.649 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -73.41 -31.93 64.14 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.667 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.76 -52.93 8.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.068 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.499 HG23 ' N ' ' A' ' 27' ' ' GLN . 19.9 m -50.12 -46.69 24.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.68 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.632 ' CB ' HG11 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -54.07 -36.36 63.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.549 . . . . 0.0 109.955 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.539 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -72.84 -47.15 48.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.43 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.488 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.9 -23.18 44.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.146 -178.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.743 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -52.87 -47.63 67.69 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.768 0.318 . . . . 0.0 111.293 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -72.01 -9.42 58.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.386 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -57.27 -23.24 46.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 111.333 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.45 -12.47 3.24 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.399 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -75.08 153.8 38.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.797 0.332 . . . . 0.0 110.605 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -87.57 131.2 34.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.979 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.81 ' CE2' HD13 ' A' ' 15' ' ' ILE . 5.0 t80 -48.8 -49.52 38.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.013 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.61 ' O ' ' HB3' ' A' ' 40' ' ' ALA . . . -54.65 -34.22 55.78 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.051 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -57.38 -53.59 56.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.943 0.402 . . . . 0.0 110.358 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.009 HD12 HD11 ' A' ' 43' ' ' LEU . 3.0 mm? -53.59 -29.93 39.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.393 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 37' ' ' GLY . . . -51.48 -53.7 34.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.697 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.76 -23.74 27.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.81 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.9 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.17 -68.38 0.42 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.009 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.29 -12.21 9.44 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.605 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -63.84 128.81 37.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.91 0.386 . . . . 0.0 111.216 -179.502 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.505 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER . . . . . 0 C--N 1.327 -0.388 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.15 179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.88 0.372 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.3 mtpt -68.12 -14.2 62.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.23 -179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 6.2 ptp180 -104.81 24.71 11.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.728 0.299 . . . . 0.0 110.405 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.414 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 0.5 OUTLIER 60.53 24.28 13.95 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.143 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 59.53 19.89 49.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.69 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 m -63.6 83.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.925 0.393 . . . . 0.0 110.677 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.743 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 16.5 mt -63.78 -24.06 67.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.882 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.04 -160.88 8.47 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.817 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.519 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -67.28 111.54 4.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.868 0.366 . . . . 0.0 111.783 -179.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.676 ' HE2' HD22 ' A' ' 56' ' ' LEU . 8.1 m-30 -119.05 156.64 29.32 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.27 -173.96 15.64 Favored Glycine 0 C--N 1.317 -0.501 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.431 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -75.53 80.0 2.55 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.99 0.424 . . . . 0.0 110.182 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.15 36.94 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.956 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.97 -43.11 1.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.623 0.249 . . . . 0.0 111.396 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.54 167.47 9.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 0.0 111.26 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.705 HG23 ' H ' ' A' ' 68' ' ' PHE . 29.1 m -56.93 160.29 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.626 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.547 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -56.5 -48.19 97.55 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.589 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 20.7 Cg_endo -66.89 -36.26 23.85 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.062 1.842 . . . . 0.0 112.205 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.705 ' H ' HG23 ' A' ' 65' ' ' VAL . 15.5 t80 -74.88 -51.0 15.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.588 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.8 -32.39 60.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.839 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 1.6 m-20 -65.75 -53.15 44.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.886 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.474 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.11 -9.15 58.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.87 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.02 -36.81 78.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.613 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.666 ' HB3' HD13 ' A' ' 10' ' ' ILE . 3.0 p90 -107.06 16.79 23.8 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.81 -28.18 13.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.76 0.314 . . . . 0.0 110.879 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 79' ' ' GLU . 3.2 mt -103.47 63.57 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.213 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -70.83 -18.27 62.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.05 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.45 -26.92 40.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.559 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.05 57.59 1.21 Allowed Glycine 0 CA--C 1.502 -0.733 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.74 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.491 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -138.54 175.92 9.14 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.746 0.308 . . . . 0.0 111.114 -178.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.632 HG11 ' CB ' ' A' ' 27' ' ' GLN . 41.6 t -81.33 145.9 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.918 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.16 164.11 12.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.162 0.505 . . . . 0.0 111.54 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.419 ' O ' HG23 ' A' ' 84' ' ' VAL . 3.5 mp0 -50.73 153.73 2.72 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.967 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.649 ' HG3' HD23 ' A' ' 24' ' ' LEU . 18.1 Cg_endo -59.27 105.5 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.361 2.041 . . . . 0.0 111.799 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.589 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 97.5 t -101.33 119.21 49.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.783 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.443 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -103.35 112.69 25.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.006 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.51 -171.7 1.9 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.276 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -60.33 -18.04 47.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.025 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.499 ' HB3' HD11 ' A' ' 16' ' ' LEU . 6.3 m-85 -89.69 -40.79 12.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.424 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.66 -158.81 29.05 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.801 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -82.11 98.14 8.53 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.457 ' CD2' ' HG ' ' A' ' 16' ' ' LEU . 34.6 m80 -84.22 170.1 14.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.044 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.439 ' CG1' HG13 ' A' ' 80' ' ' VAL . 9.5 t -146.22 153.04 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.692 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.949 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -143.11 122.36 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.665 ' HE3' HD12 ' A' ' 30' ' ' LEU . 13.8 tptp -128.88 116.88 20.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.127 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.444 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -57.33 133.99 55.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.533 0.682 . . . . 0.0 112.231 -177.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.555 ' C ' HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -154.55 116.54 4.21 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.744 -1.117 . . . . 0.0 109.573 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.451 -1.194 . . . . 0.0 112.636 179.892 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.702 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.586 0 CA-C-O 121.634 0.731 . . . . 0.0 112.112 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.522 HD12 ' HB1' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -120.23 139.51 47.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.499 178.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.453 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.2 mtpt -110.88 99.27 8.2 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.434 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.736 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 2.2 t -129.98 -179.76 5.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.7 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.545 ' HB2' HD23 ' A' ' 96' ' ' LEU . 2.8 t -118.79 163.58 16.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.746 ' HB3' HD21 ' A' ' 56' ' ' LEU . 12.0 t-80 -138.39 141.02 39.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.136 0.493 . . . . 0.0 111.821 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.74 HD12 ' C ' ' A' ' 14' ' ' HIS . 4.5 mp -151.47 119.67 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.491 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.488 HD11 ' HB3' ' A' ' 88' ' ' PHE . 0.5 OUTLIER -109.14 137.42 47.07 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.763 0.315 . . . . 0.0 111.596 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.749 HG21 ' CG ' ' A' ' 22' ' ' GLU . 17.1 m -147.95 134.39 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.481 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.407 ' HD2' HD13 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -68.27 -36.62 79.68 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.813 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.592 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.18 78.35 0.97 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.644 0.735 . . . . 0.0 109.04 178.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 5.0 pt20 -46.59 -25.81 0.77 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.288 -177.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.1 -31.29 77.33 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.178 -1.486 . . . . 0.0 111.069 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.9 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -70.45 -38.56 74.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.382 0.611 . . . . 0.0 109.828 178.371 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.647 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -51.5 -37.67 50.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.533 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.611 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.3 OUTLIER -73.13 -30.45 63.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.794 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.77 -41.04 19.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.41 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.9 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.8 m -51.11 -35.14 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.288 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.678 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -60.38 -48.41 81.87 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.678 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.57 -28.06 61.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.308 0.575 . . . . 0.0 110.642 178.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 3.1 tpp180 -78.85 -35.97 43.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.891 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.481 HD13 ' C ' ' A' ' 30' ' ' LEU . 1.2 tm? -52.74 -59.01 5.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.278 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -9.39 54.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.488 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -74.61 50.14 0.42 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.6 -10.54 44.35 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.659 -0.781 . . . . 0.0 114.143 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.04 157.64 15.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.506 0.653 . . . . 0.0 111.061 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -110.28 144.49 38.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.205 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.95 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 1.9 p90 -49.05 -28.49 4.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.726 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.408 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -59.9 -34.07 81.37 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.574 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -74.4 -49.96 20.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.593 0.235 . . . . 0.0 110.827 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.79 HD12 HD11 ' A' ' 43' ' ' LEU . 3.0 mm? -53.28 -36.14 60.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.286 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.686 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -52.1 -52.77 49.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.127 0.489 . . . . 0.0 110.744 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -85.64 -23.7 27.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.809 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.965 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -72.52 -67.51 0.55 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.227 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.965 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.6 -14.96 9.59 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -178.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.542 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 1.8 t -63.74 126.25 26.99 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.365 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.327 -0.402 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.686 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . . . . . . . . 0 CA--C 1.518 -0.286 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -86.64 -18.82 30.4 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.789 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.503 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 15.4 mtt180 -104.23 25.0 10.61 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.964 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.526 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 0.2 OUTLIER 67.61 40.52 2.51 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.429 0.633 . . . . 0.0 111.629 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 53.63 30.33 42.61 Favored Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.79 -0.641 . . . . 0.0 113.018 179.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.572 ' HA ' HD21 ' A' ' 96' ' ' LEU . 85.9 p -92.37 86.35 5.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.739 0.304 . . . . 0.0 110.993 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.746 HD21 ' HB3' ' A' ' 14' ' ' HIS . 69.9 mt -54.03 -40.0 66.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.051 0.453 . . . . 0.0 110.21 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 78.07 -168.25 53.94 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.538 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.462 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -69.75 111.39 5.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.044 0.449 . . . . 0.0 111.717 -179.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.702 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 13.0 m-85 -125.83 152.82 44.97 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -100.71 -174.03 29.43 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.238 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.95 99.93 12.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.951 0.405 . . . . 0.0 110.316 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.97 -7.91 1.24 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.426 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -92.29 -40.82 10.73 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.924 0.362 . . . . 0.0 111.522 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.2 166.59 12.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.913 0.387 . . . . 0.0 111.447 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.761 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.2 m -58.0 163.85 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.815 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.51 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 16.8 tttp -58.93 -48.33 96.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.543 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 17.7 Cg_endo -67.11 -37.34 19.0 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 121.856 1.704 . . . . 0.0 112.192 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.761 ' H ' HG23 ' A' ' 65' ' ' VAL . 40.9 t80 -74.41 -50.78 17.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.623 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -56.75 -32.35 65.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.703 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.2 OUTLIER -67.42 -49.43 63.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.072 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.404 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -74.99 -9.56 58.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.753 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.522 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -68.82 -51.26 42.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.912 0.387 . . . . 0.0 111.447 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.458 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 3.5 p90 -94.24 16.71 14.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.452 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -97.39 -29.38 13.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 110.804 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.544 HD11 ' O ' ' A' ' 80' ' ' VAL . 3.4 mt -103.48 67.1 0.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.454 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -74.35 -17.78 60.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.049 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -66.66 -26.74 38.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.447 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.14 59.8 1.09 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.521 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.513 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -141.33 176.14 9.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.841 0.353 . . . . 0.0 111.123 -178.381 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.544 ' O ' HD11 ' A' ' 75' ' ' LEU . 50.0 t -81.46 147.99 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.17 159.3 15.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.293 0.568 . . . . 0.0 111.56 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -50.68 155.23 1.99 Allowed Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.567 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.611 ' HG3' HD23 ' A' ' 24' ' ' LEU . 18.4 Cg_endo -58.53 106.67 0.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.335 2.023 . . . . 0.0 111.534 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.543 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 90.8 t -101.03 101.92 12.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.754 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.438 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 6.5 tptt -91.89 112.69 24.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.632 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.412 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 2.0 m -114.27 -173.19 2.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.55 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -58.29 -20.27 41.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.929 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.488 ' HB3' HD11 ' A' ' 16' ' ' LEU . 2.6 m-85 -89.37 -23.97 22.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.309 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.481 ' C ' HD21 ' A' ' 16' ' ' LEU . . . 136.97 -167.88 24.49 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.883 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.496 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -74.98 98.35 3.58 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.412 ' CE1' ' HB2' ' A' ' 86' ' ' SER . 53.3 m80 -80.86 167.63 19.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.343 0.592 . . . . 0.0 112.437 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.0 t -147.73 153.16 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.395 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.667 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -150.82 127.46 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -179.03 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.485 ' HG2' HG22 ' A' ' 80' ' ' VAL . 2.6 tmtm? -128.59 116.1 19.11 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.677 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.56 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -57.44 134.58 56.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.495 0.664 . . . . 0.0 112.046 -178.055 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.95 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -157.1 116.67 3.42 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.771 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 CA-C-O 118.321 -1.266 . . . . 0.0 112.57 179.845 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.547 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 1.0 OUTLIER . . . . . 0 N--CA 1.451 -0.415 0 CA-C-O 121.47 0.653 . . . . 0.0 112.138 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.575 HG22 ' SG ' ' A' ' 12' ' ' CYS . 1.5 mt -110.98 136.15 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.869 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.475 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.4 mtpt -109.17 90.76 3.39 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.21 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.775 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 13.7 m -130.69 -179.59 5.39 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.055 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.658 ' HB2' HD23 ' A' ' 96' ' ' LEU . 9.5 t -124.87 163.45 22.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.851 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.793 ' CG ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -139.87 155.54 47.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.363 0.602 . . . . 0.0 112.583 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.754 HG23 ' OG ' ' A' ' 44' ' ' SER . 3.0 mp -143.77 139.43 25.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.48 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.757 HD11 ' NE2' ' A' ' 91' ' ' HIS . 0.4 OUTLIER -127.38 133.55 50.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.968 HG21 ' CG ' ' A' ' 22' ' ' GLU . 25.3 m -154.61 134.42 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.807 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.533 ' HE3' HD13 ' A' ' 45' ' ' ILE . 9.6 mttt -65.92 -16.58 63.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.515 ' HB3' ' CG ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -72.29 78.24 0.99 Allowed 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.813 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.453 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 0.8 OUTLIER -47.27 -40.52 16.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.156 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.09 -31.54 72.27 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.848 -1.168 . . . . 0.0 112.774 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.968 ' CG ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -66.9 -43.73 82.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.237 0.541 . . . . 0.0 110.407 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.557 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -46.95 -39.28 12.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.535 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.691 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -72.79 -29.16 63.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.112 179.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.91 -54.01 6.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.459 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.4 m -49.52 -34.27 8.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.691 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.9 pt20 -59.78 -47.72 84.56 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.907 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.23 -29.22 62.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.202 0.525 . . . . 0.0 110.499 178.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.596 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.53 -36.2 45.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.792 -179.001 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.594 ' CD2' HD23 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -52.77 -58.1 7.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.259 -179.363 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -71.36 -9.58 58.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.301 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.52 -23.7 63.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.887 0.375 . . . . 0.0 111.181 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.26 -19.47 0.93 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.275 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.415 ' HG3' HD21 ' A' ' 39' ' ' LEU . 20.5 pt-20 -80.93 157.65 25.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 110.773 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -101.43 148.28 25.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.168 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.845 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 1.1 p90 -50.44 -39.35 47.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.035 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.4 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -57.94 -34.21 71.26 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.746 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -65.85 -54.12 30.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.701 0.286 . . . . 0.0 110.913 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.014 HD12 HD11 ' A' ' 43' ' ' LEU . 2.8 mm? -56.32 -32.56 64.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.681 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.566 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.44 -52.78 43.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.175 0.512 . . . . 0.0 110.642 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.39 -23.77 26.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.133 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.848 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -69.62 -68.94 0.37 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.014 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.75 -12.63 9.21 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.754 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -63.68 131.69 48.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.885 0.374 . . . . 0.0 111.436 -179.123 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.554 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.3 pt . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.941 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.875 0.369 . . . . 0.0 111.217 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.25 -12.25 60.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.827 -179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.2 ptp180 -104.43 24.88 10.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.678 0.275 . . . . 0.0 110.529 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 0.4 OUTLIER 65.79 20.83 11.49 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.129 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.84 17.92 65.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.615 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -68.53 86.07 0.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.362 . . . . 0.0 110.713 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.793 HD21 ' CG ' ' A' ' 14' ' ' HIS . 23.2 mt -54.56 -24.58 21.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.696 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 59.5 -166.18 9.41 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.233 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.499 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -67.27 111.51 4.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.9 0.381 . . . . 0.0 111.897 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.547 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 4.4 m-85 -117.43 156.3 28.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.59 -174.0 14.1 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.506 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.23 80.13 5.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.924 0.392 . . . . 0.0 110.225 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.26 36.68 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.03 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.01 -48.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 0.0 111.135 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.6 mtm -95.52 170.95 8.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.086 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.793 HG23 ' H ' ' A' ' 68' ' ' PHE . 34.3 m -59.44 159.12 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.954 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -61.0 -47.97 93.88 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 12.2 Cg_endo -63.75 -41.14 25.62 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.955 1.77 . . . . 0.0 111.836 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.804 ' CE1' HG23 ' A' ' 93' ' ' ILE . 9.3 t80 -74.96 -52.35 11.39 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.843 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -55.36 -32.24 62.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.991 0.424 . . . . 0.0 110.647 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.457 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 29.9 t70 -65.38 -53.07 48.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.744 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.21 -9.31 58.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.559 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.32 -47.0 78.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.721 0.296 . . . . 0.0 111.376 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.457 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 11.4 p90 -93.24 16.19 13.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.345 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -98.3 -30.51 12.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.585 HD11 ' HA ' ' A' ' 81' ' ' SER . 7.9 mt -97.73 56.81 1.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.177 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -63.75 -23.75 67.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.758 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.87 -26.79 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.855 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.573 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 91.16 63.08 1.2 Allowed Glycine 0 CA--C 1.499 -0.949 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.122 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.401 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -141.05 176.61 8.68 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.611 -0.294 . . . . 0.0 110.62 -178.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 27' ' ' GLN . 61.1 t -80.16 147.91 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.585 ' HA ' HD11 ' A' ' 75' ' ' LEU . 12.8 t -104.53 162.97 12.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.611 0.72 . . . . 0.0 111.924 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.607 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -50.37 163.46 0.45 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.396 -179.268 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 35.8 Cg_endo -65.71 103.59 0.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.617 2.211 . . . . 0.0 112.321 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.555 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 89.8 t -101.66 99.56 8.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.456 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -95.21 115.31 27.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.072 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.9 m -105.51 -175.64 2.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.367 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -20.13 26.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.958 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -88.18 -39.88 14.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.433 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.58 -171.6 36.03 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.978 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.46 ' CD1' ' HB3' ' A' ' 85' ' ' LYS . 0.6 OUTLIER -74.95 108.59 7.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.957 0.408 . . . . 0.0 110.043 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.757 ' NE2' HD11 ' A' ' 16' ' ' LEU . 56.6 m80 -95.46 169.39 10.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.381 0.61 . . . . 0.0 112.368 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.426 ' CG1' HG13 ' A' ' 80' ' ' VAL . 20.4 t -147.81 152.68 12.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.594 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.804 HG23 ' CE1' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -133.4 122.15 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 13' ' ' SER . 10.3 tptt -128.71 109.07 11.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.392 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.573 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 1.1 ttt-85 -57.1 138.78 54.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.776 0.798 . . . . 0.0 112.625 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.845 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -161.98 116.42 1.9 Allowed 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.484 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.626 179.8 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.463 ' CB ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.45 -0.466 0 CA-C-O 121.3 0.572 . . . . 0.0 111.553 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.618 HG22 ' SG ' ' A' ' 12' ' ' CYS . 1.2 mt -111.33 135.68 49.77 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.043 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.492 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.7 mtpt -109.67 89.49 3.02 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.132 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.793 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 8.5 m -131.97 -179.55 5.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.081 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.705 ' HB3' HD23 ' A' ' 96' ' ' LEU . 8.7 p -127.07 163.43 23.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.156 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.747 ' CD2' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -136.08 157.46 46.78 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.295 0.569 . . . . 0.0 112.412 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.722 HD12 ' C ' ' A' ' 14' ' ' HIS . 2.9 mp -149.24 125.43 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.038 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.945 HD21 ' CD2' ' A' ' 91' ' ' HIS . 1.0 OUTLIER -105.84 136.94 44.57 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.844 0.354 . . . . 0.0 111.893 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.64 HG21 ' CD ' ' A' ' 22' ' ' GLU . 22.7 m -150.67 134.39 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.389 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.404 ' HG3' HD13 ' A' ' 45' ' ' ILE . 17.3 mtmt -71.8 -35.84 70.09 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.617 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 5.9 tttt -73.15 79.19 1.26 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.469 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 3.2 pt20 -46.49 -25.89 0.76 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.153 -0.93 . . . . 0.0 113.108 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.15 -29.47 74.5 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 119.194 -1.479 . . . . 0.0 110.82 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.64 ' CD ' HG21 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -73.99 -38.02 64.27 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.26 0.553 . . . . 0.0 110.017 178.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.61 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.57 -33.76 23.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.651 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.544 HD13 ' O ' ' A' ' 24' ' ' LEU . 1.3 tm? -73.48 -39.8 64.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.417 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 28' ' ' GLU . . . -74.17 -47.03 38.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.961 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 22' ' ' GLU . 21.3 m -46.6 -37.49 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.361 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.726 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -58.4 -48.51 80.41 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.118 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.726 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.65 -30.21 62.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.072 0.463 . . . . 0.0 110.822 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.458 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 16.8 tpt180 -79.18 -27.07 42.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.866 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.668 ' O ' HD13 ' A' ' 30' ' ' LEU . 1.4 tm? -70.47 -44.82 66.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.222 0.534 . . . . 0.0 110.278 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -9.46 58.72 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.769 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.02 -27.89 69.42 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.902 0.382 . . . . 0.0 111.352 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.68 -17.92 0.98 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.629 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.48 ' HG3' HD22 ' A' ' 30' ' ' LEU . 25.3 pt-20 -74.22 157.56 35.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.813 0.339 . . . . 0.0 110.879 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.08 139.94 33.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.093 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.921 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 3.0 p90 -49.97 -33.81 18.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.99 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 40' ' ' ALA . . . -60.98 -37.43 93.83 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.352 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -64.06 -52.92 57.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.778 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.773 HD12 HD11 ' A' ' 43' ' ' LEU . 3.2 mm? -53.55 -31.14 45.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.725 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.588 ' HB1' ' O ' ' A' ' 50' ' ' ALA . . . -51.16 -55.17 19.26 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.115 0.483 . . . . 0.0 110.778 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -23.34 27.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.966 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.937 ' HB3' HD13 ' A' ' 43' ' ' LEU . 1.0 OUTLIER -70.17 -68.29 0.43 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.937 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.37 -13.3 9.28 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.582 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -64.13 135.65 56.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.163 0.506 . . . . 0.0 111.203 -179.295 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.49 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 43.2 pt . . . . . 0 C--N 1.327 -0.405 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.216 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.588 ' O ' ' HB1' ' A' ' 40' ' ' ALA . . . . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.84 0.352 . . . . 0.0 110.89 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -79.78 -4.22 51.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.396 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mtp-105 -104.33 24.62 11.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.223 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.0 22.53 12.77 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.014 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 57.45 20.44 37.6 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.799 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m -61.85 85.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.775 0.321 . . . . 0.0 110.987 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.793 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 21.5 mt -60.76 -24.86 66.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.535 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 56.78 -165.14 5.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.416 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.492 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -64.93 121.07 13.79 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.225 0.536 . . . . 0.0 112.209 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.434 ' CZ ' ' O ' ' A' ' 56' ' ' LEU . 12.0 m-30 -136.8 148.49 47.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.017 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.84 -173.81 21.37 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.44 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.46 87.36 7.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.152 0.501 . . . . 0.0 110.189 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.32 36.78 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.901 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.62 -45.24 0.67 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.712 0.292 . . . . 0.0 111.144 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.32 171.4 8.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.135 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.794 HG23 ' H ' ' A' ' 68' ' ' PHE . 34.3 m -55.13 157.56 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.106 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.52 -48.11 97.52 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.605 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 18.6 Cg_endo -65.69 -39.92 19.16 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.946 1.764 . . . . 0.0 112.187 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.794 ' H ' HG23 ' A' ' 65' ' ' VAL . 23.8 t80 -74.91 -49.17 21.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.459 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.5 OUTLIER -54.94 -32.73 61.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.524 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -67.45 -51.56 50.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.901 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.438 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -74.89 -9.59 58.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.593 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.472 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -66.84 -43.29 84.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.848 0.356 . . . . 0.0 111.448 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 1.1 p90 -102.26 16.77 25.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.401 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.07 -27.31 15.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.748 0.308 . . . . 0.0 110.831 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 79' ' ' GLU . 3.3 mt -103.53 63.55 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.305 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -70.56 -18.53 62.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.965 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -64.6 -26.91 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.35 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.544 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.19 58.15 1.17 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.802 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.521 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.8 tm-20 -140.5 176.36 8.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.672 0.272 . . . . 0.0 110.977 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.553 HG11 ' HA ' ' A' ' 27' ' ' GLN . 56.8 t -84.65 147.05 5.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.098 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.21 161.96 13.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.186 0.517 . . . . 0.0 111.434 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.7 mp0 -50.85 153.9 2.72 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.033 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.446 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 22.5 Cg_endo -60.84 106.35 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.1 1.867 . . . . 0.0 111.523 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.605 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 86.1 t -101.01 108.33 23.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.7 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 90' ' ' TYR . 14.7 tmtt? -91.7 113.17 25.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.408 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.48 -172.38 2.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.199 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -16.42 48.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.213 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -94.08 -35.28 12.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.713 0.292 . . . . 0.0 111.594 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.66 -167.03 34.57 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.666 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.579 ' O ' HD13 ' A' ' 16' ' ' LEU . 1.2 m-85 -82.44 98.26 8.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.266 0.555 . . . . 0.0 109.994 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.945 ' CD2' HD21 ' A' ' 16' ' ' LEU . 11.3 m80 -83.09 169.64 15.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.007 -177.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 38.3 t -149.03 150.72 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.014 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.54 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -130.62 122.41 52.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' SER . 3.8 tmtt? -128.58 110.44 12.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.113 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.544 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -57.47 139.44 53.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.853 0.835 . . . . 0.0 112.73 -178.463 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.921 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -162.82 116.42 1.67 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.491 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.417 ' CA ' ' HE2' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.323 -1.265 . . . . 0.0 112.621 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.579 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.445 -0.719 0 CA-C-O 121.376 0.607 . . . . 0.0 112.034 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.674 HD12 ' HB1' ' A' ' 72' ' ' ALA . 1.2 mt -111.01 136.0 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.15 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.517 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.6 mtpt -108.32 89.78 3.1 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.115 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.808 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.4 m -132.69 -179.61 5.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.747 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.588 ' OG ' HD23 ' A' ' 96' ' ' LEU . 3.0 m -131.25 163.75 27.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.371 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.808 ' O ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -132.16 156.31 46.63 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.808 HD12 ' O ' ' A' ' 14' ' ' HIS . 1.5 mp -141.43 120.01 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.045 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.55 HD11 ' CE1' ' A' ' 91' ' ' HIS . 2.0 mt -104.44 128.28 52.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.788 HG21 ' CG ' ' A' ' 22' ' ' GLU . 17.9 m -140.57 133.91 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.017 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -36.7 70.55 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.84 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.613 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.23 78.53 0.98 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.385 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -46.51 -26.05 0.8 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.058 -177.47 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.42 -31.12 76.05 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.855 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.859 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -70.06 -39.56 75.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.081 0.467 . . . . 0.0 110.3 178.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.659 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.34 -38.1 40.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.986 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.815 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.4 OUTLIER -73.61 -29.4 62.36 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.244 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.38 -43.7 14.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.543 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.5 m -54.89 -40.66 53.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.275 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.678 ' HA ' HG11 ' A' ' 80' ' ' VAL . 3.2 pt20 -53.2 -52.61 58.31 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.691 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.546 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -73.28 -31.51 64.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.08 0.467 . . . . 0.0 110.998 179.141 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.448 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -76.41 -25.61 54.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.706 -178.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -58.38 -48.31 81.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.4 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.93 -9.32 58.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.428 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -56.26 -22.15 28.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.802 0.334 . . . . 0.0 111.403 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.13 -10.76 3.59 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.536 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.452 ' OE1' HD11 ' A' ' 39' ' ' LEU . 15.2 pt-20 -79.02 153.24 30.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.929 0.395 . . . . 0.0 110.988 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.4 135.51 33.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.792 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.781 ' CZ ' HD13 ' A' ' 15' ' ' ILE . 9.6 t80 -53.29 -47.78 68.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.218 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 40' ' ' ALA . . . -56.59 -34.12 63.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.239 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -58.82 -50.26 74.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.704 0.288 . . . . 0.0 110.87 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.787 ' CD1' HD11 ' A' ' 43' ' ' LEU . 3.2 mm? -53.07 -33.28 51.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.808 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.25 -54.24 27.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.127 0.489 . . . . 0.0 110.496 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.4 pttp -85.77 -23.5 27.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.023 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.924 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -70.54 -67.91 0.47 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.924 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.94 -15.69 9.3 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -63.99 138.31 58.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 0.0 111.275 -179.475 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.419 ' CG1' ' O ' ' A' ' 16' ' ' LEU . 2.0 pt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.18 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.447 ' O ' ' HB1' ' A' ' 40' ' ' ALA . . . . . . . . 0 CA--C 1.519 -0.223 0 CA-C-O 121.388 0.613 . . . . 0.0 110.248 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.09 -16.17 63.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.065 -179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.22 24.64 11.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.29 179.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 0.3 OUTLIER 64.5 17.54 10.89 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.434 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.83 27.37 49.93 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.37 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -60.06 84.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.959 0.409 . . . . 0.0 110.815 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.808 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 22.8 mt -60.5 -19.66 57.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.725 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 50.33 -169.07 0.27 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.735 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.517 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -61.69 111.44 1.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.929 0.395 . . . . 0.0 111.723 -179.385 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.579 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 2.4 m-85 -124.78 163.8 21.34 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.35 -174.04 13.67 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.656 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -86.9 95.72 9.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.052 0.453 . . . . 0.0 110.283 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.23 36.47 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.756 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -152.05 -42.62 0.11 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.74 0.305 . . . . 0.0 111.187 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 8.9 mtm -91.07 167.12 12.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.93 0.395 . . . . 0.0 111.27 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.799 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.7 m -58.97 156.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.854 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.557 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.5 ttpt -58.14 -47.98 97.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.562 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 12.7 Cg_endo -64.4 -40.1 26.18 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 121.995 1.797 . . . . 0.0 112.239 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.799 ' H ' HG23 ' A' ' 65' ' ' VAL . 11.3 t80 -75.11 -50.17 17.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.696 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.63 -32.33 58.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.689 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 1.5 t70 -66.87 -52.47 43.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.851 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.87 -9.5 58.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.478 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.674 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -63.18 -43.19 98.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.415 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 2.8 p90 -98.29 16.54 21.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.386 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -98.18 -28.14 13.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.172 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.782 HD11 ' CB ' ' A' ' 81' ' ' SER . 8.5 mt -96.0 51.6 1.25 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 111.301 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -58.91 -33.14 70.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 109.868 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -63.55 -26.68 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.33 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.514 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 90.37 72.01 1.24 Allowed Glycine 0 CA--C 1.5 -0.905 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.819 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.749 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -142.28 177.6 8.14 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.132 -0.534 . . . . 0.0 110.014 -178.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.678 HG11 ' HA ' ' A' ' 27' ' ' GLN . 93.5 t -79.67 149.73 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.782 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -104.49 153.08 21.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.354 0.597 . . . . 0.0 111.401 -178.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.587 ' O ' HG23 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -50.76 156.1 1.73 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.834 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.815 ' HG3' HD23 ' A' ' 24' ' ' LEU . 11.2 Cg_endo -53.67 102.83 0.08 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.514 2.143 . . . . 0.0 111.96 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 82' ' ' GLU . 57.6 t -103.07 103.05 14.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.599 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.79 112.5 24.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.9 0.381 . . . . 0.0 110.966 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.63 -176.9 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.398 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -59.33 -19.07 43.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.958 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -89.93 -40.53 12.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.386 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.83 -164.09 35.65 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.826 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.477 ' CZ ' ' HB2' ' A' ' 20' ' ' GLN . 0.3 OUTLIER -83.43 98.17 9.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.55 ' CE1' HD11 ' A' ' 16' ' ' LEU . 15.5 m80 -83.68 167.1 17.55 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.557 ' CG1' HG13 ' A' ' 80' ' ' VAL . 18.0 t -145.11 153.42 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.772 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.493 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -138.02 121.58 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.489 ' CB ' ' CE1' ' A' ' 36' ' ' PHE . 5.1 tptm -129.62 113.27 14.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.168 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.514 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.8 OUTLIER -57.97 139.19 54.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.787 0.803 . . . . 0.0 112.631 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.588 HD23 ' OG ' ' A' ' 13' ' ' SER . 0.2 OUTLIER -159.62 116.18 2.56 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.351 179.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.555 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.568 ' HD2' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.668 0.27 . . . . 0.0 111.081 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.402 HD11 ' HB3' ' A' ' 73' ' ' PHE . 0.4 OUTLIER -114.14 136.97 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 121.4 0.619 . . . . 0.0 110.752 -178.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.717 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -107.29 95.39 5.67 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.738 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.842 ' SG ' HG22 ' A' ' 93' ' ' ILE . 1.9 t -120.4 179.35 4.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.794 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.917 ' HB3' HD23 ' A' ' 96' ' ' LEU . 14.7 p -120.56 163.35 18.12 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.69 ' C ' HD12 ' A' ' 15' ' ' ILE . 24.6 p-80 -134.68 151.59 51.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.517 0.675 . . . . 0.0 112.633 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.769 HG23 ' OG ' ' A' ' 44' ' ' SER . 2.9 mp -155.61 127.09 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.764 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.884 HD13 ' CD2' ' A' ' 91' ' ' HIS . 10.9 tp -114.15 129.06 56.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.935 0.398 . . . . 0.0 112.029 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.768 HG11 ' OE1' ' A' ' 22' ' ' GLU . 28.1 m -143.26 134.35 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.635 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.504 ' HD2' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -77.9 -33.97 51.64 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.478 -179.013 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.6 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 13.2 tttp -72.3 79.14 1.0 Allowed 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 0.9 OUTLIER -46.18 -25.39 0.59 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.939 -177.026 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.55 -31.33 78.35 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 118.865 -1.636 . . . . 0.0 110.429 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.868 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -73.2 -37.65 66.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.06 0.457 . . . . 0.0 109.777 178.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.602 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -53.31 -36.2 60.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.738 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.632 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.59 -29.28 62.3 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.762 178.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.9 -43.53 14.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.633 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.868 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.3 m -55.28 -36.72 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.428 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.822 ' HA ' HG11 ' A' ' 80' ' ' VAL . 3.5 pt20 -56.27 -53.27 59.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.696 0.284 . . . . 0.0 110.541 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.526 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -73.62 -26.95 61.03 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.965 0.412 . . . . 0.0 110.866 179.055 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.578 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.0 tpp180 -78.41 -34.02 48.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.784 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.506 ' CD2' HD23 ' A' ' 39' ' ' LEU . 1.3 tm? -53.52 -57.47 10.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.03 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -9.41 58.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.253 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -58.46 -23.77 58.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.938 0.399 . . . . 0.0 111.32 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.51 -17.38 1.13 Allowed Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.374 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -78.46 157.64 28.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.876 0.369 . . . . 0.0 110.861 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -100.75 140.41 35.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.107 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.882 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 5.4 p90 -49.53 -31.66 10.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.949 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.47 -33.98 88.71 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.376 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 4.9 mmmt -67.94 -53.89 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.697 0.284 . . . . 0.0 110.999 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.038 HD12 HD11 ' A' ' 43' ' ' LEU . 2.8 mm? -53.86 -33.86 57.62 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.68 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.79 -52.5 48.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.109 0.48 . . . . 0.0 110.543 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -86.51 -23.34 25.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.341 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.849 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -71.7 -69.05 0.41 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.116 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.038 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.68 -12.44 9.26 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.769 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -63.85 137.68 58.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.895 0.379 . . . . 0.0 111.151 -179.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.673 HG13 ' HB3' ' A' ' 16' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.332 -0.188 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.965 179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.089 0 CA-C-O 120.906 0.384 . . . . 0.0 110.925 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -75.23 -4.73 40.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.235 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.12 24.69 11.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.399 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 p30 56.17 33.59 22.34 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.159 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.455 ' HA2' ' CE1' ' A' ' 14' ' ' HIS . . . 50.84 24.41 8.13 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.938 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.53 87.51 7.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.018 0.437 . . . . 0.0 110.428 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.702 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 13.9 mt -62.42 -17.12 58.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.794 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 53.6 -171.76 0.71 Allowed Glycine 0 CA--C 1.507 -0.408 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.204 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.717 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 8.5 p90 -59.95 117.02 4.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.122 0.486 . . . . 0.0 111.619 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.498 ' C ' ' HB2' ' A' ' 9' ' ' LYS . 8.6 p90 -139.37 141.22 37.6 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.429 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.469 ' CA ' ' HB2' ' A' ' 9' ' ' LYS . . . -90.89 -173.78 44.02 Favored Glycine 0 C--N 1.311 -0.816 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.404 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.67 100.18 13.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.749 0.309 . . . . 0.0 110.362 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.32 36.49 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.312 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -151.18 18.44 0.76 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.861 0.331 . . . . 0.0 111.595 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.486 ' HE3' ' CE1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -151.61 174.12 13.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.697 0.284 . . . . 0.0 111.075 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.796 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.1 m -60.74 158.46 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.803 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.571 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -61.32 -47.84 92.91 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.627 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 19.8 Cg_endo -64.28 -40.1 26.99 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.024 1.816 . . . . 0.0 112.048 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.796 ' H ' HG23 ' A' ' 65' ' ' VAL . 26.1 t80 -74.95 -51.19 14.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.799 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 3.2 tm-20 -57.42 -32.47 66.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.749 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 23.7 t70 -66.08 -49.39 67.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.969 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.458 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -74.87 -9.49 58.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.816 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.408 ' HB1' ' HE1' ' A' ' 59' ' ' PHE . . . -66.31 -47.39 73.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.753 0.311 . . . . 0.0 111.556 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 8.6 p90 -92.93 16.69 12.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.499 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -100.4 -27.3 13.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.787 0.327 . . . . 0.0 110.933 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 79' ' ' GLU . 1.5 mt -103.53 58.5 0.74 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.454 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -69.22 -18.31 63.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.975 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -66.29 -26.82 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.688 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.429 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 96.23 58.2 1.1 Allowed Glycine 0 CA--C 1.502 -0.744 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.568 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.603 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -139.56 176.5 8.67 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.726 0.298 . . . . 0.0 111.055 -178.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.822 HG11 ' HA ' ' A' ' 27' ' ' GLN . 24.8 t -87.18 148.56 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.198 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -105.37 157.34 17.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.245 0.545 . . . . 0.0 111.335 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.47 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.9 mp0 -50.96 155.81 1.93 Allowed Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.066 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HG3' HD23 ' A' ' 24' ' ' LEU . 12.8 Cg_endo -56.26 106.26 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.208 1.939 . . . . 0.0 111.6 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.627 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 70.9 t -100.9 108.06 22.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.597 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.452 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 28.2 tptt -91.65 113.0 25.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.96 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.448 ' HG ' ' CE1' ' A' ' 91' ' ' HIS . 0.9 OUTLIER -110.04 -171.38 1.83 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.321 179.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.79 -18.4 21.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.277 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . 0.468 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 12.1 m-85 -93.69 -38.9 11.08 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.722 0.296 . . . . 0.0 111.677 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.401 ' HA2' ' NZ ' ' A' ' 85' ' ' LYS . . . 154.58 -166.19 32.22 Favored Glycine 0 CA--C 1.508 -0.384 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.848 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.615 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 59.3 m-85 -74.73 98.21 3.41 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.306 0.574 . . . . 0.0 110.161 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.884 ' CD2' HD13 ' A' ' 16' ' ' LEU . 79.6 m80 -86.53 169.88 12.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.575 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.6 t -145.88 147.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.848 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.842 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -134.67 123.22 41.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.407 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 3.3 tmtm? -128.14 110.1 12.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.843 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -57.39 131.74 50.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.416 0.627 . . . . 0.0 111.872 -178.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.917 HD23 ' HB3' ' A' ' 13' ' ' SER . 0.3 OUTLIER -158.7 116.92 2.94 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.989 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.407 -1.219 . . . . 0.0 112.52 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.676 ' HD3' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.456 -0.136 0 CA-C-O 120.542 0.21 . . . . 0.0 110.748 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.692 HD11 ' HB3' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -109.95 137.14 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-O 121.635 0.731 . . . . 0.0 111.161 -178.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.577 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -110.4 89.22 2.97 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.286 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.753 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 35.8 m -120.87 179.91 4.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.193 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.54 ' CB ' HD23 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -119.52 163.39 17.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.949 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.462 ' C ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -134.45 147.73 50.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.229 0.538 . . . . 0.0 112.249 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.546 HG23 ' OG ' ' A' ' 44' ' ' SER . 3.6 mp -145.41 115.3 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.942 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.643 HD11 ' NE2' ' A' ' 91' ' ' HIS . 0.8 OUTLIER -99.41 129.14 45.58 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.076 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.796 HG21 ' CG ' ' A' ' 22' ' ' GLU . 20.2 m -143.25 133.73 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.597 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HE2' HD13 ' A' ' 45' ' ' ILE . 4.7 mttm -71.18 -36.0 71.79 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.849 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.584 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -71.44 78.19 0.77 Allowed 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 1.1 tm0? -46.72 -25.78 0.8 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.935 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.85 -31.37 78.04 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 119.069 -1.538 . . . . 0.0 110.72 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.896 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -71.46 -39.64 70.84 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.195 0.522 . . . . 0.0 109.726 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.69 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -52.9 -36.5 59.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.796 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -73.64 -29.3 62.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.981 178.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.03 -42.06 13.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.888 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.4 m -54.92 -33.83 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.315 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.704 ' HA ' HG11 ' A' ' 80' ' ' VAL . 3.3 pt20 -51.31 -55.33 18.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.675 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.457 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.8 OUTLIER -73.16 -31.29 64.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.14 0.495 . . . . 0.0 110.479 178.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.553 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 10.0 tpt180 -68.38 -37.99 80.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.725 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.848 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -52.95 -58.97 5.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.345 -179.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -72.12 -9.52 58.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.396 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -58.42 -21.92 52.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 0.0 111.341 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.35 -18.49 1.17 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.293 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HG3' HD21 ' A' ' 39' ' ' LEU . 23.2 pt-20 -80.48 157.56 26.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.914 0.388 . . . . 0.0 110.824 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -97.35 138.59 34.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.029 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.848 ' HA ' HD21 ' A' ' 30' ' ' LEU . 1.9 p90 -49.23 -35.39 17.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.964 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -64.6 -34.09 88.98 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.542 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.6 OUTLIER -63.38 -53.85 46.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.626 0.25 . . . . 0.0 111.192 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.961 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.17 -34.34 56.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.044 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.45 -53.61 35.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.017 0.436 . . . . 0.0 110.524 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -85.97 -23.63 26.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.179 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.85 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.37 -68.65 0.41 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -177.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.961 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.5 -14.0 9.17 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.553 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -64.18 137.87 58.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.168 0.509 . . . . 0.0 111.549 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.575 HD13 ' HE2' ' A' ' 18' ' ' LYS . 1.4 pt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.028 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.192 0 CA-C-O 121.256 0.55 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -70.64 -12.06 61.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.659 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -103.46 24.03 11.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.582 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 72.68 10.25 5.58 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.554 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.29 22.01 66.9 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.205 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.4 89.07 2.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.106 0.479 . . . . 0.0 110.622 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.753 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 12.1 mt -63.41 -15.03 56.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.775 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 48.22 -171.17 0.06 OUTLIER Glycine 0 CA--C 1.507 -0.468 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.339 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.676 ' HB2' ' HD3' ' A' ' 9' ' ' LYS . 16.8 p90 -56.51 122.62 12.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.211 0.529 . . . . 0.0 111.872 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.66 ' HE1' ' HB1' ' A' ' 72' ' ' ALA . 7.3 p90 -146.09 140.88 27.05 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.48 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.2 -173.9 23.41 Favored Glycine 0 C--N 1.315 -0.632 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.982 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 88.54 1.1 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.033 0.444 . . . . 0.0 110.129 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.53 36.88 0.05 OUTLIER Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.934 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.63 -41.67 0.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.596 0.236 . . . . 0.0 111.462 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.435 ' HE2' ' HB2' ' A' ' 64' ' ' MET . 1.9 mpp? -105.73 174.0 6.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.032 0.444 . . . . 0.0 111.468 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.777 HG23 ' H ' ' A' ' 68' ' ' PHE . 34.4 m -56.81 161.39 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.069 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.553 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -60.36 -48.03 94.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.611 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 15.5 Cg_endo -64.85 -42.01 16.25 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 121.911 1.741 . . . . 0.0 111.731 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.777 ' H ' HG23 ' A' ' 65' ' ' VAL . 15.2 t80 -72.65 -51.51 19.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.472 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.7 tt0 -56.34 -32.29 64.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.614 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 35.2 t70 -65.97 -51.6 56.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.707 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.405 ' HB3' HD11 ' A' ' 93' ' ' ILE . . . -75.12 -12.12 60.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.429 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.66 ' HB1' ' HE1' ' A' ' 59' ' ' PHE . . . -61.83 -49.21 77.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.886 0.374 . . . . 0.0 111.265 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.692 ' HB3' HD11 ' A' ' 10' ' ' ILE . 2.8 p90 -93.96 16.58 14.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.239 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -98.27 -26.39 14.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.375 . . . . 0.0 110.705 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.572 HD12 ' O ' ' A' ' 79' ' ' GLU . 2.0 mt -103.46 53.08 0.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.145 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -59.72 -22.02 61.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.165 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 p -61.92 -26.77 40.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.533 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 94.17 55.62 1.46 Allowed Glycine 0 CA--C 1.503 -0.717 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.741 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.572 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -137.44 176.53 8.62 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.692 0.282 . . . . 0.0 111.01 -178.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.704 HG11 ' HA ' ' A' ' 27' ' ' GLN . 59.5 t -86.43 147.43 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.533 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.47 160.48 15.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.202 0.525 . . . . 0.0 111.409 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.47 ' O ' HG23 ' A' ' 84' ' ' VAL . 21.0 mp0 -50.89 155.49 2.0 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.159 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.408 ' HG3' HD23 ' A' ' 24' ' ' LEU . 14.6 Cg_endo -56.93 105.96 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.228 1.952 . . . . 0.0 111.772 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.611 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 85.0 t -100.93 106.8 20.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.115 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.467 ' CG ' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.52 112.89 25.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.494 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.445 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 0.5 OUTLIER -105.19 -171.65 1.95 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.051 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -14.94 36.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.202 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -96.47 -36.36 10.82 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.612 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.19 -166.53 34.16 Favored Glycine 0 CA--C 1.508 -0.403 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.86 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.742 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 91.7 m-85 -80.73 98.07 7.58 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.237 0.542 . . . . 0.0 109.941 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.643 ' NE2' HD11 ' A' ' 16' ' ' LEU . 50.9 m80 -82.95 169.73 15.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.812 -178.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.447 ' CG1' HG13 ' A' ' 80' ' ' VAL . 19.4 t -149.52 145.6 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.445 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.622 HG23 ' CE1' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -123.3 122.28 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.005 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 13' ' ' SER . 2.4 tptm -128.72 108.98 10.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.406 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 2.0 ttp85 -57.26 132.8 54.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.562 0.696 . . . . 0.0 112.346 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.844 HD22 ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -163.17 116.71 1.6 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.782 179.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.417 -1.213 . . . . 0.0 112.67 179.754 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.41 0 CA-C-O 121.214 0.53 . . . . 0.0 111.357 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.582 HG22 ' SG ' ' A' ' 12' ' ' CYS . 1.4 mt -110.74 136.04 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.904 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.105 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.515 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.0 mtpt -107.73 88.4 2.72 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.668 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.818 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 8.6 m -131.41 -179.82 5.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.735 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.683 ' HB2' HD23 ' A' ' 96' ' ' LEU . 45.2 t -121.1 163.44 18.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.226 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.67 ' C ' HD12 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -130.68 150.78 51.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.172 0.511 . . . . 0.0 111.857 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.67 HD12 ' C ' ' A' ' 14' ' ' HIS . 4.1 mp -154.27 130.15 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.527 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.5 HD21 ' C ' ' A' ' 89' ' ' GLY . 0.5 OUTLIER -123.2 138.04 54.74 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.868 0.366 . . . . 0.0 111.858 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 1.014 HG21 ' CG ' ' A' ' 22' ' ' GLU . 24.2 m -151.02 135.84 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.516 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -64.91 -19.5 65.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.39 76.4 1.03 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.796 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 2.6 pt20 -47.79 -33.14 6.81 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.32 -31.17 61.55 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 119.915 -1.136 . . . . 0.0 112.599 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 1.014 ' CG ' HG21 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -68.16 -42.68 79.7 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.451 0.643 . . . . 0.0 109.92 179.359 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.669 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -49.64 -36.81 25.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.526 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.706 HD13 ' O ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -72.71 -33.83 66.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.812 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.11 -44.15 22.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.514 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.807 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.8 m -47.96 -36.34 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.394 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.718 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -58.01 -49.26 77.45 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.522 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.718 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 4.0 pt-20 -73.89 -30.37 62.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.838 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.538 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 10.4 tpp85 -78.83 -33.12 46.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.83 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.571 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.8 OUTLIER -52.53 -51.93 57.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.688 0.28 . . . . 0.0 111.424 -178.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.401 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -71.99 -9.29 58.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.186 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -72.72 47.2 0.17 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.32 -10.66 41.73 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.737 -0.744 . . . . 0.0 114.153 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 29' ' ' ARG . 6.6 pt-20 -91.97 153.98 19.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.437 0.618 . . . . 0.0 110.78 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -104.22 139.22 39.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.419 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 1.023 ' CE1' HD22 ' A' ' 96' ' ' LEU . 2.2 p90 -47.18 -31.75 3.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.841 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.11 -34.17 88.15 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.372 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.8 ttpm? -68.1 -51.99 40.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.654 0.264 . . . . 0.0 111.112 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.846 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.13 -36.01 60.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.412 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.783 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -51.93 -53.2 43.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.167 0.508 . . . . 0.0 110.634 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -85.64 -23.6 27.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.791 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.973 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -72.06 -67.52 0.53 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.133 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.973 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.36 -14.62 9.75 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.559 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 1.4 t -63.42 126.8 28.66 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.227 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.522 HG12 ' HA ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER . . . . . 0 C--N 1.323 -0.553 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -178.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.783 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . . . . . . . . 0 CA--C 1.52 -0.188 0 CA-C-O 121.307 0.575 . . . . 0.0 109.624 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -88.9 -5.44 58.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.184 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.466 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 1.7 mmt85 -122.36 24.55 9.3 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.9 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER 74.51 26.96 1.43 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.344 0.592 . . . . 0.0 111.085 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 55.56 20.31 23.31 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.789 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.45 84.66 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.027 0.442 . . . . 0.0 110.752 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.818 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 12.8 mt -58.92 -21.73 58.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.788 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 55.93 -163.85 5.05 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.413 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.515 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -64.23 119.48 10.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.028 0.442 . . . . 0.0 111.835 -179.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.546 ' HE1' ' HB1' ' A' ' 72' ' ' ALA . 19.1 p90 -141.27 139.34 33.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.571 177.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.419 ' CA ' ' HE2' ' A' ' 9' ' ' LYS . . . -98.35 -173.95 32.67 Favored Glycine 0 C--N 1.318 -0.463 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.504 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -82.8 98.27 9.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.199 0.524 . . . . 0.0 109.955 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.45 36.48 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.636 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -140.25 -46.87 0.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.837 0.351 . . . . 0.0 110.952 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.431 ' CE ' ' CE1' ' A' ' 59' ' ' PHE . 1.4 mpp? -91.92 170.04 10.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.963 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.77 HG23 ' H ' ' A' ' 68' ' ' PHE . 34.8 m -59.58 162.34 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.018 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.498 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.63 -48.18 97.37 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.068 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.573 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 10.0 Cg_endo -66.02 -38.37 22.6 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 121.858 1.706 . . . . 0.0 112.171 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.77 ' H ' HG23 ' A' ' 65' ' ' VAL . 8.8 t80 -74.97 -50.01 18.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.746 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -57.04 -32.49 66.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.651 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -64.61 -50.65 66.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.849 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.85 -9.57 58.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.524 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.546 ' HB1' ' HE1' ' A' ' 59' ' ' PHE . . . -68.15 -50.45 54.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.782 0.325 . . . . 0.0 111.301 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 6.4 p90 -93.28 16.56 12.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.343 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.48 -25.19 14.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 0.0 110.863 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 79' ' ' GLU . 1.6 mt -103.53 55.15 0.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.219 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -63.49 -19.55 64.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.098 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -63.66 -26.72 41.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.403 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.503 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.13 55.58 1.37 Allowed Glycine 0 CA--C 1.503 -0.674 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.629 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.558 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -137.63 176.17 8.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.858 0.361 . . . . 0.0 111.221 -178.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.63 HG11 ' HA ' ' A' ' 27' ' ' GLN . 60.2 t -83.16 149.09 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.903 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.0 t -104.4 154.8 19.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.448 0.642 . . . . 0.0 111.764 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -50.8 163.5 0.48 Allowed Pre-proline 0 C--O 1.235 0.307 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.573 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.563 ' HG3' HD23 ' A' ' 24' ' ' LEU . 17.8 Cg_endo -59.15 104.56 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.604 2.203 . . . . 0.0 112.226 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.573 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 93.7 t -101.43 101.54 12.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.373 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.69 113.01 25.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.851 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.3 m -108.71 -171.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.6 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -57.7 -20.28 33.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.33 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -91.34 -40.49 11.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.424 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.5 ' C ' HD21 ' A' ' 16' ' ' LEU . . . 157.33 -164.51 32.97 Favored Glycine 0 CA--C 1.508 -0.354 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.073 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.484 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 0.7 OUTLIER -74.59 98.39 3.37 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.052 0.453 . . . . 0.0 110.39 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.473 ' NE2' HD12 ' A' ' 16' ' ' LEU . 31.0 m80 -81.71 169.95 16.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.236 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 t -149.29 150.6 13.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.01 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.492 HG23 ' CE1' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -138.1 124.14 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.319 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 13' ' ' SER . 15.8 tptp -128.45 109.29 11.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.594 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.503 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.5 OUTLIER -57.7 136.61 56.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.601 0.715 . . . . 0.0 112.206 -179.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 1.023 HD22 ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -161.27 116.52 2.1 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.718 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.28 -1.289 . . . . 0.0 112.659 179.76 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.76 ' HD3' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.454 -0.242 0 CA-C-O 120.498 0.19 . . . . 0.0 110.727 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 58' ' ' TYR . 1.5 mm -109.3 149.64 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 CA-C-O 121.765 0.793 . . . . 0.0 111.276 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.666 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -125.34 76.3 1.54 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.102 -179.546 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.886 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 10.3 m -117.63 -179.68 3.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.258 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.828 ' HB2' HD23 ' A' ' 96' ' ' LEU . 22.6 t -115.66 163.49 15.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.651 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.692 ' C ' HD12 ' A' ' 15' ' ' ILE . 0.7 OUTLIER -132.44 153.03 51.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.54 0.686 . . . . 0.0 112.483 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.75 HG23 ' OG ' ' A' ' 44' ' ' SER . 2.8 mp -155.85 123.18 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.899 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.759 ' HG ' HD11 ' A' ' 45' ' ' ILE . 12.8 tp -111.61 131.17 55.45 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.825 HG11 ' OE1' ' A' ' 22' ' ' GLU . 17.3 m -143.65 134.71 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.67 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HD3' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -72.41 -35.77 68.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.513 -179.227 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.623 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 3.3 tttp -74.31 79.33 1.84 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.489 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -46.28 -25.85 0.7 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.153 -0.931 . . . . 0.0 113.254 -176.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.15 -31.24 77.05 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.9 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.849 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -70.88 -38.23 73.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.009 0.433 . . . . 0.0 110.354 178.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.602 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.83 -37.68 44.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.088 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.707 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.3 OUTLIER -73.44 -29.53 62.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.773 179.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.24 -42.8 15.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.47 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.9 m -55.89 -39.24 55.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.203 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.2 pt20 -56.12 -51.49 67.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.886 0.374 . . . . 0.0 110.26 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.547 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 2.8 pt-20 -73.19 -29.62 62.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.09 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.572 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.83 -29.75 44.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.656 -178.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.639 HD21 ' HA ' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -55.27 -55.33 32.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.944 0.402 . . . . 0.0 110.827 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -9.55 58.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.202 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.2 -24.02 62.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.913 0.387 . . . . 0.0 111.232 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.1 -18.53 0.94 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.307 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -80.72 157.52 25.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.905 0.383 . . . . 0.0 110.807 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.4 138.47 39.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.048 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.865 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 2.4 p90 -47.09 -29.86 2.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.996 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -64.45 -35.8 92.39 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.429 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.4 OUTLIER -66.19 -53.3 39.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.737 0.303 . . . . 0.0 110.869 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.003 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.62 -32.55 51.72 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.484 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.556 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.7 -53.27 41.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.617 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -86.33 -23.32 26.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.245 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.849 ' HB3' HD13 ' A' ' 43' ' ' LEU . 2.6 mm-40 -70.68 -69.22 0.38 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.003 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.61 -13.44 9.17 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.75 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -63.96 136.91 57.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.95 0.405 . . . . 0.0 111.2 -179.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.759 HD11 ' HG ' ' A' ' 16' ' ' LEU . 27.9 pt . . . . . 0 C--N 1.331 -0.223 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.803 179.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.154 0 CA-C-O 121.179 0.514 . . . . 0.0 110.481 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 8.2 mmtt -73.8 -10.58 59.82 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.645 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.95 24.81 10.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.522 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.424 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 0.6 OUTLIER 60.06 27.81 17.29 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.227 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 57.36 20.08 35.53 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.759 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 99.2 p -76.24 87.73 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.944 0.402 . . . . 0.0 110.234 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.886 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 14.4 mt -63.67 -16.48 61.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.548 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 46.55 -169.34 0.04 OUTLIER Glycine 0 CA--C 1.506 -0.522 0 C-N-CA 121.028 -0.605 . . . . 0.0 112.682 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.76 ' HB2' ' HD3' ' A' ' 9' ' ' LYS . 27.5 p90 -66.82 111.48 3.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.539 ' C ' ' HB2' ' A' ' 9' ' ' LYS . 13.0 m-30 -141.96 148.05 37.98 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.0 -174.01 19.0 Favored Glycine 0 C--N 1.311 -0.811 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.406 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -75.3 154.74 37.23 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.2 -37.03 1.17 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.445 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.14 24.77 1.78 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.738 0.304 . . . . 0.0 111.059 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 13.8 mtp -112.95 162.44 15.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.675 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.799 HG23 ' H ' ' A' ' 68' ' ' PHE . 17.7 m -79.28 147.08 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.986 0.422 . . . . 0.0 110.951 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.584 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.23 -44.21 99.01 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 16.8 Cg_endo -65.3 -42.7 12.6 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 121.808 1.672 . . . . 0.0 112.207 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.799 ' H ' HG23 ' A' ' 65' ' ' VAL . 16.6 t80 -74.88 -49.39 20.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.842 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.61 -32.33 70.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.825 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 4.1 m-20 -64.6 -46.85 80.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.257 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.875 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -74.82 -18.4 60.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.749 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 10' ' ' ILE . . . -54.15 -53.06 58.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.727 0.299 . . . . 0.0 111.57 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -87.74 16.84 5.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.833 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -100.53 -31.58 11.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.822 0.344 . . . . 0.0 110.72 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 79' ' ' GLU . 2.8 mt -103.78 69.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.766 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -78.03 -16.41 58.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.088 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 p -69.07 -26.79 33.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.94 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.545 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 96.84 60.08 0.99 Allowed Glycine 0 CA--C 1.504 -0.634 0 C-N-CA 120.43 -0.89 . . . . 0.0 111.199 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.571 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -141.89 176.49 8.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.894 0.378 . . . . 0.0 111.025 -178.094 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.559 HG11 ' HA ' ' A' ' 27' ' ' GLN . 48.1 t -85.31 148.49 4.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.879 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t -104.5 163.96 12.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.212 0.529 . . . . 0.0 111.342 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.502 ' O ' HG23 ' A' ' 84' ' ' VAL . 14.8 mt-10 -50.59 158.16 1.13 Allowed Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.187 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.707 ' HG3' HD23 ' A' ' 24' ' ' LEU . 16.5 Cg_endo -57.15 104.08 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.538 2.159 . . . . 0.0 111.793 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.571 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 57.9 t -101.82 105.91 18.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.782 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 3.0 tmtt? -98.76 112.86 24.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 21.8 m -110.47 -172.47 2.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.475 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -57.76 -20.37 34.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.964 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -88.74 -30.89 18.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.381 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.428 ' C ' HD11 ' A' ' 16' ' ' LEU . . . 143.62 -169.7 25.91 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.885 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.489 ' CD1' ' HB3' ' A' ' 20' ' ' GLN . 0.4 OUTLIER -74.68 98.33 3.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.982 0.42 . . . . 0.0 110.017 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.671 ' CG ' HD13 ' A' ' 16' ' ' LEU . 6.1 m80 -89.02 169.7 11.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.421 0.629 . . . . 0.0 112.294 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.444 ' CG1' HG13 ' A' ' 80' ' ' VAL . 25.0 t -139.86 134.64 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.614 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.875 HD12 ' HB3' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -118.29 121.86 68.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.93 108.06 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.312 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.545 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.4 OUTLIER -59.07 131.87 52.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.398 0.618 . . . . 0.0 111.816 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.865 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -160.35 116.02 2.33 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.001 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.312 -1.271 . . . . 0.0 112.591 179.731 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.62 0 CA-C-O 121.214 0.53 . . . . 0.0 111.096 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.27 138.62 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.008 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.496 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -106.66 98.23 7.92 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.523 -178.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.816 ' SG ' HG22 ' A' ' 93' ' ' ILE . 2.8 t -127.25 179.98 5.17 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.929 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.742 ' HB2' HD23 ' A' ' 96' ' ' LEU . 7.5 t -121.23 163.27 18.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.904 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.805 ' HB3' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -131.04 149.55 52.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.045 0.45 . . . . 0.0 111.967 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.711 HD12 ' C ' ' A' ' 14' ' ' HIS . 3.7 mp -155.94 131.58 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.944 HD21 ' CD2' ' A' ' 91' ' ' HIS . 4.0 mm? -123.0 138.1 54.78 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.94 0.4 . . . . 0.0 111.64 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.812 HG21 ' CG ' ' A' ' 22' ' ' GLU . 18.3 m -148.98 134.11 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.93 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -69.84 -36.7 75.77 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.188 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.594 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.31 78.37 1.0 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.464 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -46.69 -25.79 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.768 -1.105 . . . . 0.0 113.238 -177.448 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.1 -31.48 77.83 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 119.045 -1.55 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.901 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -70.13 -39.22 75.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.247 0.546 . . . . 0.0 109.969 178.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.664 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -49.24 -39.5 30.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.376 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.556 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.33 -29.66 62.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.16 179.244 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.01 -36.49 23.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.755 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.901 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.4 m -57.27 -33.29 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.213 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.657 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -59.76 -50.26 74.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.657 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -73.12 -27.26 61.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.243 0.544 . . . . 0.0 110.348 178.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.567 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.9 tpt180 -77.86 -33.93 51.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.702 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.681 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -53.32 -59.4 4.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.245 -179.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -72.41 -9.39 58.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.287 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -56.78 -22.31 35.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.866 0.365 . . . . 0.0 111.416 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.01 -16.91 1.05 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.368 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -86.47 157.37 19.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.791 0.329 . . . . 0.0 110.682 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -99.51 142.38 31.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.091 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.812 ' CE1' HD22 ' A' ' 96' ' ' LEU . 2.9 p90 -47.65 -29.53 3.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.797 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -66.53 -38.93 93.79 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.563 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.557 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 5.1 ttpp -59.82 -50.98 71.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.72 0.295 . . . . 0.0 110.822 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.819 HD12 HD11 ' A' ' 43' ' ' LEU . 3.1 mm? -53.4 -34.85 59.32 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.741 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.678 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -52.09 -52.96 47.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.29 0.566 . . . . 0.0 110.665 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.46 -22.74 26.31 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.285 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.92 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -75.59 -68.4 0.57 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -176.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.92 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.63 -10.72 9.99 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.592 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -63.75 125.89 25.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.908 0.385 . . . . 0.0 109.993 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.452 HG12 ' O ' ' A' ' 16' ' ' LEU . 4.9 pt . . . . . 0 C--N 1.33 -0.259 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.678 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . . . . . . . . 0 CA--C 1.517 -0.319 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -88.78 -19.69 25.68 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.913 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.462 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 3.2 mtt180 -104.43 24.68 11.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.168 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.495 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 0.6 OUTLIER 62.19 40.96 11.13 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.259 0.552 . . . . 0.0 111.583 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 53.36 30.51 40.83 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.213 178.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.849 ' HA ' HD21 ' A' ' 96' ' ' LEU . 65.4 p -88.74 85.09 6.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.729 0.3 . . . . 0.0 110.827 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.806 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 16.4 mt -58.3 -31.67 67.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.637 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 70.76 -170.12 47.03 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.453 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.561 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -60.64 118.47 6.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.151 0.501 . . . . 0.0 111.661 -179.384 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.557 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 2.4 m-85 -127.18 164.08 22.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.76 -174.02 13.25 Favored Glycine 0 C--N 1.319 -0.411 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.672 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -74.3 84.23 1.91 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.168 0.508 . . . . 0.0 110.121 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.33 36.78 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.056 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.0 -48.6 0.61 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.674 0.273 . . . . 0.0 111.39 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.4 ' HG3' ' HB2' ' A' ' 69' ' ' GLU . 1.9 ptp -108.42 169.51 8.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.025 0.441 . . . . 0.0 111.406 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.76 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.6 m -54.72 161.71 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.666 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.57 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -61.65 -48.14 90.74 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 11.8 Cg_endo -63.33 -42.0 24.25 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 121.999 1.799 . . . . 0.0 111.744 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.76 ' H ' HG23 ' A' ' 65' ' ' VAL . 17.9 t80 -73.11 -51.78 16.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.662 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 3.4 tm-20 -59.24 -32.98 70.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.774 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 6.7 m-20 -61.48 -48.57 80.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.127 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.587 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -74.83 -9.57 58.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.737 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.42 -47.72 78.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.771 0.32 . . . . 0.0 111.515 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 10.2 p90 -92.7 16.6 11.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.476 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -99.99 -25.82 14.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 111.205 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.803 HD11 ' CB ' ' A' ' 81' ' ' SER . 11.0 mt -101.25 56.9 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.389 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -61.42 -31.7 71.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.979 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -63.15 -26.88 41.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.124 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.5 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 89.94 70.21 1.23 Allowed Glycine 0 CA--C 1.499 -0.915 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.951 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.797 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -142.29 177.35 8.31 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.122 -0.539 . . . . 0.0 109.998 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.546 HG11 ' HA ' ' A' ' 27' ' ' GLN . 87.0 t -79.72 150.61 4.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.803 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -105.04 164.31 11.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.608 0.718 . . . . 0.0 111.907 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.624 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -50.5 164.31 0.41 Allowed Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.896 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.624 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 55.5 Cg_endo -68.73 103.44 0.99 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.398 2.065 . . . . 0.0 112.123 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 81.4 t -101.89 104.31 16.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.087 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.455 ' CG ' ' CD1' ' A' ' 90' ' ' TYR . 12.2 tmtt? -99.78 112.67 24.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.584 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.441 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 74.4 m -112.82 -176.44 2.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.858 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -51.83 -25.95 8.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.178 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -80.81 -39.95 25.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.087 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.56 -163.45 31.2 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.701 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.635 ' O ' HD13 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -80.39 100.28 8.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.632 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.944 ' CD2' HD21 ' A' ' 16' ' ' LEU . 60.5 m80 -85.05 162.24 19.4 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.7 t -146.82 125.19 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.011 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.816 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -113.68 124.49 70.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.405 ' HG2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -128.25 112.77 14.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.189 178.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.27 135.92 56.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.552 0.691 . . . . 0.0 112.356 -177.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.849 HD21 ' HA ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -156.74 116.76 3.54 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.578 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.424 -1.209 . . . . 0.0 112.564 179.823 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.601 0 CA-C-O 121.089 0.471 . . . . 0.0 111.089 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.14 129.52 66.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.528 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.514 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.1 mtpt -95.79 97.74 9.91 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.948 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.79 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -126.65 -179.73 4.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.839 -177.083 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.864 ' HB3' HD23 ' A' ' 96' ' ' LEU . 5.8 p -124.43 159.81 29.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.348 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.842 ' HB3' HD11 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -131.92 146.54 52.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.17 0.51 . . . . 0.0 112.302 -179.419 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.73 HD12 ' C ' ' A' ' 14' ' ' HIS . 4.1 mp -149.73 132.78 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.673 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.75 HD21 ' CD2' ' A' ' 91' ' ' HIS . 4.1 mm? -119.54 137.55 53.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.784 0.326 . . . . 0.0 111.598 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.866 HG21 ' CG ' ' A' ' 22' ' ' GLU . 15.7 m -148.54 134.23 11.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.17 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.404 ' HD2' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -71.12 -36.46 72.13 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.412 -178.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.665 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -74.42 79.15 1.89 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.878 0.846 . . . . 0.0 108.73 178.499 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.489 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -45.82 -25.28 0.49 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.363 -1.289 . . . . 0.0 113.162 -177.447 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.61 -30.37 76.28 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.124 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.871 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -72.02 -39.72 68.97 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.049 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.724 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -49.84 -35.02 21.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.205 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.555 HD13 ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -73.3 -40.1 64.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.613 179.088 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.56 -48.78 30.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.589 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.7 m -46.55 -40.53 4.45 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.249 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.448 ' HA ' HG11 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -59.01 -45.13 91.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.444 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.4 mm-40 -73.69 -33.06 64.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.82 178.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.569 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -78.69 -30.41 46.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.842 -178.539 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.628 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -52.99 -58.95 5.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.895 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -9.38 58.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.383 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -58.29 -24.32 59.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.927 0.394 . . . . 0.0 111.327 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.93 -18.61 0.96 Allowed Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.191 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.515 ' CD ' HD21 ' A' ' 39' ' ' LEU . 6.9 pt-20 -82.15 157.59 23.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.862 0.363 . . . . 0.0 110.503 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.38 141.75 33.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.091 0.472 . . . . 0.0 111.216 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.628 ' HA ' HD21 ' A' ' 30' ' ' LEU . 3.2 p90 -45.8 -31.4 2.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.762 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.53 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.58 -41.65 99.78 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.178 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 2.9 tttt -58.16 -51.97 67.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.516 0.198 . . . . 0.0 110.785 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.803 ' CD1' HD11 ' A' ' 43' ' ' LEU . 3.1 mm? -53.36 -35.14 59.95 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.654 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.676 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -51.86 -53.52 39.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.215 0.531 . . . . 0.0 110.65 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -86.42 -23.1 26.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.126 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.911 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -75.77 -68.26 0.59 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.074 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.911 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.88 -8.3 10.3 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -179.011 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.661 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -63.66 125.79 25.44 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.66 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.46 HG12 ' O ' ' A' ' 16' ' ' LEU . 1.9 pt . . . . . 0 C--N 1.329 -0.292 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.676 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . . . . . . . . 0 C--O 1.232 0.154 0 CA-C-O 120.78 0.324 . . . . 0.0 111.42 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.504 ' HD2' ' N ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -87.96 -21.38 24.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.355 0.598 . . . . 0.0 111.716 -179.436 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.504 ' N ' ' HD2' ' A' ' 51' ' ' LYS . 1.4 ptp180 -103.59 24.92 10.37 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.193 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.53 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER 77.34 6.91 2.98 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.703 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.07 24.42 75.82 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.877 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.9 ' HA ' HD21 ' A' ' 96' ' ' LEU . 82.0 p -66.73 88.61 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.872 0.367 . . . . 0.0 111.261 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.842 HD11 ' HB3' ' A' ' 14' ' ' HIS . 16.2 mt -60.36 -27.42 67.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.402 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.79 -172.99 27.74 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.252 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.547 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -59.07 119.19 6.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.05 0.453 . . . . 0.0 111.491 -179.504 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.526 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 3.1 m-85 -128.46 163.0 25.86 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -139.19 -173.88 13.26 Favored Glycine 0 C--N 1.315 -0.592 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.803 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.27 87.47 1.98 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.116 0.484 . . . . 0.0 109.904 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.59 36.69 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.918 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -147.31 -47.04 0.17 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.701 0.286 . . . . 0.0 111.083 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.4 mtm -98.3 168.43 10.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.098 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.784 HG23 ' H ' ' A' ' 68' ' ' PHE . 36.0 m -61.22 161.44 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.786 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.57 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 4.0 mtpt -61.22 -47.98 92.93 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 12.9 Cg_endo -64.23 -41.37 21.82 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.834 1.689 . . . . 0.0 111.809 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.784 ' H ' HG23 ' A' ' 65' ' ' VAL . 30.5 t80 -73.82 -52.35 13.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.628 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -57.73 -32.46 67.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.755 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.481 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 7.2 m-20 -62.47 -51.15 68.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.854 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.02 -9.5 58.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.664 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.99 -49.19 66.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.875 0.369 . . . . 0.0 111.589 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 9.0 p90 -93.32 16.68 12.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.381 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.14 -27.98 12.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.817 0.341 . . . . 0.0 110.798 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.511 HD11 ' O ' ' A' ' 80' ' ' VAL . 2.5 mt -103.55 54.7 0.75 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.471 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -62.16 -20.13 63.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.915 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -61.01 -26.92 40.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.225 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.46 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 95.25 55.13 1.39 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.845 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.501 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.6 tm-20 -139.51 176.16 8.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.746 0.308 . . . . 0.0 111.105 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 45.0 t -83.91 148.92 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.27 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.4 m -104.93 163.91 12.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.26 0.552 . . . . 0.0 111.588 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.499 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.5 mt-10 -50.86 155.0 2.16 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.384 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.467 ' HG3' HD23 ' A' ' 24' ' ' LEU . 11.2 Cg_endo -54.37 104.68 0.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.659 2.239 . . . . 0.0 112.047 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.567 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 67.4 t -101.47 105.2 17.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 5.1 tptm -94.32 112.99 24.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.757 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.451 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 0.5 OUTLIER -107.9 -175.41 2.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.544 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -59.06 -20.24 51.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.948 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -88.5 -40.8 13.17 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.303 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.22 -164.29 35.41 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.868 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.615 ' O ' HD13 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -81.35 98.29 8.1 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.75 ' CD2' HD21 ' A' ' 16' ' ' LEU . 35.9 m80 -81.22 169.53 17.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.833 -177.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.5 t -154.61 123.76 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.719 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -105.38 122.69 59.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.501 ' HG2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -128.32 116.13 19.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.495 178.294 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.46 ' CB ' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -58.54 136.04 57.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.507 0.67 . . . . 0.0 112.315 -178.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.9 HD21 ' HA ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -160.38 116.76 2.39 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.925 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.479 -1.178 . . . . 0.0 112.718 179.866 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.587 ' CD ' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.124 0 N-CA-C 110.419 -0.215 . . . . 0.0 110.419 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 58' ' ' TYR . 1.5 mm -109.4 148.94 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 CA-C-O 121.714 0.769 . . . . 0.0 111.247 -178.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.658 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -124.75 77.22 1.58 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.943 -179.61 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.814 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 13.8 m -117.54 -179.91 3.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.171 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.825 ' HB2' HD23 ' A' ' 96' ' ' LEU . 3.5 t -109.38 163.67 13.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.297 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.698 ' C ' HD12 ' A' ' 15' ' ' ILE . 12.9 t60 -126.4 142.12 51.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.339 0.59 . . . . 0.0 112.061 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.792 HG23 ' OG ' ' A' ' 44' ' ' SER . 3.5 mp -151.27 120.32 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.93 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.866 HD11 ' CE1' ' A' ' 91' ' ' HIS . 0.4 OUTLIER -113.98 135.89 53.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.206 -178.621 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.828 HG21 ' CG ' ' A' ' 22' ' ' GLU . 15.4 m -151.83 134.11 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.682 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HE3' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -73.09 -35.0 66.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.955 0.407 . . . . 0.0 110.469 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.544 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 13.2 pttm -71.99 80.34 0.92 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.46 ' HG3' ' CZ ' ' A' ' 90' ' ' TYR . 5.7 tt0 -45.03 -25.75 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.376 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.56 -32.13 78.04 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.209 -1.472 . . . . 0.0 111.444 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.828 ' CG ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -69.05 -42.57 76.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.354 0.597 . . . . 0.0 109.662 178.326 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.511 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -46.97 -41.42 16.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.219 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.728 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -73.76 -28.9 61.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.078 179.101 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.41 -50.71 10.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.781 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 30' ' ' LEU . 11.3 m -54.25 -38.4 39.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.915 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.668 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.7 pt20 -53.7 -53.04 57.66 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.655 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.478 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.8 tt0 -73.28 -30.25 63.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.963 0.411 . . . . 0.0 110.937 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -77.47 -28.93 52.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.857 -178.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.71 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.8 OUTLIER -57.45 -58.02 10.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.785 -179.584 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -9.22 58.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.562 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.2 -25.99 64.44 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.856 0.36 . . . . 0.0 111.375 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.28 -17.21 0.52 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.694 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.448 ' CD ' HD21 ' A' ' 39' ' ' LEU . 24.6 pt-20 -88.11 157.59 18.81 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.054 0.454 . . . . 0.0 110.887 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.74 144.04 28.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.64 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.916 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 1.5 p90 -48.15 -34.8 10.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.951 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.7 -34.23 81.17 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.399 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.551 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -66.45 -53.75 31.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.706 0.288 . . . . 0.0 110.734 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.838 ' CD1' HD11 ' A' ' 43' ' ' LEU . 3.2 mm? -53.48 -34.76 59.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.34 -54.48 25.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.102 0.477 . . . . 0.0 110.893 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.15 -22.6 26.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.376 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.847 ' HB3' HD13 ' A' ' 43' ' ' LEU . 3.4 mm-40 -72.14 -69.28 0.41 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.847 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.52 -14.09 9.15 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.792 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -63.95 126.72 28.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.86 0.362 . . . . 0.0 111.088 -179.31 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.437 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.3 pt . . . . . 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.987 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.233 0.189 0 CA-C-O 120.819 0.343 . . . . 0.0 110.933 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -72.7 -10.75 60.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.148 0.499 . . . . 0.0 110.179 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.412 ' O ' ' CG ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -104.13 24.73 10.98 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.255 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.412 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 1.1 p30 59.45 28.76 18.21 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.049 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.89 20.25 25.47 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.758 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.0 92.69 4.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.963 0.411 . . . . 0.0 110.328 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.814 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 11.9 mt -66.61 -13.9 61.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.778 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 45.0 -164.56 0.06 OUTLIER Glycine 0 CA--C 1.505 -0.535 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.261 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.658 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 25.8 p90 -70.87 111.37 6.23 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.221 0.534 . . . . 0.0 111.881 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.447 ' CE2' ' O ' ' A' ' 56' ' ' LEU . 13.9 m-30 -132.95 148.4 52.28 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.406 ' CA ' ' HB2' ' A' ' 9' ' ' LYS . . . -108.1 -173.9 21.92 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.667 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . 0.4 ' NH1' ' HB2' ' A' ' 61' ' ' ARG . 8.4 mtm105 -84.7 122.84 29.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.46 -20.34 1.51 Allowed Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.083 -1.056 . . . . 0.0 113.119 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.9 tptm -120.58 -22.55 6.35 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 9.8 mtp -91.12 162.25 14.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 0.0 111.055 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.778 HG23 ' H ' ' A' ' 68' ' ' PHE . 21.6 m -67.13 154.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.93 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.574 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 14.3 tttt -60.2 -47.07 97.65 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.645 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 17.8 Cg_endo -65.27 -42.28 13.82 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.864 1.71 . . . . 0.0 112.131 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.778 ' H ' HG23 ' A' ' 65' ' ' VAL . 22.8 t80 -74.91 -49.72 19.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.646 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.01 -31.51 67.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.855 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 27.5 t70 -67.16 -48.62 67.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.194 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.543 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.14 -9.63 58.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.931 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.458 ' O ' HG21 ' A' ' 10' ' ' ILE . . . -63.27 -44.71 94.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.726 0.298 . . . . 0.0 111.542 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 18.4 p90 -90.6 16.88 8.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.928 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.434 ' CG ' ' HA ' ' A' ' 71' ' ' ALA . 3.2 mmm180 -99.76 -30.67 11.94 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.78 0.324 . . . . 0.0 110.881 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 79' ' ' GLU . 2.7 mt -103.6 68.34 0.93 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.598 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -77.45 -16.84 58.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.98 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.38 -26.87 34.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.807 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.442 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 97.03 60.76 0.96 Allowed Glycine 0 CA--C 1.504 -0.65 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.577 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.558 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -142.02 176.44 8.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.794 0.331 . . . . 0.0 110.999 -178.359 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.641 HG11 ' HA ' ' A' ' 27' ' ' GLN . 58.2 t -84.9 147.07 5.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.942 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.97 161.3 14.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.266 0.555 . . . . 0.0 111.479 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.402 ' O ' HG23 ' A' ' 84' ' ' VAL . 7.2 mt-10 -50.81 155.87 1.84 Allowed Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.263 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.728 ' HG3' HD23 ' A' ' 24' ' ' LEU . 20.3 Cg_endo -59.99 105.74 0.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.347 2.031 . . . . 0.0 111.699 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.645 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 77.2 t -100.97 108.25 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.516 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 90' ' ' TYR . 3.7 tmtt? -91.74 113.07 25.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.082 0.467 . . . . 0.0 111.423 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -104.22 -171.4 1.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.119 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -12.88 43.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.366 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -99.7 -31.94 11.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.603 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.417 ' CA ' HD21 ' A' ' 16' ' ' LEU . . . 156.04 -170.9 33.83 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.542 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 1.2 m-85 -79.62 98.19 6.81 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.299 0.571 . . . . 0.0 110.303 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.866 ' CE1' HD11 ' A' ' 16' ' ' LEU . 3.2 m80 -80.46 169.94 17.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.318 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.421 ' HB ' ' HB ' ' A' ' 15' ' ' ILE . 12.5 t -145.85 140.69 21.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.818 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.577 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -120.99 122.6 68.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.495 ' HG2' HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -128.54 108.69 10.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.907 178.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -57.68 129.68 42.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.556 0.693 . . . . 0.0 112.166 -178.658 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.916 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -161.4 116.43 2.06 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.77 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.456 -1.191 . . . . 0.0 112.64 179.746 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.448 -0.573 0 CA-C-O 121.168 0.509 . . . . 0.0 110.973 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.687 HD12 ' HB1' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -111.18 136.68 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.08 178.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.477 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.7 mtpt -105.87 97.44 7.26 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.561 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.917 ' SG ' HG22 ' A' ' 93' ' ' ILE . 3.0 t -126.34 179.34 5.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.814 -178.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.829 ' HB2' HD23 ' A' ' 96' ' ' LEU . 6.4 t -124.06 163.31 21.71 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.641 ' HB3' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -133.16 152.41 51.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.207 0.527 . . . . 0.0 112.023 -179.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.802 HG23 ' OG ' ' A' ' 44' ' ' SER . 3.0 mp -151.07 115.4 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.137 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.8 HD13 ' CD2' ' A' ' 91' ' ' HIS . 7.4 tp -102.15 128.73 48.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.874 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.823 HG11 ' OE1' ' A' ' 22' ' ' GLU . 14.5 m -142.1 134.28 27.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.596 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -74.6 -35.93 62.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.463 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.638 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 10.7 tttp -72.48 79.32 1.04 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.414 ' HG2' ' CD1' ' A' ' 90' ' ' TYR . 29.5 mt-30 -46.27 -25.94 0.71 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.969 -176.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.41 -31.24 76.38 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 119.216 -1.469 . . . . 0.0 110.953 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.823 ' OE1' HG11 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -70.68 -38.54 73.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.047 0.451 . . . . 0.0 110.296 178.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.607 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.34 -37.77 38.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.107 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.661 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.19 -29.53 62.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.809 179.129 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.05 -49.44 8.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.18 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.735 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.6 m -49.32 -37.24 10.41 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.13 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.729 ' HA ' HG11 ' A' ' 80' ' ' VAL . 2.9 pt20 -59.28 -48.95 79.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.566 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 3.7 pt-20 -73.17 -29.03 62.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.759 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.594 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 5.9 tpt180 -78.64 -35.13 45.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.965 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 36' ' ' PHE . 1.1 tm? -53.04 -55.6 22.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.271 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -9.62 58.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.273 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.09 -22.95 61.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.871 0.367 . . . . 0.0 111.159 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.08 -17.27 1.37 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.309 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -80.67 157.59 25.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.902 0.382 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -100.06 144.84 28.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.918 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.878 ' CE1' HD22 ' A' ' 96' ' ' LEU . 6.2 p90 -53.65 -33.42 55.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.932 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.77 -33.96 87.04 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.462 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 4.0 tttt -68.35 -52.9 28.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 111.165 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.995 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.42 -33.16 52.87 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.834 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.558 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.57 -52.98 42.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.122 0.487 . . . . 0.0 110.659 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -86.3 -23.41 26.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.192 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.886 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -71.2 -68.67 0.42 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.995 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.0 -13.35 9.43 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.802 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -64.06 142.22 58.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.958 0.409 . . . . 0.0 110.833 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.742 HG13 ' HB3' ' A' ' 16' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--N 1.332 -0.193 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.115 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.098 0 CA-C-O 120.979 0.419 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -6.38 51.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.463 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.32 24.78 11.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.234 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 p30 58.64 28.86 17.74 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.155 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.69 22.18 31.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.825 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.529 ' HA ' HD21 ' A' ' 96' ' ' LEU . 0.7 OUTLIER -69.88 86.94 0.52 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.874 0.369 . . . . 0.0 110.841 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.698 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 16.4 mt -56.66 -28.97 61.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.463 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 67.39 -165.12 43.97 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.739 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.527 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -67.98 120.95 15.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.203 0.525 . . . . 0.0 111.895 -179.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.524 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 11.7 m-30 -133.08 153.72 51.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.121 177.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -121.4 -174.0 14.72 Favored Glycine 0 C--N 1.318 -0.465 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.469 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.93 85.66 6.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.373 . . . . 0.0 110.186 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.33 36.75 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.048 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.91 -48.55 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.806 0.303 . . . . 0.0 111.243 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.66 170.18 10.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 111.134 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.772 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.5 m -57.48 167.37 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.776 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.525 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -64.93 -47.9 73.06 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.539 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 13.0 Cg_endo -66.3 -39.55 17.23 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.873 1.715 . . . . 0.0 112.064 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.772 ' H ' HG23 ' A' ' 65' ' ' VAL . 11.4 t80 -74.99 -50.79 15.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.819 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -58.92 -32.8 69.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.801 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 59.4 t0 -67.8 -46.39 72.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.002 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.0 -14.41 60.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.647 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.687 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -56.33 -46.38 79.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.741 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.458 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 12.1 p90 -92.05 16.64 10.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.528 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.49 -27.5 15.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.342 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.783 HD13 ' O ' ' A' ' 79' ' ' GLU . 4.8 mt -102.35 60.43 0.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.813 0.34 . . . . 0.0 111.449 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -68.08 -25.04 65.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.009 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -70.82 -26.84 28.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.556 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.479 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 92.65 69.33 1.13 Allowed Glycine 0 CA--C 1.501 -0.806 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.599 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.783 ' O ' HD13 ' A' ' 75' ' ' LEU . 1.4 tm-20 -142.25 177.86 7.96 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.111 -0.544 . . . . 0.0 110.08 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.729 HG11 ' HA ' ' A' ' 27' ' ' GLN . 97.8 t -79.58 151.25 4.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.778 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -104.69 157.06 17.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.334 0.588 . . . . 0.0 111.528 -178.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.488 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.5 mt-10 -52.36 154.67 4.13 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.237 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.424 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 14.0 Cg_endo -55.2 103.5 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.763 2.309 . . . . 0.0 111.762 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 92.9 t -101.8 99.68 8.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.564 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.449 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -92.06 112.72 24.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.063 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.428 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 74.1 m -114.48 -175.6 2.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.463 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -56.07 -21.9 24.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.751 0.31 . . . . 0.0 110.874 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -86.78 -23.67 25.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.311 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.97 -170.73 23.05 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.821 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 0.2 OUTLIER -74.66 98.66 3.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.038 0.446 . . . . 0.0 109.905 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.8 ' CD2' HD13 ' A' ' 16' ' ' LEU . 79.4 m80 -86.38 169.34 13.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.455 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.6 t -145.21 153.26 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.664 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.917 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -137.27 122.4 25.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.062 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.404 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 4.1 tptt -128.63 112.87 14.72 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.528 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -57.23 136.5 56.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.701 0.762 . . . . 0.0 112.436 -177.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.878 HD22 ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -159.01 116.82 2.83 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.814 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.565 179.871 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.63 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.425 0 CA-C-O 121.583 0.706 . . . . 0.0 112.332 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.408 HD13 ' HB3' ' A' ' 73' ' ' PHE . 0.6 OUTLIER -111.2 139.89 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.978 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.5 mtpt -108.88 96.91 6.65 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.446 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.929 ' SG ' HG22 ' A' ' 93' ' ' ILE . 3.0 t -125.86 179.13 5.34 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.876 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.834 ' OG ' HD23 ' A' ' 96' ' ' LEU . 0.9 OUTLIER -123.49 161.4 24.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.403 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.866 ' CG ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -136.59 153.4 50.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.534 0.683 . . . . 0.0 112.664 -179.376 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.749 HG23 ' OG ' ' A' ' 44' ' ' SER . 2.6 mp -152.14 115.14 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.85 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.603 HD11 ' NE2' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -100.4 128.41 46.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.852 -179.129 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.73 HG11 ' OE1' ' A' ' 22' ' ' GLU . 10.9 m -145.14 134.38 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.054 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -76.1 -35.81 59.18 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.603 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -72.25 79.7 0.99 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.45 ' HG3' ' CE1' ' A' ' 90' ' ' TYR . 34.6 tt0 -46.05 -25.47 0.58 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.9 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.86 -31.58 78.61 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 118.836 -1.65 . . . . 0.0 110.44 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.883 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -73.21 -37.96 66.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.079 0.466 . . . . 0.0 109.957 178.194 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.609 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -54.08 -35.9 62.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.908 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.647 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -73.76 -29.39 62.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.802 178.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.87 -48.33 10.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.187 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.1 m -49.74 -38.93 14.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.066 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.647 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.6 pt20 -58.83 -48.87 79.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.585 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 4.4 pt-20 -73.19 -29.36 62.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.598 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.58 -31.2 47.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.743 -178.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.634 HD12 ' NZ ' ' A' ' 94' ' ' LYS . 1.3 tm? -56.82 -58.95 5.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.238 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -9.51 58.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.626 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.3 -23.35 62.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 111.397 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.23 -15.91 0.88 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.719 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -89.37 157.49 18.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.751 0.31 . . . . 0.0 110.862 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 pttt -100.68 153.95 19.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.133 0.492 . . . . 0.0 111.148 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.7 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 2.5 p90 -52.63 -40.34 62.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.117 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.404 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -55.4 -34.17 59.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.704 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -67.21 -54.04 24.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.779 0.323 . . . . 0.0 110.854 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.002 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -55.92 -32.28 63.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.827 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.27 -53.78 32.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.948 0.404 . . . . 0.0 110.811 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -86.16 -23.37 26.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.164 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.872 ' HB3' HD13 ' A' ' 43' ' ' LEU . 3.0 mm-40 -70.02 -68.94 0.38 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.002 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.77 -13.55 9.09 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.703 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.749 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -64.1 133.59 53.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.912 0.387 . . . . 0.0 111.195 -179.178 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.464 HG13 ' HB3' ' A' ' 16' ' ' LEU . 1.4 pt . . . . . 0 N--CA 1.462 0.167 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.064 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.941 0.401 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -76.79 -4.34 42.98 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.361 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.23 24.59 11.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.422 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.404 ' HB2' ' CA ' ' A' ' 37' ' ' GLY . 1.6 p30 55.74 31.82 18.24 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.337 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 52.97 33.45 44.02 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.914 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 m -84.82 89.43 7.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 110.847 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.866 HD21 ' CG ' ' A' ' 14' ' ' HIS . 69.6 mt -56.35 -30.05 62.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.503 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 64.54 -165.67 32.01 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.887 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.518 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -68.82 111.01 4.63 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.515 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.63 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 4.9 m-85 -117.03 153.94 31.82 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.04 -174.14 17.51 Favored Glycine 0 C--N 1.312 -0.784 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.446 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -79.57 79.86 6.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.138 0.494 . . . . 0.0 110.033 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.94 36.62 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.66 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -126.6 -41.57 1.85 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.594 0.235 . . . . 0.0 111.181 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -114.51 171.3 7.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.049 0.452 . . . . 0.0 111.297 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.783 HG23 ' H ' ' A' ' 68' ' ' PHE . 32.7 m -52.35 161.92 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.406 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.598 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -65.59 -47.4 67.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.612 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 15.7 Cg_endo -63.27 -40.31 33.09 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.028 1.819 . . . . 0.0 111.893 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.783 ' H ' HG23 ' A' ' 65' ' ' VAL . 35.6 t80 -74.93 -52.64 10.71 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.036 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -57.55 -32.48 67.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.8 OUTLIER -63.13 -50.68 69.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.047 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.535 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.0 -9.98 59.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.65 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.04 99.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.808 0.337 . . . . 0.0 111.293 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 20.2 p90 -96.46 16.83 17.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.419 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.87 -30.76 12.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.931 0.396 . . . . 0.0 110.827 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 79' ' ' GLU . 4.2 mt -103.57 68.21 0.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.262 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -73.26 -18.26 61.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.155 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -66.55 -26.75 38.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.755 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.431 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 95.18 57.14 1.23 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.598 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.513 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -138.64 176.45 8.68 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.839 0.352 . . . . 0.0 110.801 -178.434 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 27' ' ' GLN . 42.6 t -84.43 146.08 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.502 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 t -105.37 164.07 12.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.171 0.51 . . . . 0.0 111.477 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 84' ' ' VAL . 6.6 mp0 -50.89 154.72 2.33 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.107 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.48 105.32 0.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.25 1.967 . . . . 0.0 111.797 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.612 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 59.4 t -101.19 102.14 13.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.549 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.472 ' HG2' ' CD2' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -92.11 113.14 25.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.315 -179.628 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.96 -171.46 1.89 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.205 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . 0.43 ' OE2' HG11 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -56.88 -19.13 15.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.532 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -92.24 -40.82 10.76 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.43 ' CA ' HD21 ' A' ' 16' ' ' LEU . . . 159.89 -172.19 36.38 Favored Glycine 0 CA--C 1.506 -0.473 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.731 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.472 ' CD2' ' HG2' ' A' ' 85' ' ' LYS . 6.2 m-85 -74.91 98.19 3.51 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.364 0.602 . . . . 0.0 110.162 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.603 ' NE2' HD11 ' A' ' 16' ' ' LEU . 79.9 m80 -82.4 169.14 16.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.465 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 17.9 t -145.49 146.51 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.295 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.929 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -131.22 122.7 51.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.634 ' NZ ' HD12 ' A' ' 30' ' ' LEU . 8.2 tptm -128.29 109.96 11.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.468 178.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.17 134.5 55.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.631 0.729 . . . . 0.0 112.298 -177.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.834 HD23 ' OG ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -157.51 116.67 3.28 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.67 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.42 -1.211 . . . . 0.0 112.604 179.831 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.615 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.604 0 CA-C-O 121.51 0.671 . . . . 0.0 111.728 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.428 HD13 ' HB3' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -111.39 139.48 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.821 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.9 mtpt -109.63 96.57 6.36 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.653 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.845 ' SG ' HG22 ' A' ' 93' ' ' ILE . 2.6 t -131.6 179.62 5.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.63 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.764 ' HB2' HD23 ' A' ' 96' ' ' LEU . 6.5 t -127.47 162.74 25.66 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.741 ' CD2' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -134.17 148.92 50.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.349 0.595 . . . . 0.0 112.556 -179.404 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.678 HD12 ' C ' ' A' ' 14' ' ' HIS . 3.6 mp -145.49 131.39 13.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.709 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.735 HD23 ' O ' ' A' ' 90' ' ' TYR . 2.0 mt -123.31 133.41 54.15 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.922 HG21 ' CG ' ' A' ' 22' ' ' GLU . 21.5 m -150.91 135.85 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.695 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -17.64 64.59 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HB3' ' CG ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -72.22 78.34 0.97 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.683 179.062 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.443 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -47.07 -41.71 17.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.017 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.6 -31.46 73.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.959 -1.115 . . . . 0.0 112.898 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.922 ' CG ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -65.58 -44.44 86.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.223 0.535 . . . . 0.0 110.666 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.547 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -47.67 -40.6 20.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.286 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.789 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.3 OUTLIER -72.9 -28.87 62.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.045 179.159 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.44 -44.23 17.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.254 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.7 m -58.2 -29.0 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.727 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.8 pt20 -54.91 -53.47 55.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.989 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.499 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.0 OUTLIER -73.83 -28.91 61.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.127 0.489 . . . . 0.0 110.634 178.551 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.9 OUTLIER -75.98 -34.29 59.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.273 -178.51 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.863 HD21 ' HA ' ' A' ' 36' ' ' PHE . 1.1 tm? -52.81 -49.68 65.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.173 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 -9.19 58.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.301 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -74.36 49.11 0.36 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.52 -10.51 36.79 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.758 -0.734 . . . . 0.0 114.171 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.426 ' OE2' HD21 ' A' ' 39' ' ' LEU . 7.0 pt-20 -92.62 153.83 18.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.378 0.589 . . . . 0.0 110.852 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 143.38 30.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.274 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.909 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 5.2 p90 -52.89 -35.79 58.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.748 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.46 -36.37 93.05 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.27 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 10.5 tttt -60.83 -53.77 53.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.843 0.354 . . . . 0.0 110.807 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.968 HD12 HD11 ' A' ' 43' ' ' LEU . 2.8 mm? -53.64 -34.12 57.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.007 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.459 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.63 -53.41 38.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.956 0.408 . . . . 0.0 110.81 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -23.55 26.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.934 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.824 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -68.96 -68.69 0.38 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.076 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.968 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.66 -16.07 8.86 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.562 ' N ' HD22 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -64.23 141.5 58.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.192 0.52 . . . . 0.0 111.522 -179.193 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.444 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.9 pt . . . . . 0 C--N 1.328 -0.328 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.894 179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 -0.162 0 CA-C-O 121.245 0.545 . . . . 0.0 110.548 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -72.6 -13.17 61.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.942 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.87 24.43 11.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.381 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 73.5 9.24 5.06 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.27 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.3 24.63 70.76 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.225 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.4 p -75.94 82.77 2.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.97 0.414 . . . . 0.0 110.615 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.741 HD21 ' CD2' ' A' ' 14' ' ' HIS . 14.6 mt -53.94 -24.5 16.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.992 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 61.04 -163.67 20.03 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.828 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.468 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -72.68 111.51 7.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.995 0.426 . . . . 0.0 111.744 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.615 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 3.8 m-85 -123.71 163.62 20.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.77 -173.99 14.96 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.628 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.55 93.89 7.94 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.897 0.38 . . . . 0.0 110.189 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.42 36.79 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.854 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.43 -44.54 0.22 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.622 0.249 . . . . 0.0 111.241 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.05 165.74 13.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 111.298 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.734 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.9 m -61.7 165.06 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.894 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.526 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -60.63 -48.06 94.34 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 13.8 Cg_endo -66.2 -37.68 23.95 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 121.897 1.731 . . . . 0.0 111.962 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.734 ' H ' HG23 ' A' ' 65' ' ' VAL . 40.0 t80 -74.96 -52.31 11.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.905 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.79 -32.27 63.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.799 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 2.6 m-20 -65.19 -52.08 57.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.995 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.437 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.09 -9.28 58.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.908 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.27 -38.31 71.85 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 2.8 p90 -106.04 16.76 24.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -98.76 -27.69 13.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.329 . . . . 0.0 110.98 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 79' ' ' GLU . 3.1 mt -103.47 66.43 0.88 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.076 0.465 . . . . 0.0 111.447 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -73.29 -18.23 61.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.005 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.96 -27.0 39.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.663 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.438 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 95.6 58.74 1.11 Allowed Glycine 0 CA--C 1.503 -0.67 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.536 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.524 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.33 176.28 8.9 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.776 0.322 . . . . 0.0 111.084 -178.477 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.657 HG11 ' HA ' ' A' ' 27' ' ' GLN . 55.6 t -82.84 146.58 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.158 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 t -104.84 164.14 12.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.346 0.593 . . . . 0.0 111.917 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -50.75 156.42 1.62 Allowed Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.634 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.789 ' HG3' HD23 ' A' ' 24' ' ' LEU . 26.9 Cg_endo -61.09 105.17 0.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.583 2.188 . . . . 0.0 112.141 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 87.7 t -101.27 99.47 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.582 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.453 ' HG3' ' CD1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -97.97 112.79 24.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.798 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.9 m -110.62 -175.75 2.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.635 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.34 -21.64 25.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.093 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -85.45 -26.73 26.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.38 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 144.18 -165.32 27.42 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.771 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.735 ' O ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -83.26 106.68 15.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.472 ' NE2' HD11 ' A' ' 16' ' ' LEU . 41.6 m80 -92.64 157.92 16.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.476 0.655 . . . . 0.0 112.597 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.1 t -140.72 153.17 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.264 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.845 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -141.26 124.16 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -128.11 113.87 16.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.282 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.5 135.4 56.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.54 0.686 . . . . 0.0 112.231 -177.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.909 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -157.38 116.65 3.32 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.733 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.605 -179.999 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.716 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.651 0 CA-C-O 121.429 0.633 . . . . 0.0 111.595 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -111.31 139.11 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.828 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.499 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.5 mtpt -107.93 98.3 7.9 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.366 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.786 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 2.1 t -130.32 -179.84 5.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.824 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.773 ' HB2' HD23 ' A' ' 96' ' ' LEU . 34.4 t -120.73 162.89 18.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.975 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.753 ' CG ' HD21 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -130.33 139.32 50.7 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.997 0.427 . . . . 0.0 111.781 -179.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.707 HD12 ' C ' ' A' ' 14' ' ' HIS . 4.7 mp -153.3 118.97 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.658 HD11 ' CD2' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -109.63 140.91 42.89 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.922 0.391 . . . . 0.0 111.034 179.649 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.731 HG21 ' HG3' ' A' ' 22' ' ' GLU . 4.4 m -149.1 134.35 10.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.732 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.545 ' CD ' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -72.0 -35.86 69.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.808 -178.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.623 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 4.7 tttp -72.83 78.8 1.14 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.497 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -46.64 -25.99 0.82 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.027 -0.988 . . . . 0.0 113.225 -176.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.54 -31.53 76.72 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 119.026 -1.559 . . . . 0.0 110.921 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.887 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -71.07 -38.81 72.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.059 0.457 . . . . 0.0 110.491 178.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.616 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -52.03 -37.15 52.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.363 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.545 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.25 -29.86 63.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.646 179.046 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.99 -41.45 18.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.496 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.887 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.1 m -52.33 -37.83 24.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.014 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.656 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -59.24 -48.84 80.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.656 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.3 pt-20 -73.27 -29.0 62.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.66 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.54 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 8.1 tpt180 -78.86 -32.28 45.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.01 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.444 ' CD2' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -53.12 -59.4 4.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.171 -179.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -72.46 -9.44 58.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.371 179.498 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.04 -24.96 63.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.858 0.361 . . . . 0.0 111.327 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.4 -17.01 0.77 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.579 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.52 ' CD ' HD21 ' A' ' 39' ' ' LEU . 8.1 pt-20 -86.84 154.99 20.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.901 0.382 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.92 146.2 27.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.129 0.49 . . . . 0.0 111.079 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.913 ' CE1' HD22 ' A' ' 96' ' ' LEU . 3.7 p90 -47.1 -30.76 2.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.743 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.47 -34.24 88.81 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.178 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -66.64 -53.47 33.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.766 0.317 . . . . 0.0 110.765 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.763 HD12 HD11 ' A' ' 43' ' ' LEU . 3.1 mm? -53.37 -36.07 60.99 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.273 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 44' ' ' SER . . . -52.1 -52.94 48.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.178 0.513 . . . . 0.0 110.701 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.57 -23.57 27.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.727 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.952 ' HB3' HD13 ' A' ' 43' ' ' LEU . 1.1 mt-10 -73.58 -67.86 0.55 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.952 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.99 -12.56 9.51 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.53 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 3.3 t -63.12 125.98 25.86 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.891 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.545 HD13 ' CD ' ' A' ' 18' ' ' LYS . 3.8 pt . . . . . 0 C--N 1.326 -0.423 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.504 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . . . . . . . . 0 CA--C 1.521 -0.167 0 CA-C-O 121.345 0.593 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -88.78 -5.29 58.17 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.2 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.431 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 2.5 mtt180 -119.06 24.98 10.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.84 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 76.39 16.06 2.15 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.332 -179.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.18 17.01 65.39 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.577 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.714 ' HA ' HD21 ' A' ' 96' ' ' LEU . 7.0 m -70.91 86.32 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.672 0.272 . . . . 0.0 110.901 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.786 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 23.4 mt -54.77 -31.15 58.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.037 0.446 . . . . 0.0 110.577 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 69.94 -170.29 44.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.43 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.499 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -67.87 111.58 4.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 111.625 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.716 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 6.4 m-85 -123.89 159.21 30.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.666 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.72 -174.06 18.67 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.293 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -88.01 96.82 10.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.988 0.423 . . . . 0.0 110.335 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.16 36.73 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.373 -0.917 . . . . 0.0 113.067 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 tptm -143.45 -47.51 0.3 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.75 0.31 . . . . 0.0 111.259 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.416 ' HG2' ' HG3' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -91.17 166.93 12.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.878 0.371 . . . . 0.0 111.278 -179.706 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.758 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.0 m -54.63 165.75 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.174 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.533 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 20.7 tttm -64.29 -47.93 77.15 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 14.0 Cg_endo -65.46 -38.16 27.02 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 121.861 1.708 . . . . 0.0 111.939 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.758 ' H ' HG23 ' A' ' 65' ' ' VAL . 24.4 t80 -74.94 -52.69 10.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.647 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.416 ' HG3' ' HG2' ' A' ' 64' ' ' MET . 0.8 OUTLIER -57.17 -34.03 68.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.779 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 23.6 t0 -69.03 -47.95 64.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.059 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.426 ' HB3' HD11 ' A' ' 93' ' ' ILE . . . -75.33 -9.69 58.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.785 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.37 -49.03 68.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.785 0.326 . . . . 0.0 111.709 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 3.0 p90 -92.7 16.92 11.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.601 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.7 -29.37 14.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 79' ' ' GLU . 4.3 mt -103.57 66.01 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.474 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -69.9 -19.97 63.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.061 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 p -64.54 -26.88 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.57 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.425 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 94.22 58.05 1.25 Allowed Glycine 0 CA--C 1.504 -0.645 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.719 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.522 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -140.13 176.37 8.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.779 0.323 . . . . 0.0 111.077 -178.475 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.508 ' O ' HD11 ' A' ' 75' ' ' LEU . 86.2 t -81.28 146.7 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.0 t -104.68 164.1 12.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.222 0.534 . . . . 0.0 111.777 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -50.54 155.08 1.96 Allowed Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.328 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.533 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 18.5 Cg_endo -60.18 106.33 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.358 2.038 . . . . 0.0 111.741 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 97.5 t -100.95 100.22 9.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.608 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.7 OUTLIER -94.53 112.96 24.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.942 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.63 -172.11 1.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.505 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -57.54 -20.95 35.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.858 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -85.86 -37.23 19.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.245 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.81 -168.46 30.56 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.656 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.533 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -75.34 98.57 3.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.005 0.431 . . . . 0.0 109.926 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.658 ' CD2' HD11 ' A' ' 16' ' ' LEU . 70.1 m80 -80.41 165.08 22.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.397 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.7 t -149.19 138.38 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.762 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.745 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -127.99 122.7 59.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.482 ' HG2' HG22 ' A' ' 80' ' ' VAL . 1.4 tmtm? -126.18 112.27 15.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.186 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.5 132.33 52.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.559 0.695 . . . . 0.0 111.89 -177.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.913 HD22 ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -155.06 116.75 4.09 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.685 179.643 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.339 -1.256 . . . . 0.0 112.619 179.914 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.484 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 3.5 mptt . . . . . 0 CA--C 1.517 -0.304 0 CA-C-O 121.123 0.487 . . . . 0.0 111.707 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 mt -111.03 128.08 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.349 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.8 mtpt -97.9 92.73 5.96 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.109 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.888 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -124.06 -179.89 4.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.309 -177.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.791 ' HB2' HD23 ' A' ' 96' ' ' LEU . 2.0 t -123.14 160.17 27.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.954 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.734 ' CD2' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -136.29 147.23 47.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.335 0.588 . . . . 0.0 111.977 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.75 HG23 ' OG ' ' A' ' 44' ' ' SER . 3.2 mp -151.91 115.39 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.314 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.584 ' HB3' ' CG1' ' A' ' 45' ' ' ILE . 7.7 tp -100.77 132.37 46.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.785 HG11 ' OE1' ' A' ' 22' ' ' GLU . 12.3 m -146.07 134.11 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.815 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -75.01 -36.29 61.94 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.415 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.614 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -71.84 79.35 0.87 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.597 0.713 . . . . 0.0 109.078 178.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.513 ' HG3' ' CZ ' ' A' ' 90' ' ' TYR . 1.3 tm0? -45.71 -25.73 0.53 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.218 -177.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.73 -31.55 78.72 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 118.774 -1.679 . . . . 0.0 110.688 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.901 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -71.77 -39.41 69.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.152 0.501 . . . . 0.0 109.803 178.146 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.689 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -51.5 -36.91 46.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.996 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.627 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.55 -29.44 62.44 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.949 179.011 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.08 -40.46 16.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.51 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.901 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.3 m -56.92 -37.55 54.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.058 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.0 pt20 -56.84 -51.33 69.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.558 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.6 pt-20 -73.45 -29.18 62.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.618 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.534 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.5 tpt180 -75.6 -33.57 60.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.633 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.462 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -52.94 -58.91 5.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 -179.44 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -8.78 56.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.521 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -56.99 -20.09 21.95 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.39 -10.47 1.73 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.131 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.493 ' OE1' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -103.77 158.2 16.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.904 0.383 . . . . 0.0 110.677 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -97.29 154.26 17.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.37 0.605 . . . . 0.0 112.17 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.71 ' CE1' HD22 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -53.0 -35.22 59.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.388 179.316 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA2' ' CA ' ' A' ' 53' ' ' ASP . . . -53.54 -34.16 49.01 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.001 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 9.7 mtpp -69.98 -53.63 16.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.656 0.265 . . . . 0.0 110.442 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.989 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -54.0 -33.36 56.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.716 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.59 -53.36 39.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.071 0.462 . . . . 0.0 110.657 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.21 -23.33 26.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.214 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.851 ' HB3' HD13 ' A' ' 43' ' ' LEU . 1.3 mt-10 -71.15 -69.18 0.39 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.989 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.78 -11.64 9.34 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.582 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.75 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -63.9 138.53 58.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.03 0.443 . . . . 0.0 111.33 -179.035 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.584 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 43.1 pt . . . . . 0 C--N 1.333 -0.139 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.959 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.141 0 CA-C-O 120.924 0.392 . . . . 0.0 111.255 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.8 -8.08 32.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.17 -179.004 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 11.5 ptp180 -104.21 23.69 12.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.89 0.376 . . . . 0.0 110.702 179.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.433 ' CA ' ' HA2' ' A' ' 37' ' ' GLY . 0.0 OUTLIER 71.96 13.0 6.04 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.241 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.3 16.69 80.52 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.418 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . 0.631 ' HA ' HD21 ' A' ' 96' ' ' LEU . 1.1 m -74.06 89.77 1.97 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.783 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.888 HD12 ' SG ' ' A' ' 12' ' ' CYS . 13.2 mt -56.5 -28.35 59.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.665 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.59 -166.62 42.35 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -68.31 118.71 11.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.112 0.482 . . . . 0.0 111.923 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.484 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 10.5 m-85 -131.57 150.44 52.15 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.39 -173.88 18.27 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.577 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 -76.27 81.97 3.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 110.084 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.46 36.67 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.939 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -134.8 -48.52 0.75 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.815 0.34 . . . . 0.0 111.232 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.58 170.61 8.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.137 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.789 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.0 m -57.06 159.56 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -62.1 -47.9 89.44 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.612 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 17.5 Cg_endo -64.63 -39.2 28.27 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.932 1.754 . . . . 0.0 112.115 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.859 ' CZ ' HG23 ' A' ' 93' ' ' ILE . 17.6 t80 -74.92 -52.02 12.3 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.728 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 4.0 tm-20 -56.01 -32.29 63.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.676 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.459 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -64.26 -52.62 57.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.871 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.531 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.0 -11.96 60.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.638 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.32 -48.5 81.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.799 0.333 . . . . 0.0 111.407 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.459 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 6.7 p90 -93.23 16.83 12.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.372 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.31 -28.58 13.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.895 0.379 . . . . 0.0 110.834 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 79' ' ' GLU . 3.0 mt -103.63 62.81 0.77 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.291 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -69.61 -18.39 63.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.087 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -64.61 -26.86 41.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.53 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.27 56.88 1.24 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.669 -0.776 . . . . 0.0 111.731 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.513 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.7 tm-20 -139.36 176.29 8.84 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.89 0.376 . . . . 0.0 110.982 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 27' ' ' GLN . 61.1 t -84.29 147.55 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.069 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.97 164.12 12.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.225 0.536 . . . . 0.0 111.431 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.0 mp0 -50.48 154.43 2.22 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.986 -178.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.517 ' HG3' HD23 ' A' ' 24' ' ' LEU . 19.1 Cg_endo -60.0 104.97 0.25 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.177 1.918 . . . . 0.0 111.819 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.612 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 59.3 t -101.33 102.0 12.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.528 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 90' ' ' TYR . 3.9 tmtt? -92.38 112.87 24.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.351 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.4 -171.58 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.141 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -16.26 40.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.217 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -94.01 -40.82 9.9 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.65 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.17 -174.24 40.25 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.812 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 1.7 m-85 -76.92 98.38 4.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.233 0.54 . . . . 0.0 110.374 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.47 ' CD2' HD13 ' A' ' 16' ' ' LEU . 58.2 m80 -78.24 169.78 17.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.669 -178.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 29.6 t -151.33 128.57 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.363 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.859 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -111.5 123.2 67.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.459 ' HE3' HD12 ' A' ' 30' ' ' LEU . 28.1 tptp -128.28 115.17 17.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.454 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.463 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -58.33 134.87 56.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.45 0.643 . . . . 0.0 112.134 -178.544 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.791 HD23 ' HB2' ' A' ' 13' ' ' SER . 0.3 OUTLIER -160.72 116.6 2.27 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.217 179.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.414 -1.214 . . . . 0.0 112.532 179.642 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.518 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.458 0 CA-C-O 121.029 0.442 . . . . 0.0 111.128 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.656 HD13 ' HB3' ' A' ' 73' ' ' PHE . 0.4 OUTLIER -111.03 135.88 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.5 mtpt -106.83 95.11 5.5 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.653 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.929 ' SG ' HG22 ' A' ' 93' ' ' ILE . 2.4 t -124.06 179.58 4.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.894 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.507 ' HB3' HD23 ' A' ' 96' ' ' LEU . 1.8 p -123.37 162.25 23.12 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.665 ' HB3' HD11 ' A' ' 56' ' ' LEU . 20.4 p-80 -133.97 153.75 51.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.399 0.619 . . . . 0.0 112.327 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.767 HG23 ' OG ' ' A' ' 44' ' ' SER . 2.9 mp -156.75 122.73 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.777 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.901 HD13 ' CD2' ' A' ' 91' ' ' HIS . 10.3 tp -110.32 132.15 54.43 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.832 HG11 ' OE1' ' A' ' 22' ' ' GLU . 15.5 m -142.88 134.45 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.391 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.53 -35.78 63.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.5 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.615 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -73.12 79.3 1.24 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.484 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 2.0 pt20 -46.28 -25.58 0.65 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.328 -0.851 . . . . 0.0 113.154 -176.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.02 -31.4 77.84 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.119 -1.515 . . . . 0.0 110.67 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.832 ' OE1' HG11 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -71.26 -37.85 71.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.084 0.469 . . . . 0.0 109.928 178.39 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.608 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.87 -38.01 46.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.15 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.619 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -73.07 -29.58 63.05 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.823 179.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.95 -53.33 5.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.795 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.8 m -47.03 -37.34 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.322 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.628 ' HA ' HG11 ' A' ' 80' ' ' VAL . 2.5 pt20 -59.92 -48.21 82.64 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.571 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 3.4 pt-20 -73.06 -29.01 62.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.648 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.615 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 10.0 tpt180 -78.62 -35.37 45.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.771 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.583 HD21 ' HA ' ' A' ' 36' ' ' PHE . 1.1 tm? -52.74 -58.81 5.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.29 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.97 -9.6 58.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.254 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.25 -24.57 63.31 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.864 0.364 . . . . 0.0 111.114 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.36 -17.21 1.15 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.436 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -78.92 157.7 28.18 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.985 0.422 . . . . 0.0 110.949 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -98.08 140.1 32.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.027 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.76 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 3.4 p90 -51.39 -32.13 25.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.848 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.412 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -62.79 -34.25 89.23 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.213 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.2 mmtt -65.96 -53.57 37.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.661 0.267 . . . . 0.0 110.783 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.998 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.85 -32.33 52.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.517 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.36 -53.78 32.88 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.549 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.18 -23.47 26.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.224 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.89 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.78 -68.8 0.41 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -177.43 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.998 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.63 -12.25 9.31 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.767 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -64.05 140.32 58.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.931 0.396 . . . . 0.0 111.289 -179.241 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.571 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 31.7 pt . . . . . 0 C--N 1.33 -0.269 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.686 179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.119 0 CA-C-O 121.28 0.562 . . . . 0.0 110.303 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -74.36 -8.79 57.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.373 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.418 ' O ' ' CG ' ' A' ' 53' ' ' ASP . 0.5 OUTLIER -103.67 24.67 10.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.423 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.418 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 2.1 p30 54.08 34.8 20.73 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.97 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.45 ' HA2' ' CE1' ' A' ' 14' ' ' HIS . . . 56.76 21.47 36.59 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.417 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.7 p -70.38 86.81 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.85 0.357 . . . . 0.0 111.257 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.709 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 46.6 mt -59.69 -33.4 71.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.102 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.94 -167.13 48.98 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.947 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.468 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -69.19 119.15 13.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.045 0.45 . . . . 0.0 111.851 -179.387 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.518 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 9.3 p90 -135.46 135.48 40.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.48 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.42 -174.01 49.89 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.601 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 ptt-85 -89.73 89.4 7.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.948 0.404 . . . . 0.0 110.505 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.1 36.45 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.057 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -146.52 7.01 0.97 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.449 ' CE ' ' CD1' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -141.33 174.24 10.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.75 0.31 . . . . 0.0 110.844 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.77 HG23 ' H ' ' A' ' 68' ' ' PHE . 23.9 m -68.35 154.48 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.804 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.584 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -59.65 -46.94 98.59 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 17.5 Cg_endo -64.45 -41.22 21.07 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.937 1.758 . . . . 0.0 112.155 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.77 ' H ' HG23 ' A' ' 65' ' ' VAL . 26.2 t80 -74.98 -51.4 13.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.77 -32.31 65.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.797 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.438 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 11.6 t70 -63.82 -51.21 65.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.109 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.804 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -74.9 -10.02 59.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.756 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.517 ' HB1' ' HE1' ' A' ' 59' ' ' PHE . . . -65.46 -50.01 66.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.727 0.299 . . . . 0.0 111.497 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.656 ' HB3' HD13 ' A' ' 10' ' ' ILE . 6.2 p90 -93.33 16.51 13.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.464 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.526 ' C ' HD23 ' A' ' 75' ' ' LEU . 4.4 ttm-85 -96.57 -31.9 12.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.658 0.266 . . . . 0.0 111.226 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.704 HD12 ' O ' ' A' ' 79' ' ' GLU . 0.7 OUTLIER -103.37 55.88 0.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.385 -179.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -58.83 -22.21 58.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.089 0.471 . . . . 0.0 110.029 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.07 -28.43 39.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.435 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.489 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 97.05 59.09 1.0 Allowed Glycine 0 CA--C 1.508 -0.397 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.303 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.704 ' O ' HD12 ' A' ' 75' ' ' LEU . 5.6 pt-20 -130.22 177.38 7.36 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.628 HG11 ' HA ' ' A' ' 27' ' ' GLN . 21.7 t -88.65 148.41 4.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.646 ' OG ' HD21 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -104.42 164.03 12.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.136 0.493 . . . . 0.0 111.282 -178.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 84' ' ' VAL . 3.1 mp0 -50.43 154.76 2.04 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.866 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.568 ' HG3' HD23 ' A' ' 24' ' ' LEU . 14.1 Cg_endo -55.58 104.53 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.367 2.045 . . . . 0.0 111.721 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.555 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 94.3 t -101.64 101.54 12.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.684 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.456 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 19.2 tptp -95.54 112.49 24.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.573 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.9 m -112.5 -176.97 3.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.468 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.81 -22.33 14.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.939 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.94 -27.57 24.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.331 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.5 -170.71 24.06 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.823 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.484 ' CD1' ' HB3' ' A' ' 20' ' ' GLN . 0.5 OUTLIER -74.56 100.78 4.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.045 0.45 . . . . 0.0 109.927 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.901 ' CD2' HD13 ' A' ' 16' ' ' LEU . 10.3 m80 -87.35 169.31 12.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.586 0.707 . . . . 0.0 112.742 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.1 t -146.76 136.29 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.119 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.929 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -126.58 122.5 61.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.352 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.571 ' HE3' HD12 ' A' ' 30' ' ' LEU . 22.0 tptp -128.54 110.33 12.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.456 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.588 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.62 134.36 56.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.596 0.713 . . . . 0.0 112.195 -177.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.76 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -153.8 116.4 4.42 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.593 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.428 ' HA3' ' HD3' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.424 -1.209 . . . . 0.0 112.541 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.681 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.446 -0.65 0 CA-C-O 121.442 0.639 . . . . 0.0 111.933 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.605 HG22 ' SG ' ' A' ' 12' ' ' CYS . 1.5 mt -111.0 136.93 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.944 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.4 mtpt -108.11 86.71 2.34 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.577 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.818 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 7.1 m -130.58 179.98 5.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.636 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.449 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 2.9 p -135.33 161.76 34.49 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.789 ' O ' HD12 ' A' ' 15' ' ' ILE . 0.7 OUTLIER -141.24 155.49 46.01 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.789 HD12 ' O ' ' A' ' 14' ' ' HIS . 1.7 mp -134.95 141.81 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.863 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.74 HD11 ' CE1' ' A' ' 91' ' ' HIS . 1.0 OUTLIER -121.48 128.84 52.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.77 0.319 . . . . 0.0 111.723 -179.499 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.839 HG21 ' CG ' ' A' ' 22' ' ' GLU . 24.7 m -144.12 134.21 20.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.465 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.538 ' CD ' HD13 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -70.12 -36.27 74.7 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.732 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.612 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.09 78.55 0.94 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.474 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -46.67 -25.98 0.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.714 -1.13 . . . . 0.0 113.191 -177.584 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.39 -31.31 76.61 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.086 -1.531 . . . . 0.0 111.091 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.89 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -70.25 -39.91 74.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.142 0.496 . . . . 0.0 110.03 178.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.679 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -51.15 -37.16 44.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.227 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.627 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.41 -29.46 62.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.922 179.17 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.66 -42.53 14.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.484 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.89 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.7 m -53.4 -39.17 34.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.881 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.5 pt20 -56.33 -50.19 72.17 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.596 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 4.6 pt-20 -73.36 -30.98 63.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.803 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 3.9 tpm_? -77.18 -27.52 53.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.011 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.676 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.8 OUTLIER -60.78 -52.76 63.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.419 -179.101 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.405 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -68.57 -9.4 49.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.525 -179.897 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -56.28 -22.05 27.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.761 0.315 . . . . 0.0 111.387 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.37 -10.73 3.8 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.387 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -77.81 157.46 29.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.823 0.344 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.411 ' HB3' ' HG2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -89.12 136.01 33.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.789 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.676 ' HA ' HD21 ' A' ' 30' ' ' LEU . 4.8 t80 -53.94 -48.15 70.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.236 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.26 -33.9 53.03 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.293 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.0 mmmt -60.33 -52.26 66.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.707 0.289 . . . . 0.0 110.873 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.965 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.34 -33.54 53.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.561 ' HB1' ' O ' ' A' ' 50' ' ' ALA . . . -51.45 -53.81 33.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.074 0.464 . . . . 0.0 110.582 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -85.94 -23.66 26.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.059 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.848 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -69.12 -68.35 0.41 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.965 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.21 -15.43 9.18 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.72 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.532 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -64.28 134.5 54.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.115 0.483 . . . . 0.0 111.14 -179.588 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.538 HD13 ' CD ' ' A' ' 18' ' ' LYS . 1.3 pt . . . . . 0 C--N 1.328 -0.359 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.172 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.561 ' O ' ' HB1' ' A' ' 40' ' ' ALA . . . . . . . . 0 CA--C 1.521 -0.171 0 CA-C-O 120.915 0.388 . . . . 0.0 111.076 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.0 -6.1 51.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.522 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.419 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -104.15 24.09 12.01 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.406 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 72.04 12.87 5.96 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.354 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 59.59 21.6 54.99 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.535 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m -74.7 84.7 2.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.972 0.415 . . . . 0.0 110.548 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.818 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 20.4 mt -59.43 -20.24 53.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.883 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 49.06 -170.94 0.08 OUTLIER Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.57 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.506 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -56.17 111.4 0.95 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.038 0.447 . . . . 0.0 111.678 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.681 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 2.3 m-85 -128.48 164.37 22.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.265 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.08 -174.09 13.65 Favored Glycine 0 C--N 1.317 -0.528 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.159 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -86.48 116.38 24.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.922 0.392 . . . . 0.0 110.023 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.28 -12.05 1.38 Allowed Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.082 -1.056 . . . . 0.0 113.357 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.43 30.78 4.42 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.031 0.415 . . . . 0.0 111.754 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.425 ' HG3' ' CG ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -151.36 149.37 29.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.804 0.335 . . . . 0.0 111.191 179.433 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.753 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.4 m -52.6 156.26 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.197 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.565 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.15 -47.8 98.2 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.022 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 18.8 Cg_endo -65.43 -38.8 24.43 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.061 1.841 . . . . 0.0 112.367 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.753 ' H ' HG23 ' A' ' 65' ' ' VAL . 18.1 t80 -74.92 -49.8 19.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.475 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.425 ' CG ' ' HG3' ' A' ' 64' ' ' MET . 0.2 OUTLIER -54.5 -35.8 63.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.21 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 6.8 t70 -68.67 -49.94 55.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.798 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.94 -10.68 59.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.659 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.453 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -65.1 -45.48 85.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.722 0.296 . . . . 0.0 111.618 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 1.4 p90 -99.33 16.94 21.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.712 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -95.07 -28.66 14.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.75 0.31 . . . . 0.0 110.918 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 79' ' ' GLU . 2.7 mt -103.7 65.37 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.026 0.441 . . . . 0.0 111.678 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -74.32 -17.65 60.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.938 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -67.66 -26.82 36.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.842 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 96.06 59.14 1.06 Allowed Glycine 0 CA--C 1.503 -0.672 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.393 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.551 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -140.5 176.24 8.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.931 0.395 . . . . 0.0 111.007 -178.253 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.601 HG11 ' HA ' ' A' ' 27' ' ' GLN . 38.4 t -83.75 147.76 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.962 178.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.66 159.09 16.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.224 0.535 . . . . 0.0 111.197 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -50.61 159.49 0.89 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.077 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.561 ' HG3' HD23 ' A' ' 24' ' ' LEU . 18.9 Cg_endo -59.02 104.08 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.474 2.116 . . . . 0.0 111.913 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.55 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 95.7 t -101.54 102.52 13.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.682 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.478 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 5.5 tptp -91.86 112.95 25.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.859 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.25 -173.12 2.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.418 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.18 -16.2 51.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.064 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -93.56 -38.76 11.21 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.534 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.97 -168.74 35.75 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.898 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -77.0 99.53 5.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.74 ' CE1' HD11 ' A' ' 16' ' ' LEU . 17.1 m80 -88.42 165.27 15.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.45 0.643 . . . . 0.0 112.734 -178.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.484 ' CG1' HG13 ' A' ' 80' ' ' VAL . 40.5 t -143.79 152.39 16.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.117 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.605 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -139.59 122.05 17.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -179.045 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.521 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -129.37 108.69 10.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.955 178.051 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.578 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 6.9 ttt85 -58.11 135.68 57.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.642 0.734 . . . . 0.0 112.275 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.546 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 0.4 OUTLIER -154.3 116.48 4.28 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.24 179.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.378 -1.234 . . . . 0.0 112.586 179.912 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.617 0 CA-C-O 121.204 0.526 . . . . 0.0 111.128 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.41 138.35 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.654 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.029 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.461 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.6 mtpt -108.72 96.16 6.15 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.067 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' CYS . . . . . 0.914 ' SG ' HG22 ' A' ' 93' ' ' ILE . 2.4 t -127.7 179.39 5.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.273 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.789 ' HB2' HD23 ' A' ' 96' ' ' LEU . 2.7 t -126.37 159.79 32.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' HIS . . . . . 0.787 ' CG ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -136.66 150.88 48.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.405 0.621 . . . . 0.0 112.553 -179.405 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.597 HD12 ' C ' ' A' ' 14' ' ' HIS . 3.5 mp -153.27 115.34 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.009 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.907 HD21 ' CD2' ' A' ' 91' ' ' HIS . 0.9 OUTLIER -100.1 139.09 36.27 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.983 HG21 ' CG ' ' A' ' 22' ' ' GLU . 30.0 m -155.22 134.19 3.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.793 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -19.31 65.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.571 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -72.38 78.36 1.02 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.149 179.093 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 5.8 pt20 -47.34 -40.0 16.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.32 -31.14 66.27 Favored Glycine 0 CA--C 1.511 -0.19 0 C-N-CA 119.925 -1.131 . . . . 0.0 112.697 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.983 ' CG ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -65.6 -39.79 91.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.339 0.59 . . . . 0.0 110.253 179.525 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.761 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . -43.8 -42.16 5.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.387 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.57 ' HA ' ' HG3' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -72.66 -45.47 58.77 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.266 178.215 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.0 -57.31 9.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.694 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 23' ' ' ALA . 4.8 m -55.07 -30.42 23.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.684 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLN . . . . . 0.776 ' HG2' HG11 ' A' ' 80' ' ' VAL . 52.9 mt-30 -53.04 -60.06 3.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.28 0.562 . . . . 0.0 109.939 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -26.03 61.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.82 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.514 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 14.2 tpp85 -78.51 -30.31 47.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.094 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.705 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -56.7 -59.04 5.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 0.0 110.932 -179.234 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -9.3 58.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.322 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.05 -25.81 64.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.996 0.427 . . . . 0.0 111.35 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.99 -17.15 0.92 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.491 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.481 ' HG3' HD21 ' A' ' 39' ' ' LEU . 21.9 pt-20 -79.76 157.81 27.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.993 0.425 . . . . 0.0 110.816 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -96.23 137.07 35.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.079 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.705 ' HA ' HD21 ' A' ' 30' ' ' LEU . 2.4 p90 -47.61 -33.53 6.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.628 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . 0.513 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -65.28 -34.93 90.83 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.137 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -60.16 -53.81 53.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.598 0.237 . . . . 0.0 110.592 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 1.004 HD12 HD11 ' A' ' 43' ' ' LEU . 2.6 mm? -55.68 -34.36 64.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.803 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.3 -53.77 32.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.029 0.442 . . . . 0.0 110.503 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -85.97 -23.63 26.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.18 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.846 ' HB3' HD13 ' A' ' 43' ' ' LEU . 1.0 OUTLIER -70.14 -68.7 0.4 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -177.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 1.004 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.54 -11.36 9.47 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.531 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.575 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -63.58 134.46 55.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.273 0.559 . . . . 0.0 111.333 -179.165 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 16' ' ' LEU . 25.1 pt . . . . . 0 N--CA 1.452 -0.345 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.358 -179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.132 0 CA-C-O 120.797 0.332 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.8 mttt -68.36 -2.95 9.51 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.972 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.466 ' O ' ' CG ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -103.65 24.78 10.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.697 0.284 . . . . 0.0 110.539 179.767 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.513 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 1.5 p30 59.58 29.62 19.19 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.189 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 53.78 23.35 21.67 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.841 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.92 89.96 4.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.809 0.338 . . . . 0.0 110.825 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.787 HD21 ' CG ' ' A' ' 14' ' ' HIS . 87.0 mt -58.37 -28.83 65.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.58 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.42 -166.26 15.74 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.991 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . 0.538 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -65.14 117.59 7.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.117 0.484 . . . . 0.0 111.749 -179.474 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.514 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 5.3 m-85 -128.44 158.63 37.79 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.52 -173.95 13.59 Favored Glycine 0 C--N 1.317 -0.49 0 C-N-CA 120.199 -1.0 . . . . 0.0 112.497 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.09 84.57 2.32 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.044 0.45 . . . . 0.0 110.126 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.42 36.85 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.063 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.05 -48.67 0.61 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.637 0.256 . . . . 0.0 111.292 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.55 169.84 9.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.937 0.399 . . . . 0.0 111.306 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . 0.772 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.9 m -59.43 165.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.965 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LYS . . . . . 0.555 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 7.5 ttpt -62.73 -48.01 86.58 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 15.2 Cg_endo -65.36 -39.34 22.75 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.863 1.709 . . . . 0.0 111.897 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.772 ' H ' HG23 ' A' ' 65' ' ' VAL . 24.5 t80 -75.0 -52.49 10.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.98 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -57.52 -32.66 67.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 1.9 m-20 -63.7 -50.56 68.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.049 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.51 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.3 -9.49 58.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.798 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.42 -47.52 75.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 111.602 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PHE . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 11.4 p90 -93.89 16.78 13.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.535 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -97.98 -30.39 12.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.93 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.53 HD11 ' O ' ' A' ' 80' ' ' VAL . 3.9 mt -103.49 68.08 0.93 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.471 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -72.8 -19.28 61.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.096 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -65.86 -26.67 39.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.725 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLY . . . . . 0.445 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 94.66 59.44 1.14 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.57 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.511 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.7 tm-20 -141.03 176.34 8.9 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.826 0.346 . . . . 0.0 111.104 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.776 HG11 ' HG2' ' A' ' 27' ' ' GLN . 26.9 t -81.01 146.6 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.84 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.2 t -104.66 164.11 12.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.258 0.551 . . . . 0.0 111.583 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.4 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.0 mp0 -50.51 152.1 3.52 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.463 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 19.5 Cg_endo -58.46 106.09 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.466 2.111 . . . . 0.0 111.65 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.549 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 93.0 t -100.96 101.14 11.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.593 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 4.8 tptm -91.63 112.8 24.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.757 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.1 m -114.73 -171.95 2.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.578 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.35 -18.62 51.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.184 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -90.91 -24.48 20.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.467 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 141.48 -161.66 26.96 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.784 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.541 ' O ' HD13 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -83.02 98.14 9.11 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' HIS . . . . . 0.907 ' CD2' HD21 ' A' ' 16' ' ' LEU . 9.8 m80 -81.49 154.35 26.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.481 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 37.2 t -139.71 135.84 39.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.296 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . 0.914 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -123.84 122.52 64.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.423 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.523 ' HG2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -128.2 112.69 14.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.197 178.36 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.552 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -57.34 136.45 56.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.705 0.764 . . . . 0.0 112.517 -177.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.789 HD23 ' HB2' ' A' ' 13' ' ' SER . 0.3 OUTLIER -157.69 116.73 3.23 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.616 179.595 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.352 -1.249 . . . . 0.0 112.554 179.93 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.155 0 N-CA-C 112.516 -0.234 . . . . 0.0 112.516 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.86 162.59 41.56 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.585 2.19 . . . . 0.0 112.268 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.38 134.03 52.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.87 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.82 46.07 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.513 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -80.63 164.84 22.57 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.79 0.328 . . . . 0.0 110.979 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 68.58 112.88 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.959 179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.11 39.87 0.69 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.976 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -51.06 -36.91 42.47 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.812 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.554 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.64 171.63 12.25 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-O 121.764 0.793 . . . . 0.0 112.142 -179.61 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.666 HD13 ' HB3' ' A' ' 73' ' ' PHE . 0.0 OUTLIER -114.84 138.36 45.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 114.488 -1.233 . . . . 0.0 108.569 178.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.466 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.9 mtpt -108.87 97.82 7.4 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.494 -178.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.949 ' SG ' HG22 ' A' ' 93' ' ' ILE . 1.9 t -135.34 179.88 6.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.555 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.491 ' HB3' HD23 ' A' ' 96' ' ' LEU . 2.4 p -134.75 162.44 32.34 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.588 ' C ' HD12 ' A' ' 15' ' ' ILE . 12.3 p-80 -136.55 148.57 47.65 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.81 HD13 ' CE2' ' A' ' 36' ' ' PHE . 1.6 mp -130.74 154.14 40.2 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 114.425 -1.261 . . . . 0.0 109.675 179.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.499 HD11 ' HB3' ' A' ' 88' ' ' PHE . 2.5 mt -137.32 135.4 37.04 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 -179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.942 HG21 ' HG3' ' A' ' 22' ' ' GLU . 23.3 m -149.2 134.27 10.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.826 -0.624 . . . . 0.0 110.589 178.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -70.24 -35.92 74.14 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.979 0.419 . . . . 0.0 110.323 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.624 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 37.2 pttt -72.13 79.66 0.95 Allowed 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 178.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.495 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 12.1 pt20 -45.62 -26.28 0.59 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 114.867 -1.061 . . . . 0.0 112.441 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.17 -31.75 75.25 Favored Glycine 0 N--CA 1.448 -0.538 0 C-N-CA 119.564 -1.303 . . . . 0.0 111.975 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.942 ' HG3' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -69.36 -42.84 74.68 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.013 0.435 . . . . 0.0 110.238 179.178 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.513 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -47.64 -38.3 14.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.279 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.649 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -73.41 -31.93 64.14 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.667 179.055 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -76.76 -52.93 8.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.068 -179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.499 HG23 ' N ' ' A' ' 27' ' ' GLN . 19.9 m -50.12 -46.69 24.61 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.504 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.68 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.632 ' CB ' HG11 ' A' ' 80' ' ' VAL . 0.3 OUTLIER -54.07 -36.36 63.05 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.254 0.549 . . . . 0.0 109.955 179.183 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.539 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -72.84 -47.15 48.64 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.181 -0.918 . . . . 0.0 111.43 179.451 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.9 -23.18 44.97 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 115.771 -0.649 . . . . 0.0 112.146 -178.639 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.743 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -52.87 -47.63 67.69 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.768 0.318 . . . . 0.0 111.293 -179.078 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -72.01 -9.42 58.35 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.386 179.695 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -57.27 -23.24 46.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.884 0.373 . . . . 0.0 111.333 -179.555 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 139.45 -12.47 3.24 Favored Glycine 0 N--CA 1.442 -0.916 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.399 -179.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -75.08 153.8 38.19 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.797 0.332 . . . . 0.0 110.605 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 tttm -87.57 131.2 34.48 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.979 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.81 ' CE2' HD13 ' A' ' 15' ' ' ILE . 5.0 t80 -48.8 -49.52 38.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.013 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.61 ' O ' ' HB3' ' A' ' 40' ' ' ALA . . . -54.65 -34.22 55.78 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.051 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 3.3 tppt? -57.38 -53.59 56.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.943 0.402 . . . . 0.0 110.358 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.009 HD12 HD11 ' A' ' 43' ' ' LEU . 3.0 mm? -53.59 -29.93 39.88 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.393 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.61 ' HB3' ' O ' ' A' ' 37' ' ' GLY . . . -51.48 -53.7 34.59 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.697 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -85.76 -23.74 27.16 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.81 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.9 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.17 -68.38 0.42 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 113.04 0.756 . . . . 0.0 113.04 -177.818 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.009 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.29 -12.21 9.44 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.769 0.655 . . . . 0.0 112.769 -179.691 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.605 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -63.84 128.81 37.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.91 0.386 . . . . 0.0 111.216 -179.502 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.505 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.0 OUTLIER -92.87 -5.83 10.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.15 179.387 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.577 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 34.3 t0 -46.34 135.48 8.05 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.083 179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.662 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.11 -178.76 3.49 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.357 -179.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.472 ' O ' ' HB2' ' A' ' 51' ' ' LYS . . . -11.73 -44.49 0.0 OUTLIER Glycine 0 N--CA 1.467 0.73 0 N-CA-C 115.464 0.946 . . . . 0.0 115.464 -178.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.662 ' N ' ' O ' ' A' ' 47' ' ' GLY . 1.4 p -51.38 -26.32 7.62 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.603 0.702 . . . . 0.0 111.476 -179.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.577 ' HB2' ' HB3' ' A' ' 46' ' ' ASP . . . -71.62 -22.39 61.71 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.88 0.372 . . . . 0.0 111.308 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.472 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 8.3 mtpt -68.12 -14.2 62.8 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.23 -179.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.404 ' CG ' ' O ' ' A' ' 49' ' ' SER . 6.2 ptp180 -104.81 24.71 11.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.728 0.299 . . . . 0.0 110.405 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.414 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 0.5 OUTLIER 60.53 24.28 13.95 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 115.852 -0.613 . . . . 0.0 111.143 -179.613 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.42 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 59.53 19.89 49.67 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.911 -0.662 . . . . 0.0 112.69 179.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 3.4 m -63.6 83.86 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.925 0.393 . . . . 0.0 110.677 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.743 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 16.5 mt -63.78 -24.06 67.61 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.882 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 57.04 -160.88 8.47 Favored Glycine 0 CA--C 1.518 0.246 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.817 179.492 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.519 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -67.28 111.54 4.05 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.868 0.366 . . . . 0.0 111.783 -179.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.676 ' HE2' HD22 ' A' ' 56' ' ' LEU . 8.1 m-30 -119.05 156.64 29.32 Favored 'General case' 0 C--N 1.324 -0.52 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 177.153 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -119.27 -173.96 15.64 Favored Glycine 0 C--N 1.317 -0.501 0 C-N-CA 120.345 -0.931 . . . . 0.0 112.431 -179.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -75.53 80.0 2.55 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-O 120.99 0.424 . . . . 0.0 110.182 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.15 36.94 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.82 0 C-N-CA 120.455 -0.879 . . . . 0.0 112.956 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.97 -43.11 1.22 Allowed 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.623 0.249 . . . . 0.0 111.396 -179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -103.54 167.47 9.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.818 0.342 . . . . 0.0 111.26 -179.486 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.705 HG23 ' H ' ' A' ' 68' ' ' PHE . 29.1 m -56.93 160.29 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.626 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.547 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -56.5 -48.19 97.55 Favored Pre-proline 0 CA--C 1.534 0.353 0 N-CA-C 112.775 0.657 . . . . 0.0 112.775 -178.733 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.589 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 20.7 Cg_endo -66.89 -36.26 23.85 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.062 1.842 . . . . 0.0 112.205 -179.347 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.705 ' H ' HG23 ' A' ' 65' ' ' VAL . 15.5 t80 -74.88 -51.0 15.04 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.588 -179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.8 -32.39 60.23 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.839 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.491 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 1.6 m-20 -65.75 -53.15 44.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.886 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.474 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.11 -9.15 58.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.87 179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -69.02 -36.81 78.19 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.571 -0.286 . . . . 0.0 111.613 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.666 ' HB3' HD13 ' A' ' 10' ' ' ILE . 3.0 p90 -107.06 16.79 23.8 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 111.787 0.291 . . . . 0.0 111.787 -179.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -99.81 -28.18 13.26 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.76 0.314 . . . . 0.0 110.879 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 79' ' ' GLU . 3.2 mt -103.47 63.57 0.8 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.213 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 8.1 mt-30 -70.83 -18.27 62.72 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.05 178.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.45 -26.92 40.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.559 179.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.444 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.05 57.59 1.21 Allowed Glycine 0 CA--C 1.502 -0.733 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.74 -179.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.491 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -138.54 175.92 9.14 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 120.746 0.308 . . . . 0.0 111.114 -178.63 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.632 HG11 ' CB ' ' A' ' 27' ' ' GLN . 41.6 t -81.33 145.9 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.918 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -105.16 164.11 12.07 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.162 0.505 . . . . 0.0 111.54 -178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.419 ' O ' HG23 ' A' ' 84' ' ' VAL . 3.5 mp0 -50.73 153.73 2.72 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-N 115.427 -0.806 . . . . 0.0 111.967 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.649 ' HG3' HD23 ' A' ' 24' ' ' LEU . 18.1 Cg_endo -59.27 105.5 0.25 Allowed 'Trans proline' 0 N--CA 1.459 -0.519 0 C-N-CA 122.361 2.041 . . . . 0.0 111.799 179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.589 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 97.5 t -101.33 119.21 49.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.783 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.443 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -103.35 112.69 25.69 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.006 179.823 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -109.51 -171.7 1.9 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.276 179.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -60.33 -18.04 47.13 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.44 -0.346 . . . . 0.0 111.025 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.499 ' HB3' HD11 ' A' ' 16' ' ' LEU . 6.3 m-85 -89.69 -40.79 12.31 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.424 -179.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 156.66 -158.81 29.05 Favored Glycine 0 C--N 1.33 0.241 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.801 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.512 ' CZ ' ' HB2' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -82.11 98.14 8.53 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.457 ' CD2' ' HG ' ' A' ' 16' ' ' LEU . 34.6 m80 -84.22 170.1 14.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.473 -0.785 . . . . 0.0 113.044 -177.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.439 ' CG1' HG13 ' A' ' 80' ' ' VAL . 9.5 t -146.22 153.04 13.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.692 178.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.949 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -143.11 122.36 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 N-CA-C 113.262 0.838 . . . . 0.0 113.262 -178.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.665 ' HE3' HD12 ' A' ' 30' ' ' LEU . 13.8 tptp -128.88 116.88 20.1 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.127 177.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.444 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -57.33 133.99 55.61 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.533 0.682 . . . . 0.0 112.231 -177.686 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.555 ' C ' HD12 ' A' ' 96' ' ' LEU . 0.3 OUTLIER -154.55 116.54 4.21 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 114.744 -1.117 . . . . 0.0 109.573 179.548 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.092 0 CA-C-O 118.451 -1.194 . . . . 0.0 112.636 179.892 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.13 0 N-CA-C 112.565 -0.214 . . . . 0.0 112.565 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.11 171.71 0.17 Allowed 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.555 2.17 . . . . 0.0 112.34 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.2 134.25 54.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.888 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 92.8 56.51 1.51 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.511 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 2.1 m -88.38 150.0 23.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.898 0.38 . . . . 0.0 110.858 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.3 ttt -113.24 121.98 46.09 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.879 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.73 35.15 3.6 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.129 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -54.03 -29.47 43.8 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.725 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.702 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.95 176.22 8.59 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 121.634 0.731 . . . . 0.0 112.112 -179.727 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.522 HD12 ' HB1' ' A' ' 72' ' ' ALA . 0.1 OUTLIER -120.23 139.51 47.3 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-N 114.32 -1.309 . . . . 0.0 108.499 178.417 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.453 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.2 mtpt -110.88 99.27 8.2 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 115.613 -0.722 . . . . 0.0 110.434 -178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.736 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 2.2 t -129.98 -179.76 5.4 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.7 -178.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.545 ' HB2' HD23 ' A' ' 96' ' ' LEU . 2.8 t -118.79 163.58 16.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.746 ' HB3' HD21 ' A' ' 56' ' ' LEU . 12.0 t-80 -138.39 141.02 39.63 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.136 0.493 . . . . 0.0 111.821 -179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.74 HD12 ' C ' ' A' ' 14' ' ' HIS . 4.5 mp -151.47 119.67 0.79 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.491 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.579 HD13 ' HB3' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -109.14 137.42 47.07 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 120.763 0.315 . . . . 0.0 111.596 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.749 HG21 ' CG ' ' A' ' 22' ' ' GLU . 17.1 m -147.95 134.39 12.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.481 178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.407 ' HD2' HD13 ' A' ' 45' ' ' ILE . 0.9 OUTLIER -68.27 -36.62 79.68 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 120.98 -0.288 . . . . 0.0 110.813 -179.5 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.592 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.18 78.35 0.97 Allowed 'General case' 0 N--CA 1.451 -0.423 0 CA-C-O 121.644 0.735 . . . . 0.0 109.04 178.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.471 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 5.0 pt20 -46.59 -25.81 0.77 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.723 -1.126 . . . . 0.0 113.288 -177.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.1 -31.29 77.33 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 119.178 -1.486 . . . . 0.0 111.069 -179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.9 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -70.45 -38.56 74.5 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.382 0.611 . . . . 0.0 109.828 178.371 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.647 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -51.5 -37.67 50.33 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.22 -0.9 . . . . 0.0 110.533 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.611 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.3 OUTLIER -73.13 -30.45 63.62 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.794 179.312 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.77 -41.04 19.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.41 -179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.9 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.8 m -51.11 -35.14 14.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.288 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.678 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -60.38 -48.41 81.87 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 179.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.678 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.57 -28.06 61.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.308 0.575 . . . . 0.0 110.642 178.436 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.455 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 3.1 tpp180 -78.85 -35.97 43.08 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.393 -0.821 . . . . 0.0 111.891 -178.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.481 HD13 ' C ' ' A' ' 30' ' ' LEU . 1.2 tm? -52.74 -59.01 5.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.278 -179.27 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.94 -9.39 54.89 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.488 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.455 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -74.61 50.14 0.42 Allowed 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.6 -10.54 44.35 Favored Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.659 -0.781 . . . . 0.0 114.143 178.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -96.04 157.64 15.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 117.506 0.653 . . . . 0.0 111.061 -179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.8 ttmt -110.28 144.49 38.91 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.205 -179.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.95 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 1.9 p90 -49.05 -28.49 4.09 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.726 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.408 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -59.9 -34.07 81.37 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.574 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -74.4 -49.96 20.43 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.593 0.235 . . . . 0.0 110.827 -179.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.79 HD12 HD11 ' A' ' 43' ' ' LEU . 3.0 mm? -53.28 -36.14 60.85 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.286 -179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.686 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -52.1 -52.77 49.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.127 0.489 . . . . 0.0 110.744 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 9.4 pttt -85.64 -23.7 27.38 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.809 179.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.965 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.7 OUTLIER -72.52 -67.51 0.55 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 112.908 0.707 . . . . 0.0 112.908 -178.227 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.965 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.6 -14.96 9.59 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 113.495 0.924 . . . . 0.0 113.495 -178.946 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.542 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 1.8 t -63.74 126.25 26.99 Favored 'General case' 0 CA--C 1.518 -0.254 0 C-N-CA 119.936 -0.706 . . . . 0.0 110.365 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.476 HG12 ' HA ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -107.74 -28.06 2.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -178.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.579 ' HB3' HD13 ' A' ' 16' ' ' LEU . 15.0 t70 -128.69 106.66 9.09 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 112.621 0.6 . . . . 0.0 112.621 -178.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.77 143.85 4.98 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.903 178.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.28 -33.55 28.46 Favored Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 110.662 -0.975 . . . . 0.0 110.662 178.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.485 ' O ' ' N ' ' A' ' 54' ' ' GLY . 1.8 p -79.57 3.75 17.94 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.333 -0.433 . . . . 0.0 110.952 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.686 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . . . -68.0 -23.97 65.07 Favored 'General case' 0 CA--C 1.518 -0.286 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.7 mmtm -86.64 -18.82 30.4 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.789 178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.503 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 15.4 mtt180 -104.23 25.0 10.61 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.964 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.526 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 0.2 OUTLIER 67.61 40.52 2.51 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-O 121.429 0.633 . . . . 0.0 111.629 -179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 53.63 30.33 42.61 Favored Glycine 0 N--CA 1.453 -0.228 0 CA-C-N 115.79 -0.641 . . . . 0.0 113.018 179.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.572 ' HA ' HD21 ' A' ' 96' ' ' LEU . 85.9 p -92.37 86.35 5.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.739 0.304 . . . . 0.0 110.993 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.746 HD21 ' HB3' ' A' ' 14' ' ' HIS . 69.9 mt -54.03 -40.0 66.66 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.051 0.453 . . . . 0.0 110.21 179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.417 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 78.07 -168.25 53.94 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.538 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.462 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -69.75 111.39 5.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.044 0.449 . . . . 0.0 111.717 -179.429 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.702 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 13.0 m-85 -125.83 152.82 44.97 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 177.189 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -100.71 -174.03 29.43 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.235 -0.983 . . . . 0.0 112.238 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.95 99.93 12.68 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.951 0.405 . . . . 0.0 110.316 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.97 -7.91 1.24 Allowed Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.346 -0.93 . . . . 0.0 113.426 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.4 mtmt -92.29 -40.82 10.73 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 116.924 0.362 . . . . 0.0 111.522 -179.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.2 166.59 12.87 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.913 0.387 . . . . 0.0 111.447 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.761 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.2 m -58.0 163.85 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.815 179.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.51 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 16.8 tttp -58.93 -48.33 96.99 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.543 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 17.7 Cg_endo -67.11 -37.34 19.0 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 121.856 1.704 . . . . 0.0 112.192 -179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.761 ' H ' HG23 ' A' ' 65' ' ' VAL . 40.9 t80 -74.41 -50.78 17.11 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.623 179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -56.75 -32.35 65.48 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.703 179.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.2 OUTLIER -67.42 -49.43 63.78 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.072 -179.986 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.404 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -74.99 -9.56 58.65 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.753 -179.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.522 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -68.82 -51.26 42.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.912 0.387 . . . . 0.0 111.447 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.458 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 3.5 p90 -94.24 16.71 14.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.452 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.4 ttt180 -97.39 -29.38 13.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.827 0.346 . . . . 0.0 110.804 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.544 HD11 ' O ' ' A' ' 80' ' ' VAL . 3.4 mt -103.48 67.1 0.9 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.454 -179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.6 mt-30 -74.35 -17.78 60.78 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.978 -0.555 . . . . 0.0 110.049 178.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -66.66 -26.74 38.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.447 179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.473 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.14 59.8 1.09 Allowed Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.611 -0.804 . . . . 0.0 111.521 -179.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.513 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -141.33 176.14 9.1 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.841 0.353 . . . . 0.0 111.123 -178.381 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.544 ' O ' HD11 ' A' ' 75' ' ' LEU . 50.0 t -81.46 147.99 5.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.658 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.17 159.3 15.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.293 0.568 . . . . 0.0 111.56 -178.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -50.68 155.23 1.99 Allowed Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.24 -0.891 . . . . 0.0 112.567 -178.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.611 ' HG3' HD23 ' A' ' 24' ' ' LEU . 18.4 Cg_endo -58.53 106.67 0.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 122.335 2.023 . . . . 0.0 111.534 179.443 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.543 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 90.8 t -101.03 101.92 12.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.754 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.438 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 6.5 tptt -91.89 112.69 24.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.632 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.412 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 2.0 m -114.27 -173.19 2.24 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.55 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -58.29 -20.27 41.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.929 179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.488 ' HB3' HD11 ' A' ' 16' ' ' LEU . 2.6 m-85 -89.37 -23.97 22.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.309 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.481 ' C ' HD21 ' A' ' 16' ' ' LEU . . . 136.97 -167.88 24.49 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.883 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.496 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -74.98 98.35 3.58 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.794 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.412 ' CE1' ' HB2' ' A' ' 86' ' ' SER . 53.3 m80 -80.86 167.63 19.68 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.343 0.592 . . . . 0.0 112.437 -178.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 40.0 t -147.73 153.16 12.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.055 -0.975 . . . . 0.0 109.395 179.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.667 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.0 OUTLIER -150.82 127.46 2.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.945 0.721 . . . . 0.0 112.945 -179.03 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.485 ' HG2' HG22 ' A' ' 80' ' ' VAL . 2.6 tmtm? -128.59 116.1 19.11 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.677 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.56 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.5 OUTLIER -57.44 134.58 56.18 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.495 0.664 . . . . 0.0 112.046 -178.055 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.95 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -157.1 116.67 3.42 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.862 -1.063 . . . . 0.0 109.771 179.754 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.082 0 CA-C-O 118.321 -1.266 . . . . 0.0 112.57 179.845 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 112.529 -0.228 . . . . 0.0 112.529 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.78 124.79 11.42 Favored 'Trans proline' 0 C--N 1.344 0.305 0 C-N-CA 122.456 2.104 . . . . 0.0 112.253 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -90.56 134.79 34.13 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.009 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.35 58.17 0.28 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.508 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.5 m -62.45 164.92 6.7 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.773 0.32 . . . . 0.0 110.646 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -163.21 -43.72 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.274 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -93.31 17.5 11.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.642 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -56.23 -25.47 47.7 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.975 0.417 . . . . 0.0 110.599 179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.547 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 1.0 OUTLIER -84.77 173.7 10.46 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.47 0.653 . . . . 0.0 112.138 -179.325 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.575 HG22 ' SG ' ' A' ' 12' ' ' CYS . 1.5 mt -110.98 136.15 47.92 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.869 0 CA-C-N 114.814 -1.085 . . . . 0.0 108.869 178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.475 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.4 mtpt -109.17 90.76 3.39 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.21 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.775 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 13.7 m -130.69 -179.59 5.39 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.055 -178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.658 ' HB2' HD23 ' A' ' 96' ' ' LEU . 9.5 t -124.87 163.45 22.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.072 -0.513 . . . . 0.0 109.851 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.793 ' CG ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -139.87 155.54 47.16 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.363 0.602 . . . . 0.0 112.583 -179.319 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.754 HG23 ' OG ' ' A' ' 44' ' ' SER . 3.0 mp -143.77 139.43 25.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.48 179.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.757 HD11 ' NE2' ' A' ' 91' ' ' HIS . 0.4 OUTLIER -127.38 133.55 50.02 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 112.518 0.562 . . . . 0.0 112.518 -178.621 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.968 HG21 ' CG ' ' A' ' 22' ' ' GLU . 25.3 m -154.61 134.42 3.88 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.235 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.807 178.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.533 ' HE3' HD13 ' A' ' 45' ' ' ILE . 9.6 mttt -65.92 -16.58 63.99 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 178.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.515 ' HB3' ' CG ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -72.29 78.24 0.99 Allowed 'General case' 0 N--CA 1.443 -0.778 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.813 179.016 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.453 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 0.8 OUTLIER -47.27 -40.52 16.9 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -178.156 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -69.09 -31.54 72.27 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 119.848 -1.168 . . . . 0.0 112.774 -179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.968 ' CG ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -66.9 -43.73 82.63 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.237 0.541 . . . . 0.0 110.407 179.462 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.557 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -46.95 -39.28 12.08 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.334 -0.848 . . . . 0.0 110.535 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.691 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -72.79 -29.16 63.06 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.56 -0.745 . . . . 0.0 111.112 179.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -78.91 -54.01 6.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.459 -179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 17.4 m -49.52 -34.27 8.15 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.344 0 N-CA-C 112.11 0.411 . . . . 0.0 112.11 -179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.691 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.9 pt20 -59.78 -47.72 84.56 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.18 -0.608 . . . . 0.0 109.907 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.535 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.23 -29.22 62.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.202 0.525 . . . . 0.0 110.499 178.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.596 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.53 -36.2 45.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.792 -179.001 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.594 ' CD2' HD23 ' A' ' 39' ' ' LEU . 0.8 OUTLIER -52.77 -58.1 7.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.259 -179.363 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.433 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -71.36 -9.58 58.37 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.301 179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.596 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.52 -23.7 63.04 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.887 0.375 . . . . 0.0 111.181 -179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.26 -19.47 0.93 Allowed Glycine 0 N--CA 1.443 -0.858 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.275 -179.641 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.415 ' HG3' HD21 ' A' ' 39' ' ' LEU . 20.5 pt-20 -80.93 157.65 25.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.856 0.36 . . . . 0.0 110.773 179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 14.1 pttt -101.43 148.28 25.36 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.168 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.845 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 1.1 p90 -50.44 -39.35 47.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.035 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.4 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -57.94 -34.21 71.26 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.746 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -65.85 -54.12 30.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.701 0.286 . . . . 0.0 110.913 -179.772 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.014 HD12 HD11 ' A' ' 43' ' ' LEU . 2.8 mm? -56.32 -32.56 64.75 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.681 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.566 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.44 -52.78 43.33 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.175 0.512 . . . . 0.0 110.642 -179.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.39 -23.77 26.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.795 -0.638 . . . . 0.0 111.133 178.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.848 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -69.62 -68.94 0.37 Allowed 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 113.305 0.854 . . . . 0.0 113.305 -177.537 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.014 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.75 -12.63 9.21 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 112.66 0.615 . . . . 0.0 112.66 -179.601 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.754 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -63.68 131.69 48.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.885 0.374 . . . . 0.0 111.436 -179.123 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.554 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.3 pt -100.04 -8.64 9.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.941 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.835 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 24.9 p-10 -45.87 135.21 7.29 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.962 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.693 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.27 -178.27 3.44 Favored Glycine 0 N--CA 1.452 -0.299 0 CA-C-N 115.867 -0.606 . . . . 0.0 112.775 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 51' ' ' LYS . . . -11.75 -41.74 0.0 OUTLIER Glycine 0 N--CA 1.467 0.736 0 N-CA-C 115.63 1.012 . . . . 0.0 115.63 -178.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.693 ' N ' ' O ' ' A' ' 47' ' ' GLY . 48.3 t -51.21 -22.3 2.57 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-N 117.564 0.682 . . . . 0.0 111.462 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.835 ' HB2' ' OD1' ' A' ' 46' ' ' ASP . . . -71.64 -21.17 61.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.875 0.369 . . . . 0.0 111.217 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -68.25 -12.25 60.7 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.827 -179.056 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.439 ' CG ' ' O ' ' A' ' 49' ' ' SER . 9.2 ptp180 -104.43 24.88 10.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.678 0.275 . . . . 0.0 110.529 179.536 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.451 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 0.4 OUTLIER 65.79 20.83 11.49 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.129 -179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.84 17.92 65.72 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.615 179.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 7.4 m -68.53 86.07 0.3 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.859 0.362 . . . . 0.0 110.713 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.793 HD21 ' CG ' ' A' ' 14' ' ' HIS . 23.2 mt -54.56 -24.58 21.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.696 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 59.5 -166.18 9.41 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.233 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.499 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -67.27 111.51 4.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.9 0.381 . . . . 0.0 111.897 -179.392 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.547 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 4.4 m-85 -117.43 156.3 28.19 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 177.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -123.59 -174.0 14.1 Favored Glycine 0 C--N 1.314 -0.65 0 C-N-CA 120.276 -0.964 . . . . 0.0 112.506 -179.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.23 80.13 5.61 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.924 0.392 . . . . 0.0 110.225 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.26 36.68 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.78 0 C-N-CA 120.42 -0.895 . . . . 0.0 113.03 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.01 -48.6 0.67 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.822 0.344 . . . . 0.0 111.135 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 37.6 mtm -95.52 170.95 8.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.086 -179.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.793 HG23 ' H ' ' A' ' 68' ' ' PHE . 34.3 m -59.44 159.12 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.954 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.568 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -61.0 -47.97 93.88 Favored Pre-proline 0 CA--C 1.534 0.339 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 -179.17 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 12.2 Cg_endo -63.75 -41.14 25.62 Favored 'Trans proline' 0 C--N 1.345 0.385 0 C-N-CA 121.955 1.77 . . . . 0.0 111.836 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.804 ' CE1' HG23 ' A' ' 93' ' ' ILE . 9.3 t80 -74.96 -52.35 11.39 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.533 -0.758 . . . . 0.0 110.843 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 8.1 tm-20 -55.36 -32.24 62.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.991 0.424 . . . . 0.0 110.647 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.457 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 29.9 t70 -65.38 -53.07 48.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.744 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.21 -9.31 58.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.559 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.32 -47.0 78.09 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.721 0.296 . . . . 0.0 111.376 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.457 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 11.4 p90 -93.24 16.19 13.71 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.345 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.4 tpm_? -98.3 -30.51 12.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.846 0.355 . . . . 0.0 110.934 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.585 HD11 ' HA ' ' A' ' 81' ' ' SER . 7.9 mt -97.73 56.81 1.3 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.177 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -63.75 -23.75 67.49 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.758 179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -61.87 -26.79 40.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 115.633 -0.712 . . . . 0.0 109.855 178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.573 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 91.16 63.08 1.2 Allowed Glycine 0 CA--C 1.499 -0.949 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.122 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.401 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -141.05 176.61 8.68 Favored 'General case' 0 C--N 1.311 -1.071 0 CA-C-N 115.611 -0.294 . . . . 0.0 110.62 -178.92 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.599 HG11 ' HA ' ' A' ' 27' ' ' GLN . 61.1 t -80.16 147.91 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.749 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.585 ' HA ' HD11 ' A' ' 75' ' ' LEU . 12.8 t -104.53 162.97 12.8 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.611 0.72 . . . . 0.0 111.924 -177.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.607 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -50.37 163.46 0.45 Allowed Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 114.63 -1.168 . . . . 0.0 111.396 -179.268 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.607 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 35.8 Cg_endo -65.71 103.59 0.59 Allowed 'Trans proline' 0 N--CA 1.46 -0.479 0 C-N-CA 122.617 2.211 . . . . 0.0 112.321 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.555 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 89.8 t -101.66 99.56 8.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.456 179.509 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -95.21 115.31 27.27 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.072 -179.979 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.9 m -105.51 -175.64 2.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.367 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -57.3 -20.13 26.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.958 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 -88.18 -39.88 14.15 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.433 -179.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.58 -171.6 36.03 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.517 -0.849 . . . . 0.0 112.978 -179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.46 ' CD1' ' HB3' ' A' ' 85' ' ' LYS . 0.6 OUTLIER -74.95 108.59 7.78 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.957 0.408 . . . . 0.0 110.043 179.95 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.757 ' NE2' HD11 ' A' ' 16' ' ' LEU . 56.6 m80 -95.46 169.39 10.09 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.381 0.61 . . . . 0.0 112.368 -178.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.426 ' CG1' HG13 ' A' ' 80' ' ' VAL . 20.4 t -147.81 152.68 12.52 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.096 -0.956 . . . . 0.0 109.594 179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.804 HG23 ' CE1' ' A' ' 68' ' ' PHE . 0.4 OUTLIER -133.4 122.15 43.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.27 0.47 . . . . 0.0 112.27 -179.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.458 ' O ' ' N ' ' A' ' 13' ' ' SER . 10.3 tptt -128.71 109.07 11.0 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.392 178.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.573 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 1.1 ttt-85 -57.1 138.78 54.04 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.776 0.798 . . . . 0.0 112.625 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.845 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -161.98 116.42 1.9 Allowed 'General case' 0 N--CA 1.441 -0.908 0 CA-C-N 114.376 -1.284 . . . . 0.0 109.484 179.41 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.626 179.8 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.183 0 N-CA-C 112.51 -0.236 . . . . 0.0 112.51 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.71 122.15 8.85 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.589 2.193 . . . . 0.0 112.262 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.88 146.84 52.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 137.15 58.6 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.532 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 87.0 p -82.78 126.54 32.52 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.794 0.33 . . . . 0.0 110.965 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -114.97 169.14 9.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.737 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -106.87 29.48 6.99 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.265 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.39 -25.15 22.91 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.356 -0.383 . . . . 0.0 110.654 179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.463 ' CB ' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -85.13 163.93 18.46 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-O 121.3 0.572 . . . . 0.0 111.553 -179.85 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.618 HG22 ' SG ' ' A' ' 12' ' ' CYS . 1.2 mt -111.33 135.68 49.77 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.894 0 CA-C-N 115.109 -0.95 . . . . 0.0 109.043 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.492 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.7 mtpt -109.67 89.49 3.02 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.132 179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.793 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 8.5 m -131.97 -179.55 5.47 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.081 -178.686 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.705 ' HB3' HD23 ' A' ' 96' ' ' LEU . 8.7 p -127.07 163.43 23.78 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.156 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.747 ' CD2' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -136.08 157.46 46.78 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.295 0.569 . . . . 0.0 112.412 -179.364 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.722 HD12 ' C ' ' A' ' 14' ' ' HIS . 2.9 mp -149.24 125.43 2.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.038 179.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.945 HD21 ' CD2' ' A' ' 91' ' ' HIS . 1.0 OUTLIER -105.84 136.94 44.57 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.844 0.354 . . . . 0.0 111.893 -179.089 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.64 HG21 ' CD ' ' A' ' 22' ' ' GLU . 22.7 m -150.67 134.39 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.389 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.404 ' HG3' HD13 ' A' ' 45' ' ' ILE . 17.3 mtmt -71.8 -35.84 70.09 Favored 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -178.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.617 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 5.9 tttt -73.15 79.19 1.26 Allowed 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.469 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 3.2 pt20 -46.49 -25.89 0.76 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.153 -0.93 . . . . 0.0 113.108 -177.097 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.15 -29.47 74.5 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 119.194 -1.479 . . . . 0.0 110.82 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.64 ' CD ' HG21 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -73.99 -38.02 64.27 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-O 121.26 0.553 . . . . 0.0 110.017 178.466 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.61 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.57 -33.76 23.1 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.651 178.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.544 HD13 ' O ' ' A' ' 24' ' ' LEU . 1.3 tm? -73.48 -39.8 64.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.569 -0.742 . . . . 0.0 110.417 178.656 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.401 ' O ' ' HG3' ' A' ' 28' ' ' GLU . . . -74.17 -47.03 38.48 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.602 -0.726 . . . . 0.0 111.961 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 22' ' ' GLU . 21.3 m -46.6 -37.49 3.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.688 -0.233 . . . . 0.0 111.361 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.726 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -58.4 -48.51 80.41 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.618 -0.433 . . . . 0.0 110.118 179.551 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.726 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -73.65 -30.21 62.8 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.072 0.463 . . . . 0.0 110.822 178.65 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.458 ' N ' ' HG3' ' A' ' 28' ' ' GLU . 16.8 tpt180 -79.18 -27.07 42.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.866 -178.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.668 ' O ' HD13 ' A' ' 30' ' ' LEU . 1.4 tm? -70.47 -44.82 66.97 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.222 0.534 . . . . 0.0 110.278 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.9 -9.46 58.72 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.769 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.02 -27.89 69.42 Favored 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 120.902 0.382 . . . . 0.0 111.352 -179.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.68 -17.92 0.98 Allowed Glycine 0 N--CA 1.443 -0.888 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.629 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.48 ' HG3' HD22 ' A' ' 30' ' ' LEU . 25.3 pt-20 -74.22 157.56 35.67 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.813 0.339 . . . . 0.0 110.879 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -99.08 139.94 33.97 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.053 -0.522 . . . . 0.0 111.093 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.921 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 3.0 p90 -49.97 -33.81 18.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.99 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' O ' ' HB3' ' A' ' 40' ' ' ALA . . . -60.98 -37.43 93.83 Favored Glycine 0 N--CA 1.449 -0.441 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.352 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.438 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -64.06 -52.92 57.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.806 0.336 . . . . 0.0 110.778 179.888 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.773 HD12 HD11 ' A' ' 43' ' ' LEU . 3.2 mm? -53.55 -31.14 45.29 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.725 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.588 ' HB1' ' O ' ' A' ' 50' ' ' ALA . . . -51.16 -55.17 19.26 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 121.115 0.483 . . . . 0.0 110.778 -179.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.79 -23.34 27.27 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.966 179.19 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.937 ' HB3' HD13 ' A' ' 43' ' ' LEU . 1.0 OUTLIER -70.17 -68.29 0.43 Allowed 'General case' 0 CA--C 1.534 0.349 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -177.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.937 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.37 -13.3 9.28 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 112.626 0.602 . . . . 0.0 112.626 -179.891 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.582 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -64.13 135.65 56.54 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.163 0.506 . . . . 0.0 111.203 -179.295 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.49 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 43.2 pt -97.56 -14.25 7.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.216 -179.854 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -46.04 134.84 7.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.217 -179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.647 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.15 -178.63 3.48 Favored Glycine 0 C--O 1.226 -0.401 0 CA-C-N 115.874 -0.603 . . . . 0.0 112.63 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.42 -45.72 0.0 OUTLIER Glycine 0 N--CA 1.467 0.702 0 N-CA-C 115.458 0.943 . . . . 0.0 115.458 -178.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.647 ' N ' ' O ' ' A' ' 47' ' ' GLY . 33.2 m -51.69 -24.96 6.37 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 117.361 0.58 . . . . 0.0 111.108 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.588 ' O ' ' HB1' ' A' ' 40' ' ' ALA . . . -71.0 -20.94 62.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.89 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 4.3 mttt -79.78 -4.22 51.09 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.396 179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.2 mtp-105 -104.33 24.62 11.28 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.223 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 61.0 22.53 12.77 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.014 -179.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 57.45 20.44 37.6 Favored Glycine 0 C--N 1.332 0.324 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.799 179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m -61.85 85.59 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.775 0.321 . . . . 0.0 110.987 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.793 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 21.5 mt -60.76 -24.86 66.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.535 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.474 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 56.78 -165.14 5.37 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.416 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.492 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -64.93 121.07 13.79 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.225 0.536 . . . . 0.0 112.209 -179.143 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.434 ' CZ ' ' O ' ' A' ' 56' ' ' LEU . 12.0 m-30 -136.8 148.49 47.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.399 -0.819 . . . . 0.0 109.017 177.117 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -108.84 -173.81 21.37 Favored Glycine 0 C--N 1.314 -0.689 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.44 -179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.46 87.36 7.23 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.152 0.501 . . . . 0.0 110.189 179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.32 36.78 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.485 -0.864 . . . . 0.0 112.901 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -135.62 -45.24 0.67 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.712 0.292 . . . . 0.0 111.144 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.32 171.4 8.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.135 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.794 HG23 ' H ' ' A' ' 68' ' ' PHE . 34.3 m -55.13 157.56 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.106 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.55 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.52 -48.11 97.52 Favored Pre-proline 0 C--N 1.329 -0.299 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -179.028 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.605 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 18.6 Cg_endo -65.69 -39.92 19.16 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 121.946 1.764 . . . . 0.0 112.187 -179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.794 ' H ' HG23 ' A' ' 65' ' ' VAL . 23.8 t80 -74.91 -49.17 21.17 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.459 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.409 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 0.5 OUTLIER -54.94 -32.73 61.61 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.524 179.69 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.426 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.9 OUTLIER -67.45 -51.56 50.05 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.901 179.745 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.438 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -74.89 -9.59 58.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.593 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.472 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -66.84 -43.29 84.08 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.848 0.356 . . . . 0.0 111.448 -179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.426 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 1.1 p90 -102.26 16.77 25.18 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.401 -179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.07 -27.31 15.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.748 0.308 . . . . 0.0 110.831 -179.841 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.521 HD12 ' O ' ' A' ' 79' ' ' GLU . 3.3 mt -103.53 63.55 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.305 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.1 mt-30 -70.56 -18.53 62.92 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.993 -0.548 . . . . 0.0 109.965 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -64.6 -26.91 41.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.35 179.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.544 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.19 58.15 1.17 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.802 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.521 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.8 tm-20 -140.5 176.36 8.84 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.672 0.272 . . . . 0.0 110.977 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.553 HG11 ' HA ' ' A' ' 27' ' ' GLN . 56.8 t -84.65 147.05 5.88 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.098 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.21 161.96 13.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.186 0.517 . . . . 0.0 111.434 -178.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.406 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.7 mp0 -50.85 153.9 2.72 Favored Pre-proline 0 C--O 1.234 0.28 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.033 -179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.446 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 22.5 Cg_endo -60.84 106.35 0.37 Allowed 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 122.1 1.867 . . . . 0.0 111.523 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.605 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 86.1 t -101.01 108.33 23.08 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.7 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 90' ' ' TYR . 14.7 tmtt? -91.7 113.17 25.37 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.408 -179.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.48 -172.38 2.08 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.199 179.283 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -16.42 48.89 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.562 -0.29 . . . . 0.0 111.213 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -94.08 -35.28 12.63 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-O 120.713 0.292 . . . . 0.0 111.594 -179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.66 -167.03 34.57 Favored Glycine 0 CA--C 1.509 -0.292 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.666 -179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.579 ' O ' HD13 ' A' ' 16' ' ' LEU . 1.2 m-85 -82.44 98.26 8.8 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 121.266 0.555 . . . . 0.0 109.994 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.945 ' CD2' HD21 ' A' ' 16' ' ' LEU . 11.3 m80 -83.09 169.64 15.66 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.007 -177.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 38.3 t -149.03 150.72 13.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 114.571 -1.195 . . . . 0.0 109.014 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.54 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -130.62 122.41 52.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 N-CA-C 112.389 0.515 . . . . 0.0 112.389 -178.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.446 ' O ' ' N ' ' A' ' 13' ' ' SER . 3.8 tmtt? -128.58 110.44 12.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.113 178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.544 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -57.47 139.44 53.27 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.853 0.835 . . . . 0.0 112.73 -178.463 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.921 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -162.82 116.42 1.67 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.491 179.455 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.417 ' CA ' ' HE2' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.249 1.07 0 CA-C-O 118.323 -1.265 . . . . 0.0 112.621 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -52.2 133.53 47.66 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.534 2.156 . . . . 0.0 112.321 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.7 ttt -130.72 127.79 39.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.943 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 95.4 -45.01 2.07 Favored Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.542 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.52 124.24 26.25 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.88 0.372 . . . . 0.0 110.825 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 4.2 ttt -134.19 152.7 51.96 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.956 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -132.65 29.27 4.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.27 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.474 ' CB ' ' HE3' ' A' ' 9' ' ' LYS . 0.3 OUTLIER -57.47 -21.5 37.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.756 179.771 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.579 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.03 168.47 15.9 Favored 'General case' 0 N--CA 1.445 -0.719 0 CA-C-O 121.376 0.607 . . . . 0.0 112.034 -179.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.674 HD12 ' HB1' ' A' ' 72' ' ' ALA . 1.2 mt -111.01 136.0 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.813 0 CA-C-N 114.95 -1.023 . . . . 0.0 109.15 178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.517 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.6 mtpt -108.32 89.78 3.1 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.404 -0.816 . . . . 0.0 109.115 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.808 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 6.4 m -132.69 -179.61 5.57 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.747 -178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.588 ' OG ' HD23 ' A' ' 96' ' ' LEU . 3.0 m -131.25 163.75 27.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.607 -0.27 . . . . 0.0 110.371 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.808 ' O ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -132.16 156.31 46.63 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 113.17 0.804 . . . . 0.0 113.17 -179.334 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.808 HD12 ' O ' ' A' ' 14' ' ' HIS . 1.5 mp -141.43 120.01 9.89 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 114.949 -1.023 . . . . 0.0 110.045 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.55 HD11 ' CE1' ' A' ' 91' ' ' HIS . 2.0 mt -104.44 128.28 52.29 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 112.045 0.387 . . . . 0.0 112.045 -179.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.788 HG21 ' CG ' ' A' ' 22' ' ' GLU . 17.9 m -140.57 133.91 33.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.017 178.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.73 -36.7 70.55 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 120.851 -0.339 . . . . 0.0 110.84 -179.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.613 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.23 78.53 0.98 Allowed 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 178.385 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.477 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 0.1 OUTLIER -46.51 -26.05 0.8 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 114.87 -1.059 . . . . 0.0 113.058 -177.47 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.42 -31.12 76.05 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 119.272 -1.442 . . . . 0.0 110.855 179.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.859 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -70.06 -39.56 75.61 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.081 0.467 . . . . 0.0 110.3 178.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.659 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.34 -38.1 40.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.986 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.815 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.4 OUTLIER -73.61 -29.4 62.36 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.244 179.212 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.38 -43.7 14.45 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.543 -179.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.859 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.5 m -54.89 -40.66 53.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.275 -179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.678 ' HA ' HG11 ' A' ' 80' ' ' VAL . 3.2 pt20 -53.2 -52.61 58.31 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 121.011 -0.275 . . . . 0.0 110.691 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.546 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.7 OUTLIER -73.28 -31.51 64.1 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.08 0.467 . . . . 0.0 110.998 179.141 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.448 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -76.41 -25.61 54.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.706 -178.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.634 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -58.38 -48.31 81.04 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.4 -179.489 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.93 -9.32 58.19 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.428 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.448 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -56.26 -22.15 28.17 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.802 0.334 . . . . 0.0 111.403 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 138.13 -10.76 3.59 Favored Glycine 0 N--CA 1.443 -0.859 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.536 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.452 ' OE1' HD11 ' A' ' 39' ' ' LEU . 15.2 pt-20 -79.02 153.24 30.41 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.929 0.395 . . . . 0.0 110.988 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.4 135.51 33.85 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.792 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.781 ' CZ ' HD13 ' A' ' 15' ' ' ILE . 9.6 t80 -53.29 -47.78 68.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.218 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.428 ' O ' ' HB3' ' A' ' 40' ' ' ALA . . . -56.59 -34.12 63.68 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.239 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.446 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.1 OUTLIER -58.82 -50.26 74.63 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.704 0.288 . . . . 0.0 110.87 179.747 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.787 ' CD1' HD11 ' A' ' 43' ' ' LEU . 3.2 mm? -53.07 -33.28 51.35 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.808 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.25 -54.24 27.75 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.127 0.489 . . . . 0.0 110.496 -179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.4 pttp -85.77 -23.5 27.23 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.023 179.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.924 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -70.54 -67.91 0.47 Allowed 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -177.914 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.924 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.94 -15.69 9.3 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.693 0.627 . . . . 0.0 112.693 -179.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.56 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -63.99 138.31 58.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.118 0.485 . . . . 0.0 111.275 -179.475 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.419 ' CG1' ' O ' ' A' ' 16' ' ' LEU . 2.0 pt -99.49 -10.02 8.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.18 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.405 ' OD2' ' CE1' ' A' ' 14' ' ' HIS . 14.2 t0 -46.21 135.31 7.92 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.959 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.646 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -61.93 -178.56 3.24 Favored Glycine 0 C--O 1.225 -0.436 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.173 -179.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.447 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.35 -45.73 0.0 OUTLIER Glycine 0 N--CA 1.467 0.73 0 N-CA-C 115.416 0.926 . . . . 0.0 115.416 -178.636 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.646 ' N ' ' O ' ' A' ' 47' ' ' GLY . 14.4 m -51.55 -24.64 5.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.365 0.582 . . . . 0.0 111.379 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.447 ' O ' ' HB1' ' A' ' 40' ' ' ALA . . . -72.08 -31.61 66.26 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.388 0.613 . . . . 0.0 110.248 179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.447 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -68.09 -16.17 63.9 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.063 -0.971 . . . . 0.0 111.065 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.408 ' HG3' ' O ' ' A' ' 49' ' ' SER . 0.0 OUTLIER -104.22 24.64 11.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.29 179.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.429 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 0.3 OUTLIER 64.5 17.54 10.89 Favored 'General case' 0 CA--C 1.528 0.105 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.434 -179.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.83 27.37 49.93 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.37 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.7 m -60.06 84.68 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.959 0.409 . . . . 0.0 110.815 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.808 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 22.8 mt -60.5 -19.66 57.6 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.725 179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 50.33 -169.07 0.27 Allowed Glycine 0 C--N 1.333 0.369 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.735 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.517 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -61.69 111.44 1.85 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.929 0.395 . . . . 0.0 111.723 -179.385 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.579 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 2.4 m-85 -124.78 163.8 21.34 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 177.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -127.35 -174.04 13.67 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.212 -0.994 . . . . 0.0 112.656 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 17.2 ptt180 -86.9 95.72 9.98 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-O 121.052 0.453 . . . . 0.0 110.283 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.23 36.47 0.05 OUTLIER Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.584 -0.817 . . . . 0.0 112.756 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 2.3 mmtt -152.05 -42.62 0.11 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.74 0.305 . . . . 0.0 111.187 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 8.9 mtm -91.07 167.12 12.6 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.93 0.395 . . . . 0.0 111.27 -179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.799 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.7 m -58.97 156.31 2.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.854 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.557 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 2.5 ttpt -58.14 -47.98 97.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -179.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.562 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 12.7 Cg_endo -64.4 -40.1 26.18 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 121.995 1.797 . . . . 0.0 112.239 -179.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.799 ' H ' HG23 ' A' ' 65' ' ' VAL . 11.3 t80 -75.11 -50.17 17.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.696 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -54.63 -32.33 58.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.689 179.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.42 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 1.5 t70 -66.87 -52.47 43.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.851 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.87 -9.5 58.6 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.478 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.674 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -63.18 -43.19 98.92 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.415 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.42 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 2.8 p90 -98.29 16.54 21.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.386 -179.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.6 mtp180 -98.18 -28.14 13.85 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.618 -0.265 . . . . 0.0 111.172 -179.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.782 HD11 ' CB ' ' A' ' 81' ' ' SER . 8.5 mt -96.0 51.6 1.25 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.843 0.354 . . . . 0.0 111.301 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -58.91 -33.14 70.2 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.169 0.509 . . . . 0.0 109.868 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -63.55 -26.68 41.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.33 178.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.514 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 90.37 72.01 1.24 Allowed Glycine 0 CA--C 1.5 -0.905 0 C-N-CA 120.934 -0.651 . . . . 0.0 111.819 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.749 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -142.28 177.6 8.14 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.132 -0.534 . . . . 0.0 110.014 -178.744 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.678 HG11 ' HA ' ' A' ' 27' ' ' GLN . 93.5 t -79.67 149.73 5.25 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 N-CA-C 109.226 -0.657 . . . . 0.0 109.226 179.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.782 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -104.49 153.08 21.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.354 0.597 . . . . 0.0 111.401 -178.419 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.587 ' O ' HG23 ' A' ' 84' ' ' VAL . 0.9 OUTLIER -50.76 156.1 1.73 Allowed Pre-proline 0 C--N 1.326 -0.429 0 CA-C-N 115.053 -0.976 . . . . 0.0 111.834 -179.22 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.815 ' HG3' HD23 ' A' ' 24' ' ' LEU . 11.2 Cg_endo -53.67 102.83 0.08 OUTLIER 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.514 2.143 . . . . 0.0 111.96 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 82' ' ' GLU . 57.6 t -103.07 103.05 14.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.599 179.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.79 112.5 24.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.9 0.381 . . . . 0.0 110.966 -179.923 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.63 -176.9 3.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.398 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -59.33 -19.07 43.61 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.958 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.4 m-85 -89.93 -40.53 12.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.386 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.83 -164.09 35.65 Favored Glycine 0 C--N 1.331 0.274 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.826 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.477 ' CZ ' ' HB2' ' A' ' 20' ' ' GLN . 0.3 OUTLIER -83.43 98.17 9.36 Favored 'General case' 0 N--CA 1.447 -0.587 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.55 ' CE1' HD11 ' A' ' 16' ' ' LEU . 15.5 m80 -83.68 167.1 17.55 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.557 ' CG1' HG13 ' A' ' 80' ' ' VAL . 18.0 t -145.11 153.42 14.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 114.44 -1.255 . . . . 0.0 108.772 178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.493 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.8 OUTLIER -138.02 121.58 20.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 N-CA-C 113.118 0.784 . . . . 0.0 113.118 -178.661 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.489 ' CB ' ' CE1' ' A' ' 36' ' ' PHE . 5.1 tptm -129.62 113.27 14.6 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.168 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.514 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.8 OUTLIER -57.97 139.19 54.95 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.787 0.803 . . . . 0.0 112.631 -178.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.588 HD23 ' OG ' ' A' ' 13' ' ' SER . 0.2 OUTLIER -159.62 116.18 2.56 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 114.253 -1.34 . . . . 0.0 109.351 179.098 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.066 0 CA-C-O 118.444 -1.198 . . . . 0.0 112.555 179.955 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.171 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -71.62 88.5 0.76 Allowed 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.602 2.201 . . . . 0.0 112.28 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.56 147.1 46.24 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 126.33 -1.71 7.66 Favored Glycine 0 CA--C 1.519 0.284 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.786 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 8.6 t -62.33 130.62 46.11 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.875 0.369 . . . . 0.0 110.819 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -171.49 -163.82 0.3 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.878 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.11 47.96 1.46 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.129 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -66.8 -39.34 87.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.769 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.568 ' HD2' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -85.84 174.96 8.94 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.081 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.402 HD11 ' HB3' ' A' ' 73' ' ' PHE . 0.4 OUTLIER -114.14 136.97 48.98 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.685 0 CA-C-O 121.4 0.619 . . . . 0.0 110.752 -178.703 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.717 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -107.29 95.39 5.67 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.738 -179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.842 ' SG ' HG22 ' A' ' 93' ' ' ILE . 1.9 t -120.4 179.35 4.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.772 -0.649 . . . . 0.0 111.794 -177.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.917 ' HB3' HD23 ' A' ' 96' ' ' LEU . 14.7 p -120.56 163.35 18.12 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.69 ' C ' HD12 ' A' ' 15' ' ' ILE . 24.6 p-80 -134.68 151.59 51.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.517 0.675 . . . . 0.0 112.633 -179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.769 HG23 ' OG ' ' A' ' 44' ' ' SER . 2.9 mp -155.61 127.09 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 114.817 -1.083 . . . . 0.0 109.764 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.884 HD13 ' CD2' ' A' ' 91' ' ' HIS . 10.9 tp -114.15 129.06 56.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.935 0.398 . . . . 0.0 112.029 -179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.768 HG11 ' OE1' ' A' ' 22' ' ' GLU . 28.1 m -143.26 134.35 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.635 178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.504 ' HD2' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -77.9 -33.97 51.64 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.916 -0.314 . . . . 0.0 111.478 -179.013 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.6 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 13.2 tttp -72.3 79.14 1.0 Allowed 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 178.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 0.9 OUTLIER -46.18 -25.39 0.59 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.161 -0.927 . . . . 0.0 112.939 -177.026 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.55 -31.33 78.35 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 118.865 -1.636 . . . . 0.0 110.429 179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.868 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -73.2 -37.65 66.39 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.06 0.457 . . . . 0.0 109.777 178.062 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.602 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -53.31 -36.2 60.99 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.738 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.632 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.59 -29.28 62.3 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.762 178.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.9 -43.53 14.0 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.633 -179.354 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.868 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.3 m -55.28 -36.72 41.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.428 -179.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.822 ' HA ' HG11 ' A' ' 80' ' ' VAL . 3.5 pt20 -56.27 -53.27 59.24 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.696 0.284 . . . . 0.0 110.541 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.526 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.4 OUTLIER -73.62 -26.95 61.03 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.965 0.412 . . . . 0.0 110.866 179.055 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.578 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.0 tpp180 -78.41 -34.02 48.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.784 -178.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.506 ' CD2' HD23 ' A' ' 39' ' ' LEU . 1.3 tm? -53.52 -57.47 10.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.03 -179.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -9.41 58.35 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.253 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.578 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -58.46 -23.77 58.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.938 0.399 . . . . 0.0 111.32 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.51 -17.38 1.13 Allowed Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.374 -179.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.0 pt-20 -78.46 157.64 28.88 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.876 0.369 . . . . 0.0 110.861 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 28.3 ttmt -100.75 140.41 35.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.107 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.882 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 5.4 p90 -49.53 -31.66 10.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.949 179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -63.47 -33.98 88.71 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.837 -0.697 . . . . 0.0 112.376 179.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 4.9 mmmt -67.94 -53.89 22.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.697 0.284 . . . . 0.0 110.999 -179.793 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.038 HD12 HD11 ' A' ' 43' ' ' LEU . 2.8 mm? -53.86 -33.86 57.62 Favored 'General case' 0 C--N 1.333 -0.12 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.68 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.559 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.79 -52.5 48.5 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.109 0.48 . . . . 0.0 110.543 -179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.9 pttp -86.51 -23.34 25.94 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.341 179.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.849 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -71.7 -69.05 0.41 Allowed 'General case' 0 CA--C 1.533 0.32 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -177.116 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.038 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.68 -12.44 9.26 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -179.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.769 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -63.85 137.68 58.14 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.895 0.379 . . . . 0.0 111.151 -179.282 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.673 HG13 ' HB3' ' A' ' 16' ' ' LEU . 0.7 OUTLIER -106.55 -3.25 9.97 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.965 179.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.796 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 24.8 p-10 -46.41 135.66 8.04 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.021 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.691 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.08 -178.46 3.34 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.046 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.75 -42.9 0.0 OUTLIER Glycine 0 N--CA 1.468 0.802 0 N-CA-C 115.395 0.918 . . . . 0.0 115.395 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.691 ' N ' ' O ' ' A' ' 47' ' ' GLY . 20.8 t -51.4 -19.42 1.35 Allowed 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 117.427 0.613 . . . . 0.0 111.736 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.796 ' HB2' ' OD1' ' A' ' 46' ' ' ASP . . . -70.75 -20.43 62.63 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 120.906 0.384 . . . . 0.0 110.925 179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 9.6 mtpt -75.23 -4.73 40.67 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.235 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.12 24.69 11.05 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.399 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 p30 56.17 33.59 22.34 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.159 -179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.455 ' HA2' ' CE1' ' A' ' 14' ' ' HIS . . . 50.84 24.41 8.13 Favored Glycine 0 C--N 1.331 0.288 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.938 179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.53 87.51 7.4 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.018 0.437 . . . . 0.0 110.428 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.702 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 13.9 mt -62.42 -17.12 58.53 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.794 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.445 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 53.6 -171.76 0.71 Allowed Glycine 0 CA--C 1.507 -0.408 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.204 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.717 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 8.5 p90 -59.95 117.02 4.56 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 121.122 0.486 . . . . 0.0 111.619 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.498 ' C ' ' HB2' ' A' ' 9' ' ' LYS . 8.6 p90 -139.37 141.22 37.6 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.429 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.469 ' CA ' ' HB2' ' A' ' 9' ' ' LYS . . . -90.89 -173.78 44.02 Favored Glycine 0 C--N 1.311 -0.816 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.404 -178.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -89.67 100.18 13.03 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.749 0.309 . . . . 0.0 110.362 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.32 36.49 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.732 0 C-N-CA 120.221 -0.99 . . . . 0.0 113.312 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 1.4 tmtt? -151.18 18.44 0.76 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.861 0.331 . . . . 0.0 111.595 -179.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.486 ' HE3' ' CE1' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -151.61 174.12 13.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.697 0.284 . . . . 0.0 111.075 179.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.796 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.1 m -60.74 158.46 2.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.803 179.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.571 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -61.32 -47.84 92.91 Favored Pre-proline 0 C--N 1.328 -0.352 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -179.194 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.627 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 19.8 Cg_endo -64.28 -40.1 26.99 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.024 1.816 . . . . 0.0 112.048 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.796 ' H ' HG23 ' A' ' 65' ' ' VAL . 26.1 t80 -74.95 -51.19 14.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.799 -179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.41 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 3.2 tm-20 -57.42 -32.47 66.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.749 179.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 23.7 t70 -66.08 -49.39 67.77 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.969 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.458 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -74.87 -9.49 58.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.816 -179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.408 ' HB1' ' HE1' ' A' ' 59' ' ' PHE . . . -66.31 -47.39 73.73 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.753 0.311 . . . . 0.0 111.556 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 8.6 p90 -92.93 16.69 12.03 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.499 -179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 -100.4 -27.3 13.53 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.787 0.327 . . . . 0.0 110.933 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.603 HD12 ' O ' ' A' ' 79' ' ' GLU . 1.5 mt -103.53 58.5 0.74 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.454 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -69.22 -18.31 63.88 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.975 178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -66.29 -26.82 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.688 179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.429 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 96.23 58.2 1.1 Allowed Glycine 0 CA--C 1.502 -0.744 0 C-N-CA 120.452 -0.88 . . . . 0.0 111.568 -179.23 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.603 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -139.56 176.5 8.67 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 120.726 0.298 . . . . 0.0 111.055 -178.445 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.822 HG11 ' HA ' ' A' ' 27' ' ' GLN . 24.8 t -87.18 148.56 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.198 179.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.5 m -105.37 157.34 17.4 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.245 0.545 . . . . 0.0 111.335 -178.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.47 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.9 mp0 -50.96 155.81 1.93 Allowed Pre-proline 0 C--O 1.236 0.355 0 CA-C-N 115.427 -0.806 . . . . 0.0 112.066 -179.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HG3' HD23 ' A' ' 24' ' ' LEU . 12.8 Cg_endo -56.26 106.26 0.2 Allowed 'Trans proline' 0 N--CA 1.457 -0.632 0 C-N-CA 122.208 1.939 . . . . 0.0 111.6 179.463 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.627 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 70.9 t -100.9 108.06 22.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.597 -179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.452 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 28.2 tptt -91.65 113.0 25.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.96 -179.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.448 ' HG ' ' CE1' ' A' ' 91' ' ' HIS . 0.9 OUTLIER -110.04 -171.38 1.83 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.321 179.354 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -57.79 -18.4 21.52 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.277 179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . 0.468 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 12.1 m-85 -93.69 -38.9 11.08 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.722 0.296 . . . . 0.0 111.677 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.401 ' HA2' ' NZ ' ' A' ' 85' ' ' LYS . . . 154.58 -166.19 32.22 Favored Glycine 0 CA--C 1.508 -0.384 0 C-N-CA 120.568 -0.825 . . . . 0.0 112.848 -179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.615 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 59.3 m-85 -74.73 98.21 3.41 Favored 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 121.306 0.574 . . . . 0.0 110.161 -179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.884 ' CD2' HD13 ' A' ' 16' ' ' LEU . 79.6 m80 -86.53 169.88 12.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.276 -0.875 . . . . 0.0 112.575 -178.187 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 30.6 t -145.88 147.52 18.27 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.078 -0.965 . . . . 0.0 109.848 179.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.842 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -134.67 123.22 41.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -179.081 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.407 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 3.3 tmtm? -128.14 110.1 12.14 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.843 178.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.562 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -57.39 131.74 50.98 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 121.416 0.627 . . . . 0.0 111.872 -178.031 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.917 HD23 ' HB3' ' A' ' 13' ' ' SER . 0.3 OUTLIER -158.7 116.92 2.94 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.989 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.41 ' HA3' ' HB2' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.407 -1.219 . . . . 0.0 112.52 179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.133 0 N-CA-C 112.554 -0.218 . . . . 0.0 112.554 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.13 149.76 20.84 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.499 2.133 . . . . 0.0 112.383 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.5 ptp -145.48 143.78 30.2 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.922 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 139.71 -27.39 2.59 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.465 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.8 p -88.38 141.44 28.54 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.911 0.386 . . . . 0.0 110.897 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.3 ttt -152.85 179.82 8.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.741 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -121.5 22.04 10.78 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.388 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -56.07 -46.92 78.8 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.274 0.559 . . . . 0.0 110.462 179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.676 ' HD3' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -85.53 178.0 7.56 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.371 -0.831 . . . . 0.0 110.748 179.711 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.692 HD11 ' HB3' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -109.95 137.14 43.53 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.821 0 CA-C-O 121.635 0.731 . . . . 0.0 111.161 -178.537 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.577 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -110.4 89.22 2.97 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 114.612 -1.176 . . . . 0.0 109.286 179.729 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.753 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 35.8 m -120.87 179.91 4.21 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.193 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.54 ' CB ' HD23 ' A' ' 96' ' ' LEU . 0.0 OUTLIER -119.52 163.39 17.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.0 -0.546 . . . . 0.0 109.949 -179.909 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.462 ' C ' HD12 ' A' ' 15' ' ' ILE . 0.0 OUTLIER -134.45 147.73 50.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.229 0.538 . . . . 0.0 112.249 -179.668 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.546 HG23 ' OG ' ' A' ' 44' ' ' SER . 3.6 mp -145.41 115.3 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.276 -0.875 . . . . 0.0 109.942 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.643 HD11 ' NE2' ' A' ' 91' ' ' HIS . 0.8 OUTLIER -99.41 129.14 45.58 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -179.076 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.796 HG21 ' CG ' ' A' ' 22' ' ' GLU . 20.2 m -143.25 133.73 22.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.597 178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HE2' HD13 ' A' ' 45' ' ' ILE . 4.7 mttm -71.18 -36.0 71.79 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.615 -0.434 . . . . 0.0 110.849 -179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.584 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -71.44 78.19 0.77 Allowed 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 178.675 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.467 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 1.1 tm0? -46.72 -25.78 0.8 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 114.802 -1.09 . . . . 0.0 112.935 -177.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.85 -31.37 78.04 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 119.069 -1.538 . . . . 0.0 110.72 179.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.896 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -71.46 -39.64 70.84 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.195 0.522 . . . . 0.0 109.726 178.177 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.69 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -52.9 -36.5 59.5 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.796 179.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.758 HD13 ' O ' ' A' ' 24' ' ' LEU . 0.6 OUTLIER -73.64 -29.3 62.26 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.981 178.934 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -87.03 -42.06 13.38 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.888 -178.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.896 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.4 m -54.92 -33.83 29.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.315 -179.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.704 ' HA ' HG11 ' A' ' 80' ' ' VAL . 3.3 pt20 -51.31 -55.33 18.92 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.675 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.457 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.8 OUTLIER -73.16 -31.29 64.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.14 0.495 . . . . 0.0 110.479 178.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.553 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 10.0 tpt180 -68.38 -37.99 80.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.569 -0.742 . . . . 0.0 111.725 -179.202 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.848 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -52.95 -58.97 5.17 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.345 -179.293 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.409 ' HD3' ' HA ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -72.12 -9.52 58.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.396 179.803 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -58.42 -21.92 52.42 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.879 0.371 . . . . 0.0 111.341 -179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.35 -18.49 1.17 Allowed Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.293 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.435 ' HG3' HD21 ' A' ' 39' ' ' LEU . 23.2 pt-20 -80.48 157.56 26.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.914 0.388 . . . . 0.0 110.824 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.3 tttm -97.35 138.59 34.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.029 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.848 ' HA ' HD21 ' A' ' 30' ' ' LEU . 1.9 p90 -49.23 -35.39 17.29 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.964 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.4 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -64.6 -34.09 88.98 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.542 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.479 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.6 OUTLIER -63.38 -53.85 46.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.626 0.25 . . . . 0.0 111.192 -179.709 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.961 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.17 -34.34 56.47 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.044 -179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.553 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.45 -53.61 35.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.017 0.436 . . . . 0.0 110.524 -179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 10.2 ptmt -85.97 -23.63 26.83 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.179 179.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.85 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.37 -68.65 0.41 Allowed 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -177.776 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.961 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.5 -14.0 9.17 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 -179.647 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.553 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -64.18 137.87 58.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.168 0.509 . . . . 0.0 111.549 -179.158 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.575 HD13 ' HE2' ' A' ' 18' ' ' LYS . 1.4 pt -102.76 -8.29 9.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.028 179.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.485 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 12.9 t70 -46.17 135.3 7.85 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.992 179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.66 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -61.83 -178.54 3.13 Favored Glycine 0 C--O 1.225 -0.41 0 C-N-CA 121.085 -0.578 . . . . 0.0 112.303 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.577 ' O ' ' HB2' ' A' ' 51' ' ' LYS . . . -11.32 -44.91 0.0 OUTLIER Glycine 0 N--CA 1.467 0.712 0 N-CA-C 115.399 0.92 . . . . 0.0 115.399 -178.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.66 ' N ' ' O ' ' A' ' 47' ' ' GLY . 32.5 m -51.63 -28.47 14.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 117.673 0.736 . . . . 0.0 111.248 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 46' ' ' ASP . . . -72.28 -24.46 61.35 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-O 121.256 0.55 . . . . 0.0 110.624 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.577 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.3 OUTLIER -70.64 -12.06 61.32 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.659 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 0.1 OUTLIER -103.46 24.03 11.66 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.582 -179.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.44 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 72.68 10.25 5.58 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.554 179.926 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 64.29 22.01 66.9 Favored Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.495 -0.859 . . . . 0.0 112.205 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -75.4 89.07 2.62 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.106 0.479 . . . . 0.0 110.622 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.753 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 12.1 mt -63.41 -15.03 56.39 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.775 179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.416 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 48.22 -171.17 0.06 OUTLIER Glycine 0 CA--C 1.507 -0.468 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.339 -179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.676 ' HB2' ' HD3' ' A' ' 9' ' ' LYS . 16.8 p90 -56.51 122.62 12.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.211 0.529 . . . . 0.0 111.872 -179.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.66 ' HE1' ' HB1' ' A' ' 72' ' ' ALA . 7.3 p90 -146.09 140.88 27.05 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 115.419 -0.809 . . . . 0.0 109.48 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -106.2 -173.9 23.41 Favored Glycine 0 C--N 1.315 -0.632 0 C-N-CA 120.593 -0.813 . . . . 0.0 112.982 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 88.54 1.1 Allowed 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 121.033 0.444 . . . . 0.0 110.129 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.53 36.88 0.05 OUTLIER Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.934 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.63 -41.67 0.61 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.596 0.236 . . . . 0.0 111.462 -179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.435 ' HE2' ' HB2' ' A' ' 64' ' ' MET . 1.9 mpp? -105.73 174.0 6.07 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.032 0.444 . . . . 0.0 111.468 -179.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.777 HG23 ' H ' ' A' ' 68' ' ' PHE . 34.4 m -56.81 161.39 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.069 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.553 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -60.36 -48.03 94.95 Favored Pre-proline 0 C--N 1.329 -0.29 0 N-CA-C 112.692 0.627 . . . . 0.0 112.692 -179.084 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.611 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 15.5 Cg_endo -64.85 -42.01 16.25 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 121.911 1.741 . . . . 0.0 111.731 -179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.777 ' H ' HG23 ' A' ' 65' ' ' VAL . 15.2 t80 -72.65 -51.51 19.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.472 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.424 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.7 tt0 -56.34 -32.29 64.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.064 -0.517 . . . . 0.0 110.614 179.743 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.462 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 35.2 t70 -65.97 -51.6 56.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.707 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.405 ' HB3' HD11 ' A' ' 93' ' ' ILE . . . -75.12 -12.12 60.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.429 179.922 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.66 ' HB1' ' HE1' ' A' ' 59' ' ' PHE . . . -61.83 -49.21 77.2 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-O 120.886 0.374 . . . . 0.0 111.265 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.692 ' HB3' HD11 ' A' ' 10' ' ' ILE . 2.8 p90 -93.96 16.58 14.05 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.239 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 5.5 ttt180 -98.27 -26.39 14.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.375 . . . . 0.0 110.705 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.572 HD12 ' O ' ' A' ' 79' ' ' GLU . 2.0 mt -103.46 53.08 0.76 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.145 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 30.5 mt-30 -59.72 -22.02 61.47 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.165 179.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 p -61.92 -26.77 40.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.533 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.43 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 94.17 55.62 1.46 Allowed Glycine 0 CA--C 1.503 -0.717 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.741 -179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.572 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -137.44 176.53 8.62 Favored 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 120.692 0.282 . . . . 0.0 111.01 -178.758 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.704 HG11 ' HA ' ' A' ' 27' ' ' GLN . 59.5 t -86.43 147.43 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.536 0 C-N-CA 120.763 -0.375 . . . . 0.0 110.533 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -105.47 160.48 15.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.202 0.525 . . . . 0.0 111.409 -178.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.47 ' O ' HG23 ' A' ' 84' ' ' VAL . 21.0 mp0 -50.89 155.49 2.0 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 115.381 -0.827 . . . . 0.0 112.159 -179.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.408 ' HG3' HD23 ' A' ' 24' ' ' LEU . 14.6 Cg_endo -56.93 105.96 0.2 Allowed 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.228 1.952 . . . . 0.0 111.772 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.611 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 85.0 t -100.93 106.8 20.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.115 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.467 ' CG ' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -91.52 112.89 25.0 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.494 -179.279 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.445 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 0.5 OUTLIER -105.19 -171.65 1.95 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.051 179.246 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.72 -14.94 36.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.61 -0.268 . . . . 0.0 111.202 179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -96.47 -36.36 10.82 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.612 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 158.19 -166.53 34.16 Favored Glycine 0 CA--C 1.508 -0.403 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.86 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.742 ' HB2' ' O ' ' A' ' 17' ' ' VAL . 91.7 m-85 -80.73 98.07 7.58 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.237 0.542 . . . . 0.0 109.941 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.643 ' NE2' HD11 ' A' ' 16' ' ' LEU . 50.9 m80 -82.95 169.73 15.7 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.283 -0.871 . . . . 0.0 112.812 -178.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.447 ' CG1' HG13 ' A' ' 80' ' ' VAL . 19.4 t -149.52 145.6 17.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 114.775 -1.102 . . . . 0.0 109.445 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.622 HG23 ' CE1' ' A' ' 68' ' ' PHE . 0.5 OUTLIER -123.3 122.28 64.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 N-CA-C 112.172 0.434 . . . . 0.0 112.172 -179.005 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 13' ' ' SER . 2.4 tptm -128.72 108.98 10.92 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.406 178.847 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 2.0 ttp85 -57.26 132.8 54.1 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.562 0.696 . . . . 0.0 112.346 -178.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.844 HD22 ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -163.17 116.71 1.6 Allowed 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 114.67 -1.15 . . . . 0.0 109.782 179.747 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.417 -1.213 . . . . 0.0 112.67 179.754 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 112.497 -0.241 . . . . 0.0 112.497 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -69.05 156.6 64.71 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.521 2.147 . . . . 0.0 112.347 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.1 mtt -144.67 118.47 9.28 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.954 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.25 58.61 0.96 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.53 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 23.7 m -88.35 135.86 33.26 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.717 0.294 . . . . 0.0 111.01 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 58.3 mtt -116.1 -177.64 3.22 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.827 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -137.82 28.12 2.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.454 -179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.465 ' C ' ' HE3' ' A' ' 9' ' ' LYS . 0.9 OUTLIER -57.07 -23.38 46.28 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.98 0.419 . . . . 0.0 110.671 179.682 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.487 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.07 166.2 17.89 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.357 -179.484 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.582 HG22 ' SG ' ' A' ' 12' ' ' CYS . 1.4 mt -110.74 136.04 48.0 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.904 0 CA-C-N 115.408 -0.814 . . . . 0.0 109.105 178.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.515 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.0 mtpt -107.73 88.4 2.72 Favored 'General case' 0 C--N 1.306 -1.315 0 CA-C-N 115.478 -0.783 . . . . 0.0 109.668 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.818 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 8.6 m -131.41 -179.82 5.59 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.735 -179.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.683 ' HB2' HD23 ' A' ' 96' ' ' LEU . 45.2 t -121.1 163.44 18.38 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.226 -179.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.67 ' C ' HD12 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -130.68 150.78 51.71 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 121.172 0.511 . . . . 0.0 111.857 -179.62 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.67 HD12 ' C ' ' A' ' 14' ' ' HIS . 4.1 mp -154.27 130.15 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.527 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.6 HD13 ' HB3' ' A' ' 46' ' ' ASP . 0.5 OUTLIER -123.2 138.04 54.74 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-O 120.868 0.366 . . . . 0.0 111.858 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 1.014 HG21 ' CG ' ' A' ' 22' ' ' GLU . 24.2 m -151.02 135.84 9.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.516 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -64.91 -19.5 65.96 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.532 ' HB3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.39 76.4 1.03 Allowed 'General case' 0 N--CA 1.444 -0.762 0 CA-C-N 115.516 -0.765 . . . . 0.0 109.796 178.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.456 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 2.6 pt20 -47.79 -33.14 6.81 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -178.507 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -73.32 -31.17 61.55 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 119.915 -1.136 . . . . 0.0 112.599 -179.654 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 1.014 ' CG ' HG21 ' A' ' 17' ' ' VAL . 0.2 OUTLIER -68.16 -42.68 79.7 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.451 0.643 . . . . 0.0 109.92 179.359 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.669 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -49.64 -36.81 25.87 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.064 -0.971 . . . . 0.0 110.526 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.706 HD13 ' O ' ' A' ' 24' ' ' LEU . 0.9 OUTLIER -72.71 -33.83 66.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.812 179.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.11 -44.15 22.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.514 -179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.807 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.8 m -47.96 -36.34 5.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.488 -0.324 . . . . 0.0 111.394 -179.79 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.718 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -58.01 -49.26 77.45 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.522 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.718 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 4.0 pt-20 -73.89 -30.37 62.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.838 178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.538 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 10.4 tpp85 -78.83 -33.12 46.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.476 -0.784 . . . . 0.0 112.83 -178.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.571 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.8 OUTLIER -52.53 -51.93 57.17 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.688 0.28 . . . . 0.0 111.424 -178.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.401 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -71.99 -9.29 58.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.186 179.586 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.538 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -72.72 47.2 0.17 Allowed 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 112.947 0.721 . . . . 0.0 112.947 -179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.32 -10.66 41.73 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.737 -0.744 . . . . 0.0 114.153 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.413 ' HG2' ' O ' ' A' ' 29' ' ' ARG . 6.6 pt-20 -91.97 153.98 19.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 117.437 0.618 . . . . 0.0 110.78 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 3.2 ttmm -104.22 139.22 39.55 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.419 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 1.023 ' CE1' HD22 ' A' ' 96' ' ' LEU . 2.2 p90 -47.18 -31.75 3.85 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.841 179.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.456 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.11 -34.17 88.15 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.372 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.533 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.8 ttpm? -68.1 -51.99 40.08 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.654 0.264 . . . . 0.0 111.112 -179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.846 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.13 -36.01 60.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.412 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.783 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -51.93 -53.2 43.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.167 0.508 . . . . 0.0 110.634 -179.672 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -85.64 -23.6 27.44 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.791 179.098 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.973 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -72.06 -67.52 0.53 Allowed 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -178.133 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.973 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.36 -14.62 9.75 Favored 'General case' 0 N--CA 1.467 0.405 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -178.875 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.559 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 1.4 t -63.42 126.8 28.66 Favored 'General case' 0 C--N 1.332 -0.194 0 C-N-CA 120.043 -0.663 . . . . 0.0 110.227 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.522 HG12 ' HA ' ' A' ' 17' ' ' VAL . 0.9 OUTLIER -107.3 -26.7 3.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 113.209 0.818 . . . . 0.0 113.209 -178.744 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.6 ' HB3' HD13 ' A' ' 16' ' ' LEU . 12.6 t70 -127.44 103.0 7.12 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 112.841 0.682 . . . . 0.0 112.841 -178.125 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.82 143.45 4.82 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.58 177.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.96 -33.83 28.7 Favored Glycine 0 N--CA 1.449 -0.487 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.037 178.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.492 ' O ' ' N ' ' A' ' 54' ' ' GLY . 3.9 m -76.81 -1.83 30.18 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.324 -0.438 . . . . 0.0 111.249 179.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.783 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . . . -62.13 -22.79 66.12 Favored 'General case' 0 CA--C 1.52 -0.188 0 CA-C-O 121.307 0.575 . . . . 0.0 109.624 179.069 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 5.2 mttt -88.9 -5.44 58.0 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.184 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.466 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 1.7 mmt85 -122.36 24.55 9.3 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 115.497 -0.774 . . . . 0.0 110.9 -179.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.466 ' OD1' ' O ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER 74.51 26.96 1.43 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.344 0.592 . . . . 0.0 111.085 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 55.56 20.31 23.31 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.921 -0.657 . . . . 0.0 112.789 179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.45 84.66 1.99 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.027 0.442 . . . . 0.0 110.752 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.818 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 12.8 mt -58.92 -21.73 58.39 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.788 179.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.43 ' O ' ' O ' ' A' ' 10' ' ' ILE . . . 55.93 -163.85 5.05 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.413 179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.515 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.1 OUTLIER -64.23 119.48 10.32 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.028 0.442 . . . . 0.0 111.835 -179.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.546 ' HE1' ' HB1' ' A' ' 72' ' ' ALA . 19.1 p90 -141.27 139.34 33.67 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.571 177.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.419 ' CA ' ' HE2' ' A' ' 9' ' ' LYS . . . -98.35 -173.95 32.67 Favored Glycine 0 C--N 1.318 -0.463 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.504 -179.35 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 10.9 ptm180 -82.8 98.27 9.04 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.199 0.524 . . . . 0.0 109.955 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.45 36.48 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.914 0 C-N-CA 120.534 -0.841 . . . . 0.0 112.636 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.7 tptm -140.25 -46.87 0.43 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.837 0.351 . . . . 0.0 110.952 -179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.431 ' CE ' ' CE1' ' A' ' 59' ' ' PHE . 1.4 mpp? -91.92 170.04 10.19 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.963 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.77 HG23 ' H ' ' A' ' 68' ' ' PHE . 34.8 m -59.58 162.34 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.018 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.498 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.63 -48.18 97.37 Favored Pre-proline 0 C--N 1.329 -0.324 0 N-CA-C 112.55 0.574 . . . . 0.0 112.55 -179.068 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.573 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 10.0 Cg_endo -66.02 -38.37 22.6 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 121.858 1.706 . . . . 0.0 112.171 -179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.77 ' H ' HG23 ' A' ' 65' ' ' VAL . 8.8 t80 -74.97 -50.01 18.09 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.746 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -57.04 -32.49 66.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.651 179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -64.61 -50.65 66.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.849 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.85 -9.57 58.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.524 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.546 ' HB1' ' HE1' ' A' ' 59' ' ' PHE . . . -68.15 -50.45 54.45 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.782 0.325 . . . . 0.0 111.301 -179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 6.4 p90 -93.28 16.56 12.93 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.343 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.48 -25.19 14.28 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.82 0.343 . . . . 0.0 110.863 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 79' ' ' GLU . 1.6 mt -103.53 55.15 0.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.219 -179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -63.49 -19.55 64.84 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.098 178.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -63.66 -26.72 41.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.403 179.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.503 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.13 55.58 1.37 Allowed Glycine 0 CA--C 1.503 -0.674 0 C-N-CA 120.689 -0.767 . . . . 0.0 111.629 -179.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.558 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.9 OUTLIER -137.63 176.17 8.94 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 120.858 0.361 . . . . 0.0 111.221 -178.388 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.63 HG11 ' HA ' ' A' ' 27' ' ' GLN . 60.2 t -83.16 149.09 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.572 0 CA-C-N 116.145 -0.48 . . . . 0.0 109.903 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.0 t -104.4 154.8 19.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.448 0.642 . . . . 0.0 111.764 -178.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -50.8 163.5 0.48 Allowed Pre-proline 0 C--O 1.235 0.307 0 CA-C-N 115.096 -0.957 . . . . 0.0 112.573 -178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.563 ' HG3' HD23 ' A' ' 24' ' ' LEU . 17.8 Cg_endo -59.15 104.56 0.21 Allowed 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 122.604 2.203 . . . . 0.0 112.226 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.573 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 93.7 t -101.43 101.54 12.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.373 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -91.69 113.01 25.16 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.916 -0.583 . . . . 0.0 110.851 -179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 15.3 m -108.71 -171.53 1.87 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.6 179.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -57.7 -20.28 33.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.33 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 -91.34 -40.49 11.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.424 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.5 ' C ' HD21 ' A' ' 16' ' ' LEU . . . 157.33 -164.51 32.97 Favored Glycine 0 CA--C 1.508 -0.354 0 C-N-CA 120.513 -0.851 . . . . 0.0 113.073 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.484 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 0.7 OUTLIER -74.59 98.39 3.37 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.052 0.453 . . . . 0.0 110.39 -179.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.473 ' NE2' HD12 ' A' ' 16' ' ' LEU . 31.0 m80 -81.71 169.95 16.35 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 115.797 -0.638 . . . . 0.0 112.236 -178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 35.5 t -149.29 150.6 13.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 115.158 -0.928 . . . . 0.0 110.01 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.492 HG23 ' CE1' ' A' ' 68' ' ' PHE . 0.3 OUTLIER -138.1 124.14 25.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 111.894 0.331 . . . . 0.0 111.894 -179.319 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.432 ' O ' ' N ' ' A' ' 13' ' ' SER . 15.8 tptp -128.45 109.29 11.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.594 179.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.503 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.5 OUTLIER -57.7 136.61 56.88 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.601 0.715 . . . . 0.0 112.206 -179.289 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 1.023 HD22 ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -161.27 116.52 2.1 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-N 114.675 -1.148 . . . . 0.0 109.718 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.093 0 CA-C-O 118.28 -1.289 . . . . 0.0 112.659 179.76 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.178 0 N-CA-C 112.439 -0.264 . . . . 0.0 112.439 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.18 90.02 0.03 OUTLIER 'Trans proline' 0 C--N 1.345 0.355 0 C-N-CA 122.544 2.163 . . . . 0.0 112.292 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 4.8 mmt -98.48 136.57 38.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.823 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 97.57 -56.04 1.2 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.464 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 40.3 t -88.33 123.37 32.84 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.86 0.362 . . . . 0.0 110.839 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -132.94 111.39 11.0 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.872 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -126.12 25.62 6.67 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.345 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -54.45 -35.61 63.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.113 0.482 . . . . 0.0 110.371 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.76 ' HD3' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -105.71 178.56 4.53 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.485 -0.78 . . . . 0.0 110.727 179.595 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 58' ' ' TYR . 1.5 mm -109.3 149.64 12.37 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.044 0 CA-C-O 121.765 0.793 . . . . 0.0 111.276 -178.185 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.666 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -125.34 76.3 1.54 Allowed 'General case' 0 C--N 1.309 -1.154 0 CA-C-N 114.208 -1.36 . . . . 0.0 110.102 -179.546 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.886 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 10.3 m -117.63 -179.68 3.81 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.258 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.828 ' HB2' HD23 ' A' ' 96' ' ' LEU . 22.6 t -115.66 163.49 15.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.651 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.692 ' C ' HD12 ' A' ' 15' ' ' ILE . 0.7 OUTLIER -132.44 153.03 51.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.54 0.686 . . . . 0.0 112.483 -179.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.75 HG23 ' OG ' ' A' ' 44' ' ' SER . 2.8 mp -155.85 123.18 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.899 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.759 ' HG ' HD11 ' A' ' 45' ' ' ILE . 12.8 tp -111.61 131.17 55.45 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.992 0.368 . . . . 0.0 111.992 -178.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.825 HG11 ' OE1' ' A' ' 22' ' ' GLU . 17.3 m -143.65 134.71 22.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.67 178.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.531 ' HD3' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -72.41 -35.77 68.46 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.513 -179.227 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.623 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 3.3 tttp -74.31 79.33 1.84 Allowed 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.489 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -46.28 -25.85 0.7 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.153 -0.931 . . . . 0.0 113.254 -176.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.15 -31.24 77.05 Favored Glycine 0 N--CA 1.447 -0.595 0 C-N-CA 119.123 -1.513 . . . . 0.0 110.9 179.436 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.849 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -70.88 -38.23 73.08 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.009 0.433 . . . . 0.0 110.354 178.798 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.602 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.83 -37.68 44.45 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.088 179.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.707 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.3 OUTLIER -73.44 -29.53 62.62 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.773 179.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.24 -42.8 15.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.47 -179.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.849 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.9 m -55.89 -39.24 55.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.203 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.61 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.2 pt20 -56.12 -51.49 67.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.886 0.374 . . . . 0.0 110.26 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.547 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 2.8 pt-20 -73.19 -29.62 62.95 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.09 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.572 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.83 -29.75 44.9 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.656 -178.771 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.639 HD21 ' HA ' ' A' ' 36' ' ' PHE . 1.0 OUTLIER -55.27 -55.33 32.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.944 0.402 . . . . 0.0 110.827 -179.703 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.91 -9.55 58.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.202 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.572 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.2 -24.02 62.77 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.913 0.387 . . . . 0.0 111.232 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.1 -18.53 0.94 Allowed Glycine 0 N--CA 1.444 -0.794 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.307 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -80.72 157.52 25.84 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.905 0.383 . . . . 0.0 110.807 179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.4 138.47 39.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.048 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.865 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 2.4 p90 -47.09 -29.86 2.44 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.996 179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.424 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -64.45 -35.8 92.39 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.429 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.4 OUTLIER -66.19 -53.3 39.06 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.737 0.303 . . . . 0.0 110.869 179.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.003 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.62 -32.55 51.72 Favored 'General case' 0 C--N 1.332 -0.159 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.484 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.556 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.7 -53.27 41.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.617 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 3.6 ptpp? -86.33 -23.32 26.29 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.245 179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.849 ' HB3' HD13 ' A' ' 43' ' ' LEU . 2.6 mm-40 -70.68 -69.22 0.38 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.541 0.941 . . . . 0.0 113.541 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.003 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.61 -13.44 9.17 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.335 0.494 . . . . 0.0 112.335 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.75 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -63.96 136.91 57.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.95 0.405 . . . . 0.0 111.2 -179.231 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.759 HD11 ' HG ' ' A' ' 16' ' ' LEU . 27.9 pt -101.55 -6.71 9.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.803 179.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.807 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 31.0 p-10 -46.04 135.21 7.66 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.24 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.67 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.39 -178.48 3.64 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.617 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.424 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.77 -43.05 0.0 OUTLIER Glycine 0 C--N 1.34 0.8 0 N-CA-C 115.493 0.957 . . . . 0.0 115.493 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.67 ' N ' ' O ' ' A' ' 47' ' ' GLY . 30.5 t -51.44 -17.6 0.82 Allowed 'General case' 0 CA--C 1.534 0.363 0 CA-C-N 117.463 0.631 . . . . 0.0 111.824 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.807 ' HB2' ' OD1' ' A' ' 46' ' ' ASP . . . -71.43 -21.14 62.02 Favored 'General case' 0 CA--C 1.521 -0.154 0 CA-C-O 121.179 0.514 . . . . 0.0 110.481 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.421 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 8.2 mmtt -73.8 -10.58 59.82 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.645 179.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.95 24.81 10.75 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.234 -0.894 . . . . 0.0 110.522 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.424 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 0.6 OUTLIER 60.06 27.81 17.29 Favored 'General case' 0 CA--C 1.529 0.146 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.227 -179.769 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 57.36 20.08 35.53 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.833 -0.698 . . . . 0.0 112.759 179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 99.2 p -76.24 87.73 3.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.944 0.402 . . . . 0.0 110.234 179.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.886 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 14.4 mt -63.67 -16.48 61.12 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.548 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.482 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 46.55 -169.34 0.04 OUTLIER Glycine 0 CA--C 1.506 -0.522 0 C-N-CA 121.028 -0.605 . . . . 0.0 112.682 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.76 ' HB2' ' HD3' ' A' ' 9' ' ' LYS . 27.5 p90 -66.82 111.48 3.76 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 112.287 0.477 . . . . 0.0 112.287 -179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.539 ' C ' ' HB2' ' A' ' 9' ' ' LYS . 13.0 m-30 -141.96 148.05 37.98 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 177.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.0 -174.01 19.0 Favored Glycine 0 C--N 1.311 -0.811 0 C-N-CA 120.678 -0.773 . . . . 0.0 112.406 -179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 3.9 ppt_? -75.3 154.74 37.23 Favored 'General case' 0 N--CA 1.448 -0.562 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.2 -37.03 1.17 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.315 -0.945 . . . . 0.0 112.445 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.14 24.77 1.78 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.738 0.304 . . . . 0.0 111.059 -179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 13.8 mtp -112.95 162.44 15.85 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.675 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.799 HG23 ' H ' ' A' ' 68' ' ' PHE . 17.7 m -79.28 147.08 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.986 0.422 . . . . 0.0 110.951 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.584 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.23 -44.21 99.01 Favored Pre-proline 0 CA--C 1.534 0.351 0 N-CA-C 112.861 0.689 . . . . 0.0 112.861 -179.221 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 16.8 Cg_endo -65.3 -42.7 12.6 Favored 'Trans proline' 0 C--N 1.348 0.505 0 C-N-CA 121.808 1.672 . . . . 0.0 112.207 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.799 ' H ' HG23 ' A' ' 65' ' ' VAL . 16.6 t80 -74.88 -49.39 20.55 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.842 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.61 -32.33 70.31 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.825 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.46 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 4.1 m-20 -64.6 -46.85 80.9 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.257 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.875 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -74.82 -18.4 60.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.749 -179.56 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.457 ' O ' HG21 ' A' ' 10' ' ' ILE . . . -54.15 -53.06 58.53 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.727 0.299 . . . . 0.0 111.57 -179.576 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.46 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 1.0 OUTLIER -87.74 16.84 5.24 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.409 -0.36 . . . . 0.0 111.833 -179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 7.6 ttt180 -100.53 -31.58 11.2 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.822 0.344 . . . . 0.0 110.72 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 79' ' ' GLU . 2.8 mt -103.78 69.36 0.96 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.766 -179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.9 mt-30 -78.03 -16.41 58.1 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.088 178.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.9 p -69.07 -26.79 33.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.181 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.94 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.545 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 96.84 60.08 0.99 Allowed Glycine 0 CA--C 1.504 -0.634 0 C-N-CA 120.43 -0.89 . . . . 0.0 111.199 -178.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.571 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -141.89 176.49 8.89 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-O 120.894 0.378 . . . . 0.0 111.025 -178.094 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.559 HG11 ' HA ' ' A' ' 27' ' ' GLN . 48.1 t -85.31 148.49 4.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.879 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 1.4 t -104.5 163.96 12.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.212 0.529 . . . . 0.0 111.342 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.502 ' O ' HG23 ' A' ' 84' ' ' VAL . 14.8 mt-10 -50.59 158.16 1.13 Allowed Pre-proline 0 C--O 1.234 0.238 0 CA-C-N 115.465 -0.789 . . . . 0.0 112.187 -178.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.707 ' HG3' HD23 ' A' ' 24' ' ' LEU . 16.5 Cg_endo -57.15 104.08 0.14 Allowed 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.538 2.159 . . . . 0.0 111.793 179.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.571 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 57.9 t -101.82 105.91 18.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.782 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.464 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 3.0 tmtt? -98.76 112.86 24.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 21.8 m -110.47 -172.47 2.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.475 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -57.76 -20.37 34.53 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.964 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 12.0 m-85 -88.74 -30.89 18.72 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.381 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.428 ' C ' HD11 ' A' ' 16' ' ' LEU . . . 143.62 -169.7 25.91 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.448 -0.882 . . . . 0.0 112.885 -179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.489 ' CD1' ' HB3' ' A' ' 20' ' ' GLN . 0.4 OUTLIER -74.68 98.33 3.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.982 0.42 . . . . 0.0 110.017 179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.671 ' CG ' HD13 ' A' ' 16' ' ' LEU . 6.1 m80 -89.02 169.7 11.29 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.421 0.629 . . . . 0.0 112.294 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.444 ' CG1' HG13 ' A' ' 80' ' ' VAL . 25.0 t -139.86 134.64 37.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.614 179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.875 HD12 ' HB3' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -118.29 121.86 68.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.655 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -128.93 108.06 10.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.312 178.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.545 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.4 OUTLIER -59.07 131.87 52.34 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.398 0.618 . . . . 0.0 111.816 -179.408 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.865 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -160.35 116.02 2.33 Favored 'General case' 0 N--CA 1.442 -0.829 0 CA-C-N 115.135 -0.939 . . . . 0.0 110.001 179.549 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.312 -1.271 . . . . 0.0 112.591 179.731 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.216 0 N-CA-C 112.511 -0.236 . . . . 0.0 112.511 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_exo -52.05 163.85 1.35 Allowed 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.559 2.172 . . . . 0.0 112.319 -179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.61 112.72 7.76 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.848 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.63 39.52 2.03 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.502 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.3 m -68.01 131.09 44.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.87 0.367 . . . . 0.0 110.859 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.67 -22.66 11.49 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.114 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.21 28.26 3.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.218 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.459 ' C ' ' HE3' ' A' ' 9' ' ' LYS . 26.2 t70 -55.94 -23.13 30.13 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.765 179.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -84.08 166.14 17.93 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 121.214 0.53 . . . . 0.0 111.096 -179.605 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -111.27 138.62 38.89 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 CA-C-N 115.468 -0.787 . . . . 0.0 109.008 179.064 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.496 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 0.7 OUTLIER -106.66 98.23 7.92 Favored 'General case' 0 C--N 1.307 -1.254 0 CA-C-N 115.509 -0.769 . . . . 0.0 110.523 -178.614 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.816 ' SG ' HG22 ' A' ' 93' ' ' ILE . 2.8 t -127.25 179.98 5.17 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.929 -178.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.742 ' HB2' HD23 ' A' ' 96' ' ' LEU . 7.5 t -121.23 163.27 18.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.284 -0.416 . . . . 0.0 109.904 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.805 ' HB3' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -131.04 149.55 52.56 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.045 0.45 . . . . 0.0 111.967 -179.717 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.711 HD12 ' C ' ' A' ' 14' ' ' HIS . 3.7 mp -155.94 131.58 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.874 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.944 HD21 ' CD2' ' A' ' 91' ' ' HIS . 4.0 mm? -123.0 138.1 54.78 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-O 120.94 0.4 . . . . 0.0 111.64 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.812 HG21 ' CG ' ' A' ' 22' ' ' GLU . 18.3 m -148.98 134.11 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.654 -0.703 . . . . 0.0 109.93 178.788 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.6 mptm? -69.84 -36.7 75.77 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.822 -0.351 . . . . 0.0 111.188 -179.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.594 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.31 78.37 1.0 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.841 -0.8 . . . . 0.0 108.841 178.464 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.473 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -46.69 -25.79 0.8 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 114.768 -1.105 . . . . 0.0 113.238 -177.448 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.1 -31.48 77.83 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 119.045 -1.55 . . . . 0.0 110.945 179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.901 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.2 OUTLIER -70.13 -39.22 75.56 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.247 0.546 . . . . 0.0 109.969 178.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.664 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -49.24 -39.5 30.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.376 179.562 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.556 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.33 -29.66 62.83 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.16 179.244 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.01 -36.49 23.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.755 -179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.901 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.4 m -57.27 -33.29 43.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.582 -0.281 . . . . 0.0 111.213 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.657 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -59.76 -50.26 74.5 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.745 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.657 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -73.12 -27.26 61.58 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.243 0.544 . . . . 0.0 110.348 178.507 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.567 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.9 tpt180 -77.86 -33.93 51.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.43 -0.804 . . . . 0.0 111.702 -179.185 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.681 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.7 OUTLIER -53.32 -59.4 4.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.245 -179.255 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.422 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -72.41 -9.39 58.46 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.287 179.604 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.567 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -56.78 -22.31 35.08 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.866 0.365 . . . . 0.0 111.416 -179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.01 -16.91 1.05 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.931 -0.652 . . . . 0.0 112.368 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.2 pt-20 -86.47 157.37 19.82 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.791 0.329 . . . . 0.0 110.682 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 2.0 tppp? -99.51 142.38 31.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.091 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.812 ' CE1' HD22 ' A' ' 96' ' ' LEU . 2.9 p90 -47.65 -29.53 3.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.797 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.462 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -66.53 -38.93 93.79 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.563 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.557 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 5.1 ttpp -59.82 -50.98 71.68 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.72 0.295 . . . . 0.0 110.822 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.819 HD12 HD11 ' A' ' 43' ' ' LEU . 3.1 mm? -53.4 -34.85 59.32 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.741 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.678 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -52.09 -52.96 47.99 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.29 0.566 . . . . 0.0 110.665 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.46 -22.74 26.31 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.674 -0.694 . . . . 0.0 111.285 179.082 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.92 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -75.59 -68.4 0.57 Allowed 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 114.008 1.114 . . . . 0.0 114.008 -176.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.92 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.63 -10.72 9.99 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -179.232 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.592 ' HB2' ' O ' ' A' ' 40' ' ' ALA . 0.4 OUTLIER -63.75 125.89 25.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.908 0.385 . . . . 0.0 109.993 179.783 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.476 HG13 ' N ' ' A' ' 46' ' ' ASP . 4.9 pt -107.54 -26.6 3.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 113.599 0.963 . . . . 0.0 113.599 -177.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.476 ' N ' HG13 ' A' ' 45' ' ' ILE . 18.9 t70 -127.89 103.05 7.04 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 113.103 0.779 . . . . 0.0 113.103 -178.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.77 143.31 4.75 Favored Glycine 0 N--CA 1.448 -0.552 0 C-N-CA 120.392 -0.909 . . . . 0.0 113.022 177.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.97 -31.13 32.95 Favored Glycine 0 N--CA 1.448 -0.526 0 N-CA-C 110.769 -0.932 . . . . 0.0 110.769 178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.419 ' O ' ' N ' ' A' ' 54' ' ' GLY . 0.7 OUTLIER -76.73 8.13 3.96 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.188 -0.506 . . . . 0.0 111.093 179.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.678 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . . . -64.54 -24.2 67.52 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 178.304 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 7.4 mmpt? -88.78 -19.69 25.68 Favored 'General case' 0 N--CA 1.445 -0.683 0 CA-C-N 114.635 -1.166 . . . . 0.0 109.913 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.462 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 3.2 mtt180 -104.43 24.68 11.24 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.168 -179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.495 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 0.6 OUTLIER 62.19 40.96 11.13 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 121.259 0.552 . . . . 0.0 111.583 -179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 49' ' ' SER . . . 53.36 30.51 40.83 Favored Glycine 0 N--CA 1.453 -0.203 0 CA-C-N 115.89 -0.595 . . . . 0.0 113.213 178.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.849 ' HA ' HD21 ' A' ' 96' ' ' LEU . 65.4 p -88.74 85.09 6.71 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.729 0.3 . . . . 0.0 110.827 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.806 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 16.4 mt -58.3 -31.67 67.73 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.637 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 70.76 -170.12 47.03 Favored Glycine 0 N--CA 1.45 -0.424 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.453 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.561 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -60.64 118.47 6.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.151 0.501 . . . . 0.0 111.661 -179.384 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.557 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 2.4 m-85 -127.18 164.08 22.44 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 177.443 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -138.76 -174.02 13.25 Favored Glycine 0 C--N 1.319 -0.411 0 C-N-CA 119.981 -1.104 . . . . 0.0 112.672 -179.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -74.3 84.23 1.91 Allowed 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.168 0.508 . . . . 0.0 110.121 -179.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.33 36.78 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.949 0 C-N-CA 120.269 -0.967 . . . . 0.0 113.056 -179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.0 -48.6 0.61 Allowed 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.674 0.273 . . . . 0.0 111.39 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.4 ' HG3' ' HB2' ' A' ' 69' ' ' GLU . 1.9 ptp -108.42 169.51 8.6 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.025 0.441 . . . . 0.0 111.406 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.76 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.6 m -54.72 161.71 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 CA-C-N 115.894 -0.593 . . . . 0.0 111.666 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.57 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -61.65 -48.14 90.74 Favored Pre-proline 0 CA--C 1.533 0.295 0 N-CA-C 112.492 0.552 . . . . 0.0 112.492 -179.337 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 11.8 Cg_endo -63.33 -42.0 24.25 Favored 'Trans proline' 0 C--N 1.348 0.538 0 C-N-CA 121.999 1.799 . . . . 0.0 111.744 -179.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.76 ' H ' HG23 ' A' ' 65' ' ' VAL . 17.9 t80 -73.11 -51.78 16.69 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.662 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.421 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 3.4 tm-20 -59.24 -32.98 70.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.774 179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 6.7 m-20 -61.48 -48.57 80.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.127 -179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.587 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -74.83 -9.57 58.67 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.737 -179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -64.42 -47.72 78.08 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.771 0.32 . . . . 0.0 111.515 -179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.448 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 10.2 p90 -92.7 16.6 11.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.476 -179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.1 ttt85 -99.99 -25.82 14.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.781 0.324 . . . . 0.0 111.205 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.803 HD11 ' CB ' ' A' ' 81' ' ' SER . 11.0 mt -101.25 56.9 0.85 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.389 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 15.7 mt-30 -61.42 -31.7 71.63 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.318 -0.401 . . . . 0.0 109.979 179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -63.15 -26.88 41.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.124 178.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.5 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 89.94 70.21 1.23 Allowed Glycine 0 CA--C 1.499 -0.915 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.951 -179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.797 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -142.29 177.35 8.31 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 115.122 -0.539 . . . . 0.0 109.998 -178.796 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.546 HG11 ' HA ' ' A' ' 27' ' ' GLN . 87.0 t -79.72 150.61 4.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.869 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.803 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -105.04 164.31 11.9 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.608 0.718 . . . . 0.0 111.907 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.624 ' HB2' ' HD2' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -50.5 164.31 0.41 Allowed Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.896 -179.909 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.624 ' HD2' ' HB2' ' A' ' 82' ' ' GLU . 55.5 Cg_endo -68.73 103.44 0.99 Allowed 'Trans proline' 0 N--CA 1.461 -0.388 0 C-N-CA 122.398 2.065 . . . . 0.0 112.123 179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 81.4 t -101.89 104.31 16.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.087 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.455 ' CG ' ' CD1' ' A' ' 90' ' ' TYR . 12.2 tmtt? -99.78 112.67 24.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.584 179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.441 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 74.4 m -112.82 -176.44 2.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.858 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -51.83 -25.95 8.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.178 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -80.81 -39.95 25.8 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.087 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 154.56 -163.45 31.2 Favored Glycine 0 C--N 1.33 0.2 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.701 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.635 ' O ' HD13 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -80.39 100.28 8.37 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 179.632 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.944 ' CD2' HD21 ' A' ' 16' ' ' LEU . 60.5 m80 -85.05 162.24 19.4 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 113.08 0.771 . . . . 0.0 113.08 -177.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.7 t -146.82 125.19 4.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 114.618 -1.174 . . . . 0.0 109.011 178.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.816 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -113.68 124.49 70.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -178.046 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.405 ' HG2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -128.25 112.77 14.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.407 -0.815 . . . . 0.0 109.189 178.521 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.556 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.27 135.92 56.48 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.552 0.691 . . . . 0.0 112.356 -177.746 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.849 HD21 ' HA ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -156.74 116.76 3.54 Favored 'General case' 0 N--CA 1.439 -1.021 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.578 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.981 0 CA-C-O 118.424 -1.209 . . . . 0.0 112.564 179.823 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.192 0 N-CA-C 112.449 -0.26 . . . . 0.0 112.449 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_exo -52.17 110.52 0.46 Allowed 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.649 2.233 . . . . 0.0 112.292 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 3.4 mmt -86.74 129.4 34.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.935 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 117.64 -36.57 3.63 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.512 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.6 m -77.44 123.85 27.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.758 0.314 . . . . 0.0 110.89 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.1 ttt 79.35 -5.02 1.99 Allowed 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.682 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -151.22 28.57 0.66 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.708 0.289 . . . . 0.0 110.96 179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.474 ' C ' ' HE3' ' A' ' 9' ' ' LYS . 21.7 t0 -53.47 -26.15 19.19 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.905 179.869 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.547 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -84.17 161.67 20.49 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 121.089 0.471 . . . . 0.0 111.089 -179.618 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -111.14 129.52 66.26 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.804 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.528 178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.514 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.1 mtpt -95.79 97.74 9.91 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 114.809 -1.087 . . . . 0.0 108.948 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.79 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -126.65 -179.73 4.94 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.618 -0.719 . . . . 0.0 111.839 -177.083 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.864 ' HB3' HD23 ' A' ' 96' ' ' LEU . 5.8 p -124.43 159.81 29.61 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.348 179.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.842 ' HB3' HD11 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -131.92 146.54 52.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.17 0.51 . . . . 0.0 112.302 -179.419 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.73 HD12 ' C ' ' A' ' 14' ' ' HIS . 4.1 mp -149.73 132.78 7.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.673 179.371 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.75 HD21 ' CD2' ' A' ' 91' ' ' HIS . 4.1 mm? -119.54 137.55 53.75 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-O 120.784 0.326 . . . . 0.0 111.598 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.866 HG21 ' CG ' ' A' ' 22' ' ' GLU . 15.7 m -148.54 134.23 11.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.17 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.404 ' HD2' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -71.12 -36.46 72.13 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 121.003 -0.279 . . . . 0.0 111.412 -178.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.665 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.2 OUTLIER -74.42 79.15 1.89 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.878 0.846 . . . . 0.0 108.73 178.499 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.489 ' HB3' ' CE1' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -45.82 -25.28 0.49 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.363 -1.289 . . . . 0.0 113.162 -177.447 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.61 -30.37 76.28 Favored Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.124 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.871 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -72.02 -39.72 68.97 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 178.049 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.724 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -49.84 -35.02 21.58 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.175 -0.92 . . . . 0.0 110.205 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.555 HD13 ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER -73.3 -40.1 64.8 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.613 179.088 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -73.56 -48.78 30.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.787 -0.642 . . . . 0.0 111.589 -179.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.871 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.7 m -46.55 -40.53 4.45 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.228 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.249 -179.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.448 ' HA ' HG11 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -59.01 -45.13 91.46 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 179.536 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.444 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.4 mm-40 -73.69 -33.06 64.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.82 178.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.569 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.1 OUTLIER -78.69 -30.41 46.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.496 -0.774 . . . . 0.0 111.842 -178.539 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.628 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.6 OUTLIER -52.99 -58.95 5.26 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.895 -179.474 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.15 -9.38 58.35 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.383 179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.569 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -58.29 -24.32 59.17 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.927 0.394 . . . . 0.0 111.327 -179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.93 -18.61 0.96 Allowed Glycine 0 N--CA 1.444 -0.829 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.191 -179.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.515 ' CD ' HD21 ' A' ' 39' ' ' LEU . 6.9 pt-20 -82.15 157.59 23.96 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.862 0.363 . . . . 0.0 110.503 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.38 141.75 33.78 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.091 0.472 . . . . 0.0 111.216 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.628 ' HA ' HD21 ' A' ' 30' ' ' LEU . 3.2 p90 -45.8 -31.4 2.04 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.762 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.53 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.58 -41.65 99.78 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.178 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.571 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 2.9 tttt -58.16 -51.97 67.5 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.516 0.198 . . . . 0.0 110.785 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.803 ' CD1' HD11 ' A' ' 43' ' ' LEU . 3.1 mm? -53.36 -35.14 59.95 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.654 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.676 ' HB1' ' HA ' ' A' ' 50' ' ' ALA . . . -51.86 -53.52 39.63 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.215 0.531 . . . . 0.0 110.65 -179.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.0 mtmt -86.42 -23.1 26.21 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.126 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.911 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.4 OUTLIER -75.77 -68.26 0.59 Allowed 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 113.706 1.002 . . . . 0.0 113.706 -177.074 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.911 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.88 -8.3 10.3 Favored 'General case' 0 N--CA 1.466 0.337 0 N-CA-C 112.936 0.717 . . . . 0.0 112.936 -179.011 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.661 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -63.66 125.79 25.44 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.391 -0.524 . . . . 0.0 109.66 179.919 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.469 HG13 ' N ' ' A' ' 46' ' ' ASP . 1.9 pt -107.61 -26.64 3.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 -177.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.469 ' N ' HG13 ' A' ' 45' ' ' ILE . 34.1 t70 -127.7 97.32 4.8 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -177.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.94 142.25 4.33 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.493 -0.861 . . . . 0.0 112.813 177.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.566 ' O ' ' HE2' ' A' ' 51' ' ' LYS . . . -79.61 -43.73 9.99 Favored Glycine 0 N--CA 1.446 -0.635 0 C-N-CA 120.542 -0.837 . . . . 0.0 111.237 178.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.47 ' CA ' ' HG2' ' A' ' 52' ' ' ARG . 50.7 m -63.66 -0.6 1.02 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.429 -0.385 . . . . 0.0 111.634 179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.676 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . . . -49.79 -27.37 4.89 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.78 0.324 . . . . 0.0 111.42 179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.566 ' HE2' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -87.96 -21.38 24.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.355 0.598 . . . . 0.0 111.716 -179.436 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.504 ' N ' ' HD2' ' A' ' 51' ' ' LYS . 1.4 ptp180 -103.59 24.92 10.37 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.193 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.53 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 0.0 OUTLIER 77.34 6.91 2.98 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.703 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.445 ' HA2' ' CB ' ' A' ' 49' ' ' SER . . . 73.07 24.42 75.82 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.425 -0.893 . . . . 0.0 111.877 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.9 ' HA ' HD21 ' A' ' 96' ' ' LEU . 82.0 p -66.73 88.61 0.14 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.872 0.367 . . . . 0.0 111.261 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.842 HD11 ' HB3' ' A' ' 14' ' ' HIS . 16.2 mt -60.36 -27.42 67.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.402 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 66.79 -172.99 27.74 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.252 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.547 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -59.07 119.19 6.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.05 0.453 . . . . 0.0 111.491 -179.504 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.526 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 3.1 m-85 -128.46 163.0 25.86 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 177.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -139.19 -173.88 13.26 Favored Glycine 0 C--N 1.315 -0.592 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.803 -179.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.27 87.47 1.98 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.116 0.484 . . . . 0.0 109.904 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.59 36.69 0.05 OUTLIER Glycine 0 N--CA 1.44 -1.044 0 C-N-CA 120.351 -0.928 . . . . 0.0 112.918 -179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -147.31 -47.04 0.17 Allowed 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.701 0.286 . . . . 0.0 111.083 -179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 15.4 mtm -98.3 168.43 10.23 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.098 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.784 HG23 ' H ' ' A' ' 68' ' ' PHE . 36.0 m -61.22 161.44 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.786 179.688 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.57 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 4.0 mtpt -61.22 -47.98 92.93 Favored Pre-proline 0 C--N 1.327 -0.384 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.57 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 12.9 Cg_endo -64.23 -41.37 21.82 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 121.834 1.689 . . . . 0.0 111.809 -179.531 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.784 ' H ' HG23 ' A' ' 65' ' ' VAL . 30.5 t80 -73.82 -52.35 13.35 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.628 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -57.73 -32.46 67.45 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.755 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.481 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 7.2 m-20 -62.47 -51.15 68.61 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.854 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.02 -9.5 58.59 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.664 -179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.99 -49.19 66.17 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.875 0.369 . . . . 0.0 111.589 -179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.481 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 9.0 p90 -93.32 16.68 12.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.381 -179.657 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -102.14 -27.98 12.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.817 0.341 . . . . 0.0 110.798 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.511 HD11 ' O ' ' A' ' 80' ' ' VAL . 2.5 mt -103.55 54.7 0.75 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.471 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -62.16 -20.13 63.79 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.915 178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -61.01 -26.92 40.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.225 179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.46 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 95.25 55.13 1.39 Allowed Glycine 0 N--CA 1.446 -0.638 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.845 -179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.501 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.6 tm-20 -139.51 176.16 8.96 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 120.746 0.308 . . . . 0.0 111.105 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 93' ' ' ILE . 45.0 t -83.91 148.92 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.27 179.289 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.4 m -104.93 163.91 12.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.26 0.552 . . . . 0.0 111.588 -178.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.499 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.5 mt-10 -50.86 155.0 2.16 Favored Pre-proline 0 C--O 1.235 0.304 0 CA-C-N 115.278 -0.874 . . . . 0.0 112.384 -178.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.467 ' HG3' HD23 ' A' ' 24' ' ' LEU . 11.2 Cg_endo -54.37 104.68 0.12 Allowed 'Trans proline' 0 N--CA 1.461 -0.412 0 C-N-CA 122.659 2.239 . . . . 0.0 112.047 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.567 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 67.4 t -101.47 105.2 17.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.814 179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.46 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 5.1 tptm -94.32 112.99 24.81 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.757 179.767 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.451 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 0.5 OUTLIER -107.9 -175.41 2.78 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.544 179.722 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 3.1 pt-20 -59.06 -20.24 51.48 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.948 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 1.8 m-85 -88.5 -40.8 13.17 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.303 -179.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 162.22 -164.29 35.41 Favored Glycine 0 C--N 1.331 0.305 0 C-N-CA 120.548 -0.834 . . . . 0.0 112.868 -179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.615 ' O ' HD13 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -81.35 98.29 8.1 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.738 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.75 ' CD2' HD21 ' A' ' 16' ' ' LEU . 35.9 m80 -81.22 169.53 17.23 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.833 -177.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.5 t -154.61 123.76 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 114.77 -1.104 . . . . 0.0 109.719 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.519 ' O ' ' HA ' ' A' ' 80' ' ' VAL . 0.2 OUTLIER -105.38 122.69 59.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -178.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.501 ' HG2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -128.32 116.13 19.34 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.495 178.294 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.46 ' CB ' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -58.54 136.04 57.46 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.507 0.67 . . . . 0.0 112.315 -178.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.9 HD21 ' HA ' ' A' ' 55' ' ' SER . 0.3 OUTLIER -160.38 116.76 2.39 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.925 179.418 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.479 -1.178 . . . . 0.0 112.718 179.866 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 112.56 -0.216 . . . . 0.0 112.56 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.86 -178.86 2.58 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.58 2.186 . . . . 0.0 112.237 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 28.3 mtt -69.23 125.87 28.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.845 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 105.08 42.94 1.7 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.509 -179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.0 t -69.76 155.83 39.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.903 0.382 . . . . 0.0 110.876 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.7 ttm -142.48 76.5 1.54 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.888 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -123.19 25.64 8.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.337 179.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 47.7 m-20 -54.83 -49.18 71.68 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 121.176 0.512 . . . . 0.0 110.393 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.587 ' CD ' ' HB2' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -88.26 178.19 6.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.419 179.376 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 58' ' ' TYR . 1.5 mm -109.4 148.94 12.79 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.043 0 CA-C-O 121.714 0.769 . . . . 0.0 111.247 -178.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.658 ' HG2' ' HB3' ' A' ' 58' ' ' TYR . 0.1 OUTLIER -124.75 77.22 1.58 Allowed 'General case' 0 C--N 1.308 -1.196 0 CA-C-N 114.313 -1.312 . . . . 0.0 109.943 -179.61 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.814 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 13.8 m -117.54 -179.91 3.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.171 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.825 ' HB2' HD23 ' A' ' 96' ' ' LEU . 3.5 t -109.38 163.67 13.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.8 -0.636 . . . . 0.0 110.297 -179.617 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.698 ' C ' HD12 ' A' ' 15' ' ' ILE . 12.9 t60 -126.4 142.12 51.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.339 0.59 . . . . 0.0 112.061 -179.192 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.792 HG23 ' OG ' ' A' ' 44' ' ' SER . 3.5 mp -151.27 120.32 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.93 179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.866 HD11 ' CE1' ' A' ' 91' ' ' HIS . 0.4 OUTLIER -113.98 135.89 53.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.206 -178.621 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.828 HG21 ' CG ' ' A' ' 22' ' ' GLU . 15.4 m -151.83 134.11 6.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.682 178.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.401 ' HE3' HG21 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -73.09 -35.0 66.54 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.955 0.407 . . . . 0.0 110.469 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.544 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 13.2 pttm -71.99 80.34 0.92 Allowed 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 178.577 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.46 ' HG3' ' CZ ' ' A' ' 90' ' ' TYR . 5.7 tt0 -45.03 -25.75 0.36 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.217 -0.901 . . . . 0.0 112.376 -177.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.56 -32.13 78.04 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 119.209 -1.472 . . . . 0.0 111.444 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.828 ' CG ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -69.05 -42.57 76.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.354 0.597 . . . . 0.0 109.662 178.326 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.511 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -46.97 -41.42 16.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.055 -0.975 . . . . 0.0 110.219 179.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.728 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -73.76 -28.9 61.91 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.078 179.101 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -79.41 -50.71 10.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.781 -179.143 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.476 ' O ' ' N ' ' A' ' 30' ' ' LEU . 11.3 m -54.25 -38.4 39.41 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.915 -179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.668 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.7 pt20 -53.7 -53.04 57.66 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.699 -0.4 . . . . 0.0 110.655 -179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.478 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.8 tt0 -73.28 -30.25 63.29 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.963 0.411 . . . . 0.0 110.937 179.213 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.481 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -77.47 -28.93 52.48 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.857 -178.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.71 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.8 OUTLIER -57.45 -58.02 10.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.785 -179.584 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.0 -9.22 58.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.562 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.481 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.2 -25.99 64.44 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-O 120.856 0.36 . . . . 0.0 111.375 -179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 155.28 -17.21 0.52 Allowed Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.694 -179.74 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.448 ' CD ' HD21 ' A' ' 39' ' ' LEU . 24.6 pt-20 -88.11 157.59 18.81 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-O 121.054 0.454 . . . . 0.0 110.887 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -98.74 144.04 28.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.64 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.916 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 1.5 p90 -48.15 -34.8 10.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.951 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -59.7 -34.23 81.17 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.399 179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.551 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -66.45 -53.75 31.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.706 0.288 . . . . 0.0 110.734 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.838 ' CD1' HD11 ' A' ' 43' ' ' LEU . 3.2 mm? -53.48 -34.76 59.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.918 -179.684 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.56 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.34 -54.48 25.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.102 0.477 . . . . 0.0 110.893 -179.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -86.15 -22.6 26.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.376 179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.847 ' HB3' HD13 ' A' ' 43' ' ' LEU . 3.4 mm-40 -72.14 -69.28 0.41 Allowed 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -177.039 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.847 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -119.52 -14.09 9.15 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -179.744 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.792 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.4 OUTLIER -63.95 126.72 28.57 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 120.86 0.362 . . . . 0.0 111.088 -179.31 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.437 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.3 pt -95.89 -0.93 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.987 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.829 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 20.7 p-10 -46.35 135.9 7.71 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.017 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.691 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -61.6 -178.08 2.75 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.855 -0.688 . . . . 0.0 112.309 -179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.432 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.53 -42.34 0.0 OUTLIER Glycine 0 N--CA 1.468 0.794 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 -178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.691 ' N ' ' O ' ' A' ' 47' ' ' GLY . 0.4 OUTLIER -51.27 -20.01 1.48 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 117.504 0.652 . . . . 0.0 111.641 179.973 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.829 ' HB2' ' OD1' ' A' ' 46' ' ' ASP . . . -70.96 -20.67 62.42 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.819 0.343 . . . . 0.0 110.933 179.374 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.4 mttt -72.7 -10.75 60.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.148 0.499 . . . . 0.0 110.179 179.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.412 ' O ' ' CG ' ' A' ' 53' ' ' ASP . 0.0 OUTLIER -104.13 24.73 10.98 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.255 179.73 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.412 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 1.1 p30 59.45 28.76 18.21 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.049 -179.331 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.89 20.25 25.47 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.758 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -78.0 92.69 4.36 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.963 0.411 . . . . 0.0 110.328 179.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.814 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 11.9 mt -66.61 -13.9 61.7 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.778 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.544 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 45.0 -164.56 0.06 OUTLIER Glycine 0 CA--C 1.505 -0.535 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.261 -179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.658 ' HB3' ' HG2' ' A' ' 11' ' ' LYS . 25.8 p90 -70.87 111.37 6.23 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-O 121.221 0.534 . . . . 0.0 111.881 -179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.447 ' CE2' ' O ' ' A' ' 56' ' ' LEU . 13.9 m-30 -132.95 148.4 52.28 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 177.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.406 ' CA ' ' HB2' ' A' ' 9' ' ' LYS . . . -108.1 -173.9 21.92 Favored Glycine 0 C--N 1.312 -0.794 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.667 -178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . 0.4 ' NH1' ' HB2' ' A' ' 61' ' ' ARG . 8.4 mtm105 -84.7 122.84 29.66 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.46 -20.34 1.51 Allowed Glycine 0 N--CA 1.441 -0.988 0 C-N-CA 120.083 -1.056 . . . . 0.0 113.119 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.9 tptm -120.58 -22.55 6.35 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -179.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 9.8 mtp -91.12 162.25 14.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.89 0.376 . . . . 0.0 111.055 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.778 HG23 ' H ' ' A' ' 68' ' ' PHE . 21.6 m -67.13 154.45 8.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.93 179.871 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.574 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 14.3 tttt -60.2 -47.07 97.65 Favored Pre-proline 0 C--N 1.329 -0.32 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.645 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 17.8 Cg_endo -65.27 -42.28 13.82 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 121.864 1.71 . . . . 0.0 112.131 -179.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.778 ' H ' HG23 ' A' ' 65' ' ' VAL . 22.8 t80 -74.91 -49.72 19.3 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.572 -0.74 . . . . 0.0 110.646 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -58.01 -31.51 67.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.855 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.45 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 27.5 t70 -67.16 -48.62 67.47 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.194 -179.913 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.543 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.14 -9.63 58.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.931 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.458 ' O ' HG21 ' A' ' 10' ' ' ILE . . . -63.27 -44.71 94.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.726 0.298 . . . . 0.0 111.542 -179.596 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.45 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 18.4 p90 -90.6 16.88 8.23 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.928 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.434 ' CG ' ' HA ' ' A' ' 71' ' ' ALA . 3.2 mmm180 -99.76 -30.67 11.94 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.78 0.324 . . . . 0.0 110.881 -179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.558 HD12 ' O ' ' A' ' 79' ' ' GLU . 2.7 mt -103.6 68.34 0.93 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.598 -179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.8 mt-30 -77.45 -16.84 58.55 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.98 178.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 1.8 p -68.38 -26.87 34.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.807 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.442 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 97.03 60.76 0.96 Allowed Glycine 0 CA--C 1.504 -0.65 0 C-N-CA 120.613 -0.803 . . . . 0.0 111.577 -179.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.558 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -142.02 176.44 8.95 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 120.794 0.331 . . . . 0.0 110.999 -178.359 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.641 HG11 ' HA ' ' A' ' 27' ' ' GLN . 58.2 t -84.9 147.07 5.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.271 -0.422 . . . . 0.0 109.942 179.172 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -104.97 161.3 14.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.266 0.555 . . . . 0.0 111.479 -178.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.402 ' O ' HG23 ' A' ' 84' ' ' VAL . 7.2 mt-10 -50.81 155.87 1.84 Allowed Pre-proline 0 C--O 1.235 0.311 0 CA-C-N 115.34 -0.846 . . . . 0.0 112.263 -179.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.728 ' HG3' HD23 ' A' ' 24' ' ' LEU . 20.3 Cg_endo -59.99 105.74 0.29 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.347 2.031 . . . . 0.0 111.699 179.439 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.645 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 77.2 t -100.97 108.25 22.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.516 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.52 ' HA ' ' HA ' ' A' ' 90' ' ' TYR . 3.7 tmtt? -91.74 113.07 25.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.082 0.467 . . . . 0.0 111.423 -179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -104.22 -171.4 1.92 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.119 179.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.14 -12.88 43.92 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.366 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -99.7 -31.94 11.3 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.668 -0.242 . . . . 0.0 111.603 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.417 ' CA ' HD21 ' A' ' 16' ' ' LEU . . . 156.04 -170.9 33.83 Favored Glycine 0 CA--C 1.509 -0.282 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.542 -179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.52 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 1.2 m-85 -79.62 98.19 6.81 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-O 121.299 0.571 . . . . 0.0 110.303 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.866 ' CE1' HD11 ' A' ' 16' ' ' LEU . 3.2 m80 -80.46 169.94 17.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.078 -0.965 . . . . 0.0 112.318 -178.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.421 ' HB ' ' HB ' ' A' ' 15' ' ' ILE . 12.5 t -145.85 140.69 21.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 CA-C-N 115.174 -0.921 . . . . 0.0 109.818 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.577 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -120.99 122.6 68.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 N-CA-C 112.282 0.475 . . . . 0.0 112.282 -178.958 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.495 ' HG2' HG22 ' A' ' 80' ' ' VAL . 0.2 OUTLIER -128.54 108.69 10.73 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.907 178.606 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -57.68 129.68 42.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.556 0.693 . . . . 0.0 112.166 -178.658 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.916 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -161.4 116.43 2.06 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.751 -1.113 . . . . 0.0 109.77 179.566 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.006 0 CA-C-O 118.456 -1.191 . . . . 0.0 112.64 179.746 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.204 0 N-CA-C 112.53 -0.228 . . . . 0.0 112.53 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -52.49 99.66 0.05 OUTLIER 'Trans proline' 0 C--N 1.344 0.312 0 C-N-CA 122.601 2.2 . . . . 0.0 112.317 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 12.4 ptp -99.6 129.08 45.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 -179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.92 45.47 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.555 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 9.1 p -74.31 164.11 27.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.795 0.331 . . . . 0.0 110.889 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 2.1 mmt -106.82 -74.02 0.67 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.897 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -150.01 31.13 0.7 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.268 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.45 ' C ' ' HE3' ' A' ' 9' ' ' LYS . 1.6 m-20 -54.54 -27.23 37.0 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.607 179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.527 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -84.22 163.68 19.56 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.973 -179.578 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.687 HD12 ' HB1' ' A' ' 72' ' ' ALA . 0.3 OUTLIER -111.18 136.68 46.49 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.616 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.08 178.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.477 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.7 mtpt -105.87 97.44 7.26 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.561 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.917 ' SG ' HG22 ' A' ' 93' ' ' ILE . 3.0 t -126.34 179.34 5.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.814 -178.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.829 ' HB2' HD23 ' A' ' 96' ' ' LEU . 6.4 t -124.06 163.31 21.71 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.641 ' HB3' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -133.16 152.41 51.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.207 0.527 . . . . 0.0 112.023 -179.605 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.802 HG23 ' OG ' ' A' ' 44' ' ' SER . 3.0 mp -151.07 115.4 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.367 -0.833 . . . . 0.0 110.137 179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.8 HD13 ' CD2' ' A' ' 91' ' ' HIS . 7.4 tp -102.15 128.73 48.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.874 -179.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.823 HG11 ' OE1' ' A' ' 22' ' ' GLU . 14.5 m -142.1 134.28 27.15 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.596 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.8 mttt -74.6 -35.93 62.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.463 -179.129 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.638 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 10.7 tttp -72.48 79.32 1.04 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.414 ' HG2' ' CD1' ' A' ' 90' ' ' TYR . 29.5 mt-30 -46.27 -25.94 0.71 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.969 -176.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.41 -31.24 76.38 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 119.216 -1.469 . . . . 0.0 110.953 179.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.823 ' OE1' HG11 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -70.68 -38.54 73.74 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.047 0.451 . . . . 0.0 110.296 178.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.607 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.34 -37.77 38.64 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.107 179.252 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.661 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.19 -29.53 62.89 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.809 179.129 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -84.05 -49.44 8.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.18 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.735 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.6 m -49.32 -37.24 10.41 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.225 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.13 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.729 ' HA ' HG11 ' A' ' 80' ' ' VAL . 2.9 pt20 -59.28 -48.95 79.69 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.398 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.566 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 3.7 pt-20 -73.17 -29.03 62.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.759 178.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.594 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 5.9 tpt180 -78.64 -35.13 45.83 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.965 -178.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.55 HD21 ' HA ' ' A' ' 36' ' ' PHE . 1.1 tm? -53.04 -55.6 22.47 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.271 -179.365 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.77 -9.62 58.57 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.273 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.594 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.09 -22.95 61.62 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.871 0.367 . . . . 0.0 111.159 -179.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 148.08 -17.27 1.37 Allowed Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.309 -179.615 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -80.67 157.59 25.88 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.902 0.382 . . . . 0.0 110.977 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -100.06 144.84 28.62 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.918 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.878 ' CE1' HD22 ' A' ' 96' ' ' LEU . 6.2 p90 -53.65 -33.42 55.15 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.932 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -61.77 -33.96 87.04 Favored Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.462 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.444 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 4.0 tttt -68.35 -52.9 28.14 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.705 0.288 . . . . 0.0 111.165 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.995 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.42 -33.16 52.87 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.834 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.558 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.57 -52.98 42.8 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.122 0.487 . . . . 0.0 110.659 -179.644 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 ptpt -86.3 -23.41 26.31 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.192 179.01 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.886 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -71.2 -68.67 0.42 Allowed 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 113.473 0.916 . . . . 0.0 113.473 -177.412 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.995 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.0 -13.35 9.43 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 -179.495 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.802 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.5 OUTLIER -64.06 142.22 58.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.958 0.409 . . . . 0.0 110.833 -179.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.742 HG13 ' HB3' ' A' ' 16' ' ' LEU . 0.9 OUTLIER -105.5 -6.19 9.89 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.115 -179.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.771 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 29.4 p-10 -46.37 135.51 8.09 Favored 'General case' 0 CA--C 1.529 0.149 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 179.312 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.674 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.33 -178.63 3.65 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.626 -179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.426 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.84 -43.63 0.0 OUTLIER Glycine 0 C--N 1.34 0.762 0 N-CA-C 115.483 0.953 . . . . 0.0 115.483 -179.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.674 ' N ' ' O ' ' A' ' 47' ' ' GLY . 1.1 m -51.53 -18.27 1.06 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 117.301 0.551 . . . . 0.0 111.764 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.771 ' HB2' ' OD1' ' A' ' 46' ' ' ASP . . . -70.79 -20.81 62.55 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 120.979 0.419 . . . . 0.0 110.842 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.26 -6.38 51.2 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.463 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -104.32 24.78 11.02 Favored 'General case' 0 N--CA 1.453 -0.293 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.234 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.1 p30 58.64 28.86 17.74 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.155 -179.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 55.69 22.18 31.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.949 -0.643 . . . . 0.0 112.825 179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.529 ' HA ' HD21 ' A' ' 96' ' ' LEU . 0.7 OUTLIER -69.88 86.94 0.52 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.874 0.369 . . . . 0.0 110.841 179.923 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.698 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 16.4 mt -56.66 -28.97 61.77 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.463 179.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.424 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 67.39 -165.12 43.97 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.932 -0.651 . . . . 0.0 112.739 179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.527 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -67.98 120.95 15.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 121.203 0.525 . . . . 0.0 111.895 -179.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.524 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 11.7 m-30 -133.08 153.72 51.24 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.121 177.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -121.4 -174.0 14.72 Favored Glycine 0 C--N 1.318 -0.465 0 C-N-CA 120.447 -0.882 . . . . 0.0 112.469 -179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.93 85.66 6.18 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.373 . . . . 0.0 110.186 -179.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.33 36.75 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.411 -0.899 . . . . 0.0 113.048 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -140.91 -48.55 0.42 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.806 0.303 . . . . 0.0 111.243 -179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.66 170.18 10.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.853 0.359 . . . . 0.0 111.134 -179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.772 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.5 m -57.48 167.37 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.16 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.776 179.694 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.525 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -64.93 -47.9 73.06 Favored Pre-proline 0 C--N 1.327 -0.378 0 N-CA-C 112.597 0.592 . . . . 0.0 112.597 -178.989 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.539 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 13.0 Cg_endo -66.3 -39.55 17.23 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.873 1.715 . . . . 0.0 112.064 -179.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.772 ' H ' HG23 ' A' ' 65' ' ' VAL . 11.4 t80 -74.99 -50.79 15.42 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.819 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -58.92 -32.8 69.9 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.801 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.458 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 59.4 t0 -67.8 -46.39 72.08 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.002 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.483 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.0 -14.41 60.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.647 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.687 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -56.33 -46.38 79.95 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.741 -179.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.458 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 12.1 p90 -92.05 16.64 10.8 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.528 -179.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -95.49 -27.5 15.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.342 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.783 HD13 ' O ' ' A' ' 79' ' ' GLU . 4.8 mt -102.35 60.43 0.83 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.813 0.34 . . . . 0.0 111.449 -179.703 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -68.08 -25.04 65.14 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.984 0.421 . . . . 0.0 110.009 179.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -70.82 -26.84 28.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.556 179.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.479 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 92.65 69.33 1.13 Allowed Glycine 0 CA--C 1.501 -0.806 0 C-N-CA 120.77 -0.728 . . . . 0.0 111.599 -179.41 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.783 ' O ' HD13 ' A' ' 75' ' ' LEU . 1.4 tm-20 -142.25 177.86 7.96 Favored 'General case' 0 C--N 1.312 -1.054 0 CA-C-N 115.111 -0.544 . . . . 0.0 110.08 -178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.729 HG11 ' HA ' ' A' ' 27' ' ' GLN . 97.8 t -79.58 151.25 4.85 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.778 ' CB ' HD11 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -104.69 157.06 17.44 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.334 0.588 . . . . 0.0 111.528 -178.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.488 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.5 mt-10 -52.36 154.67 4.13 Favored Pre-proline 0 C--N 1.325 -0.474 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.237 -179.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.424 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 14.0 Cg_endo -55.2 103.5 0.1 Allowed 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 122.763 2.309 . . . . 0.0 111.762 179.391 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.539 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 92.9 t -101.8 99.68 8.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.564 179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.449 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -92.06 112.72 24.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.063 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.428 ' HB2' ' CE1' ' A' ' 91' ' ' HIS . 74.1 m -114.48 -175.6 2.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.463 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.0 pm0 -56.07 -21.9 24.61 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.751 0.31 . . . . 0.0 110.874 179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -86.78 -23.67 25.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.311 -179.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 135.97 -170.73 23.05 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.573 -0.822 . . . . 0.0 112.821 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.449 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 0.2 OUTLIER -74.66 98.66 3.48 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.038 0.446 . . . . 0.0 109.905 179.793 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.8 ' CD2' HD13 ' A' ' 16' ' ' LEU . 79.4 m80 -86.38 169.34 13.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.455 -178.257 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 38.6 t -145.21 153.26 14.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.664 179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.917 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -137.27 122.4 25.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -179.062 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.404 ' C ' ' SG ' ' A' ' 12' ' ' CYS . 4.1 tptt -128.63 112.87 14.72 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.528 178.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.2 OUTLIER -57.23 136.5 56.48 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.701 0.762 . . . . 0.0 112.436 -177.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.878 HD22 ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -159.01 116.82 2.83 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-N 114.689 -1.141 . . . . 0.0 109.814 179.742 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.015 0 CA-C-O 118.4 -1.222 . . . . 0.0 112.565 179.871 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.609 -0.196 . . . . 0.0 112.609 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -70.5 92.99 0.58 Allowed 'Trans proline' 0 C--N 1.343 0.272 0 C-N-CA 122.623 2.215 . . . . 0.0 112.408 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.56 112.81 6.15 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.856 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 101.15 44.18 2.08 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.575 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.2 t -72.79 123.44 23.35 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.732 0.301 . . . . 0.0 110.742 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 19.3 mtt -146.2 -43.58 0.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.286 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -92.66 30.73 1.48 Allowed 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.408 -179.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -63.03 -17.96 62.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.883 0.373 . . . . 0.0 110.73 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.63 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.71 172.52 11.45 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-O 121.583 0.706 . . . . 0.0 112.332 -179.172 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.408 HD13 ' HB3' ' A' ' 73' ' ' PHE . 0.6 OUTLIER -111.2 139.89 33.06 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.612 0 CA-C-N 114.768 -1.106 . . . . 0.0 108.978 178.809 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.46 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.5 mtpt -108.88 96.91 6.65 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 115.627 -0.715 . . . . 0.0 110.446 -178.879 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.929 ' SG ' HG22 ' A' ' 93' ' ' ILE . 3.0 t -125.86 179.13 5.34 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.402 -0.817 . . . . 0.0 110.876 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.834 ' OG ' HD23 ' A' ' 96' ' ' LEU . 0.9 OUTLIER -123.49 161.4 24.93 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 179.403 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.866 ' CG ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -136.59 153.4 50.97 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 121.534 0.683 . . . . 0.0 112.664 -179.376 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.749 HG23 ' OG ' ' A' ' 44' ' ' SER . 2.6 mp -152.14 115.14 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.932 -1.031 . . . . 0.0 109.85 179.653 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.603 HD11 ' NE2' ' A' ' 91' ' ' HIS . 0.3 OUTLIER -100.4 128.41 46.48 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.852 -179.129 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.73 HG11 ' OE1' ' A' ' 22' ' ' GLU . 10.9 m -145.14 134.38 17.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.054 178.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 2.9 mttt -76.1 -35.81 59.18 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 111.871 0.323 . . . . 0.0 111.871 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.603 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 0.5 OUTLIER -72.25 79.7 0.99 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 178.911 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.45 ' HG3' ' CE1' ' A' ' 90' ' ' TYR . 34.6 tt0 -46.05 -25.47 0.58 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.9 -176.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.86 -31.58 78.61 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 118.836 -1.65 . . . . 0.0 110.44 179.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.883 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -73.21 -37.96 66.26 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.079 0.466 . . . . 0.0 109.957 178.194 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.609 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -54.08 -35.9 62.57 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.908 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.647 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.1 OUTLIER -73.76 -29.39 62.19 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.802 178.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.87 -48.33 10.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.187 -179.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.883 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.1 m -49.74 -38.93 14.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.066 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.647 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.6 pt20 -58.83 -48.87 79.83 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.585 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 4.4 pt-20 -73.19 -29.36 62.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.598 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.449 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.0 OUTLIER -78.58 -31.2 47.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.743 -178.846 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.634 HD12 ' NZ ' ' A' ' 94' ' ' LYS . 1.3 tm? -56.82 -58.95 5.9 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.238 -179.235 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.02 -9.51 58.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.626 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.3 -23.35 62.36 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.799 0.333 . . . . 0.0 111.397 -179.513 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 151.23 -15.91 0.88 Allowed Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.719 -179.728 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -89.37 157.49 18.15 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 120.751 0.31 . . . . 0.0 110.862 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.1 pttt -100.68 153.95 19.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.133 0.492 . . . . 0.0 111.148 -179.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.7 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 2.5 p90 -52.63 -40.34 62.67 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.117 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.404 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -55.4 -34.17 59.31 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.704 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -67.21 -54.04 24.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.779 0.323 . . . . 0.0 110.854 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.002 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -55.92 -32.28 63.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.827 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.576 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.27 -53.78 32.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.948 0.404 . . . . 0.0 110.811 -179.38 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.5 pttt -86.16 -23.37 26.58 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.164 179.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.872 ' HB3' HD13 ' A' ' 43' ' ' LEU . 3.0 mm-40 -70.02 -68.94 0.38 Allowed 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -177.389 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.002 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.77 -13.55 9.09 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -179.703 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.749 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -64.1 133.59 53.29 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.912 0.387 . . . . 0.0 111.195 -179.178 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.464 HG13 ' HB3' ' A' ' 16' ' ' LEU . 1.4 pt -99.94 -8.51 9.05 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.167 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.064 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.8 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 18.9 p-10 -46.05 135.62 7.34 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.106 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.674 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.02 -178.45 3.28 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 121.119 -0.562 . . . . 0.0 113.0 -179.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.66 -43.1 0.0 OUTLIER Glycine 0 C--N 1.34 0.797 0 N-CA-C 115.629 1.012 . . . . 0.0 115.629 -178.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.674 ' N ' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -51.43 -18.69 1.11 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 117.394 0.597 . . . . 0.0 111.614 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.8 ' HB2' ' OD1' ' A' ' 46' ' ' ASP . . . -70.58 -20.37 62.78 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-O 120.941 0.401 . . . . 0.0 110.926 179.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.5 mttt -76.79 -4.34 42.98 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.361 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.23 24.59 11.27 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.422 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.404 ' HB2' ' CA ' ' A' ' 37' ' ' GLY . 1.6 p30 55.74 31.82 18.24 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.337 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 52.97 33.45 44.02 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.926 -0.654 . . . . 0.0 112.914 179.492 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.1 m -84.82 89.43 7.54 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.874 0.369 . . . . 0.0 110.847 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.866 HD21 ' CG ' ' A' ' 14' ' ' HIS . 69.6 mt -56.35 -30.05 62.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.503 179.73 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.427 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 64.54 -165.67 32.01 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.66 -0.781 . . . . 0.0 111.887 -179.795 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.518 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.0 OUTLIER -68.82 111.01 4.63 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 120.758 -0.377 . . . . 0.0 111.515 -179.549 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.63 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 4.9 m-85 -117.03 153.94 31.82 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 177.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -116.04 -174.14 17.51 Favored Glycine 0 C--N 1.312 -0.784 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.446 -179.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 1.1 ptp180 -79.57 79.86 6.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.138 0.494 . . . . 0.0 110.033 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 146.94 36.62 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.66 -179.694 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 18.9 mmtm -126.6 -41.57 1.85 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.594 0.235 . . . . 0.0 111.181 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 1.1 ptt? -114.51 171.3 7.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.049 0.452 . . . . 0.0 111.297 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.783 HG23 ' H ' ' A' ' 68' ' ' PHE . 32.7 m -52.35 161.92 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 CA-C-N 116.033 -0.531 . . . . 0.0 111.406 -179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.598 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.4 OUTLIER -65.59 -47.4 67.54 Favored Pre-proline 0 C--N 1.328 -0.34 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 -179.342 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.612 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 15.7 Cg_endo -63.27 -40.31 33.09 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.028 1.819 . . . . 0.0 111.893 -179.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.783 ' H ' HG23 ' A' ' 65' ' ' VAL . 35.6 t80 -74.93 -52.64 10.71 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.436 -0.802 . . . . 0.0 111.036 -179.699 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 1.0 OUTLIER -57.55 -32.48 67.15 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.904 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.461 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.8 OUTLIER -63.13 -50.68 69.48 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.047 179.956 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.535 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.0 -9.98 59.05 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.65 -179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -62.6 -43.04 99.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.808 0.337 . . . . 0.0 111.293 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.461 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 20.2 p90 -96.46 16.83 17.53 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.419 -179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -97.87 -30.76 12.57 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.931 0.396 . . . . 0.0 110.827 -179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 79' ' ' GLU . 4.2 mt -103.57 68.21 0.93 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.262 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 5.8 mt-30 -73.26 -18.26 61.24 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.155 178.977 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -66.55 -26.75 38.27 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.755 179.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.431 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 95.18 57.14 1.23 Allowed Glycine 0 CA--C 1.503 -0.679 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.598 -179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.513 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -138.64 176.45 8.68 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-O 120.839 0.352 . . . . 0.0 110.801 -178.434 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.537 HG11 ' HA ' ' A' ' 27' ' ' GLN . 42.6 t -84.43 146.08 7.23 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.571 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.502 179.432 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 2.2 t -105.37 164.07 12.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.171 0.51 . . . . 0.0 111.477 -178.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.43 ' O ' HG23 ' A' ' 84' ' ' VAL . 6.6 mp0 -50.89 154.72 2.33 Favored Pre-proline 0 C--O 1.234 0.288 0 CA-C-N 115.482 -0.781 . . . . 0.0 112.107 -179.017 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.48 105.32 0.25 Allowed 'Trans proline' 0 N--CA 1.46 -0.477 0 C-N-CA 122.25 1.967 . . . . 0.0 111.797 179.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.612 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 59.4 t -101.19 102.14 13.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.549 179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.472 ' HG2' ' CD2' ' A' ' 90' ' ' TYR . 0.5 OUTLIER -92.11 113.14 25.33 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.315 -179.628 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.96 -171.46 1.89 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.205 179.203 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' OE2' HG11 ' A' ' 65' ' ' VAL . 0.8 OUTLIER -56.88 -19.13 15.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.532 -179.942 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -92.24 -40.82 10.76 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 111.814 0.302 . . . . 0.0 111.814 -179.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.43 ' CA ' HD21 ' A' ' 16' ' ' LEU . . . 159.89 -172.19 36.38 Favored Glycine 0 CA--C 1.506 -0.473 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.731 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.472 ' CD2' ' HG2' ' A' ' 85' ' ' LYS . 6.2 m-85 -74.91 98.19 3.51 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.364 0.602 . . . . 0.0 110.162 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.603 ' NE2' HD11 ' A' ' 16' ' ' LEU . 79.9 m80 -82.4 169.14 16.78 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.206 -0.906 . . . . 0.0 112.465 -178.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 17.9 t -145.49 146.51 19.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 114.836 -1.075 . . . . 0.0 109.295 179.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.929 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -131.22 122.7 51.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 N-CA-C 112.419 0.525 . . . . 0.0 112.419 -178.675 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.634 ' NZ ' HD12 ' A' ' 30' ' ' LEU . 8.2 tptm -128.29 109.96 11.94 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 115.661 -0.7 . . . . 0.0 109.468 178.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.53 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.17 134.5 55.95 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.631 0.729 . . . . 0.0 112.298 -177.62 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.834 HD23 ' OG ' ' A' ' 13' ' ' SER . 0.3 OUTLIER -157.51 116.67 3.28 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 114.605 -1.18 . . . . 0.0 109.67 179.845 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.42 -1.211 . . . . 0.0 112.604 179.831 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.224 0 N-CA-C 112.491 -0.244 . . . . 0.0 112.491 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.11 163.16 39.55 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.574 2.183 . . . . 0.0 112.323 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -69.99 149.4 47.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.9 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 118.84 31.49 1.45 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.616 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.11 123.74 32.49 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.787 0.327 . . . . 0.0 110.855 179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 8.5 tpp 61.16 103.48 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.589 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.51 35.06 1.54 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.29 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.501 ' CB ' ' HE3' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -55.97 -25.57 44.43 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.606 179.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.615 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.26 168.33 15.8 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 121.51 0.671 . . . . 0.0 111.728 -179.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.428 HD13 ' HB3' ' A' ' 73' ' ' PHE . 0.1 OUTLIER -111.39 139.48 35.29 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.545 0 CA-C-N 114.924 -1.035 . . . . 0.0 108.821 178.509 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.9 mtpt -109.63 96.57 6.36 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.653 -178.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.845 ' SG ' HG22 ' A' ' 93' ' ' ILE . 2.6 t -131.6 179.62 5.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.63 -178.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.764 ' HB2' HD23 ' A' ' 96' ' ' LEU . 6.5 t -127.47 162.74 25.66 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.741 ' CD2' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -134.17 148.92 50.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.349 0.595 . . . . 0.0 112.556 -179.404 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.678 HD12 ' C ' ' A' ' 14' ' ' HIS . 3.6 mp -145.49 131.39 13.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 115.256 -0.883 . . . . 0.0 109.709 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.735 HD23 ' O ' ' A' ' 90' ' ' TYR . 2.0 mt -123.31 133.41 54.15 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 -178.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.922 HG21 ' CG ' ' A' ' 22' ' ' GLU . 21.5 m -150.91 135.85 10.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.695 178.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.98 -17.64 64.59 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.748 -0.464 . . . . 0.0 109.748 178.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HB3' ' CG ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -72.22 78.34 0.97 Allowed 'General case' 0 N--CA 1.441 -0.877 0 CA-C-N 115.603 -0.726 . . . . 0.0 109.683 179.062 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.443 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -47.07 -41.71 17.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 -178.017 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -68.6 -31.46 73.57 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 119.959 -1.115 . . . . 0.0 112.898 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.922 ' CG ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -65.58 -44.44 86.68 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.223 0.535 . . . . 0.0 110.666 179.585 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.547 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -47.67 -40.6 20.38 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.461 -0.791 . . . . 0.0 110.286 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.789 HD23 ' HG3' ' A' ' 83' ' ' PRO . 0.3 OUTLIER -72.9 -28.87 62.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.045 179.159 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -81.44 -44.23 17.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.134 -0.485 . . . . 0.0 112.254 -178.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . . . . . . . . . 14.7 m -58.2 -29.0 36.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 112.281 0.474 . . . . 0.0 112.281 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.727 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.8 pt20 -54.91 -53.47 55.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.277 -0.569 . . . . 0.0 109.989 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.499 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.0 OUTLIER -73.83 -28.91 61.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.127 0.489 . . . . 0.0 110.634 178.551 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.515 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 0.9 OUTLIER -75.98 -34.29 59.78 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.694 -0.684 . . . . 0.0 112.273 -178.51 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.863 HD21 ' HA ' ' A' ' 36' ' ' PHE . 1.1 tm? -52.81 -49.68 65.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.418 -0.355 . . . . 0.0 111.173 -179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.18 -9.19 58.11 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.301 179.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.515 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -74.36 49.11 0.36 Allowed 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 112.742 0.645 . . . . 0.0 112.742 -178.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 79.52 -10.51 36.79 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.758 -0.734 . . . . 0.0 114.171 178.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.426 ' OE2' HD21 ' A' ' 39' ' ' LEU . 7.0 pt-20 -92.62 153.83 18.76 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.378 0.589 . . . . 0.0 110.852 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.42 143.38 30.68 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.274 -179.692 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.909 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 5.2 p90 -52.89 -35.79 58.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.748 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.46 -36.37 93.05 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.27 179.887 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.475 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 10.5 tttt -60.83 -53.77 53.3 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.843 0.354 . . . . 0.0 110.807 179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.968 HD12 HD11 ' A' ' 43' ' ' LEU . 2.8 mm? -53.64 -34.12 57.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.007 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.459 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.63 -53.41 38.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.956 0.408 . . . . 0.0 110.81 -179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.9 -23.55 26.97 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.934 179.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.824 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -68.96 -68.69 0.38 Allowed 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 112.785 0.661 . . . . 0.0 112.785 -178.076 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.968 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.66 -16.07 8.86 Favored 'General case' 0 N--CA 1.467 0.415 0 N-CA-C 112.751 0.648 . . . . 0.0 112.751 -179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.562 ' N ' HD22 ' A' ' 43' ' ' LEU . 0.3 OUTLIER -64.23 141.5 58.75 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.192 0.52 . . . . 0.0 111.522 -179.193 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.444 HG12 ' HA ' ' A' ' 17' ' ' VAL . 1.9 pt -105.74 -9.08 10.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 115.534 -0.757 . . . . 0.0 110.894 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.46 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 3.2 t70 -46.08 135.6 7.42 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.005 179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.675 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -61.47 -178.08 2.63 Favored Glycine 0 C--O 1.226 -0.35 0 CA-C-N 115.9 -0.591 . . . . 0.0 112.508 -179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 51' ' ' LYS . . . -11.14 -44.22 0.0 OUTLIER Glycine 0 N--CA 1.468 0.827 0 N-CA-C 115.512 0.965 . . . . 0.0 115.512 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.675 ' N ' ' O ' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -51.58 -31.14 23.55 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 117.759 0.78 . . . . 0.0 111.042 179.957 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 46' ' ' ASP . . . -72.49 -26.37 61.76 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.245 0.545 . . . . 0.0 110.548 178.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.6 OUTLIER -72.6 -13.17 61.32 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.942 -179.727 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.87 24.43 11.3 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.381 179.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.436 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 73.5 9.24 5.06 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.27 -179.811 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 65.3 24.63 70.76 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.663 -0.78 . . . . 0.0 112.225 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 4.4 p -75.94 82.77 2.84 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.97 0.414 . . . . 0.0 110.615 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.741 HD21 ' CD2' ' A' ' 14' ' ' HIS . 14.6 mt -53.94 -24.5 16.63 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.992 179.899 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 61.04 -163.67 20.03 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.828 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.468 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -72.68 111.51 7.89 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.995 0.426 . . . . 0.0 111.744 -179.426 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.615 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 3.8 m-85 -123.71 163.62 20.76 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 177.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -120.77 -173.99 14.96 Favored Glycine 0 N--CA 1.449 -0.486 0 C-N-CA 120.161 -1.019 . . . . 0.0 112.628 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -83.55 93.89 7.94 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 120.897 0.38 . . . . 0.0 110.189 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.42 36.79 0.05 OUTLIER Glycine 0 N--CA 1.442 -0.912 0 C-N-CA 120.349 -0.929 . . . . 0.0 112.854 -179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -145.43 -44.54 0.22 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.622 0.249 . . . . 0.0 111.241 -179.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -91.05 165.74 13.36 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.826 0.346 . . . . 0.0 111.298 -179.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.734 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.9 m -61.7 165.06 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.894 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.526 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -60.63 -48.06 94.34 Favored Pre-proline 0 CA--C 1.532 0.276 0 N-CA-C 112.703 0.631 . . . . 0.0 112.703 -178.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.526 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 13.8 Cg_endo -66.2 -37.68 23.95 Favored 'Trans proline' 0 N--CA 1.463 -0.302 0 C-N-CA 121.897 1.731 . . . . 0.0 111.962 -179.494 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.734 ' H ' HG23 ' A' ' 65' ' ' VAL . 40.0 t80 -74.96 -52.31 11.47 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.905 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.79 -32.27 63.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.799 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.482 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 2.6 m-20 -65.19 -52.08 57.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.881 -0.599 . . . . 0.0 110.995 179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.437 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.09 -9.28 58.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.908 -179.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -71.27 -38.31 71.85 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 112.088 0.403 . . . . 0.0 112.088 -179.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.482 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 2.8 p90 -106.04 16.76 24.58 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -179.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 71' ' ' ALA . 1.0 OUTLIER -98.76 -27.69 13.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.79 0.329 . . . . 0.0 110.98 179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.524 HD12 ' O ' ' A' ' 79' ' ' GLU . 3.1 mt -103.47 66.43 0.88 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.076 0.465 . . . . 0.0 111.447 -179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.8 mt-30 -73.29 -18.23 61.23 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.005 178.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -65.96 -27.0 39.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.663 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.438 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 95.6 58.74 1.11 Allowed Glycine 0 CA--C 1.503 -0.67 0 C-N-CA 120.57 -0.824 . . . . 0.0 111.536 -179.309 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.524 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -140.33 176.28 8.9 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.776 0.322 . . . . 0.0 111.084 -178.477 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.657 HG11 ' HA ' ' A' ' 27' ' ' GLN . 55.6 t -82.84 146.58 6.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.158 179.249 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 4.0 t -104.84 164.14 12.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.346 0.593 . . . . 0.0 111.917 -178.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -50.75 156.42 1.62 Allowed Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.634 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.789 ' HG3' HD23 ' A' ' 24' ' ' LEU . 26.9 Cg_endo -61.09 105.17 0.31 Allowed 'Trans proline' 0 N--CA 1.462 -0.326 0 C-N-CA 122.583 2.188 . . . . 0.0 112.141 179.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.523 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 87.7 t -101.27 99.47 8.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.582 179.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.453 ' HG3' ' CD1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -97.97 112.79 24.59 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.798 179.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.9 m -110.62 -175.75 2.8 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.635 179.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.34 -21.64 25.75 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.093 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -85.45 -26.73 26.15 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.38 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 144.18 -165.32 27.42 Favored Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.486 -0.864 . . . . 0.0 112.771 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.735 ' O ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -83.26 106.68 15.24 Favored 'General case' 0 N--CA 1.45 -0.46 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 179.871 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.472 ' NE2' HD11 ' A' ' 16' ' ' LEU . 41.6 m80 -92.64 157.92 16.23 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.476 0.655 . . . . 0.0 112.597 -178.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 23.1 t -140.72 153.17 20.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 114.853 -1.067 . . . . 0.0 109.264 178.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.845 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -141.26 124.16 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -178.878 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -128.11 113.87 16.31 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.282 178.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.5 135.4 56.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.54 0.686 . . . . 0.0 112.231 -177.617 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.909 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -157.38 116.65 3.32 Favored 'General case' 0 N--CA 1.438 -1.037 0 CA-C-N 114.669 -1.15 . . . . 0.0 109.733 179.552 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.119 0 CA-C-O 118.393 -1.226 . . . . 0.0 112.605 -179.999 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.214 0 N-CA-C 112.454 -0.258 . . . . 0.0 112.454 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.21 125.44 17.46 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.643 2.229 . . . . 0.0 112.308 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.2 mtp -110.21 126.1 53.77 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.854 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 94.82 52.42 1.8 Allowed Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.573 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -87.43 140.89 29.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.754 0.312 . . . . 0.0 110.878 179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 12.4 tpt -96.32 158.37 15.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.915 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -99.15 29.86 3.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.132 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.477 ' CB ' ' HE3' ' A' ' 9' ' ' LYS . 0.2 OUTLIER -56.84 -22.36 36.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.844 179.862 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.716 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -84.27 168.55 15.58 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.429 0.633 . . . . 0.0 111.595 -179.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -111.31 139.11 36.88 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.617 0 CA-C-N 115.01 -0.995 . . . . 0.0 108.828 178.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.499 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.5 mtpt -107.93 98.3 7.9 Favored 'General case' 0 C--N 1.309 -1.193 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.366 -178.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.786 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 2.1 t -130.32 -179.84 5.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.824 -178.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.773 ' HB2' HD23 ' A' ' 96' ' ' LEU . 34.4 t -120.73 162.89 18.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.337 -0.392 . . . . 0.0 109.975 179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.753 ' CG ' HD21 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -130.33 139.32 50.7 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.997 0.427 . . . . 0.0 111.781 -179.694 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.707 HD12 ' C ' ' A' ' 14' ' ' HIS . 4.7 mp -153.3 118.97 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.838 HD13 ' HB3' ' A' ' 46' ' ' ASP . 0.3 OUTLIER -109.63 140.91 42.89 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.922 0.391 . . . . 0.0 111.034 179.649 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.731 HG21 ' HG3' ' A' ' 22' ' ' GLU . 4.4 m -149.1 134.35 10.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.732 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.545 ' CD ' HD13 ' A' ' 45' ' ' ILE . 0.0 OUTLIER -72.0 -35.86 69.58 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.808 -178.796 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.623 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 4.7 tttp -72.83 78.8 1.14 Allowed 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 178.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.497 ' HG2' ' CE1' ' A' ' 90' ' ' TYR . 0.0 OUTLIER -46.64 -25.99 0.82 Allowed 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.027 -0.988 . . . . 0.0 113.225 -176.73 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.54 -31.53 76.72 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 119.026 -1.559 . . . . 0.0 110.921 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.887 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -71.07 -38.81 72.45 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 121.059 0.457 . . . . 0.0 110.491 178.725 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.616 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -52.03 -37.15 52.48 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.363 179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.545 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.25 -29.86 63.05 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.646 179.046 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -82.99 -41.45 18.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.496 -179.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.887 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.1 m -52.33 -37.83 24.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.014 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.656 ' HG3' ' N ' ' A' ' 28' ' ' GLU . 0.3 OUTLIER -59.24 -48.84 80.11 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 179.68 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.656 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.3 pt-20 -73.27 -29.0 62.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.66 178.613 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.54 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 8.1 tpt180 -78.86 -32.28 45.95 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.371 -0.832 . . . . 0.0 112.01 -178.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.444 ' CD2' HD23 ' A' ' 39' ' ' LEU . 0.7 OUTLIER -53.12 -59.4 4.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.471 -0.332 . . . . 0.0 111.171 -179.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.419 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -72.46 -9.44 58.55 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.371 179.498 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.54 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.04 -24.96 63.3 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.858 0.361 . . . . 0.0 111.327 -179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 152.4 -17.01 0.77 Allowed Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.579 -179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.52 ' CD ' HD21 ' A' ' 39' ' ' LEU . 8.1 pt-20 -86.84 154.99 20.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.901 0.382 . . . . 0.0 110.79 179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.92 146.2 27.66 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.129 0.49 . . . . 0.0 111.079 -179.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.913 ' CE1' HD22 ' A' ' 96' ' ' LEU . 3.7 p90 -47.1 -30.76 2.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.789 -0.641 . . . . 0.0 110.743 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.472 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -62.47 -34.24 88.81 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.866 -0.683 . . . . 0.0 112.178 179.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.539 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -66.64 -53.47 33.72 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.766 0.317 . . . . 0.0 110.765 179.895 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.763 HD12 HD11 ' A' ' 43' ' ' LEU . 3.1 mm? -53.37 -36.07 60.99 Favored 'General case' 0 N--CA 1.462 0.16 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.273 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.53 ' O ' ' HB3' ' A' ' 44' ' ' SER . . . -52.1 -52.94 48.21 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.178 0.513 . . . . 0.0 110.701 -179.685 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.57 -23.57 27.58 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.727 179.236 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.952 ' HB3' HD13 ' A' ' 43' ' ' LEU . 1.1 mt-10 -73.58 -67.86 0.55 Allowed 'General case' 0 CA--C 1.531 0.247 0 N-CA-C 113.074 0.768 . . . . 0.0 113.074 -178.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.952 HD13 ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -118.99 -12.56 9.51 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.53 ' HB3' ' O ' ' A' ' 40' ' ' ALA . 3.3 t -63.12 125.98 25.86 Favored 'General case' 0 CA--C 1.516 -0.337 0 C-N-CA 119.634 -0.826 . . . . 0.0 109.891 -179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.545 HD13 ' CD ' ' A' ' 18' ' ' LYS . 3.8 pt -107.86 -26.97 3.09 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 113.647 0.98 . . . . 0.0 113.647 -178.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.838 ' HB3' HD13 ' A' ' 16' ' ' LEU . 23.7 t0 -127.57 102.38 6.82 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 113.051 0.76 . . . . 0.0 113.051 -178.128 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 176.81 143.64 4.9 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.358 -0.925 . . . . 0.0 112.86 178.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.25 -35.39 23.74 Favored Glycine 0 N--CA 1.447 -0.568 0 N-CA-C 110.74 -0.944 . . . . 0.0 110.74 178.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.68 0.16 21.36 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.244 -0.478 . . . . 0.0 111.008 179.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.504 ' HA ' ' HB1' ' A' ' 40' ' ' ALA . . . -62.16 -23.67 66.73 Favored 'General case' 0 CA--C 1.521 -0.167 0 CA-C-O 121.345 0.593 . . . . 0.0 109.586 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 12.8 mtpt -88.78 -5.29 58.17 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.2 178.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.431 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 2.5 mtt180 -119.06 24.98 10.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.84 -179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.516 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 76.39 16.06 2.15 Favored 'General case' 0 N--CA 1.465 0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.332 -179.722 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 66.18 17.01 65.39 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.577 179.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.714 ' HA ' HD21 ' A' ' 96' ' ' LEU . 7.0 m -70.91 86.32 0.7 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.672 0.272 . . . . 0.0 110.901 179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.786 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 23.4 mt -54.77 -31.15 58.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.037 0.446 . . . . 0.0 110.577 179.725 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . 0.41 ' O ' ' HA ' ' A' ' 11' ' ' LYS . . . 69.94 -170.29 44.15 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.43 179.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.499 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -67.87 111.58 4.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.949 0.404 . . . . 0.0 111.625 -179.605 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.716 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 6.4 m-85 -123.89 159.21 30.15 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.666 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -113.72 -174.06 18.67 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.421 -0.895 . . . . 0.0 112.293 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 16.6 ptp180 -88.01 96.82 10.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.988 0.423 . . . . 0.0 110.335 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.16 36.73 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 120.373 -0.917 . . . . 0.0 113.067 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 5.5 tptm -143.45 -47.51 0.3 Allowed 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.75 0.31 . . . . 0.0 111.259 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.416 ' HG2' ' HG3' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -91.17 166.93 12.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.878 0.371 . . . . 0.0 111.278 -179.706 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.758 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.0 m -54.63 165.75 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.164 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.174 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.533 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 20.7 tttm -64.29 -47.93 77.15 Favored Pre-proline 0 CA--C 1.532 0.286 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.533 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 14.0 Cg_endo -65.46 -38.16 27.02 Favored 'Trans proline' 0 C--N 1.346 0.403 0 C-N-CA 121.861 1.708 . . . . 0.0 111.939 -179.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.758 ' H ' HG23 ' A' ' 65' ' ' VAL . 24.4 t80 -74.94 -52.69 10.55 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.647 -179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.416 ' HG3' ' HG2' ' A' ' 64' ' ' MET . 0.8 OUTLIER -57.17 -34.03 68.05 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.779 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.471 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 23.6 t0 -69.03 -47.95 64.13 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.059 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.426 ' HB3' HD11 ' A' ' 93' ' ' ILE . . . -75.33 -9.69 58.79 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.785 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -66.37 -49.03 68.26 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.785 0.326 . . . . 0.0 111.709 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.471 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 3.0 p90 -92.7 16.92 11.17 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.601 -179.578 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -94.7 -29.37 14.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.764 0.316 . . . . 0.0 110.816 -179.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.522 HD12 ' O ' ' A' ' 79' ' ' GLU . 4.3 mt -103.57 66.01 0.86 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.474 -179.72 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -69.9 -19.97 63.39 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.061 179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.3 p -64.54 -26.88 41.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.57 179.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.425 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 94.22 58.05 1.25 Allowed Glycine 0 CA--C 1.504 -0.645 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.719 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.522 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -140.13 176.37 8.81 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.779 0.323 . . . . 0.0 111.077 -178.475 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.508 ' O ' HD11 ' A' ' 75' ' ' LEU . 86.2 t -81.28 146.7 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.812 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 21.0 t -104.68 164.1 12.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.222 0.534 . . . . 0.0 111.777 -178.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.0 mt-10 -50.54 155.08 1.96 Allowed Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.238 -0.892 . . . . 0.0 112.328 -178.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.533 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 18.5 Cg_endo -60.18 106.33 0.34 Allowed 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 122.358 2.038 . . . . 0.0 111.741 179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.53 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 97.5 t -100.95 100.22 9.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.608 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.457 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 0.7 OUTLIER -94.53 112.96 24.72 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.942 179.869 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.63 -172.11 1.97 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.505 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.9 pt-20 -57.54 -20.95 35.26 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.858 179.74 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -85.86 -37.23 19.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.245 -179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 150.81 -168.46 30.56 Favored Glycine 0 C--N 1.33 0.224 0 C-N-CA 120.597 -0.811 . . . . 0.0 112.656 -179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.533 ' CE2' ' HB2' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -75.34 98.57 3.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.005 0.431 . . . . 0.0 109.926 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.658 ' CD2' HD11 ' A' ' 16' ' ' LEU . 70.1 m80 -80.41 165.08 22.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.75 -0.659 . . . . 0.0 112.397 -178.29 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 39.7 t -149.19 138.38 15.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 115.103 -0.953 . . . . 0.0 109.762 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.745 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -127.99 122.7 59.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 N-CA-C 112.249 0.463 . . . . 0.0 112.249 -178.741 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.482 ' HG2' HG22 ' A' ' 80' ' ' VAL . 1.4 tmtm? -126.18 112.27 15.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.186 178.382 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.546 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.5 132.33 52.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.559 0.695 . . . . 0.0 111.89 -177.697 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.913 HD22 ' CE1' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -155.06 116.75 4.09 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 114.81 -1.087 . . . . 0.0 109.685 179.643 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.125 0 CA-C-O 118.339 -1.256 . . . . 0.0 112.619 179.914 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.21 0 N-CA-C 112.407 -0.277 . . . . 0.0 112.407 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -69.96 126.98 13.8 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.652 2.235 . . . . 0.0 112.294 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.1 ttm -96.35 145.76 25.33 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.937 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 134.61 43.31 0.12 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.748 -0.739 . . . . 0.0 112.547 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.0 m -76.09 141.07 42.1 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.711 0.291 . . . . 0.0 110.954 179.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 82.5 mtp -123.0 -41.01 2.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.143 -179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -101.54 31.3 3.83 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.457 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -55.17 -24.77 28.45 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.906 0.384 . . . . 0.0 110.661 179.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.484 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 3.5 mptt -85.01 161.22 19.83 Favored 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.707 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.9 mt -111.03 128.08 67.72 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.717 0 CA-C-N 115.416 -0.811 . . . . 0.0 109.349 178.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.448 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 2.8 mtpt -97.9 92.73 5.96 Favored 'General case' 0 C--N 1.306 -1.311 0 CA-C-N 114.729 -1.123 . . . . 0.0 109.109 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.888 ' SG ' HD12 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -124.06 -179.89 4.6 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.309 -177.552 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.791 ' HB2' HD23 ' A' ' 96' ' ' LEU . 2.0 t -123.14 160.17 27.02 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.954 179.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.734 ' CD2' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -136.29 147.23 47.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.335 0.588 . . . . 0.0 111.977 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.75 HG23 ' OG ' ' A' ' 44' ' ' SER . 3.2 mp -151.91 115.39 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.314 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.584 ' HB3' ' CG1' ' A' ' 45' ' ' ILE . 7.7 tp -100.77 132.37 46.2 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.785 HG11 ' OE1' ' A' ' 22' ' ' GLU . 12.3 m -146.07 134.11 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.815 178.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 21.0 mttt -75.01 -36.29 61.94 Favored 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.415 -178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.614 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -71.84 79.35 0.87 Allowed 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.597 0.713 . . . . 0.0 109.078 178.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.513 ' HG3' ' CZ ' ' A' ' 90' ' ' TYR . 1.3 tm0? -45.71 -25.73 0.53 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.742 -1.117 . . . . 0.0 113.218 -177.254 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -66.73 -31.55 78.72 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 118.774 -1.679 . . . . 0.0 110.688 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.901 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.3 OUTLIER -71.77 -39.41 69.99 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.152 0.501 . . . . 0.0 109.803 178.146 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.689 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -51.5 -36.91 46.63 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.996 179.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.627 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.55 -29.44 62.44 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.949 179.011 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.08 -40.46 16.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.51 -179.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.901 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.3 m -56.92 -37.55 54.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.566 -0.288 . . . . 0.0 111.058 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 3.0 pt20 -56.84 -51.33 69.43 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.558 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 1.6 pt-20 -73.45 -29.18 62.39 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.618 178.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.534 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 2.5 tpt180 -75.6 -33.57 60.56 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 115.565 -0.743 . . . . 0.0 111.633 -179.028 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.462 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.9 OUTLIER -52.94 -58.91 5.37 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.067 -179.44 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.13 -8.78 56.57 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.521 179.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.534 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -56.99 -20.09 21.95 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 111.878 0.325 . . . . 0.0 111.878 -178.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 145.39 -10.47 1.73 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.368 -0.92 . . . . 0.0 113.131 -179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.493 ' OE1' HD21 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -103.77 158.2 16.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.904 0.383 . . . . 0.0 110.677 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 1.1 ptmt -97.29 154.26 17.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.37 0.605 . . . . 0.0 112.17 -179.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.71 ' CE1' HD22 ' A' ' 96' ' ' LEU . 0.2 OUTLIER -53.0 -35.22 59.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.388 179.316 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.433 ' HA2' ' CA ' ' A' ' 53' ' ' ASP . . . -53.54 -34.16 49.01 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.001 179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 9.7 mtpp -69.98 -53.63 16.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.656 0.265 . . . . 0.0 110.442 179.602 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.989 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -54.0 -33.36 56.89 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.716 179.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.552 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.59 -53.36 39.12 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 121.071 0.462 . . . . 0.0 110.657 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -86.21 -23.33 26.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.794 -0.639 . . . . 0.0 111.214 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.851 ' HB3' HD13 ' A' ' 43' ' ' LEU . 1.3 mt-10 -71.15 -69.18 0.39 Allowed 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 113.483 0.92 . . . . 0.0 113.483 -177.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.989 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.78 -11.64 9.34 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -179.582 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.75 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -63.9 138.53 58.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.03 0.443 . . . . 0.0 111.33 -179.035 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.584 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 43.1 pt -104.66 -12.67 9.26 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.959 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.78 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 21.7 p-10 -45.67 135.14 6.91 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.325 -179.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.66 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.68 -178.63 3.99 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 115.797 -0.638 . . . . 0.0 113.109 -179.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 51' ' ' LYS . . . -11.86 -43.13 0.0 OUTLIER Glycine 0 N--CA 1.468 0.802 0 N-CA-C 115.571 0.988 . . . . 0.0 115.571 -179.09 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.66 ' N ' ' O ' ' A' ' 47' ' ' GLY . 3.8 m -51.17 -21.5 2.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 117.573 0.686 . . . . 0.0 111.379 -179.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.78 ' HB2' ' OD1' ' A' ' 46' ' ' ASP . . . -71.2 -20.77 62.23 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.924 0.392 . . . . 0.0 111.255 179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -67.8 -8.08 32.98 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 112.17 -179.004 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.406 ' HG2' ' O ' ' A' ' 49' ' ' SER . 11.5 ptp180 -104.21 23.69 12.68 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.89 0.376 . . . . 0.0 110.702 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.433 ' CA ' ' HA2' ' A' ' 37' ' ' GLY . 0.0 OUTLIER 71.96 13.0 6.04 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.241 179.871 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 76.3 16.69 80.52 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.581 -0.819 . . . . 0.0 112.418 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . 0.631 ' HA ' HD21 ' A' ' 96' ' ' LEU . 1.1 m -74.06 89.77 1.97 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.889 0.376 . . . . 0.0 110.783 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.888 HD12 ' SG ' ' A' ' 12' ' ' CYS . 13.2 mt -56.5 -28.35 59.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.665 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 67.59 -166.62 42.35 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.474 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.448 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -68.31 118.71 11.77 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.112 0.482 . . . . 0.0 111.923 -179.353 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.484 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 10.5 m-85 -131.57 150.44 52.15 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 177.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -114.39 -173.88 18.27 Favored Glycine 0 C--N 1.314 -0.677 0 C-N-CA 120.503 -0.856 . . . . 0.0 112.577 -179.231 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 7.8 mtt-85 -76.27 81.97 3.05 Favored 'General case' 0 N--CA 1.452 -0.337 0 CA-C-O 121.033 0.444 . . . . 0.0 110.084 179.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.46 36.67 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.712 0 C-N-CA 120.39 -0.91 . . . . 0.0 112.939 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 3.8 mttp -134.8 -48.52 0.75 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.815 0.34 . . . . 0.0 111.232 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -97.58 170.61 8.91 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.137 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.789 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.0 m -57.06 159.56 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.933 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.562 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.1 OUTLIER -62.1 -47.9 89.44 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.039 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.612 ' HB2' ' CG1' ' A' ' 84' ' ' VAL . 17.5 Cg_endo -64.63 -39.2 28.27 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 121.932 1.754 . . . . 0.0 112.115 -179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.859 ' CZ ' HG23 ' A' ' 93' ' ' ILE . 17.6 t80 -74.92 -52.02 12.3 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.728 179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.402 ' HB2' ' O ' ' A' ' 65' ' ' VAL . 4.0 tm-20 -56.01 -32.29 63.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.676 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.459 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 0.5 OUTLIER -64.26 -52.62 57.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.871 179.838 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.531 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.0 -11.96 60.22 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.638 -179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -61.32 -48.5 81.07 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.799 0.333 . . . . 0.0 111.407 -179.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.459 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 6.7 p90 -93.23 16.83 12.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.372 -179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.31 -28.58 13.6 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.895 0.379 . . . . 0.0 110.834 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.513 HD12 ' O ' ' A' ' 79' ' ' GLU . 3.0 mt -103.63 62.81 0.77 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.291 -179.815 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -69.61 -18.39 63.6 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.087 178.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.1 p -64.61 -26.86 41.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.53 179.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.463 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 95.27 56.88 1.24 Allowed Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.669 -0.776 . . . . 0.0 111.731 -179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.513 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.7 tm-20 -139.36 176.29 8.84 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-O 120.89 0.376 . . . . 0.0 110.982 -178.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.547 HG11 ' HA ' ' A' ' 27' ' ' GLN . 61.1 t -84.29 147.55 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.069 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -104.97 164.12 12.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.225 0.536 . . . . 0.0 111.431 -178.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.448 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.0 mp0 -50.48 154.43 2.22 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.986 -178.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.517 ' HG3' HD23 ' A' ' 24' ' ' LEU . 19.1 Cg_endo -60.0 104.97 0.25 Allowed 'Trans proline' 0 N--CA 1.462 -0.378 0 C-N-CA 122.177 1.918 . . . . 0.0 111.819 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.612 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 59.3 t -101.33 102.0 12.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.528 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.528 ' HA ' ' HA ' ' A' ' 90' ' ' TYR . 3.9 tmtt? -92.38 112.87 24.98 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.351 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.4 -171.58 1.99 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.141 179.312 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -60.98 -16.26 40.98 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.217 179.682 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -94.01 -40.82 9.9 Favored 'General case' 0 CA--C 1.529 0.164 0 CA-C-N 116.559 -0.292 . . . . 0.0 111.65 -179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 164.17 -174.24 40.25 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 120.612 -0.804 . . . . 0.0 112.812 -179.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.528 ' HA ' ' HA ' ' A' ' 85' ' ' LYS . 1.7 m-85 -76.92 98.38 4.89 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 121.233 0.54 . . . . 0.0 110.374 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.47 ' CD2' HD13 ' A' ' 16' ' ' LEU . 58.2 m80 -78.24 169.78 17.7 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.669 -178.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 29.6 t -151.33 128.57 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 114.82 -1.082 . . . . 0.0 109.363 179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.859 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.2 OUTLIER -111.5 123.2 67.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -178.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.459 ' HE3' HD12 ' A' ' 30' ' ' LEU . 28.1 tptp -128.28 115.17 17.9 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.454 178.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.463 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 0.0 OUTLIER -58.33 134.87 56.97 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.45 0.643 . . . . 0.0 112.134 -178.544 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.791 HD23 ' HB2' ' A' ' 13' ' ' SER . 0.3 OUTLIER -160.72 116.6 2.27 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 115.067 -0.969 . . . . 0.0 110.217 179.605 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.414 -1.214 . . . . 0.0 112.532 179.642 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 112.409 -0.277 . . . . 0.0 112.409 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_exo -52.02 127.44 23.36 Favored 'Trans proline' 0 C--N 1.343 0.279 0 C-N-CA 122.667 2.244 . . . . 0.0 112.259 179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.2 mtp -80.94 145.92 31.01 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.922 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 69.6 53.8 15.1 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.43 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 11.2 t -77.54 123.3 26.41 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.857 0.36 . . . . 0.0 110.844 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.29 -22.34 10.96 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.207 -179.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -96.4 29.89 2.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.303 -179.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -51.39 -27.63 10.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.948 0.404 . . . . 0.0 110.551 179.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.518 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.8 OUTLIER -85.22 160.84 19.79 Favored 'General case' 0 N--CA 1.45 -0.458 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.128 179.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.656 HD13 ' HB3' ' A' ' 73' ' ' PHE . 0.4 OUTLIER -111.03 135.88 48.81 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.585 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 177.848 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.5 mtpt -106.83 95.11 5.5 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.653 -178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.929 ' SG ' HG22 ' A' ' 93' ' ' ILE . 2.4 t -124.06 179.58 4.8 Favored 'General case' 0 N--CA 1.454 -0.251 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.894 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.507 ' HB3' HD23 ' A' ' 96' ' ' LEU . 1.8 p -123.37 162.25 23.12 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 110.014 -0.365 . . . . 0.0 110.014 179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.665 ' HB3' HD11 ' A' ' 56' ' ' LEU . 20.4 p-80 -133.97 153.75 51.57 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.399 0.619 . . . . 0.0 112.327 -179.494 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.767 HG23 ' OG ' ' A' ' 44' ' ' SER . 2.9 mp -156.75 122.73 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 114.996 -1.002 . . . . 0.0 109.777 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.901 HD13 ' CD2' ' A' ' 91' ' ' HIS . 10.3 tp -110.32 132.15 54.43 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.076 0.398 . . . . 0.0 112.076 -178.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.832 HG11 ' OE1' ' A' ' 22' ' ' GLU . 15.5 m -142.88 134.45 24.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.391 178.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.53 -35.78 63.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.5 -179.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.615 ' HG2' ' HB3' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -73.12 79.3 1.24 Allowed 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.484 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 2.0 pt20 -46.28 -25.58 0.65 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.328 -0.851 . . . . 0.0 113.154 -176.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.02 -31.4 77.84 Favored Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 119.119 -1.515 . . . . 0.0 110.67 179.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.832 ' OE1' HG11 ' A' ' 17' ' ' VAL . 0.4 OUTLIER -71.26 -37.85 71.92 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.084 0.469 . . . . 0.0 109.928 178.39 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.608 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -50.87 -38.01 46.9 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.61 -0.723 . . . . 0.0 110.15 179.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.619 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.3 OUTLIER -73.07 -29.58 63.05 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.823 179.278 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -83.95 -53.33 5.65 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.795 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.754 HG13 ' O ' ' A' ' 22' ' ' GLU . 3.8 m -47.03 -37.34 3.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.322 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.628 ' HA ' HG11 ' A' ' 80' ' ' VAL . 2.5 pt20 -59.92 -48.21 82.64 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 179.446 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.571 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 3.4 pt-20 -73.06 -29.01 62.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.648 178.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.615 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 10.0 tpt180 -78.62 -35.37 45.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.771 -178.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.583 HD21 ' HA ' ' A' ' 36' ' ' PHE . 1.1 tm? -52.74 -58.81 5.65 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.29 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.97 -9.6 58.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.254 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.615 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.25 -24.57 63.31 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.864 0.364 . . . . 0.0 111.114 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 149.36 -17.21 1.15 Allowed Glycine 0 N--CA 1.444 -0.804 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.436 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -78.92 157.7 28.18 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.985 0.422 . . . . 0.0 110.949 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 15.2 ttmt -98.08 140.1 32.91 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.027 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.76 ' CZ ' HD22 ' A' ' 96' ' ' LEU . 3.4 p90 -51.39 -32.13 25.02 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.848 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.412 ' CA ' ' HB2' ' A' ' 53' ' ' ASP . . . -62.79 -34.25 89.23 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.213 179.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 1.2 mmtt -65.96 -53.57 37.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.661 0.267 . . . . 0.0 110.783 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.998 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.85 -32.33 52.62 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.517 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.36 -53.78 32.88 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.549 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -86.18 -23.47 26.51 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.224 179.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.89 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.0 OUTLIER -70.78 -68.8 0.41 Allowed 'General case' 0 CA--C 1.535 0.371 0 N-CA-C 113.32 0.859 . . . . 0.0 113.32 -177.43 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.998 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.63 -12.25 9.31 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.767 ' OG ' HG23 ' A' ' 15' ' ' ILE . 0.6 OUTLIER -64.05 140.32 58.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.931 0.396 . . . . 0.0 111.289 -179.241 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.571 ' CG1' ' HB3' ' A' ' 16' ' ' LEU . 31.7 pt -103.43 -10.81 9.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.686 179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.811 ' OD1' ' HB2' ' A' ' 50' ' ' ALA . 24.4 p-10 -45.84 134.98 7.4 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 115.945 -0.57 . . . . 0.0 111.404 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.681 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.44 -178.31 3.62 Favored Glycine 0 N--CA 1.451 -0.35 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.683 -179.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.425 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.76 -42.9 0.0 OUTLIER Glycine 0 N--CA 1.468 0.782 0 N-CA-C 115.485 0.954 . . . . 0.0 115.485 -179.183 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.681 ' N ' ' O ' ' A' ' 47' ' ' GLY . 1.5 t -51.46 -16.91 0.66 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 117.5 0.65 . . . . 0.0 111.701 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.811 ' HB2' ' OD1' ' A' ' 46' ' ' ASP . . . -71.04 -20.82 62.34 Favored 'General case' 0 CA--C 1.522 -0.119 0 CA-C-O 121.28 0.562 . . . . 0.0 110.303 179.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.3 OUTLIER -74.36 -8.79 57.45 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.373 179.444 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.418 ' O ' ' CG ' ' A' ' 53' ' ' ASP . 0.5 OUTLIER -103.67 24.67 10.81 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.423 -179.769 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.418 ' CG ' ' O ' ' A' ' 52' ' ' ARG . 2.1 p30 54.08 34.8 20.73 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.97 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.45 ' HA2' ' CE1' ' A' ' 14' ' ' HIS . . . 56.76 21.47 36.59 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.417 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 60.7 p -70.38 86.81 0.61 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.85 0.357 . . . . 0.0 111.257 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.709 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 46.6 mt -59.69 -33.4 71.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.102 179.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 69.94 -167.13 48.98 Favored Glycine 0 N--CA 1.451 -0.357 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.947 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.468 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -69.19 119.15 13.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.045 0.45 . . . . 0.0 111.851 -179.387 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.518 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 9.3 p90 -135.46 135.48 40.55 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.48 177.482 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -85.42 -174.01 49.89 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.601 -179.229 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 2.2 ptt-85 -89.73 89.4 7.77 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 120.948 0.404 . . . . 0.0 110.505 -179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.1 36.45 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.454 -0.879 . . . . 0.0 113.057 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 10.0 tptt -146.52 7.01 0.97 Allowed 'General case' 0 C--N 1.332 -0.189 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.449 ' CE ' ' CD1' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -141.33 174.24 10.73 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 120.75 0.31 . . . . 0.0 110.844 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.77 HG23 ' H ' ' A' ' 68' ' ' PHE . 23.9 m -68.35 154.48 8.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.804 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.584 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -59.65 -46.94 98.59 Favored Pre-proline 0 C--N 1.329 -0.321 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -179.069 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 17.5 Cg_endo -64.45 -41.22 21.07 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 121.937 1.758 . . . . 0.0 112.155 -179.257 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.77 ' H ' HG23 ' A' ' 65' ' ' VAL . 26.2 t80 -74.98 -51.4 13.76 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.918 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -56.77 -32.31 65.5 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.797 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.438 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 11.6 t70 -63.82 -51.21 65.76 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.109 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.804 ' HB3' HD12 ' A' ' 93' ' ' ILE . . . -74.9 -10.02 59.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.756 -179.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.517 ' HB1' ' HE1' ' A' ' 59' ' ' PHE . . . -65.46 -50.01 66.98 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.727 0.299 . . . . 0.0 111.497 -179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.656 ' HB3' HD13 ' A' ' 10' ' ' ILE . 6.2 p90 -93.33 16.51 13.13 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.464 -179.623 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.526 ' C ' HD23 ' A' ' 75' ' ' LEU . 4.4 ttm-85 -96.57 -31.9 12.52 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.658 0.266 . . . . 0.0 111.226 -179.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.704 HD12 ' O ' ' A' ' 79' ' ' GLU . 0.7 OUTLIER -103.37 55.88 0.75 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.385 -179.792 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 14.9 mt-30 -58.83 -22.21 58.26 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.089 0.471 . . . . 0.0 110.029 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -69.07 -28.43 39.22 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 CA-C-N 115.729 -0.668 . . . . 0.0 110.435 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.489 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 97.05 59.09 1.0 Allowed Glycine 0 CA--C 1.508 -0.397 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.303 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.704 ' O ' HD12 ' A' ' 75' ' ' LEU . 5.6 pt-20 -130.22 177.38 7.36 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.628 HG11 ' HA ' ' A' ' 27' ' ' GLN . 21.7 t -88.65 148.41 4.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.695 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.646 ' OG ' HD21 ' A' ' 75' ' ' LEU . 0.6 OUTLIER -104.42 164.03 12.02 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.136 0.493 . . . . 0.0 111.282 -178.883 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.503 ' O ' HG23 ' A' ' 84' ' ' VAL . 3.1 mp0 -50.43 154.76 2.04 Favored Pre-proline 0 C--N 1.328 -0.358 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.866 -178.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.568 ' HG3' HD23 ' A' ' 24' ' ' LEU . 14.1 Cg_endo -55.58 104.53 0.13 Allowed 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.367 2.045 . . . . 0.0 111.721 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.555 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 94.3 t -101.64 101.54 12.26 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.684 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.456 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 19.2 tptp -95.54 112.49 24.2 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.573 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.9 m -112.5 -176.97 3.04 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.468 179.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.81 -22.33 14.08 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.367 -0.378 . . . . 0.0 110.939 179.712 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -85.94 -27.57 24.85 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.331 -179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 139.5 -170.71 24.06 Favored Glycine 0 C--N 1.33 0.234 0 C-N-CA 120.483 -0.865 . . . . 0.0 112.823 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.484 ' CD1' ' HB3' ' A' ' 20' ' ' GLN . 0.5 OUTLIER -74.56 100.78 4.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-O 121.045 0.45 . . . . 0.0 109.927 179.974 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.901 ' CD2' HD13 ' A' ' 16' ' ' LEU . 10.3 m80 -87.35 169.31 12.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.586 0.707 . . . . 0.0 112.742 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . . . . . . . . . 34.1 t -146.76 136.29 16.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 114.613 -1.176 . . . . 0.0 109.119 178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.929 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -126.58 122.5 61.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -178.352 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.571 ' HE3' HD12 ' A' ' 30' ' ' LEU . 22.0 tptp -128.54 110.33 12.18 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.456 178.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.588 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.0 OUTLIER -57.62 134.36 56.1 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.596 0.713 . . . . 0.0 112.195 -177.89 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.76 HD22 ' CZ ' ' A' ' 36' ' ' PHE . 0.3 OUTLIER -153.8 116.4 4.42 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 114.755 -1.111 . . . . 0.0 109.593 179.598 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.428 ' HA3' ' HD3' ' A' ' 11' ' ' LYS . . . . . . . . 0 C--O 1.249 1.087 0 CA-C-O 118.424 -1.209 . . . . 0.0 112.541 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.231 0 N-CA-C 112.518 -0.233 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -68.14 151.85 76.78 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.579 2.186 . . . . 0.0 112.257 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 5.0 mtp -85.25 149.49 25.45 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.967 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 68.1 20.62 73.09 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.762 -0.733 . . . . 0.0 112.665 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 97.3 p -88.43 123.38 32.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.905 0.384 . . . . 0.0 111.007 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 1.2 mtt -108.29 129.23 55.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.547 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -142.07 26.87 1.82 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.606 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.501 ' CB ' ' HE3' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -59.49 -22.13 61.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.818 0.342 . . . . 0.0 110.595 179.642 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.681 ' HB3' ' N ' ' A' ' 59' ' ' PHE . 0.0 OUTLIER -83.96 172.95 11.59 Favored 'General case' 0 N--CA 1.446 -0.65 0 CA-C-O 121.442 0.639 . . . . 0.0 111.933 -179.545 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.605 HG22 ' SG ' ' A' ' 12' ' ' CYS . 1.5 mt -111.0 136.93 45.52 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-N 114.967 -1.015 . . . . 0.0 108.944 178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.506 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.4 mtpt -108.11 86.71 2.34 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.577 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.818 ' O ' ' HB2' ' A' ' 56' ' ' LEU . 7.1 m -130.58 179.98 5.63 Favored 'General case' 0 N--CA 1.453 -0.308 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.636 -179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.449 ' HB2' ' CE2' ' A' ' 36' ' ' PHE . 2.9 p -135.33 161.76 34.49 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.789 ' O ' HD12 ' A' ' 15' ' ' ILE . 0.7 OUTLIER -141.24 155.49 46.01 Favored 'General case' 0 N--CA 1.463 0.19 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -179.196 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.789 HD12 ' O ' ' A' ' 14' ' ' HIS . 1.7 mp -134.95 141.81 41.97 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 CA-C-N 114.918 -1.037 . . . . 0.0 109.863 179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.74 HD11 ' CE1' ' A' ' 91' ' ' HIS . 1.0 OUTLIER -121.48 128.84 52.51 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.77 0.319 . . . . 0.0 111.723 -179.499 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.839 HG21 ' CG ' ' A' ' 22' ' ' GLU . 24.7 m -144.12 134.21 20.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.465 179.072 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.538 ' CD ' HD13 ' A' ' 45' ' ' ILE . 0.1 OUTLIER -70.12 -36.27 74.7 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 120.89 -0.324 . . . . 0.0 110.732 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.612 ' HG3' ' HG2' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -72.09 78.55 0.94 Allowed 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 178.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.474 ' HB3' ' CD1' ' A' ' 90' ' ' TYR . 0.2 OUTLIER -46.67 -25.98 0.83 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.714 -1.13 . . . . 0.0 113.191 -177.584 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -67.39 -31.31 76.61 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 119.086 -1.531 . . . . 0.0 111.091 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.89 ' O ' HG13 ' A' ' 26' ' ' VAL . 0.1 OUTLIER -70.25 -39.91 74.74 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.142 0.496 . . . . 0.0 110.03 178.568 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.679 ' N ' ' HG3' ' A' ' 22' ' ' GLU . . . -51.15 -37.16 44.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.471 -0.786 . . . . 0.0 110.227 179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.627 ' O ' ' HG2' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -73.41 -29.46 62.6 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.922 179.17 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -85.66 -42.53 14.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.31 -0.404 . . . . 0.0 111.484 -179.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.89 HG13 ' O ' ' A' ' 22' ' ' GLU . 2.7 m -53.4 -39.17 34.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.881 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.627 ' HG2' ' O ' ' A' ' 24' ' ' LEU . 2.5 pt20 -56.33 -50.19 72.17 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.589 -0.522 . . . . 0.0 109.589 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.596 ' N ' ' HG3' ' A' ' 27' ' ' GLN . 4.6 pt-20 -73.36 -30.98 63.68 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.803 178.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.418 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 3.9 tpm_? -77.18 -27.52 53.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.373 -0.831 . . . . 0.0 112.011 -178.51 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.676 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.8 OUTLIER -60.78 -52.76 63.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.419 -179.101 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.405 ' HD3' ' O ' ' A' ' 27' ' ' GLN . 0.0 OUTLIER -68.57 -9.4 49.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.525 -179.897 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.418 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -56.28 -22.05 27.76 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.761 0.315 . . . . 0.0 111.387 -179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 137.37 -10.73 3.8 Favored Glycine 0 N--CA 1.443 -0.835 0 C-N-CA 120.871 -0.68 . . . . 0.0 112.387 -179.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 24.1 pt-20 -77.81 157.46 29.93 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.823 0.344 . . . . 0.0 110.928 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.411 ' HB3' ' HG2' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -89.12 136.01 33.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.789 179.969 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.676 ' HA ' HD21 ' A' ' 30' ' ' LEU . 4.8 t80 -53.94 -48.15 70.55 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.236 -179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . -54.26 -33.9 53.03 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.293 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 3.0 mmmt -60.33 -52.26 66.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.707 0.289 . . . . 0.0 110.873 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.965 HD12 HD11 ' A' ' 43' ' ' LEU . 2.9 mm? -53.34 -33.54 53.91 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.885 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.561 ' HB1' ' O ' ' A' ' 50' ' ' ALA . . . -51.45 -53.81 33.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.074 0.464 . . . . 0.0 110.582 -179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.8 pttt -85.94 -23.66 26.87 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.059 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.848 ' HB3' HD13 ' A' ' 43' ' ' LEU . 0.2 OUTLIER -69.12 -68.35 0.41 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -177.941 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.965 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.21 -15.43 9.18 Favored 'General case' 0 N--CA 1.468 0.43 0 N-CA-C 112.565 0.58 . . . . 0.0 112.565 -179.72 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.532 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -64.28 134.5 54.83 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.115 0.483 . . . . 0.0 111.14 -179.588 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.538 HD13 ' CD ' ' A' ' 18' ' ' LYS . 1.3 pt -97.26 -8.77 9.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.172 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.795 ' HB3' ' HB2' ' A' ' 50' ' ' ALA . 6.0 t0 -46.42 135.25 8.42 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.977 179.719 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.629 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.44 -178.86 3.85 Favored Glycine 0 C--O 1.225 -0.427 0 C-N-CA 120.979 -0.629 . . . . 0.0 112.441 -179.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 47' ' ' GLY . . . -11.83 -46.02 0.0 OUTLIER Glycine 0 N--CA 1.467 0.763 0 N-CA-C 115.563 0.985 . . . . 0.0 115.563 -178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.629 ' N ' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -51.42 -34.56 35.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.454 0.627 . . . . 0.0 111.342 -179.848 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.795 ' HB2' ' HB3' ' A' ' 46' ' ' ASP . . . -71.21 -21.16 62.17 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.076 179.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.418 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 0.0 OUTLIER -77.0 -6.1 51.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.522 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.419 ' O ' ' OD2' ' A' ' 53' ' ' ASP . 0.3 OUTLIER -104.15 24.09 12.01 Favored 'General case' 0 N--CA 1.45 -0.473 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.406 179.681 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.434 ' O ' ' OD1' ' A' ' 53' ' ' ASP . 0.0 OUTLIER 72.04 12.87 5.96 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.354 -179.783 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 59.59 21.6 54.99 Favored Glycine 0 C--N 1.333 0.377 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.535 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 1.2 m -74.7 84.7 2.12 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.972 0.415 . . . . 0.0 110.548 179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.818 ' HB2' ' O ' ' A' ' 12' ' ' CYS . 20.4 mt -59.43 -20.24 53.54 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.883 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 49.06 -170.94 0.08 OUTLIER Glycine 0 C--N 1.333 0.398 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.57 179.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.506 ' CD2' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -56.17 111.4 0.95 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.038 0.447 . . . . 0.0 111.678 -179.247 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.681 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 2.3 m-85 -128.48 164.37 22.91 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.265 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.08 -174.09 13.65 Favored Glycine 0 C--N 1.317 -0.528 0 C-N-CA 120.022 -1.085 . . . . 0.0 112.159 179.543 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 14.0 ptt180 -86.48 116.38 24.58 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-O 120.922 0.392 . . . . 0.0 110.023 -179.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.28 -12.05 1.38 Allowed Glycine 0 N--CA 1.442 -0.961 0 C-N-CA 120.082 -1.056 . . . . 0.0 113.357 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.43 30.78 4.42 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-N 117.031 0.415 . . . . 0.0 111.754 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.425 ' HG3' ' CG ' ' A' ' 69' ' ' GLU . 0.0 OUTLIER -151.36 149.37 29.25 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.804 0.335 . . . . 0.0 111.191 179.433 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.753 HG23 ' H ' ' A' ' 68' ' ' PHE . 33.4 m -52.6 156.26 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.197 -179.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.565 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 0.0 OUTLIER -58.15 -47.8 98.2 Favored Pre-proline 0 C--N 1.328 -0.344 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.022 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 18.8 Cg_endo -65.43 -38.8 24.43 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.061 1.841 . . . . 0.0 112.367 -179.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.753 ' H ' HG23 ' A' ' 65' ' ' VAL . 18.1 t80 -74.92 -49.8 19.01 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.475 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.425 ' CG ' ' HG3' ' A' ' 64' ' ' MET . 0.2 OUTLIER -54.5 -35.8 63.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.21 179.566 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.429 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 6.8 t70 -68.67 -49.94 55.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.798 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.94 -10.68 59.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.659 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.453 ' HB1' HD12 ' A' ' 10' ' ' ILE . . . -65.1 -45.48 85.04 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.722 0.296 . . . . 0.0 111.618 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.429 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 1.4 p90 -99.33 16.94 21.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.712 -179.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -95.07 -28.66 14.99 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.75 0.31 . . . . 0.0 110.918 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.551 HD12 ' O ' ' A' ' 79' ' ' GLU . 2.7 mt -103.7 65.37 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.026 0.441 . . . . 0.0 111.678 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 6.0 mt-30 -74.32 -17.65 60.81 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.938 178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.0 p -67.66 -26.82 36.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.842 179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.578 ' HA2' ' HB3' ' A' ' 95' ' ' ARG . . . 96.06 59.14 1.06 Allowed Glycine 0 CA--C 1.503 -0.672 0 C-N-CA 120.442 -0.885 . . . . 0.0 111.393 -179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.551 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.8 OUTLIER -140.5 176.24 8.94 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 120.931 0.395 . . . . 0.0 111.007 -178.253 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.601 HG11 ' HA ' ' A' ' 27' ' ' GLN . 38.4 t -83.75 147.76 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 CA-C-N 116.046 -0.525 . . . . 0.0 109.962 178.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -104.66 159.09 16.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.224 0.535 . . . . 0.0 111.197 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -50.61 159.49 0.89 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.077 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.561 ' HG3' HD23 ' A' ' 24' ' ' LEU . 18.9 Cg_endo -59.02 104.08 0.19 Allowed 'Trans proline' 0 N--CA 1.461 -0.432 0 C-N-CA 122.474 2.116 . . . . 0.0 111.913 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.55 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 95.7 t -101.54 102.52 13.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.682 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.478 ' HB2' ' CE1' ' A' ' 90' ' ' TYR . 5.5 tptp -91.86 112.95 25.08 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.859 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -107.25 -173.12 2.21 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.418 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -62.18 -16.2 51.46 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.064 179.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 3.6 m-85 -93.56 -38.76 11.21 Favored 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.534 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 159.97 -168.74 35.75 Favored Glycine 0 C--N 1.333 0.37 0 C-N-CA 120.438 -0.887 . . . . 0.0 112.898 -179.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.478 ' CE1' ' HB2' ' A' ' 85' ' ' LYS . 0.3 OUTLIER -77.0 99.53 5.32 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.74 ' CE1' HD11 ' A' ' 16' ' ' LEU . 17.1 m80 -88.42 165.27 15.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.45 0.643 . . . . 0.0 112.734 -178.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.484 ' CG1' HG13 ' A' ' 80' ' ' VAL . 40.5 t -143.79 152.39 16.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 114.806 -1.088 . . . . 0.0 109.117 179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.605 HG23 ' CZ ' ' A' ' 68' ' ' PHE . 0.1 OUTLIER -139.59 122.05 17.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 N-CA-C 112.921 0.711 . . . . 0.0 112.921 -179.045 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.521 ' HB2' ' CE1' ' A' ' 36' ' ' PHE . 0.0 OUTLIER -129.37 108.69 10.48 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.427 -0.806 . . . . 0.0 109.955 178.051 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.578 ' HB3' ' HA2' ' A' ' 78' ' ' GLY . 6.9 ttt85 -58.11 135.68 57.07 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.642 0.734 . . . . 0.0 112.275 -178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.546 ' O ' ' HG ' ' A' ' 96' ' ' LEU . 0.4 OUTLIER -154.3 116.48 4.28 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 114.487 -1.233 . . . . 0.0 109.24 179.415 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.378 -1.234 . . . . 0.0 112.586 179.912 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.179 0 N-CA-C 112.448 -0.261 . . . . 0.0 112.448 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -54.96 140.5 79.52 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.459 2.106 . . . . 0.0 112.254 -179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.4 137.32 58.16 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.968 179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 146.61 -18.25 1.65 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.925 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.1 p -62.31 132.83 53.96 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.837 0.351 . . . . 0.0 111.065 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' MET . . . . . . . . . . . . . 5.0 ptt? -179.25 -174.1 0.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.829 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -91.79 32.35 1.12 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.268 179.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASP . . . . . 0.439 ' C ' ' HE3' ' A' ' 9' ' ' LYS . 29.8 t70 -56.39 -25.93 51.41 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.675 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LYS . . . . . 0.538 ' HB2' ' HB3' ' A' ' 58' ' ' TYR . 0.0 OUTLIER -84.2 164.98 18.78 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.128 -179.623 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -111.41 138.35 40.27 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.654 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.029 178.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.461 ' HG2' ' CD2' ' A' ' 58' ' ' TYR . 1.6 mtpt -108.72 96.16 6.15 Favored 'General case' 0 C--N 1.31 -1.124 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.067 -179.182 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' CYS . . . . . 0.914 ' SG ' HG22 ' A' ' 93' ' ' ILE . 2.4 t -127.7 179.39 5.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.273 -178.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.789 ' HB2' HD23 ' A' ' 96' ' ' LEU . 2.7 t -126.37 159.79 32.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' HIS . . . . . 0.787 ' CG ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -136.66 150.88 48.73 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.405 0.621 . . . . 0.0 112.553 -179.405 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.597 HD12 ' C ' ' A' ' 14' ' ' HIS . 3.5 mp -153.27 115.34 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.009 179.595 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.907 HD21 ' CD2' ' A' ' 91' ' ' HIS . 0.9 OUTLIER -100.1 139.09 36.27 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -178.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.983 HG21 ' CG ' ' A' ' 22' ' ' GLU . 30.0 m -155.22 134.19 3.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.793 177.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.96 -19.31 65.9 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 178.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.571 ' HB3' ' HB3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -72.38 78.36 1.02 Allowed 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.149 179.093 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.46 ' HB2' ' CZ ' ' A' ' 90' ' ' TYR . 5.8 pt20 -47.34 -40.0 16.27 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -178.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -71.32 -31.14 66.27 Favored Glycine 0 CA--C 1.511 -0.19 0 C-N-CA 119.925 -1.131 . . . . 0.0 112.697 -179.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.983 ' CG ' HG21 ' A' ' 17' ' ' VAL . 0.0 OUTLIER -65.6 -39.79 91.94 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.339 0.59 . . . . 0.0 110.253 179.525 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.761 ' O ' ' HG3' ' A' ' 27' ' ' GLN . . . -43.8 -42.16 5.42 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.387 -179.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.57 ' HA ' ' HG3' ' A' ' 27' ' ' GLN . 0.2 OUTLIER -72.66 -45.47 58.77 Favored 'General case' 0 N--CA 1.465 0.275 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.266 178.215 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -52.0 -57.31 9.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.694 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 23' ' ' ALA . 4.8 m -55.07 -30.42 23.82 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.263 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.684 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLN . . . . . 0.776 ' HG2' HG11 ' A' ' 80' ' ' VAL . 52.9 mt-30 -53.04 -60.06 3.75 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.28 0.562 . . . . 0.0 109.939 179.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -26.03 61.88 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.82 179.407 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.514 ' O ' ' HB3' ' A' ' 32' ' ' ALA . 14.2 tpp85 -78.51 -30.31 47.09 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.023 -0.535 . . . . 0.0 112.094 -178.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.705 HD21 ' HA ' ' A' ' 36' ' ' PHE . 0.5 OUTLIER -56.7 -59.04 5.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.754 0.312 . . . . 0.0 110.932 -179.234 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.07 -9.3 58.21 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.322 179.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.514 ' HB3' ' O ' ' A' ' 29' ' ' ARG . . . -59.05 -25.81 64.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.996 0.427 . . . . 0.0 111.35 -179.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 150.99 -17.15 0.92 Allowed Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.491 -179.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.481 ' HG3' HD21 ' A' ' 39' ' ' LEU . 21.9 pt-20 -79.76 157.81 27.02 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.993 0.425 . . . . 0.0 110.816 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.2 tttt -96.23 137.07 35.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.079 -179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.705 ' HA ' HD21 ' A' ' 30' ' ' LEU . 2.4 p90 -47.61 -33.53 6.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.628 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . 0.513 ' HA3' ' HB2' ' A' ' 53' ' ' ASP . . . -65.28 -34.93 90.83 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.137 179.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.542 ' O ' ' HB2' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -60.16 -53.81 53.3 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.598 0.237 . . . . 0.0 110.592 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 1.004 HD12 HD11 ' A' ' 43' ' ' LEU . 2.6 mm? -55.68 -34.36 64.96 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.803 179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.575 ' HA ' ' HB2' ' A' ' 44' ' ' SER . . . -51.3 -53.77 32.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.029 0.442 . . . . 0.0 110.503 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.4 mtmp? -85.97 -23.63 26.82 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.18 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.846 ' HB3' HD13 ' A' ' 43' ' ' LEU . 1.0 OUTLIER -70.14 -68.7 0.4 Allowed 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 113.186 0.809 . . . . 0.0 113.186 -177.721 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 1.004 HD11 HD12 ' A' ' 39' ' ' LEU . 0.0 OUTLIER -119.54 -11.36 9.47 Favored 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 112.78 0.659 . . . . 0.0 112.78 -179.531 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.575 ' HB2' ' HA ' ' A' ' 40' ' ' ALA . 0.1 OUTLIER -63.58 134.46 55.54 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.273 0.559 . . . . 0.0 111.333 -179.165 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 16' ' ' LEU . 25.1 pt -94.7 -17.45 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.345 0 CA-C-N 115.443 -0.799 . . . . 0.0 111.358 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -45.78 134.25 7.75 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 121.106 0.479 . . . . 0.0 111.079 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.668 ' O ' ' N ' ' A' ' 49' ' ' SER . . . -62.89 -178.62 4.19 Favored Glycine 0 N--CA 1.451 -0.345 0 CA-C-N 115.644 -0.707 . . . . 0.0 112.939 -179.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.451 ' O ' ' HB2' ' A' ' 51' ' ' LYS . . . -12.91 -42.2 0.0 OUTLIER Glycine 0 C--N 1.339 0.737 0 N-CA-C 115.349 0.9 . . . . 0.0 115.349 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . 0.668 ' N ' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER -51.21 -21.07 1.83 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 117.333 0.567 . . . . 0.0 111.484 -179.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . . . . . . . . . . . -70.71 -21.04 62.6 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.797 0.332 . . . . 0.0 110.924 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 48' ' ' GLY . 2.8 mttt -68.36 -2.95 9.51 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.972 -179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.466 ' O ' ' CG ' ' A' ' 53' ' ' ASP . 0.2 OUTLIER -103.65 24.78 10.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.697 0.284 . . . . 0.0 110.539 179.767 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.513 ' HB2' ' HA3' ' A' ' 37' ' ' GLY . 1.5 p30 59.58 29.62 19.19 Favored 'General case' 0 N--CA 1.461 0.118 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.189 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 13' ' ' SER . . . 53.78 23.35 21.67 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.841 179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.92 89.96 4.73 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.809 0.338 . . . . 0.0 110.825 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.787 HD21 ' CG ' ' A' ' 14' ' ' HIS . 87.0 mt -58.37 -28.83 65.51 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.58 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 61.42 -166.26 15.74 Favored Glycine 0 N--CA 1.449 -0.492 0 C-N-CA 120.701 -0.762 . . . . 0.0 111.991 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . 0.538 ' HB3' ' HB2' ' A' ' 9' ' ' LYS . 0.1 OUTLIER -65.14 117.59 7.97 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.117 0.484 . . . . 0.0 111.749 -179.474 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.514 ' N ' ' HB3' ' A' ' 9' ' ' LYS . 5.3 m-85 -128.44 158.63 37.79 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.977 -0.749 . . . . 0.0 108.977 177.568 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -128.52 -173.95 13.59 Favored Glycine 0 C--N 1.317 -0.49 0 C-N-CA 120.199 -1.0 . . . . 0.0 112.497 -179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.09 84.57 2.32 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-O 121.044 0.45 . . . . 0.0 110.126 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 147.42 36.85 0.05 OUTLIER Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.362 -0.923 . . . . 0.0 113.063 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.05 -48.67 0.61 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.637 0.256 . . . . 0.0 111.292 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -99.55 169.84 9.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.937 0.399 . . . . 0.0 111.306 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.772 HG23 ' H ' ' A' ' 68' ' ' PHE . 35.9 m -59.43 165.1 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.965 179.734 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.555 ' N ' ' HD2' ' A' ' 67' ' ' PRO . 7.5 ttpt -62.73 -48.01 86.58 Favored Pre-proline 0 C--N 1.328 -0.348 0 N-CA-C 112.651 0.611 . . . . 0.0 112.651 -179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 66' ' ' LYS . 15.2 Cg_endo -65.36 -39.34 22.75 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 121.863 1.709 . . . . 0.0 111.897 -179.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.772 ' H ' HG23 ' A' ' 65' ' ' VAL . 24.5 t80 -75.0 -52.49 10.98 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.98 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 4.8 tm-20 -57.52 -32.66 67.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.862 -179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 73' ' ' PHE . 1.9 m-20 -63.7 -50.56 68.69 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.049 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.51 ' HB3' ' CD1' ' A' ' 93' ' ' ILE . . . -75.3 -9.49 58.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.798 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -65.42 -47.52 75.98 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.85 0.357 . . . . 0.0 111.602 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PHE . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 70' ' ' ASP . 11.4 p90 -93.89 16.78 13.46 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.535 -179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -97.98 -30.39 12.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.93 -179.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.53 HD11 ' O ' ' A' ' 80' ' ' VAL . 3.9 mt -103.49 68.08 0.93 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.471 -179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . . . . . . . . . 10.4 mt-30 -72.8 -19.28 61.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.096 178.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 2.2 p -65.86 -26.67 39.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 115.615 -0.721 . . . . 0.0 110.725 179.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLY . . . . . 0.445 ' HA2' ' CB ' ' A' ' 95' ' ' ARG . . . 94.66 59.44 1.14 Allowed Glycine 0 N--CA 1.446 -0.669 0 C-N-CA 120.596 -0.812 . . . . 0.0 111.57 -179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.511 ' O ' HD12 ' A' ' 75' ' ' LEU . 1.7 tm-20 -141.03 176.34 8.9 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.826 0.346 . . . . 0.0 111.104 -178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.776 HG11 ' HG2' ' A' ' 27' ' ' GLN . 26.9 t -81.01 146.6 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.563 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.84 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.2 t -104.66 164.11 12.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.258 0.551 . . . . 0.0 111.583 -178.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.4 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.0 mp0 -50.51 152.1 3.52 Favored Pre-proline 0 C--O 1.235 0.326 0 CA-C-N 115.309 -0.86 . . . . 0.0 112.463 -178.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.474 ' HB2' ' CE2' ' A' ' 90' ' ' TYR . 19.5 Cg_endo -58.46 106.09 0.25 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 122.466 2.111 . . . . 0.0 111.65 179.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.549 ' CG1' ' HB2' ' A' ' 67' ' ' PRO . 93.0 t -100.96 101.14 11.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.593 -179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . 0.446 ' HB2' ' CD1' ' A' ' 90' ' ' TYR . 4.8 tptm -91.63 112.8 24.87 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.757 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.1 m -114.73 -171.95 2.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.578 179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -60.35 -18.62 51.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.184 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -90.91 -24.48 20.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.467 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 141.48 -161.66 26.96 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.536 -0.84 . . . . 0.0 112.784 -179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.541 ' O ' HD13 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -83.02 98.14 9.11 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 179.739 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' HIS . . . . . 0.907 ' CD2' HD21 ' A' ' 16' ' ' LEU . 9.8 m80 -81.49 154.35 26.37 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.735 -0.666 . . . . 0.0 112.481 -178.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' A' ' 14' ' ' HIS . 37.2 t -139.71 135.84 39.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.296 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . 0.914 HG22 ' SG ' ' A' ' 12' ' ' CYS . 0.1 OUTLIER -123.84 122.52 64.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.423 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.523 ' HG2' HG22 ' A' ' 80' ' ' VAL . 0.0 OUTLIER -128.2 112.69 14.8 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.197 178.36 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.552 ' HA ' ' HA ' ' A' ' 12' ' ' CYS . 0.3 OUTLIER -57.34 136.45 56.57 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.705 0.764 . . . . 0.0 112.517 -177.436 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.789 HD23 ' HB2' ' A' ' 13' ' ' SER . 0.3 OUTLIER -157.69 116.73 3.23 Favored 'General case' 0 N--CA 1.438 -1.03 0 CA-C-N 114.469 -1.241 . . . . 0.0 109.616 179.595 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.137 0 CA-C-O 118.352 -1.249 . . . . 0.0 112.554 179.93 . . . . . . . . 0 0 . 1 stop_ save_